S8338131B2	NNP	O
-	:	O
Amylases	NNS	O
and	CC	O
methods	NNS	O
for	IN	O
use	NN	O
in	IN	O
starch	NN	O
processing	NN	O
-	:	O
Google	NN	O
Patents	NNS	O
Info	NNP	O
Links	NNP	O
Images	NNP	O
Classifications	NNP	O
Abstract	NNP	O
Description	NNP	O
CROSS-REFERENCE	NNP	O
TO	NNP	O
RELATED	NNP	O
APPLICATIONS	NNP	O
This	DT	O
application	NN	O
is	VBZ	O
a	DT	O
continuation	NN	O
of	IN	O
U.S.	NNP	O
patent	NN	O
application	NN	O
Ser.	.	O
No.	.	O
10/489,510,	,	O
filed	VBD	O
Jan.	NNP	O
12,	,	O
2005,	,	O
now	RB	O
pending,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
Continuation-in-Part	NNP	O
of	IN	O
U.S.	NNP	O
Ser.	.	O
No.	.	O
10/105,733,	,	O
filed	VBN	O
Mar.	.	O
22,	,	O
2002,	,	O
now	RB	O
U.S.	NNP	O
Pat.	.	O
No.	.	O
7,323,336,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
Continuation-in-Part	NNP	O
of	IN	O
U.S.	NNP	O
Ser.	.	O
No.	.	O
10/081,739,	,	O
filed	VBD	O
Feb.	NNP	O
21,	,	O
2002,	,	O
now	RB	O
U.S.	NNP	O
Pat.	.	O
No.	.	O
7,273,740,	,	O
which	WDT	O
claims	VBZ	O
the	DT	O
benefit	NN	O
of	IN	O
priority	NN	O
under	IN	O
35	CD	O
U.S.C.	.	O
§119(e)	)	O
of	IN	O
60/270,495,	,	O
filed	VBD	O
Feb.	NNP	O
21,	,	O
2001;	:	O
U.S.	NNP	O
Ser.	.	O
No.	.	O
60/270,496,	,	O
filed	VBD	O
Feb.	NNP	O
21,	,	O
2001;	:	O
and	CC	O
U.S.	NNP	O
Ser.	.	O
No.	.	O
60/291,122,	,	O
filed	VBD	O
May	NNP	O
14,	,	O
2001,	,	O
now	RB	O
pending.	.	O
Each	DT	O
of	IN	O
the	DT	O
aforementioned	JJ	O
applications	NNS	O
are	VBP	O
explicitly	RB	O
incorporated	VBN	O
herein	NN	O
by	IN	O
reference	NN	O
in	IN	O
their	PRP$	O
entirety	NN	O
and	CC	O
for	IN	O
all	DT	O
purposes.	.	O
REFERENCE	NNP	O
TO	NNP	O
SEQUENCE	NNP	O
LISTING	NNP	O
SUBMITTED	NNP	O
VIA	NNP	O
EFS-WEB	NNP	O
The	DT	O
entire	JJ	O
content	NN	O
of	IN	O
the	DT	O
following	JJ	O
electronic	JJ	O
submission	NN	O
of	IN	O
the	DT	O
sequence	NN	O
listing	NN	O
via	IN	O
the	DT	O
USPTO	NNP	O
EFS-WEB	NNP	O
server,	,	O
as	IN	O
authorized	JJ	O
and	CC	O
set	VBD	O
forth	NN	O
in	IN	O
MPEP	NNP	O
§1730	NNP	O
II.B.2(a)(C),	,	O
is	VBZ	O
incorporated	VBN	O
herein	NN	O
by	IN	O
reference	NN	O
in	IN	O
its	PRP$	O
entirety	NN	O
for	IN	O
all	DT	O
purposes.	.	O
The	DT	O
sequence	NN	O
listing	NN	O
is	VBZ	O
identified	VBN	O
on	IN	O
the	DT	O
electronically	RB	O
filed	VBN	O
text	NN	O
file	NN	O
as	IN	O
follows:	:	O
TECHNICAL	JJ	O
FIELD	NNP	O
This	DT	O
invention	NN	O
relates	VBZ	O
to	TO	O
molecular	VB	O
and	CC	O
cellular	JJ	O
biology	NN	O
and	CC	O
biochemistry.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
invention	NN	O
is	VBZ	O
directed	VBN	O
to	TO	O
polypeptides	VB	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
e.g.,	,	O
alpha	JJ	O
amylase	NN	O
activity,	,	O
polynucleotides	VBZ	O
encoding	VBG	O
the	DT	O
polypeptides,	,	O
and	CC	O
methods	NNS	O
for	IN	O
making	VBG	O
and	CC	O
using	VBG	O
these	DT	O
polynucleotides	NNS	O
and	CC	O
polypeptides.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
as	IN	O
amylases,	,	O
for	IN	O
example,	,	O
alpha	NN	O
amylases,	,	O
to	TO	O
catalyze	VB	O
the	DT	O
hydrolysis	NN	O
of	IN	O
starch	NN	O
into	IN	O
sugars.	.	O
BACKGROUND	NNP	O
Starch	NNP	O
is	VBZ	O
a	DT	O
complex	JJ	O
carbohydrate	NN	O
often	RB	O
found	VBN	O
in	IN	O
the	DT	O
human	JJ	O
diet.	.	O
The	DT	O
structure	NN	O
of	IN	O
starch	NN	O
is	VBZ	O
glucose	JJ	O
polymers	NNS	O
linked	VBN	O
by	IN	O
α-1,4	JJ	O
and	CC	O
α-1,6	JJ	O
glucosidic	JJ	O
bonds.	.	O
Amylase	NNP	O
is	VBZ	O
an	DT	O
enzyme	NN	O
that	WDT	O
catalyzes	VBZ	O
the	DT	O
hydrolysis	NN	O
of	IN	O
starches	NNS	O
into	IN	O
sugars.	.	O
Amylases	NNS	O
hydrolyze	VBP	O
internal	JJ	O
Amylases	NNS	O
are	VBP	O
produced	VBN	O
by	IN	O
a	DT	O
wide	JJ	O
variety	NN	O
of	IN	O
microorganisms	NNS	O
including	VBG	O
Bacillus	NNP	O
and	CC	O
Aspergillus,	,	O
with	IN	O
most	JJS	O
commercial	JJ	O
amylases	NNS	O
being	VBG	O
produced	VBN	O
from	IN	O
bacterial	JJ	O
sources	NNS	O
such	JJ	O
as	IN	O
Bacillus	NNP	O
licheniformis,	,	O
Bacillus	NNP	O
amyloliquefaciens,	,	O
Bacillus	NNP	O
subtilis,	,	O
or	CC	O
Bacillus	NNP	O
stearothermophilus.	.	O
In	IN	O
recent	JJ	O
years,	,	O
the	DT	O
enzymes	NNS	O
in	IN	O
commercial	JJ	O
use	NN	O
have	VBP	O
been	VBN	O
those	DT	O
from	IN	O
Bacillus	CC	O
licheniformis	JJ	O
because	IN	O
of	IN	O
their	PRP$	O
heat	NN	O
stability	NN	O
and	CC	O
performance,	,	O
at	IN	O
least	JJS	O
at	IN	O
neutral	JJ	O
and	CC	O
mildly	RB	O
alkaline	JJ	O
pHs.	.	O
In	IN	O
general,	,	O
starch	NN	O
to	TO	O
fructose	VB	O
processing	VBG	O
consists	NNS	O
of	IN	O
four	CD	O
steps:	:	O
liquefaction	NN	O
of	IN	O
granular	JJ	O
starch,	,	O
saccharification	NN	O
of	IN	O
the	DT	O
liquefied	JJ	O
starch	NN	O
into	IN	O
dextrose,	,	O
purification,	,	O
and	CC	O
isomerization	NN	O
to	TO	O
fructose.	.	O
The	DT	O
object	NN	O
of	IN	O
a	DT	O
starch	JJ	O
liquefaction	NN	O
process	NN	O
is	VBZ	O
to	TO	O
convert	VB	O
a	DT	O
concentrated	JJ	O
suspension	NN	O
of	IN	O
starch	NN	O
polymer	NN	O
granules	NNS	O
into	IN	O
a	DT	O
solution	NN	O
of	IN	O
soluble	JJ	O
shorter	NN	O
chain	NN	O
length	NN	O
dextrins	NNS	O
of	IN	O
low	JJ	O
viscosity.	.	O
This	DT	O
step	NN	O
is	VBZ	O
essential	JJ	O
for	IN	O
convenient	NN	O
handling	VBG	O
with	IN	O
standard	JJ	O
equipment	NN	O
and	CC	O
for	IN	O
efficient	JJ	O
conversion	NN	O
to	TO	O
glucose	VB	O
or	CC	O
other	JJ	O
sugars.	.	O
To	TO	O
liquefy	VB	O
granular	JJ	O
starch,	,	O
it	PRP	O
is	VBZ	O
necessary	JJ	O
to	TO	O
gelatinize	VB	O
the	DT	O
granules	NNS	O
by	IN	O
raising	VBG	O
the	DT	O
temperature	NN	O
of	IN	O
the	DT	O
granular	JJ	O
starch	NN	O
to	TO	O
over	VB	O
about	IN	O
72°	CD	O
C.	NNP	O
The	DT	O
heating	NN	O
process	NN	O
instantaneously	RB	O
disrupts	VBZ	O
the	DT	O
insoluble	JJ	O
starch	NN	O
granules	NNS	O
to	TO	O
produce	VB	O
a	DT	O
water	NN	O
soluble	JJ	O
starch	NN	O
solution.	.	O
The	DT	O
solubilized	VBN	O
starch	NN	O
solution	NN	O
is	VBZ	O
then	RB	O
liquefied	VBN	O
by	IN	O
amylase.	.	O
A	DT	O
starch	NN	O
granule	NN	O
is	VBZ	O
composed	VBN	O
of:	:	O
69-74%	NN	O
amylopectin,	,	O
26-31%	NN	O
amylose,	,	O
11-14%	NN	O
water,	,	O
0.2-0.4%	NN	O
protein,	,	O
0.5-0.9%	NN	O
lipid,	,	O
0.05-0.1%	NN	O
ash,	,	O
0.02-0.03%	NN	O
phosphorus,	,	O
0.1%	NN	O
pentosan.	.	O
Approximately	RB	O
70%	NN	O
of	IN	O
a	DT	O
granule	NN	O
is	VBZ	O
amorphous	JJ	O
and	CC	O
30%	NN	O
is	VBZ	O
crystalline.	.	O
A	DT	O
common	JJ	O
enzymatic	JJ	O
liquefaction	NN	O
process	NN	O
involves	VBZ	O
adjusting	VBG	O
the	DT	O
pH	NN	O
of	IN	O
a	DT	O
granular	JJ	O
starch	NN	O
slurry	NN	O
to	TO	O
between	IN	O
6.0	CD	O
and	CC	O
6.5,	,	O
the	DT	O
pH	NN	O
optimum	NN	O
of	IN	O
alpha-amylase	JJ	O
derived	VBN	O
from	IN	O
Bacillus	NNP	O
licheniformis,	,	O
with	IN	O
the	DT	O
addition	NN	O
of	IN	O
calcium	NN	O
hydroxide,	,	O
sodium	NN	O
hydroxide	NN	O
or	CC	O
sodium	NN	O
carbonate.	.	O
The	DT	O
addition	NN	O
of	IN	O
calcium	NN	O
hydroxide	NN	O
has	VBZ	O
the	DT	O
advantage	NN	O
of	IN	O
also	RB	O
providing	VBG	O
calcium	NN	O
ions	NNS	O
which	WDT	O
are	VBP	O
known	VBN	O
to	TO	O
stabilize	VB	O
the	DT	O
alpha-amylase	NN	O
against	IN	O
inactivation.	.	O
Upon	IN	O
addition	NN	O
of	IN	O
alpha-amylase,	,	O
the	DT	O
suspension	NN	O
is	VBZ	O
pumped	VBN	O
through	IN	O
a	DT	O
steam	NN	O
jet	NN	O
to	TO	O
instantaneously	RB	O
raise	VB	O
the	DT	O
temperature	NN	O
to	TO	O
between	IN	O
80°	CD	O
C.	NNP	O
to	TO	O
115°	CD	O
C.	NNP	O
The	DT	O
starch	NN	O
is	VBZ	O
immediately	RB	O
gelatinized	VBN	O
and,	,	O
due	JJ	O
to	TO	O
the	DT	O
presence	NN	O
of	IN	O
alpha-amylase,	,	O
depolymerized	VBN	O
through	IN	O
random	JJ	O
hydrolysis	NN	O
of	IN	O
a	DT	O
(1-4)	)	O
glycosidic	JJ	O
bonds	NNS	O
by	IN	O
alpha-amylase	NN	O
to	TO	O
a	DT	O
fluid	NN	O
mass	NN	O
which	WDT	O
is	VBZ	O
easily	RB	O
pumped.	.	O
In	IN	O
a	DT	O
second	JJ	O
variation	NN	O
to	TO	O
the	DT	O
liquefaction	NN	O
process,	,	O
alpha-amylase	NN	O
is	VBZ	O
added	VBN	O
to	TO	O
the	DT	O
starch	NN	O
suspension,	,	O
the	DT	O
suspension	NN	O
is	VBZ	O
held	VBN	O
at	IN	O
a	DT	O
temperature	NN	O
of	IN	O
80-100°	JJ	O
C.	NNP	O
to	TO	O
partially	RB	O
hydrolyze	VB	O
the	DT	O
starch	NN	O
granules,	,	O
and	CC	O
the	DT	O
partially	RB	O
hydrolyzed	VBN	O
starch	NN	O
suspension	NN	O
is	VBZ	O
pumped	VBN	O
through	IN	O
a	DT	O
jet	NN	O
at	IN	O
temperatures	NNS	O
in	IN	O
excess	NN	O
of	IN	O
about	IN	O
105°	CD	O
C.	NNP	O
to	TO	O
thoroughly	VB	O
gelatinize	VB	O
any	DT	O
remaining	VBG	O
granular	JJ	O
structure.	.	O
After	IN	O
cooling	VBG	O
the	DT	O
gelatinized	VBN	O
starch,	,	O
a	DT	O
second	JJ	O
addition	NN	O
of	IN	O
alpha-amylase	NN	O
can	MD	O
be	VB	O
made	VBN	O
to	TO	O
further	RBR	O
hydrolyze	VB	O
the	DT	O
starch.	.	O
A	DT	O
third	JJ	O
variation	NN	O
of	IN	O
this	DT	O
process	NN	O
is	VBZ	O
called	VBN	O
the	DT	O
dry	JJ	O
milling	NN	O
process.	.	O
In	IN	O
dry	JJ	O
milling,	,	O
whole	JJ	O
grain	NN	O
is	VBZ	O
ground	NN	O
and	CC	O
combined	VBN	O
with	IN	O
water.	.	O
The	DT	O
germ	NN	O
is	VBZ	O
optionally	RB	O
removed	VBN	O
by	IN	O
flotation	NN	O
separation	NN	O
or	CC	O
equivalent	JJ	O
techniques.	.	O
The	DT	O
resulting	JJ	O
mixture,	,	O
which	WDT	O
contains	VBZ	O
starch,	,	O
fiber,	,	O
protein	NN	O
and	CC	O
other	JJ	O
components	NNS	O
of	IN	O
the	DT	O
grain,	,	O
is	VBZ	O
liquefied	VBN	O
using	VBG	O
alpha-amylase.	.	O
The	DT	O
general	JJ	O
practice	NN	O
in	IN	O
the	DT	O
art	NN	O
is	VBZ	O
to	TO	O
undertake	VB	O
enzymatic	JJ	O
liquefaction	NN	O
at	IN	O
a	DT	O
lower	JJR	O
temperature	NN	O
when	WRB	O
using	VBG	O
the	DT	O
dry	JJ	O
milling	NN	O
process.	.	O
Generally,	,	O
low	JJ	O
temperature	NN	O
liquefaction	NN	O
is	VBZ	O
believed	VBN	O
to	TO	O
be	VB	O
less	RBR	O
efficient	JJ	O
than	IN	O
high	JJ	O
temperature	NN	O
liquefaction	NN	O
in	IN	O
converting	VBG	O
starch	NN	O
to	TO	O
soluble	JJ	O
dextrins.	.	O
Typically,	,	O
after	IN	O
gelatinization	NN	O
the	DT	O
starch	NN	O
solution	NN	O
is	VBZ	O
held	VBN	O
at	IN	O
an	DT	O
elevated	JJ	O
temperature	NN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
alpha-amylase	NN	O
until	IN	O
a	DT	O
DE	NNP	O
of	IN	O
10-20	JJ	O
is	VBZ	O
achieved,	,	O
usually	RB	O
a	DT	O
period	NN	O
of	IN	O
1-3	JJ	O
hours.	.	O
Dextrose	NNP	O
equivalent	JJ	O
(DE)	)	O
is	VBZ	O
the	DT	O
industry	NN	O
standard	NN	O
for	IN	O
measuring	VBG	O
the	DT	O
concentration	NN	O
of	IN	O
total	JJ	O
reducing	VBG	O
sugars,	,	O
calculated	VBD	O
as	IN	O
D-glucose	NNP	O
on	IN	O
a	DT	O
dry	JJ	O
weight	JJ	O
basis.	.	O
Unhydrolyzed	VBN	O
granular	JJ	O
starch	NN	O
has	VBZ	O
a	DT	O
DE	NNP	O
of	IN	O
virtually	RB	O
zero,	,	O
whereas	IN	O
the	DT	O
DE	NNP	O
of	IN	O
D-glucose	NNP	O
is	VBZ	O
defined	VBN	O
as	IN	O
100.	.	O
Corn	NNP	O
wet	NN	O
milling	NN	O
is	VBZ	O
a	DT	O
process	NN	O
which	WDT	O
produces	VBZ	O
corn	NN	O
oil,	,	O
gluten	VB	O
meal,	,	O
gluten	VBP	O
feed	NN	O
and	CC	O
starch.	.	O
Alkaline-amylase	NNP	O
is	VBZ	O
used	VBN	O
in	IN	O
the	DT	O
liquefaction	NN	O
of	IN	O
starch	NN	O
and	CC	O
glucoamylase	NN	O
is	VBZ	O
used	VBN	O
in	IN	O
saccharification,	,	O
producing	VBG	O
glucose.	.	O
Corn,	,	O
a	DT	O
kernel	NN	O
of	IN	O
which	WDT	O
consists	VBZ	O
of	IN	O
a	DT	O
outer	NN	O
seed	NN	O
coat	NN	O
(fiber),	,	O
starch,	,	O
a	DT	O
combination	NN	O
of	IN	O
starch	NN	O
and	CC	O
glucose	NN	O
and	CC	O
the	DT	O
inner	JJ	O
germ,	,	O
is	VBZ	O
subjected	VBN	O
to	TO	O
a	DT	O
four	CD	O
step	NN	O
process,	,	O
which	WDT	O
results	NNS	O
in	IN	O
the	DT	O
production	NN	O
of	IN	O
starch.	.	O
The	DT	O
corn	NN	O
is	VBZ	O
steeped,	,	O
de-germed,	,	O
de-fibered,	,	O
and	CC	O
finally	RB	O
the	DT	O
gluten	NN	O
is	VBZ	O
separated.	.	O
In	IN	O
the	DT	O
steeping	NN	O
process,	,	O
the	DT	O
solubles	NNS	O
are	VBP	O
taken	VBN	O
out.	.	O
The	DT	O
product	NN	O
remaining	VBG	O
after	IN	O
removal	NN	O
of	IN	O
the	DT	O
solubles	NNS	O
is	VBZ	O
de-germed,	,	O
resulting	VBG	O
in	IN	O
production	NN	O
of	IN	O
corn	NN	O
oil	NN	O
and	CC	O
production	NN	O
of	IN	O
an	DT	O
oil	NN	O
cake,	,	O
which	WDT	O
is	VBZ	O
added	VBN	O
to	TO	O
the	DT	O
solubles	NNS	O
from	IN	O
the	DT	O
steeping	VBG	O
step.	.	O
The	DT	O
remaining	VBG	O
product	NN	O
is	VBZ	O
de-fibered	JJ	O
and	CC	O
the	DT	O
fiber	NN	O
solids	NNS	O
are	VBP	O
added	VBN	O
to	TO	O
the	DT	O
oil	NN	O
cake/solubles	VBZ	O
mixture.	.	O
This	DT	O
mixture	NN	O
of	IN	O
fiber	NN	O
solids,	,	O
oil	NN	O
cake	NN	O
and	CC	O
solubles	NNS	O
forms	VBZ	O
a	DT	O
gluten	JJ	O
feed.	.	O
After	IN	O
de-fibering,	,	O
the	DT	O
remaining	VBG	O
product	NN	O
is	VBZ	O
subjected	VBN	O
to	TO	O
gluten	VB	O
separation.	.	O
This	DT	O
separation	NN	O
results	NNS	O
in	IN	O
a	DT	O
gluten	JJ	O
meal	NN	O
and	CC	O
starch.	.	O
The	DT	O
starch	NN	O
is	VBZ	O
then	RB	O
subjected	VBN	O
to	TO	O
liquefaction	NN	O
and	CC	O
saccharification	NN	O
to	TO	O
produce	VB	O
glucose.	.	O
Staling	VBG	O
of	IN	O
baked	JJ	O
products	NNS	O
(such	JJ	O
as	IN	O
bread)	)	O
has	VBZ	O
been	VBN	O
recognized	VBN	O
as	IN	O
a	DT	O
problem	NN	O
which	WDT	O
becomes	VBZ	O
more	RBR	O
serious	JJ	O
as	IN	O
more	JJR	O
time	NN	O
lies	VBZ	O
between	IN	O
the	DT	O
moment	NN	O
of	IN	O
preparation	NN	O
of	IN	O
the	DT	O
bread	JJ	O
product	NN	O
and	CC	O
the	DT	O
moment	NN	O
of	IN	O
consumption.	.	O
The	DT	O
term	NN	O
staling	NN	O
is	VBZ	O
used	VBN	O
to	TO	O
describe	VB	O
changes	NNS	O
undesirable	JJ	O
to	TO	O
the	DT	O
consumer	NN	O
in	IN	O
the	DT	O
properties	NNS	O
of	IN	O
the	DT	O
bread	JJ	O
product	NN	O
after	IN	O
leaving	VBG	O
the	DT	O
oven,	,	O
such	JJ	O
as	IN	O
an	DT	O
increase	NN	O
of	IN	O
the	DT	O
firmness	NN	O
of	IN	O
the	DT	O
crumb,	,	O
a	DT	O
decrease	NN	O
of	IN	O
the	DT	O
elasticity	NN	O
of	IN	O
the	DT	O
crumb,	,	O
and	CC	O
changes	NNS	O
in	IN	O
the	DT	O
crust,	,	O
which	WDT	O
becomes	VBZ	O
tough	JJ	O
and	CC	O
leathery.	.	O
The	DT	O
firmness	NN	O
of	IN	O
the	DT	O
bread	NN	O
crumb	NN	O
increases	VBZ	O
further	RBR	O
during	IN	O
storage	NN	O
up	RB	O
to	TO	O
a	DT	O
level,	,	O
which	WDT	O
is	VBZ	O
considered	VBN	O
as	IN	O
negative.	.	O
The	DT	O
increase	NN	O
in	IN	O
crumb	JJ	O
firmness,	,	O
which	WDT	O
is	VBZ	O
considered	VBN	O
as	IN	O
the	DT	O
most	RBS	O
important	JJ	O
aspect	NN	O
of	IN	O
staling,	,	O
is	VBZ	O
recognized	VBN	O
by	IN	O
the	DT	O
consumer	NN	O
a	DT	O
long	JJ	O
time	NN	O
before	IN	O
the	DT	O
bread	NN	O
product	NN	O
has	VBZ	O
otherwise	RB	O
become	VBN	O
unsuitable	JJ	O
for	IN	O
consumption.	.	O
There	EX	O
is	VBZ	O
a	DT	O
need	NN	O
in	IN	O
the	DT	O
industry	NN	O
for	IN	O
the	DT	O
identification	NN	O
and	CC	O
optimization	NN	O
of	IN	O
amylases,	,	O
useful	JJ	O
for	IN	O
various	JJ	O
uses,	,	O
including	VBG	O
commercial	JJ	O
cornstarch	NN	O
liquefaction	NN	O
processes.	.	O
These	DT	O
second	JJ	O
generation	NN	O
acid	NN	O
amylases	NNS	O
will	MD	O
offer	VB	O
improved	JJ	O
manufacturing	NN	O
and/or	NN	O
performance	NN	O
characteristics	NNS	O
over	IN	O
the	DT	O
industry	NN	O
standard	NN	O
enzymes	VBZ	O
from	IN	O
Bacillus	NNP	O
licheniformis,	,	O
for	IN	O
example.	.	O
There	EX	O
is	VBZ	O
also	RB	O
a	DT	O
need	NN	O
for	IN	O
the	DT	O
identification	NN	O
and	CC	O
optimization	NN	O
of	IN	O
amylases	NNS	O
having	VBG	O
utility	NN	O
in	IN	O
automatic	JJ	O
dish	NN	O
wash	NN	O
(ADW)	)	O
products	NNS	O
and	CC	O
laundry	JJ	O
detergent.	.	O
In	IN	O
ADW	NNP	O
products,	,	O
the	DT	O
amylase	NN	O
will	MD	O
function	VB	O
at	IN	O
pH	JJ	O
10-11	JJ	O
and	CC	O
at	IN	O
45-60°	JJ	O
C.	NNP	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
calcium	NN	O
chelators	NNS	O
and	CC	O
oxidative	JJ	O
conditions.	.	O
For	IN	O
laundry,	,	O
activity	NN	O
at	IN	O
pH	JJ	O
9-10	CD	O
and	CC	O
40°	CD	O
C.	NNP	O
in	IN	O
the	DT	O
appropriate	JJ	O
detergent	NN	O
matrix	NN	O
will	MD	O
be	VB	O
required.	.	O
Amylases	NNS	O
are	VBP	O
also	RB	O
useful	JJ	O
in	IN	O
textile	NN	O
desizing,	,	O
brewing	NN	O
processes,	,	O
starch	NN	O
modification	NN	O
in	IN	O
the	DT	O
paper	NN	O
and	CC	O
pulp	NN	O
industry	NN	O
and	CC	O
other	JJ	O
processes	NNS	O
described	VBN	O
in	IN	O
the	DT	O
art.	.	O
Amylases	NNS	O
can	MD	O
be	VB	O
used	VBN	O
commercially	RB	O
in	IN	O
the	DT	O
initial	JJ	O
stages	NNS	O
(liquefaction)	)	O
of	IN	O
starch	NN	O
processing;	:	O
in	IN	O
wet	JJ	O
corn	NN	O
milling;	:	O
in	IN	O
alcohol	NN	O
production;	:	O
as	IN	O
cleaning	NN	O
agents	NNS	O
in	IN	O
detergent	NN	O
matrices;	:	O
in	IN	O
the	DT	O
textile	NN	O
industry	NN	O
for	IN	O
starch	NN	O
desizing;	:	O
in	IN	O
baking	VBG	O
applications;	:	O
in	IN	O
the	DT	O
beverage	NN	O
industry;	:	O
in	IN	O
oilfields	NNS	O
in	IN	O
drilling	NN	O
processes;	:	O
in	IN	O
inking	NN	O
of	IN	O
recycled	JJ	O
paper	NN	O
and	CC	O
in	IN	O
animal	JJ	O
feed.	.	O
Amylases	NNS	O
are	VBP	O
also	RB	O
useful	JJ	O
in	IN	O
textile	NN	O
desizing,	,	O
brewing	NN	O
processes,	,	O
starch	NN	O
modification	NN	O
in	IN	O
the	DT	O
paper	NN	O
and	CC	O
pulp	NN	O
industry	NN	O
and	CC	O
other	JJ	O
processes.	.	O
The	DT	O
publications	NNS	O
discussed	VBN	O
herein	NNS	O
are	VBP	O
provided	VBN	O
solely	RB	O
for	IN	O
their	PRP$	O
disclosure	NN	O
prior	RB	O
to	TO	O
the	DT	O
filing	NN	O
date	NN	O
of	IN	O
the	DT	O
present	JJ	O
application.	.	O
Nothing	NN	O
herein	NN	O
is	VBZ	O
to	TO	O
be	VB	O
construed	VBN	O
as	IN	O
an	DT	O
admission	NN	O
that	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
not	RB	O
entitled	VBN	O
to	TO	O
antedate	VB	O
such	JJ	O
disclosure	NN	O
by	IN	O
virtue	NN	O
of	IN	O
prior	JJ	O
invention.	.	O
SUMMARY	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acids	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50%,	,	O
51%,	,	O
52%,	,	O
53%,	,	O
54%,	,	O
55%,	,	O
56%,	,	O
57%,	,	O
58%,	,	O
59%,	,	O
60%,	,	O
61%,	,	O
62%,	,	O
63%,	,	O
64%,	,	O
65%,	,	O
66%,	,	O
67%,	,	O
68%,	,	O
69%,	,	O
70%,	,	O
71%,	,	O
72%,	,	O
73%,	,	O
74%,	,	O
75%,	,	O
76%,	,	O
77%,	,	O
78%,	,	O
79%,	,	O
80%,	,	O
81%,	,	O
82%,	,	O
83%,	,	O
84%,	,	O
85%,	,	O
86%,	,	O
87%,	,	O
88%,	,	O
89%,	,	O
90%,	,	O
91%,	,	O
92%,	,	O
93%,	,	O
94%,	,	O
95%,	,	O
96%,	,	O
97%,	,	O
98%,	,	O
99%,	,	O
or	CC	O
more,	,	O
or	CC	O
complete	JJ	O
(100%)	)	O
sequence	NN	O
identity	NN	O
to	TO	O
an	DT	O
exemplary	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
50,	,	O
75,	,	O
100,	,	O
150,	,	O
200,	,	O
250,	,	O
300,	,	O
350,	,	O
400,	,	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000,	,	O
1050,	,	O
1100,	,	O
1150,	,	O
1200,	,	O
1250,	,	O
1300,	,	O
1350,	,	O
1400,	,	O
1450,	,	O
1500,	,	O
1550	CD	O
or	CC	O
more,	,	O
residues,	,	O
wherein	VBP	O
the	DT	O
nucleic	JJ	O
acid	NN	O
encodes	NNS	O
at	IN	O
least	JJS	O
one	CD	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
and	CC	O
the	DT	O
sequence	NN	O
identities	NNS	O
are	VBP	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
a	DT	O
visual	JJ	O
inspection.	.	O
Exemplary	JJ	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
isolated	VBN	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acids	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1,	,	O
and	CC	O
subsequences	NNS	O
thereof,	,	O
e.g.,	,	O
at	IN	O
least	JJS	O
about	IN	O
10,	,	O
15,	,	O
20,	,	O
25,	,	O
30,	,	O
35,	,	O
40,	,	O
45,	,	O
50,	,	O
75,	,	O
100,	,	O
150,	,	O
200,	,	O
250,	,	O
300,	,	O
350,	,	O
400,	,	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000,	,	O
1050,	,	O
1100,	,	O
1150,	,	O
1200,	,	O
1250,	,	O
1300,	,	O
1350,	,	O
1400,	,	O
1450,	,	O
1500	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
in	IN	O
length,	,	O
or	CC	O
over	IN	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
a	DT	O
gene	NN	O
or	CC	O
transcript.	.	O
Exemplary	JJ	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
also	RB	O
include	VBP	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
and	CC	O
subsequences	NNS	O
thereof	NN	O
and	CC	O
variants	NNS	O
thereof.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
polypeptide	NN	O
has	VBZ	O
an	DT	O
amylase	NN	O
activity,	,	O
e.g.,	,	O
an	DT	O
alpha	JJ	O
amylase	NN	O
activity.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
with	IN	O
a	DT	O
common	JJ	O
novelty	NN	O
in	IN	O
that	DT	O
they	PRP	O
are	VBP	O
derived	VBN	O
from	IN	O
mixed	JJ	O
cultures.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
isolated	VBN	O
from	IN	O
mixed	JJ	O
cultures	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50%,	,	O
51%,	,	O
52%,	,	O
53%,	,	O
54%,	,	O
55%,	,	O
56%,	,	O
57%,	,	O
58%,	,	O
59%,	,	O
60%,	,	O
61%,	,	O
62%,	,	O
63%,	,	O
64%,	,	O
65%,	,	O
66%,	,	O
67%,	,	O
68%,	,	O
69%,	,	O
70%,	,	O
71%,	,	O
72%,	,	O
73%,	,	O
74%,	,	O
75%,	,	O
76%,	,	O
77%,	,	O
78%,	,	O
79%,	,	O
80%,	,	O
81%,	,	O
82%,	,	O
83%,	,	O
84%,	,	O
85%,	,	O
86%,	,	O
87%,	,	O
88%,	,	O
89%,	,	O
90%,	,	O
91%,	,	O
92%,	,	O
93%,	,	O
94%,	,	O
95%,	,	O
96%,	,	O
97%,	,	O
98%,	,	O
99%,	,	O
or	CC	O
more,	,	O
or	CC	O
complete	JJ	O
(100%)	)	O
sequence	NN	O
identity	NN	O
to	TO	O
an	DT	O
exemplary	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
50,	,	O
75,	,	O
100,	,	O
150,	,	O
200,	,	O
250,	,	O
300,	,	O
350,	,	O
400,	,	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000,	,	O
1050,	,	O
1100,	,	O
1150,	,	O
1200,	,	O
1250,	,	O
1300,	,	O
1350,	,	O
1400,	,	O
1450,	,	O
1500,	,	O
1550	CD	O
or	CC	O
more,	,	O
residues,	,	O
wherein	VBP	O
the	DT	O
nucleic	JJ	O
acid	NN	O
encodes	NNS	O
at	IN	O
least	JJS	O
one	CD	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
and	CC	O
the	DT	O
sequence	NN	O
identities	NNS	O
are	VBP	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
a	DT	O
visual	JJ	O
inspection.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
isolated	VBN	O
from	IN	O
mixed	JJ	O
cultures	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1,	,	O
and	CC	O
subsequences	NNS	O
thereof,	,	O
e.g.,	,	O
at	IN	O
least	JJS	O
about	IN	O
10,	,	O
15,	,	O
20,	,	O
25,	,	O
30,	,	O
35,	,	O
40,	,	O
45,	,	O
50,	,	O
75,	,	O
100,	,	O
150,	,	O
200,	,	O
250,	,	O
300,	,	O
350,	,	O
400,	,	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000,	,	O
1050,	,	O
1100,	,	O
1150,	,	O
1200,	,	O
1250,	,	O
1300,	,	O
1350,	,	O
1400,	,	O
1450,	,	O
1500	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
in	IN	O
length,	,	O
or	CC	O
over	IN	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
a	DT	O
gene	NN	O
or	CC	O
transcript.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
with	IN	O
a	DT	O
common	JJ	O
novelty	NN	O
in	IN	O
that	DT	O
they	PRP	O
are	VBP	O
derived	VBN	O
from	IN	O
environmental	JJ	O
sources,	,	O
e.g.,	,	O
mixed	JJ	O
environmental	JJ	O
sources.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
isolated	VBN	O
from	IN	O
environmental	JJ	O
sources,	,	O
e.g.,	,	O
mixed	JJ	O
environmental	JJ	O
sources,	,	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50%,	,	O
51%,	,	O
52%,	,	O
53%,	,	O
54%,	,	O
55%,	,	O
56%,	,	O
57%,	,	O
58%,	,	O
59%,	,	O
60%,	,	O
61%,	,	O
62%,	,	O
63%,	,	O
64%,	,	O
65%,	,	O
66%,	,	O
67%,	,	O
68%,	,	O
69%,	,	O
70%,	,	O
71%,	,	O
72%,	,	O
73%,	,	O
74%,	,	O
75%,	,	O
76%,	,	O
77%,	,	O
78%,	,	O
79%,	,	O
80%,	,	O
81%,	,	O
82%,	,	O
83%,	,	O
84%,	,	O
85%,	,	O
86%,	,	O
87%,	,	O
88%,	,	O
89%,	,	O
90%,	,	O
91%,	,	O
92%,	,	O
93%,	,	O
94%,	,	O
95%,	,	O
96%,	,	O
97%,	,	O
98%,	,	O
99%,	,	O
or	CC	O
more,	,	O
or	CC	O
complete	JJ	O
(100%)	)	O
sequence	NN	O
identity	NN	O
to	TO	O
an	DT	O
exemplary	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
50,	,	O
75,	,	O
100,	,	O
150,	,	O
200,	,	O
250,	,	O
300,	,	O
350,	,	O
400,	,	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000,	,	O
1050,	,	O
1100,	,	O
1150,	,	O
1200,	,	O
1250,	,	O
1300,	,	O
1350,	,	O
1400,	,	O
1450,	,	O
1500,	,	O
1550	CD	O
or	CC	O
more,	,	O
residues,	,	O
wherein	VBP	O
the	DT	O
nucleic	JJ	O
acid	NN	O
encodes	NNS	O
at	IN	O
least	JJS	O
one	CD	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
and	CC	O
the	DT	O
sequence	NN	O
identities	NNS	O
are	VBP	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
a	DT	O
visual	JJ	O
inspection.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
isolated	VBN	O
from	IN	O
environmental	JJ	O
sources,	,	O
e.g.,	,	O
mixed	JJ	O
environmental	JJ	O
sources,	,	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1,	,	O
and	CC	O
subsequences	NNS	O
thereof,	,	O
e.g.,	,	O
at	IN	O
least	JJS	O
about	IN	O
10,	,	O
15,	,	O
20,	,	O
25,	,	O
30,	,	O
35,	,	O
40,	,	O
45,	,	O
50,	,	O
75,	,	O
100,	,	O
150,	,	O
200,	,	O
250,	,	O
300,	,	O
350,	,	O
400,	,	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000,	,	O
1050,	,	O
1100,	,	O
1150,	,	O
1200,	,	O
1250,	,	O
1300,	,	O
1350,	,	O
1400,	,	O
1450,	,	O
1500	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
in	IN	O
length,	,	O
or	CC	O
over	IN	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
a	DT	O
gene	NN	O
or	CC	O
transcript.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
is	VBZ	O
a	DT	O
BLAST	NNP	O
version	NN	O
2.2.2	CD	O
algorithm	NN	O
where	WRB	O
a	DT	O
filtering	NN	O
setting	NN	O
is	VBZ	O
set	VBN	O
to	TO	O
blastall-p	JJ	O
blastp-d	JJ	O
“nr	JJ	O
pataa”-F	JJ	O
F,	,	O
and	CC	O
all	DT	O
other	JJ	O
options	NNS	O
are	VBP	O
set	VBN	O
to	TO	O
default.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acid	NN	O
including	VBG	O
at	IN	O
least	JJS	O
10	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention,	,	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto,	,	O
and	CC	O
the	DT	O
sequences	NNS	O
complementary	JJ	O
thereto.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
α-amylase	JJ	O
activity,	,	O
including	VBG	O
the	DT	O
ability	NN	O
to	TO	O
hydrolyze	VB	O
internal	JJ	O
alpha-1,4-glucosidic	JJ	O
linkages	NNS	O
in	IN	O
starch	NN	O
to	TO	O
produce	VB	O
smaller	JJR	O
molecular	JJ	O
weight	VBD	O
malto-dextrins.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
α-amylase	JJ	O
activity	NN	O
includes	VBZ	O
hydrolyzing	VBG	O
internal	JJ	O
alpha-1,4-glucosidic	JJ	O
linkages	NNS	O
in	IN	O
starch	NN	O
at	IN	O
random.	.	O
The	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
comprise	VB	O
a	DT	O
glucoamylase	NN	O
activity,	,	O
a	DT	O
1,4-α-D-glucan	JJ	O
glucohydrolase	NN	O
activity,	,	O
an	DT	O
α-amylase	JJ	O
activity,	,	O
an	DT	O
exoamylase	NN	O
activity,	,	O
or	CC	O
a	DT	O
β-amylase	JJ	O
activity.	.	O
The	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
comprise	VB	O
hydrolyzing	VBG	O
glucosidic	JJ	O
bonds.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
glucosidic	JJ	O
bonds	NNS	O
comprise	VBP	O
an	DT	O
α-1,4-glucosidic	JJ	O
bond.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
glucosidic	JJ	O
bonds	NNS	O
comprise	VBP	O
an	DT	O
α-1,6-glucosidic	JJ	O
bond.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
hydrolyzing	VBG	O
glucosidic	JJ	O
bonds	NNS	O
in	IN	O
starch,	,	O
e.g.,	,	O
liquefied	VBN	O
starch.	.	O
The	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
further	RB	O
comprise	VB	O
hydrolyzing	VBG	O
glucosidic	JJ	O
bonds	NNS	O
into	IN	O
maltodextrins.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
cleaving	VBG	O
a	DT	O
maltose	NN	O
or	CC	O
a	DT	O
D-glucose	JJ	O
unit	NN	O
from	IN	O
non-reducing	JJ	O
end	NN	O
of	IN	O
the	DT	O
starch.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acid	NN	O
encodes	VBZ	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
which	WDT	O
is	VBZ	O
thermostable.	.	O
The	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
under	IN	O
conditions	NNS	O
comprising	VBG	O
a	DT	O
temperature	NN	O
range	NN	O
of	IN	O
between	IN	O
about	IN	O
37°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.;	:	O
between	IN	O
about	IN	O
55°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
85°	CD	O
C.,	,	O
between	IN	O
about	IN	O
70°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.,	,	O
or,	,	O
between	IN	O
about	IN	O
90°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acid	NN	O
encodes	VBZ	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
which	WDT	O
is	VBZ	O
thermotolerant.	.	O
The	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
after	IN	O
exposure	NN	O
to	TO	O
a	DT	O
temperature	NN	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
37°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
or	CC	O
anywhere	RB	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
55°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
85°	CD	O
C.	NNP	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
polypeptide	NN	O
retains	VBZ	O
an	DT	O
amylase	NN	O
activity	NN	O
after	IN	O
exposure	NN	O
to	TO	O
a	DT	O
temperature	NN	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
90°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
at	IN	O
pH	NN	O
4.5.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acids	NNS	O
comprising	VBG	O
a	DT	O
sequence	NN	O
that	WDT	O
hybridizes	VBZ	O
under	IN	O
stringent	JJ	O
conditions	NNS	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
comprising	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1,	,	O
or	CC	O
fragments	NNS	O
or	CC	O
subsequences	NNS	O
thereof.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
nucleic	JJ	O
acid	NN	O
encodes	VBZ	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity.	.	O
The	DT	O
nucleic	JJ	O
acid	NN	O
can	MD	O
be	VB	O
at	IN	O
least	JJS	O
about	IN	O
50,	,	O
75,	,	O
100,	,	O
150,	,	O
200,	,	O
250,	,	O
300,	,	O
350,	,	O
400,	,	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000,	,	O
1050,	,	O
1100,	,	O
1150,	,	O
1200,	,	O
1250,	,	O
1300,	,	O
1350,	,	O
1400,	,	O
1450,	,	O
1500	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
in	IN	O
length	NN	O
or	CC	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
the	DT	O
gene	NN	O
or	CC	O
transcript.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
stringent	JJ	O
conditions	NNS	O
include	VBP	O
a	DT	O
wash	JJ	O
step	NN	O
comprising	VBG	O
a	DT	O
wash	NN	O
in	IN	O
0.2×SSC	CD	O
at	IN	O
a	DT	O
temperature	NN	O
of	IN	O
about	IN	O
65°	CD	O
C.	NNP	O
for	IN	O
about	RB	O
15	CD	O
minutes.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
probe	NN	O
for	IN	O
identifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
probe	NN	O
comprises	VBZ	O
at	IN	O
least	JJS	O
about	IN	O
10,	,	O
15,	,	O
20,	,	O
25,	,	O
30,	,	O
35,	,	O
40,	,	O
45,	,	O
50,	,	O
55,	,	O
60,	,	O
65,	,	O
70,	,	O
75,	,	O
80,	,	O
85,	,	O
90,	,	O
95,	,	O
100,	,	O
150,	,	O
200,	,	O
250,	,	O
300,	,	O
350,	,	O
400,	,	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000	CD	O
or	CC	O
more,	,	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
comprising	VBG	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention,	,	O
or	CC	O
fragments	NNS	O
or	CC	O
subsequences	NNS	O
thereof,	,	O
wherein	VBD	O
the	DT	O
probe	NN	O
identifies	VBZ	O
the	DT	O
nucleic	JJ	O
acid	NN	O
by	IN	O
binding	VBG	O
or	CC	O
hybridization.	.	O
The	DT	O
probe	NN	O
can	MD	O
comprise	VB	O
an	DT	O
oligonucleotide	NN	O
comprising	VBG	O
at	IN	O
least	JJS	O
about	RB	O
10	CD	O
to	TO	O
50,	,	O
about	RB	O
20	CD	O
to	TO	O
60,	,	O
about	RB	O
30	CD	O
to	TO	O
70,	,	O
about	RB	O
40	CD	O
to	TO	O
80,	,	O
or	CC	O
about	RB	O
60	CD	O
to	TO	O
100	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
comprising	VBG	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention,	,	O
or	CC	O
fragments	NNS	O
or	CC	O
subsequences	NNS	O
thereof.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
probe	NN	O
for	IN	O
identifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
probe	NN	O
comprises	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
comprising	VBG	O
a	DT	O
sequence	NN	O
at	IN	O
least	JJS	O
about	IN	O
10,	,	O
15,	,	O
20,	,	O
30,	,	O
40,	,	O
50,	,	O
60,	,	O
70,	,	O
80,	,	O
90,	,	O
100,	,	O
150,	,	O
200,	,	O
250,	,	O
300,	,	O
350,	,	O
400,	,	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50%,	,	O
51%,	,	O
52%,	,	O
53%,	,	O
54%,	,	O
55%,	,	O
56%,	,	O
57%,	,	O
58%,	,	O
59%,	,	O
60%,	,	O
61%,	,	O
62%,	,	O
63%,	,	O
64%,	,	O
65%,	,	O
66%,	,	O
67%,	,	O
68%,	,	O
69%,	,	O
70%,	,	O
71%,	,	O
72%,	,	O
73%,	,	O
74%,	,	O
75%,	,	O
76%,	,	O
77%,	,	O
78%,	,	O
79%,	,	O
80%,	,	O
81%,	,	O
82%,	,	O
83%,	,	O
84%,	,	O
85%,	,	O
86%,	,	O
87%,	,	O
88%,	,	O
89%,	,	O
90%,	,	O
91%,	,	O
92%,	,	O
93%,	,	O
94%,	,	O
95%,	,	O
96%,	,	O
97%,	,	O
98%,	,	O
99%,	,	O
or	CC	O
more,	,	O
or	CC	O
complete	JJ	O
(100%)	)	O
sequence	NN	O
identity	NN	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention,	,	O
wherein	VBP	O
the	DT	O
sequence	NN	O
identities	NNS	O
are	VBP	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
visual	JJ	O
inspection.	.	O
The	DT	O
probe	NN	O
can	MD	O
comprise	VB	O
an	DT	O
oligonucleotide	NN	O
comprising	VBG	O
at	IN	O
least	JJS	O
about	RB	O
10	CD	O
to	TO	O
50,	,	O
about	RB	O
20	CD	O
to	TO	O
60,	,	O
about	RB	O
30	CD	O
to	TO	O
70,	,	O
about	RB	O
40	CD	O
to	TO	O
80,	,	O
or	CC	O
about	RB	O
60	CD	O
to	TO	O
100	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention,	,	O
or	CC	O
a	DT	O
subsequence	NN	O
thereof.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
amplification	NN	O
primer	NN	O
sequence	NN	O
pair	NN	O
for	IN	O
amplifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
primer	NN	O
pair	NN	O
is	VBZ	O
capable	JJ	O
of	IN	O
amplifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
comprising	VBG	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention,	,	O
or	CC	O
fragments	NNS	O
or	CC	O
subsequences	NNS	O
thereof.	.	O
One	CD	O
or	CC	O
each	DT	O
member	NN	O
of	IN	O
the	DT	O
amplification	NN	O
primer	NN	O
sequence	NN	O
pair	NN	O
can	MD	O
comprise	VB	O
an	DT	O
oligonucleotide	NN	O
comprising	VBG	O
at	IN	O
least	JJS	O
about	RB	O
10	CD	O
to	TO	O
50	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
the	DT	O
sequence.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
amplifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
comprising	VBG	O
amplification	NN	O
of	IN	O
a	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
with	IN	O
an	DT	O
amplification	NN	O
primer	NN	O
sequence	NN	O
pair	NN	O
capable	JJ	O
of	IN	O
amplifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention,	,	O
or	CC	O
fragments	NNS	O
or	CC	O
subsequences	NNS	O
thereof.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
expression	NN	O
cassettes	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
subsequence	NN	O
thereof.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
expression	NN	O
cassette	NN	O
can	MD	O
comprise	VB	O
the	DT	O
nucleic	JJ	O
acid	NN	O
that	WDT	O
is	VBZ	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
promoter.	.	O
The	DT	O
promoter	NN	O
can	MD	O
be	VB	O
a	DT	O
viral,	,	O
bacterial,	,	O
mammalian	JJ	O
or	CC	O
plant	NN	O
promoter.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
plant	NN	O
promoter	NN	O
can	MD	O
be	VB	O
a	DT	O
potato,	,	O
rice,	,	O
corn,	,	O
wheat,	,	O
tobacco	NN	O
or	CC	O
barley	NN	O
promoter.	.	O
The	DT	O
promoter	NN	O
can	MD	O
be	VB	O
a	DT	O
constitutive	JJ	O
promoter.	.	O
The	DT	O
constitutive	JJ	O
promoter	NN	O
can	MD	O
comprise	VB	O
CaMV35S.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
promoter	NN	O
can	MD	O
be	VB	O
an	DT	O
inducible	JJ	O
promoter.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
promoter	NN	O
can	MD	O
be	VB	O
a	DT	O
tissue-specific	JJ	O
promoter	NN	O
or	CC	O
an	DT	O
environmentally	RB	O
regulated	VBN	O
or	CC	O
a	DT	O
developmentally	RB	O
regulated	VBN	O
promoter.	.	O
Thus,	,	O
the	DT	O
promoter	NN	O
can	MD	O
be,	,	O
e.g.,	,	O
a	DT	O
seed-specific,	,	O
a	DT	O
leaf-specific,	,	O
a	DT	O
root-specific,	,	O
a	DT	O
stem-specific	JJ	O
or	CC	O
an	DT	O
abscission-induced	JJ	O
promoter.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
expression	NN	O
cassette	NN	O
can	MD	O
further	RB	O
comprise	VB	O
a	DT	O
plant	NN	O
or	CC	O
plant	NN	O
virus	NN	O
expression	NN	O
vector.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
cloning	VBG	O
vehicles	NNS	O
comprising	VBG	O
an	DT	O
expression	NN	O
cassette	NN	O
(e.g.,	,	O
a	DT	O
vector)	)	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
cloning	NN	O
vehicle	NN	O
can	MD	O
be	VB	O
a	DT	O
viral	JJ	O
vector,	,	O
a	DT	O
plasmid,	,	O
a	DT	O
phage,	,	O
a	DT	O
phagemid,	,	O
a	DT	O
cosmid,	,	O
a	DT	O
fosmid,	,	O
a	DT	O
bacteriophage	NN	O
or	CC	O
an	DT	O
artificial	JJ	O
chromosome.	.	O
The	DT	O
viral	JJ	O
vector	NN	O
can	MD	O
comprise	VB	O
an	DT	O
adenovirus	NN	O
vector,	,	O
a	DT	O
retroviral	JJ	O
vector	NN	O
or	CC	O
an	DT	O
adeno-associated	JJ	O
viral	JJ	O
vector.	.	O
The	DT	O
cloning	NN	O
vehicle	NN	O
can	MD	O
comprise	VB	O
a	DT	O
bacterial	JJ	O
artificial	JJ	O
chromosome	NN	O
(BAC),	,	O
a	DT	O
plasmid,	,	O
a	DT	O
bacteriophage	NN	O
P1-derived	JJ	O
vector	NN	O
(PAC),	,	O
a	DT	O
yeast	JJ	O
artificial	JJ	O
chromosome	NN	O
(YAC),	,	O
or	CC	O
a	DT	O
mammalian	JJ	O
artificial	JJ	O
chromosome	NN	O
(MAC).	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
transformed	VBN	O
cell	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
an	DT	O
expression	NN	O
cassette	NN	O
(e.g.,	,	O
a	DT	O
vector)	)	O
of	IN	O
the	DT	O
invention,	,	O
or	CC	O
a	DT	O
cloning	JJ	O
vehicle	NN	O
of	IN	O
the	DT	O
invention.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
transformed	VBN	O
cell	NN	O
can	MD	O
be	VB	O
a	DT	O
bacterial	JJ	O
cell,	,	O
a	DT	O
mammalian	JJ	O
cell,	,	O
a	DT	O
fungal	NN	O
cell,	,	O
a	DT	O
yeast	NN	O
cell,	,	O
an	DT	O
insect	NN	O
cell	NN	O
or	CC	O
a	DT	O
plant	NN	O
cell.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
plant	NN	O
cell	NN	O
can	MD	O
be	VB	O
a	DT	O
potato,	,	O
wheat,	,	O
rice,	,	O
corn,	,	O
tobacco	NN	O
or	CC	O
barley	NN	O
cell.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
transgenic	JJ	O
non-human	JJ	O
animals	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
an	DT	O
expression	NN	O
cassette	NN	O
(e.g.,	,	O
a	DT	O
vector)	)	O
of	IN	O
the	DT	O
invention.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
animal	NN	O
is	VBZ	O
a	DT	O
mouse.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
transgenic	JJ	O
plants	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
an	DT	O
expression	NN	O
cassette	NN	O
(e.g.,	,	O
a	DT	O
vector)	)	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
transgenic	JJ	O
plant	NN	O
can	MD	O
be	VB	O
a	DT	O
corn	NN	O
plant,	,	O
a	DT	O
potato	NN	O
plant,	,	O
a	DT	O
tomato	NN	O
plant,	,	O
a	DT	O
wheat	NN	O
plant,	,	O
an	DT	O
oilseed	NN	O
plant,	,	O
a	DT	O
rapeseed	NN	O
plant,	,	O
a	DT	O
soybean	NN	O
plant,	,	O
a	DT	O
rice	NN	O
plant,	,	O
a	DT	O
barley	NN	O
plant	NN	O
or	CC	O
a	DT	O
tobacco	NN	O
plant.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
transgenic	JJ	O
seeds	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
an	DT	O
expression	NN	O
cassette	NN	O
(e.g.,	,	O
a	DT	O
vector)	)	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
transgenic	JJ	O
seed	NN	O
can	MD	O
be	VB	O
a	DT	O
corn	NN	O
seed,	,	O
a	DT	O
wheat	NN	O
kernel,	,	O
an	DT	O
oilseed,	,	O
a	DT	O
rapeseed,	,	O
a	DT	O
soybean	NN	O
seed,	,	O
a	DT	O
palm	NN	O
kernel,	,	O
a	DT	O
sunflower	JJR	O
seed,	,	O
a	DT	O
sesame	NN	O
seed,	,	O
a	DT	O
peanut	NN	O
or	CC	O
a	DT	O
tobacco	NN	O
plant	NN	O
seed.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
antisense	JJ	O
oligonucleotide	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
complementary	JJ	O
to	TO	O
or	CC	O
capable	JJ	O
of	IN	O
hybridizing	VBG	O
under	IN	O
stringent	JJ	O
conditions	NNS	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
inhibiting	VBG	O
the	DT	O
translation	NN	O
of	IN	O
an	DT	O
amylase	JJ	O
message	NN	O
in	IN	O
a	DT	O
cell	NN	O
comprising	VBG	O
administering	VBG	O
to	TO	O
the	DT	O
cell	NN	O
or	CC	O
expressing	VBG	O
in	IN	O
the	DT	O
cell	NN	O
an	DT	O
antisense	JJ	O
oligonucleotide	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
complementary	JJ	O
to	TO	O
or	CC	O
capable	JJ	O
of	IN	O
hybridizing	VBG	O
under	IN	O
stringent	JJ	O
conditions	NNS	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
polypeptide	NN	O
comprising	VBG	O
an	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50%,	,	O
51%,	,	O
52%,	,	O
53%,	,	O
54%,	,	O
55%,	,	O
56%,	,	O
57%,	,	O
58%,	,	O
59%,	,	O
60%,	,	O
61%,	,	O
62%,	,	O
63%,	,	O
64%,	,	O
65%,	,	O
66%,	,	O
67%,	,	O
68%,	,	O
69%,	,	O
70%,	,	O
71%,	,	O
72%,	,	O
73%,	,	O
74%,	,	O
75%,	,	O
76%,	,	O
77%,	,	O
78%,	,	O
79%,	,	O
80%,	,	O
81%,	,	O
82%,	,	O
83%,	,	O
84%,	,	O
85%,	,	O
86%,	,	O
87%,	,	O
88%,	,	O
89%,	,	O
90%,	,	O
91%,	,	O
92%,	,	O
93%,	,	O
94%,	,	O
95%,	,	O
96%,	,	O
97%,	,	O
98%,	,	O
99%,	,	O
or	CC	O
more,	,	O
or	CC	O
complete	JJ	O
(100%)	)	O
sequence	NN	O
identity	NN	O
to	TO	O
an	DT	O
exemplary	JJ	O
polypeptide	NN	O
or	CC	O
peptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
50,	,	O
75,	,	O
100,	,	O
150,	,	O
200,	,	O
250,	,	O
300,	,	O
350,	,	O
400,	,	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000,	,	O
1050,	,	O
1100,	,	O
1150,	,	O
1200,	,	O
1250,	,	O
1300,	,	O
1350,	,	O
1400,	,	O
1450,	,	O
1500,	,	O
1550	CD	O
or	CC	O
more	JJR	O
residues,	,	O
or	CC	O
over	IN	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
the	DT	O
polypeptide,	,	O
and	CC	O
the	DT	O
sequence	NN	O
identities	NNS	O
are	VBP	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
a	DT	O
visual	JJ	O
inspection.	.	O
Exemplary	JJ	O
polypeptide	NN	O
or	CC	O
peptide	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
and	CC	O
subsequences	NNS	O
thereof	NN	O
and	CC	O
variants	NNS	O
thereof,	,	O
e.g.,	,	O
at	IN	O
least	JJS	O
about	IN	O
10,	,	O
15,	,	O
20,	,	O
25,	,	O
30,	,	O
35,	,	O
40,	,	O
45,	,	O
50,	,	O
75,	,	O
100,	,	O
150,	,	O
200,	,	O
250,	,	O
300,	,	O
350,	,	O
400,	,	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000,	,	O
1050,	,	O
1100,	,	O
1150,	,	O
1200,	,	O
1250,	,	O
1300,	,	O
1350,	,	O
1400,	,	O
1450,	,	O
1500	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
in	IN	O
length,	,	O
or	CC	O
over	IN	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
an	DT	O
enzyme.	.	O
Exemplary	JJ	O
polypeptide	NN	O
or	CC	O
peptide	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
sequence	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention.	.	O
Exemplary	JJ	O
polypeptide	NN	O
or	CC	O
peptide	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
polypeptides	NNS	O
or	CC	O
peptides	NNS	O
specifically	RB	O
bound	VBN	O
by	IN	O
an	DT	O
antibody	NN	O
of	IN	O
the	DT	O
invention.	.	O
In	IN	O
one	CD	O
aspect,	,	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
has	VBZ	O
at	IN	O
least	JJS	O
one	CD	O
amylase	NN	O
activity,	,	O
e.g.,	,	O
an	DT	O
alpha	JJ	O
amylase	NN	O
activity.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
polypeptide	NN	O
or	CC	O
peptide	VB	O
including	VBG	O
at	IN	O
least	JJS	O
10	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
polypeptide	NN	O
or	CC	O
peptide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention,	,	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto,	,	O
and	CC	O
the	DT	O
sequences	NNS	O
complementary	JJ	O
thereto.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
of	IN	O
a	DT	O
polypeptide	NN	O
or	CC	O
peptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
comprises	VBZ	O
an	DT	O
α-amylase	JJ	O
activity,	,	O
including	VBG	O
the	DT	O
ability	NN	O
to	TO	O
hydrolyze	VB	O
internal	JJ	O
alpha-1,4-glucosidic	JJ	O
linkages	NNS	O
in	IN	O
starch	NN	O
to	TO	O
produce	VB	O
smaller	JJR	O
molecular	JJ	O
weight	VBD	O
malto-dextrins.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
α-amylase	JJ	O
activity	NN	O
includes	VBZ	O
hydrolyzing	VBG	O
internal	JJ	O
alpha-1,4-glucosidic	JJ	O
linkages	NNS	O
in	IN	O
starch	NN	O
at	IN	O
random.	.	O
The	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
comprise	VB	O
a	DT	O
glucoamylase	NN	O
activity,	,	O
a	DT	O
1,4-α-D-glucan	JJ	O
glucohydrolase	NN	O
activity,	,	O
an	DT	O
α-amylase	JJ	O
activity,	,	O
an	DT	O
exoamylase	NN	O
activity,	,	O
or	CC	O
a	DT	O
β-amylase	JJ	O
activity.	.	O
The	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
comprise	VB	O
hydrolyzing	VBG	O
glucosidic	JJ	O
bonds.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
glucosidic	JJ	O
bonds	NNS	O
comprise	VBP	O
an	DT	O
α-1,4-glucosidic	JJ	O
bond.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
glucosidic	JJ	O
bonds	NNS	O
comprise	VBP	O
an	DT	O
α-1,6-glucosidic	JJ	O
bond.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
hydrolyzing	VBG	O
glucosidic	JJ	O
bonds	NNS	O
in	IN	O
starch,	,	O
e.g.,	,	O
liquefied	VBN	O
starch.	.	O
The	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
further	RB	O
comprise	VB	O
hydrolyzing	VBG	O
glucosidic	JJ	O
bonds	NNS	O
into	IN	O
maltodextrins.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
cleaving	VBG	O
a	DT	O
maltose	NN	O
or	CC	O
a	DT	O
D-glucose	JJ	O
unit	NN	O
from	IN	O
non-reducing	JJ	O
end	NN	O
of	IN	O
the	DT	O
starch.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
be	VB	O
thermostable.	.	O
The	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
under	IN	O
conditions	NNS	O
comprising	VBG	O
a	DT	O
temperature	NN	O
range	NN	O
of	IN	O
between	IN	O
about	IN	O
37°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.,	,	O
between	IN	O
about	IN	O
55°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
85°	CD	O
C.,	,	O
between	IN	O
about	IN	O
70°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.,	,	O
or	CC	O
between	IN	O
about	IN	O
90°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
be	VB	O
thermotolerant.	.	O
The	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
after	IN	O
exposure	NN	O
to	TO	O
a	DT	O
temperature	NN	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
37°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.,	,	O
or	CC	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
55°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
85°	CD	O
C.	NNP	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
after	IN	O
exposure	NN	O
to	TO	O
a	DT	O
temperature	NN	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
90°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
at	IN	O
pH	NN	O
4.5.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
polypeptide	NN	O
can	MD	O
comprise	VB	O
the	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
that	WDT	O
lacks	VBZ	O
a	DT	O
signal	JJ	O
sequence.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
polypeptide	NN	O
can	MD	O
comprise	VB	O
the	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
comprising	VBG	O
a	DT	O
heterologous	JJ	O
signal	NN	O
sequence,	,	O
such	JJ	O
as	IN	O
a	DT	O
heterologous	JJ	O
amylase	NN	O
or	CC	O
non-amylase	JJ	O
signal	JJ	O
sequence.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
signal	JJ	O
sequence	NN	O
comprising	VBG	O
an	DT	O
amino	JJ	O
terminal	JJ	O
peptide	NN	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
signal	JJ	O
sequence	NN	O
consisting	NN	O
of	IN	O
a	DT	O
peptide	NN	O
having	VBG	O
a	DT	O
subsequence	NN	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
chimeric	JJ	O
proteins	NNS	O
comprising	VBG	O
a	DT	O
first	JJ	O
domain	NN	O
comprising	VBG	O
a	DT	O
signal	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
at	IN	O
least	JJS	O
a	DT	O
second	JJ	O
domain.	.	O
The	DT	O
protein	NN	O
can	MD	O
be	VB	O
a	DT	O
fusion	NN	O
protein.	.	O
The	DT	O
second	JJ	O
domain	NN	O
can	MD	O
comprise	VB	O
an	DT	O
enzyme.	.	O
The	DT	O
enzyme	NN	O
can	MD	O
be	VB	O
an	DT	O
amylase	NN	O
(e.g.,	,	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention,	,	O
or,	,	O
another	DT	O
amylase).	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
a	DT	O
specific	JJ	O
activity	NN	O
at	IN	O
about	RB	O
37°	CD	O
C.	NNP	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
about	IN	O
100	CD	O
to	TO	O
about	IN	O
1000	CD	O
units	NNS	O
per	IN	O
milligram	NN	O
of	IN	O
protein.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
a	DT	O
specific	JJ	O
activity	NN	O
from	IN	O
about	RB	O
500	CD	O
to	TO	O
about	IN	O
750	CD	O
units	NNS	O
per	IN	O
milligram	NN	O
of	IN	O
protein.	.	O
Alternatively,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
a	DT	O
specific	JJ	O
activity	NN	O
at	IN	O
37°	CD	O
C.	NNP	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
about	IN	O
500	CD	O
to	TO	O
about	IN	O
1200	CD	O
units	NNS	O
per	IN	O
milligram	NN	O
of	IN	O
protein.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
a	DT	O
specific	JJ	O
activity	NN	O
at	IN	O
37°	CD	O
C.	NNP	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
about	IN	O
750	CD	O
to	TO	O
about	IN	O
1000	CD	O
units	NNS	O
per	IN	O
milligram	NN	O
of	IN	O
protein.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
thermotolerance	NN	O
comprises	VBZ	O
retention	NN	O
of	IN	O
at	IN	O
least	JJS	O
half	NN	O
of	IN	O
the	DT	O
specific	JJ	O
activity	NN	O
of	IN	O
the	DT	O
amylase	NN	O
at	IN	O
37°	CD	O
C.	NNP	O
after	IN	O
being	VBG	O
heated	VBN	O
to	TO	O
the	DT	O
elevated	JJ	O
temperature.	.	O
Alternatively,	,	O
the	DT	O
thermotolerance	NN	O
can	MD	O
comprise	VB	O
retention	NN	O
of	IN	O
specific	JJ	O
activity	NN	O
at	IN	O
37°	CD	O
C.	NNP	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
about	IN	O
500	CD	O
to	TO	O
about	IN	O
1200	CD	O
units	NNS	O
per	IN	O
milligram	NN	O
of	IN	O
protein	NN	O
after	IN	O
being	VBG	O
heated	VBN	O
to	TO	O
the	DT	O
elevated	JJ	O
temperature.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
the	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
at	IN	O
least	JJS	O
one	CD	O
glycosylation	NN	O
site.	.	O
In	IN	O
one	CD	O
aspect,	,	O
glycosylation	NN	O
can	MD	O
be	VB	O
an	DT	O
N-linked	JJ	O
glycosylation.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
polypeptide	NN	O
can	MD	O
be	VB	O
glycosylated	VBN	O
after	IN	O
being	VBG	O
expressed	VBN	O
in	IN	O
a	DT	O
P.	NNP	O
pastoris	NN	O
or	CC	O
a	DT	O
S.	NNP	O
pombe.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
under	IN	O
conditions	NNS	O
comprising	VBG	O
about	IN	O
pH	NN	O
6.5,	,	O
pH	NN	O
6,	,	O
pH	NN	O
5.5,	,	O
pH	NN	O
5,	,	O
pH	VBZ	O
4.5	CD	O
or	CC	O
pH	VB	O
4.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
under	IN	O
conditions	NNS	O
comprising	VBG	O
about	IN	O
pH	NN	O
7,	,	O
pH	VBD	O
7.5	CD	O
pH	NN	O
8.0,	,	O
pH	NN	O
8.5,	,	O
pH	NN	O
9,	,	O
pH	NN	O
9.5,	,	O
pH	NN	O
10,	,	O
pH	VBZ	O
10.5	CD	O
or	CC	O
pH	VB	O
11.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
protein	JJ	O
preparations	NNS	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention,	,	O
wherein	VBP	O
the	DT	O
protein	NN	O
preparation	NN	O
comprises	VBZ	O
a	DT	O
liquid,	,	O
a	DT	O
solid	JJ	O
or	CC	O
a	DT	O
gel.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
heterodimers	NNS	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
a	DT	O
second	JJ	O
domain.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
second	JJ	O
domain	NN	O
can	MD	O
be	VB	O
a	DT	O
polypeptide	NN	O
and	CC	O
the	DT	O
heterodimer	NN	O
can	MD	O
be	VB	O
a	DT	O
fusion	NN	O
protein.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
second	JJ	O
domain	NN	O
can	MD	O
be	VB	O
an	DT	O
epitope	NN	O
or	CC	O
a	DT	O
tag.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
homodimers	NNS	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
immobilized	JJ	O
polypeptides	NNS	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention,	,	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention,	,	O
or	CC	O
a	DT	O
polypeptide	JJ	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
a	DT	O
second	JJ	O
domain.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
polypeptide	NN	O
can	MD	O
be	VB	O
immobilized	VBN	O
on	IN	O
a	DT	O
cell,	,	O
a	DT	O
metal,	,	O
a	DT	O
resin,	,	O
a	DT	O
polymer,	,	O
a	DT	O
ceramic,	,	O
a	DT	O
glass,	,	O
a	DT	O
microelectrode,	,	O
a	DT	O
graphitic	JJ	O
particle,	,	O
a	DT	O
bead,	,	O
a	DT	O
gel,	,	O
a	DT	O
plate,	,	O
an	DT	O
array	NN	O
or	CC	O
a	DT	O
capillary	JJ	O
tube.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
arrays	RP	O
comprising	VBG	O
an	DT	O
immobilized	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
arrays	RP	O
comprising	VBG	O
an	DT	O
antibody	NN	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
antibodies	NNS	O
that	WDT	O
specifically	RB	O
bind	VBP	O
to	TO	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
to	TO	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
antibody	NN	O
can	MD	O
be	VB	O
a	DT	O
monoclonal	JJ	O
or	CC	O
a	DT	O
polyclonal	JJ	O
antibody.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
hybridomas	RB	O
comprising	VBG	O
an	DT	O
antibody	NN	O
of	IN	O
the	DT	O
invention,	,	O
e.g.,	,	O
an	DT	O
antibody	NN	O
that	WDT	O
specifically	RB	O
binds	VBZ	O
to	TO	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
to	TO	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
food	NN	O
supplements	NNS	O
for	IN	O
an	DT	O
animal	JJ	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention,	,	O
e.g.,	,	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
polypeptide	NN	O
in	IN	O
the	DT	O
food	NN	O
supplement	NN	O
can	MD	O
be	VB	O
glycosylated.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
edible	JJ	O
enzyme	JJ	O
delivery	NN	O
matrices	NNS	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention,	,	O
e.g.,	,	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
delivery	NN	O
matrix	NN	O
comprises	VBZ	O
a	DT	O
pellet.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
polypeptide	NN	O
can	MD	O
be	VB	O
glycosylated.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
is	VBZ	O
thermotolerant.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
is	VBZ	O
thermostable.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
method	NN	O
of	IN	O
isolating	VBG	O
or	CC	O
identifying	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of:	:	O
(a)	)	O
providing	VBG	O
an	DT	O
antibody	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
sample	JJ	O
comprising	NN	O
polypeptides;	:	O
and	CC	O
(c)	)	O
contacting	VBG	O
the	DT	O
sample	NN	O
of	IN	O
step	NN	O
(b)	)	O
with	IN	O
the	DT	O
antibody	NN	O
of	IN	O
step	NN	O
(a)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
antibody	NN	O
can	MD	O
specifically	RB	O
bind	VB	O
to	TO	O
the	DT	O
polypeptide,	,	O
thereby	RB	O
isolating	VBG	O
or	CC	O
identifying	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
making	VBG	O
an	DT	O
anti-amylase	JJ	O
antibody	NN	O
comprising	VBG	O
administering	VBG	O
to	TO	O
a	DT	O
non-human	JJ	O
animal	NN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
subsequences	NNS	O
thereof	RP	O
in	IN	O
an	DT	O
amount	NN	O
sufficient	NN	O
to	TO	O
generate	VB	O
a	DT	O
humoral	JJ	O
immune	NN	O
response,	,	O
thereby	RB	O
making	VBG	O
an	DT	O
anti-amylase	JJ	O
antibody.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
making	VBG	O
an	DT	O
anti-amylase	JJ	O
immune	NN	O
comprising	VBG	O
administering	VBG	O
to	TO	O
a	DT	O
non-human	JJ	O
animal	NN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
subsequences	NNS	O
thereof	RP	O
in	IN	O
an	DT	O
amount	NN	O
sufficient	NN	O
to	TO	O
generate	VB	O
an	DT	O
immune	JJ	O
response.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
producing	VBG	O
a	DT	O
recombinant	JJ	O
polypeptide	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
promoter;	:	O
and	CC	O
(b)	)	O
expressing	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(a)	)	O
under	IN	O
conditions	NNS	O
that	WDT	O
allow	VBP	O
expression	NN	O
of	IN	O
the	DT	O
polypeptide,	,	O
thereby	RB	O
producing	VBG	O
a	DT	O
recombinant	JJ	O
polypeptide.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
method	NN	O
can	MD	O
further	RBR	O
comprise	VB	O
transforming	VBG	O
a	DT	O
host	NN	O
cell	NN	O
with	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(a)	)	O
followed	VBN	O
by	IN	O
expressing	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(a),	,	O
thereby	RB	O
producing	VBG	O
a	DT	O
recombinant	JJ	O
polypeptide	NN	O
in	IN	O
a	DT	O
transformed	JJ	O
cell.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
identifying	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention;	:	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
an	DT	O
amylase	JJ	O
substrate;	:	O
and	CC	O
(c)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
or	CC	O
a	DT	O
fragment	NN	O
or	CC	O
variant	JJ	O
thereof	NN	O
of	IN	O
step	NN	O
(a)	)	O
with	IN	O
the	DT	O
substrate	NN	O
of	IN	O
step	NN	O
(b)	)	O
and	CC	O
detecting	VBG	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
a	DT	O
reaction	NN	O
product,	,	O
wherein	VBP	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
reaction	NN	O
product	NN	O
detects	VBZ	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
substrate	NN	O
can	MD	O
be	VB	O
a	DT	O
starch,	,	O
e.g.,	,	O
a	DT	O
liquefied	VBN	O
starch.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
identifying	VBG	O
an	DT	O
amylase	NN	O
substrate	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention;	:	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
test	NN	O
substrate;	:	O
and	CC	O
(c)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
with	IN	O
the	DT	O
test	NN	O
substrate	NN	O
of	IN	O
step	NN	O
(b)	)	O
and	CC	O
detecting	VBG	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
reaction	NN	O
product,	,	O
wherein	VBP	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
a	DT	O
reaction	NN	O
product	NN	O
identifies	VBZ	O
the	DT	O
test	NN	O
substrate	NN	O
as	IN	O
an	DT	O
amylase	NN	O
substrate.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
determining	VBG	O
whether	IN	O
a	DT	O
test	NN	O
compound	NN	O
specifically	RB	O
binds	VBZ	O
to	TO	O
a	DT	O
polypeptide	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
expressing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
or	CC	O
a	DT	O
vector	NN	O
comprising	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
under	IN	O
conditions	NNS	O
permissive	VBP	O
for	IN	O
translation	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
to	TO	O
a	DT	O
polypeptide,	,	O
wherein	VBP	O
the	DT	O
nucleic	JJ	O
acid	NN	O
comprises	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention,	,	O
or,	,	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
test	NN	O
compound;	:	O
(c)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
with	IN	O
the	DT	O
test	NN	O
compound;	:	O
and	CC	O
(d)	)	O
determining	VBG	O
whether	IN	O
the	DT	O
test	NN	O
compound	NN	O
of	IN	O
step	NN	O
(b)	)	O
specifically	RB	O
binds	VBZ	O
to	TO	O
the	DT	O
polypeptide.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
identifying	VBG	O
a	DT	O
modulator	NN	O
of	IN	O
an	DT	O
amylase	NN	O
activity	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
test	NN	O
compound;	:	O
(c)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
with	IN	O
the	DT	O
test	NN	O
compound	NN	O
of	IN	O
step	NN	O
(b)	)	O
and	CC	O
measuring	VBG	O
an	DT	O
activity	NN	O
of	IN	O
the	DT	O
amylase,	,	O
wherein	VBP	O
a	DT	O
change	NN	O
in	IN	O
the	DT	O
amylase	NN	O
activity	NN	O
measured	VBN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
test	NN	O
compound	NN	O
compared	VBN	O
to	TO	O
the	DT	O
activity	NN	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
the	DT	O
test	NN	O
compound	NN	O
provides	VBZ	O
a	DT	O
determination	NN	O
that	IN	O
the	DT	O
test	NN	O
compound	NN	O
modulates	VBZ	O
the	DT	O
amylase	NN	O
activity.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
be	VB	O
measured	VBN	O
by	IN	O
providing	VBG	O
an	DT	O
amylase	NN	O
substrate	NN	O
and	CC	O
detecting	VBG	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
a	DT	O
reaction	NN	O
product,	,	O
or,	,	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
a	DT	O
reaction	NN	O
product.	.	O
A	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
reaction	NN	O
product	NN	O
with	IN	O
the	DT	O
test	NN	O
compound	NN	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
amount	NN	O
of	IN	O
substrate	NN	O
or	CC	O
reaction	NN	O
product	NN	O
without	IN	O
the	DT	O
test	NN	O
compound	NN	O
identifies	VBZ	O
the	DT	O
test	NN	O
compound	NN	O
as	IN	O
an	DT	O
activator	NN	O
of	IN	O
amylase	NN	O
activity.	.	O
An	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
reaction	NN	O
product	NN	O
with	IN	O
the	DT	O
test	NN	O
compound	NN	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
amount	NN	O
of	IN	O
substrate	NN	O
or	CC	O
reaction	NN	O
product	NN	O
without	IN	O
the	DT	O
test	NN	O
compound	NN	O
identifies	VBZ	O
the	DT	O
test	NN	O
compound	NN	O
as	IN	O
an	DT	O
inhibitor	NN	O
of	IN	O
amylase	NN	O
activity.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
computer	NN	O
systems	NNS	O
comprising	VBG	O
a	DT	O
processor	NN	O
and	CC	O
a	DT	O
data	NN	O
storage	NN	O
device	NN	O
wherein	NN	O
said	VBD	O
data	NNS	O
storage	NN	O
device	NN	O
has	VBZ	O
stored	VBN	O
thereon	RP	O
a	DT	O
polypeptide	JJ	O
sequence	NN	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
(e.g.,	,	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention).	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
computer	NN	O
system	NN	O
can	MD	O
further	RB	O
comprise	VB	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
and	CC	O
a	DT	O
data	NN	O
storage	NN	O
device	NN	O
having	VBG	O
at	IN	O
least	JJS	O
one	CD	O
reference	NN	O
sequence	NN	O
stored	VBD	O
thereon.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
comprises	VBZ	O
a	DT	O
computer	NN	O
program	NN	O
that	WDT	O
indicates	VBZ	O
polymorphisms.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
computer	NN	O
system	NN	O
can	MD	O
further	RB	O
comprise	VB	O
an	DT	O
identifier	NN	O
that	WDT	O
identifies	VBZ	O
one	CD	O
or	CC	O
more	JJR	O
features	NNS	O
in	IN	O
said	VBD	O
sequence.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
computer	NN	O
readable	JJ	O
media	NNS	O
having	VBG	O
stored	VBN	O
thereon	IN	O
a	DT	O
polypeptide	JJ	O
sequence	NN	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
identifying	VBG	O
a	DT	O
feature	NN	O
in	IN	O
a	DT	O
sequence	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of:	:	O
(a)	)	O
reading	VBG	O
the	DT	O
sequence	NN	O
using	VBG	O
a	DT	O
computer	NN	O
program	NN	O
which	WDT	O
identifies	VBZ	O
one	CD	O
or	CC	O
more	JJR	O
features	NNS	O
in	IN	O
a	DT	O
sequence,	,	O
wherein	VBP	O
the	DT	O
sequence	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	JJ	O
sequence	NN	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention;	:	O
and	CC	O
(b)	)	O
identifying	VBG	O
one	CD	O
or	CC	O
more	JJR	O
features	NNS	O
in	IN	O
the	DT	O
sequence	NN	O
with	IN	O
the	DT	O
computer	NN	O
program.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
comparing	VBG	O
a	DT	O
first	JJ	O
sequence	NN	O
to	TO	O
a	DT	O
second	JJ	O
sequence	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of:	:	O
(a)	)	O
reading	VBG	O
the	DT	O
first	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
second	JJ	O
sequence	NN	O
through	IN	O
use	NN	O
of	IN	O
a	DT	O
computer	NN	O
program	NN	O
which	WDT	O
compares	VBZ	O
sequences,	,	O
wherein	VBD	O
the	DT	O
first	JJ	O
sequence	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	JJ	O
sequence	NN	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention;	:	O
and	CC	O
(b)	)	O
determining	VBG	O
differences	NNS	O
between	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
second	JJ	O
sequence	NN	O
with	IN	O
the	DT	O
computer	NN	O
program.	.	O
The	DT	O
step	NN	O
of	IN	O
determining	VBG	O
differences	NNS	O
between	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
second	JJ	O
sequence	NN	O
can	MD	O
further	RBR	O
comprise	VB	O
the	DT	O
step	NN	O
of	IN	O
identifying	VBG	O
polymorphisms.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
method	NN	O
can	MD	O
further	RB	O
comprise	VB	O
an	DT	O
identifier	NN	O
that	WDT	O
identifies	VBZ	O
one	CD	O
or	CC	O
more	JJR	O
features	NNS	O
in	IN	O
a	DT	O
sequence.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
method	NN	O
can	MD	O
comprise	VB	O
reading	VBG	O
the	DT	O
first	JJ	O
sequence	NN	O
using	VBG	O
a	DT	O
computer	NN	O
program	NN	O
and	CC	O
identifying	VBG	O
one	CD	O
or	CC	O
more	JJR	O
features	NNS	O
in	IN	O
the	DT	O
sequence.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
isolating	VBG	O
or	CC	O
recovering	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
from	IN	O
an	DT	O
environmental	JJ	O
sample	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of:	:	O
(a)	)	O
providing	VBG	O
an	DT	O
amplification	NN	O
primer	NN	O
sequence	NN	O
pair	NN	O
for	IN	O
amplifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
primer	NN	O
pair	NN	O
is	VBZ	O
capable	JJ	O
of	IN	O
amplifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
isolating	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
from	IN	O
the	DT	O
environmental	JJ	O
sample	NN	O
or	CC	O
treating	VBG	O
the	DT	O
environmental	JJ	O
sample	NN	O
such	JJ	O
that	IN	O
nucleic	JJ	O
acid	NN	O
in	IN	O
the	DT	O
sample	NN	O
is	VBZ	O
accessible	JJ	O
for	IN	O
hybridization	NN	O
to	TO	O
the	DT	O
amplification	NN	O
primer	NN	O
pair;	:	O
and,	,	O
(c)	)	O
combining	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(b)	)	O
with	IN	O
the	DT	O
amplification	NN	O
primer	NN	O
pair	NN	O
of	IN	O
step	NN	O
(a)	)	O
and	CC	O
amplifying	VBG	O
nucleic	JJ	O
acid	NN	O
from	IN	O
the	DT	O
environmental	JJ	O
sample,	,	O
thereby	RB	O
isolating	VBG	O
or	CC	O
recovering	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
from	IN	O
an	DT	O
environmental	JJ	O
sample.	.	O
One	CD	O
or	CC	O
each	DT	O
member	NN	O
of	IN	O
the	DT	O
amplification	NN	O
primer	NN	O
sequence	NN	O
pair	NN	O
can	MD	O
comprise	VB	O
an	DT	O
oligonucleotide	NN	O
comprising	VBG	O
at	IN	O
least	JJS	O
about	RB	O
10	CD	O
to	TO	O
50	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
isolating	VBG	O
or	CC	O
recovering	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
from	IN	O
an	DT	O
environmental	JJ	O
sample	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polynucleotide	JJ	O
probe	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
subsequence	NN	O
thereof;	:	O
(b)	)	O
isolating	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
from	IN	O
the	DT	O
environmental	JJ	O
sample	NN	O
or	CC	O
treating	VBG	O
the	DT	O
environmental	JJ	O
sample	NN	O
such	JJ	O
that	IN	O
nucleic	JJ	O
acid	NN	O
in	IN	O
the	DT	O
sample	NN	O
is	VBZ	O
accessible	JJ	O
for	IN	O
hybridization	NN	O
to	TO	O
a	DT	O
polynucleotide	JJ	O
probe	NN	O
of	IN	O
step	NN	O
(a);	:	O
(c)	)	O
combining	VBG	O
the	DT	O
isolated	JJ	O
nucleic	JJ	O
acid	NN	O
or	CC	O
the	DT	O
treated	JJ	O
environmental	JJ	O
sample	NN	O
of	IN	O
step	NN	O
(b)	)	O
with	IN	O
the	DT	O
polynucleotide	JJ	O
probe	NN	O
of	IN	O
step	NN	O
(a);	:	O
and	CC	O
(d)	)	O
isolating	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
that	WDT	O
specifically	RB	O
hybridizes	VBZ	O
with	IN	O
the	DT	O
polynucleotide	JJ	O
probe	NN	O
of	IN	O
step	NN	O
(a),	,	O
thereby	RB	O
isolating	VBG	O
or	CC	O
recovering	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
from	IN	O
an	DT	O
environmental	JJ	O
sample.	.	O
The	DT	O
environmental	JJ	O
sample	NN	O
can	MD	O
comprise	VB	O
a	DT	O
water	NN	O
sample,	,	O
a	DT	O
liquid	JJ	O
sample,	,	O
a	DT	O
soil	NN	O
sample,	,	O
an	DT	O
air	NN	O
sample	NN	O
or	CC	O
a	DT	O
biological	JJ	O
sample.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
biological	JJ	O
sample	NN	O
can	MD	O
be	VB	O
derived	VBN	O
from	IN	O
a	DT	O
bacterial	JJ	O
cell,	,	O
a	DT	O
protozoan	NN	O
cell,	,	O
an	DT	O
insect	NN	O
cell,	,	O
a	DT	O
yeast	NN	O
cell,	,	O
a	DT	O
plant	NN	O
cell,	,	O
a	DT	O
fungal	JJ	O
cell	NN	O
or	CC	O
a	DT	O
mammalian	JJ	O
cell.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
generating	VBG	O
a	DT	O
variant	NN	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
template	JJ	O
nucleic	JJ	O
acid	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
and	CC	O
(b)	)	O
modifying,	,	O
deleting	VBG	O
or	CC	O
adding	VBG	O
one	CD	O
or	CC	O
more	JJR	O
nucleotides	NNS	O
in	IN	O
the	DT	O
template	NN	O
sequence,	,	O
or	CC	O
a	DT	O
combination	NN	O
thereof,	,	O
to	TO	O
generate	VB	O
a	DT	O
variant	NN	O
of	IN	O
the	DT	O
template	NN	O
nucleic	JJ	O
acid.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
method	NN	O
can	MD	O
further	RBR	O
comprise	VB	O
expressing	VBG	O
the	DT	O
variant	JJ	O
nucleic	JJ	O
acid	NN	O
to	TO	O
generate	VB	O
a	DT	O
variant	JJ	O
amylase	NN	O
polypeptide.	.	O
The	DT	O
modifications,	,	O
additions	NNS	O
or	CC	O
deletions	NNS	O
can	MD	O
be	VB	O
introduced	VBN	O
by	IN	O
a	DT	O
method	NN	O
comprising	VBG	O
error-prone	JJ	O
PCR,	,	O
shuffling,	,	O
oligonucleotide-directed	JJ	O
mutagenesis,	,	O
assembly	RB	O
PCR,	,	O
sexual	JJ	O
PCR	NNP	O
mutagenesis,	,	O
in	IN	O
vivo	JJ	O
mutagenesis,	,	O
cassette	NN	O
mutagenesis,	,	O
recursive	JJ	O
ensemble	JJ	O
mutagenesis,	,	O
exponential	JJ	O
ensemble	JJ	O
mutagenesis,	,	O
site-specific	JJ	O
mutagenesis,	,	O
gene	NN	O
reassembly,	,	O
gene	NN	O
site	NN	O
saturated	VBN	O
mutagenesis	NN	O
(GSSM),	,	O
synthetic	JJ	O
ligation	NN	O
reassembly	RB	O
(SLR)	)	O
or	CC	O
a	DT	O
combination	NN	O
thereof.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
modifications,	,	O
additions	NNS	O
or	CC	O
deletions	NNS	O
are	VBP	O
introduced	VBN	O
by	IN	O
a	DT	O
method	NN	O
comprising	VBG	O
recombination,	,	O
recursive	JJ	O
sequence	NN	O
recombination,	,	O
phosphothioate-modified	JJ	O
DNA	NNP	O
mutagenesis,	,	O
uracil-containing	JJ	O
template	NN	O
mutagenesis,	,	O
gapped	VBD	O
duplex	JJ	O
mutagenesis,	,	O
point	NN	O
mismatch	NN	O
repair	NN	O
mutagenesis,	,	O
repair-deficient	JJ	O
host	NN	O
strain	NN	O
mutagenesis,	,	O
chemical	JJ	O
mutagenesis,	,	O
radiogenic	JJ	O
mutagenesis,	,	O
deletion	NN	O
mutagenesis,	,	O
restriction-selection	NN	O
mutagenesis,	,	O
restriction-purification	NN	O
mutagenesis,	,	O
artificial	JJ	O
gene	NN	O
synthesis,	,	O
ensemble	JJ	O
mutagenesis,	,	O
chimeric	JJ	O
nucleic	NN	O
acid	NN	O
multimer	NN	O
creation	NN	O
and	CC	O
a	DT	O
combination	NN	O
thereof.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
method	NN	O
can	MD	O
be	VB	O
iteratively	RB	O
repeated	VBN	O
until	IN	O
an	DT	O
amylase	NN	O
having	VBG	O
an	DT	O
altered	JJ	O
or	CC	O
different	JJ	O
activity	NN	O
or	CC	O
an	DT	O
altered	JJ	O
or	CC	O
different	JJ	O
stability	NN	O
from	IN	O
that	DT	O
of	IN	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
produced.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
variant	JJ	O
amylase	NN	O
polypeptide	NN	O
is	VBZ	O
thermotolerant,	,	O
and	CC	O
retains	VBZ	O
some	DT	O
activity	NN	O
after	IN	O
being	VBG	O
exposed	VBN	O
to	TO	O
an	DT	O
elevated	JJ	O
temperature.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
variant	JJ	O
amylase	NN	O
polypeptide	NN	O
has	VBZ	O
increased	VBN	O
glycosylation	NN	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
amylase	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
template	NN	O
nucleic	JJ	O
acid.	.	O
Alternatively,	,	O
the	DT	O
variant	JJ	O
amylase	NN	O
polypeptide	NN	O
has	VBZ	O
an	DT	O
amylase	NN	O
activity	NN	O
under	IN	O
a	DT	O
high	JJ	O
temperature,	,	O
wherein	VBP	O
the	DT	O
amylase	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
not	RB	O
active	JJ	O
under	IN	O
the	DT	O
high	JJ	O
temperature.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
method	NN	O
can	MD	O
be	VB	O
iteratively	RB	O
repeated	VBN	O
until	IN	O
an	DT	O
amylase	NN	O
coding	VBG	O
sequence	NN	O
having	VBG	O
an	DT	O
altered	JJ	O
codon	NN	O
usage	NN	O
from	IN	O
that	DT	O
of	IN	O
the	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
produced.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
method	NN	O
can	MD	O
be	VB	O
iteratively	RB	O
repeated	VBN	O
until	IN	O
an	DT	O
amylase	NN	O
gene	NN	O
having	VBG	O
higher	JJR	O
or	CC	O
lower	JJR	O
level	NN	O
of	IN	O
message	NN	O
expression	NN	O
or	CC	O
stability	NN	O
from	IN	O
that	DT	O
of	IN	O
the	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
produced.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
codons	NNS	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
to	TO	O
increase	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell,	,	O
the	DT	O
method	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity;	:	O
and,	,	O
(b)	)	O
identifying	VBG	O
a	DT	O
non-preferred	JJ	O
or	CC	O
a	DT	O
less	JJR	O
preferred	JJ	O
codon	NN	O
in	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(a)	)	O
and	CC	O
replacing	VBG	O
it	PRP	O
with	IN	O
a	DT	O
preferred	JJ	O
or	CC	O
neutrally	RB	O
used	JJ	O
codon	NN	O
encoding	VBG	O
the	DT	O
same	JJ	O
amino	NN	O
acid	NN	O
as	IN	O
the	DT	O
replaced	JJ	O
codon,	,	O
wherein	VBZ	O
a	DT	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
over-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
the	DT	O
host	NN	O
cell	NN	O
and	CC	O
a	DT	O
non-preferred	JJ	O
or	CC	O
less	RBR	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
under-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
the	DT	O
host	NN	O
cell,	,	O
thereby	RB	O
modifying	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
to	TO	O
increase	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
codons	NNS	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity;	:	O
the	DT	O
method	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
and,	,	O
(b)	)	O
identifying	VBG	O
a	DT	O
codon	NN	O
in	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(a)	)	O
and	CC	O
replacing	VBG	O
it	PRP	O
with	IN	O
a	DT	O
different	JJ	O
codon	NN	O
encoding	VBG	O
the	DT	O
same	JJ	O
amino	NN	O
acid	NN	O
as	IN	O
the	DT	O
replaced	JJ	O
codon,	,	O
thereby	RB	O
modifying	VBG	O
codons	NNS	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
an	DT	O
amylase.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
codons	NNS	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
to	TO	O
increase	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell,	,	O
the	DT	O
method	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
encoding	VBG	O
an	DT	O
amylase	NN	O
polypeptide;	:	O
and,	,	O
(b)	)	O
identifying	VBG	O
a	DT	O
non-preferred	JJ	O
or	CC	O
a	DT	O
less	JJR	O
preferred	JJ	O
codon	NN	O
in	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(a)	)	O
and	CC	O
replacing	VBG	O
it	PRP	O
with	IN	O
a	DT	O
preferred	JJ	O
or	CC	O
neutrally	RB	O
used	JJ	O
codon	NN	O
encoding	VBG	O
the	DT	O
same	JJ	O
amino	NN	O
acid	NN	O
as	IN	O
the	DT	O
replaced	JJ	O
codon,	,	O
wherein	VBZ	O
a	DT	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
over-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
the	DT	O
host	NN	O
cell	NN	O
and	CC	O
a	DT	O
non-preferred	JJ	O
or	CC	O
less	RBR	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
under-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
the	DT	O
host	NN	O
cell,	,	O
thereby	RB	O
modifying	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
to	TO	O
increase	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
a	DT	O
codon	NN	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
to	TO	O
decrease	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell,	,	O
the	DT	O
method	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
and	CC	O
(b)	)	O
identifying	NN	O
at	IN	O
least	JJS	O
one	CD	O
preferred	JJ	O
codon	NN	O
in	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(a)	)	O
and	CC	O
replacing	VBG	O
it	PRP	O
with	IN	O
a	DT	O
non-preferred	JJ	O
or	CC	O
less	RBR	O
preferred	JJ	O
codon	NN	O
encoding	VBG	O
the	DT	O
same	JJ	O
amino	NN	O
acid	NN	O
as	IN	O
the	DT	O
replaced	JJ	O
codon,	,	O
wherein	VBZ	O
a	DT	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
over-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
a	DT	O
host	NN	O
cell	NN	O
and	CC	O
a	DT	O
non-preferred	JJ	O
or	CC	O
less	RBR	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
under-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
the	DT	O
host	NN	O
cell,	,	O
thereby	RB	O
modifying	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
to	TO	O
decrease	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
host	NN	O
cell	NN	O
can	MD	O
be	VB	O
a	DT	O
bacterial	JJ	O
cell,	,	O
a	DT	O
fungal	NN	O
cell,	,	O
an	DT	O
insect	NN	O
cell,	,	O
a	DT	O
yeast	NN	O
cell,	,	O
a	DT	O
plant	NN	O
cell	NN	O
or	CC	O
a	DT	O
mammalian	JJ	O
cell.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
producing	VBG	O
a	DT	O
library	NN	O
of	IN	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
a	DT	O
plurality	NN	O
of	IN	O
modified	JJ	O
amylase	NN	O
active	JJ	O
sites	NNS	O
or	CC	O
substrate	VB	O
binding	NN	O
sites,	,	O
wherein	VBP	O
the	DT	O
modified	JJ	O
active	JJ	O
sites	NNS	O
or	CC	O
substrate	VB	O
binding	NN	O
sites	NNS	O
are	VBP	O
derived	VBN	O
from	IN	O
a	DT	O
first	JJ	O
nucleic	JJ	O
acid	NN	O
comprising	VBG	O
a	DT	O
sequence	NN	O
encoding	VBG	O
a	DT	O
first	JJ	O
active	JJ	O
site	NN	O
or	CC	O
a	DT	O
first	JJ	O
substrate	NN	O
binding	NN	O
site	NN	O
the	DT	O
method	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
first	JJ	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
first	JJ	O
active	JJ	O
site	NN	O
or	CC	O
first	JJ	O
substrate	NN	O
binding	NN	O
site,	,	O
wherein	WP	O
the	DT	O
first	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
comprises	VBZ	O
a	DT	O
sequence	NN	O
that	WDT	O
hybridizes	VBZ	O
under	IN	O
stringent	JJ	O
conditions	NNS	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention,	,	O
and	CC	O
the	DT	O
nucleic	JJ	O
acid	NN	O
encodes	VBZ	O
an	DT	O
amylase	NN	O
active	JJ	O
site	NN	O
or	CC	O
an	DT	O
amylase	JJ	O
substrate	NN	O
binding	NN	O
site;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
set	NN	O
of	IN	O
mutagenic	JJ	O
oligonucleotides	NNS	O
that	IN	O
encode	VBP	O
naturally-occurring	JJ	O
amino	NN	O
acid	NN	O
variants	NNS	O
at	IN	O
a	DT	O
plurality	NN	O
of	IN	O
targeted	JJ	O
codons	NNS	O
in	IN	O
the	DT	O
first	JJ	O
nucleic	JJ	O
acid;	:	O
and,	,	O
(c)	)	O
using	VBG	O
the	DT	O
set	NN	O
of	IN	O
mutagenic	JJ	O
oligonucleotides	NNS	O
to	TO	O
generate	VB	O
a	DT	O
set	NN	O
of	IN	O
active	JJ	O
site-encoding	NN	O
or	CC	O
substrate	VB	O
binding	JJ	O
site-encoding	JJ	O
variant	NN	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
a	DT	O
range	NN	O
of	IN	O
amino	NN	O
acid	JJ	O
variations	NNS	O
at	IN	O
each	DT	O
amino	NN	O
acid	VBP	O
codon	NN	O
that	WDT	O
was	VBD	O
mutagenized,	,	O
thereby	RB	O
producing	VBG	O
a	DT	O
library	NN	O
of	IN	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
a	DT	O
plurality	NN	O
of	IN	O
modified	JJ	O
amylase	NN	O
active	JJ	O
sites	NNS	O
or	CC	O
substrate	VB	O
binding	NN	O
sites.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
method	NN	O
comprises	VBZ	O
mutagenizing	VBG	O
the	DT	O
first	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(a)	)	O
by	IN	O
a	DT	O
method	NN	O
comprising	VBG	O
an	DT	O
optimized	VBN	O
directed	VBN	O
evolution	NN	O
system,	,	O
gene	NN	O
site-saturation	JJ	O
mutagenesis	NN	O
(GSSM),	,	O
synthetic	JJ	O
ligation	NN	O
reassembly	RB	O
(SLR),	,	O
error-prone	JJ	O
PCR,	,	O
shuffling,	,	O
oligonucleotide-directed	JJ	O
mutagenesis,	,	O
assembly	RB	O
PCR,	,	O
sexual	JJ	O
PCR	NNP	O
mutagenesis,	,	O
in	IN	O
vivo	JJ	O
mutagenesis,	,	O
cassette	NN	O
mutagenesis,	,	O
recursive	JJ	O
ensemble	JJ	O
mutagenesis,	,	O
exponential	JJ	O
ensemble	JJ	O
mutagenesis,	,	O
site-specific	JJ	O
mutagenesis,	,	O
gene	NN	O
reassembly,	,	O
gene	NN	O
site	NN	O
saturated	VBN	O
mutagenesis	NN	O
(GSSM),	,	O
synthetic	JJ	O
ligation	NN	O
reassembly	RB	O
(SLR)	)	O
and	CC	O
a	DT	O
combination	NN	O
thereof.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
method	NN	O
comprises	VBZ	O
mutagenizing	VBG	O
the	DT	O
first	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(a)	)	O
or	CC	O
variants	NNS	O
by	IN	O
a	DT	O
method	NN	O
comprising	VBG	O
recombination,	,	O
recursive	JJ	O
sequence	NN	O
recombination,	,	O
phosphothioate-modified	JJ	O
DNA	NNP	O
mutagenesis,	,	O
uracil-containing	JJ	O
template	NN	O
mutagenesis,	,	O
gapped	VBD	O
duplex	JJ	O
mutagenesis,	,	O
point	NN	O
mismatch	NN	O
repair	NN	O
mutagenesis,	,	O
repair-deficient	JJ	O
host	NN	O
strain	NN	O
mutagenesis,	,	O
chemical	JJ	O
mutagenesis,	,	O
radiogenic	JJ	O
mutagenesis,	,	O
deletion	NN	O
mutagenesis,	,	O
restriction-selection	NN	O
mutagenesis,	,	O
restriction-purification	NN	O
mutagenesis,	,	O
artificial	JJ	O
gene	NN	O
synthesis,	,	O
ensemble	JJ	O
mutagenesis,	,	O
chimeric	JJ	O
nucleic	NN	O
acid	NN	O
multimer	NN	O
creation	NN	O
and	CC	O
a	DT	O
combination	NN	O
thereof.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
making	VBG	O
a	DT	O
small	JJ	O
molecule	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
plurality	NN	O
of	IN	O
biosynthetic	JJ	O
enzymes	NNS	O
capable	JJ	O
of	IN	O
synthesizing	VBG	O
or	CC	O
modifying	VBG	O
a	DT	O
small	JJ	O
molecule,	,	O
wherein	VBP	O
one	CD	O
of	IN	O
the	DT	O
enzymes	NNS	O
comprises	VBZ	O
an	DT	O
amylase	NN	O
enzyme	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
substrate	NN	O
for	IN	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
enzymes	NNS	O
of	IN	O
step	NN	O
(a);	:	O
and	CC	O
(c)	)	O
reacting	VBG	O
the	DT	O
substrate	NN	O
of	IN	O
step	NN	O
(b)	)	O
with	IN	O
the	DT	O
enzymes	NNS	O
under	IN	O
conditions	NNS	O
that	WDT	O
facilitate	VBP	O
a	DT	O
plurality	NN	O
of	IN	O
biocatalytic	JJ	O
reactions	NNS	O
to	TO	O
generate	VB	O
a	DT	O
small	JJ	O
molecule	NN	O
by	IN	O
a	DT	O
series	NN	O
of	IN	O
biocatalytic	JJ	O
reactions.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
a	DT	O
small	JJ	O
molecule	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
an	DT	O
amylase	NN	O
enzyme,	,	O
wherein	VBP	O
the	DT	O
enzyme	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention,	,	O
or,	,	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention,	,	O
or	CC	O
a	DT	O
subsequence	NN	O
thereof;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
small	JJ	O
molecule;	:	O
and	CC	O
(c)	)	O
reacting	VBG	O
the	DT	O
enzyme	NN	O
of	IN	O
step	NN	O
(a)	)	O
with	IN	O
the	DT	O
small	JJ	O
molecule	NN	O
of	IN	O
step	NN	O
(b)	)	O
under	IN	O
conditions	NNS	O
that	WDT	O
facilitate	VBP	O
an	DT	O
enzymatic	JJ	O
reaction	NN	O
catalyzed	VBN	O
by	IN	O
the	DT	O
amylase	NN	O
enzyme,	,	O
thereby	RB	O
modifying	VBG	O
a	DT	O
small	JJ	O
molecule	NN	O
by	IN	O
an	DT	O
amylase	NN	O
enzymatic	JJ	O
reaction.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
method	NN	O
can	MD	O
comprise	VB	O
a	DT	O
plurality	NN	O
of	IN	O
small	JJ	O
molecule	NN	O
substrates	NNS	O
for	IN	O
the	DT	O
enzyme	NN	O
of	IN	O
step	NN	O
(a),	,	O
thereby	RB	O
generating	VBG	O
a	DT	O
library	NN	O
of	IN	O
modified	VBN	O
small	JJ	O
molecules	NNS	O
produced	VBN	O
by	IN	O
at	IN	O
least	JJS	O
one	CD	O
enzymatic	JJ	O
reaction	NN	O
catalyzed	VBN	O
by	IN	O
the	DT	O
amylase	NN	O
enzyme.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
method	NN	O
can	MD	O
comprise	VB	O
a	DT	O
plurality	NN	O
of	IN	O
additional	JJ	O
enzymes	NNS	O
under	IN	O
conditions	NNS	O
that	WDT	O
facilitate	VBP	O
a	DT	O
plurality	NN	O
of	IN	O
biocatalytic	JJ	O
reactions	NNS	O
by	IN	O
the	DT	O
enzymes	NNS	O
to	TO	O
form	VB	O
a	DT	O
library	NN	O
of	IN	O
modified	VBN	O
small	JJ	O
molecules	NNS	O
produced	VBN	O
by	IN	O
the	DT	O
plurality	NN	O
of	IN	O
enzymatic	JJ	O
reactions.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
method	NN	O
can	MD	O
further	RBR	O
comprise	VB	O
the	DT	O
step	NN	O
of	IN	O
testing	VBG	O
the	DT	O
library	NN	O
to	TO	O
determine	VB	O
if	IN	O
a	DT	O
particular	JJ	O
modified	VBN	O
small	JJ	O
molecule	NN	O
which	WDT	O
exhibits	VBZ	O
a	DT	O
desired	JJ	O
activity	NN	O
is	VBZ	O
present	JJ	O
within	IN	O
the	DT	O
library.	.	O
The	DT	O
step	NN	O
of	IN	O
testing	VBG	O
the	DT	O
library	NN	O
can	MD	O
further	RBR	O
comprise	VB	O
the	DT	O
steps	NNS	O
of	IN	O
systematically	RB	O
eliminating	VBG	O
all	DT	O
but	CC	O
one	CD	O
of	IN	O
the	DT	O
biocatalytic	JJ	O
reactions	NNS	O
used	VBN	O
to	TO	O
produce	VB	O
a	DT	O
portion	NN	O
of	IN	O
the	DT	O
plurality	NN	O
of	IN	O
the	DT	O
modified	JJS	O
small	JJ	O
molecules	NNS	O
within	IN	O
the	DT	O
library	JJ	O
by	IN	O
testing	VBG	O
the	DT	O
portion	NN	O
of	IN	O
the	DT	O
modified	JJS	O
small	JJ	O
molecule	NN	O
for	IN	O
the	DT	O
presence	NN	O
or	CC	O
absence	NN	O
of	IN	O
the	DT	O
particular	JJ	O
modified	VBD	O
small	JJ	O
molecule	NN	O
with	IN	O
a	DT	O
desired	JJ	O
activity,	,	O
and	CC	O
identifying	VBG	O
at	IN	O
least	JJS	O
one	CD	O
specific	JJ	O
biocatalytic	JJ	O
reaction	NN	O
that	WDT	O
produces	VBZ	O
the	DT	O
particular	JJ	O
modified	VBD	O
small	JJ	O
molecule	NN	O
of	IN	O
desired	JJ	O
activity.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
determining	VBG	O
a	DT	O
functional	JJ	O
fragment	NN	O
of	IN	O
an	DT	O
amylase	NN	O
enzyme	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of:	:	O
(a)	)	O
providing	VBG	O
an	DT	O
amylase	NN	O
enzyme,	,	O
wherein	VBP	O
the	DT	O
enzyme	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention,	,	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention,	,	O
or	CC	O
a	DT	O
subsequence	NN	O
thereof;	:	O
and	CC	O
(b)	)	O
deleting	VBG	O
a	DT	O
plurality	NN	O
of	IN	O
amino	NN	O
acid	NN	O
residues	NNS	O
from	IN	O
the	DT	O
sequence	NN	O
of	IN	O
step	NN	O
(a)	)	O
and	CC	O
testing	VBG	O
the	DT	O
remaining	VBG	O
subsequence	NN	O
for	IN	O
an	DT	O
amylase	NN	O
activity,	,	O
thereby	RB	O
determining	VBG	O
a	DT	O
functional	JJ	O
fragment	NN	O
of	IN	O
an	DT	O
amylase	NN	O
enzyme.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
is	VBZ	O
measured	VBN	O
by	IN	O
providing	VBG	O
an	DT	O
amylase	NN	O
substrate	NN	O
and	CC	O
detecting	VBG	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
a	DT	O
reaction	NN	O
product.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
whole	JJ	O
cell	NN	O
engineering	NN	O
of	IN	O
new	JJ	O
or	CC	O
modified	VBN	O
phenotypes	NNS	O
by	IN	O
using	VBG	O
real-time	JJ	O
metabolic	JJ	O
flux	NN	O
analysis,	,	O
the	DT	O
method	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
making	VBG	O
a	DT	O
modified	VBN	O
cell	NN	O
by	IN	O
modifying	VBG	O
the	DT	O
genetic	JJ	O
composition	NN	O
of	IN	O
a	DT	O
cell,	,	O
wherein	VBZ	O
the	DT	O
genetic	JJ	O
composition	NN	O
is	VBZ	O
modified	VBN	O
by	IN	O
addition	NN	O
to	TO	O
the	DT	O
cell	NN	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
culturing	VBG	O
the	DT	O
modified	VBN	O
cell	NN	O
to	TO	O
generate	VB	O
a	DT	O
plurality	NN	O
of	IN	O
modified	JJ	O
cells;	:	O
(c)	)	O
measuring	NN	O
at	IN	O
least	JJS	O
one	CD	O
metabolic	JJ	O
parameter	NN	O
of	IN	O
the	DT	O
cell	NN	O
by	IN	O
monitoring	VBG	O
the	DT	O
cell	NN	O
culture	NN	O
of	IN	O
step	NN	O
(b)	)	O
in	IN	O
real	JJ	O
time;	:	O
and,	,	O
(d)	)	O
analyzing	VBG	O
the	DT	O
data	NN	O
of	IN	O
step	NN	O
(c)	)	O
to	TO	O
determine	VB	O
if	IN	O
the	DT	O
measured	VBN	O
parameter	NN	O
differs	NNS	O
from	IN	O
a	DT	O
comparable	JJ	O
measurement	NN	O
in	IN	O
an	DT	O
unmodified	JJ	O
cell	NN	O
under	IN	O
similar	JJ	O
conditions,	,	O
thereby	RB	O
identifying	VBG	O
an	DT	O
engineered	JJ	O
phenotype	NN	O
in	IN	O
the	DT	O
cell	NN	O
using	VBG	O
real-time	JJ	O
metabolic	JJ	O
flux	NN	O
analysis.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
genetic	JJ	O
composition	NN	O
of	IN	O
the	DT	O
cell	NN	O
can	MD	O
be	VB	O
modified	VBN	O
by	IN	O
a	DT	O
method	NN	O
comprising	VBG	O
deletion	NN	O
of	IN	O
a	DT	O
sequence	NN	O
or	CC	O
modification	NN	O
of	IN	O
a	DT	O
sequence	NN	O
in	IN	O
the	DT	O
cell,	,	O
or,	,	O
knocking	VBG	O
out	RP	O
the	DT	O
expression	NN	O
of	IN	O
a	DT	O
gene.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
method	NN	O
can	MD	O
further	RBR	O
comprise	VB	O
selecting	VBG	O
a	DT	O
cell	NN	O
comprising	VBG	O
a	DT	O
newly	RB	O
engineered	VBN	O
phenotype.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
method	NN	O
can	MD	O
comprise	VB	O
culturing	VBG	O
the	DT	O
selected	VBN	O
cell,	,	O
thereby	RB	O
generating	VBG	O
a	DT	O
new	JJ	O
cell	NN	O
strain	NN	O
comprising	VBG	O
a	DT	O
newly	RB	O
engineered	VBN	O
phenotype.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
hydrolyzing	VBG	O
a	DT	O
starch	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
comprising	VBG	O
a	DT	O
starch;	:	O
and	CC	O
(c)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
with	IN	O
the	DT	O
composition	NN	O
of	IN	O
step	NN	O
(b)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
hydrolyzes	VBZ	O
the	DT	O
starch.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
composition	NN	O
comprising	VBG	O
starch	NN	O
that	WDT	O
comprises	VBZ	O
an	DT	O
α-1,4-glucosidic	JJ	O
bond	NN	O
or	CC	O
an	DT	O
α-1,6-glucosidic	JJ	O
bond.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
is	VBZ	O
an	DT	O
α-amylase	JJ	O
activity.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
α-amylase	JJ	O
activity	NN	O
hydrolyzes	VBZ	O
internal	JJ	O
bonds	NNS	O
in	IN	O
a	DT	O
starch	NN	O
or	CC	O
other	JJ	O
polysaccharide.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
liquefying	VBG	O
or	CC	O
removing	VBG	O
a	DT	O
starch	NN	O
from	IN	O
a	DT	O
composition	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
comprising	VBG	O
a	DT	O
starch;	:	O
and	CC	O
(c)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
with	IN	O
the	DT	O
composition	NN	O
of	IN	O
step	NN	O
(b)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
removes	VBZ	O
or	CC	O
liquefies	VBZ	O
the	DT	O
starch.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
increasing	VBG	O
thermotolerance	NN	O
or	CC	O
thermostability	NN	O
of	IN	O
an	DT	O
amylase	NN	O
polypeptide,	,	O
the	DT	O
method	NN	O
comprising	VBG	O
glycosylating	VBG	O
an	DT	O
amylase	NN	O
polypeptide,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
at	IN	O
least	JJS	O
thirty	JJ	O
contiguous	JJ	O
amino	NN	O
acids	NNS	O
of	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention;	:	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention,	,	O
thereby	RB	O
increasing	VBG	O
the	DT	O
thermotolerance	NN	O
or	CC	O
thermostability	NN	O
of	IN	O
the	DT	O
amylase	NN	O
polypeptide.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
specific	JJ	O
activity	NN	O
can	MD	O
be	VB	O
thermostable	JJ	O
or	CC	O
thermotolerant	NN	O
at	IN	O
a	DT	O
temperature	NN	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
about	RB	O
37°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
overexpressing	VBG	O
a	DT	O
recombinant	JJ	O
amylase	NN	O
polypeptide	NN	O
in	IN	O
a	DT	O
cell	NN	O
comprising	VBG	O
expressing	VBG	O
a	DT	O
vector	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention,	,	O
wherein	VBP	O
the	DT	O
sequence	NN	O
identities	NNS	O
are	VBP	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
visual	JJ	O
inspection,	,	O
wherein	JJ	O
overexpression	NN	O
is	VBZ	O
effected	VBN	O
by	IN	O
use	NN	O
of	IN	O
a	DT	O
high	JJ	O
activity	NN	O
promoter,	,	O
a	DT	O
dicistronic	JJ	O
vector	NN	O
or	CC	O
by	IN	O
gene	NN	O
amplification	NN	O
of	IN	O
the	DT	O
vector.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
detergent	JJ	O
compositions	NNS	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
an	DT	O
amylase	NN	O
activity.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylase	NN	O
can	MD	O
be	VB	O
a	DT	O
nonsurface-active	JJ	O
amylase.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
amylase	NN	O
can	MD	O
be	VB	O
a	DT	O
surface-active	JJ	O
amylase.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
washing	VBG	O
an	DT	O
object	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises:	:	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
an	DT	O
object;	:	O
and	CC	O
(c)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
and	CC	O
the	DT	O
object	NN	O
of	IN	O
step	NN	O
(b)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
composition	NN	O
can	MD	O
wash	VB	O
the	DT	O
object.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
hydrolyzing	VBG	O
starch,	,	O
e.g.,	,	O
in	IN	O
a	DT	O
feed	NN	O
or	CC	O
a	DT	O
food	NN	O
prior	RB	O
to	TO	O
consumption	NN	O
by	IN	O
an	DT	O
animal,	,	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
obtaining	VBG	O
a	DT	O
composition,	,	O
e.g.,	,	O
a	DT	O
feed	NN	O
material,	,	O
comprising	VBG	O
a	DT	O
starch,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises:	:	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
and	CC	O
(b)	)	O
adding	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
to	TO	O
the	DT	O
composition,	,	O
e.g.,	,	O
the	DT	O
feed	NN	O
or	CC	O
food	NN	O
material,	,	O
in	IN	O
an	DT	O
amount	NN	O
sufficient	NN	O
for	IN	O
a	DT	O
sufficient	JJ	O
time	NN	O
period	NN	O
to	TO	O
cause	VB	O
hydrolysis	NN	O
of	IN	O
the	DT	O
starch,	,	O
thereby	RB	O
hydrolyzing	VBG	O
the	DT	O
starch.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
food	NN	O
or	CC	O
feed	NN	O
comprises	NNS	O
rice,	,	O
corn,	,	O
barley,	,	O
wheat,	,	O
legumes,	,	O
or	CC	O
potato.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
textile	NN	O
desizing	VBG	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
fabric;	:	O
and	CC	O
(c)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
and	CC	O
the	DT	O
fabric	NN	O
of	IN	O
step	NN	O
(b)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
amylase	NN	O
can	MD	O
desize	VB	O
the	DT	O
fabric.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
deinking	NN	O
of	IN	O
paper	NN	O
or	CC	O
fibers	NNS	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
comprising	VBG	O
paper	NN	O
or	CC	O
fiber;	:	O
and	CC	O
(c)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
and	CC	O
the	DT	O
composition	NN	O
of	IN	O
step	NN	O
(b)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
can	MD	O
deink	VB	O
the	DT	O
paper	NN	O
or	CC	O
fiber.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
treatment	NN	O
of	IN	O
lignocellulosic	JJ	O
fibers	NNS	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
lignocellulosic	JJ	O
fiber;	:	O
and	CC	O
(c)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
and	CC	O
the	DT	O
fiber	NN	O
of	IN	O
step	NN	O
(b)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
can	MD	O
treat	VB	O
the	DT	O
fiber	NN	O
thereby	RB	O
improving	VBG	O
the	DT	O
fiber	NN	O
properties.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
producing	VBG	O
a	DT	O
high-maltose	JJ	O
or	CC	O
a	DT	O
high-glucose	JJ	O
syrup	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
comprising	VBG	O
a	DT	O
starch;	:	O
and	CC	O
(c)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
and	CC	O
the	DT	O
fabric	NN	O
of	IN	O
step	NN	O
(b)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
can	MD	O
liquefy	VB	O
the	DT	O
composition	NN	O
of	IN	O
step	NN	O
(b)	)	O
thereby	RB	O
producing	VBG	O
a	DT	O
soluble	JJ	O
starch	NN	O
hydrolysate	NN	O
and	CC	O
saccharify	VB	O
the	DT	O
soluble	JJ	O
starch	NN	O
hydrolysate	NN	O
thereby	RB	O
producing	VBG	O
the	DT	O
syrup.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
starch	NN	O
can	MD	O
be	VB	O
from	IN	O
rice,	,	O
corn,	,	O
barley,	,	O
wheat,	,	O
legumes,	,	O
potato,	,	O
or	CC	O
sweet	JJ	O
potato.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
improving	VBG	O
the	DT	O
flow	NN	O
of	IN	O
the	DT	O
starch-containing	JJ	O
production	NN	O
fluids	NNS	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
production	NN	O
fluid;	:	O
and	CC	O
(c)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
and	CC	O
the	DT	O
production	NN	O
fluid	NN	O
of	IN	O
step	NN	O
(b)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
amylase	NN	O
can	MD	O
hydrolyze	VB	O
the	DT	O
starch	NN	O
in	IN	O
the	DT	O
production	NN	O
fluid	NN	O
thereby	RB	O
improving	VBG	O
its	PRP$	O
flow	NN	O
by	IN	O
decreasing	VBG	O
its	PRP$	O
density.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
production	NN	O
fluid	NN	O
can	MD	O
be	VB	O
from	IN	O
a	DT	O
subterranean	JJ	O
formation.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
anti-staling	JJ	O
compositions	NNS	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
preventing	VBG	O
staling	NN	O
of	IN	O
the	DT	O
baked	JJ	O
products	NNS	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
containing	VBG	O
starch	NN	O
used	VBN	O
for	IN	O
baking;	:	O
(c)	)	O
combining	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
with	IN	O
the	DT	O
composition	NN	O
of	IN	O
the	DT	O
step	NN	O
(b)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
can	MD	O
hydrolyze	VB	O
the	DT	O
starch	NN	O
in	IN	O
the	DT	O
composition	NN	O
used	VBN	O
for	IN	O
baking	VBG	O
thereby	RB	O
preventing	VBG	O
staling	NN	O
of	IN	O
the	DT	O
baked	JJ	O
product.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
baked	JJ	O
product	NN	O
can	MD	O
be	VB	O
bread.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
using	VBG	O
amylase	NN	O
in	IN	O
brewing	NN	O
or	CC	O
alcohol	NN	O
production	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
containing	VBG	O
starch	NN	O
and	CC	O
used	VBN	O
for	IN	O
brewing	NN	O
or	CC	O
in	IN	O
alcohol	JJ	O
production;	:	O
(c)	)	O
combining	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(a)	)	O
with	IN	O
the	DT	O
composition	NN	O
of	IN	O
the	DT	O
step	NN	O
(b)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
can	MD	O
hydrolyze	VB	O
the	DT	O
starch	NN	O
in	IN	O
the	DT	O
composition	NN	O
used	VBN	O
for	IN	O
brewing	NN	O
or	CC	O
in	IN	O
alcohol	JJ	O
production.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
composition	NN	O
containing	VBG	O
starch	NN	O
can	MD	O
be	VB	O
beer.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
making	VBG	O
a	DT	O
transgenic	JJ	O
plant	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
introducing	VBG	O
a	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
into	IN	O
the	DT	O
cell,	,	O
wherein	VBZ	O
the	DT	O
heterologous	JJ	O
nucleic	JJ	O
sequence	NN	O
comprises	VBZ	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention,	,	O
thereby	RB	O
producing	VBG	O
a	DT	O
transformed	JJ	O
plant	NN	O
cell;	:	O
and	CC	O
(b)	)	O
producing	VBG	O
a	DT	O
transgenic	JJ	O
plant	NN	O
from	IN	O
the	DT	O
transformed	VBN	O
cell.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
step	NN	O
(a)	)	O
can	MD	O
further	RB	O
comprise	VB	O
introducing	VBG	O
the	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
by	IN	O
electroporation	NN	O
or	CC	O
microinjection	NN	O
of	IN	O
plant	NN	O
cell	NN	O
protoplasts.	.	O
In	IN	O
another	DT	O
aspect,	,	O
the	DT	O
step	NN	O
(a)	)	O
can	MD	O
further	RB	O
comprise	VB	O
introducing	VBG	O
the	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
directly	RB	O
to	TO	O
plant	NN	O
tissue	NN	O
by	IN	O
DNA	NNP	O
particle	NN	O
bombardment.	.	O
Alternatively,	,	O
the	DT	O
step	NN	O
(a)	)	O
can	MD	O
further	RB	O
comprise	VB	O
introducing	VBG	O
the	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
into	IN	O
the	DT	O
plant	NN	O
cell	NN	O
DNA	NNP	O
using	VBG	O
an	DT	O
Agrobacterium	NN	O
tumefaciens	VBZ	O
host.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
plant	NN	O
cell	NN	O
can	MD	O
be	VB	O
a	DT	O
potato,	,	O
corn,	,	O
rice,	,	O
wheat,	,	O
tobacco,	,	O
or	CC	O
barley	NN	O
cell.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
expressing	VBG	O
a	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
in	IN	O
a	DT	O
plant	NN	O
cell	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps:	:	O
(a)	)	O
transforming	VBG	O
the	DT	O
plant	NN	O
cell	NN	O
with	IN	O
a	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
operably	RB	O
linked	VBD	O
to	TO	O
a	DT	O
promoter,	,	O
wherein	VBP	O
the	DT	O
heterologous	JJ	O
nucleic	JJ	O
sequence	NN	O
comprises	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention;	:	O
(b)	)	O
growing	VBG	O
the	DT	O
plant	NN	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
heterologous	JJ	O
nucleic	JJ	O
acids	NNS	O
sequence	NN	O
is	VBZ	O
expressed	VBN	O
in	IN	O
the	DT	O
plant	NN	O
cell.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
process	NN	O
for	IN	O
preparing	VBG	O
a	DT	O
dough	NN	O
or	CC	O
a	DT	O
baked	JJ	O
product	NN	O
prepared	VBN	O
from	IN	O
the	DT	O
dough	NN	O
which	WDT	O
comprises	VBZ	O
adding	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
the	DT	O
dough	NN	O
in	IN	O
an	DT	O
amount	NN	O
which	WDT	O
is	VBZ	O
effective	JJ	O
to	TO	O
retard	VB	O
the	DT	O
staling	NN	O
of	IN	O
the	DT	O
bread.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
dough	NN	O
comprising	NN	O
said	VBD	O
amylase	NN	O
and	CC	O
a	DT	O
premix	NN	O
comprising	VBG	O
flour	PRP$	O
together	NN	O
with	IN	O
said	VBD	O
amylase.	.	O
Finally,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
enzymatic	JJ	O
baking	NN	O
additive,	,	O
which	WDT	O
contains	VBZ	O
said	VBD	O
amylase.	.	O
The	DT	O
use	NN	O
of	IN	O
the	DT	O
amylase	NN	O
in	IN	O
accordance	NN	O
with	IN	O
the	DT	O
present	JJ	O
invention	NN	O
provides	VBZ	O
an	DT	O
improved	JJ	O
anti-staling	JJ	O
effect	NN	O
as	IN	O
measured	VBN	O
by,	,	O
e.g.	.	O
less	RBR	O
crumb	JJ	O
firming,	,	O
retained	VBD	O
crumb	JJ	O
elasticity,	,	O
improved	VBN	O
slice-ability	NN	O
(e.g.	.	O
fewer	JJR	O
crumbs,	,	O
non-gummy	JJ	O
crumb),	,	O
improved	VBN	O
palatability	NN	O
or	CC	O
flavor.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
isolated	JJ	O
nucleic	NN	O
acid	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:	:	O
1	CD	O
and	CC	O
variants	NNS	O
thereof	VBP	O
having	VBG	O
at	IN	O
least	JJS	O
50%	NN	O
sequence	NN	O
identity	NN	O
to	TO	O
SEQ	NNP	O
ID	NNP	O
NO:	:	O
1	CD	O
and	CC	O
encoding	VBG	O
polypeptides	NNS	O
having	VBG	O
alpha	JJ	O
amylase	NN	O
activity.	.	O
One	CD	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
nucleic	NN	O
acid	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:	:	O
1,	,	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto,	,	O
and	CC	O
sequences	NNS	O
complementary	JJ	O
thereto.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
nucleic	JJ	O
acid	NN	O
including	VBG	O
at	IN	O
least	JJS	O
10	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences,	,	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto,	,	O
and	CC	O
the	DT	O
sequences	NNS	O
complementary	JJ	O
thereto.	.	O
In	IN	O
yet	RB	O
another	DT	O
aspect,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
isolated	JJ	O
nucleic	NN	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO.:	:	O
2	CD	O
and	CC	O
variants	NNS	O
thereof	VBP	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
alpha	JJ	O
amylase	NN	O
activity	NN	O
and	CC	O
having	VBG	O
at	IN	O
least	JJS	O
50%	NN	O
sequence	NN	O
identity	NN	O
to	TO	O
such	JJ	O
sequences.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
nucleic	NN	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
or	CC	O
a	DT	O
functional	JJ	O
fragment	NN	O
thereof	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:	:	O
2	CD	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
nucleic	NN	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
at	IN	O
least	JJS	O
10	CD	O
consecutive	JJ	O
amino	NN	O
acids	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto.	.	O
In	IN	O
yet	RB	O
another	DT	O
aspect,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
purified	JJ	O
polypeptide	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
or	CC	O
purified	JJ	O
antibody	NN	O
that	WDT	O
specifically	RB	O
binds	VBZ	O
to	TO	O
a	DT	O
polypeptide	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
or	CC	O
purified	JJ	O
antibody	NN	O
or	CC	O
binding	VBG	O
fragment	JJ	O
thereof,	,	O
which	WDT	O
specifically	RB	O
binds	VBZ	O
to	TO	O
a	DT	O
polypeptide	NN	O
having	VBG	O
at	IN	O
least	JJS	O
10	CD	O
consecutive	JJ	O
amino	NN	O
acids	NNS	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
polypeptides	NNS	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
method	NN	O
of	IN	O
making	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto.	.	O
The	DT	O
method	NN	O
includes	VBZ	O
introducing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
the	DT	O
polypeptide	NN	O
into	IN	O
a	DT	O
host	NN	O
cell,	,	O
wherein	VBZ	O
the	DT	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
promoter,	,	O
and	CC	O
culturing	VBG	O
the	DT	O
host	NN	O
cell	NN	O
under	IN	O
conditions	NNS	O
that	WDT	O
allow	VBP	O
expression	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
method	NN	O
of	IN	O
making	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
at	IN	O
least	JJS	O
10	CD	O
amino	JJ	O
acids	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto.	.	O
The	DT	O
method	NN	O
includes	VBZ	O
introducing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
the	DT	O
polypeptide	NN	O
into	IN	O
a	DT	O
host	NN	O
cell,	,	O
wherein	VBZ	O
the	DT	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
promoter,	,	O
and	CC	O
culturing	VBG	O
the	DT	O
host	NN	O
cell	NN	O
under	IN	O
conditions	NNS	O
that	WDT	O
allow	VBP	O
expression	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid,	,	O
thereby	RB	O
producing	VBG	O
the	DT	O
polypeptide.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
method	NN	O
of	IN	O
generating	VBG	O
a	DT	O
variant	JJ	O
including	VBG	O
obtaining	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences,	,	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto,	,	O
sequences	NNS	O
complementary	VBP	O
to	TO	O
the	DT	O
sequences	NNS	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences,	,	O
fragments	NNS	O
comprising	VBG	O
at	IN	O
least	JJS	O
30	CD	O
consecutive	JJ	O
nucleotides	NNS	O
of	IN	O
the	DT	O
foregoing	NN	O
sequences,	,	O
and	CC	O
changing	VBG	O
one	CD	O
or	CC	O
more	JJR	O
nucleotides	NNS	O
in	IN	O
the	DT	O
sequence	NN	O
to	TO	O
another	DT	O
nucleotide,	,	O
deleting	VBG	O
one	CD	O
or	CC	O
more	JJR	O
nucleotides	NNS	O
in	IN	O
the	DT	O
sequence,	,	O
or	CC	O
adding	VBG	O
one	CD	O
or	CC	O
more	JJR	O
nucleotides	NNS	O
to	TO	O
the	DT	O
sequence.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
computer	NN	O
readable	JJ	O
medium	NN	O
having	VBG	O
stored	VBN	O
thereon	IN	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto,	,	O
or	CC	O
a	DT	O
polypeptide	JJ	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
computer	NN	O
system	NN	O
including	VBG	O
a	DT	O
processor	NN	O
and	CC	O
a	DT	O
data	NN	O
storage	NN	O
device	NN	O
wherein	IN	O
the	DT	O
data	NNS	O
storage	NN	O
device	NN	O
has	VBZ	O
stored	VBN	O
thereon	RP	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto,	,	O
or	CC	O
a	DT	O
polypeptide	JJ	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
method	NN	O
for	IN	O
comparing	VBG	O
a	DT	O
first	JJ	O
sequence	NN	O
to	TO	O
a	DT	O
reference	NN	O
sequence	NN	O
wherein	VBD	O
the	DT	O
first	JJ	O
sequence	NN	O
is	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto,	,	O
or	CC	O
a	DT	O
polypeptide	JJ	O
code	NN	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto.	.	O
The	DT	O
method	NN	O
includes	VBZ	O
reading	VBG	O
the	DT	O
first	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
reference	NN	O
sequence	NN	O
through	IN	O
use	NN	O
of	IN	O
a	DT	O
computer	NN	O
program	NN	O
which	WDT	O
compares	VBZ	O
sequences;	:	O
and	CC	O
determining	VBG	O
differences	NNS	O
between	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
reference	NN	O
sequence	NN	O
with	IN	O
the	DT	O
computer	NN	O
program.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
method	NN	O
for	IN	O
identifying	VBG	O
a	DT	O
feature	NN	O
in	IN	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto,	,	O
or	CC	O
a	DT	O
polypeptide	JJ	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto,	,	O
including	VBG	O
reading	VBG	O
the	DT	O
sequence	NN	O
through	IN	O
the	DT	O
use	NN	O
of	IN	O
a	DT	O
computer	NN	O
program	NN	O
which	WDT	O
identifies	VBZ	O
features	NNS	O
in	IN	O
sequences;	:	O
and	CC	O
identifying	VBG	O
features	NNS	O
in	IN	O
the	DT	O
sequence	NN	O
with	IN	O
the	DT	O
computer	NN	O
program.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
assay	NN	O
for	IN	O
identifying	VBG	O
fragments	NNS	O
or	CC	O
variants	NNS	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto,	,	O
which	WDT	O
retain	VBP	O
the	DT	O
enzymatic	JJ	O
function	NN	O
of	IN	O
the	DT	O
polypeptides	NNS	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto.	.	O
The	DT	O
assay	NN	O
includes	VBZ	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
sequences	VBZ	O
substantially	RB	O
identical	JJ	O
thereto,	,	O
or	CC	O
polypeptide	VB	O
fragment	NN	O
or	CC	O
variant	NN	O
with	IN	O
a	DT	O
substrate	NN	O
molecule	NN	O
under	IN	O
conditions	NNS	O
which	WDT	O
allow	VBP	O
the	DT	O
polypeptide	JJ	O
fragment	NN	O
or	CC	O
variant	NN	O
to	TO	O
function,	,	O
and	CC	O
detecting	VBG	O
either	CC	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
level	NN	O
of	IN	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
level	NN	O
of	IN	O
the	DT	O
specific	JJ	O
reaction	NN	O
product	NN	O
of	IN	O
the	DT	O
reaction	NN	O
between	IN	O
the	DT	O
polypeptide	NN	O
and	CC	O
substrate	VB	O
thereby	RB	O
identifying	VBG	O
a	DT	O
fragment	NN	O
or	CC	O
variant	NN	O
of	IN	O
such	JJ	O
sequences.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
process	NN	O
for	IN	O
preparing	VBG	O
a	DT	O
dough	NN	O
or	CC	O
a	DT	O
baked	JJ	O
product	NN	O
prepared	VBN	O
from	IN	O
the	DT	O
dough	NN	O
which	WDT	O
comprises	VBZ	O
adding	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
the	DT	O
dough	NN	O
in	IN	O
an	DT	O
amount	NN	O
which	WDT	O
is	VBZ	O
effective	JJ	O
to	TO	O
retard	VB	O
the	DT	O
staling	NN	O
of	IN	O
the	DT	O
bread.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
dough	NN	O
comprising	NN	O
said	VBD	O
amylase	NN	O
and	CC	O
a	DT	O
premix	NN	O
comprising	VBG	O
flour	PRP$	O
together	NN	O
with	IN	O
said	VBD	O
amylase.	.	O
Finally,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
enzymatic	JJ	O
baking	NN	O
additive,	,	O
which	WDT	O
contains	VBZ	O
said	VBD	O
amylase.	.	O
The	DT	O
use	NN	O
of	IN	O
the	DT	O
amylase	NN	O
in	IN	O
accordance	NN	O
with	IN	O
the	DT	O
present	JJ	O
invention	NN	O
provides	VBZ	O
an	DT	O
improved	JJ	O
anti-staling	JJ	O
effect	NN	O
as	IN	O
measured	VBN	O
by,	,	O
e.g.	.	O
less	RBR	O
crumb	JJ	O
firming,	,	O
retained	VBD	O
crumb	JJ	O
elasticity,	,	O
improved	VBN	O
slice-ability	NN	O
(e.g.	.	O
fewer	JJR	O
crumbs,	,	O
non-gummy	JJ	O
crumb),	,	O
improved	VBN	O
palatability	NN	O
or	CC	O
flavor.	.	O
The	DT	O
details	NNS	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
embodiments	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
set	VBN	O
forth	NN	O
in	IN	O
the	DT	O
accompanying	JJ	O
drawings	NNS	O
and	CC	O
the	DT	O
description	NN	O
below.	.	O
Other	JJ	O
features,	,	O
objects,	,	O
and	CC	O
advantages	NNS	O
of	IN	O
the	DT	O
invention	NN	O
will	MD	O
be	VB	O
apparent	JJ	O
from	IN	O
the	DT	O
description	NN	O
and	CC	O
drawings,	,	O
and	CC	O
from	IN	O
the	DT	O
claims.	.	O
All	DT	O
publications,	,	O
patents,	,	O
patent	NN	O
applications,	,	O
GenBank	NNP	O
sequences	NNS	O
and	CC	O
ATCC	NNP	O
deposits,	,	O
cited	VBN	O
herein	NN	O
are	VBP	O
hereby	RB	O
expressly	RB	O
incorporated	VBN	O
by	IN	O
reference	NN	O
for	IN	O
all	DT	O
purposes.	.	O
DESCRIPTION	NNP	O
OF	NNP	O
DRAWINGS	NNP	O
FIG.	.	O
1	CD	O
is	VBZ	O
a	DT	O
block	NN	O
diagram	NN	O
of	IN	O
a	DT	O
computer	NN	O
system.	.	O
FIG.	.	O
2	CD	O
is	VBZ	O
a	DT	O
flow	JJ	O
diagram	NN	O
illustrating	VBG	O
one	CD	O
aspect	NN	O
of	IN	O
a	DT	O
process	NN	O
for	IN	O
comparing	VBG	O
a	DT	O
new	JJ	O
nucleotide	NN	O
or	CC	O
protein	NN	O
sequence	NN	O
with	IN	O
a	DT	O
database	NN	O
of	IN	O
sequences	NNS	O
in	IN	O
order	NN	O
to	TO	O
determine	VB	O
the	DT	O
homology	NN	O
levels	NNS	O
between	IN	O
the	DT	O
new	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
sequences	NNS	O
in	IN	O
the	DT	O
database.	.	O
FIG.	.	O
3	CD	O
is	VBZ	O
a	DT	O
flow	JJ	O
diagram	NN	O
illustrating	VBG	O
one	CD	O
aspect	NN	O
of	IN	O
a	DT	O
process	NN	O
in	IN	O
a	DT	O
computer	NN	O
for	IN	O
determining	VBG	O
whether	IN	O
two	CD	O
sequences	NNS	O
are	VBP	O
homologous.	.	O
FIG.	.	O
4	CD	O
is	VBZ	O
a	DT	O
flow	JJ	O
diagram	NN	O
illustrating	VBG	O
one	CD	O
aspect	NN	O
of	IN	O
an	DT	O
identifier	NN	O
process	NN	O
300	CD	O
for	IN	O
detecting	VBG	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
feature	NN	O
in	IN	O
a	DT	O
sequence.	.	O
FIG.	.	O
5	CD	O
illustrates	VBZ	O
a	DT	O
sample	JJ	O
Standard	NNP	O
Curve	NNP	O
of	IN	O
the	DT	O
assay	NN	O
of	IN	O
Example	NNP	O
3.	.	O
FIG.	.	O
6	CD	O
a	DT	O
and	CC	O
FIG.	.	O
6	CD	O
b	NN	O
show	NN	O
the	DT	O
molecular	JJ	O
weight	NN	O
fragments	NNS	O
in	IN	O
syrups	NNS	O
using	VBG	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
commercial	JJ	O
enzymes,	,	O
as	IN	O
discussed	VBN	O
below.	.	O
FIG.	.	O
7	CD	O
illustrates	VBZ	O
the	DT	O
sequences	NNS	O
of	IN	O
the	DT	O
invention.	.	O
FIG.	.	O
8	CD	O
shows	VBZ	O
a	DT	O
comparison	NN	O
of	IN	O
oligosaccharide	JJ	O
profiles	NNS	O
for	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
and	CC	O
commercial	JJ	O
amylases.	.	O
Like	IN	O
reference	NN	O
symbols	NNS	O
in	IN	O
the	DT	O
various	JJ	O
drawings	NNS	O
indicate	VBP	O
like	IN	O
elements.	.	O
DETAILED	JJ	O
DESCRIPTION	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
amylase	JJ	O
enzymes,	,	O
e.g.,	,	O
an	DT	O
alpha	JJ	O
amylase,	,	O
polynucleotides	VBZ	O
encoding	VBG	O
the	DT	O
enzymes,	,	O
methods	NNS	O
of	IN	O
making	VBG	O
and	CC	O
using	VBG	O
these	DT	O
polynucleotides	NNS	O
and	CC	O
polypeptides.	.	O
The	DT	O
invention	NN	O
is	VBZ	O
directed	VBN	O
to	TO	O
novel	VB	O
polypeptides	NNS	O
having	VBG	O
an	DT	O
amylase	NN	O
activity,	,	O
e.g.,	,	O
an	DT	O
alpha	JJ	O
amylase	NN	O
activity,	,	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
them	PRP	O
and	CC	O
antibodies	NNS	O
that	WDT	O
bind	VBP	O
to	TO	O
them.	.	O
The	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
diagnostic,	,	O
therapeutic,	,	O
and	CC	O
industrial	JJ	O
contexts.	.	O
The	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
as,	,	O
e.g.,	,	O
an	DT	O
additive	NN	O
for	IN	O
a	DT	O
detergent,	,	O
for	IN	O
processing	VBG	O
foods	NNS	O
and	CC	O
for	IN	O
chemical	JJ	O
synthesis	NN	O
utilizing	VBG	O
a	DT	O
reverse	JJ	O
reaction.	.	O
Additionally,	,	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
fabric	JJ	O
treatment,	,	O
alcohol	NN	O
production,	,	O
and	CC	O
as	IN	O
additives	NNS	O
to	TO	O
food	NN	O
or	CC	O
animal	NN	O
feed.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
active	JJ	O
at	IN	O
a	DT	O
high	JJ	O
and/or	NN	O
at	IN	O
a	DT	O
low	JJ	O
temperature,	,	O
or,	,	O
over	IN	O
a	DT	O
wide	JJ	O
range	NN	O
of	IN	O
temperature.	.	O
For	IN	O
example,	,	O
they	PRP	O
can	MD	O
be	VB	O
active	JJ	O
in	IN	O
the	DT	O
temperatures	NNS	O
ranging	VBG	O
between	IN	O
20°	CD	O
C.	NNP	O
to	TO	O
90°	CD	O
C.,	,	O
between	IN	O
30°	CD	O
C.	NNP	O
to	TO	O
80°	CD	O
C.,	,	O
or	CC	O
between	IN	O
40°	CD	O
C.	NNP	O
to	TO	O
70°	CD	O
C.	NNP	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
amylases	NNS	O
that	WDT	O
have	VBP	O
activity	NN	O
at	IN	O
alkaline	JJ	O
pHs	NN	O
or	CC	O
at	IN	O
acidic	JJ	O
pHs,	,	O
e.g.,	,	O
low	JJ	O
water	NN	O
acidity.	.	O
In	IN	O
alternative	JJ	O
aspects,	,	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
have	VB	O
activity	NN	O
in	IN	O
acidic	JJ	O
pHs	NN	O
as	RB	O
low	JJ	O
as	IN	O
pH	NN	O
5.0,	,	O
pH	NN	O
4.5,	,	O
pH	NN	O
4.0,	,	O
and	CC	O
pH	RB	O
3.5.	.	O
In	IN	O
alternative	JJ	O
aspects,	,	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
have	VB	O
activity	NN	O
in	IN	O
alkaline	NN	O
pHs	NN	O
as	RB	O
high	JJ	O
as	IN	O
pH	NN	O
9.5,	,	O
pH	NN	O
10,	,	O
pH	NN	O
10.5,	,	O
and	CC	O
pH	RB	O
11.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
active	JJ	O
in	IN	O
the	DT	O
temperature	NN	O
range	NN	O
of	IN	O
between	IN	O
about	IN	O
40°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
70°	CD	O
C.	NNP	O
under	IN	O
conditions	NNS	O
of	IN	O
low	JJ	O
water	NN	O
activity	NN	O
(low	JJ	O
water	NN	O
content).	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
methods	NNS	O
for	IN	O
further	JJ	O
modifying	VBG	O
the	DT	O
exemplary	JJ	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
generate	VB	O
proteins	NNS	O
with	IN	O
desirable	JJ	O
properties.	.	O
For	IN	O
example,	,	O
amylases	NNS	O
generated	VBN	O
by	IN	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
have	VB	O
altered	VBN	O
enzymatic	JJ	O
activity,	,	O
thermal	JJ	O
stability,	,	O
pH/activity	NN	O
profile,	,	O
pH/stability	NN	O
profile	NN	O
(such	JJ	O
as	IN	O
increased	JJ	O
stability	NN	O
at	IN	O
low,	,	O
e.g.	.	O
pH<6	CD	O
or	CC	O
pH<5,	,	O
or	CC	O
high,	,	O
e.g.	.	O
pH>9,	,	O
pH	NN	O
values),	,	O
stability	NN	O
towards	NNS	O
oxidation,	,	O
Ca2+	NNP	O
dependency,	,	O
specific	JJ	O
activity	NN	O
and	CC	O
the	DT	O
like.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
for	IN	O
altering	VBG	O
any	DT	O
property	NN	O
of	IN	O
interest.	.	O
For	IN	O
instance,	,	O
the	DT	O
alteration	NN	O
may	MD	O
result	VB	O
in	IN	O
a	DT	O
variant	NN	O
which,	,	O
as	IN	O
compared	VBN	O
to	TO	O
a	DT	O
parent	NN	O
enzyme,	,	O
has	VBZ	O
altered	VBN	O
enzymatic	JJ	O
activity,	,	O
or,	,	O
pH	''	O
or	CC	O
temperature	NN	O
activity	NN	O
profiles.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
present	JJ	O
invention	NN	O
relates	VBZ	O
to	TO	O
alpha	VB	O
amylases	NNS	O
and	CC	O
polynucleotides	NNS	O
encoding	VBG	O
them.	.	O
As	IN	O
used	VBN	O
herein,	,	O
the	DT	O
term	NN	O
“alpha	NNP	O
amylase”	NN	O
encompasses	VBZ	O
enzymes	RB	O
having	VBG	O
alpha	JJ	O
amylase	NN	O
activity,	,	O
for	IN	O
example,	,	O
enzymes	VBZ	O
capable	JJ	O
of	IN	O
hydrolyzing	VBG	O
starch	NN	O
to	TO	O
sugars.	.	O
Unlike	IN	O
many	JJ	O
known	VBN	O
amylases,	,	O
the	DT	O
exemplary	JJ	O
amylase	NN	O
of	IN	O
the	DT	O
invention,	,	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
is	VBZ	O
not	RB	O
a	DT	O
calcium-dependent	JJ	O
enzyme.	.	O
It	PRP	O
is	VBZ	O
highly	RB	O
desirable	JJ	O
to	TO	O
be	VB	O
able	JJ	O
to	TO	O
decrease	VB	O
the	DT	O
Ca2+	NNP	O
dependency	NN	O
of	IN	O
an	DT	O
alpha	JJ	O
amylase.	.	O
Accordingly,	,	O
one	CD	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
amylase	NN	O
enzyme	NN	O
that	WDT	O
has	VBZ	O
a	DT	O
decreased	VBN	O
Ca2+	NNP	O
dependency	NN	O
as	RB	O
compared	VBN	O
to	TO	O
commercial	JJ	O
or	CC	O
parent	JJ	O
amylases.	.	O
Decreased	VBN	O
Ca2+	NNP	O
dependency	NN	O
will	MD	O
in	IN	O
general	JJ	O
have	VBP	O
the	DT	O
functional	JJ	O
consequence	NN	O
that	IN	O
the	DT	O
variant	JJ	O
exhibits	VBZ	O
a	DT	O
satisfactory	JJ	O
amylolytic	JJ	O
activity	NN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
lower	JJR	O
concentration	NN	O
of	IN	O
calcium	NN	O
ion	NN	O
in	IN	O
the	DT	O
extraneous	JJ	O
medium	NN	O
than	IN	O
is	VBZ	O
necessary	JJ	O
for	IN	O
a	DT	O
commercial	JJ	O
or	CC	O
parent	JJ	O
enzyme.	.	O
It	PRP	O
will	MD	O
further	RBR	O
often	RB	O
have	VBP	O
the	DT	O
consequence	NN	O
that	IN	O
the	DT	O
variant	NN	O
is	VBZ	O
less	RBR	O
sensitive	JJ	O
to	TO	O
calcium	VB	O
ion-depleting	JJ	O
conditions	NNS	O
such	JJ	O
as	IN	O
those	DT	O
obtained	VBN	O
in	IN	O
media	NNS	O
containing	VBG	O
calcium-complexing	JJ	O
agents	NNS	O
(such	JJ	O
as	IN	O
certain	JJ	O
detergent	NN	O
builders).	.	O
The	DT	O
polynucleotides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
have	VBP	O
been	VBN	O
identified	VBN	O
as	IN	O
encoding	VBG	O
polypeptides	NNS	O
having	VBG	O
alpha	JJ	O
amylase	NN	O
activity.	.	O
An	DT	O
exemplary	JJ	O
alpha	NN	O
amylase	NN	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
shown	VBN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
also	RB	O
referred	VBD	O
to	TO	O
herein	VB	O
as	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2.	.	O
Such	JJ	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
particularly	RB	O
useful	JJ	O
in	IN	O
corn-wet	JJ	O
milling	NN	O
processes,	,	O
detergents,	,	O
baking	VBG	O
processes,	,	O
beverages	NNS	O
and	CC	O
in	IN	O
oilfields	NNS	O
(fuel	NN	O
ethanol).	.	O
Alterations	NNS	O
in	IN	O
properties	NNS	O
which	WDT	O
may	MD	O
be	VB	O
achieved	VBN	O
in	IN	O
variants	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
alterations	NNS	O
in,	,	O
e.g.,	,	O
substrate	JJ	O
specificity,	,	O
substrate	NN	O
binding,	,	O
substrate	JJ	O
cleavage	NN	O
pattern,	,	O
thermal	JJ	O
stability,	,	O
pH/activity	NN	O
profile,	,	O
pH/stability	NN	O
profile,	,	O
such	JJ	O
as	IN	O
increased	JJ	O
stability	NN	O
at	IN	O
low	JJ	O
(e.g.	.	O
pH<6,	,	O
in	IN	O
particular	JJ	O
pH<5)	)	O
or	CC	O
high	JJ	O
(e.g.	.	O
pH>9)	)	O
pH	NN	O
values],	,	O
stability	NN	O
towards	NNS	O
oxidation,	,	O
Ca2+	NNP	O
dependency,	,	O
specific	JJ	O
activity,	,	O
and	CC	O
other	JJ	O
properties	NNS	O
of	IN	O
interest.	.	O
For	IN	O
instance,	,	O
the	DT	O
alteration	NN	O
may	MD	O
result	VB	O
in	IN	O
a	DT	O
variant	NN	O
which,	,	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
parent	NN	O
amylase,	,	O
has	VBZ	O
a	DT	O
reduced	VBN	O
Ca2+	NNP	O
dependency	NN	O
and/or	VBD	O
an	DT	O
altered	JJ	O
pH/activity	NN	O
profile.	.	O
Corn	NNP	O
wet	NN	O
milling	NN	O
is	VBZ	O
a	DT	O
process	NN	O
which	WDT	O
produces	VBZ	O
corn	NN	O
oil,	,	O
gluten	VB	O
meal,	,	O
gluten	VBP	O
feed	NN	O
and	CC	O
starch.	.	O
Amylases	NNS	O
of	IN	O
the	DT	O
invention,	,	O
including	VBG	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
are	VBP	O
used	VBN	O
in	IN	O
the	DT	O
liquefaction	NN	O
of	IN	O
starch	NN	O
and	CC	O
glucoamylase	NN	O
is	VBZ	O
used	VBN	O
in	IN	O
saccharification,	,	O
producing	VBG	O
glucose.	.	O
The	DT	O
properties	NNS	O
of	IN	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
are	VBP	O
unique	JJ	O
in	IN	O
that	DT	O
they	PRP	O
allow	VBP	O
production	NN	O
of	IN	O
liquefied	VBN	O
syrups	NNS	O
which	WDT	O
can	MD	O
be	VB	O
converted	VBN	O
to	TO	O
higher	JJR	O
dextrose	NN	O
levels	NNS	O
than	IN	O
a	DT	O
conventional	JJ	O
Bacillus	NNP	O
amylase	NN	O
liquefied	VBD	O
syrup.	.	O
As	IN	O
can	MD	O
be	VB	O
seen	VBN	O
in	IN	O
FIG.	.	O
6	CD	O
a	DT	O
and	CC	O
FIG.	.	O
6	CD	O
b	NN	O
and	CC	O
in	IN	O
the	DT	O
Examples,	,	O
the	DT	O
molecular	JJ	O
weight	NN	O
profile	NN	O
of	IN	O
liquefied	VBN	O
starch	NN	O
produced	VBN	O
by	IN	O
commercial	JJ	O
amylases	NNS	O
derived	VBN	O
from	IN	O
Bacillus	NNP	O
licheniformis	NNS	O
and	CC	O
Bacillus	NNP	O
stearothermophilus	VBP	O
exhibit	VB	O
a	DT	O
bimodal	JJ	O
distribution	NN	O
with	IN	O
a	DT	O
primary	JJ	O
peak	NN	O
at	IN	O
1000-2000	CD	O
MW	NNP	O
representing	VBG	O
approximately	RB	O
60%	NN	O
of	IN	O
the	DT	O
mass	NN	O
with	IN	O
a	DT	O
secondary	JJ	O
peak	NN	O
at	IN	O
30,000-40,000	CD	O
MW.	.	O
In	IN	O
addition,	,	O
there	EX	O
is	VBZ	O
a	DT	O
substantial	JJ	O
fraction	NN	O
at	IN	O
greater	JJR	O
than	IN	O
100,000	CD	O
MW.	.	O
The	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
exhibit	NN	O
a	DT	O
homogeneous	JJ	O
MW	NNP	O
distribution	NN	O
centered	VBD	O
at	IN	O
1000-2000	CD	O
MW	NNP	O
with	IN	O
less	JJR	O
than	IN	O
10%	NN	O
of	IN	O
the	DT	O
mass	NN	O
greater	JJR	O
than	IN	O
25,000	CD	O
MW.	.	O
The	DT	O
higher	JJR	O
MW	NNP	O
oligosaccharides	NNS	O
are	VBP	O
not	RB	O
fully	RB	O
converted	VBN	O
to	TO	O
glucose	VB	O
during	IN	O
saccharification.	.	O
Consequently,	,	O
the	DT	O
commercial	JJ	O
amylases	NNS	O
will	MD	O
contain	VB	O
less	JJR	O
dextrose	JJ	O
than	IN	O
saccharified	JJ	O
syrups	NNS	O
from	IN	O
the	DT	O
liquefaction	NN	O
process	NN	O
carried	VBD	O
out	RP	O
by	IN	O
amylase	JJ	O
enzymes	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention,	,	O
such	JJ	O
as	IN	O
that	DT	O
represented	VBD	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
and	CC	O
functional	JJ	O
equivalents	NNS	O
thereof.	.	O
Maltodextrins	NNS	O
are	VBP	O
utilized	VBN	O
in	IN	O
a	DT	O
wide	JJ	O
variety	NN	O
of	IN	O
food	NN	O
and	CC	O
coating	NN	O
applications.	.	O
Amylases	NNS	O
from	IN	O
Archeal	NNP	O
sources	NNS	O
generate	VBP	O
an	DT	O
extremely	RB	O
uniform	JJ	O
maltodextrin	NN	O
composition	NN	O
(see	VB	O
also	RB	O
Leveque	NNP	B
et	CC	I
al.,	,	I
Enzyme	NNP	I
and	CC	I
Microbial	NNP	I
Technology	NNP	I
26:3-14,	,	I
2000,	,	I
herein	RB	O
incorporated	VBN	O
by	IN	O
reference).	.	O
The	DT	O
use	NN	O
of	IN	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
liquefy	VB	O
corn	NN	O
starch	NN	O
results	NNS	O
in	IN	O
a	DT	O
uniform	JJ	O
maltodextrin	NN	O
composition.	.	O
The	DT	O
liquefaction	NN	O
can	MD	O
be	VB	O
performed	VBN	O
at	IN	O
a	DT	O
pH	NN	O
of	IN	O
about	IN	O
4.5-6.5,	,	O
and	CC	O
preferably	RB	O
around	IN	O
pH	JJ	O
5.0	CD	O
and	CC	O
at	IN	O
temperatures	NNS	O
of	IN	O
up	IN	O
to	TO	O
105	CD	O
degrees	NNS	O
C.	NNP	O
or	CC	O
higher.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
liquefaction	NN	O
is	VBZ	O
performed	VBN	O
at	IN	O
a	DT	O
pH	NN	O
of	IN	O
4.5.	.	O
In	IN	O
addition	NN	O
to	TO	O
the	DT	O
benefits	NNS	O
demonstrated	VBN	O
in	IN	O
saccharification,	,	O
the	DT	O
liquefied	JJ	O
syrups	NNS	O
can	MD	O
be	VB	O
carbon	VBN	O
treated,	,	O
spray	NN	O
dried	VBD	O
and	CC	O
utilized	JJ	O
as	IN	O
food	NN	O
additives,	,	O
thickeners,	,	O
low	JJ	O
caloric	NN	O
bulking	NN	O
agents,	,	O
film	NN	O
forming	VBG	O
agents,	,	O
etc.	.	O
It	PRP	O
is	VBZ	O
anticipated	VBN	O
(but	CC	O
not	RB	O
yet	RB	O
proven)	)	O
that	IN	O
the	DT	O
homogenous	JJ	O
molecular	JJ	O
weight	NN	O
profile	NN	O
maltodextrins	NNS	O
will	MD	O
have	VB	O
performance	NN	O
advantages	NNS	O
vs.	VBP	O
the	DT	O
bimodal	JJ	O
distribution	NN	O
maltodextrins	NNS	O
produced	VBN	O
by	IN	O
the	DT	O
conventional	JJ	O
Bacillus	NNP	O
enzymes.	.	O
Definitions	NNS	O
The	DT	O
term	NN	O
“amylase”	NNP	O
includes	VBZ	O
all	DT	O
polypeptides,	,	O
e.g.,	,	O
enzymes,	,	O
which	WDT	O
catalyze	VBP	O
the	DT	O
hydrolysis	NN	O
of	IN	O
starches.	.	O
For	IN	O
example,	,	O
an	DT	O
amylase	NN	O
activity	NN	O
of	IN	O
the	DT	O
invention	NN	O
includes	VBZ	O
α-amylase	JJ	O
activity,	,	O
including	VBG	O
the	DT	O
ability	NN	O
to	TO	O
hydrolyze	VB	O
internal	JJ	O
alpha-1,4-glucosidic	JJ	O
linkages	NNS	O
in	IN	O
starch	NN	O
to	TO	O
produce	VB	O
smaller	JJR	O
molecular	JJ	O
weight	VBD	O
malto-dextrins.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
α-amylase	JJ	O
activity	NN	O
includes	VBZ	O
hydrolyzing	VBG	O
internal	JJ	O
alpha-1,4-glucosidic	JJ	O
linkages	NNS	O
in	IN	O
starch	NN	O
at	IN	O
random.	.	O
An	DT	O
amylase	NN	O
activity	NN	O
of	IN	O
the	DT	O
invention	NN	O
includes	VBZ	O
polypeptides	NNS	O
having	VBG	O
glucoamylase	NN	O
activity,	,	O
such	JJ	O
as	IN	O
the	DT	O
ability	NN	O
to	TO	O
hydrolase	VB	O
glucose	JJ	O
polymers	NNS	O
linked	VBN	O
by	IN	O
α-1,4-	JJ	O
and	CC	O
α-1,6-glucosidic	JJ	O
bonds.	.	O
In	IN	O
one	CD	O
aspect,	,	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
have	VBP	O
glucoamylase	VBN	O
activity,	,	O
hydrolyzing	VBG	O
internal	JJ	O
α-1,4-glucosidic	JJ	O
linkages	NNS	O
to	TO	O
yield	VB	O
smaller	JJR	O
molecular	JJ	O
weight	VBD	O
malto-dextrins.	.	O
An	DT	O
amylase	NN	O
activity	NN	O
of	IN	O
the	DT	O
invention	NN	O
also	RB	O
includes	VBZ	O
glucan	JJ	O
1,4-α-glucosidase	JJ	O
activity,	,	O
or,	,	O
1,4-α-D-glucan	JJ	O
glucohydrolase,	,	O
commonly	RB	O
called	VBD	O
glucoamylase	NN	O
but	CC	O
also	RB	O
called	VBD	O
amyloglucosidase	NN	O
and	CC	O
γ-amylase	NN	O
that,	,	O
in	IN	O
one	CD	O
aspect,	,	O
releases	VBZ	O
β-D-glucose	JJ	O
from	IN	O
1,4-α-,	,	O
1,6-α-	JJ	O
and	CC	O
1,3-α-linked	JJ	O
glucans.	.	O
An	DT	O
amylase	NN	O
activity	NN	O
of	IN	O
the	DT	O
invention	NN	O
also	RB	O
includes	VBZ	O
exo-amylase	JJ	O
activity.	.	O
An	DT	O
amylase	NN	O
activity	NN	O
of	IN	O
the	DT	O
invention	NN	O
also	RB	O
includes	VBZ	O
hydrolyzing	VBG	O
starch	NN	O
at	IN	O
high	JJ	O
temperatures,	,	O
low	JJ	O
temperatures,	,	O
alkaline	JJ	O
pHs	NN	O
and	CC	O
at	IN	O
acidic	JJ	O
pHs.	.	O
An	DT	O
“amylase	NN	O
variant”	NN	O
comprises	VBZ	O
an	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
which	WDT	O
is	VBZ	O
derived	VBN	O
from	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
a	DT	O
“precursor	NN	O
amylase”.	.	O
The	DT	O
precursor	NN	O
amylase	NN	O
can	MD	O
include	VB	O
naturally-occurring	JJ	O
amylases	NNS	O
and	CC	O
recombinant	JJ	O
amylases.	.	O
The	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
amylase	NN	O
variant	NN	O
can	MD	O
be	VB	O
“derived”	VBN	O
from	IN	O
the	DT	O
precursor	NN	O
amylase	NN	O
amino	NN	O
acid	JJ	O
sequence	NN	O
by	IN	O
the	DT	O
substitution,	,	O
deletion	NN	O
or	CC	O
insertion	NN	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
amino	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
precursor	NN	O
amino	NN	O
acid	JJ	O
sequence.	.	O
Such	JJ	O
modification	NN	O
can	MD	O
be	VB	O
of	IN	O
the	DT	O
“precursor	NNP	O
DNA	NNP	O
sequence”	NN	O
which	WDT	O
encodes	VBZ	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
precursor	NN	O
amylase	NN	O
rather	RB	O
than	IN	O
manipulation	NN	O
of	IN	O
the	DT	O
precursor	NN	O
amylase	NN	O
enzyme	FW	O
per	IN	O
se.	.	O
Suitable	JJ	O
methods	NNS	O
for	IN	O
such	JJ	O
manipulation	NN	O
of	IN	O
the	DT	O
precursor	NN	O
DNA	NNP	O
sequence	NN	O
include	VBP	O
methods	NNS	O
disclosed	VBD	O
herein,	,	O
as	RB	O
well	RB	O
as	IN	O
methods	NNS	O
known	VBN	O
to	TO	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art.	.	O
Liquefaction”	NNP	O
or	CC	O
“liquefy”	NNP	O
means	VBZ	O
a	DT	O
process	NN	O
by	IN	O
which	WDT	O
starch	NN	O
is	VBZ	O
converted	VBN	O
to	TO	O
shorter	JJR	O
chain	NN	O
and	CC	O
less	RBR	O
viscous	JJ	O
dextrins.	.	O
Generally,	,	O
this	DT	O
process	NN	O
involves	VBZ	O
gelatinization	NN	O
of	IN	O
starch	NN	O
simultaneously	RB	O
with	IN	O
or	CC	O
followed	VBN	O
by	IN	O
the	DT	O
addition	NN	O
of	IN	O
alpha	JJ	O
amylase.	.	O
In	IN	O
commercial	JJ	O
processes,	,	O
it	PRP	O
is	VBZ	O
preferred	VBN	O
that	IN	O
the	DT	O
granular	JJ	O
starch	NN	O
is	VBZ	O
derived	VBN	O
from	IN	O
a	DT	O
source	NN	O
comprising	VBG	O
corn,	,	O
wheat,	,	O
milo,	,	O
sorghum,	,	O
rye	NN	O
or	CC	O
bulgher.	.	O
However,	,	O
the	DT	O
present	JJ	O
invention	NN	O
applies	NNS	O
to	TO	O
any	DT	O
grain	NN	O
starch	NN	O
source	NN	O
which	WDT	O
is	VBZ	O
useful	JJ	O
in	IN	O
liquefaction,	,	O
e.g.,	,	O
any	DT	O
other	JJ	O
grain	NN	O
or	CC	O
vegetable	JJ	O
source	NN	O
known	VBN	O
to	TO	O
produce	VB	O
starch	NN	O
suitable	JJ	O
for	IN	O
liquefaction.	.	O
“Granular	JJ	O
starch”	NN	O
or	CC	O
“starch	NN	O
granules”	NN	O
means	VBZ	O
a	DT	O
water-insoluble	JJ	O
component	NN	O
of	IN	O
edible	JJ	O
grains	NNS	O
which	WDT	O
remains	VBZ	O
after	IN	O
removal	NN	O
of	IN	O
the	DT	O
hull,	,	O
fiber,	,	O
protein,	,	O
fat,	,	O
germ,	,	O
and	CC	O
solubles	NNS	O
through	IN	O
the	DT	O
steeping,	,	O
mechanical	JJ	O
cracking,	,	O
separations,	,	O
screening,	,	O
countercurrent	NN	O
rinsing	NN	O
and	CC	O
centrifugation	NN	O
steps	NNS	O
typical	JJ	O
of	IN	O
the	DT	O
grain	NN	O
wet-milling	JJ	O
process.	.	O
Granular	JJ	O
starch	NN	O
comprises	VBZ	O
intact	JJ	O
starch	NN	O
granules	NNS	O
containing,	,	O
almost	RB	O
exclusively,	,	O
packed	VBD	O
starch	NN	O
molecules	NNS	O
(i.e.,	,	O
amylopectin	NN	O
and	CC	O
amylose).	.	O
In	IN	O
corn,	,	O
the	DT	O
granular	JJ	O
starch	NN	O
component	NN	O
comprises	VBZ	O
about	IN	O
99%	NN	O
starch;	:	O
the	DT	O
remaining	VBG	O
1%	NN	O
being	VBG	O
comprised	VBN	O
of	IN	O
protein,	,	O
fat,	,	O
ash,	,	O
fiber	NN	O
and	CC	O
trace	NN	O
components	NNS	O
tightly	RB	O
associated	VBN	O
with	IN	O
the	DT	O
granules.	.	O
The	DT	O
packing	NN	O
structure	NN	O
of	IN	O
granular	JJ	O
starch	NN	O
severely	RB	O
retards	VBZ	O
the	DT	O
ability	NN	O
of	IN	O
.alpha.-amylase	NN	O
to	TO	O
hydrolyze	VB	O
starch.	.	O
Gelatinization	NN	O
of	IN	O
the	DT	O
starch	NN	O
is	VBZ	O
utilized	VBN	O
to	TO	O
disrupt	VB	O
the	DT	O
granules	NNS	O
to	TO	O
form	VB	O
a	DT	O
soluble	JJ	O
starch	NN	O
solution	NN	O
and	CC	O
facilitate	VB	O
enzymatic	JJ	O
hydrolysis.	.	O
“Starch	NN	O
solution”	NN	O
means	VBZ	O
the	DT	O
water	NN	O
soluble	JJ	O
gelatinized	VBN	O
starch	NN	O
which	WDT	O
results	NNS	O
from	IN	O
heating	VBG	O
granular	JJ	O
starch.	.	O
Upon	IN	O
heating	NN	O
of	IN	O
the	DT	O
granules	NNS	O
to	TO	O
above	VB	O
about	IN	O
72	CD	O
degrees	NNS	O
C.,	,	O
granular	JJ	O
starch	NN	O
dissociates	VBZ	O
to	TO	O
form	VB	O
an	DT	O
aqueous	JJ	O
mixture	NN	O
of	IN	O
loose	JJ	O
starch	NN	O
molecules.	.	O
This	DT	O
mixture	NN	O
comprising,	,	O
for	IN	O
example,	,	O
about	RB	O
75%	NN	O
amylopectin	NN	O
and	CC	O
25%	NN	O
amylose	NN	O
in	IN	O
yellow	JJ	O
dent	NN	O
corn	NN	O
forms	VBZ	O
a	DT	O
viscous	JJ	O
solution	NN	O
in	IN	O
water.	.	O
In	IN	O
commercial	JJ	O
processes	NNS	O
to	TO	O
form	VB	O
glucose	NN	O
or	CC	O
fructose,	,	O
it	PRP	O
is	VBZ	O
the	DT	O
starch	NN	O
solution	NN	O
which	WDT	O
is	VBZ	O
liquefied	VBN	O
to	TO	O
form	VB	O
a	DT	O
soluble	JJ	O
dextrin	JJ	O
solution.	.	O
“alpha	JJ	O
amylase”	NN	O
means	VBZ	O
an	DT	O
enzymatic	JJ	O
activity	NN	O
which	WDT	O
cleaves	VBZ	O
or	CC	O
hydrolyzes	VBZ	O
the	DT	O
alpha	NN	O
(1-4)	)	O
glycosidic	JJ	O
bond,	,	O
e.g.,	,	O
that	IN	O
in	IN	O
starch,	,	O
amylopectin	NN	O
or	CC	O
amylose	JJ	O
polymers.	.	O
Suitable	JJ	O
alpha	NN	O
amylases	NNS	O
are	VBP	O
the	DT	O
naturally	RB	O
occurring	VBG	O
alpha	JJ	O
amylases	NNS	O
as	RB	O
well	RB	O
as	IN	O
recombinant	NN	O
or	CC	O
mutant	NN	O
amylases	NNS	O
which	WDT	O
are	VBP	O
useful	JJ	O
in	IN	O
liquefaction	NN	O
of	IN	O
starch.	.	O
Techniques	NNS	O
for	IN	O
producing	VBG	O
variant	JJ	O
amylases	NNS	O
having	VBG	O
activity	NN	O
at	IN	O
a	DT	O
pH	NN	O
or	CC	O
temperature,	,	O
for	IN	O
example,	,	O
that	WDT	O
is	VBZ	O
different	JJ	O
from	IN	O
the	DT	O
wild-type	JJ	O
amylase,	,	O
are	VBP	O
included	VBN	O
herein.	.	O
In	IN	O
practicing	VBG	O
the	DT	O
invention,	,	O
the	DT	O
temperature	NN	O
range	NN	O
of	IN	O
the	DT	O
liquefaction	NN	O
can	MD	O
be	VB	O
any	DT	O
liquefaction	NN	O
temperature	NN	O
which	WDT	O
is	VBZ	O
known	VBN	O
to	TO	O
be	VB	O
effective	JJ	O
in	IN	O
liquefying	VBG	O
starch.	.	O
The	DT	O
temperature	NN	O
of	IN	O
the	DT	O
starch	NN	O
can	MD	O
be	VB	O
between	IN	O
about	RB	O
80°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
115°	CD	O
C.,	,	O
or	CC	O
from	IN	O
about	IN	O
100°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
110°	CD	O
C.,	,	O
and/or	NN	O
from	IN	O
about	IN	O
105°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
108°	CD	O
C.	NNP	O
The	DT	O
term	NN	O
“antibody”	NNP	O
includes	VBZ	O
a	DT	O
peptide	NN	O
or	CC	O
polypeptide	NN	O
derived	VBN	O
from,	,	O
modeled	VBN	O
after	IN	O
or	CC	O
substantially	RB	O
encoded	VBN	O
by	IN	O
an	DT	O
immunoglobulin	JJ	O
gene	NN	O
or	CC	O
immunoglobulin	NN	O
genes,	,	O
or	CC	O
fragments	NNS	O
thereof,	,	O
capable	JJ	O
of	IN	O
specifically	RB	O
binding	VBG	O
an	DT	O
antigen	NN	O
or	CC	O
epitope,	,	O
see,	,	O
e.g.	.	O
Fundamental	JJ	B
Immunology,	,	I
Third	NNP	I
Edition,	,	I
W.	NNP	I
E.	NNP	I
Paul,	,	I
ed.,	,	I
Raven	NNP	I
Press,	,	I
N.Y.	NNP	I
(1993);	:	I
Wilson	NNP	O
(1994)	)	O
J.	NNP	O
Immunol.	.	O
Methods	NNS	O
175:267-273;	:	O
Yarmush	NNP	O
(1992)	)	O
J.	NNP	O
Biochem.	.	O
Biophys.	.	O
Methods	NNS	O
25:85-97.	.	O
The	DT	O
term	NN	O
antibody	NN	O
includes	VBZ	O
antigen-binding	JJ	O
portions,	,	O
i.e.,	,	O
“antigen	FW	O
binding	VBG	O
sites,”	NNP	O
(e.g.,	,	O
fragments,	,	O
subsequences,	,	O
complementarity	NN	O
determining	VBG	O
regions	NNS	O
(CDRs))	)	O
that	WDT	O
retain	VBP	O
capacity	NN	O
to	TO	O
bind	VB	O
antigen,	,	O
including	VBG	O
(i)	)	O
a	DT	O
Fab	NNP	O
fragment,	,	O
a	DT	O
monovalent	JJ	O
fragment	NN	O
consisting	NN	O
of	IN	O
the	DT	O
VL,	,	O
VH,	,	O
CL	NNP	O
and	CC	O
CH1	NNP	O
domains;	:	O
(ii)	)	O
a	DT	O
F(ab′)2	CD	O
fragment,	,	O
a	DT	O
bivalent	JJ	O
fragment	NN	O
comprising	VBG	O
two	CD	O
Fab	NNP	O
fragments	NNS	O
linked	VBN	O
by	IN	O
a	DT	O
disulfide	NN	O
bridge	NN	O
at	IN	O
the	DT	O
hinge	NN	O
region;	:	O
(iii)	)	O
a	DT	O
Fd	NNP	O
fragment	NN	O
consisting	NN	O
of	IN	O
the	DT	O
VH	NNP	O
and	CC	O
CH1	NNP	O
domains;	:	O
(iv)	)	O
a	DT	O
Fv	NNP	O
fragment	NN	O
consisting	NN	O
of	IN	O
the	DT	O
VL	NNP	O
and	CC	O
VH	NNP	O
domains	NNS	O
of	IN	O
a	DT	O
single	JJ	O
arm	NN	O
of	IN	O
an	DT	O
antibody,	,	O
(v)	)	O
a	DT	O
dAb	JJ	O
fragment	NN	O
Ward	NNP	B
et	VBZ	I
al.,	,	I
(1989)	)	I
Nature	NNP	I
341:544-546),(	,	O
which	WDT	O
consists	VBZ	O
of	IN	O
a	DT	O
VH	NNP	O
domain;	:	O
and	CC	O
(vi)	)	O
an	DT	O
isolated	JJ	O
complementarity	NN	O
determining	VBG	O
region	NN	O
(CDR).	.	O
Single	NNP	O
chain	NN	O
antibodies	NNS	O
are	VBP	O
also	RB	O
included	VBN	O
by	IN	O
reference	NN	O
in	IN	O
the	DT	O
term	NN	O
“antibody.”	VBZ	O
The	DT	O
terms	NNS	O
“array”	VBP	O
or	CC	O
“microarray”	VBP	O
or	CC	O
“biochip”	VBP	O
or	CC	O
“chip”	VBP	O
as	IN	O
used	VBN	O
herein	NN	O
is	VBZ	O
a	DT	O
plurality	NN	O
of	IN	O
target	NN	O
elements,	,	O
each	DT	O
target	NN	O
element	NN	O
comprising	VBG	O
a	DT	O
defined	JJ	O
amount	NN	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
polypeptides	NNS	O
(including	VBG	O
antibodies)	)	O
or	CC	O
nucleic	JJ	O
acids	NNS	O
immobilized	VBN	O
onto	IN	O
a	DT	O
defined	JJ	O
area	NN	O
of	IN	O
a	DT	O
substrate	JJ	O
surface,	,	O
as	IN	O
discussed	VBN	O
in	IN	O
further	JJ	O
detail,	,	O
below.	.	O
As	IN	O
used	VBN	O
herein,	,	O
the	DT	O
terms	NNS	O
“computer,”	NNP	O
“computer	NNP	O
program”	NN	O
and	CC	O
“processor”	NN	O
are	VBP	O
used	VBN	O
in	IN	O
their	PRP$	O
broadest	JJS	O
general	JJ	O
contexts	NN	O
and	CC	O
incorporate	VB	O
all	DT	O
such	JJ	O
devices,	,	O
as	IN	O
described	VBN	O
in	IN	O
detail,	,	O
below.	.	O
A	DT	O
“coding	VBG	O
sequence	NN	O
of”	NN	O
or	CC	O
a	DT	O
“sequence	NN	O
encodes”	NN	O
a	DT	O
particular	JJ	O
polypeptide	NN	O
or	CC	O
protein,	,	O
is	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
which	WDT	O
is	VBZ	O
transcribed	VBN	O
and	CC	O
translated	VBN	O
into	IN	O
a	DT	O
polypeptide	NN	O
or	CC	O
protein	NN	O
when	WRB	O
placed	VBN	O
under	IN	O
the	DT	O
control	NN	O
of	IN	O
appropriate	JJ	O
regulatory	JJ	O
sequences.	.	O
The	DT	O
term	NN	O
“expression	NN	O
cassette”	NN	O
as	IN	O
used	VBN	O
herein	NN	O
refers	NNS	O
to	TO	O
a	DT	O
nucleotide	JJ	O
sequence	NN	O
which	WDT	O
is	VBZ	O
capable	JJ	O
of	IN	O
affecting	VBG	O
expression	NN	O
of	IN	O
a	DT	O
structural	JJ	O
gene	NN	O
(i.e.,	,	O
a	DT	O
protein	NN	O
coding	VBG	O
sequence,	,	O
such	JJ	O
as	IN	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention)	)	O
in	IN	O
a	DT	O
host	NN	O
compatible	JJ	O
with	IN	O
such	JJ	O
sequences.	.	O
Expression	NN	O
cassettes	NNS	O
include	VBP	O
at	IN	O
least	JJS	O
a	DT	O
promoter	NN	O
operably	RB	O
linked	VBN	O
with	IN	O
the	DT	O
polypeptide	NN	O
coding	VBG	O
sequence;	:	O
and,	,	O
optionally,	,	O
with	IN	O
other	JJ	O
sequences,	,	O
e.g.,	,	O
transcription	NN	O
termination	NN	O
signals.	.	O
Additional	JJ	O
factors	NNS	O
necessary	JJ	O
or	CC	O
helpful	JJ	O
in	IN	O
effecting	VBG	O
expression	NN	O
may	MD	O
also	RB	O
be	VB	O
used,	,	O
e.g.,	,	O
enhancers.	.	O
Thus,	,	O
expression	NN	O
cassettes	NNS	O
also	RB	O
include	VBP	O
plasmids,	,	O
expression	NN	O
vectors,	,	O
recombinant	JJ	O
viruses,	,	O
any	DT	O
form	NN	O
of	IN	O
recombinant	JJ	O
“naked	VBN	O
DNA”	NNP	O
vector,	,	O
and	CC	O
the	DT	O
like.	.	O
“Operably	RB	O
linked”	NN	O
as	IN	O
used	VBN	O
herein	NN	O
refers	NNS	O
to	TO	O
a	DT	O
functional	JJ	O
relationship	NN	O
between	IN	O
two	CD	O
or	CC	O
more	JJR	O
nucleic	JJ	O
acid	NN	O
(e.g.,	,	O
DNA)	)	O
segments.	.	O
Typically,	,	O
it	PRP	O
refers	VBZ	O
to	TO	O
the	DT	O
functional	JJ	O
relationship	NN	O
of	IN	O
transcriptional	JJ	O
regulatory	JJ	O
sequence	NN	O
to	TO	O
a	DT	O
transcribed	JJ	O
sequence.	.	O
For	IN	O
example,	,	O
a	DT	O
promoter	NN	O
is	VBZ	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
coding	NN	O
sequence,	,	O
such	JJ	O
as	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention,	,	O
if	IN	O
it	PRP	O
stimulates	VBZ	O
or	CC	O
modulates	VBZ	O
the	DT	O
transcription	NN	O
of	IN	O
the	DT	O
coding	VBG	O
sequence	NN	O
in	IN	O
an	DT	O
appropriate	JJ	O
host	NN	O
cell	NN	O
or	CC	O
other	JJ	O
expression	NN	O
system.	.	O
Generally,	,	O
promoter	NN	O
transcriptional	JJ	O
regulatory	JJ	O
sequences	NNS	O
that	WDT	O
are	VBP	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
transcribed	JJ	O
sequence	NN	O
are	VBP	O
physically	RB	O
contiguous	JJ	O
to	TO	O
the	DT	O
transcribed	JJ	O
sequence,	,	O
i.e.,	,	O
they	PRP	O
are	VBP	O
cis-acting.	.	O
However,	,	O
some	DT	O
transcriptional	JJ	O
regulatory	JJ	O
sequences,	,	O
such	JJ	O
as	IN	O
enhancers,	,	O
need	MD	O
not	RB	O
be	VB	O
physically	RB	O
contiguous	JJ	O
or	CC	O
located	VBN	O
in	IN	O
close	JJ	O
proximity	NN	O
to	TO	O
the	DT	O
coding	NN	O
sequences	NNS	O
whose	WP$	O
transcription	NN	O
they	PRP	O
enhance.	.	O
A	DT	O
“vector”	NN	O
comprises	VBZ	O
a	DT	O
nucleic	NN	O
acid	NN	O
which	WDT	O
can	MD	O
infect,	,	O
transfect,	,	O
transiently	RB	O
or	CC	O
permanently	RB	O
transduce	VB	O
a	DT	O
cell.	.	O
It	PRP	O
will	MD	O
be	VB	O
recognized	VBN	O
that	IN	O
a	DT	O
vector	NN	O
can	MD	O
be	VB	O
a	DT	O
naked	JJ	O
nucleic	JJ	O
acid,	,	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	NN	O
complexed	NN	O
with	IN	O
protein	NN	O
or	CC	O
lipid.	.	O
The	DT	O
vector	NN	O
optionally	RB	O
comprises	VBZ	O
viral	JJ	O
or	CC	O
bacterial	JJ	O
nucleic	JJ	O
acids	NNS	O
and/or	NN	O
proteins,	,	O
and/or	JJ	O
membranes	NNS	O
(e.g.,	,	O
a	DT	O
cell	NN	O
membrane,	,	O
a	DT	O
viral	JJ	O
lipid	JJ	O
envelope,	,	O
etc.).	.	O
Vectors	NNS	O
include,	,	O
but	CC	O
are	VBP	O
not	RB	O
limited	VBN	O
to	TO	O
replicons	NNS	O
(e.g.,	,	O
RNA	NNP	O
replicons,	,	O
bacteriophages)	)	O
to	TO	O
which	WDT	O
fragments	NNS	O
of	IN	O
DNA	NN	O
may	MD	O
be	VB	O
attached	VBN	O
and	CC	O
become	VBN	O
replicated.	.	O
Vectors	NNS	O
thus	RB	O
include,	,	O
but	CC	O
are	VBP	O
not	RB	O
limited	VBN	O
to	TO	O
RNA,	,	O
autonomous	JJ	O
self-replicating	JJ	O
circular	NN	O
or	CC	O
linear	JJ	O
DNA	NN	O
or	CC	O
RNA	NNP	O
(e.g.,	,	O
plasmids,	,	O
viruses,	,	O
and	CC	O
the	DT	O
like,	,	O
see,	,	O
e.g.,	,	O
U.S.	NNP	O
Pat.	.	O
No.	.	O
5,217,879),	,	O
and	CC	O
include	VBP	O
both	DT	O
the	DT	O
expression	NN	O
and	CC	O
non-expression	JJ	O
plasmids.	.	O
Where	WRB	O
a	DT	O
recombinant	JJ	O
microorganism	NN	O
or	CC	O
cell	NN	O
culture	NN	O
is	VBZ	O
described	VBN	O
as	IN	O
hosting	VBG	O
an	DT	O
“expression	NN	O
vector”	NN	O
this	DT	O
includes	VBZ	O
both	DT	O
extra-chromosomal	JJ	O
circular	NN	O
and	CC	O
linear	JJ	O
DNA	NNP	O
and	CC	O
DNA	NNP	O
that	WDT	O
has	VBZ	O
been	VBN	O
incorporated	VBN	O
into	IN	O
the	DT	O
host	NN	O
chromosome(s).	.	O
Where	WRB	O
a	DT	O
vector	NN	O
is	VBZ	O
being	VBG	O
maintained	VBN	O
by	IN	O
a	DT	O
host	NN	O
cell,	,	O
the	DT	O
vector	NN	O
may	MD	O
either	RB	O
be	VB	O
stably	RB	O
replicated	VBN	O
by	IN	O
the	DT	O
cells	NNS	O
during	IN	O
mitosis	NN	O
as	IN	O
an	DT	O
autonomous	JJ	O
structure,	,	O
or	CC	O
is	VBZ	O
incorporated	VBN	O
within	IN	O
the	DT	O
host's	POS	O
genome.	.	O
As	IN	O
used	VBN	O
herein,	,	O
the	DT	O
term	NN	O
“promoter”	NNP	O
includes	VBZ	O
all	DT	O
sequences	NNS	O
capable	JJ	O
of	IN	O
driving	VBG	O
transcription	NN	O
of	IN	O
a	DT	O
coding	VBG	O
sequence	NN	O
in	IN	O
a	DT	O
cell,	,	O
e.g.,	,	O
a	DT	O
plant	NN	O
cell.	.	O
Thus,	,	O
promoters	NNS	O
used	VBD	O
in	IN	O
the	DT	O
constructs	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
cis-acting	JJ	O
transcriptional	JJ	O
control	NN	O
elements	NNS	O
and	CC	O
regulatory	JJ	O
sequences	NNS	O
that	WDT	O
are	VBP	O
involved	VBN	O
in	IN	O
regulating	VBG	O
or	CC	O
modulating	VBG	O
the	DT	O
timing	NN	O
and/or	JJ	O
rate	NN	O
of	IN	O
transcription	NN	O
of	IN	O
a	DT	O
gene.	.	O
For	IN	O
example,	,	O
a	DT	O
promoter	NN	O
can	MD	O
be	VB	O
a	DT	O
cis-acting	JJ	O
transcriptional	JJ	O
control	NN	O
element,	,	O
including	VBG	O
an	DT	O
enhancer,	,	O
a	DT	O
promoter,	,	O
a	DT	O
transcription	NN	O
terminator,	,	O
an	DT	O
origin	NN	O
of	IN	O
replication,	,	O
a	DT	O
chromosomal	JJ	O
integration	NN	O
sequence,	,	O
5′	CD	O
and	CC	O
3′	CD	O
untranslated	JJ	O
regions,	,	O
or	CC	O
an	DT	O
intronic	JJ	O
sequence,	,	O
which	WDT	O
are	VBP	O
involved	VBN	O
in	IN	O
transcriptional	JJ	O
regulation.	.	O
These	DT	O
cis-acting	JJ	O
sequences	NNS	O
typically	RB	O
interact	VBP	O
with	IN	O
proteins	NNS	O
or	CC	O
other	JJ	O
biomolecules	NNS	O
to	TO	O
carry	VB	O
out	RP	O
(turn	VB	O
on/off,	,	O
regulate,	,	O
modulate,	,	O
etc.)	)	O
transcription.	.	O
“Constitutive”	NN	O
promoters	NNS	O
are	VBP	O
those	DT	O
that	IN	O
drive	JJ	O
expression	NN	O
continuously	RB	O
under	IN	O
most	JJS	O
environmental	JJ	O
conditions	NNS	O
and	CC	O
states	NNS	O
of	IN	O
development	NN	O
or	CC	O
cell	NN	O
differentiation.	.	O
“Inducible”	NN	O
or	CC	O
“regulatable”	JJ	O
promoters	NNS	O
direct	JJ	O
expression	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
under	IN	O
the	DT	O
influence	NN	O
of	IN	O
environmental	JJ	O
conditions	NNS	O
or	CC	O
developmental	JJ	O
conditions.	.	O
Examples	NNS	O
of	IN	O
environmental	JJ	O
conditions	NNS	O
that	WDT	O
may	MD	O
affect	VB	O
transcription	NN	O
by	IN	O
inducible	JJ	O
promoters	NNS	O
include	VBP	O
anaerobic	JJ	O
conditions,	,	O
elevated	VBN	O
temperature,	,	O
drought,	,	O
or	CC	O
the	DT	O
presence	NN	O
of	IN	O
light.	.	O
“Tissue-specific”	JJ	O
promoters	NNS	O
are	VBP	O
transcriptional	JJ	O
control	NN	O
elements	NNS	O
that	WDT	O
are	VBP	O
only	RB	O
active	JJ	O
in	IN	O
particular	JJ	O
cells	NNS	O
or	CC	O
tissues	NNS	O
or	CC	O
organs,	,	O
e.g.,	,	O
in	IN	O
plants	NNS	O
or	CC	O
animals.	.	O
Tissue-specific	JJ	O
regulation	NN	O
may	MD	O
be	VB	O
achieved	VBN	O
by	IN	O
certain	JJ	O
intrinsic	JJ	O
factors	NNS	O
which	WDT	O
ensure	VB	O
that	IN	O
genes	NNS	O
encoding	VBG	O
proteins	NNS	O
specific	JJ	O
to	TO	O
a	DT	O
given	VBN	O
tissue	NN	O
are	VBP	O
expressed.	.	O
Such	JJ	O
factors	NNS	O
are	VBP	O
known	VBN	O
to	TO	O
exist	VB	O
in	IN	O
mammals	NNS	O
and	CC	O
plants	NNS	O
so	RB	O
as	IN	O
to	TO	O
allow	VB	O
for	IN	O
specific	JJ	O
tissues	NNS	O
to	TO	O
develop.	.	O
The	DT	O
term	NN	O
“plant”	NNP	O
includes	VBZ	O
whole	JJ	O
plants,	,	O
plant	NN	O
parts	NNS	O
(e.g.,	,	O
leaves,	,	O
stems,	,	O
flowers,	,	O
roots,	,	O
etc.),	,	O
plant	NN	O
protoplasts,	,	O
seeds	NNS	O
and	CC	O
plant	NN	O
cells	NNS	O
and	CC	O
progeny	NN	O
of	IN	O
same.	.	O
The	DT	O
class	NN	O
of	IN	O
plants	NNS	O
which	WDT	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
the	DT	O
method	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
generally	RB	O
as	RB	O
broad	JJ	O
as	IN	O
the	DT	O
class	NN	O
of	IN	O
higher	JJR	O
plants	NNS	O
amenable	JJ	O
to	TO	O
transformation	NN	O
techniques,	,	O
including	VBG	O
angiosperms	NNS	O
(monocotyledonous	JJ	O
and	CC	O
dicotyledonous	JJ	O
plants),	,	O
as	RB	O
well	RB	O
as	IN	O
gymnosperms.	.	O
It	PRP	O
includes	VBZ	O
plants	NNS	O
of	IN	O
a	DT	O
variety	NN	O
of	IN	O
ploidy	NN	O
levels,	,	O
including	VBG	O
polyploid,	,	O
diploid,	,	O
haploid	NN	O
and	CC	O
hemizygous	JJ	O
states.	.	O
As	IN	O
used	VBN	O
herein,	,	O
the	DT	O
term	NN	O
“transgenic	JJ	O
plant”	NN	O
includes	VBZ	O
plants	NNS	O
or	CC	O
plant	NN	O
cells	NNS	O
into	IN	O
which	WDT	O
a	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
has	VBZ	O
been	VBN	O
inserted,	,	O
e.g.,	,	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
and	CC	O
various	JJ	O
recombinant	JJ	O
constructs	NNS	O
(e.g.,	,	O
expression	NN	O
cassettes)	)	O
of	IN	O
the	DT	O
invention.	.	O
“Plasmids”	NN	O
can	MD	O
be	VB	O
commercially	RB	O
available,	,	O
publicly	RB	O
available	JJ	O
on	IN	O
an	DT	O
unrestricted	JJ	O
basis,	,	O
or	CC	O
can	MD	O
be	VB	O
constructed	VBN	O
from	IN	O
available	JJ	O
plasmids	NNS	O
in	IN	O
accord	NN	O
with	IN	O
published	JJ	O
procedures.	.	O
Equivalent	JJ	O
plasmids	NNS	O
to	TO	O
those	DT	O
described	VBN	O
herein	NNS	O
are	VBP	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
and	CC	O
will	MD	O
be	VB	O
apparent	JJ	O
to	TO	O
the	DT	O
ordinarily	RB	O
skilled	VBN	O
artisan.	.	O
The	DT	O
term	NN	O
“gene”	NNP	O
includes	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
comprising	VBG	O
a	DT	O
segment	NN	O
of	IN	O
DNA	NNP	O
involved	VBN	O
in	IN	O
producing	VBG	O
a	DT	O
transcription	NN	O
product	NN	O
(e.g.,	,	O
a	DT	O
message),	,	O
which	WDT	O
in	IN	O
turn	NN	O
is	VBZ	O
translated	VBN	O
to	TO	O
produce	VB	O
a	DT	O
polypeptide	NN	O
chain,	,	O
or	CC	O
regulates	VBZ	O
gene	NN	O
transcription,	,	O
reproduction	NN	O
or	CC	O
stability.	.	O
Genes	NNS	O
can	MD	O
include	VB	O
regions	NNS	O
preceding	VBG	O
and	CC	O
following	VBG	O
the	DT	O
coding	VBG	O
region,	,	O
such	JJ	O
as	IN	O
leader	NN	O
and	CC	O
trailer,	,	O
promoters	NNS	O
and	CC	O
enhancers,	,	O
as	RB	O
well	RB	O
as,	,	O
where	WRB	O
applicable,	,	O
intervening	JJ	O
sequences	NNS	O
(introns)	)	O
between	IN	O
individual	JJ	O
coding	NN	O
segments	NNS	O
(exons).	.	O
The	DT	O
phrases	NNS	O
“nucleic	VBP	O
acid”	NN	O
or	CC	O
“nucleic	JJ	O
acid	JJ	O
sequence”	NN	O
includes	VBZ	O
oligonucleotide,	,	O
nucleotide,	,	O
polynucleotide,	,	O
or	CC	O
to	TO	O
a	DT	O
fragment	NN	O
of	IN	O
any	DT	O
of	IN	O
these,	,	O
to	TO	O
DNA	NNP	O
or	CC	O
RNA	NNP	O
(e.g.,	,	O
mRNA,	,	O
rRNA,	,	O
tRNA)	)	O
of	IN	O
genomic	NN	O
or	CC	O
synthetic	JJ	O
origin	NN	O
which	WDT	O
may	MD	O
be	VB	O
single-stranded	JJ	O
or	CC	O
double-stranded	JJ	O
and	CC	O
may	MD	O
represent	VB	O
a	DT	O
sense	NN	O
or	CC	O
antisense	NN	O
strand,	,	O
to	TO	O
peptide	VB	O
nucleic	JJ	O
acid	NN	O
(PNA),	,	O
or	CC	O
to	TO	O
any	DT	O
DNA-like	JJ	O
or	CC	O
RNA-like	JJ	O
material,	,	O
natural	JJ	O
or	CC	O
synthetic	JJ	O
in	IN	O
origin,	,	O
including,	,	O
e.g.,	,	O
iRNA,	,	O
ribonucleoproteins	NNS	O
(e.g.,	,	O
iRNPs).	.	O
The	DT	O
term	NN	O
encompasses	VBZ	O
nucleic	JJ	O
acids,	,	O
i.e.,	,	O
oligonucleotides,	,	O
containing	VBG	O
known	VBN	O
analogues	NNS	O
of	IN	O
natural	JJ	O
nucleotides.	.	O
The	DT	O
term	NN	O
also	RB	O
encompasses	VBZ	O
nucleic-acid-like	JJ	O
structures	NNS	O
with	IN	O
synthetic	JJ	O
backbones,	,	O
see	VBP	O
e.g.,	,	O
Mata	NNP	B
(1997)	)	I
Toxicol.	.	I
Appl.	.	I
Pharmacol.	.	I
144:189-197;	:	I
Strauss-Soukup	NNP	B
(1997)	)	I
Biochemistry	NNP	I
36:8692-8698;	:	I
Samstag	NNP	B
(1996)	)	I
Antisense	NNP	I
Nucleic	NNP	I
Acid	NNP	I
Drug	NNP	I
Dev	NNP	I
6:153-156.
“Amino	.	O
acid”	NN	O
or	NN	O
“amino	CC	O
acid	NN	O
sequence”	JJ	O
include	NN	O
an	VBP	O
oligopeptide,	DT	O
peptide,	,	O
polypeptide,	,	O
or	,	O
protein	CC	O
sequence,	NN	O
or	,	O
to	CC	O
a	TO	O
fragment,	DT	O
portion,	,	O
or	,	O
subunit	CC	O
of	NN	O
any	IN	O
of	DT	O
these,	IN	O
and	,	O
to	CC	O
naturally	TO	O
occurring	RB	O
or	VBG	O
synthetic	CC	O
molecules.	JJ	O
The	.	O
terms	DT	O
“polypeptide”	NNS	O
and	VBP	O
“protein”	CC	O
include	NNP	O
amino	VBP	O
acids	JJ	O
joined	NNS	O
to	VBD	O
each	TO	O
other	DT	O
by	JJ	O
peptide	IN	O
bonds	JJ	O
or	NNS	O
modified	CC	O
peptide	VBN	O
bonds,	JJ	O
i.e.,	,	O
peptide	,	O
isosteres,	NN	O
and	,	O
may	CC	O
contain	MD	O
modified	VB	O
amino	JJ	O
acids	NN	O
other	VBZ	O
than	JJ	O
the	IN	O
20	DT	O
gene-encoded	CD	O
amino	JJ	O
acids.	NN	O
The	.	O
term	DT	O
“polypeptide”	NN	O
also	NNP	O
includes	RB	O
peptides	VBZ	O
and	NNS	O
polypeptide	CC	O
fragments,	NN	O
motifs	,	O
and	NNS	O
the	CC	O
like.	DT	O
The	.	O
term	DT	O
also	NN	O
includes	RB	O
glycosylated	VBZ	O
polypeptides.	JJ	O
The	.	O
peptides	DT	O
and	NNS	O
polypeptides	CC	O
of	NNS	O
the	IN	O
invention	DT	O
also	NN	O
include	RB	O
all	VBP	O
“mimetic”	DT	O
and	NNP	O
“peptidomimetic”	CC	O
forms,	NNP	O
as	,	O
described	IN	O
in	VBN	O
further	IN	O
detail,	JJ	O
below.	,	O
The	.	O
term	DT	O
“isolated”	NN	O
includes	NNP	O
a	VBZ	O
material	DT	O
removed	NN	O
from	VBN	O
its	IN	O
original	PRP$	O
environment,	JJ	O
e.g.,	,	O
the	,	O
natural	DT	O
environment	JJ	O
if	NN	O
it	IN	O
is	PRP	O
naturally	VBZ	O
occurring.	RB	O
For	.	O
example,	IN	O
a	,	O
naturally	DT	O
occurring	RB	O
polynucleotide	VBG	O
or	NN	O
polypeptide	CC	O
present	JJ	O
in	NN	O
a	IN	O
living	DT	O
animal	NN	O
is	NN	O
not	VBZ	O
isolated,	RB	O
but	,	O
the	CC	O
same	DT	O
polynucleotide	JJ	O
or	NN	O
polypeptide,	CC	O
separated	,	O
from	VBN	O
some	IN	O
or	DT	O
all	CC	O
of	DT	O
the	IN	O
coexisting	DT	O
materials	NN	O
in	NNS	O
the	IN	O
natural	DT	O
system,	JJ	O
is	,	O
isolated.	VBZ	O
Such	.	O
polynucleotides	JJ	O
could	NNS	O
be	MD	O
part	VB	O
of	NN	O
a	IN	O
vector	DT	O
and/or	NN	O
such	NN	O
polynucleotides	JJ	O
or	NNS	O
polypeptides	CC	O
could	NNS	O
be	MD	O
part	VB	O
of	NN	O
a	IN	O
composition,	DT	O
and	,	O
still	CC	O
be	RB	O
isolated	VB	O
in	VBN	O
that	IN	O
such	DT	O
vector	JJ	O
or	NN	O
composition	CC	O
is	NN	O
not	VBZ	O
part	RB	O
of	NN	O
its	IN	O
natural	PRP$	O
environment.	JJ	O
As	.	O
used	IN	O
herein,	VBN	O
an	,	O
isolated	DT	O
material	JJ	O
or	NN	O
composition	CC	O
can	NN	O
also	MD	O
be	RB	O
a	VB	O
“purified”	DT	O
composition,	JJ	O
i.e.,	,	O
it	,	O
does	PRP	O
not	VBZ	O
require	RB	O
absolute	VB	O
purity;	JJ	O
rather,	:	O
it	,	O
is	PRP	O
intended	VBZ	O
as	VBN	O
a	IN	O
relative	DT	O
definition.	JJ	O
Individual	.	O
nucleic	JJ	O
acids	JJ	O
obtained	NNS	O
from	VBN	O
a	IN	O
library	DT	O
can	NN	O
be	MD	O
conventionally	VB	O
purified	RB	O
to	VBN	O
electrophoretic	TO	O
homogeneity.	JJ	O
In	.	O
alternative	IN	O
aspects,	JJ	O
the	,	O
invention	DT	O
provides	NN	O
nucleic	VBZ	O
acids	JJ	O
which	NNS	O
have	WDT	O
been	VBP	O
purified	VBN	O
from	VBN	O
genomic	IN	O
DNA	JJ	O
or	NN	O
from	CC	O
other	IN	O
sequences	JJ	O
in	NNS	O
a	IN	O
library	DT	O
or	NN	O
other	CC	O
environment	JJ	O
by	NN	O
at	IN	O
least	IN	O
one,	JJS	O
two,	,	O
three,	,	O
four,	,	O
five	,	O
or	CD	O
more	CC	O
orders	JJR	O
of	NNS	O
magnitude.	IN	O
As	.	O
used	IN	O
herein,	VBN	O
the	,	O
term	DT	O
“recombinant”	NN	O
can	NN	O
include	MD	O
nucleic	VB	O
acids	JJ	O
adjacent	NNS	O
to	NN	O
a	TO	O
“backbone”	DT	O
nucleic	JJ	O
acid	JJ	O
to	NN	O
which	TO	O
it	WDT	O
is	PRP	O
not	VBZ	O
adjacent	RB	O
in	JJ	O
its	IN	O
natural	PRP$	O
environment.	JJ	O
In	.	O
one	IN	O
aspect,	CD	O
nucleic	,	O
acids	JJ	O
represent	NNS	O
5%	VBP	O
or	NN	O
more	CC	O
of	JJR	O
the	IN	O
number	DT	O
of	NN	O
nucleic	IN	O
acid	JJ	O
inserts	NN	O
in	NNS	O
a	IN	O
population	DT	O
of	NN	O
nucleic	IN	O
acid	JJ	O
“backbone	NN	O
molecules.”	NN	O
“Backbone	NN	O
molecules”	NN	O
according	NN	O
to	VBG	O
the	TO	O
invention	DT	O
include	NN	O
nucleic	VBP	O
acids	JJ	O
such	NNS	O
as	JJ	O
expression	IN	O
vectors,	NN	O
self-replicating	,	O
nucleic	JJ	O
acids,	JJ	O
viruses,	,	O
integrating	,	O
nucleic	VBG	O
acids,	JJ	O
and	,	O
other	CC	O
vectors	JJ	O
or	NNS	O
nucleic	CC	O
acids	JJ	O
used	NNS	O
to	VBN	O
maintain	TO	O
or	VB	O
manipulate	CC	O
a	VB	O
nucleic	DT	O
acid	JJ	O
insert	NN	O
of	NN	O
interest.	IN	O
In	.	O
one	IN	O
aspect,	CD	O
the	,	O
enriched	DT	O
nucleic	JJ	O
acids	JJ	O
represent	NNS	O
10%,	VBP	O
15%,	,	O
20%,	,	O
30%,	,	O
40%,	,	O
50%,	,	O
60%,	,	O
70%,	,	O
80%,	,	O
90%,	,	O
95%,	,	O
98%	,	O
or	NN	O
more	CC	O
of	JJR	O
the	IN	O
number	DT	O
of	NN	O
nucleic	IN	O
acid	JJ	O
inserts	NN	O
in	NNS	O
the	IN	O
population	DT	O
of	NN	O
recombinant	IN	O
backbone	JJ	O
molecules.	NN	O
“Recombinant”	.	O
polypeptides	JJ	O
or	NNS	O
proteins	CC	O
refer	NNS	O
to	VBP	O
polypeptides	TO	O
or	NNS	O
proteins	CC	O
produced	NNS	O
by	VBN	O
recombinant	IN	O
DNA	JJ	O
techniques;	NNP	O
e.g.,	:	O
produced	,	O
from	VBN	O
cells	IN	O
transformed	NNS	O
by	VBN	O
an	IN	O
exogenous	DT	O
DNA	JJ	O
construct	NNP	O
encoding	NN	O
the	VBG	O
desired	DT	O
polypeptide	JJ	O
or	NN	O
protein.	CC	O
“Synthetic”	.	O
polypeptides	JJ	O
or	NNS	O
protein	CC	O
are	NNS	O
those	VBP	O
prepared	DT	O
by	JJ	O
chemical	IN	O
synthesis,	JJ	O
as	,	O
described	IN	O
in	VBN	O
further	IN	O
detail,	JJ	O
below.	,	O
A	.	O
promoter	DT	O
sequence	NN	O
can	NN	O
be	MD	O
“operably	VB	O
linked	RB	O
to”	VBN	O
a	RP	O
coding	DT	O
sequence	NN	O
when	NN	O
RNA	WRB	O
polymerase	NNP	O
which	NN	O
initiates	WDT	O
transcription	VBZ	O
at	NN	O
the	IN	O
promoter	DT	O
will	NN	O
transcribe	MD	O
the	VB	O
coding	DT	O
sequence	NN	O
into	NN	O
mRNA,	IN	O
as	,	O
discussed	IN	O
further,	VBN	O
below.	,	O
“Oligonucleotide”	.	O
includes	NN	O
either	VBZ	O
a	CC	O
single	DT	O
stranded	JJ	O
polydeoxynucleotide	JJ	O
or	NN	O
two	CC	O
complementary	CD	O
polydeoxynucleotide	JJ	O
strands	NN	O
which	NNS	O
may	WDT	O
be	MD	O
chemically	VB	O
synthesized.	RB	O
Such	.	O
synthetic	JJ	O
oligonucleotides	JJ	O
have	NNS	O
no	VBP	O
5′	DT	O
phosphate	JJ	O
and	NN	O
thus	CC	O
will	RB	O
not	MD	O
ligate	RB	O
to	VB	O
another	TO	O
oligonucleotide	DT	O
without	NN	O
adding	IN	O
a	VBG	O
phosphate	DT	O
with	NN	O
an	IN	O
ATP	DT	O
in	NNP	O
the	IN	O
presence	DT	O
of	NN	O
a	IN	O
kinase.	DT	O
A	.	O
synthetic	DT	O
oligonucleotide	JJ	O
can	NN	O
ligate	MD	O
to	VB	O
a	TO	O
fragment	DT	O
that	NN	O
has	WDT	O
not	VBZ	O
been	RB	O
dephosphorylated.	VBN	O
The	.	O
phrase	DT	O
“substantially	NN	O
identical”	RB	O
in	VBZ	O
the	IN	O
context	DT	O
of	NN	O
two	IN	O
nucleic	CD	O
acids	JJ	O
or	NNS	O
polypeptides,	CC	O
can	,	O
refer	MD	O
to	VB	O
two	TO	O
or	CD	O
more	CC	O
sequences	JJR	O
that	NNS	O
have,	WDT	O
e.g.,	,	O
at	,	O
least	IN	O
about	JJS	O
50%,	IN	O
51%,	,	O
52%,	,	O
53%,	,	O
54%,	,	O
55%,	,	O
56%,	,	O
57%,	,	O
58%,	,	O
59%,	,	O
60%,	,	O
61%,	,	O
62%,	,	O
63%,	,	O
64%,	,	O
65%,	,	O
66%,	,	O
67%,	,	O
68%,	,	O
69%,	,	O
70%,	,	O
71%,	,	O
72%,	,	O
73%,	,	O
74%,	,	O
75%,	,	O
76%,	,	O
77%,	,	O
78%,	,	O
79%,	,	O
80%,	,	O
81%,	,	O
82%,	,	O
83%,	,	O
84%,	,	O
85%,	,	O
86%,	,	O
87%,	,	O
88%,	,	O
89%,	,	O
90%,	,	O
91%,	,	O
92%,	,	O
93%,	,	O
94%,	,	O
95%,	,	O
96%,	,	O
97%,	,	O
98%,	,	O
99%,	,	O
or	,	O
more	CC	O
nucleotide	JJR	O
or	JJ	O
amino	CC	O
acid	JJ	O
residue	NNS	O
(sequence)	JJ	O
identity,	)	O
when	,	O
compared	WRB	O
and	VBN	O
aligned	CC	O
for	VBN	O
maximum	IN	O
correspondence,	JJ	O
as	,	O
measured	IN	O
using	VBN	O
one	VBG	O
any	CD	O
known	DT	O
sequence	JJ	O
comparison	NN	O
algorithm,	NN	O
as	,	O
discussed	IN	O
in	VBN	O
detail	IN	O
below,	NN	O
or	,	O
by	CC	O
visual	IN	O
inspection.	JJ	O
In	.	O
alternative	IN	O
aspects,	JJ	O
the	,	O
invention	DT	O
provides	NN	O
nucleic	VBZ	O
acid	JJ	O
and	NN	O
polypeptide	CC	O
sequences	NN	O
having	NNS	O
substantial	VBG	O
identity	JJ	O
to	NN	O
an	TO	O
exemplary	DT	O
sequence	JJ	O
of	NN	O
the	IN	O
invention,	DT	O
e.g.,	,	O
SEQ	,	O
ID	NNP	O
NO:1,	NNP	O
SEQ	,	O
ID	NNP	O
NO:2,	NNP	O
over	,	O
a	IN	O
region	DT	O
of	NN	O
at	IN	O
least	IN	O
about	JJS	O
10,	IN	O
20,	,	O
30,	,	O
40,	,	O
50,	,	O
100,	,	O
150,	,	O
200,	,	O
250,	,	O
300,	,	O
350,	,	O
400,	,	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000	,	O
or	CD	O
more	CC	O
residues,	JJR	O
or	,	O
a	CC	O
region	DT	O
ranging	NN	O
from	VBG	O
between	IN	O
about	IN	O
50	IN	O
residues	CD	O
to	NNS	O
the	TO	O
full	DT	O
length	JJ	O
of	NN	O
the	IN	O
nucleic	DT	O
acid	JJ	O
or	NN	O
polypeptide.	CC	O
Nucleic	.	O
acid	NNP	O
sequences	JJ	O
of	NNS	O
the	IN	O
invention	DT	O
can	NN	O
be	MD	O
substantially	VB	O
identical	RB	O
over	JJ	O
the	IN	O
entire	DT	O
length	JJ	O
of	NN	O
a	IN	O
polypeptide	DT	O
coding	NN	O
region.	VBG	O
A	.	O
“substantially	DT	O
identical”	RB	O
amino	JJ	O
acid	NN	O
sequence	NN	O
also	NN	O
can	RB	O
include	MD	O
a	VB	O
sequence	DT	O
that	NN	O
differs	WDT	O
from	VBZ	O
a	IN	O
reference	DT	O
sequence	NN	O
by	NN	O
one	IN	O
or	CD	O
more	CC	O
conservative	RBR	O
or	JJ	O
non-conservative	CC	O
amino	JJ	O
acid	NN	O
substitutions,	NN	O
deletions,	,	O
or	,	O
insertions,	CC	O
particularly	,	O
when	RB	O
such	WRB	O
a	JJ	O
substitution	DT	O
occurs	NN	O
at	VBZ	O
a	IN	O
site	DT	O
that	NN	O
is	WDT	O
not	VBZ	O
the	RB	O
active	DT	O
site	JJ	O
of	NN	O
the	IN	O
molecule,	DT	O
and	,	O
provided	CC	O
that	VBD	O
the	IN	O
polypeptide	DT	O
essentially	NN	O
retains	RB	O
its	VBZ	O
functional	PRP$	O
properties.	JJ	O
A	.	O
conservative	DT	O
amino	JJ	O
acid	NN	O
substitution,	JJ	O
for	,	O
example,	IN	O
substitutes	,	O
one	VBZ	O
amino	CD	O
acid	NN	O
for	NN	O
another	IN	O
of	DT	O
the	IN	O
same	DT	O
class	JJ	O
(e.g.,	NN	O
substitution	,	O
of	NN	O
one	IN	O
hydrophobic	CD	O
amino	NN	O
acid,	NN	O
such	,	O
as	JJ	O
isoleucine,	IN	O
valine,	,	O
leucine,	,	O
or	,	O
methionine,	CC	O
for	,	O
another,	IN	O
or	,	O
substitution	CC	O
of	NN	O
one	IN	O
polar	CD	O
amino	NN	O
acid	NN	O
for	NN	O
another,	IN	O
such	,	O
as	JJ	O
substitution	IN	O
of	NN	O
arginine	IN	O
for	NN	O
lysine,	IN	O
glutamic	,	O
acid	JJ	O
for	NN	O
aspartic	IN	O
acid	JJ	O
or	NN	O
glutamine	CC	O
for	NN	O
asparagine).	IN	O
One	.	O
or	CD	O
more	CC	O
amino	JJR	O
acids	JJ	O
can	NNS	O
be	MD	O
deleted,	VB	O
for	,	O
example,	IN	O
from	,	O
an	IN	O
amylase,	DT	O
resulting	,	O
in	VBG	O
modification	IN	O
of	NN	O
the	IN	O
structure	DT	O
of	NN	O
the	IN	O
polypeptide,	DT	O
without	,	O
significantly	IN	O
altering	RB	O
its	VBG	O
biological	PRP$	O
activity.	JJ	O
For	.	O
example,	IN	O
amino-	,	O
or	JJ	O
carboxyl-terminal	CC	O
amino	JJ	O
acids	NN	O
that	NNS	O
are	WDT	O
not	VBP	O
required	RB	O
for	VBN	O
amylase	IN	O
activity	NN	O
can	NN	O
be	MD	O
removed.	VB	O
“Hybridization”	.	O
includes	WDT	O
the	VBZ	O
process	DT	O
by	NN	O
which	IN	O
a	WDT	O
nucleic	DT	O
acid	NN	O
strand	NN	O
joins	NN	O
with	VBZ	O
a	IN	O
complementary	DT	O
strand	JJ	O
through	NN	O
base	IN	O
pairing.	NN	O
Hybridization	.	O
reactions	NN	O
can	NNS	O
be	MD	O
sensitive	VB	O
and	JJ	O
selective	CC	O
so	JJ	O
that	RB	O
a	IN	O
particular	DT	O
sequence	JJ	O
of	NN	O
interest	IN	O
can	NN	O
be	MD	O
identified	VB	O
even	VBN	O
in	RB	O
samples	IN	O
in	NNS	O
which	IN	O
it	WDT	O
is	PRP	O
present	VBZ	O
at	JJ	O
low	IN	O
concentrations.	JJ	O
Stringent	.	O
conditions	JJ	O
can	NNS	O
be	MD	O
defined	VB	O
by,	VBN	O
for	,	O
example,	IN	O
the	,	O
concentrations	DT	O
of	NNS	O
salt	IN	O
or	NN	O
formamide	CC	O
in	NN	O
the	IN	O
prehybridization	DT	O
and	NN	O
hybridization	CC	O
solutions,	NN	O
or	,	O
by	CC	O
the	IN	O
hybridization	DT	O
temperature,	NN	O
and	,	O
are	CC	O
well	VBP	O
known	RB	O
in	VBN	O
the	IN	O
art.	DT	O
For	.	O
example,	IN	O
stringency	,	O
can	NN	O
be	MD	O
increased	VB	O
by	VBN	O
reducing	IN	O
the	VBG	O
concentration	DT	O
of	NN	O
salt,	IN	O
increasing	,	O
the	VBG	O
concentration	DT	O
of	NN	O
formamide,	IN	O
or	,	O
raising	CC	O
the	VBG	O
hybridization	DT	O
temperature,	NN	O
altering	,	O
the	VBG	O
time	DT	O
of	NN	O
hybridization,	IN	O
as	,	O
described	IN	O
in	VBN	O
detail,	IN	O
below.	,	O
In	.	O
alternative	IN	O
aspects,	JJ	O
nucleic	,	O
acids	JJ	O
of	NNS	O
the	IN	O
invention	DT	O
are	NN	O
defined	VBP	O
by	VBN	O
their	IN	O
ability	PRP$	O
to	NN	O
hybridize	TO	O
under	VB	O
various	IN	O
stringency	JJ	O
conditions	NN	O
(e.g.,	NNS	O
high,	,	O
medium,	,	O
and	,	O
low),	CC	O
as	,	O
set	IN	O
forth	VBN	O
herein.	NN	O
“Variant”	.	O
includes	NN	O
polynucleotides	VBZ	O
or	NNS	O
polypeptides	CC	O
of	NNS	O
the	IN	O
invention	DT	O
modified	NN	O
at	VBD	O
one	IN	O
or	CD	O
more	CC	O
base	JJR	O
pairs,	NN	O
codons,	,	O
introns,	,	O
exons,	,	O
or	,	O
amino	CC	O
acid	NN	O
residues	NN	O
(respectively)	NNS	O
yet	)	O
still	RB	O
retain	RB	O
the	VB	O
biological	DT	O
activity	JJ	O
of	NN	O
an	IN	O
amylase	DT	O
of	NN	O
the	IN	O
invention.	DT	O
Variants	.	O
can	NNS	O
be	MD	O
produced	VB	O
by	VBN	O
any	IN	O
number	DT	O
of	NN	O
means	IN	O
included	NNS	O
methods	VBN	O
such	NNS	O
as,	JJ	O
for	,	O
example,	IN	O
error-prone	,	O
PCR,	JJ	O
shuffling,	,	O
oligonucleotide-directed	,	O
mutagenesis,	JJ	O
assembly	,	O
PCR,	RB	O
sexual	,	O
PCR	JJ	O
mutagenesis,	NNP	O
in	,	O
vivo	IN	O
mutagenesis,	JJ	O
cassette	,	O
mutagenesis,	NN	O
recursive	,	O
ensemble	JJ	O
mutagenesis,	JJ	O
exponential	,	O
ensemble	JJ	O
mutagenesis,	JJ	O
site-specific	,	O
mutagenesis,	JJ	O
gene	,	O
reassembly,	NN	O
GSSM	,	O
and	NNP	O
any	CC	O
combination	DT	O
thereof.	NN	O
Techniques	.	O
for	NNS	O
producing	IN	O
variant	VBG	O
amylase	JJ	O
having	NN	O
activity	VBG	O
at	NN	O
a	IN	O
pH	DT	O
or	NN	O
temperature,	CC	O
for	,	O
example,	IN	O
that	,	O
is	WDT	O
different	VBZ	O
from	JJ	O
a	IN	O
wild-type	DT	O
amylase,	JJ	O
are	,	O
included	VBP	O
herein.	VBN	O
The	.	O
term	DT	O
“saturation	NN	O
mutagenesis”	NN	O
or	NN	O
“GSSM”	CC	O
includes	NN	O
a	VBZ	O
method	DT	O
that	NN	O
uses	WDT	O
degenerate	VBZ	O
oligonucleotide	JJ	O
primers	JJ	O
to	NNS	O
introduce	TO	O
point	VB	O
mutations	NN	O
into	NNS	O
a	IN	O
polynucleotide,	DT	O
as	,	O
described	IN	O
in	VBN	O
detail,	IN	O
below.	,	O
The	.	O
term	DT	O
“optimized	NN	O
directed	VBD	O
evolution	JJ	O
system”	NN	O
or	NN	O
“optimized	CC	O
directed	VBN	O
evolution”	JJ	O
includes	NN	O
a	VBZ	O
method	DT	O
for	NN	O
reassembling	IN	O
fragments	VBG	O
of	NNS	O
related	IN	O
nucleic	JJ	O
acid	JJ	O
sequences,	NN	O
e.g.,	,	O
related	,	O
genes,	VBN	O
and	,	O
explained	CC	O
in	VBD	O
detail,	IN	O
below.	,	O
The	.	O
term	DT	O
“synthetic	NN	O
ligation	JJ	O
reassembly”	NN	O
or	NN	O
“SLR”	CC	O
includes	NN	O
a	VBZ	O
method	DT	O
of	NN	O
ligating	IN	O
oligonucleotide	VBG	O
fragments	JJ	O
in	NNS	O
a	IN	O
non-stochastic	DT	O
fashion,	JJ	O
and	,	O
explained	CC	O
in	VBD	O
detail,	IN	O
below.	,	O
Generating	.	O
and	VBG	O
Manipulating	CC	O
Nucleic	NNP	O
Acids	NNP	O
The	NNP	O
invention	DT	O
provides	NN	O
nucleic	VBZ	O
acids,	JJ	O
including	,	O
expression	VBG	O
cassettes	NN	O
such	NNS	O
as	JJ	O
expression	IN	O
vectors,	NN	O
encoding	,	O
the	VBG	O
polypeptides	DT	O
of	NNS	O
the	IN	O
invention.	DT	O
The	.	O
invention	DT	O
also	NN	O
includes	RB	O
methods	VBZ	O
for	NNS	O
discovering	IN	O
new	VBG	O
amylase	JJ	O
sequences	NN	O
using	NNS	O
the	VBG	O
nucleic	DT	O
acids	JJ	O
of	NNS	O
the	IN	O
invention.	DT	O
The	.	O
invention	DT	O
also	NN	O
includes	RB	O
methods	VBZ	O
for	NNS	O
inhibiting	IN	O
the	VBG	O
expression	DT	O
of	NN	O
amylase	IN	O
genes,	NN	O
transcripts	,	O
and	NNS	O
polypeptides	CC	O
using	NNS	O
the	VBG	O
nucleic	DT	O
acids	JJ	O
of	NNS	O
the	IN	O
invention.	DT	O
Also	.	O
provided	RB	O
are	VBN	O
methods	VBP	O
for	NNS	O
modifying	IN	O
the	VBG	O
nucleic	DT	O
acids	JJ	O
of	NNS	O
the	IN	O
invention	DT	O
by,	NN	O
e.g.,	,	O
synthetic	,	O
ligation	JJ	O
reassembly,	NN	O
optimized	,	O
directed	VBD	O
evolution	VBN	O
system	NN	O
and/or	NN	O
saturation	JJ	O
mutagenesis.	NN	O
The	.	O
nucleic	DT	O
acids	JJ	O
of	NNS	O
the	IN	O
invention	DT	O
can	NN	O
be	MD	O
made,	VB	O
isolated	,	O
and/or	JJ	O
manipulated	NN	O
by,	VBN	O
e.g.,	,	O
cloning	,	O
and	VBG	O
expression	CC	O
of	NN	O
cDNA	IN	O
libraries,	NN	O
amplification	,	O
of	NN	O
message	IN	O
or	NN	O
genomic	CC	O
DNA	JJ	O
by	NN	O
PCR,	IN	O
and	,	O
the	CC	O
like.	DT	O
In	.	O
practicing	IN	O
the	VBG	O
methods	DT	O
of	NNS	O
the	IN	O
invention,	DT	O
homologous	,	O
genes	JJ	O
can	NNS	O
be	MD	O
modified	VB	O
by	VBN	O
manipulating	IN	O
a	VBG	O
template	DT	O
nucleic	NN	O
acid,	NN	O
as	,	O
described	IN	O
herein.	VBN	O
The	.	O
invention	DT	O
can	NN	O
be	MD	O
practiced	VB	O
in	VBN	O
conjunction	IN	O
with	NN	O
any	IN	O
method	DT	O
or	NN	O
protocol	CC	O
or	NN	O
device	CC	O
known	NN	O
in	VBN	O
the	IN	O
art,	DT	O
which	,	O
are	WDT	O
well	VBP	O
described	RB	O
in	VBN	O
the	IN	O
scientific	DT	O
and	JJ	O
patent	CC	O
literature.	JJ	O
General	.	O
Techniques	NNP	O
The	NNP	O
nucleic	DT	O
acids	JJ	O
used	NNS	O
to	VBD	O
practice	TO	O
this	NN	O
invention,	DT	O
whether	,	O
RNA,	IN	O
iRNA,	,	O
antisense	,	O
nucleic	JJ	O
acid,	NN	O
cDNA,	,	O
genomic	,	O
DNA,	JJ	O
vectors,	,	O
viruses	,	O
or	NNS	O
hybrids	CC	O
thereof,	NNS	O
may	,	O
be	MD	O
isolated	VB	O
from	VBN	O
a	IN	O
variety	DT	O
of	NN	O
sources,	IN	O
genetically	,	O
engineered,	RB	O
amplified,	,	O
and/or	,	O
expressed/generated	RB	O
recombinantly.	VBN	O
Recombinant	.	O
polypeptides	NNP	O
generated	NNS	O
from	VBD	O
these	IN	O
nucleic	DT	O
acids	JJ	O
can	NNS	O
be	MD	O
individually	VB	O
isolated	RB	O
or	JJ	O
cloned	CC	O
and	VBN	O
tested	CC	O
for	VBN	O
a	IN	O
desired	DT	O
activity.	JJ	O
Any	.	O
recombinant	DT	O
expression	JJ	O
system	NN	O
can	NN	O
be	MD	O
used,	VB	O
including	,	O
bacterial,	VBG	O
mammalian,	,	O
yeast,	,	O
insect	,	O
or	NN	O
plant	CC	O
cell	NN	O
expression	NN	O
systems.	NN	O
Alternatively,	.	O
these	,	O
nucleic	DT	O
acids	JJ	O
can	NNS	O
be	MD	O
synthesized	VB	O
in	VBN	O
vitro	IN	O
by	NN	O
well-known	IN	O
chemical	JJ	O
synthesis	JJ	O
techniques,	NN	O
as	,	O
described	IN	O
in,	VBN	O
e.g.,	,	O
Adams	,	B
(1983)	NNP	I
J.	)	I
Am.	.	I
Chem.	.	I
Soc.	.	I
105:661;	.	I
Belousov	:	B
(1997)	NNP	I
Nucleic	)	I
Acids	NNP	I
Res.	NNP	I
25:3440-3444;	.	I
Frenkel	:	B
(1995)	NNP	I
Free	)	I
Radic.	NNP	I
Biol.	.	I
Med.	.	I
19:373-380;	.	I
Blommers	:	B
(1994)	NNS	I
Biochemistry	)	I
33:7886-7896;	NNP	I
Narang	:	B
(1979)	NNP	I
Meth.	)	I
Enzymol.	.	I
68:90;	.	I
Brown	:	B
(1979)	NNP	I
Meth.	)	I
Enzymol.	.	I
68:109;	.	I
Beaucage	:	B
(1981)	NNP	I
Tetra.	)	I
Lett.	.	I
22:1859;	.	I
U.S.	:	O
Pat.	NNP	O
No.	.	O
4,458,066.	.	O
Techniques	.	O
for	NNS	O
the	IN	O
manipulation	DT	O
of	NN	O
nucleic	IN	O
acids,	JJ	O
such	,	O
as,	JJ	O
e.g.,	,	O
subcloning,	,	O
labeling	,	O
probes	VBG	O
(e.g.,	NNS	O
random-primer	,	O
labeling	JJ	O
using	NN	O
Klenow	VBG	O
polymerase,	NNP	O
nick	,	O
translation,	JJ	O
amplification),	,	O
sequencing,	,	O
hybridization	,	O
and	NN	O
the	CC	O
like	DT	O
are	JJ	O
well	VBP	O
described	RB	O
in	VBN	O
the	IN	O
scientific	DT	O
and	JJ	O
patent	CC	O
literature,	JJ	O
see,	,	O
e.g.,	,	O
Sambrook,	,	B
ed.,	,	I
MOLECULAR	,	I
CLONING:	NNP	I
A	:	I
LABORATORY	DT	I
MANUAL	NNP	I
(2ND	NNP	I
ED.),	CD	I
Vols.	,	I
1-3,	.	I
Cold	,	I
Spring	NNP	I
Harbor	NNP	I
Laboratory,	NNP	I
(1989);	,	I
CURRENT	:	B
PROTOCOLS	NNP	I
1N	NNP	I
MOLECULAR	CD	I
BIOLOGY,	NNP	I
Ausubel,	,	I
ed.	,	I
John	.	I
Wiley	NNP	I
&	NNP	I
Sons,	CC	I
Inc.,	,	I
New	,	I
York	NNP	I
(1997);	NNP	I
LABORATORY	:	B
TECHNIQUES	NNP	I
IN	NNP	I
BIOCHEMISTRY	NNP	I
AND	NNP	I
MOLECULAR	NNP	I
BIOLOGY:	NNP	I
HYBRIDIZATION	:	I
WITH	NN	I
NUCLEIC	NNP	I
ACID	NNP	I
PROBES,	NNP	I
Part	,	I
I.	NNP	I
Theory	.	I
and	NN	I
Nucleic	CC	I
Acid	NNP	I
Preparation,	NNP	I
Tijssen,	,	I
ed.	,	I
Elsevier,	.	I
N.Y.	,	I
(1993).
Another	NNP	O
useful	.	O
means	DT	O
of	JJ	O
obtaining	NNS	O
and	IN	O
manipulating	VBG	O
nucleic	CC	O
acids	VBG	O
used	JJ	O
to	NNS	O
practice	VBD	O
the	TO	O
methods	NN	O
of	DT	O
the	NNS	O
invention	IN	O
is	DT	O
to	NN	O
clone	VBZ	O
from	TO	O
genomic	VB	O
samples,	IN	O
and,	JJ	O
if	,	O
desired,	,	O
screen	IN	O
and	,	O
re-clone	JJ	O
inserts	CC	O
isolated	JJ	O
or	NNS	O
amplified	VBD	O
from,	CC	O
e.g.,	VBN	O
genomic	,	O
clones	,	O
or	JJ	O
cDNA	NNS	O
clones.	CC	O
Sources	NN	O
of	.	O
nucleic	NNS	O
acid	IN	O
used	JJ	O
in	NNS	O
the	VBN	O
methods	IN	O
of	DT	O
the	NNS	O
invention	IN	O
include	DT	O
genomic	NN	O
or	VBP	O
cDNA	JJ	O
libraries	CC	O
contained	JJ	O
in,	NNS	O
e.g.,	VBN	O
mammalian	,	O
artificial	,	O
chromosomes	JJ	O
(MACs),	JJ	O
see,	NNS	O
e.g.,	,	O
U.S.	,	O
Pat.	,	O
Nos.	NNP	O
5,721,118;	.	O
6,025,155;	.	O
human	:	O
artificial	:	O
chromosomes,	JJ	O
see,	JJ	O
e.g.,	,	O
Rosenfeld	,	B
(1997)	,	I
Nat.	NNP	I
Genet.	)	I
15:333-335;	.	I
yeast	.	O
artificial	:	O
chromosomes	CC	O
(YAC);	JJ	O
bacterial	NNS	O
artificial	:	O
chromosomes	JJ	O
(BAC);	JJ	O
P1	NNS	O
artificial	:	O
chromosomes,	NNP	O
see,	JJ	O
e.g.,	,	O
Woon	,	B
(1998)	,	I
Genomics	NNP	I
50:306-316;	)	I
P1-derived	NNPS	O
vectors	:	O
(PACs),	JJ	O
see,	NNS	O
e.g.,	,	O
Kern	,	B
(1997)	,	I
Biotechniques	NNP	I
23:120-124;	)	I
cosmids,	NNP	O
recombinant	:	O
viruses,	,	O
phages	JJ	O
or	,	O
plasmids.	NNS	O
In	CC	O
one	.	O
aspect,	IN	O
a	CD	O
nucleic	,	O
acid	DT	O
encoding	JJ	O
a	NN	O
polypeptide	VBG	O
of	DT	O
the	NN	O
invention	IN	O
is	DT	O
assembled	NN	O
in	VBZ	O
appropriate	VBN	O
phase	IN	O
with	JJ	O
a	NN	O
leader	IN	O
sequence	DT	O
capable	NN	O
of	NN	O
directing	JJ	O
secretion	IN	O
of	VBG	O
the	NN	O
translated	IN	O
polypeptide	DT	O
or	JJ	O
fragment	NN	O
thereof.	CC	O
The	JJ	O
invention	.	O
provides	DT	O
fusion	NN	O
proteins	VBZ	O
and	NN	O
nucleic	NNS	O
acids	CC	O
encoding	JJ	O
them.	NNS	O
A	VBG	O
polypeptide	.	O
of	DT	O
the	NN	O
invention	IN	O
can	DT	O
be	NN	O
fused	MD	O
to	VB	O
a	VBN	O
heterologous	TO	O
peptide	DT	O
or	JJ	O
polypeptide,	NN	O
such	CC	O
as	,	O
N-terminal	JJ	O
identification	IN	O
peptides	JJ	O
which	NN	O
impart	NNS	O
desired	WDT	O
characteristics,	VBP	O
such	VBN	O
as	,	O
increased	JJ	O
stability	IN	O
or	JJ	O
simplified	NN	O
purification.	CC	O
Peptides	VBN	O
and	.	O
polypeptides	NNS	O
of	CC	O
the	NNS	O
invention	IN	O
can	DT	O
also	NN	O
be	MD	O
synthesized	RB	O
and	VB	O
expressed	VBN	O
as	CC	O
fusion	VBN	O
proteins	IN	O
with	NN	O
one	VBZ	O
or	IN	O
more	CD	O
additional	CC	O
domains	JJR	O
linked	JJ	O
thereto	NNS	O
for,	VBN	O
e.g.,	NN	O
producing	,	O
a	,	O
more	VBG	O
immunogenic	DT	O
peptide,	RBR	O
to	JJ	O
more	,	O
readily	TO	O
isolate	RBR	O
a	RB	O
recombinantly	VB	O
synthesized	DT	O
peptide,	RB	O
to	VBN	O
identify	,	O
and	TO	O
isolate	VB	O
antibodies	CC	O
and	VB	O
antibody-expressing	NNS	O
B	CC	O
cells,	JJ	O
and	NNP	O
the	,	O
like.	CC	O
Detection	DT	O
and	.	O
purification	NN	O
facilitating	CC	O
domains	NN	O
include,	NN	O
e.g.,	NNS	O
metal	,	O
chelating	,	O
peptides	JJ	O
such	VBG	O
as	NNS	O
polyhistidine	JJ	O
tracts	IN	O
and	NN	O
histidine-tryptophan	NNS	O
modules	CC	O
that	JJ	O
allow	NNS	O
purification	WDT	O
on	VBP	O
immobilized	NN	O
metals,	IN	O
protein	JJ	O
A	,	O
domains	VBP	O
that	DT	O
allow	NNS	O
purification	WDT	O
on	VBP	O
immobilized	NN	O
immunoglobulin,	IN	O
and	JJ	O
the	,	O
domain	CC	O
utilized	DT	O
in	NN	O
the	JJ	O
FLAGS	IN	O
extension/affinity	DT	O
purification	NNP	O
system	NN	O
(Immunex	NN	O
Corp,	NN	O
Seattle	NNP	O
Wash.).	,	O
The	NNP	O
inclusion	.	O
of	DT	O
a	NN	O
cleavable	IN	O
linker	DT	O
sequences	JJ	O
such	NN	O
as	NNS	O
Factor	JJ	O
Xa	IN	O
or	NNP	O
enterokinase	NNP	O
(Invitrogen,	CC	O
San	NN	O
Diego	,	O
Calif.)	NNP	O
between	NNP	O
a	)	O
purification	IN	O
domain	DT	O
and	NN	O
the	NN	O
motif-comprising	CC	O
peptide	DT	O
or	JJ	O
polypeptide	NN	O
to	CC	O
facilitate	NN	O
purification.	TO	O
For	VB	O
example,	.	O
an	IN	O
expression	,	O
vector	DT	O
can	NN	O
include	NN	O
an	MD	O
epitope-encoding	VB	O
nucleic	DT	O
acid	JJ	O
sequence	NN	O
linked	NN	O
to	NN	O
six	VBD	O
histidine	TO	O
residues	CD	O
followed	NN	O
by	NNS	O
a	VBN	O
thioredoxin	IN	O
and	DT	O
an	NN	O
enterokinase	CC	O
cleavage	DT	O
site	NN	O
(see	NN	O
e.g.,	NN	O
Williams	VB	B
(1995)	,	I
Biochemistry	NNP	I
34:1787-1797;	)	I
Dobeli	NNP	B
(1998)	:	I
Protein	NNP	I
Expr.	)	I
Purif	NNP	I
12:404-414).The	.	O
histidine	NNP	O
residues	.	O
facilitate	DT	O
detection	NN	O
and	VBZ	O
purification	JJ	O
while	NN	O
the	CC	O
enterokinase	NN	O
cleavage	IN	O
site	DT	O
provides	NN	O
a	NN	O
means	NN	O
for	VBZ	O
purifying	DT	O
the	NN	O
epitope	IN	O
from	VBG	O
the	DT	O
remainder	NN	O
of	IN	O
the	DT	O
fusion	NN	O
protein.	IN	O
Technology	DT	O
pertaining	NN	O
to	.	O
vectors	NN	O
encoding	VBG	O
fusion	TO	O
proteins	NNS	O
and	VBG	O
application	NN	O
of	NNS	O
fusion	CC	O
proteins	NN	O
are	IN	O
well	NN	O
described	NNS	O
in	VBP	O
the	RB	O
scientific	VBN	O
and	IN	O
patent	DT	O
literature,	JJ	O
see	CC	O
e.g.,	JJ	O
Kroll	,	B
(1993)	VBP	I
DNA	,	I
Cell.	NNP	I
Biol.,	)	I
12:441-53.
Transcriptional	NN	O
and	.	O
Translational	,	O
Control	.	O
Sequences	NNP	O
The	CC	O
invention	NNP	O
provides	NNP	O
nucleic	VBZ	O
acid	DT	O
(e.g.,	NN	O
DNA)	VBZ	O
sequences	JJ	O
of	NN	O
the	,	O
invention	)	O
operatively	NNS	O
linked	IN	O
to	DT	O
expression	NN	O
(e.g.,	RB	O
transcriptional	VBN	O
or	TO	O
translational)	NN	O
control	,	O
sequence(s),	JJ	O
e.g.,	CC	O
promoters	)	O
or	NN	O
enhancers,	,	O
to	,	O
direct	NNS	O
or	CC	O
modulate	,	O
RNA	TO	O
synthesis/expression.	VB	O
The	CC	O
expression	VB	O
control	NNP	O
sequence	.	O
can	DT	O
be	NN	O
in	NN	O
an	NN	O
expression	MD	O
vector.	VB	O
Exemplary	IN	O
bacterial	DT	O
promoters	NN	O
include	.	O
lacI,	JJ	O
lacZ,	JJ	O
T3,	NNS	O
T7,	VBP	O
gpt,	,	O
lambda	,	O
PR,	,	O
PL	,	O
and	,	O
tip.	JJ	O
Exemplary	,	O
eukaryotic	NNP	O
promoters	CC	O
include	.	O
CMV	NNP	O
immediate	JJ	O
early,	NNS	O
HSV	VBP	O
thymidine	NNP	O
kinase,	JJ	O
early	,	O
and	NNP	O
late	NN	O
SV40,	,	O
LTRs	RB	O
from	CC	O
retrovirus,	JJ	O
and	,	O
mouse	NNP	O
metallothionein	IN	O
I.	,	O
Promoters	CC	O
suitable	RB	O
for	JJ	O
expressing	NNP	O
a	NNP	O
polypeptide	JJ	O
in	IN	O
bacteria	VBG	O
include	DT	O
the	NN	O
E.	IN	O
coli	NNS	O
lac	VBP	O
or	DT	O
trp	NNP	O
promoters,	NNS	O
the	VBD	O
lacI	CC	O
promoter,	JJ	O
the	,	O
lacZ	DT	O
promoter,	NN	O
the	,	O
T3	DT	O
promoter,	NN	O
the	,	O
T7	DT	O
promoter,	NNP	O
the	,	O
gpt	DT	O
promoter,	NNP	O
the	,	O
lambda	DT	O
PR	NN	O
promoter,	,	O
the	DT	O
lambda	NN	O
PL	NNP	O
promoter,	,	O
promoters	DT	O
from	NN	O
operons	NNP	O
encoding	,	O
glycolytic	NNS	O
enzymes	IN	O
such	NNS	O
as	VBG	O
3-phosphoglycerate	JJ	O
kinase	NNS	O
(PGK),	JJ	O
and	IN	O
the	JJ	O
acid	NN	O
phosphatase	,	O
promoter.	CC	O
Eukaryotic	DT	O
promoters	JJ	O
include	NN	O
the	.	O
CMV	JJ	O
immediate	NNS	O
early	VBP	O
promoter,	DT	O
the	NNP	O
HSV	VBP	O
thymidine	JJ	O
kinase	,	O
promoter,	DT	O
heat	NNP	O
shock	NN	O
promoters,	NN	O
the	,	O
early	NN	O
and	NN	O
late	,	O
SV40	DT	O
promoter,	JJ	O
LTRs	CC	O
from	JJ	O
retroviruses,	NNP	O
and	,	O
the	NNP	O
mouse	IN	O
metallothionein-I	,	O
promoter.	CC	O
Other	DT	O
promoters	NN	O
known	JJ	O
to	.	O
control	JJ	O
expression	NNS	O
of	VBN	O
genes	TO	O
in	VB	O
prokaryotic	NN	O
or	IN	O
eukaryotic	NNS	O
cells	IN	O
or	JJ	O
their	CC	O
viruses	JJ	O
may	NNS	O
also	CC	O
be	PRP$	O
used.	NNS	O
Tissue-Specific	MD	O
Plant	RB	O
Promoters	VB	O
The	.	O
invention	JJ	O
provides	NNP	O
expression	NNPS	O
cassettes	DT	O
that	NN	O
can	VBZ	O
be	NN	O
expressed	NNS	O
in	WDT	O
a	MD	O
tissue-specific	VB	O
manner,	VBN	O
e.g.,	IN	O
that	DT	O
can	JJ	O
express	,	O
an	,	O
amylase	WDT	O
of	MD	O
the	VB	O
invention	DT	O
in	NN	O
a	IN	O
tissue-specific	DT	O
manner.	NN	O
The	IN	O
invention	DT	O
also	JJ	O
provides	.	O
plants	DT	O
or	NN	O
seeds	RB	O
that	VBZ	O
express	NNS	O
an	CC	O
amylase	NNS	O
of	WDT	O
the	VBP	O
invention	DT	O
in	NN	O
a	IN	O
tissue-specific	DT	O
manner.	NN	O
The	IN	O
tissue-specificity	DT	O
can	JJ	O
be	.	O
seed	DT	O
specific,	NN	O
stem	MD	O
specific,	VB	O
leaf	NN	O
specific,	,	O
root	NN	O
specific,	,	O
fruit	JJ	O
specific	,	O
and	NN	O
the	,	O
like.	NN	O
In	NN	O
one	CC	O
aspect,	DT	O
a	.	O
constitutive	IN	O
promoter	CD	O
such	,	O
as	DT	O
the	JJ	O
CaMV	NN	O
35S	JJ	O
promoter	IN	O
can	DT	O
be	NNP	O
used	CD	O
for	NN	O
expression	MD	O
in	VB	O
specific	VBN	O
parts	IN	O
of	NN	O
the	IN	O
plant	JJ	O
or	NNS	O
seed	IN	O
or	DT	O
throughout	NN	O
the	CC	O
plant.	NN	O
For	CC	O
example,	IN	O
for	DT	O
overexpression,	.	O
a	IN	O
plant	,	O
promoter	IN	O
fragment	,	O
can	DT	O
be	NN	O
employed	NN	O
which	NN	O
will	MD	O
direct	VB	O
expression	VBN	O
of	WDT	O
a	MD	O
nucleic	VB	O
acid	NN	O
in	IN	O
some	DT	O
or	JJ	O
all	NN	O
tissues	IN	O
of	DT	O
a	CC	O
plant,	DT	O
e.g.,	NNS	O
a	IN	O
regenerated	DT	O
plant.	,	O
Such	,	O
promoters	DT	O
are	JJ	O
referred	.	O
to	JJ	O
herein	NNS	O
as	VBP	O
“constitutive”	VBN	O
promoters	TO	O
and	VB	O
are	IN	O
active	JJ	O
under	NNS	O
most	CC	O
environmental	VBP	O
conditions	JJ	O
and	IN	O
states	JJS	O
of	JJ	O
development	NNS	O
or	CC	O
cell	NNS	O
differentiation.	IN	O
Examples	NN	O
of	CC	O
constitutive	NN	O
promoters	.	O
include	NNS	O
the	IN	O
cauliflower	JJ	O
mosaic	NNS	O
virus	VBP	O
(CaMV)	DT	O
35S	JJR	O
transcription	JJ	O
initiation	NN	O
region,	)	O
the	CD	O
1′-	NN	O
or	NN	O
2′-promoter	,	O
derived	DT	O
from	JJ	O
T-DNA	CC	O
of	JJ	O
Agrobacterium	VBN	O
tumefaciens,	IN	O
and	NNP	O
other	IN	O
transcription	NNP	O
initiation	,	O
regions	CC	O
from	JJ	O
various	NN	O
plant	NN	O
genes	NNS	O
known	IN	O
to	JJ	O
those	NN	O
of	NNS	O
skill.	VBN	O
Such	TO	O
genes	DT	O
include,	IN	O
e.g.,	.	O
ACT11	JJ	O
from	NNS	O
Arabidopsis	,	O
Huang	,	B
(1996)	NNP	I
Plant	IN	I
Mol.	NNP	I
Biol.	NNP	I
33:125-139);(	)	O
Cat3	NNP	O
from	.	O
Arabidopsis	.	O
GenBank	:	B
No.	NNP	I
U43147,	IN	I
Zhong	NNP	I
(1996)	NNP	I
Mol.	.	I
Gen.	,	I
Genet.	NNP	I
251:196-203);(	)	O
the	.	O
gene	NNP	O
encoding	.	O
stearoyl-acyl	:	O
carrier	DT	O
protein	NN	O
desaturase	VBG	O
from	JJ	O
Brassica	NN	O
napus	NN	O
Genbank	NN	B
No.	IN	I
X74782,	NNP	I
Solocombe	NN	I
(1994)	NNP	I
Plant	.	I
Physiol.	,	I
104:1167-1176);(	NNP	O
GPc1	)	O
from	NNP	O
maize	.	O
GenBank	:	B
No.	NNP	I
X15596;	IN	I
Martinez	NN	I
(1989)	NNP	I
J.	.	I
Mol.	:	I
Biol	NNP	I
208:551-565);(	)	O
the	NNP	O
Gpc2	.	O
from	NNP	O
maize	:	O
GenBank	DT	B
No.	NNP	I
U45855,	IN	I
Manjunath	NN	I
(1997)	NNP	I
Plant	.	I
Mol.	,	I
Biol.	NNP	I
33:97-112);(	)	O
plant	NNP	O
promoters	.	O
described	.	O
in	:	O
U.S.	NN	O
Pat.	NNS	O
Nos.	VBN	O
4,962,028;	IN	O
5,633,440.	NNP	O
The	.	O
invention	.	O
uses	:	O
tissue-specific	.	O
or	DT	O
constitutive	NN	O
promoters	VBZ	O
derived	JJ	O
from	CC	O
viruses	JJ	O
which	NNS	O
can	VBN	O
include,	IN	O
e.g.,	NNS	O
the	WDT	O
tobamovirus	MD	O
subgenomic	,	O
promoter	,	O
Kumagai	DT	B
(1995)	NN	I
Proc.	JJ	I
Natl.	NN	I
Acad.	NNP	I
Sci.	)	I
USA	.	I
92:1679-1683;	.	I
(the	.	O
rice	.	O
tungro	NNP	O
bacilliform	:	O
virus	DT	O
(RTBV),	NN	O
which	NN	O
replicates	NN	O
only	NN	O
in	,	O
phloem	WDT	O
cells	VBZ	O
in	RB	O
infected	IN	O
rice	NN	O
plants,	NNS	O
with	IN	O
its	JJ	O
promoter	NN	O
which	,	O
drives	IN	O
strong	PRP$	O
phloem-specific	NN	O
reporter	WDT	O
gene	VBZ	O
expression;	JJ	O
the	JJ	O
cassava	NN	O
vein	NN	O
mosaic	:	O
virus	DT	O
(CVMV)	NN	O
promoter,	NN	O
with	NN	O
highest	NN	O
activity	)	O
in	,	O
vascular	IN	O
elements,	JJS	O
in	NN	O
leaf	IN	O
mesophyll	JJ	O
cells,	,	O
and	IN	O
in	JJ	O
root	NN	O
tips	,	O
Verdaguer	CC	B
(1996)	IN	I
Plant	JJ	I
Mol.	NNS	I
Biol.	NNP	I
31:1129-1139).(	)	O
Alternatively,	NNP	O
the	.	O
plant	.	O
promoter	.	O
may	,	O
direct	DT	O
expression	NN	O
of	NN	O
amylase-expressing	MD	O
nucleic	VB	O
acid	NN	O
in	IN	O
a	JJ	O
specific	JJ	O
tissue,	NN	O
organ	IN	O
or	DT	O
cell	JJ	O
type	,	O
(i.e.	''	O
tissue-specific	CC	O
promoters)	VB	O
or	NN	O
may	.	O
be	JJ	O
otherwise	)	O
under	CC	O
more	MD	O
precise	VB	O
environmental	RB	O
or	IN	O
developmental	RBR	O
control	JJ	O
or	JJ	O
under	CC	O
the	JJ	O
control	NN	O
of	CC	O
an	IN	O
inducible	DT	O
promoter.	NN	O
Examples	IN	O
of	DT	O
environmental	JJ	O
conditions	.	O
that	NNS	O
may	IN	O
affect	JJ	O
transcription	NNS	O
include	WDT	O
anaerobic	MD	O
conditions,	VB	O
elevated	NN	O
temperature,	VBP	O
the	JJ	O
presence	,	O
of	VBN	O
light,	,	O
or	DT	O
sprayed	NN	O
with	IN	O
chemicals/hormones.	,	O
For	CC	O
example,	VBN	O
the	IN	O
invention	.	O
incorporates	IN	O
the	,	O
drought-inducible	DT	O
promoter	NN	O
of	VBZ	O
maize	DT	O
(Busk	JJ	O
(1997)	NN	O
supra);	IN	O
the	NN	O
cold,	NNP	O
drought,	)	O
and	:	O
high	DT	O
salt	,	O
inducible	,	O
promoter	CC	O
from	JJ	O
potato	NN	O
Kirch	JJ	B
(1997)	NN	I
Plant	IN	I
Mol.	NN	I
Biol.	NNP	I
33:897	)	I
909).(	NNP	O
Tissue-specific	.	O
promoters	.	O
can	CD	O
promote	.	O
transcription	JJ	O
only	NNS	O
within	MD	O
a	VB	O
certain	NN	O
time	RB	O
frame	IN	O
of	DT	O
developmental	JJ	O
stage	NN	O
within	NN	O
that	IN	O
tissue.	JJ	O
See,	NN	O
e.g.,	IN	O
Blazquez	DT	B
(1998)	.	I
Plant	,	I
Cell	,	I
10:791-800,	NNP	I
characterizing	)	O
the	NNP	O
Arabidopsis	NNP	O
LEAFY	,	O
gene	VBG	O
promoter.	DT	O
See	NNP	O
also	NNP	O
Cardon	NN	B
(1997)	.	I
Plant	NNP	I
J	RB	I
12:367-77,	NNP	I
describing	)	O
the	NNP	O
transcription	NNP	O
factor	,	O
SPL3,	VBG	O
which	DT	O
recognizes	NN	O
a	NN	O
conserved	,	O
sequence	WDT	O
motif	VBZ	O
in	DT	O
the	JJ	O
promoter	NN	O
region	NN	O
of	IN	O
the	DT	O
A.	NN	O
thaliana	NN	O
floral	IN	O
meristem	DT	O
identity	NNP	O
gene	NNP	O
AP1;	JJ	O
and	NN	O
Mandel	NN	B
(1995)	NN	I
Plant	:	I
Molecular	CC	I
Biology,	NNP	I
Vol.	)	I
29,	NNP	I
pp	NNP	I
995-1004,	,	I
describing	.	O
the	,	O
meristem	JJ	O
promoter	,	O
eIF4.	VBG	O
Tissue	DT	O
specific	NN	O
promoters	NN	O
which	.	O
are	NNP	O
active	NN	O
throughout	NNS	O
the	WDT	O
life	VBP	O
cycle	JJ	O
of	IN	O
a	DT	O
particular	NN	O
tissue	NN	O
can	IN	O
be	DT	O
used.	JJ	O
In	NN	O
one	MD	O
aspect,	VB	O
the	.	O
nucleic	IN	O
acids	CD	O
of	,	O
the	DT	O
invention	JJ	O
are	NNS	O
operably	IN	O
linked	DT	O
to	NN	O
a	VBP	O
promoter	RB	O
active	VBN	O
primarily	TO	O
only	DT	O
in	NN	O
cotton	JJ	O
fiber	RB	O
cells.	RB	O
In	IN	O
one	NN	O
aspect,	NN	O
the	.	O
nucleic	IN	O
acids	CD	O
of	,	O
the	DT	O
invention	JJ	O
are	NNS	O
operably	IN	O
linked	DT	O
to	NN	O
a	VBP	O
promoter	RB	O
active	VBN	O
primarily	TO	O
during	DT	O
the	NN	O
stages	JJ	O
of	RB	O
cotton	IN	O
fiber	DT	O
cell	NNS	O
elongation,	IN	O
e.g.,	NN	O
as	NN	O
described	NN	O
by	,	O
Rinehart	,	O
(1996)	IN	O
supra.	VBN	O
The	IN	O
nucleic	NNP	O
acids	)	O
can	.	O
be	DT	O
operably	JJ	O
linked	NNS	O
to	MD	O
the	VB	O
Fbl2A	RB	O
gene	VBN	O
promoter	TO	O
to	DT	O
be	NNP	O
preferentially	NN	O
expressed	NN	O
in	TO	O
cotton	VB	O
fiber	RB	O
cells	VBN	O
(Ibid).	IN	O
See	NN	O
also,	NN	O
John	NNS	B
(1997)	.	I
Proc.	NNP	I
Natl.	,	I
Acad.	NNP	I
Sci.	)	I
USA	.	I
89:5769-5773;	.	I
John,	.	O
et	.	O
al.,	NNP	O
U.S.	:	O
Pat.	,	O
Nos.	FW	O
5,608,148	,	O
and	NNP	O
5,602,321,	.	O
describing	.	O
cotton	CD	O
fiber-specific	CC	O
promoters	,	O
and	VBG	O
methods	NN	O
for	JJ	O
the	NNS	O
construction	CC	O
of	NNS	O
transgenic	IN	O
cotton	DT	O
plants.	NN	O
Root-specific	IN	O
promoters	JJ	O
may	NN	O
also	.	O
be	JJ	O
used	NNS	O
to	MD	O
express	RB	O
the	VB	O
nucleic	VBN	O
acids	TO	O
of	VB	O
the	DT	O
invention.	JJ	O
Examples	NNS	O
of	IN	O
root-specific	DT	O
promoters	.	O
include	NNS	O
the	IN	O
promoter	JJ	O
from	NNS	O
the	VBP	O
alcohol	DT	O
dehydrogenase	NN	O
gene	IN	O
DeLisle	DT	B
(1990)	NN	I
Int.	NN	I
Rev.	NN	I
Cytol.	NNP	I
123:39-60).(	)	O
Other	.	O
promoters	.	O
that	.	O
can	.	O
be	JJ	O
used	NNS	O
to	WDT	O
express	MD	O
the	VB	O
nucleic	VBN	O
acids	TO	O
of	VB	O
the	DT	O
invention	JJ	O
include,	NNS	O
e.g.,	IN	O
ovule-specific,	DT	O
embryo-specific,	NN	O
endosperm-specific,	,	O
integument-specific,	,	O
seed	,	O
coat-specific	,	O
promoters,	,	O
or	,	O
some	NN	O
combination	JJ	O
thereof;	,	O
a	CC	O
leaf-specific	DT	O
promoter	NN	O
(see,	:	O
e.g.,	DT	O
Busk	JJ	B
(1997)	NN	I
Plant	,	I
J.	,	I
11:1285	NNP	I
1295,	)	I
describing	NNP	O
a	.	O
leaf-specific	CD	O
promoter	,	O
in	VBG	O
maize);	DT	O
the	JJ	O
ORF13	NN	O
promoter	IN	O
from	:	O
Agrobacterium	DT	O
rhizogenes	NNP	O
(which	NN	O
exhibits	IN	O
high	NNP	O
activity	NNS	O
in	WDT	O
roots,	VBZ	O
see,	JJ	O
e.g.,	NN	O
Hansen	IN	O
(1997)	,	O
supra);	,	O
a	,	O
maize	NNP	O
pollen	)	O
specific	:	O
promoter	DT	O
(see,	NN	O
e.g.,	NN	O
Guerrero	JJ	B
(1990)	NN	I
Mol.	,	I
Gen.	,	I
Genet.	NNP	I
224:161	)	I
168);a	.	O
tomato	NNP	O
promoter	.	O
active	CD	O
during	:	O
fruit	DT	O
ripening,	NN	O
senescence	NN	O
and	JJ	O
abscission	IN	O
of	NN	O
leaves	,	O
and,	NN	O
to	CC	O
a	NN	O
lesser	IN	O
extent,	NNS	O
of	,	O
flowers	TO	O
can	DT	O
be	JJR	O
used	,	O
(see,	IN	O
e.g.,	NNS	O
Blume	MD	B
(1997)	VB	I
Plant	VBN	I
J.	,	I
12:731	,	I
746);a	NNP	O
pistil-specific	)	O
promoter	NNP	O
from	.	O
the	CD	O
potato	:	O
SK2	DT	O
gene	JJ	O
(see,	NN	O
e.g.,	IN	O
Ficker	DT	B
(1997)	NN	I
Plant	NNP	I
Mol.	NN	I
Biol.	,	I
35:425	,	I
431);the	NNP	O
Blec4	)	O
gene	NNP	O
from	.	O
pea,	.	O
which	CD	O
is	:	O
active	DT	O
in	NNP	O
epidermal	NN	O
tissue	IN	O
of	,	O
vegetative	WDT	O
and	VBZ	O
floral	JJ	O
shoot	IN	O
apices	JJ	O
of	NN	O
transgenic	IN	O
alfalfa	JJ	O
making	CC	O
it	JJ	O
a	NN	O
useful	NNS	O
tool	IN	O
to	JJ	O
target	NN	O
the	VBG	O
expression	PRP	O
of	DT	O
foreign	JJ	O
genes	NN	O
to	TO	O
the	VB	O
epidermal	DT	O
layer	NN	O
of	IN	O
actively	JJ	O
growing	NNS	O
shoots	TO	O
or	DT	O
fibers;	JJ	O
the	NN	O
ovule-specific	IN	O
BEL1	RB	O
gene	VBG	O
(see,	NNS	O
e.g.,	CC	O
Reiser	:	B
(1995)	DT	I
Cell	JJ	I
83:735-742,	NNP	I
GenBank	NN	I
No.	,	I
U39944);and/or,	,	O
the	NNP	O
promoter	)	O
in	NNP	O
Klee,	,	O
U.S.	NNP	O
Pat.	.	O
No.	:	O
5,589,583,	,	O
describing	DT	O
a	NN	O
plant	IN	O
promoter	,	O
region	NNP	O
is	.	O
capable	.	O
of	,	O
conferring	VBG	O
high	DT	O
levels	NN	O
of	NN	O
transcription	NN	O
in	VBZ	O
meristematic	JJ	O
tissue	IN	O
and/or	VBG	O
rapidly	JJ	O
dividing	NNS	O
cells.	IN	O
Alternatively,	NN	O
plant	IN	O
promoters	JJ	O
which	NN	O
are	RB	O
inducible	RB	O
upon	VBG	O
exposure	.	O
to	,	O
plant	NN	O
hormones,	NNS	O
such	WDT	O
as	VBP	O
auxins,	JJ	O
are	IN	O
used	NN	O
to	TO	O
express	NN	O
the	,	O
nucleic	JJ	O
acids	IN	O
of	,	O
the	VBP	O
invention.	VBN	O
For	TO	O
example,	VB	O
the	DT	O
invention	JJ	O
can	NNS	O
use	IN	O
the	DT	O
auxin-response	.	O
elements	IN	O
E1	,	O
promoter	DT	O
fragment	NN	O
(AuxREs)	MD	O
in	VB	O
the	DT	O
soybean	JJ	O
(Glycine	NNS	O
max	NNP	O
L.)	NN	O
Liu	NN	B
(1997)	)	I
Plant	IN	I
Physiol.	DT	I
115:397-407);(	NN	O
the	NNP	O
auxin-responsive	NNP	O
Arabidopsis	)	O
GST6	NNP	O
promoter	)	O
(also	NNP	O
responsive	.	O
to	:	O
salicylic	DT	O
acid	JJ	O
and	NNP	O
hydrogen	NNP	O
peroxide)	NN	O
Chen	RB	B
(1996)	VBP	I
Plant	TO	I
J.	VB	I
10:	NN	I
955-966);(	CC	O
the	NN	O
auxin-inducible	)	O
parC	NNP	O
promoter	)	O
from	NNP	O
tobacco	.	O
Sakai	:	B
(1996)	:	I
37:906-913);(	DT	O
a	JJ	O
plant	NN	O
biotin	NN	O
response	IN	O
element	NN	O
Streit	NNP	B
(1997)	)	I
Mol.	:	I
Plant	DT	I
Microbe	NN	I
Interact.	NN	I
10:933-937);(	NN	O
and,	NN	O
the	NNP	O
promoter	)	O
responsive	.	O
to	NN	O
the	NNP	O
stress	.	O
hormone	:	O
abscisic	,	O
acid	DT	O
Sheen	NN	B
(1996)	NN	I
Science	TO	I
274:1900-1902).(	DT	O
The	NN	O
nucleic	NN	O
acids	JJ	O
of	NN	O
the	NNP	O
invention	)	O
can	NNP	O
also	.	O
be	DT	O
operably	JJ	O
linked	NNS	O
to	IN	O
plant	DT	O
promoters	NN	O
which	MD	O
are	RB	O
inducible	VB	O
upon	RB	O
exposure	VBN	O
to	TO	O
chemicals	NN	O
reagents	NNS	O
which	WDT	O
can	VBP	O
be	JJ	O
applied	IN	O
to	NN	O
the	TO	O
plant,	NNS	O
such	NNS	O
as	WDT	O
herbicides	MD	O
or	VB	O
antibiotics.	VBN	O
For	TO	O
example,	DT	O
the	,	O
maize	JJ	O
In2-2	IN	O
promoter,	NNS	O
activated	CC	O
by	.	O
benzenesulfonamide	IN	O
herbicide	,	O
safeners,	DT	O
can	JJ	O
be	NNP	O
used	,	O
De	VBN	B
Veylder	IN	I
(1997)	JJ	I
Plant	NN	I
Cell	,	I
Physiol.	MD	I
38:568-577);(	VB	O
application	VBN	O
of	NNP	O
different	NNP	O
herbicide	)	O
safeners	NNP	O
induces	NNP	O
distinct	.	O
gene	:	O
expression	NN	O
patterns,	IN	O
including	JJ	O
expression	NN	O
in	NNS	O
the	NNS	O
root,	JJ	O
hydathodes,	NN	O
and	NN	O
the	,	O
shoot	VBG	O
apical	NN	O
meristem.	IN	O
Coding	DT	O
sequence	,	O
can	,	O
be	CC	O
under	DT	O
the	JJ	O
control	JJ	O
of,	.	O
e.g.,	VBG	O
a	NN	O
tetracycline-inducible	MD	O
promoter,	VB	O
e.g.,	IN	O
as	DT	O
described	NN	O
with	,	O
transgenic	,	O
tobacco	DT	O
plants	JJ	O
containing	,	O
the	,	O
Avena	IN	O
sativa	VBN	O
L.	IN	O
(oat)	JJ	O
arginine	NN	O
decarboxylase	NNS	O
gene	VBG	O
Masgrau	DT	B
(1997)	NNP	I
Plant	NN	I
J.	NNP	I
11:465-473);(	)	O
or,	NN	O
a	NN	O
salicylic	NN	O
acid-responsive	NNP	O
element	)	O
Stange	NNP	B
(1997)	.	I
Plant	:	I
J.	,	I
11:1315-1324).(	DT	O
Using	JJ	O
chemically—(e.g.,	JJ	O
hormone-	NN	O
or	NNP	O
pesticide-)	)	O
induced	NNP	O
promoters,	.	O
i.e.,	.	O
promoter	VBG	O
responsive	,	O
to	JJ	O
a	CC	O
chemical	)	O
which	VBD	O
can	,	O
be	,	O
applied	RB	O
to	JJ	O
the	TO	O
transgenic	DT	O
plant	NN	O
in	WDT	O
the	MD	O
field,	VB	O
expression	VBN	O
of	TO	O
a	DT	O
polypeptide	JJ	O
of	NN	O
the	IN	O
invention	DT	O
can	,	O
be	NN	O
induced	IN	O
at	DT	O
a	NN	O
particular	IN	O
stage	DT	O
of	NN	O
development	MD	O
of	VB	O
the	VBN	O
plant.	IN	O
Thus,	DT	O
the	JJ	O
invention	NN	O
also	IN	O
provides	NN	O
for	IN	O
transgenic	DT	O
plants	.	O
containing	,	O
an	DT	O
inducible	NN	O
gene	RB	O
encoding	VBZ	O
for	IN	O
polypeptides	JJ	O
of	NNS	O
the	VBG	O
invention	DT	O
whose	JJ	O
host	NN	O
range	VBG	O
is	IN	O
limited	NNS	O
to	IN	O
target	DT	O
plant	NN	O
species,	WP$	O
such	NN	O
as	NN	O
corn,	VBZ	O
rice,	VBN	O
barley,	TO	O
wheat,	VB	O
potato	NN	O
or	,	O
other	JJ	O
crops,	IN	O
inducible	,	O
at	,	O
any	,	O
stage	,	O
of	NN	O
development	CC	O
of	JJ	O
the	,	O
crop.	JJ	O
One	IN	O
of	DT	O
skill	NN	O
will	IN	O
recognize	NN	O
that	IN	O
a	DT	O
tissue-specific	.	O
plant	CD	O
promoter	IN	O
may	NN	O
drive	MD	O
expression	VB	O
of	IN	O
operably	DT	O
linked	JJ	O
sequences	NN	O
in	NN	O
tissues	MD	O
other	VB	O
than	NN	O
the	IN	O
target	RB	O
tissue.	VBN	O
Thus,	NNS	O
a	IN	O
tissue-specific	NNS	O
promoter	JJ	O
is	IN	O
one	DT	O
that	NN	O
drives	.	O
expression	,	O
preferentially	DT	O
in	JJ	O
the	NN	O
target	VBZ	O
tissue	CD	O
or	WDT	O
cell	VBZ	O
type,	NN	O
but	RB	O
may	IN	O
also	DT	O
lead	NN	O
to	NN	O
some	CC	O
expression	NN	O
in	,	O
other	CC	O
tissues	MD	O
as	RB	O
well.	VB	O
The	TO	O
nucleic	DT	O
acids	NN	O
of	IN	O
the	JJ	O
invention	NNS	O
can	IN	O
also	.	O
be	DT	O
operably	JJ	O
linked	NNS	O
to	IN	O
plant	DT	O
promoters	NN	O
which	MD	O
are	RB	O
inducible	VB	O
upon	RB	O
exposure	VBN	O
to	TO	O
chemicals	NN	O
reagents.	NNS	O
These	WDT	O
reagents	VBP	O
include,	JJ	O
e.g.,	IN	O
herbicides,	NN	O
synthetic	TO	O
auxins,	NNS	O
or	.	O
antibiotics	DT	O
which	NNS	O
can	,	O
be	,	O
applied,	,	O
e.g.,	JJ	O
sprayed,	,	O
onto	CC	O
transgenic	NNS	O
plants.	WDT	O
Inducible	MD	O
expression	VB	O
of	,	O
the	,	O
amylase-producing	,	O
nucleic	IN	O
acids	JJ	O
of	.	O
the	JJ	O
invention	NN	O
will	IN	O
allow	DT	O
the	JJ	O
grower	JJ	O
to	NNS	O
select	IN	O
plants	DT	O
with	NN	O
the	MD	O
optimal	VB	O
starch/sugar	DT	O
ratio.	NN	O
The	TO	O
development	VB	O
of	NNS	O
plant	IN	O
parts	DT	O
can	JJ	O
thus	NN	O
controlled.	.	O
In	DT	O
this	NN	O
way	IN	O
the	NN	O
invention	NNS	O
provides	MD	O
the	RB	O
means	.	O
to	IN	O
facilitate	DT	O
the	NN	O
harvesting	DT	O
of	NN	O
plants	VBZ	O
and	DT	O
plant	NNS	O
parts.	TO	O
For	VB	O
example,	DT	O
in	NN	O
various	IN	O
embodiments,	NNS	O
the	CC	O
maize	NN	O
In2-2	.	O
promoter,	IN	O
activated	,	O
by	IN	O
benzenesulfonamide	JJ	O
herbicide	,	O
safeners,	DT	O
is	JJ	O
used	NNP	O
De	,	B
Veylder	VBN	I
(1997)	IN	I
Plant	JJ	I
Cell	NN	I
Physiol.	,	I
38:568-577);(	VBZ	O
application	VBN	O
of	NNP	O
different	NNP	O
herbicide	)	O
safeners	NNP	O
induces	NNP	O
distinct	.	O
gene	:	O
expression	NN	O
patterns,	IN	O
including	JJ	O
expression	NN	O
in	NNS	O
the	NNS	O
root,	JJ	O
hydathodes,	NN	O
and	NN	O
the	,	O
shoot	VBG	O
apical	NN	O
meristem.	IN	O
Coding	DT	O
sequences	,	O
of	,	O
the	CC	O
invention	DT	O
are	JJ	O
also	JJ	O
under	.	O
the	VBG	O
control	NNS	O
of	IN	O
a	DT	O
tetracycline-inducible	NN	O
promoter,	VBP	O
e.g.,	RB	O
as	IN	O
described	DT	O
with	NN	O
transgenic	IN	O
tobacco	DT	O
plants	JJ	O
containing	,	O
the	,	O
Avena	IN	O
sativa	VBN	O
L.	IN	O
(oat)	JJ	O
arginine	NN	O
decarboxylase	NNS	O
gene	VBG	O
Masgrau	DT	B
(1997)	NNP	I
Plant	NN	I
J.	NNP	I
11:465-473);(	)	O
or,	NN	O
a	NN	O
salicylic	NN	O
acid-responsive	NNP	O
element	)	O
Stange	NNP	B
(1997)	.	I
Plant	:	I
J.	,	I
11:1315-1324).(	DT	O
If	JJ	O
proper	JJ	O
polypeptide	NN	O
expression	NNP	O
is	)	O
desired,	NNP	O
a	.	O
polyadenylation	.	O
region	IN	O
at	JJ	O
the	NN	O
3′-end	NN	O
of	VBZ	O
the	,	O
coding	DT	O
region	NN	O
should	NN	O
be	IN	O
included.	DT	O
The	CD	O
polyadenylation	IN	O
region	DT	O
can	VBG	O
be	NN	O
derived	MD	O
from	VB	O
the	.	O
natural	DT	O
gene,	NN	O
from	NN	O
a	MD	O
variety	VB	O
of	VBN	O
other	IN	O
plant	DT	O
genes,	JJ	O
or	,	O
from	IN	O
genes	DT	O
in	NN	O
the	IN	O
Agrobacterial	JJ	O
T-DNA.	NN	O
Expression	,	O
Vectors	CC	O
and	IN	O
Cloning	NNS	O
Vehicles	IN	O
The	DT	O
invention	NNP	O
provides	.	O
expression	NN	O
vectors	NNS	O
and	CC	O
cloning	NNP	O
vehicles	NNP	O
comprising	DT	O
nucleic	NN	O
acids	VBZ	O
of	NN	O
the	NNS	O
invention,	CC	O
e.g.,	VBG	O
sequences	NNS	O
encoding	VBG	O
the	JJ	O
amylases	NNS	O
of	IN	O
the	DT	O
invention.	,	O
Expression	,	O
vectors	NNS	O
and	VBG	O
cloning	DT	O
vehicles	NNS	O
of	IN	O
the	DT	O
invention	.	O
can	NN	O
comprise	NNS	O
viral	CC	O
particles,	VBG	O
baculovirus,	NNS	O
phage,	IN	O
plasmids,	DT	O
phagemids,	NN	O
cosmids,	MD	O
fosmids,	VB	O
bacterial	JJ	O
artificial	,	O
chromosomes,	,	O
viral	,	O
DNA	,	O
(e.g.,	,	O
vaccinia,	,	O
adenovirus,	,	O
foul	JJ	O
pox	JJ	O
virus,	,	O
pseudorabies	JJ	O
and	NNP	O
derivatives	,	O
of	,	O
SV40),	,	O
P1-based	JJ	O
artificial	NN	O
chromosomes,	,	O
yeast	NNS	O
plasmids,	CC	O
yeast	NNS	O
artificial	IN	O
chromosomes,	,	O
and	JJ	O
any	JJ	O
other	,	O
vectors	NN	O
specific	,	O
for	RB	O
specific	JJ	O
hosts	,	O
of	CC	O
interest	DT	O
(such	JJ	O
as	NNS	O
bacillus,	VBP	O
Aspergillus	IN	O
and	JJ	O
yeast).	NNS	O
Vectors	IN	O
of	NN	O
the	JJ	O
invention	IN	O
can	,	O
include	NNP	O
chromosomal,	CC	O
non-chromosomal	.	O
and	NNS	O
synthetic	IN	O
DNA	DT	O
sequences.	NN	O
Large	MD	O
numbers	VB	O
of	,	O
suitable	JJ	O
vectors	CC	O
are	JJ	O
known	NNP	O
to	.	O
those	JJ	O
of	NNS	O
skill	IN	O
in	JJ	O
the	NNS	O
art,	VBP	O
and	VBN	O
are	TO	O
commercially	DT	O
available.	IN	O
Exemplary	NN	O
vectors	IN	O
are	DT	O
include:	,	O
bacterial:	CC	O
pQE	VBP	O
vectors	RB	O
(Qiagen),	.	O
pBluescript	JJ	O
plasmids,	NNS	O
pNH	VBP	O
vectors,	:	O
(lambda-ZAP	:	O
vectors	NN	O
(Stratagene);	NNS	O
ptrc99a,	,	O
pKK223-3,	JJ	O
pDR540,	,	O
pRIT2T	NN	O
(Pharmacia);	,	O
Eukaryotic:	JJ	O
pXT1,	NNS	O
pSG5	:	O
(Stratagene),	,	O
pSVK3,	,	O
pBPV,	,	O
pMSG,	NN	O
pSVLSV40	:	O
(Pharmacia).	:	O
However,	,	O
any	NN	O
other	,	O
plasmid	,	O
or	,	O
other	,	O
vector	NN	O
may	.	O
be	,	O
used	DT	O
so	JJ	O
long	NN	O
as	CC	O
they	JJ	O
are	NN	O
replicable	MD	O
and	VB	O
viable	VBN	O
in	RB	O
the	RB	O
host.	IN	O
Low	PRP	O
copy	VBP	O
number	JJ	O
or	CC	O
high	JJ	O
copy	IN	O
number	DT	O
vectors	.	O
may	JJ	O
be	NN	O
employed	NN	O
with	CC	O
the	JJ	O
present	NN	O
invention.	NN	O
The	NNS	O
expression	MD	O
vector	VB	O
can	VBN	O
comprise	IN	O
a	DT	O
promoter,	JJ	O
a	.	O
ribosome	DT	O
binding	NN	O
site	NN	O
for	MD	O
translation	VB	O
initiation	DT	O
and	,	O
a	DT	O
transcription	NN	O
terminator.	NN	O
The	NN	O
vector	IN	O
may	NN	O
also	NN	O
include	CC	O
appropriate	DT	O
sequences	NN	O
for	.	O
amplifying	DT	O
expression.	NN	O
Mammalian	MD	O
expression	RB	O
vectors	VB	O
can	JJ	O
comprise	NNS	O
an	IN	O
origin	VBG	O
of	.	O
replication,	JJ	O
any	NN	O
necessary	NNS	O
ribosome	MD	O
binding	VB	O
sites,	DT	O
a	NN	O
polyadenylation	IN	O
site,	,	O
splice	DT	O
donor	JJ	O
and	NN	O
acceptor	NN	O
sites,	,	O
transcriptional	DT	O
termination	NN	O
sequences,	,	O
and	JJ	O
5′	NN	O
flanking	CC	O
non-transcribed	NN	O
sequences.	,	O
In	JJ	O
some	NN	O
aspects,	,	O
DNA	CC	O
sequences	CD	O
derived	VBG	O
from	JJ	O
the	.	O
SV40	IN	O
splice	DT	O
and	,	O
polyadenylation	NNP	O
sites	VBZ	O
may	VBN	O
be	IN	O
used	DT	O
to	NNP	O
provide	NN	O
the	CC	O
required	NN	O
non-transcribed	NNS	O
genetic	MD	O
elements.	VB	O
In	VBN	O
one	TO	O
aspect,	VB	O
the	DT	O
expression	JJ	O
vectors	JJ	O
contain	JJ	O
one	.	O
or	IN	O
more	CD	O
selectable	,	O
marker	DT	O
genes	NN	O
to	NNS	O
permit	VBP	O
selection	CD	O
of	CC	O
host	JJR	O
cells	JJ	O
containing	NN	O
the	NNS	O
vector.	TO	O
Such	VB	O
selectable	NN	O
markers	IN	O
include	NN	O
genes	NNS	O
encoding	VBG	O
dihydrofolate	DT	O
reductase	.	O
or	JJ	O
genes	JJ	O
conferring	NNS	O
neomycin	VBP	O
resistance	NNS	O
for	VBG	O
eukaryotic	JJ	O
cell	NN	O
culture,	CC	O
genes	NNS	O
conferring	VBG	O
tetracycline	JJ	O
or	NN	O
ampicillin	IN	O
resistance	JJ	O
in	NN	O
E.	,	O
coli,	NNS	O
and	VBG	O
the	NN	O
S.	CC	O
cerevisiae	NN	O
TRP1	NN	O
gene.	IN	O
Promoter	NNP	O
regions	,	O
can	CC	O
be	DT	O
selected	NNP	O
from	NN	O
any	NNP	O
desired	.	O
gene	NN	O
using	NNS	O
chloramphenicol	MD	O
transferase	VB	O
(CAT)	VBN	O
vectors	IN	O
or	DT	O
other	JJ	O
vectors	NN	O
with	VBG	O
selectable	JJ	O
markers.	NN	O
Vectors	)	O
for	NNS	O
expressing	CC	O
the	JJ	O
polypeptide	NNS	O
or	IN	O
fragment	JJ	O
thereof	.	O
in	NNS	O
eukaryotic	IN	O
cells	VBG	O
can	DT	O
also	NN	O
contain	CC	O
enhancers	JJ	O
to	NN	O
increase	IN	O
expression	JJ	O
levels.	NNS	O
Enhancers	MD	O
are	RB	O
cis-acting	VB	O
elements	NNS	O
of	TO	O
DNA,	VB	O
usually	NN	O
from	.	O
about	NNS	O
10	VBP	O
to	JJ	O
about	NNS	O
300	IN	O
bp	,	O
in	RB	O
length	IN	O
that	RB	O
act	CD	O
on	TO	O
a	IN	O
promoter	CD	O
to	NN	O
increase	IN	O
its	NN	O
transcription.	WDT	O
Examples	NN	O
include	IN	O
the	DT	O
SV40	NN	O
enhancer	TO	O
on	VB	O
the	PRP$	O
late	.	O
side	NNS	O
of	VBP	O
the	DT	O
replication	NNP	O
origin	NN	O
by	IN	O
100	DT	O
to	JJ	O
270,	NN	O
the	IN	O
cytomegalovirus	DT	O
early	NN	O
promoter	NN	O
enhancer,	IN	O
the	CD	O
polyoma	TO	O
enhancer	,	O
on	DT	O
the	NN	O
late	JJ	O
side	NN	O
of	,	O
the	DT	O
replication	NN	O
origin,	NN	O
and	IN	O
the	DT	O
adenovirus	JJ	O
enhancers.	NN	O
A	IN	O
nucleic	DT	O
acid	NN	O
sequence	,	O
can	CC	O
be	DT	O
inserted	NN	O
into	.	O
a	DT	O
vector	JJ	O
by	NN	O
a	NN	O
variety	MD	O
of	VB	O
procedures.	VBN	O
In	IN	O
general,	DT	O
the	NN	O
sequence	IN	O
is	DT	O
ligated	NN	O
to	IN	O
the	.	O
desired	IN	O
position	,	O
in	DT	O
the	NN	O
vector	VBZ	O
following	VBN	O
digestion	TO	O
of	DT	O
the	VBN	O
insert	NN	O
and	IN	O
the	DT	O
vector	NN	O
with	VBG	O
appropriate	NN	O
restriction	IN	O
endonucleases.	DT	O
Alternatively,	NN	O
blunt	CC	O
ends	DT	O
in	NN	O
both	IN	O
the	JJ	O
insert	NN	O
and	.	O
the	,	O
vector	NN	O
may	NNS	O
be	IN	O
ligated.	DT	O
A	DT	O
variety	NN	O
of	CC	O
cloning	DT	O
techniques	NN	O
are	MD	O
known	VB	O
in	.	O
the	DT	O
art,	NN	O
e.g.,	IN	O
as	VBG	O
described	NNS	O
in	VBP	O
Ausubel	VBN	O
and	IN	O
Sambrook.	DT	O
Such	,	O
procedures	,	O
and	IN	O
others	VBN	O
are	IN	O
deemed	NNP	O
to	CC	O
be	.	O
within	JJ	O
the	NNS	O
scope	CC	O
of	NNS	O
those	VBP	O
skilled	VBN	O
in	TO	O
the	VB	O
art.	IN	O
The	DT	O
vector	NN	O
can	IN	O
be	DT	O
in	VBN	O
the	IN	O
form	DT	O
of	.	O
a	DT	O
plasmid,	NN	O
a	MD	O
viral	VB	O
particle,	IN	O
or	DT	O
a	NN	O
phage.	IN	O
Other	DT	O
vectors	,	O
include	DT	O
chromosomal,	JJ	O
non-chromosomal	,	O
and	CC	O
synthetic	DT	O
DNA	.	O
sequences,	JJ	O
derivatives	NNS	O
of	VBP	O
SV40;	,	O
bacterial	JJ	O
plasmids,	CC	O
phage	JJ	O
DNA,	NNP	O
baculovirus,	,	O
yeast	NNS	O
plasmids,	IN	O
vectors	:	O
derived	JJ	O
from	,	O
combinations	NN	O
of	,	O
plasmids	,	O
and	NN	O
phage	,	O
DNA,	NNS	O
viral	VBD	O
DNA	IN	O
such	NNS	O
as	IN	O
vaccinia,	NNS	O
adenovirus,	CC	O
fowl	NN	O
pox	,	O
virus,	JJ	O
and	NNP	O
pseudorabies.	JJ	O
A	IN	O
variety	,	O
of	,	O
cloning	NN	O
and	NN	O
expression	,	O
vectors	CC	O
for	.	O
use	DT	O
with	NN	O
prokaryotic	IN	O
and	VBG	O
eukaryotic	CC	O
hosts	NN	O
are	NNS	O
described	IN	O
by,	NN	O
e.g.,	IN	O
Sambrook.	JJ	O
Particular	CC	O
bacterial	JJ	O
vectors	NNS	O
which	VBP	O
can	VBN	O
be	,	O
used	,	O
include	.	O
the	JJ	O
commercially	NN	O
available	NNS	O
plasmids	WDT	O
comprising	MD	O
genetic	VB	O
elements	VBN	O
of	VBP	O
the	DT	O
well	RB	O
known	JJ	O
cloning	NNS	O
vector	VBG	O
pBR322	JJ	O
(ATCC	NNS	O
37017),	IN	O
pKK223-3	DT	O
(Pharmacia	NN	O
Fine	VBN	O
Chemicals,	VBG	O
Uppsala,	NN	O
Sweden),	NN	O
GEM1	NNP	O
(Promega	,	O
Biotec,	JJ	O
Madison,	NNP	O
Wis.,	NNP	O
USA)	,	O
pQE70,	,	O
pQE60,	,	O
pQE-9	NNP	O
(Qiagen),	NNP	O
pD10,	,	O
psiX174	,	O
pBluescript	,	O
II	)	O
KS,	,	O
pNH8A,	,	O
pNH16a,	NN	O
pNH18A,	,	O
pNH46A	,	O
(Stratagene),	NN	O
ptrc99a,	NN	O
pKK223-3,	NNP	O
pKK233-3,	,	O
DR540,	,	O
pRIT5	,	O
(Pharmacia),	,	O
pKK232-8	NN	O
and	,	O
pCM7.	,	O
Particular	,	O
eukaryotic	,	O
vectors	,	O
include	NN	O
pSV2CAT,	,	O
pOG44,	JJ	O
pXT1,	CC	O
pSG	.	O
(Stratagene)	JJ	O
pSVK3,	JJ	O
pBPV,	NNS	O
pMSG,	VBP	O
and	,	O
pSVL	,	O
(Pharmacia).	,	O
However,	NN	O
any	)	O
other	,	O
vector	,	O
may	,	O
be	CC	O
used	NN	O
as	.	O
long	,	O
as	DT	O
it	JJ	O
is	NN	O
replicable	MD	O
and	VB	O
viable	VBN	O
in	RB	O
the	RB	O
host	IN	O
cell.	PRP	O
The	VBZ	O
nucleic	JJ	O
acids	CC	O
of	JJ	O
the	IN	O
invention	DT	O
can	NN	O
be	.	O
expressed	DT	O
in	JJ	O
expression	NNS	O
cassettes,	IN	O
vectors	DT	O
or	NN	O
viruses	MD	O
and	VB	O
transiently	VBN	O
or	IN	O
stably	NN	O
expressed	,	O
in	NNS	O
plant	CC	O
cells	NNS	O
and	CC	O
seeds.	RB	O
One	CC	O
exemplary	RB	O
transient	VBN	O
expression	IN	O
system	NN	O
uses	NNS	O
episomal	CC	O
expression	.	O
systems,	CD	O
e.g.,	JJ	O
cauliflower	NN	O
mosaic	NN	O
virus	NN	O
(CaMV)	VBZ	O
viral	JJ	O
RNA	NN	O
generated	,	O
in	,	O
the	JJR	O
nucleus	NN	O
by	NN	O
transcription	)	O
of	JJ	O
an	NNP	O
episomal	VBD	O
mini-chromosome	IN	O
containing	DT	O
supercoiled	NN	O
DNA,	IN	O
see,	NN	O
e.g.,	IN	O
Covey	DT	B
(1990)	JJ	I
Proc.	JJ	I
Natl.	NN	I
Acad.	VBD	I
Sci.	,	I
USA	,	I
87:1633-1637.	,	I
Alternatively,	NNP	O
coding	)	O
sequences,	.	O
i.e.,	.	O
all	.	O
or	.	O
sub-fragments	NNP	O
of	.	O
sequences	,	O
of	VBG	O
the	,	O
invention	,	O
can	DT	O
be	CC	O
inserted	NNS	O
into	IN	O
a	NNS	O
plant	IN	O
host	DT	O
cell	NN	O
genome	MD	O
becoming	VB	O
an	VBN	O
integral	IN	O
part	DT	O
of	NN	O
the	NN	O
host	NN	O
chromosomal	NN	O
DNA.	VBG	O
Sense	DT	O
or	JJ	O
antisense	NN	O
transcripts	IN	O
can	DT	O
be	NN	O
expressed	JJ	O
in	.	O
this	NN	O
manner.	CC	O
A	NN	O
vector	NNS	O
comprising	MD	O
the	VB	O
sequences	VBN	O
(e.g.,	IN	O
promoters	DT	O
or	.	O
coding	DT	O
regions)	NN	O
from	VBG	O
nucleic	DT	O
acids	NNS	O
of	,	O
the	NNS	O
invention	CC	O
can	VBG	O
comprise	)	O
a	IN	O
marker	JJ	O
gene	NNS	O
that	IN	O
confers	DT	O
a	NN	O
selectable	MD	O
phenotype	VB	O
on	DT	O
a	NN	O
plant	NN	O
cell	WDT	O
or	VBZ	O
a	DT	O
seed.	JJ	O
For	NN	O
example,	IN	O
the	DT	O
marker	NN	O
may	NN	O
encode	CC	O
biocide	DT	O
resistance,	.	O
particularly	IN	O
antibiotic	,	O
resistance,	DT	O
such	NN	O
as	MD	O
resistance	VB	O
to	NN	O
kanamycin,	,	O
G418,	RB	O
bleomycin,	JJ	O
hygromycin,	,	O
or	JJ	O
herbicide	IN	O
resistance,	NN	O
such	TO	O
as	,	O
resistance	,	O
to	,	O
chlorosulfuron	,	O
or	CC	O
Basta.	NN	O
Expression	,	O
vectors	JJ	O
capable	IN	O
of	NN	O
expressing	TO	O
nucleic	VB	O
acids	CC	O
and	.	O
proteins	NN	O
in	NNS	O
plants	JJ	O
are	IN	O
well	VBG	O
known	JJ	O
in	NNS	O
the	CC	O
art,	NNS	O
and	IN	O
can	NNS	O
include,	VBP	O
e.g.,	RB	O
vectors	VBN	O
from	IN	O
Agrobacterium	DT	O
spp.,	,	O
potato	CC	O
virus	MD	O
X	,	O
(see,	,	O
e.g.,	NNS	O
Angell	IN	B
(1997)	NNP	I
EMBO	,	I
J.	NN	I
16:3675-3684),tobacco	NN	O
mosaic	NNP	O
virus	,	O
(see,	,	O
e.g.,	NNP	O
Casper	)	B
(1996)	NNP	I
Gene	.	I
173:69-73),tomato	,	O
bushy	NN	O
stunt	NN	O
virus	NN	O
(see,	,	O
e.g.,	,	O
Hillman	NNP	B
(1989)	)	I
Virology	NNP	I
169:42-50),tobacco	,	O
etch	JJ	O
virus	NN	O
(see,	NN	O
e.g.,	NN	O
Dolja	,	B
(1997)	,	I
Virology	NNP	I
234:243-252),bean	)	O
golden	NNP	O
mosaic	,	O
virus	NN	O
(see,	NN	O
e.g.,	NN	O
Morinaga	,	B
(1993)	,	I
Microbiol	NNP	I
Immunol.	)	I
37:471-476),cauliflower	NNP	O
mosaic	,	O
virus	JJ	O
(see,	JJ	O
e.g.,	NN	O
Cecchini	NN	B
(1997)	,	I
Mol.	,	I
Plant	NNP	I
Microbe	)	I
Interact.	NNP	I
10:1094-1101),maize	.	O
Ac/Ds	,	O
transposable	JJR	O
element	NN	O
(see,	NN	O
e.g.,	,	O
Rubin	,	B
(1997)	NNP	I
Mol.	)	I
Cell.	.	I
Biol.	NN	I
17:6294-6302;	NNP	I
Kunze	.	B
(1996)	,	I
Curr.	VB	I
Top.	NNP	I
Microbiol.	JJ	I
Immunol.	NN	I
204:161-194),and	,	O
the	,	O
maize	NNP	O
suppressor-mutator	)	O
(Spm)	.	O
transposable	.	O
element	.	O
(see,	:	O
e.g.,	NNP	O
Schlappi	)	B
(1996)	.	I
Plant	.	I
Mol.	.	I
Biol.	.	I
32:717-725);and	,	O
derivatives	CC	O
thereof.	DT	O
In	JJ	O
one	NN	O
aspect,	)	O
the	JJ	O
expression	NN	O
vector	,	O
can	,	O
have	NNP	O
two	)	O
replication	NNP	O
systems	.	O
to	.	O
allow	:	O
it	CC	O
to	NNS	O
be	.	O
maintained	IN	O
in	CD	O
two	,	O
organisms,	DT	O
for	NN	O
example	NN	O
in	MD	O
mammalian	VB	O
or	CD	O
insect	NN	O
cells	NNS	O
for	TO	O
expression	VB	O
and	PRP	O
in	TO	O
a	VB	O
prokaryotic	VBN	O
host	IN	O
for	CD	O
cloning	,	O
and	IN	O
amplification.	NN	O
Furthermore,	IN	O
for	JJ	O
integrating	CC	O
expression	JJ	O
vectors,	NNS	O
the	IN	O
expression	NN	O
vector	CC	O
can	IN	O
contain	DT	O
at	JJ	O
least	NN	O
one	IN	O
sequence	VBG	O
homologous	CC	O
to	.	O
the	,	O
host	IN	O
cell	VBG	O
genome.	NN	O
It	,	O
can	DT	O
contain	NN	O
two	NN	O
homologous	MD	O
sequences	VB	O
which	IN	O
flank	JJS	O
the	CD	O
expression	NN	O
construct.	JJ	O
The	TO	O
integrating	DT	O
vector	NN	O
can	NN	O
be	.	O
directed	PRP	O
to	MD	O
a	VB	O
specific	CD	O
locus	JJ	O
in	NNS	O
the	WDT	O
host	VBP	O
cell	DT	O
by	NN	O
selecting	.	O
the	DT	O
appropriate	VBG	O
homologous	NN	O
sequence	MD	O
for	VB	O
inclusion	VBN	O
in	TO	O
the	DT	O
vector.	JJ	O
Constructs	NN	O
for	IN	O
integrating	DT	O
vectors	NN	O
are	NN	O
well	IN	O
known	VBG	O
in	DT	O
the	JJ	O
art.	JJ	O
Expression	NN	O
vectors	IN	O
of	NN	O
the	IN	O
invention	DT	O
may	.	O
also	NNS	O
include	IN	O
a	VBG	O
selectable	NNS	O
marker	VBP	O
gene	RB	O
to	VBN	O
allow	IN	O
for	DT	O
the	.	O
selection	NN	O
of	NNS	O
bacterial	IN	O
strains	DT	O
that	NN	O
have	MD	O
been	RB	O
transformed,	VB	O
e.g.,	DT	O
genes	JJ	O
which	NN	O
render	NN	O
the	TO	O
bacteria	VB	O
resistant	IN	O
to	DT	O
drugs	NN	O
such	IN	O
as	JJ	O
ampicillin,	NNS	O
chloramphenicol,	WDT	O
erythromycin,	VBP	O
kanamycin,	VBN	O
neomycin	,	O
and	,	O
tetracycline.	NNS	O
Selectable	WDT	O
markers	VBP	O
can	DT	O
also	NN	O
include	NN	O
biosynthetic	TO	O
genes,	NNS	O
such	JJ	O
as	IN	O
those	,	O
in	,	O
the	,	O
histidine,	,	O
tryptophan	NN	O
and	CC	O
leucine	.	O
biosynthetic	JJ	O
pathways.	NNS	O
Host	MD	O
Cells	RB	O
and	VB	O
Transformed	JJ	O
Cells	,	O
The	JJ	O
invention	IN	O
also	DT	O
provides	IN	O
a	DT	O
transformed	,	O
cell	NN	O
comprising	CC	O
a	JJ	O
nucleic	JJ	O
acid	.	O
sequence	NNP	O
of	NNP	O
the	CC	O
invention,	NNP	O
e.g.,	NNP	O
a	DT	O
sequence	NN	O
encoding	RB	O
an	VBZ	O
amylase	DT	O
of	JJ	O
the	NN	O
invention,	VBG	O
or	DT	O
a	JJ	O
vector	JJ	O
of	NN	O
the	IN	O
invention.	DT	O
The	,	O
host	,	O
cell	DT	O
may	NN	O
be	VBG	O
any	DT	O
of	NN	O
the	IN	O
host	DT	O
cells	,	O
familiar	CC	O
to	DT	O
those	NN	O
skilled	IN	O
in	DT	O
the	.	O
art,	DT	O
including	NN	O
prokaryotic	NN	O
cells,	MD	O
eukaryotic	VB	O
cells,	DT	O
such	IN	O
as	DT	O
bacterial	NN	O
cells,	NNS	O
fungal	JJ	O
cells,	TO	O
yeast	DT	O
cells,	VBN	O
mammalian	IN	O
cells,	DT	O
insect	,	O
cells,	VBG	O
or	JJ	O
plant	,	O
cells.	JJ	O
Exemplary	,	O
bacterial	JJ	O
cells	IN	O
include	JJ	O
E.	,	O
coli,	JJ	O
Streptomyces,	,	O
Bacillus	NN	O
subtilis,	,	O
Salmonella	JJ	O
typhimurium	,	O
and	JJ	O
various	,	O
species	CC	O
within	NN	O
the	.	O
genera	JJ	O
Pseudomonas,	JJ	O
Streptomyces,	NNS	O
and	VBP	O
Staphylococcus.	NNP	O
Exemplary	,	O
insect	,	O
cells	NNP	O
include	,	O
Drosophila	NNP	O
S2	NN	O
and	CC	O
Spodoptera	JJ	O
Sf9.	NNS	O
Exemplary	IN	O
animal	DT	O
cells	NN	O
include	,	O
CHO,	,	O
COS	CC	O
or	.	O
Bowes	JJ	O
melanoma	NN	O
or	NNS	O
any	VBP	O
mouse	NNP	O
or	NNP	O
human	CC	O
cell	NNP	O
line.	.	O
The	NNP	O
selection	NN	O
of	NNS	O
an	VBP	O
appropriate	,	O
host	NNP	O
is	CC	O
within	NNP	O
the	CD	O
abilities	CC	O
of	DT	O
those	NN	O
skilled	CC	O
in	JJ	O
the	NN	O
art.	.	O
Techniques	DT	O
for	NN	O
transforming	IN	O
a	DT	O
wide	JJ	O
variety	NN	O
of	VBZ	O
higher	IN	O
plant	DT	O
species	NNS	O
are	IN	O
well	DT	O
known	VBN	O
and	IN	O
described	DT	O
in	.	O
the	NNS	O
technical	IN	O
and	VBG	O
scientific	DT	O
literature.	JJ	O
See,	NN	O
e.g.,	IN	O
Weising	JJR	O
(1988)	NN	O
Ann.	NNS	O
Rev.	VBP	O
Genet.	RB	O
22:421-477,	VBN	O
U.S.	CC	O
Pat.	VBN	O
No.	IN	O
5,750,870.	DT	O
The	JJ	O
vector	CC	O
can	JJ	O
be	.	O
introduced	,	O
into	,	O
the	NNP	O
host	)	O
cells	.	O
using	.	O
any	.	O
of	,	O
a	NNP	O
variety	.	O
of	.	O
techniques,	.	O
including	DT	O
transformation,	NN	O
transfection,	MD	O
transduction,	VB	O
viral	VBN	O
infection,	IN	O
gene	DT	O
guns,	NN	O
or	NNS	O
Ti-mediated	VBG	O
gene	DT	O
transfer.	IN	O
Particular	DT	O
methods	NN	O
include	IN	O
calcium	,	O
phosphate	VBG	O
transfection,	,	O
DEAE-Dextran	,	O
mediated	,	O
transfection,	JJ	O
lipofection,	,	O
or	NN	O
electroporation	,	O
Davis,	CC	B
L.,	JJ	I
Dibner,	NN	I
M.,	.	I
Battey,	JJ	I
I.,	NNS	I
Basic	VBP	I
Methods	JJ	I
in	JJ	I
Molecular	,	I
Biology,	NNP	I
(1986)).(	VBD	O
In	,	O
one	,	O
aspect,	CC	O
the	NN	O
nucleic	,	O
acids	,	O
or	,	O
vectors	,	O
of	,	O
the	,	O
invention	NNP	O
are	NNP	O
introduced	IN	O
into	NNP	O
the	,	O
cells	.	O
for	IN	O
screening,	CD	O
thus,	,	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
enter	CC	O
the	NNS	O
cells	IN	O
in	DT	O
a	NN	O
manner	VBP	O
suitable	VBN	O
for	IN	O
subsequent	DT	O
expression	NNS	O
of	IN	O
the	,	O
nucleic	,	O
acid.	DT	O
The	JJ	O
method	NNS	O
of	VBP	O
introduction	DT	O
is	NNS	O
largely	IN	O
dictated	DT	O
by	NN	O
the	JJ	O
targeted	IN	O
cell	JJ	O
type.	NN	O
Exemplary	IN	O
methods	DT	O
include	JJ	O
CaPO4	.	O
precipitation,	DT	O
liposome	NN	O
fusion,	IN	O
lipofection	NN	O
(e.g.,	VBZ	O
LIPOFECTIN™),	RB	O
electroporation,	VBN	O
viral	IN	O
infection,	DT	O
etc.	VBN	O
The	NN	O
candidate	.	O
nucleic	JJ	O
acids	NNS	O
may	VBP	O
stably	NNP	O
integrate	,	O
into	JJ	O
the	,	O
genome	NN	O
of	,	O
the	,	O
host	,	O
cell	JJ	O
(for	,	O
example,	.	O
with	DT	O
retroviral	NN	O
introduction)	JJ	O
or	NNS	O
may	MD	O
exist	VB	O
either	VB	O
transiently	IN	O
or	DT	O
stably	NN	O
in	IN	O
the	DT	O
cytoplasm	NN	O
(i.e.	NN	O
through	IN	O
the	,	O
use	IN	O
of	JJ	O
traditional	)	O
plasmids,	CC	O
utilizing	MD	O
standard	VB	O
regulatory	CC	O
sequences,	RB	O
selection	CC	O
markers,	RB	O
etc.).	IN	O
As	DT	O
many	NN	O
pharmaceutically	.	O
important	IN	O
screens	DT	O
require	NN	O
human	IN	O
or	JJ	O
model	,	O
mammalian	VBG	O
cell	JJ	O
targets,	JJ	O
retroviral	,	O
vectors	NN	O
capable	,	O
of	.	O
transfecting	IN	O
such	JJ	O
targets	RB	O
are	JJ	O
preferred.	NNS	O
Where	VBP	O
appropriate,	JJ	O
the	CC	O
engineered	NN	O
host	JJ	O
cells	NN	O
can	,	O
be	JJ	O
cultured	NNS	O
in	JJ	O
conventional	IN	O
nutrient	VBG	O
media	JJ	O
modified	NNS	O
as	VBP	O
appropriate	.	O
for	WRB	O
activating	,	O
promoters,	DT	O
selecting	JJ	O
transformants	NN	O
or	NNS	O
amplifying	MD	O
the	VB	O
genes	VBN	O
of	IN	O
the	JJ	O
invention.	JJ	O
Following	NNS	O
transformation	VBD	O
of	IN	O
a	NN	O
suitable	IN	O
host	VBG	O
strain	,	O
and	VBG	O
growth	NNS	O
of	CC	O
the	VBG	O
host	DT	O
strain	NNS	O
to	IN	O
an	DT	O
appropriate	.	O
cell	VBG	O
density,	NN	O
the	IN	O
selected	DT	O
promoter	JJ	O
may	NN	O
be	NN	O
induced	CC	O
by	NN	O
appropriate	IN	O
means	DT	O
(e.g.,	NN	O
temperature	NN	O
shift	TO	O
or	DT	O
chemical	JJ	O
induction)	NN	O
and	,	O
the	DT	O
cells	VBN	O
may	NN	O
be	MD	O
cultured	VB	O
for	VBN	O
an	IN	O
additional	JJ	O
period	NNS	O
to	,	O
allow	NN	O
them	NN	O
to	CC	O
produce	JJ	O
the	)	O
desired	CC	O
polypeptide	DT	O
or	NNS	O
fragment	MD	O
thereof.	VB	O
Cells	VBN	O
can	IN	O
be	DT	O
harvested	JJ	O
by	NN	O
centrifugation,	TO	O
disrupted	VB	O
by	PRP	O
physical	TO	O
or	VB	O
chemical	DT	O
means,	JJ	O
and	NN	O
the	CC	O
resulting	JJ	O
crude	.	O
extract	NNS	O
is	MD	O
retained	VB	O
for	VBN	O
further	IN	O
purification.	,	O
Microbial	VBN	O
cells	IN	O
employed	JJ	O
for	CC	O
expression	NN	O
of	,	O
proteins	CC	O
can	DT	O
be	VBG	O
disrupted	JJ	O
by	NN	O
any	VBZ	O
convenient	VBN	O
method,	IN	O
including	JJ	O
freeze-thaw	.	O
cycling,	NNP	O
sonication,	NNS	O
mechanical	VBN	O
disruption,	IN	O
or	NN	O
use	IN	O
of	NNS	O
cell	MD	O
lysing	VB	O
agents.	VBN	O
Such	IN	O
methods	DT	O
are	JJ	O
well	,	O
known	VBG	O
to	JJ	O
those	,	O
skilled	,	O
in	JJ	O
the	,	O
art.	CC	O
The	NN	O
expressed	IN	O
polypeptide	NN	O
or	VBG	O
fragment	.	O
thereof	JJ	O
can	NNS	O
be	VBP	O
recovered	RB	O
and	VBN	O
purified	TO	O
from	DT	O
recombinant	VBN	O
cell	IN	O
cultures	DT	O
by	.	O
methods	DT	O
including	JJ	O
ammonium	NN	O
sulfate	CC	O
or	JJ	O
ethanol	NN	O
precipitation,	MD	O
acid	VB	O
extraction,	VBN	O
anion	CC	O
or	VBN	O
cation	IN	O
exchange	NN	O
chromatography,	NN	O
phosphocellulose	NNS	O
chromatography,	IN	O
hydrophobic	NNS	O
interaction	VBG	O
chromatography,	NN	O
affinity	NN	O
chromatography,	CC	O
hydroxylapatite	JJ	O
chromatography	,	O
and	JJ	O
lectin	,	O
chromatography.	NN	O
Protein	CC	O
refolding	NN	O
steps	NN	O
can	,	O
be	JJ	O
used,	,	O
as	JJ	O
necessary,	NN	O
in	,	O
completing	NN	O
configuration	,	O
of	JJ	O
the	NN	O
polypeptide.	CC	O
If	NN	O
desired,	.	O
high	NNP	O
performance	VBG	O
liquid	NNS	O
chromatography	MD	O
(HPLC)	VB	O
can	,	O
be	IN	O
employed	,	O
for	IN	O
final	VBG	O
purification	NN	O
steps.	IN	O
Various	DT	O
mammalian	.	O
cell	IN	O
culture	,	O
systems	JJ	O
can	NN	O
also	NN	O
be	NN	O
employed	)	O
to	MD	O
express	VB	O
recombinant	VBN	O
protein.	IN	O
Examples	JJ	O
of	NN	O
mammalian	.	O
expression	JJ	O
systems	JJ	O
include	NN	O
the	NN	O
COS-7	NNS	O
lines	MD	O
of	RB	O
monkey	VB	O
kidney	VBN	O
fibroblasts	TO	O
and	VB	O
other	JJ	O
cell	.	O
lines	NNS	O
capable	IN	O
of	JJ	O
expressing	NN	O
proteins	NNS	O
from	VBP	O
a	DT	O
compatible	NNP	O
vector,	NNS	O
such	IN	O
as	JJ	O
the	NN	O
C127,	NNS	O
3T3,	CC	O
CHO,	JJ	O
HeLa	NN	O
and	NNS	O
BHK	JJ	O
cell	IN	O
lines.	VBG	O
The	NNS	O
constructs	IN	O
in	DT	O
host	JJ	O
cells	,	O
can	JJ	O
be	IN	O
used	DT	O
in	,	O
a	,	O
conventional	,	O
manner	NNP	O
to	CC	O
produce	NNP	O
the	NN	O
gene	.	O
product	DT	O
encoded	NNS	O
by	IN	O
the	NN	O
recombinant	NNS	O
sequence.	MD	O
Depending	VB	O
upon	VBN	O
the	IN	O
host	DT	O
employed	JJ	O
in	NN	O
a	TO	O
recombinant	VB	O
production	DT	O
procedure,	NN	O
the	NN	O
polypeptides	VBN	O
produced	IN	O
by	DT	O
host	JJ	O
cells	.	O
containing	VBG	O
the	IN	O
vector	DT	O
may	NN	O
be	VBN	O
glycosylated	IN	O
or	DT	O
may	JJ	O
be	NN	O
non-glycosylated.	,	O
Polypeptides	DT	O
of	NNS	O
the	VBN	O
invention	IN	O
may	NN	O
or	NNS	O
may	VBG	O
not	DT	O
also	NN	O
include	MD	O
an	VB	O
initial	VBN	O
methionine	CC	O
amino	MD	O
acid	VB	O
residue.	.	O
Cell-free	NNS	O
translation	IN	O
systems	DT	O
can	NN	O
also	MD	O
be	CC	O
employed	MD	O
to	RB	O
produce	RB	O
a	VBP	O
polypeptide	DT	O
of	JJ	O
the	NN	O
invention.	NN	O
Cell-free	NN	O
translation	.	O
systems	JJ	O
can	NN	O
use	NNS	O
mRNAs	MD	O
transcribed	RB	O
from	VB	O
a	VBN	O
DNA	TO	O
construct	VB	O
comprising	DT	O
a	NN	O
promoter	IN	O
operably	DT	O
linked	.	O
to	JJ	O
a	NN	O
nucleic	NNS	O
acid	MD	O
encoding	VB	O
the	JJ	O
polypeptide	NN	O
or	IN	O
fragment	DT	O
thereof.	NNP	O
In	NN	O
some	VBG	O
aspects,	DT	O
the	NN	O
DNA	RB	O
construct	VBD	O
may	TO	O
be	DT	O
linearized	JJ	O
prior	NN	O
to	VBG	O
conducting	DT	O
an	NN	O
in	CC	O
vitro	JJ	O
transcription	.	O
reaction.	IN	O
The	DT	O
transcribed	,	O
mRNA	DT	O
is	NNP	O
then	NN	O
incubated	MD	O
with	VB	O
an	VBN	O
appropriate	RB	O
cell-free	TO	O
translation	VBG	O
extract,	DT	O
such	IN	O
as	JJ	O
a	NN	O
rabbit	.	O
reticulocyte	DT	O
extract,	JJ	O
to	NN	O
produce	VBZ	O
the	RB	O
desired	VBN	O
polypeptide	IN	O
or	DT	O
fragment	JJ	O
thereof.	JJ	O
The	NN	O
expression	,	O
vectors	JJ	O
can	IN	O
contain	DT	O
one	NN	O
or	NN	O
more	,	O
selectable	TO	O
marker	VB	O
genes	DT	O
to	JJ	O
provide	NN	O
a	CC	O
phenotypic	JJ	O
trait	.	O
for	DT	O
selection	NN	O
of	NNS	O
transformed	MD	O
host	VB	O
cells	CD	O
such	CC	O
as	JJR	O
dihydrofolate	JJ	O
reductase	NN	O
or	NNS	O
neomycin	TO	O
resistance	VB	O
for	DT	O
eukaryotic	NN	O
cell	NN	O
culture,	IN	O
or	NN	O
such	IN	O
as	JJ	O
tetracycline	NN	O
or	NNS	O
ampicillin	JJ	O
resistance	IN	O
in	JJ	O
E.	NN	O
coli.	CC	O
Amplification	JJ	O
of	NN	O
Nucleic	IN	O
Acids	JJ	O
In	NN	O
practicing	,	O
the	CC	O
invention,	JJ	O
nucleic	IN	O
acids	NN	O
of	CC	O
the	NN	O
invention	NN	O
and	IN	O
nucleic	NNP	O
acids	.	O
encoding	NN	O
the	IN	O
polypeptides	NNP	O
of	NNP	O
the	IN	O
invention,	VBG	O
or	DT	O
modified	,	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention,	NN	O
can	CC	O
be	JJ	O
reproduced	NNS	O
by	VBG	O
amplification.	DT	O
Amplification	NNS	O
can	IN	O
also	DT	O
be	,	O
used	CC	O
to	VBN	O
clone	JJ	O
or	NNS	O
modify	IN	O
the	DT	O
nucleic	,	O
acids	MD	O
of	VB	O
the	VBN	O
invention.	IN	O
Thus,	.	O
the	NN	O
invention	MD	O
provides	RB	O
amplification	VB	O
primer	VBN	O
sequence	TO	O
pairs	VB	O
for	CC	O
amplifying	VB	O
nucleic	DT	O
acids	JJ	O
of	NNS	O
the	IN	O
invention.	DT	O
One	.	O
of	,	O
skill	DT	O
in	NN	O
the	VBZ	O
art	NN	O
can	NN	O
design	NN	O
amplification	NNS	O
primer	IN	O
sequence	VBG	O
pairs	JJ	O
for	NNS	O
any	IN	O
part	DT	O
of	.	O
or	CD	O
the	IN	O
full	NN	O
length	IN	O
of	DT	O
these	NN	O
sequences.	MD	O
Amplification	VB	O
reactions	NN	O
can	NN	O
also	NN	O
be	NNS	O
used	IN	O
to	DT	O
quantify	NN	O
the	IN	O
amount	CC	O
of	DT	O
nucleic	JJ	O
acid	NN	O
in	IN	O
a	DT	O
sample	.	O
(such	NN	O
as	NNS	O
the	MD	O
amount	RB	O
of	VB	O
message	VBN	O
in	TO	O
a	VB	O
cell	DT	O
sample),	NN	O
label	IN	O
the	JJ	O
nucleic	NN	O
acid	IN	O
(e.g.,	DT	O
to	NN	O
apply	JJ	O
it	IN	O
to	DT	O
an	NN	O
array	IN	O
or	NN	O
a	IN	O
blot),	DT	O
detect	NN	O
the	,	O
nucleic	VBZ	O
acid,	DT	O
or	JJ	O
quantify	NN	O
the	,	O
amount	TO	O
of	VB	O
a	PRP	O
specific	TO	O
nucleic	DT	O
acid	NN	O
in	CC	O
a	DT	O
sample.	,	O
In	VBP	O
one	DT	O
aspect	JJ	O
of	,	O
the	CC	O
invention,	VB	O
message	DT	O
isolated	NN	O
from	IN	O
a	DT	O
cell	JJ	O
or	JJ	O
a	NN	O
cDNA	IN	O
library	DT	O
are	.	O
amplified.	IN	O
The	CD	O
skilled	NN	O
artisan	IN	O
can	DT	O
select	,	O
and	NN	O
design	VBD	O
suitable	IN	O
oligonucleotide	DT	O
amplification	NN	O
primers.	CC	O
Amplification	DT	O
methods	JJ	O
are	NN	O
also	VBP	O
well	.	O
known	DT	O
in	JJ	O
the	NN	O
art,	MD	O
and	VB	O
include,	CC	O
e.g.,	VB	O
polymerase	JJ	O
chain	JJ	O
reaction,	NN	O
PCR	.	O
(see,	NNP	O
e.g.,	NNS	O
PCR	VBP	O
PROTOCOLS,	RB	O
A	RB	O
GUIDE	VBN	O
TO	IN	O
METHODS	DT	O
AND	,	O
APPLICATIONS,	CC	O
ed.	,	O
Innis,	,	O
Academic	NN	O
Press,	NN	O
N.Y.	,	O
(1990)	NNP	O
and	,	O
PCR	,	O
STRATEGIES	NNP	O
(1995),	,	O
ed.	NNP	O
Innis,	NNP	O
Academic	NNP	O
Press,	NNP	O
Inc.,	NNP	O
N.Y.,	,	O
ligase	.	O
chain	,	O
reaction	NNP	O
(LCR)	,	O
(see,	NNP	O
e.g.,	)	O
Wu	CC	B
(1989)	NNP	I
Genomics	NNP	I
4:560;	,	I
Landegren	.	B
(1988)	,	I
Science	NNP	I
241:1077;	,	I
Barringer	,	B
(1990)	,	I
Gene	NN	I
89:117);transcription	NN	O
amplification	NN	O
(see,	)	O
e.g.,	,	O
Kwoh	,	B
(1989)	NNP	I
Proc.	)	I
Natl.	NNPS	I
Acad.	:	I
Sci.	NNP	I
USA	)	I
86:1173);and,	NN	O
self-sustained	:	O
sequence	NNP	O
replication	)	O
(see,	NNP	O
e.g.,	:	O
Guatelli	NN	B
(1990)	NN	I
Proc.	,	I
Natl.	,	I
Acad.	NNP	I
Sci.	)	I
USA	.	I
87:1874);Q	.	O
Beta	.	O
replicase	.	O
amplification	NNP	O
(see,	:	O
e.g.,	,	O
Smith	JJ	B
(1997)	NN	I
J.	NN	I
Clin.	,	I
Microbiol.	,	I
35:1477-1491),automated	NNP	O
Q-beta	)	O
replicase	.	O
amplification	.	O
assay	.	O
(see,	.	O
e.g.,	NNP	O
Burg	:	B
(1996)	NNP	I
Mol.	NNP	I
Cell.	NN	I
Probes	NN	I
10:257-271)	,	I
and	,	O
other	NNP	O
RNA	)	O
polymerase	NNP	O
mediated	.	O
techniques	.	O
(e.g.,	,	O
NASBA,	VBD	O
Cangene,	NNP	O
Mississauga,	NN	O
Ontario);	NN	O
see	NN	O
also	,	O
Berger	,	O
(1987)	NNP	O
Methods	)	O
Enzymol.	.	O
152:307-316;	.	O
Sambrook;	NNP	O
Ausubel;	)	O
U.S.	CC	O
Pat.	JJ	O
Nos.	NNP	O
4,683,195	NN	O
and	VBD	O
4,683,202;	NNS	O
Sooknanan	,	B
(1995)	,	I
Biotechnology	,	I
13:563-564.
Determining	,	O
the	:	O
Degree	VB	O
of	RB	O
Sequence	NNP	O
Identity	)	O
The	NNP	O
invention	.	O
provides	:	O
nucleic	:	O
acids	:	O
comprising	NNP	O
sequences	.	O
having	.	O
at	CD	O
least	CC	O
about	:	O
50%,	NNP	O
51%,	)	O
52%,	NNP	O
53%,	.	O
54%,	VBG	O
55%,	DT	O
56%,	NNP	O
57%,	IN	O
58%,	NNP	O
59%,	NNP	O
60%,	DT	O
61%,	NN	O
62%,	VBZ	O
63%,	JJ	O
64%,	NNS	O
65%,	VBG	O
66%,	NNS	O
67%,	VBG	O
68%,	IN	O
69%,	JJS	O
70%,	IN	O
71%,	,	O
72%,	,	O
73%,	,	O
74%,	,	O
75%,	,	O
76%,	,	O
77%,	,	O
78%,	,	O
79%,	,	O
80%,	,	O
81%,	,	O
82%,	,	O
83%,	,	O
84%,	,	O
85%,	,	O
86%,	,	O
87%,	,	O
88%,	,	O
89%,	,	O
90%,	,	O
91%,	,	O
92%,	,	O
93%,	,	O
94%,	,	O
95%,	,	O
96%,	,	O
97%,	,	O
98%,	,	O
99%,	,	O
or	,	O
more,	,	O
or	,	O
complete	,	O
(100%)	,	O
sequence	,	O
identity	,	O
to	,	O
an	,	O
exemplary	,	O
nucleic	,	O
acid	,	O
of	,	O
the	,	O
invention	,	O
over	,	O
a	,	O
region	,	O
of	,	O
at	,	O
least	,	O
about	CC	O
50,	,	O
75,	CC	O
100,	JJ	O
150,	)	O
200,	NN	O
250,	NN	O
300,	TO	O
350,	DT	O
400,	JJ	O
450,	JJ	O
500,	NN	O
550,	IN	O
600,	DT	O
650,	NN	O
700,	IN	O
750,	DT	O
800,	NN	O
850,	IN	O
900,	IN	O
950,	JJS	O
1000,	IN	O
1050,	,	O
1100,	,	O
1150,	,	O
1200,	,	O
1250,	,	O
1300,	,	O
1350,	,	O
1400,	,	O
1450,	,	O
1500,	,	O
1550	,	O
or	,	O
more,	,	O
residues.	,	O
The	,	O
invention	,	O
provides	,	O
polypeptides	,	O
comprising	,	O
sequences	,	O
having	,	O
at	,	O
least	,	O
about	,	O
50%,	,	O
51%,	,	O
52%,	,	O
53%,	,	O
54%,	,	O
55%,	,	O
56%,	,	O
57%,	CD	O
58%,	CC	O
59%,	,	O
60%,	.	O
61%,	DT	O
62%,	NN	O
63%,	VBZ	O
64%,	IN	O
65%,	VBG	O
66%,	NNS	O
67%,	VBG	O
68%,	IN	O
69%,	JJS	O
70%,	IN	O
71%,	,	O
72%,	,	O
73%,	,	O
74%,	,	O
75%,	,	O
76%,	,	O
77%,	,	O
78%,	,	O
79%,	,	O
80%,	,	O
81%,	,	O
82%,	,	O
83%,	,	O
84%,	,	O
85%,	,	O
86%,	,	O
87%,	,	O
88%,	,	O
89%,	,	O
90%,	,	O
91%,	,	O
92%,	,	O
93%,	,	O
94%,	,	O
95%,	,	O
96%,	,	O
97%,	,	O
98%,	,	O
99%,	,	O
or	,	O
more,	,	O
or	,	O
complete	,	O
(100%)	,	O
sequence	,	O
identity	,	O
to	,	O
an	,	O
exemplary	,	O
polypeptide	,	O
of	,	O
the	,	O
invention.	,	O
The	,	O
extent	,	O
of	,	O
sequence	,	O
identity	,	O
(homology)	,	O
may	,	O
be	CC	O
determined	,	O
using	CC	O
any	JJ	O
computer	)	O
program	NN	O
and	NN	O
associated	TO	O
parameters,	DT	O
including	JJ	O
those	NN	O
described	IN	O
herein,	DT	O
such	.	O
as	DT	O
BLAST	NN	O
2.2.2.	IN	O
or	NN	O
FASTA	NN	O
version	)	O
3.0t78,	MD	O
with	VB	O
the	VBN	O
default	VBG	O
parameters.	DT	O
Homologous	NN	O
sequences	NN	O
also	CC	O
include	JJ	O
RNA	,	O
sequences	VBG	O
in	DT	O
which	JJ	O
uridines	,	O
replace	JJ	O
the	IN	O
thymines	NNP	O
in	CD	O
the	CC	O
nucleic	NNP	O
acid	NN	O
sequences.	,	O
The	IN	O
homologous	DT	O
sequences	NN	O
may	.	O
be	JJ	O
obtained	NNS	O
using	RB	O
any	VBP	O
of	NNP	O
the	NNS	O
procedures	IN	O
described	WDT	O
herein	JJ	O
or	VB	O
may	DT	O
result	NNS	O
from	IN	O
the	DT	O
correction	JJ	O
of	NN	O
a	.	O
sequencing	DT	O
error.	JJ	O
It	NNS	O
will	MD	O
be	VB	O
appreciated	VBN	O
that	VBG	O
the	DT	O
nucleic	IN	O
acid	DT	O
sequences	NNS	O
as	VBD	O
set	NNS	O
forth	CC	O
herein	MD	O
can	VB	O
be	IN	O
represented	DT	O
in	NN	O
the	IN	O
traditional	DT	O
single	JJ	O
character	.	O
format	PRP	O
(see,	MD	O
e.g.,	VB	O
Stryer,	VBN	O
Lubert.	IN	O
Biochemistry,	DT	O
3rd	JJ	O
Ed.,	NN	O
W.	NNS	O
H	IN	O
Freeman	NN	O
&	NN	O
Co.,	NN	O
New	MD	O
York)	VB	O
or	VBN	O
in	IN	O
any	DT	O
other	JJ	O
format	JJ	O
which	NN	O
records	NN	O
the	,	O
identity	,	O
of	,	O
the	.	O
nucleotides	,	O
in	CD	O
a	,	O
sequence.	NNP	O
Various	NNP	O
sequence	NNP	O
comparison	CC	O
programs	,	O
identified	NNP	O
herein	)	O
are	CC	O
used	IN	O
in	DT	O
this	JJ	O
aspect	NN	O
of	WDT	O
the	VBZ	O
invention.	DT	O
Protein	NN	O
and/or	IN	O
nucleic	DT	O
acid	NNS	O
sequence	IN	O
identities	DT	O
(homologies)	.	O
may	JJ	O
be	NN	O
evaluated	NN	O
using	NNS	O
any	VBN	O
of	NNS	O
the	VBP	O
variety	VBN	O
of	IN	O
sequence	DT	O
comparison	NN	O
algorithms	IN	O
and	DT	O
programs	.	O
known	NNP	O
in	VBZ	O
the	JJ	O
art.	JJ	O
Such	NN	O
algorithms	NNS	O
and	)	O
programs	MD	O
include,	VB	O
but	VBN	O
are	VBG	O
not	DT	O
limited	IN	O
to,	DT	O
TBLASTN,	NN	O
BLASTP,	IN	O
FASTA,	NN	O
TFASTA,	NN	O
and	NN	O
CLUSTALW	CC	O
Pearson	NNS	B
and	VBN	I
Lipman,	IN	I
Proc.	DT	I
Natl.	.	I
Acad.	JJ	I
Sci.	NNS	I
USA	CC	I
85(8):2444-2448,	NNS	I
1988;	,	I
Altschul	CC	B
et	VBP	I
al.,	RB	I
J.	VBN	I
Mol.	,	I
Biol.	,	I
215(3):403-410,	,	I
1990;	,	I
Thompson	,	B
et	CC	I
al.,	NNP	I
Nucleic	NNP	I
Acids	CC	I
Res.	,	I
22(2):4673-4680,	.	I
1994;	.	I
Higgins	.	B
et	.	I
al.,	NNP	I
Methods	,	I
Enzymol.	:	I
266:383-402,	NNP	I
1996;	FW	I
Altschul	,	B
et	NNP	I
al.,	.	I
J.	.	I
Mol.	,	I
Biol.	:	I
215(3):403-410,	NNP	I
1990;	FW	I
Altschul	,	B
et	NNP	I
al.,	NNP	I
Nature	.	I
Genetics	,	I
3:266-272,	:	I
1993).(	NNP	O
Homology	FW	O
or	,	O
identity	NNP	O
can	.	O
be	,	O
measured	:	O
using	NNP	O
sequence	FW	O
analysis	,	O
software	NNP	O
(e.g.,	.	O
Sequence	.	O
Analysis	,	O
Software	:	O
Package	NNP	O
of	FW	O
the	,	O
Genetics	NNP	O
Computer	NNP	O
Group,	,	O
University	.	O
of	NNP	O
Wisconsin	CC	O
Biotechnology	NN	O
Center,	MD	O
1710	VB	O
University	VBN	O
Avenue,	VBG	O
Madison,	NN	O
Wis.	NN	O
53705).	NN	O
Such	,	O
software	NNP	O
matches	NNP	O
similar	NNP	O
sequences	NNP	O
by	IN	O
assigning	DT	O
degrees	NNP	O
of	NNP	O
homology	,	O
to	NNP	O
various	IN	O
deletions,	NNP	O
substitutions	NNP	O
and	,	O
other	CD	O
modifications.	NNP	O
The	,	O
terms	,	O
“homology”	NNP	O
and	.	O
“identity”	JJ	O
in	NN	O
the	NNS	O
context	JJ	O
of	NNS	O
two	IN	O
or	VBG	O
more	NNS	O
nucleic	IN	O
acids	NN	O
or	TO	O
polypeptide	JJ	O
sequences,	,	O
refer	NNS	O
to	CC	O
two	JJ	O
or	.	O
more	DT	O
sequences	NNS	O
or	VBP	O
subsequences	CC	O
that	VBP	O
are	IN	O
the	DT	O
same	NN	O
or	IN	O
have	CD	O
a	CC	O
specified	JJR	O
percentage	JJ	O
of	NNS	O
amino	CC	O
acid	NN	O
residues	,	O
or	VBP	O
nucleotides	TO	O
that	CD	O
are	CC	O
the	JJR	O
same	NNS	O
when	CC	O
compared	NNS	O
and	WDT	O
aligned	VBP	O
for	DT	O
maximum	JJ	O
correspondence	CC	O
over	VBP	O
a	DT	O
comparison	VBN	O
window	NN	O
or	IN	O
designated	NN	O
region	NN	O
as	NNS	O
measured	CC	O
using	NNS	O
any	WDT	O
number	VBP	O
of	DT	O
sequence	JJ	O
comparison	WRB	O
algorithms	VBN	O
or	CC	O
by	VBN	O
manual	IN	O
alignment	JJ	O
and	NN	O
visual	IN	O
inspection.	DT	O
For	NN	O
sequence	NN	O
comparison,	CC	O
one	VBN	O
sequence	NN	O
can	IN	O
act	VBN	O
as	VBG	O
a	DT	O
reference	NN	O
sequence,	IN	O
e.g.,	NN	O
a	NN	O
sequence	NN	O
of	CC	O
the	IN	O
invention,	JJ	O
to	NN	O
which	CC	O
test	JJ	O
sequences	.	O
are	IN	O
compared.	NN	O
When	,	O
using	CD	O
a	NN	O
sequence	MD	O
comparison	VB	O
algorithm,	IN	O
test	DT	O
and	NN	O
reference	,	O
sequences	,	O
are	DT	O
entered	NN	O
into	IN	O
a	DT	O
computer,	,	O
subsequence	TO	O
coordinates	WDT	O
are	NN	O
designated,	NNS	O
if	VBP	O
necessary,	.	O
and	WRB	O
sequence	VBG	O
algorithm	DT	O
program	NN	O
parameters	NN	O
are	,	O
designated.	NN	O
Default	CC	O
program	NN	O
parameters	NNS	O
can	VBP	O
be	VBN	O
used,	IN	O
or	DT	O
alternative	,	O
parameters	NN	O
can	NNS	O
be	VBP	O
designated.	,	O
The	IN	O
sequence	,	O
comparison	CC	O
algorithm	NN	O
then	NN	O
calculates	NN	O
the	NNS	O
percent	VBP	O
sequence	.	O
identities	NNP	O
for	NN	O
the	NNS	O
test	MD	O
sequences	VB	O
relative	,	O
to	CC	O
the	JJ	O
reference	NNS	O
sequence,	MD	O
based	VB	O
on	.	O
the	DT	O
program	NN	O
parameters.	NN	O
A	NN	O
“comparison	RB	O
window”,	VBZ	O
as	DT	O
used	NN	O
herein,	NN	O
includes	NNS	O
reference	IN	O
to	DT	O
a	NN	O
segment	NNS	O
of	VBP	O
any	TO	O
one	DT	O
of	NN	O
the	,	O
numbers	VBN	O
of	IN	O
contiguous	DT	O
residues.	NN	O
For	.	O
example,	DT	O
in	NNP	O
alternative	,	O
aspects	IN	O
of	VBN	O
the	,	O
invention,	VBZ	O
contiguous	NN	O
residues	TO	O
ranging	DT	O
anywhere	NN	O
from	IN	O
20	DT	O
to	CD	O
the	IN	O
full	DT	O
length	NNS	O
of	IN	O
an	JJ	O
exemplary	.	O
polypeptide	IN	O
or	,	O
nucleic	IN	O
acid	JJ	O
sequence	NNS	O
of	IN	O
the	DT	O
invention	,	O
are	JJ	O
compared	NNS	O
to	VBG	O
a	RB	O
reference	IN	O
sequence	CD	O
of	TO	O
the	DT	O
same	JJ	O
number	NN	O
of	IN	O
contiguous	DT	O
positions	JJ	O
after	NN	O
the	CC	O
two	JJ	O
sequences	JJ	O
are	NN	O
optimally	IN	O
aligned.	DT	O
If	NN	O
the	VBP	O
reference	VBN	O
sequence	TO	O
has	DT	O
the	NN	O
requisite	NN	O
sequence	IN	O
identity	DT	O
to	JJ	O
an	NN	O
exemplary	IN	O
polypeptide	JJ	O
or	NNS	O
nucleic	IN	O
acid	DT	O
sequence	CD	O
of	NNS	O
the	VBP	O
invention,	RB	O
e.g.,	.	O
50%,	IN	O
51%,	DT	O
52%,	NN	O
53%,	NN	O
54%,	VBZ	O
55%,	DT	O
56%,	JJ	O
57%,	NN	O
58%,	NN	O
59%,	TO	O
60%,	DT	O
61%,	JJ	O
62%,	NN	O
63%,	CC	O
64%,	JJ	O
65%,	JJ	O
66%,	NN	O
67%,	IN	O
68%,	DT	O
69%,	,	O
70%,	,	O
71%,	,	O
72%,	,	O
73%,	,	O
74%,	,	O
75%,	,	O
76%,	,	O
77%,	,	O
78%,	,	O
79%,	,	O
80%,	,	O
81%,	,	O
82%,	,	O
83%,	,	O
84%,	,	O
85%,	,	O
86%,	,	O
87%,	,	O
88%,	,	O
89%,	,	O
90%,	,	O
91%,	,	O
92%,	,	O
93%,	,	O
94%,	,	O
95%,	,	O
96%,	,	O
97%,	,	O
98%,	,	O
99%,	,	O
or	,	O
more	,	O
sequence	,	O
identity	,	O
to	,	O
a	,	O
sequence	,	O
of	,	O
the	,	O
invention,	,	O
that	,	O
sequence	,	O
is	,	O
within	,	O
the	,	O
scope	,	O
of	,	O
the	,	O
invention.	,	O
In	,	O
alternative	,	O
embodiments,	CC	O
subsequences	JJR	O
ranging	NN	O
from	NN	O
about	TO	O
20	DT	O
to	NN	O
600,	IN	O
about	DT	O
50	,	O
to	DT	O
200,	NN	O
and	VBZ	O
about	IN	O
100	DT	O
to	NN	O
150	IN	O
are	DT	O
compared	.	O
to	IN	O
a	JJ	O
reference	,	O
sequence	NNS	O
of	VBG	O
the	IN	O
same	IN	O
number	CD	O
of	TO	O
contiguous	,	O
positions	RB	O
after	CD	O
the	TO	O
two	,	O
sequences	CC	O
are	RB	O
optimally	CD	O
aligned.	TO	O
Methods	CD	O
of	VBP	O
alignment	VBN	O
of	TO	O
sequence	DT	O
for	NN	O
comparison	NN	O
are	IN	O
well	DT	O
known	JJ	O
in	NN	O
the	IN	O
art.	JJ	O
Optimal	NNS	O
alignment	IN	O
of	DT	O
sequences	CD	O
for	NNS	O
comparison	VBP	O
can	RB	O
be	.	O
conducted,	NNS	O
e.g.,	IN	O
by	NN	O
the	IN	O
local	NN	O
homology	IN	O
algorithm	NN	O
of	VBP	O
Smith	RB	B
&	VBN	I
Waterman,	IN	I
Adv.	DT	I
Appl.	.	I
Math.	JJ	I
2:482,	NN	I
1981,	IN	I
by	NNS	O
the	IN	O
homology	NN	O
alignment	MD	O
algorithm	VB	O
of	,	O
Needleman	,	B
&	IN	I
Wunsch,	DT	I
J.	JJ	I
Mol.	NN	I
Biol.	NN	I
48:443,	IN	I
1970,	NNP	I
by	CC	O
the	,	O
search	.	O
for	.	O
similarity	.	O
method	,	O
of	,	O
person	IN	B
&	DT	I
Lipman,	NN	I
Proc.	JJ	I
Nat'l.	NN	I
Acad.	IN	I
Sci.	NNP	I
USA	CC	I
85:2444,	,	I
1988,	NNP	I
by	.	O
computerized	.	O
implementations	,	O
of	,	O
these	IN	O
algorithms	DT	O
(GAP,	NN	O
BESTFIT,	IN	O
FASTA,	NN	O
and	NN	O
TFASTA	IN	O
in	NN	O
the	CC	O
Wisconsin	,	O
Genetics	.	O
Software	.	O
Package,	.	O
Genetics	.	O
Computer	NNP	O
Group,	,	O
575	,	O
Science	IN	O
Dr.,	JJ	O
Madison,	NNS	O
Wis.),	IN	O
or	DT	O
by	NNS	O
manual	,	O
alignment	,	O
and	,	O
visual	CC	O
inspection.	NNP	O
Other	IN	O
algorithms	DT	O
for	NNP	O
determining	NNP	O
homology	NNP	O
or	,	O
identity	NNP	O
include,	NNP	O
for	,	O
example,	CD	O
in	NNP	O
addition	,	O
to	,	O
a	,	O
BLAST	CC	O
program	IN	O
(Basic	JJ	O
Local	NN	O
Alignment	CC	O
Search	JJ	O
Tool	.	O
at	JJ	O
the	NN	O
National	IN	O
Center	VBG	O
for	NN	O
Biological	CC	O
Information),	NN	O
ALIGN,	,	O
AMAS	IN	O
(Analysis	,	O
of	IN	O
Multiply	NN	O
Aligned	TO	O
Sequences),	DT	O
AMPS	NNP	O
(Protein	NN	O
Multiple	NNP	O
Sequence	NNP	O
Alignment),	NNP	O
ASSET	NNP	O
(Aligned	NNP	O
Segment	IN	O
Statistical	DT	O
Evaluation	NNP	O
Tool),	NNP	O
BANDS,	IN	O
BESTSCOR,	NNP	O
BIOSCAN	,	O
(Biological	,	O
Sequence	NNP	O
Comparative	NNP	O
Analysis	IN	O
Node),	NNP	O
BLIMPS	NNP	O
(BLocks	,	O
IMProved	NNP	O
Searcher),	NNP	O
FASTA,	NNP	O
Intervals	NNP	O
&	,	O
Points,	NNP	O
BMB,	VBN	O
CLUSTAL	NNP	O
V,	NNP	O
CLUSTAL	NNP	O
W,	,	O
CONSENSUS,	,	O
LCONSENSUS,	,	O
WCONSENSUS,	NNP	O
Smith-Waterman	NNP	O
algorithm,	NNP	O
DARWIN,	NNP	O
Las	NNP	O
Vegas	,	O
algorithm,	NNP	O
FNAT	NNP	O
(Forced	NNP	O
Nucleotide	,	O
Alignment	,	O
Tool),	NNP	O
Framealign,	CC	O
Framesearch,	,	O
DYNAMIC,	,	O
FILTER,	NNP	O
FSAP	,	O
(Fristensky	NNP	O
Sequence	,	O
Analysis	,	O
Package),	,	O
GAP	,	O
(Global	NNP	O
Alignment	,	O
Program),	,	O
GENAL,	NNP	O
GIBBS,	NNP	O
GenQuest,	,	O
ISSC	NNP	O
(Sensitive	NNP	O
Sequence	NNP	O
Comparison),	NNP	O
LALIGN	,	O
(Local	,	O
Sequence	,	O
Alignment),	,	O
LCP	,	O
(Local	NNP	O
Content	NNP	O
Program),	NNP	O
MACAW	NNP	O
(Multiple	,	O
Alignment	NNP	O
Construction	NNP	O
&	NNP	O
Analysis	,	O
Workbench),	,	O
MAP	,	O
(Multiple	,	O
Alignment	NNP	O
Program),	JJ	O
MBLKP,	NNP	O
MBLKN,	,	O
PIMA	NNP	O
(Pattern-Induced	JJ	O
Multi-sequence	NNP	O
Alignment),	,	O
SAGA	NNP	O
(Sequence	JJ	O
Alignment	NNP	O
by	,	O
Genetic	NNP	O
Algorithm)	NNP	O
and	NNP	O
WHAT-IF.	NNP	O
Such	CC	O
alignment	NNP	O
programs	,	O
can	NNP	O
also	JJ	O
be	NNP	O
used	,	O
to	,	O
screen	,	O
genome	NNP	O
databases	NNP	O
to	NNP	O
identify	,	O
polynucleotide	NNP	O
sequences	NNP	O
having	NNP	O
substantially	IN	O
identical	NNP	O
sequences.	)	O
A	CC	O
number	.	O
of	JJ	O
genome	JJ	O
databases	NNS	O
are	MD	O
available,	RB	O
for	VB	O
example,	VBN	O
a	TO	O
substantial	VB	O
portion	JJ	O
of	NNS	O
the	TO	O
human	VB	O
genome	NN	O
is	NNS	O
available	VBG	O
as	RB	O
part	JJ	O
of	.	O
the	DT	O
Human	NN	O
Genome	IN	O
Sequencing	JJ	O
Project	NNS	O
(Gibbs,	VBP	O
1995).	,	O
Several	IN	O
genomes	,	O
have	DT	O
been	JJ	O
sequenced,	NN	O
e.g.,	IN	O
M.	DT	O
genitalium	JJ	O
(Fraser	NN	O
et	VBZ	O
al.,	JJ	O
1995),	IN	O
M.	NN	O
jannaschii	IN	O
(Bult	DT	O
et	NNP	O
al.,	NNP	O
1996),	NNP	O
H.	NNP	O
influenzae	,	O
(Fleischmann	.	O
et	JJ	O
al.,	NNS	O
1995),	VBP	O
E.	VBN	O
coli	,	O
(Blattner	,	O
et	NNP	O
al.,	NN	O
1997),	NNP	O
and	RB	O
yeast	,	O
(S.	,	O
cerevisiae)	NNP	O
(Mewes	NN	O
et	NNP	O
al.,	RB	O
1997),	,	O
and	,	O
D.	NNP	O
melanogaster	NN	O
(Adams	NNP	O
et	RB	O
al.,	,	O
2000).	,	O
Significant	NNP	O
progress	NNS	O
has	NNP	O
also	RB	O
been	,	O
made	,	O
in	CC	O
sequencing	NN	O
the	NNP	O
genomes	)	O
of	NNP	O
model	RB	O
organism,	,	O
such	,	O
as	CC	O
mouse,	NNP	O
C.	NN	O
elegans,	NNP	O
and	RB	O
Arabadopsis	,	O
sp.	.	O
Databases	NNP	O
containing	NN	O
genomic	VBZ	O
information	RB	O
annotated	VBN	O
with	VBN	O
some	IN	O
functional	VBG	O
information	DT	O
are	NNS	O
maintained	IN	O
by	NN	O
different	,	O
organization,	JJ	O
and	IN	O
are	,	O
accessible	NNP	O
via	,	O
the	CC	O
internet.	NNP	O
BLAST,	.	O
BLAST	NNS	O
2.0	VBG	O
and	JJ	O
BLAST	NN	O
2.2.2	VBN	O
algorithms	IN	O
are	DT	O
also	JJ	O
used	NN	O
to	VBP	O
practice	VBN	O
the	IN	O
invention.	JJ	O
They	,	O
are	CC	O
described,	VBP	O
e.g.,	JJ	O
in	IN	O
Altschul	DT	B
(1977)	.	I
Nuc.	,	I
Acids	NNP	I
Res.	CD	I
25:3389-3402;	CC	I
Altschul	NNP	B
(1990)	CD	I
J.	NN	I
Mol.	VBP	I
Biol.	RB	I
215:403-410.	VBN	I
Software	TO	O
for	NN	O
performing	DT	O
BLAST	.	O
analyses	PRP	O
is	VBP	O
publicly	,	O
available	,	O
through	IN	O
the	NNP	O
National	)	O
Center	.	O
for	NNP	O
Biotechnology	.	O
Information.	:	O
This	NNP	O
algorithm	)	O
involves	NNP	O
first	.	O
identifying	.	O
high	.	O
scoring	NNP	O
sequence	IN	O
pairs	VBG	O
(HSPs)	NNP	O
by	NNS	O
identifying	VBZ	O
short	RB	O
words	JJ	O
of	IN	O
length	DT	O
W	NNP	O
in	NNP	O
the	IN	O
query	NNP	O
sequence,	.	O
which	DT	O
either	NN	O
match	VBZ	O
or	RB	O
satisfy	JJ	O
some	JJ	O
positive-valued	VBG	O
threshold	NN	O
score	NNS	O
T	)	O
when	IN	O
aligned	VBG	O
with	JJ	O
a	NNS	O
word	IN	O
of	NN	O
the	NNP	O
same	IN	O
length	DT	O
in	NN	O
a	,	O
database	WDT	O
sequence.	CC	O
T	NN	O
is	CC	O
referred	VB	O
to	DT	O
as	JJ	O
the	NN	O
neighborhood	NN	O
word	NNP	O
score	WRB	O
threshold	VBN	O
(Altschul	IN	O
(1990)	DT	O
supra).	NN	O
These	IN	O
initial	DT	O
neighborhood	JJ	O
word	NN	O
hits	IN	O
act	DT	O
as	NN	O
seeds	.	O
for	NNP	O
initiating	VBZ	O
searches	VBN	O
to	TO	O
find	IN	O
longer	DT	O
HSPs	NN	O
containing	NN	O
them.	NN	O
The	NN	O
word	NNP	O
hits	)	O
are	.	O
extended	DT	O
in	JJ	O
both	NN	O
directions	NN	O
along	VBZ	O
each	NN	O
sequence	IN	O
for	NNS	O
as	IN	O
far	VBG	O
as	NNS	O
the	TO	O
cumulative	VB	O
alignment	JJR	O
score	NNP	O
can	VBG	O
be	.	O
increased.	DT	O
Cumulative	NN	O
scores	NNS	O
are	VBP	O
calculated	VBN	O
using,	IN	O
for	DT	O
nucleotide	NNS	O
sequences,	IN	O
the	DT	O
parameters	NN	O
M	IN	O
(reward	RB	O
score	RB	O
for	IN	O
a	DT	O
pair	JJ	O
of	NN	O
matching	NN	O
residues;	MD	O
always	VB	O
>0).	.	O
For	JJ	O
amino	NNS	O
acid	VBP	O
sequences,	VBN	O
a	,	O
scoring	IN	O
matrix	JJ	O
is	,	O
used	DT	O
to	NNS	O
calculate	NNP	O
the	NN	O
cumulative	NN	O
score.	IN	O
Extension	DT	O
of	NN	O
the	IN	O
word	VBG	O
hits	:	O
in	RB	O
each	.	O
direction	IN	O
are	NN	O
halted	NN	O
when:	,	O
the	DT	O
cumulative	NN	O
alignment	NN	O
score	VBZ	O
falls	VBN	O
off	TO	O
by	VB	O
the	DT	O
quantity	JJ	O
X	.	O
from	NN	O
its	IN	O
maximum	DT	O
achieved	NN	O
value;	VBZ	O
the	IN	O
cumulative	DT	O
score	NN	O
goes	VBP	O
to	VBN	O
zero	:	O
or	DT	O
below,	JJ	O
due	NN	O
to	NN	O
the	VBZ	O
accumulation	RP	O
of	IN	O
one	DT	O
or	NN	O
more	NNP	O
negative-scoring	IN	O
residue	PRP$	O
alignments;	NN	O
or	VBN	O
the	:	O
end	DT	O
of	JJ	O
either	NN	O
sequence	VBZ	O
is	TO	O
reached.	CD	O
The	CC	O
BLAST	,	O
algorithm	JJ	O
parameters	TO	O
W,	DT	O
T,	NN	O
and	IN	O
X	CD	O
determine	CC	O
the	JJR	O
sensitivity	JJ	O
and	JJ	O
speed	:	O
of	CC	O
the	DT	O
alignment.	NN	O
The	IN	O
BLASTN	DT	O
program	NN	O
(for	VBZ	O
nucleotide	.	O
sequences)	DT	O
uses	NNP	O
as	NN	O
defaults	NNS	O
a	,	O
wordlength	,	O
(W)	CC	O
of	NNP	O
11,	VBP	O
an	DT	O
expectation	NN	O
(E)	CC	O
of	NN	O
10,	IN	O
M=5,	DT	O
N=−4	.	O
and	DT	O
a	NNP	O
comparison	NN	O
of	IN	O
both	RB	O
strands.	)	O
For	VBZ	O
amino	IN	O
acid	NNS	O
sequences,	DT	O
the	NN	O
BLASTP	)	O
program	IN	O
uses	,	O
as	DT	O
defaults	NN	O
a	)	O
wordlength	IN	O
of	,	O
3,	,	O
and	NNP	O
expectations	CC	O
(E)	DT	O
of	NN	O
10,	IN	O
and	DT	O
the	.	O
BLOSUM62	IN	O
scoring	NN	O
matrix	NN	O
(see	,	O
Henikoff	DT	B
&	NNP	I
Henikoff	NN	I
(1989)	VBZ	I
Proc.	IN	I
Natl.	NNS	I
Acad.	DT	I
Sci.	NN	I
USA	IN	I
89:10915)	,	I
alignments	CC	O
(B)	NNS	O
of	)	O
50,	IN	O
expectation	,	O
(E)	CC	O
of	DT	O
10,	NNP	O
M=5,	NN	O
N=−4,	NN	O
and	VB	O
a	NNP	O
comparison	CC	O
of	NNP	O
both	)	O
strands.	.	O
The	.	O
BLAST	.	O
algorithm	.	O
also	NNP	O
performs	)	O
a	NNS	O
statistical	)	O
analysis	IN	O
of	,	O
the	NN	O
similarity	)	O
between	IN	O
two	,	O
sequences	,	O
(see,	,	O
e.g.,	CC	O
Karlin	DT	B
&	NN	I
Altschul	IN	I
(1993)	DT	I
Proc.	.	I
Natl.	DT	I
Acad.	NNP	I
Sci.	NN	I
USA	RB	I
90:5873).One	VBZ	O
measure	DT	O
of	JJ	O
similarity	NN	O
provided	IN	O
by	DT	O
BLAST	NN	O
algorithm	IN	O
is	CD	O
the	NNS	O
smallest	,	O
sum	,	O
probability	NNP	O
(P(N)),	CC	O
which	NNP	O
provides	)	O
an	.	O
indication	.	O
of	.	O
the	.	O
probability	NNP	O
by	.	O
which	CD	O
a	NN	O
match	IN	O
between	NN	O
two	VBN	O
nucleotide	IN	O
or	NNP	O
amino	NN	O
acid	VBZ	O
sequences	DT	O
would	JJS	O
occur	JJ	O
by	NN	O
chance.	,	O
For	WDT	O
example,	VBZ	O
a	DT	O
nucleic	NN	O
acid	IN	O
is	DT	O
considered	NN	O
similar	IN	O
to	WDT	O
a	DT	O
references	NN	O
sequence	IN	O
if	CD	O
the	NN	O
smallest	CC	O
sum	NN	O
probability	JJ	O
in	NNS	O
a	MD	O
comparison	VB	O
of	IN	O
the	.	O
test	IN	O
nucleic	,	O
acid	DT	O
to	JJ	O
the	NN	O
reference	VBZ	O
nucleic	VBN	O
acid	JJ	O
is	TO	O
less	DT	O
than	NNS	O
about	NN	O
0.2,	IN	O
more	DT	O
preferably	JJS	O
less	JJ	O
than	NN	O
about	IN	O
0.01,	DT	O
and	NN	O
most	IN	O
preferably	DT	O
less	NN	O
than	NN	O
about	NN	O
0.001.	TO	O
In	DT	O
one	NN	O
aspect,	JJ	O
protein	NN	O
and	VBZ	O
nucleic	JJR	O
acid	IN	O
sequence	RB	O
homologies	,	O
are	JJR	O
evaluated	RB	O
using	RBR	O
the	IN	O
Basic	RB	O
Local	,	O
Alignment	CC	O
Search	JJS	O
Tool	RB	O
(“BLAST”).	JJR	O
For	IN	O
example,	RB	O
five	.	O
specific	IN	O
BLAST	CD	O
programs	,	O
can	NN	O
be	CC	O
used	JJ	O
to	NN	O
perform	NN	O
the	NNS	O
following	VBP	O
task:	VBN	O
(1)	VBG	O
BLASTP	DT	O
and	NNP	O
BLAST3	NNP	O
compare	NNP	O
an	NNP	O
amino	NNP	O
acid	.	O
query	IN	O
sequence	,	O
against	CD	O
a	JJ	O
protein	NNP	O
sequence	NNS	O
database;	MD	O
(2)	VB	O
BLASTN	VBN	O
compares	TO	O
a	VB	O
nucleotide	DT	O
query	JJ	O
sequence	:	O
against	)	O
a	NNP	O
nucleotide	CC	O
sequence	NNP	O
database;	VBP	O
(3)	DT	O
BLASTX	NN	O
compares	NN	O
the	NN	O
six-frame	NN	O
conceptual	IN	O
translation	DT	O
products	JJ	O
of	NN	O
a	:	O
query	)	O
nucleotide	NNP	O
sequence	VBZ	O
(both	DT	O
strands)	JJ	O
against	NN	O
a	NN	O
protein	IN	O
sequence	DT	O
database;	JJ	O
(4)	NN	O
TBLASTN	:	O
compares	)	O
a	NNP	O
query	VBZ	O
protein	DT	O
sequence	JJ	O
against	JJ	O
a	NN	O
nucleotide	NNS	O
sequence	IN	O
database	DT	O
translated	NN	O
in	JJ	O
all	NN	O
six	DT	O
reading	)	O
frames	IN	O
(both	DT	O
strands);	JJ	O
and,	NN	O
(5)	:	O
TBLASTX	)	O
compares	NNP	O
the	VBZ	O
six-frame	DT	O
translations	NN	O
of	NN	O
a	NN	O
nucleotide	IN	O
query	DT	O
sequence	JJ	O
against	NN	O
the	NN	O
six-frame	VBN	O
translations	IN	O
of	DT	O
a	CD	O
nucleotide	VBG	O
sequence	NNS	O
database.	DT	O
The	:	O
BLAST	,	O
programs	)	O
identify	NN	O
homologous	VBZ	O
sequences	DT	O
by	JJ	O
identifying	NNS	O
similar	IN	O
segments,	DT	O
which	JJ	O
are	NN	O
referred	NN	O
to	IN	O
herein	DT	O
as	JJ	O
“high-scoring	NNS	O
segment	IN	O
pairs,”	DT	O
between	JJ	O
a	NN	O
query	.	O
amino	DT	O
or	NNP	O
nucleic	NNS	O
acid	VBP	O
sequence	JJ	O
and	NNS	O
a	IN	O
test	VBG	O
sequence	JJ	O
which	,	O
is	WDT	O
preferably	VBP	O
obtained	VBN	O
from	TO	O
a	VB	O
protein	IN	O
or	JJ	O
nucleic	NN	O
acid	VBP	O
sequence	IN	O
database.	DT	O
High-scoring	NN	O
segment	NN	O
pairs	CC	O
are	JJ	O
preferably	JJ	O
identified	NN	O
(i.e.,	CC	O
aligned)	DT	O
by	NN	O
means	NN	O
of	WDT	O
a	VBZ	O
scoring	RB	O
matrix,	VBN	O
many	IN	O
of	DT	O
which	NN	O
are	CC	O
known	JJ	O
in	JJ	O
the	NN	O
art.	.	O
Preferably,	JJ	O
the	NN	O
scoring	NNS	O
matrix	VBP	O
used	RB	O
is	VBN	O
the	,	O
BLOSUM62	)	O
matrix	IN	O
Gonnet	NNS	B
et	IN	I
al.,	DT	I
Science	NN	I
256:1443-1445,	,	I
1992;	JJ	I
Henikoff	IN	B
and	WDT	I
Henikoff,	VBP	I
Proteins	VBN	I
17:49-61,	IN	I
1993).(	DT	O
Less	.	O
preferably,	,	O
the	DT	O
PAM	VBG	O
or	NN	O
PAM250	VBN	O
matrices	VBZ	O
may	DT	O
also	NNP	O
be	NN	O
used	NNP	O
(see,	RB	O
e.g.,	,	O
Schwartz	NNP	B
and	,	I
Dayhoff,	:	I
eds.,	NNP	I
1978,	CC	I
Matrices	,	I
for	NNP	I
Detecting	,	I
Distance	.	I
Relationships:	NNP	I
Atlas	,	I
of	DT	I
Protein	NNP	I
Sequence	CC	I
and	NNP	I
Structure,	NNS	I
Washington:	MD	I
National	RB	I
Biomedical	VB	I
Research	VBN	I
Foundation).In	,	O
one	,	O
aspect	NNP	O
of	CC	O
the	,	O
invention,	,	O
to	,	O
determine	NNS	O
if	IN	O
a	VBG	O
nucleic	NNP	O
acid	:	O
has	NNP	O
the	IN	O
requisite	NNP	O
sequence	NNP	O
identity	CC	O
to	,	O
be	:	O
within	NNP	O
the	NNP	O
scope	NNP	O
of	.	O
the	IN	O
invention,	CD	O
the	NN	O
NCBI	IN	O
BLAST	DT	O
2.2.2	,	O
programs	TO	O
is	VB	O
used,	IN	O
default	DT	O
options	JJ	O
to	NN	O
blastp.	VBZ	O
There	DT	O
are	JJ	O
about	NN	O
38	NN	O
setting	TO	O
options	VB	O
in	IN	O
the	DT	O
BLAST	NN	O
2.2.2	IN	O
program.	DT	O
In	,	O
this	DT	O
exemplary	NNP	O
aspect	NNP	O
of	CD	O
the	NNS	O
invention,	VBZ	O
all	,	O
default	NN	O
values	NNS	O
are	TO	O
used	.	O
except	EX	O
for	VBP	O
the	IN	O
default	CD	O
filtering	NN	O
setting	NNS	O
(i.e.,	IN	O
all	DT	O
parameters	NNP	O
set	CD	O
to	.	O
default	IN	O
except	DT	O
filtering	JJ	O
which	NN	O
is	IN	O
set	DT	O
to	,	O
OFF);	DT	O
in	NN	O
its	NNS	O
place	VBP	O
a	VBN	O
“-F	IN	O
F”	IN	O
setting	DT	O
is	NN	O
used,	VBG	O
which	NN	O
disables	,	O
filtering.	DT	O
Use	NNS	O
of	VBD	O
default	TO	O
filtering	VB	O
often	IN	O
results	VBG	O
in	WDT	O
Karlin-Altschul	VBZ	O
violations	VBN	O
due	TO	O
to	:	O
short	IN	O
length	PRP$	O
of	NN	O
sequence.	DT	O
The	JJ	O
default	NNP	O
values	NN	O
used	VBZ	O
in	,	O
this	WDT	O
exemplary	VBZ	O
aspect	.	O
of	NNP	O
the	IN	O
invention	NN	O
include:	VBG	O
Other	RB	O
default	NNS	O
settings	IN	O
can	NNP	O
be:	NNS	O
filter	JJ	O
for	TO	O
low	JJ	O
complexity	NN	O
OFF,	IN	O
word	.	O
size	DT	O
of	NN	O
3	NNS	O
for	VBN	O
protein,	IN	O
BLOSUM62	DT	O
matrix,	JJ	O
gap	NN	O
existence	IN	O
penalty	DT	O
of	NN	O
−11	:	O
and	JJ	O
a	NN	O
gap	NNS	O
extension	MD	O
penalty	:	O
of	NN	O
−1.	IN	O
An	JJ	O
exemplary	NN	O
NCBI	,	O
BLAST	NN	O
2.2.2	NN	O
program	IN	O
setting	CD	O
has	IN	O
the	,	O
“−W”	NNP	O
option	,	O
default	NN	O
to	NN	O
0.	NN	O
This	IN	O
means	NNP	O
that,	CC	O
if	DT	O
not	NN	O
set,	NN	O
the	NN	O
word	IN	O
size	.	O
defaults	DT	O
to	JJ	O
3	NNP	O
for	NNP	O
proteins	CD	O
and	NN	O
11	NN	O
for	VBZ	O
nucleotides.	DT	O
Computer	NN	O
Systems	NN	O
and	NN	O
Computer	TO	O
Program	.	O
Products	DT	O
To	VBZ	O
determine	,	O
and	IN	O
identify	RB	O
sequence	,	O
identities,	DT	O
structural	NN	O
homologies,	NN	O
motifs	NNS	O
and	TO	O
the	CD	O
like	IN	O
in	NNS	O
silico,	CC	O
the	CD	O
sequence	IN	O
of	.	O
the	NNP	O
invention	NNPS	O
can	CC	O
be	NNP	O
stored,	NNP	O
recorded,	NNPS	O
and	TO	O
manipulated	VB	O
on	CC	O
any	VB	O
medium	NN	O
which	,	O
can	JJ	O
be	,	O
read	NNS	O
and	CC	O
accessed	DT	O
by	JJ	O
a	IN	O
computer.	,	O
Accordingly,	DT	O
the	NN	O
invention	IN	O
provides	DT	O
computers,	NN	O
computer	MD	O
systems,	VB	O
computer	,	O
readable	,	O
mediums,	CC	O
computer	VBD	O
programs	IN	O
products	DT	O
and	NN	O
the	WDT	O
like	MD	O
recorded	VB	O
or	VBN	O
stored	CC	O
thereon	VBN	O
the	IN	O
nucleic	DT	O
acid	.	O
and	,	O
polypeptide	DT	O
sequences	NN	O
of	VBZ	O
the	,	O
invention.	NN	O
As	,	O
used	NN	O
herein,	JJ	O
the	,	O
words	NN	O
“recorded”	NNS	O
and	NNS	O
“stored”	CC	O
refer	DT	O
to	JJ	O
a	VBD	O
process	CC	O
for	VBD	O
storing	IN	O
information	DT	O
on	JJ	O
a	NN	O
computer	CC	O
medium.	JJ	O
A	NNS	O
skilled	IN	O
artisan	DT	O
can	.	O
readily	IN	O
adopt	VBN	O
any	,	O
known	DT	O
methods	NNS	O
for	NNP	O
recording	CC	O
information	NNP	O
on	VBP	O
a	TO	O
computer	DT	O
readable	NN	O
medium	IN	O
to	VBG	O
generate	NN	O
manufactures	IN	O
comprising	DT	O
one	NN	O
or	.	O
more	DT	O
of	JJ	O
the	NN	O
nucleic	MD	O
acid	VB	O
and/or	VB	O
polypeptide	DT	O
sequences	JJ	O
of	NNS	O
the	IN	O
invention.	VBG	O
Another	NN	O
aspect	IN	O
of	DT	O
the	NN	O
invention	JJ	O
is	NN	O
a	TO	O
computer	VB	O
readable	NNS	O
medium	VBG	O
having	CD	O
recorded	CC	O
thereon	JJR	O
at	IN	O
least	DT	O
one	JJ	O
nucleic	NN	O
acid	NN	O
and/or	NN	O
polypeptide	NNS	O
sequence	IN	O
of	DT	O
the	.	O
invention.	DT	O
Computer	NN	O
readable	IN	O
media	DT	O
include	NN	O
magnetically	VBZ	O
readable	DT	O
media,	NN	O
optically	JJ	O
readable	NN	O
media,	VBG	O
electronically	VBN	O
readable	NN	O
media	IN	O
and	JJS	O
magnetic/optical	CD	O
media.	JJ	O
For	NN	O
example,	NN	O
the	JJ	O
computer	NN	O
readable	IN	O
media	DT	O
may	.	O
be	NNP	O
a	JJ	O
hard	NNS	O
disk,	VBP	O
a	RB	O
floppy	JJ	O
disk,	,	O
a	RB	O
magnetic	JJ	O
tape,	,	O
CD-ROM,	RB	O
Digital	JJ	O
Versatile	NNS	O
Disk	CC	O
(DVD),	JJ	O
Random	.	O
Access	IN	O
Memory	,	O
(RAM),	DT	O
or	NN	O
Read	JJ	O
Only	NNS	O
Memory	MD	O
(ROM)	VB	O
as	DT	O
well	JJ	O
as	,	O
other	DT	O
types	JJ	O
of	,	O
other	DT	O
media	JJ	O
known	,	O
to	,	O
those	NNP	O
skilled	NNP	O
in	NNP	O
the	,	O
art.	NNP	O
Aspects	NNP	O
of	NNP	O
the	,	O
invention	CC	O
include	NNP	O
systems	RB	O
(e.g.,	NNP	O
internet	)	O
based	RB	O
systems),	RB	O
particularly	IN	O
computer	JJ	O
systems,	NNS	O
which	IN	O
store	JJ	O
and	NNS	O
manipulate	VBN	O
the	TO	O
sequences	DT	O
and	VBN	O
sequence	IN	O
information	DT	O
described	.	O
herein.	NNS	O
One	IN	O
example	DT	O
of	NN	O
a	VBP	O
computer	NNS	O
system	,	O
100	NN	O
is	VBN	O
illustrated	,	O
in	RB	O
block	NN	O
diagram	,	O
form	WDT	O
in	NN	O
FIG.	CC	O
1.	VB	O
As	DT	O
used	NNS	O
herein,	CC	O
“a	NN	O
computer	NN	O
system”	VBD	O
refers	.	O
to	CD	O
the	NN	O
hardware	IN	O
components,	DT	O
software	NN	O
components,	NN	O
and	CD	O
data	VBZ	O
storage	VBN	O
components	IN	O
used	NN	O
to	NN	O
analyze	NN	O
a	IN	O
nucleotide	.	O
or	.	O
polypeptide	IN	O
sequence	VBN	O
of	,	O
the	NNP	O
invention.	NN	O
The	NN	O
computer	NNS	O
system	TO	O
100	DT	O
can	NN	O
include	,	O
a	NN	O
processor	,	O
for	CC	O
processing,	NNS	O
accessing	NN	O
and	NNS	O
manipulating	VBN	O
the	TO	O
sequence	VB	O
data.	DT	O
The	NN	O
processor	CC	O
105	JJ	O
can	NN	O
be	IN	O
any	DT	O
well-known	.	O
type	DT	O
of	NN	O
central	NN	O
processing	CD	O
unit,	MD	O
such	VB	O
as,	DT	O
for	NN	O
example,	IN	O
the	,	O
Pentium	VBG	O
III	CC	O
from	VBG	O
Intel	DT	O
Corporation,	NN	O
or	.	O
similar	DT	O
processor	NN	O
from	CD	O
Sun,	MD	O
Motorola,	VB	O
Compaq,	DT	O
AMD	JJ	O
or	NN	O
International	IN	O
Business	JJ	O
Machines.	NN	O
The	,	O
computer	JJ	O
system	,	O
100	IN	O
is	,	O
a	DT	O
general	NNP	O
purpose	NNP	O
system	IN	O
that	NNP	O
comprises	,	O
the	CC	O
processor	JJ	O
105	NN	O
and	IN	O
one	,	O
or	,	O
more	,	O
internal	NNP	O
data	CC	O
storage	NNP	O
components	NNP	O
110	.	O
for	DT	O
storing	NN	O
data,	NN	O
and	CD	O
one	VBZ	O
or	DT	O
more	JJ	O
data	NN	O
retrieving	NN	O
devices	WDT	O
for	VBZ	O
retrieving	DT	O
the	NN	O
data	CD	O
stored	CC	O
on	CD	O
the	CC	O
data	JJR	O
storage	JJ	O
components.	NNS	O
A	NN	O
skilled	NNS	O
artisan	CD	O
can	IN	O
readily	VBG	O
appreciate	,	O
that	CC	O
any	CD	O
one	CC	O
of	JJR	O
the	NNS	O
currently	VBG	O
available	NNS	O
computer	IN	O
systems	VBG	O
are	DT	O
suitable.	NN	O
In	VBD	O
one	IN	O
aspect,	DT	O
the	NNS	O
computer	NN	O
system	.	O
100	DT	O
includes	JJ	O
a	NN	O
processor	MD	O
105	VB	O
connected	VB	O
to	IN	O
a	DT	O
bus	CD	O
which	IN	O
is	DT	O
connected	RB	O
to	JJ	O
a	NN	O
main	NNS	O
memory	VBP	O
115	.	O
(preferably	IN	O
implemented	CD	O
as	,	O
RAM)	DT	O
and	NN	O
one	NN	O
or	CD	O
more	VBZ	O
internal	DT	O
data	NN	O
storage	CD	O
devices	VBN	O
110,	TO	O
such	DT	O
as	NN	O
a	WDT	O
hard	VBZ	O
drive	VBN	O
and/or	TO	O
other	DT	O
computer	JJ	O
readable	NN	O
media	CD	O
having	RB	O
data	VBN	O
recorded	IN	O
thereon.	)	O
The	CC	O
computer	CD	O
system	CC	O
100	JJR	O
can	JJ	O
further	NNS	O
include	NN	O
one	NNS	O
or	,	O
more	JJ	O
data	IN	O
retrieving	DT	O
device	JJ	O
118	NN	O
for	NN	O
reading	JJ	O
the	NN	O
data	JJ	O
stored	NNS	O
on	VBG	O
the	NNS	O
internal	VBN	O
data	.	O
storage	DT	O
devices	NN	O
110.	NN	O
The	CD	O
data	MD	O
retrieving	RB	O
device	VB	O
118	CD	O
may	CC	O
represent,	JJR	O
for	NNS	O
example,	VBG	O
a	NN	O
floppy	CD	O
disk	IN	O
drive,	VBG	O
a	DT	O
compact	NNS	O
disk	VBD	O
drive,	IN	O
a	DT	O
magnetic	JJ	O
tape	NNS	O
drive,	NN	O
or	NNS	O
a	.	O
modem	DT	O
capable	NN	O
of	NN	O
connection	NN	O
to	CD	O
a	MD	O
remote	,	O
data	IN	O
storage	,	O
system	DT	O
(e.g.,	JJ	O
via	NN	O
the	,	O
internet)	DT	O
etc.	JJ	O
In	NN	O
some	,	O
embodiments,	DT	O
the	JJ	O
internal	NN	O
data	,	O
storage	CC	O
device	DT	O
110	NN	O
is	JJ	O
a	IN	O
removable	NN	O
computer	TO	O
readable	DT	O
medium	JJ	O
such	NN	O
as	NN	O
a	NN	O
floppy	,	O
disk,	IN	O
a	DT	O
compact	)	O
disk,	.	O
a	IN	O
magnetic	DT	O
tape,	,	O
etc.	DT	O
containing	JJ	O
control	NNS	O
logic	NN	O
and/or	NN	O
data	CD	O
recorded	VBZ	O
thereon.	DT	O
The	JJ	O
computer	NN	O
system	JJ	O
100	NN	O
may	JJ	O
advantageously	IN	O
include	DT	O
or	JJ	O
be	,	O
programmed	DT	O
by	JJ	O
appropriate	,	O
software	DT	O
for	JJ	O
reading	,	O
the	.	O
control	VBG	O
logic	NN	O
and/or	JJ	O
the	NN	O
data	NNS	O
from	VBD	O
the	.	O
data	DT	O
storage	NN	O
component	NN	O
once	CD	O
inserted	MD	O
in	RB	O
the	VB	O
data	CC	O
retrieving	VB	O
device.	VBN	O
The	IN	O
computer	JJ	O
system	NN	O
100	IN	O
includes	VBG	O
a	DT	O
display	NN	O
120	VBZ	O
which	VBP	O
is	DT	O
used	NN	O
to	IN	O
display	DT	O
output	NNS	O
to	NN	O
a	NN	O
computer	RB	O
user.	VBN	O
It	IN	O
should	DT	O
also	NNS	O
be	NN	O
noted	.	O
that	DT	O
the	NN	O
computer	NN	O
system	CD	O
100	VBZ	O
can	DT	O
be	NN	O
linked	CD	O
to	WDT	O
other	VBZ	O
computer	VBN	O
systems	TO	O
125	VB	O
a-c	NN	O
in	TO	O
a	DT	O
network	NN	O
or	.	O
wide	PRP	O
area	MD	O
network	RB	O
to	VB	O
provide	VBN	O
centralized	IN	O
access	DT	O
to	NN	O
the	NN	O
computer	CD	O
system	MD	O
100.	VB	O
Software	VBN	O
for	TO	O
accessing	JJ	O
and	NN	O
processing	NNS	O
the	CD	O
nucleotide	JJ	O
or	IN	O
amino	DT	O
acid	NN	O
sequences	CC	O
of	JJ	O
the	NN	O
invention	NN	O
can	TO	O
reside	VB	O
in	JJ	O
main	NN	O
memory	TO	O
115	DT	O
during	NN	O
execution.	NN	O
In	.	O
some	NNP	O
aspects,	IN	O
the	VBG	O
computer	CC	O
system	VBG	O
100	DT	O
may	NN	O
further	CC	O
comprise	NN	O
a	JJ	O
sequence	NNS	O
comparison	IN	O
algorithm	DT	O
for	NN	O
comparing	MD	O
a	VB	O
nucleic	IN	O
acid	JJ	O
sequence	NN	O
of	CD	O
the	IN	O
invention.	.	O
The	IN	O
algorithm	DT	O
and	,	O
sequence(s)	DT	O
can	NN	O
be	NN	O
stored	CD	O
on	MD	O
a	RB	O
computer	VB	O
readable	DT	O
medium.	NN	O
A	NN	O
“sequence	NN	O
comparison	IN	O
algorithm”	VBG	O
refers	DT	O
to	JJ	O
one	JJ	O
or	NN	O
more	IN	O
programs	DT	O
which	.	O
are	DT	O
implemented	NN	O
(locally	CC	O
or	)	O
remotely)	MD	O
on	VB	O
the	VBN	O
computer	IN	O
system	DT	O
100	NN	O
to	JJ	O
compare	.	O
a	DT	O
nucleotide	NN	O
sequence	NN	O
with	NN	O
other	NNS	O
nucleotide	TO	O
sequences	CD	O
and/or	CC	O
compounds	JJR	O
stored	NNS	O
within	WDT	O
a	VBP	O
data	VBN	O
storage	RB	O
means.	CC	O
For	)	O
example,	IN	O
the	DT	O
sequence	NN	O
comparison	NN	O
algorithm	CD	O
may	TO	O
compare	VB	O
the	DT	O
nucleotide	JJ	O
sequences	NN	O
of	IN	O
the	JJ	O
invention	JJ	O
stored	NNS	O
on	VBP	O
a	NNS	O
computer	VBN	O
readable	IN	O
medium	DT	O
to	NN	O
reference	NN	O
sequences	.	O
stored	IN	O
on	,	O
a	DT	O
computer	NN	O
readable	NN	O
medium	NN	O
to	MD	O
identify	VB	O
homologies	DT	O
or	JJ	O
structural	NNS	O
motifs.	IN	O
The	DT	O
parameters	NN	O
used	VBN	O
with	IN	O
the	DT	O
above	NN	O
algorithms	JJ	O
may	NN	O
be	TO	O
adapted	VB	O
depending	NNS	O
on	VBN	O
the	IN	O
sequence	DT	O
length	NN	O
and	JJ	O
degree	NN	O
of	TO	O
homology	VB	O
studied.	NNS	O
In	CC	O
some	JJ	O
aspects,	.	O
the	DT	O
parameters	NNS	O
may	VBN	O
be	IN	O
the	DT	O
default	JJ	O
parameters	NN	O
used	MD	O
by	VB	O
the	VBN	O
algorithms	VBG	O
in	IN	O
the	DT	O
absence	NN	O
of	NN	O
instructions	CC	O
from	NN	O
the	IN	O
user.	NN	O
FIG.	.	O
2	IN	O
is	DT	O
a	,	O
flow	DT	O
diagram	NNS	O
illustrating	MD	O
one	VB	O
aspect	DT	O
of	NN	O
a	NNS	O
process	VBN	O
200	IN	O
for	DT	O
comparing	NN	O
a	IN	O
new	DT	O
nucleotide	NN	O
or	IN	O
protein	NNS	O
sequence	IN	O
with	DT	O
a	.	O
database	.	O
of	CD	O
sequences	VBZ	O
in	DT	O
order	JJ	O
to	NN	O
determine	VBG	O
the	CD	O
homology	NN	O
levels	IN	O
between	DT	O
the	NN	O
new	CD	O
sequence	IN	O
and	VBG	O
the	DT	O
sequences	JJ	O
in	NN	O
the	CC	O
database.	NN	O
The	NN	O
database	IN	O
of	DT	O
sequences	NN	O
can	IN	O
be	NNS	O
a	IN	O
private	NN	O
database	TO	O
stored	VB	O
within	DT	O
the	NN	O
computer	NNS	O
system	IN	O
100,	DT	O
or	JJ	O
a	NN	O
public	CC	O
database	DT	O
such	NNS	O
as	IN	O
GENBANK	DT	O
that	.	O
is	DT	O
available	NN	O
through	IN	O
the	NNS	O
Internet.	MD	O
The	VB	O
process	DT	O
200	JJ	O
begins	NN	O
at	VBD	O
a	IN	O
start	DT	O
state	NN	O
201	NN	O
and	,	O
then	CC	O
moves	DT	O
to	JJ	O
a	NN	O
state	JJ	O
202	IN	O
wherein	NNP	O
the	WDT	O
new	VBZ	O
sequence	JJ	O
to	IN	O
be	DT	O
compared	.	O
is	DT	O
stored	NN	O
to	CD	O
a	NNS	O
memory	IN	O
in	DT	O
a	NN	O
computer	NN	O
system	CD	O
100.	CC	O
As	RB	O
discussed	NNS	O
above,	TO	O
the	DT	O
memory	NN	O
could	CD	O
be	VBD	O
any	DT	O
type	JJ	O
of	NN	O
memory,	TO	O
including	VB	O
RAM	VBN	O
or	VBZ	O
an	VBN	O
internal	TO	O
storage	DT	O
device.	NN	O
The	IN	O
process	DT	O
200	NN	O
then	NN	O
moves	.	O
to	IN	O
a	VBN	O
state	,	O
204	DT	O
wherein	NN	O
a	MD	O
database	VB	O
of	DT	O
sequences	NN	O
is	IN	O
opened	,	O
for	VBG	O
analysis	NNP	O
and	CC	O
comparison.	DT	O
The	JJ	O
process	NN	O
200	.	O
then	DT	O
moves	NN	O
to	CD	O
a	RB	O
state	NNS	O
206	TO	O
wherein	DT	O
the	NN	O
first	CD	O
sequence	NN	O
stored	DT	O
in	NN	O
the	IN	O
database	NNS	O
is	VBZ	O
read	VBN	O
into	IN	O
a	NN	O
memory	CC	O
on	.	O
the	DT	O
computer.	NN	O
A	CD	O
comparison	RB	O
is	NNS	O
then	TO	O
performed	DT	O
at	NN	O
a	CD	O
state	NN	O
210	DT	O
to	JJ	O
determine	NN	O
if	VBN	O
the	IN	O
first	DT	O
sequence	NN	O
is	VBZ	O
the	VBN	O
same	IN	O
as	DT	O
the	NN	O
second	IN	O
sequence.	DT	O
It	.	O
is	DT	O
important	NN	O
to	VBZ	O
note	RB	O
that	VBN	O
this	IN	O
step	DT	O
is	NN	O
not	CD	O
limited	TO	O
to	VB	O
performing	IN	O
an	DT	O
exact	JJ	O
comparison	NN	O
between	VBZ	O
the	DT	O
new	JJ	O
sequence	IN	O
and	DT	O
the	JJ	O
first	.	O
sequence	PRP	O
in	VBZ	O
the	JJ	O
database.	TO	O
Well-known	VB	O
methods	IN	O
are	DT	O
known	NN	O
to	VBZ	O
those	RB	O
of	VBN	O
skill	TO	O
in	VBG	O
the	DT	O
art	JJ	O
for	NN	O
comparing	IN	O
two	DT	O
nucleotide	JJ	O
or	NN	O
protein	CC	O
sequences,	DT	O
even	JJ	O
if	NN	O
they	IN	O
are	DT	O
not	.	O
identical.	JJ	O
For	NNS	O
example,	VBP	O
gaps	VBN	O
can	TO	O
be	DT	O
introduced	IN	O
into	NN	O
one	IN	O
sequence	DT	O
in	NN	O
order	IN	O
to	VBG	O
raise	CD	O
the	JJ	O
homology	CC	O
level	JJ	O
between	,	O
the	RB	O
two	IN	O
tested	PRP	O
sequences.	VBP	O
The	RB	O
parameters	.	O
that	IN	O
control	,	O
whether	NNS	O
gaps	MD	O
or	VB	O
other	VBN	O
features	IN	O
are	CD	O
introduced	NN	O
into	IN	O
a	NN	O
sequence	TO	O
during	VB	O
comparison	DT	O
are	NN	O
normally	NN	O
entered	IN	O
by	DT	O
the	CD	O
user	VBD	O
of	.	O
the	DT	O
computer	NNS	O
system.	WDT	O
Once	VBP	O
a	IN	O
comparison	NNS	O
of	CC	O
the	JJ	O
two	NNS	O
sequences	VBP	O
has	VBN	O
been	IN	O
performed	DT	O
at	NN	O
the	IN	O
state	NN	O
210,	VBP	O
a	RB	O
determination	VBN	O
is	IN	O
made	DT	O
at	NN	O
a	IN	O
decision	DT	O
state	NN	O
210	.	O
whether	RB	O
the	DT	O
two	NN	O
sequences	IN	O
are	DT	O
the	CD	O
same.	NNS	O
Of	VBZ	O
course,	VBN	O
the	VBN	O
term	IN	O
“same”	DT	O
is	NN	O
not	,	O
limited	DT	O
to	NN	O
sequences	VBZ	O
that	VBN	O
are	IN	O
absolutely	DT	O
identical.	NN	O
Sequences	NN	O
that	CD	O
are	IN	O
within	DT	O
the	CD	O
homology	NNS	O
parameters	VBP	O
entered	DT	O
by	.	O
the	IN	O
user	,	O
will	DT	O
be	NN	O
marked	NNP	O
as	VBZ	O
“same”	RB	O
in	VBN	O
the	TO	O
process	NNS	O
200.	WDT	O
If	VBP	O
a	RB	O
determination	.	O
is	NNS	O
made	WDT	O
that	VBP	O
the	IN	O
two	DT	O
sequences	NN	O
are	NNS	O
the	VBN	O
same,	IN	O
the	DT	O
process	NN	O
200	MD	O
moves	VB	O
to	VBN	O
a	IN	O
state	NN	O
214	IN	O
wherein	DT	O
the	NN	O
name	.	O
of	IN	O
the	DT	O
sequence	NN	O
from	VBZ	O
the	VBN	O
database	IN	O
is	DT	O
displayed	CD	O
to	NNS	O
the	VBP	O
user.	DT	O
This	,	O
state	DT	O
notifies	NN	O
the	CD	O
user	NNS	O
that	TO	O
the	DT	O
sequence	NN	O
with	CD	O
the	NN	O
displayed	DT	O
name	NN	O
fulfills	IN	O
the	DT	O
homology	NN	O
constraints	IN	O
that	DT	O
were	NN	O
entered.	VBZ	O
Once	VBN	O
the	TO	O
name	DT	O
of	.	O
the	DT	O
stored	NN	O
sequence	VBZ	O
is	DT	O
displayed	NN	O
to	IN	O
the	DT	O
user,	NN	O
the	IN	O
process	DT	O
200	JJ	O
moves	NN	O
to	VBZ	O
a	DT	O
decision	NN	O
state	NNS	O
218	WDT	O
wherein	VBD	O
a	.	O
determination	RB	O
is	DT	O
made	NN	O
whether	IN	O
more	DT	O
sequences	JJ	O
exist	NN	O
in	VBZ	O
the	VBN	O
database.	TO	O
If	DT	O
no	,	O
more	DT	O
sequences	NN	O
exist	CD	O
in	NNS	O
the	TO	O
database,	DT	O
then	NN	O
the	NN	O
process	CD	O
200	NN	O
terminates	DT	O
at	NN	O
an	VBZ	O
end	VBN	O
state	IN	O
220.	JJR	O
However,	NNS	O
if	VBP	O
more	IN	O
sequences	DT	O
do	.	O
exist	IN	O
in	DT	O
the	JJR	O
database,	NNS	O
then	VBP	O
the	IN	O
process	DT	O
200	,	O
moves	RB	O
to	DT	O
a	NN	O
state	CD	O
224	NNS	O
wherein	IN	O
a	DT	O
pointer	NN	O
is	NN	O
moved	.	O
to	,	O
the	IN	O
next	JJR	O
sequence	NNS	O
in	VBP	O
the	VB	O
database	IN	O
so	DT	O
that	,	O
it	RB	O
can	DT	O
be	NN	O
compared	CD	O
to	NNS	O
the	TO	O
new	DT	O
sequence.	NN	O
In	CD	O
this	NN	O
manner,	DT	O
the	NN	O
new	VBZ	O
sequence	VBN	O
is	TO	O
aligned	DT	O
and	JJ	O
compared	NN	O
with	IN	O
every	DT	O
sequence	NN	O
in	RB	O
the	IN	O
database.	PRP	O
It	MD	O
should	VB	O
be	VBN	O
noted	TO	O
that	DT	O
if	JJ	O
a	.	O
determination	IN	O
had	DT	O
been	,	O
made	DT	O
at	JJ	O
the	NN	O
decision	VBZ	O
state	VBN	O
212	CC	O
that	VBN	O
the	IN	O
sequences	DT	O
were	NN	O
not	IN	O
homologous,	DT	O
then	.	O
the	PRP	O
process	MD	O
200	VB	O
would	VBN	O
move	IN	O
immediately	IN	O
to	DT	O
the	NN	O
decision	VBD	O
state	VBN	O
218	VBN	O
in	IN	O
order	DT	O
to	NN	O
determine	NN	O
if	CD	O
any	IN	O
other	DT	O
sequences	NNS	O
were	VBD	O
available	RB	O
in	,	O
the	RB	O
database	DT	O
for	NN	O
comparison.	CD	O
Accordingly,	MD	O
one	VB	O
aspect	RB	O
of	TO	O
the	DT	O
invention	NN	O
is	NN	O
a	CD	O
computer	IN	O
system	NN	O
comprising	TO	O
a	VB	O
processor,	IN	O
a	DT	O
data	JJ	O
storage	NNS	O
device	VBD	O
having	JJ	O
stored	IN	O
thereon	DT	O
a	NN	O
nucleic	IN	O
acid	.	O
sequence	,	O
of	CD	O
the	NN	O
invention	IN	O
and	DT	O
a	NN	O
sequence	VBZ	O
comparer	DT	O
for	NN	O
conducting	NN	O
the	VBG	O
comparison.	DT	O
The	,	O
sequence	DT	O
comparer	NN	O
may	NN	O
indicate	NN	O
a	VBG	O
homology	VBN	O
level	IN	O
between	DT	O
the	JJ	O
sequences	JJ	O
compared	NN	O
or	IN	O
identify	DT	O
structural	NN	O
motifs,	CC	O
or	DT	O
it	NN	O
may	NN	O
identify	IN	O
structural	VBG	O
motifs	DT	O
in	.	O
sequences	DT	O
which	NN	O
are	NN	O
compared	MD	O
to	VB	O
these	DT	O
nucleic	NN	O
acid	NN	O
codes	IN	O
and	DT	O
polypeptide	NNS	O
codes.	VBN	O
FIG.	CC	O
3	VB	O
is	JJ	O
a	,	O
flow	CC	O
diagram	PRP	O
illustrating	MD	O
one	VB	O
embodiment	JJ	O
of	NNS	O
a	IN	O
process	NNS	O
250	WDT	O
in	VBP	O
a	VBN	O
computer	TO	O
for	DT	O
determining	JJ	O
whether	NN	O
two	NNS	O
sequences	CC	O
are	NN	O
homologous.	.	O
The	.	O
process	CD	O
250	VBZ	O
begins	DT	O
at	JJ	O
a	NN	O
start	VBG	O
state	CD	O
252	NN	O
and	IN	O
then	DT	O
moves	NN	O
to	CD	O
a	IN	O
state	DT	O
254	NN	O
wherein	IN	O
a	VBG	O
first	IN	O
sequence	CD	O
to	NNS	O
be	VBP	O
compared	.	O
is	DT	O
stored	NN	O
to	CD	O
a	NNS	O
memory.	IN	O
The	DT	O
second	NN	O
sequence	NN	O
to	CD	O
be	CC	O
compared	RB	O
is	NNS	O
then	TO	O
stored	DT	O
to	NN	O
a	CD	O
memory	NN	O
at	DT	O
a	JJ	O
state	NN	O
256.	TO	O
The	VB	O
process	VBN	O
250	VBZ	O
then	VBN	O
moves	TO	O
to	DT	O
a	.	O
state	DT	O
260	JJ	O
wherein	NN	O
the	TO	O
first	VB	O
character	VBN	O
in	VBZ	O
the	RB	O
first	VBN	O
sequence	TO	O
is	DT	O
read	NN	O
and	IN	O
then	DT	O
to	NN	O
a	.	O
state	DT	O
262	NN	O
wherein	CD	O
the	RB	O
first	NNS	O
character	TO	O
of	DT	O
the	NN	O
second	CD	O
sequence	NN	O
is	DT	O
read.	JJ	O
It	NN	O
should	IN	O
be	DT	O
understood	JJ	O
that	NN	O
if	VBZ	O
the	VBN	O
sequence	CC	O
is	RB	O
a	TO	O
nucleotide	DT	O
sequence,	NN	O
then	CD	O
the	NN	O
character	DT	O
would	JJ	O
normally	NN	O
be	IN	O
either	DT	O
A,	JJ	O
T,	NN	O
C,	VBZ	O
G	.	O
or	PRP	O
U.	MD	O
If	VB	O
the	VBN	O
sequence	IN	O
is	IN	O
a	DT	O
protein	NN	O
sequence,	VBZ	O
then	DT	O
it	JJ	O
can	,	O
be	RB	O
a	DT	O
single	NN	O
letter	MD	O
amino	RB	O
acid	VB	O
code	CC	O
so	,	O
that	,	O
the	,	O
first	NNP	O
and	CC	O
sequence	.	O
sequences	IN	O
can	DT	O
be	NN	O
easily	VBZ	O
compared.	DT	O
A	JJ	O
determination	,	O
is	RB	O
then	PRP	O
made	MD	O
at	VB	O
a	DT	O
decision	JJ	O
state	NN	O
264	NN	O
whether	NN	O
the	NN	O
two	IN	O
characters	IN	O
are	DT	O
the	JJ	O
same.	CC	O
If	NN	O
they	NNS	O
are	MD	O
the	VB	O
same,	RB	O
then	.	O
the	DT	O
process	NN	O
250	VBZ	O
moves	RB	O
to	VBN	O
a	IN	O
state	DT	O
268	NN	O
wherein	NN	O
the	CD	O
next	IN	O
characters	DT	O
in	CD	O
the	NNS	O
first	VBP	O
and	DT	O
second	.	O
sequences	IN	O
are	PRP	O
read.	VBP	O
A	DT	O
determination	,	O
is	RB	O
then	DT	O
made	NN	O
whether	CD	O
the	NNS	O
next	TO	O
characters	DT	O
are	NN	O
the	CD	O
same.	IN	O
If	DT	O
they	JJ	O
are,	NNS	O
then	IN	O
the	DT	O
process	JJ	O
250	CC	O
continues	JJ	O
this	NNS	O
loop	VBP	O
until	.	O
two	DT	O
characters	NN	O
are	VBZ	O
not	RB	O
the	VBN	O
same.	IN	O
If	DT	O
a	JJ	O
determination	NNS	O
is	VBP	O
made	DT	O
that	.	O
the	IN	O
next	PRP	O
two	,	O
characters	RB	O
are	DT	O
not	NN	O
the	CD	O
same,	VBZ	O
the	DT	O
process	NN	O
250	IN	O
moves	CD	O
to	NNS	O
a	VBP	O
decision	RB	O
state	DT	O
274	.	O
to	IN	O
determine	DT	O
whether	NN	O
there	VBZ	O
are	VBN	O
any	IN	O
more	DT	O
characters	JJ	O
either	CD	O
sequence	NNS	O
to	VBP	O
read.	RB	O
If	DT	O
there	,	O
are	DT	O
not	NN	O
any	CD	O
more	NNS	O
characters	TO	O
to	DT	O
read,	NN	O
then	NN	O
the	CD	O
process	TO	O
250	VB	O
moves	IN	O
to	EX	O
a	VBP	O
state	DT	O
276	JJR	O
wherein	NNS	O
the	CC	O
level	NN	O
of	TO	O
homology	.	O
between	IN	O
the	EX	O
first	VBP	O
and	RB	O
second	DT	O
sequences	JJR	O
is	NNS	O
displayed	TO	O
to	,	O
the	RB	O
user.	DT	O
The	NN	O
level	CD	O
of	NNS	O
homology	TO	O
is	DT	O
determined	NN	O
by	CD	O
calculating	VBD	O
the	DT	O
proportion	NN	O
of	IN	O
characters	NN	O
between	IN	O
the	DT	O
sequences	JJ	O
that	CC	O
were	JJ	O
the	NNS	O
same	VBZ	O
out	VBN	O
of	TO	O
the	DT	O
total	.	O
number	DT	O
of	NN	O
sequences	IN	O
in	NN	O
the	VBZ	O
first	VBN	O
sequence.	IN	O
Thus,	VBG	O
if	DT	O
every	NN	O
character	IN	O
in	NNS	O
a	IN	O
first	DT	O
100	NNS	O
nucleotide	WDT	O
sequence	VBD	O
aligned	DT	O
with	JJ	O
an	IN	O
every	IN	O
character	DT	O
in	JJ	O
a	NN	O
second	IN	O
sequence,	NNS	O
the	IN	O
homology	DT	O
level	JJ	O
would	.	O
be	,	O
100%.	IN	O
Alternatively,	DT	O
the	NN	O
computer	IN	O
program	DT	O
can	JJ	O
compare	CD	O
a	JJ	O
reference	NN	O
sequence	VBN	O
to	IN	O
a	DT	O
sequence	DT	O
of	NN	O
the	IN	O
invention	DT	O
to	JJ	O
determine	,	O
whether	DT	O
the	NN	O
sequences	NN	O
differ	MD	O
at	VB	O
one	.	O
or	,	O
more	DT	O
positions.	NN	O
The	NN	O
program	MD	O
can	VB	O
record	DT	O
the	NN	O
length	NN	O
and	TO	O
identity	DT	O
of	NN	O
inserted,	IN	O
deleted	DT	O
or	NN	O
substituted	TO	O
nucleotides	VB	O
or	IN	O
amino	DT	O
acid	NNS	O
residues	VBP	O
with	IN	O
respect	CD	O
to	CC	O
the	JJR	O
sequence	.	O
of	DT	O
either	NN	O
the	MD	O
reference	VB	O
or	DT	O
the	NN	O
invention.	CC	O
The	NN	O
computer	IN	O
program	,	O
may	VBD	O
be	CC	O
a	VBD	O
program	NNS	O
which	CC	O
determines	NN	O
whether	NN	O
a	NNS	O
reference	IN	O
sequence	NN	O
contains	TO	O
a	DT	O
single	NN	O
nucleotide	IN	O
polymorphism	CC	O
(SNP)	DT	O
with	NN	O
respect	CC	O
to	DT	O
a	.	O
sequence	DT	O
of	NN	O
the	NN	O
invention,	MD	O
or,	VB	O
whether	DT	O
a	NN	O
sequence	WDT	O
of	VBZ	O
the	IN	O
invention	DT	O
comprises	NN	O
a	NN	O
SNP	VBZ	O
of	DT	O
a	JJ	O
known	NN	O
sequence.	NN	O
Thus,	)	O
in	IN	O
some	NN	O
aspects,	TO	O
the	DT	O
computer	NN	O
program	IN	O
is	DT	O
a	,	O
program	,	O
which	IN	O
identifies	DT	O
SNPs.	NN	O
The	IN	O
method	DT	O
may	NN	O
be	VBZ	O
implemented	DT	O
by	NNP	O
the	IN	O
computer	DT	O
systems	JJ	O
described	.	O
above	,	O
and	IN	O
the	DT	O
method	,	O
illustrated	DT	O
in	NN	O
FIG.	NN	O
3.	VBZ	O
The	DT	O
method	NN	O
can	WDT	O
be	VBZ	O
performed	.	O
by	DT	O
reading	NN	O
a	MD	O
sequence	VB	O
of	VBN	O
the	IN	O
invention	DT	O
and	NN	O
the	NNS	O
reference	VBN	O
sequences	IN	O
through	CC	O
the	DT	O
use	NN	O
of	VBN	O
the	IN	O
computer	.	O
program	.	O
and	DT	O
identifying	NN	O
differences	MD	O
with	VB	O
the	VBN	O
computer	IN	O
program.	VBG	O
In	DT	O
other	NN	O
aspects	IN	O
the	DT	O
computer	NN	O
based	CC	O
system	DT	O
comprises	NN	O
an	NNS	O
identifier	IN	O
for	DT	O
identifying	NN	O
features	IN	O
within	DT	O
a	NN	O
nucleic	NN	O
acid	CC	O
or	VBG	O
polypeptide	NNS	O
of	IN	O
the	DT	O
invention.	NN	O
An	.	O
“identifier”	IN	O
refers	JJ	O
to	NNS	O
one	DT	O
or	NN	O
more	VBN	O
programs	NN	O
which	VBZ	O
identifies	DT	O
certain	NN	O
features	IN	O
within	VBG	O
a	NNS	O
nucleic	IN	O
acid	DT	O
sequence.	JJ	O
For	NN	O
example,	CC	O
an	NN	O
identifier	IN	O
may	DT	O
comprise	.	O
a	DT	O
program	JJ	O
which	NNS	O
identifies	TO	O
an	CD	O
open	CC	O
reading	JJR	O
frame	NNS	O
(ORF)	WDT	O
in	VBP	O
a	JJ	O
nucleic	NNS	O
acid	IN	O
sequence.	DT	O
FIG.	JJ	O
4	NN	O
is	.	O
a	IN	O
flow	,	O
diagram	DT	O
illustrating	NN	O
one	MD	O
aspect	VB	O
of	DT	O
an	NN	O
identifier	WDT	O
process	VBZ	O
300	DT	O
for	JJ	O
detecting	NN	O
the	NN	O
presence	)	O
of	IN	O
a	DT	O
feature	JJ	O
in	NN	O
a	.	O
sequence.	.	O
The	CD	O
process	VBZ	O
300	DT	O
begins	JJ	O
at	NN	O
a	VBG	O
start	CD	O
state	NN	O
302	IN	O
and	DT	O
then	NN	O
moves	NN	O
to	CD	O
a	IN	O
state	VBG	O
304	DT	O
wherein	NN	O
a	IN	O
first	DT	O
sequence	NN	O
that	IN	O
is	DT	O
to	.	O
be	DT	O
checked	NN	O
for	CD	O
features	NNS	O
is	IN	O
stored	DT	O
to	NN	O
a	NN	O
memory	CD	O
115	CC	O
in	RB	O
the	NNS	O
computer	TO	O
system	DT	O
100.	NN	O
The	CD	O
process	NN	O
300	DT	O
then	JJ	O
moves	NN	O
to	WDT	O
a	VBZ	O
state	TO	O
306	VB	O
wherein	VBN	O
a	IN	O
database	NNS	O
of	VBZ	O
sequence	VBN	O
features	TO	O
is	DT	O
opened.	NN	O
Such	CD	O
a	IN	O
database	DT	O
would	NN	O
include	NN	O
a	.	O
list	DT	O
of	NN	O
each	CD	O
feature's	RB	O
attributes	NNS	O
along	TO	O
with	DT	O
the	NN	O
name	CD	O
of	NN	O
the	DT	O
feature.	NN	O
For	IN	O
example,	NN	O
a	NNS	O
feature	VBZ	O
name	.	O
could	JJ	O
be	DT	O
“Initiation	NN	O
Codon”	MD	O
and	VB	O
the	DT	O
attribute	NN	O
would	IN	O
be	DT	O
“ATG”.	POS	O
Another	NNS	O
example	IN	O
would	IN	O
be	DT	O
the	NN	O
feature	IN	O
name	DT	O
“TAATAA	.	O
Box”	IN	O
and	,	O
the	DT	O
feature	NN	O
attribute	NN	O
would	MD	O
be	VB	O
“TAATAA”.	JJ	O
An	NNP	O
example	CC	O
of	DT	O
such	NN	O
a	MD	O
database	VB	O
is	.	O
produced	DT	O
by	NN	O
the	MD	O
University	VB	O
of	DT	O
Wisconsin	NN	O
Genetics	NN	O
Computer	NNP	O
Group.	NNP	O
Alternatively,	CC	O
the	DT	O
features	NN	O
may	NN	O
be	MD	O
structural	VB	O
polypeptide	.	O
motifs	DT	O
such	NN	O
as	IN	O
alpha	PDT	O
helices,	DT	O
beta	NN	O
sheets,	VBZ	O
or	VBN	O
functional	IN	O
polypeptide	DT	O
motifs	NNP	O
such	IN	O
as	NNP	O
enzymatic	NNP	O
active	NNP	O
sites,	.	O
helix-turn-helix	,	O
motifs	DT	O
or	NNS	O
other	MD	O
motifs	VB	O
known	JJ	O
to	JJ	O
those	NNS	O
skilled	JJ	O
in	IN	O
the	JJ	O
art.	,	O
Once	NN	O
the	,	O
database	CC	O
of	JJ	O
features	NN	O
is	NNS	O
opened	JJ	O
at	IN	O
the	JJ	O
state	JJ	O
306,	,	O
the	JJ	O
process	NNS	O
300	CC	O
moves	JJ	O
to	NNS	O
a	VBN	O
state	TO	O
308	DT	O
wherein	VBN	O
the	IN	O
first	DT	O
feature	.	O
is	RB	O
read	DT	O
from	NN	O
the	IN	O
database.	NNS	O
A	VBZ	O
comparison	VBN	O
of	IN	O
the	DT	O
attribute	NN	O
of	,	O
the	DT	O
first	NN	O
feature	CD	O
with	NNS	O
the	TO	O
first	DT	O
sequence	NN	O
is	CD	O
then	NN	O
made	DT	O
at	JJ	O
a	NN	O
state	VBZ	O
310.	VBN	O
A	IN	O
determination	DT	O
is	.	O
then	DT	O
made	NN	O
at	IN	O
a	DT	O
decision	NN	O
state	IN	O
316	DT	O
whether	JJ	O
the	NN	O
attribute	IN	O
of	DT	O
the	JJ	O
feature	NN	O
was	VBZ	O
found	RB	O
in	VBN	O
the	IN	O
first	DT	O
sequence.	NN	O
If	.	O
the	DT	O
attribute	NN	O
was	VBZ	O
found,	RB	O
then	VBN	O
the	IN	O
process	DT	O
300	NN	O
moves	NN	O
to	CD	O
a	IN	O
state	DT	O
318	NN	O
wherein	IN	O
the	DT	O
name	NN	O
of	VBD	O
the	VBN	O
found	IN	O
feature	DT	O
is	JJ	O
displayed	.	O
to	IN	O
the	DT	O
user.	NN	O
The	VBD	O
process	,	O
300	RB	O
then	DT	O
moves	NN	O
to	CD	O
a	NNS	O
decision	TO	O
state	DT	O
320	NN	O
wherein	CD	O
a	NN	O
determination	DT	O
is	NN	O
made	IN	O
whether	DT	O
move	JJ	O
features	NN	O
exist	VBZ	O
in	VBN	O
the	TO	O
database.	DT	O
If	.	O
no	DT	O
more	NN	O
features	CD	O
do	RB	O
exist,	NNS	O
then	TO	O
the	DT	O
process	NN	O
300	NN	O
terminates	CD	O
at	NN	O
an	DT	O
end	NN	O
state	VBZ	O
324.	VBN	O
However,	IN	O
if	NN	O
more	NNS	O
features	VBP	O
do	IN	O
exist	DT	O
in	.	O
the	IN	O
database,	DT	O
then	JJR	O
the	NNS	O
process	VBP	O
300	,	O
reads	RB	O
the	DT	O
next	NN	O
sequence	CD	O
feature	NNS	O
at	IN	O
a	DT	O
state	NN	O
326	NN	O
and	.	O
loops	,	O
back	IN	O
to	JJR	O
the	NNS	O
state	VBP	O
310	VB	O
wherein	IN	O
the	DT	O
attribute	,	O
of	RB	O
the	DT	O
next	NN	O
feature	CD	O
is	VBZ	O
compared	DT	O
against	JJ	O
the	NN	O
first	NN	O
sequence.	IN	O
If	DT	O
the	NN	O
feature	CD	O
attribute	CC	O
is	VBZ	O
not	RB	O
found	TO	O
in	DT	O
the	NN	O
first	CD	O
sequence	VBD	O
at	DT	O
the	NN	O
decision	IN	O
state	DT	O
316,	JJ	O
the	NN	O
process	VBZ	O
300	VBN	O
moves	IN	O
directly	DT	O
to	JJ	O
the	.	O
decision	IN	O
state	DT	O
320	NN	O
in	NN	O
order	VBZ	O
to	RB	O
determine	VBN	O
if	IN	O
any	DT	O
more	JJ	O
features	NN	O
exist	IN	O
in	DT	O
the	NN	O
database.	NN	O
Thus,	,	O
in	DT	O
one	NN	O
aspect,	CD	O
the	NNS	O
invention	RB	O
provides	TO	O
a	DT	O
computer	NN	O
program	NN	O
that	CD	O
identifies	IN	O
open	NN	O
reading	TO	O
frames	VB	O
(ORFs).	IN	O
A	DT	O
polypeptide	JJR	O
or	NNS	O
nucleic	VBP	O
acid	IN	O
sequence	DT	O
of	.	O
the	,	O
invention	IN	O
can	CD	O
be	,	O
stored	DT	O
and	NN	O
manipulated	VBZ	O
in	DT	O
a	NN	O
variety	NN	O
of	WDT	O
data	VBZ	O
processor	JJ	O
programs	VBG	O
in	NNS	O
a	.	O
variety	DT	O
of	NN	O
formats.	CC	O
For	JJ	O
example,	JJ	O
a	NN	O
sequence	IN	O
can	DT	O
be	NN	O
stored	MD	O
as	VB	O
text	VBN	O
in	CC	O
a	VBN	O
word	IN	O
processing	DT	O
file,	NN	O
such	IN	O
as	NNS	O
MicrosoftWORD	NN	O
or	NNS	O
WORDPERFECT	IN	O
or	DT	O
as	NN	O
an	IN	O
ASCII	.	O
file	IN	O
in	,	O
a	DT	O
variety	NN	O
of	MD	O
database	VB	O
programs	VBN	O
familiar	IN	O
to	NN	O
those	IN	O
of	DT	O
skill	NN	O
in	NN	O
the	,	O
art,	JJ	O
such	IN	O
as	NNP	O
DB2,	CC	O
SYBASE,	NNP	O
or	CC	O
ORACLE.	IN	O
In	DT	O
addition,	NNP	O
many	NN	O
computer	IN	O
programs	DT	O
and	NN	O
databases	IN	O
may	NN	O
be	NNS	O
used	JJ	O
as	TO	O
sequence	DT	O
comparison	IN	O
algorithms,	NN	O
identifiers,	IN	O
or	DT	O
sources	,	O
of	JJ	O
reference	IN	O
nucleotide	,	O
sequences	,	O
or	CC	O
polypeptide	.	O
sequences	IN	O
to	,	O
be	JJ	O
compared	NN	O
to	NNS	O
a	CC	O
nucleic	NNS	O
acid	MD	O
sequence	VB	O
of	VBN	O
the	IN	O
invention.	NN	O
The	NN	O
programs	,	O
and	,	O
databases	CC	O
used	NNS	O
to	IN	O
practice	NN	O
the	JJ	O
invention	NNS	O
include,	CC	O
but	VB	O
are	NNS	O
not	TO	O
limited	VB	O
to:	VBN	O
MacPattern	TO	O
(EMBL),	DT	O
DiscoveryBase	JJ	O
(Molecular	JJ	O
Applications	NN	O
Group),	IN	O
GeneMine	DT	O
(Molecular	.	O
Applications	DT	O
Group),	NNS	O
Look	CC	O
(Molecular	NNS	O
Applications	VBN	O
Group),	TO	O
MacLook	NN	O
(Molecular	DT	O
Applications	NN	O
Group),	,	O
BLAST	CC	O
and	VBP	O
BLAST2	RB	O
(NCBI),	VBN	O
BLASTN	:	O
and	NNP	O
BLASTX	,	O
(Altschul	NNP	O
et	NNP	O
al,	NNP	O
J.	,	O
Mol.	NNP	O
Biol.	NNP	O
215:	NNP	O
403,	,	O
1990),	NNP	O
FASTA	NNP	O
(Pearson	NNP	O
and	,	O
Lipman,	NNP	O
Proc.	NNP	O
Natl.	NNP	O
Acad.	,	O
Sci.	NNP	O
USA,	CC	O
85:	NNP	O
2444,	,	O
1988),	NNP	O
FASTDB	CC	O
(Brutlag	NNP	O
et	NNP	O
al.	RB	O
Comp.	,	O
App.	NNP	O
Biosci.	.	O
6:237-245,	.	O
1990),	:	O
Catalyst	,	O
(Molecular	,	O
Simulations	NNP	O
Inc.),	NNP	O
Catalyst/SHAPE	CC	O
(Molecular	,	O
Simulations	.	O
Inc.),	.	O
Cerius2.DBAccess	.	O
(Molecular	.	O
Simulations	,	O
Inc.),	:	O
HypoGen	,	O
(Molecular	,	O
Simulations	NNP	O
Inc.),	NNP	O
Insight	RB	O
II,	.	O
(Molecular	.	O
Simulations	.	O
Inc.),	.	O
Discover	,	O
(Molecular	,	O
Simulations	NNP	O
Inc.),	NNP	O
CHARMm	NNP	O
(Molecular	,	O
Simulations	NNP	O
Inc.),	NNP	O
Felix	NNP	O
(Molecular	,	O
Simulations	NNP	O
Inc.),	NNP	O
DelPhi,	NNP	O
(Molecular	,	O
Simulations	NNP	O
Inc.),	NNP	O
QuanteMM,	NNP	O
(Molecular	,	O
Simulations	NNP	O
Inc.),	,	O
Homology	NNP	O
(Molecular	NNP	O
Simulations	,	O
Inc.),	NNP	O
Modeler	NNP	O
(Molecular	NNP	O
Simulations	,	O
Inc.),	NNP	O
ISIS	NNP	O
(Molecular	NNP	O
Simulations	,	O
Inc.),	NNP	O
Quanta/Protein	NNP	O
Design	NNP	O
(Molecular	,	O
Simulations	,	O
Inc.),	NNP	O
WebLab	NNP	O
(Molecular	,	O
Simulations	,	O
Inc.),	NNP	O
WebLab	NNP	O
Diversity	,	O
Explorer	NNP	O
(Molecular	NNP	O
Simulations	NNP	O
Inc.),	,	O
Gene	NNP	O
Explorer	NNP	O
(Molecular	NNP	O
Simulations	,	O
Inc.),	NNP	O
SeqFold	NNP	O
(Molecular	NNP	O
Simulations	,	O
Inc.),	NNP	O
the	NNP	O
MDL	NNP	O
Available	NNP	O
Chemicals	,	O
Directory	NNP	O
database,	NNP	O
the	NNP	O
MDL	,	O
Drug	NNP	O
Data	NNP	O
Report	NNP	O
data	NNP	O
base,	NNP	O
the	,	O
Comprehensive	NNP	O
Medicinal	NNP	O
Chemistry	NNP	O
database,	NNP	O
Derwent's	,	O
World	NNP	O
Drug	NNP	O
Index	NNP	O
database,	,	O
the	DT	O
BioByteMasterFile	NNP	O
database,	NNP	O
the	NNPS	O
Genbank	NNP	O
database,	,	O
and	DT	O
the	NNP	O
Genseqn	NNP	O
database.	NNP	O
Many	NNP	O
other	NNS	O
programs	,	O
and	DT	O
data	NNP	O
bases	NNP	O
would	NNP	O
be	,	O
apparent	POS	O
to	NNP	O
one	NNP	O
of	NNP	O
skill	,	O
in	DT	O
the	NNP	O
art	,	O
given	DT	O
the	NNP	O
present	,	O
disclosure.	CC	O
Motifs	DT	O
which	NNP	O
may	.	O
be	JJ	O
detected	JJ	O
using	NNS	O
the	CC	O
above	NNS	O
programs	NNS	O
include	MD	O
sequences	VB	O
encoding	JJ	O
leucine	TO	O
zippers,	CD	O
helix-turn-helix	IN	O
motifs,	NN	O
glycosylation	IN	O
sites,	DT	O
ubiquitination	NN	O
sites,	VBN	O
alpha	DT	O
helices,	JJ	O
and	.	O
beta	NNP	O
sheets,	WDT	O
signal	MD	O
sequences	VB	O
encoding	VBN	O
signal	VBG	O
peptides	DT	O
which	JJ	O
direct	NNS	O
the	VBP	O
secretion	NNS	O
of	VBG	O
the	NN	O
encoded	,	O
proteins,	JJ	O
sequences	,	O
implicated	NN	O
in	,	O
transcription	NN	O
regulation	,	O
such	JJ	O
as	,	O
homeoboxes,	CC	O
acidic	NN	O
stretches,	,	O
enzymatic	JJ	O
active	NNS	O
sites,	VBG	O
substrate	NN	O
binding	NNS	O
sites,	WDT	O
and	VBP	O
enzymatic	DT	O
cleavage	NN	O
sites.	IN	O
Hybridization	DT	O
of	JJ	O
Nucleic	,	O
Acids	NNS	O
The	VBN	O
invention	IN	O
provides	NN	O
isolated	NN	O
or	JJ	O
recombinant	IN	O
nucleic	,	O
acids	JJ	O
that	,	O
hybridize	JJ	O
under	JJ	O
stringent	,	O
conditions	NN	O
to	NN	O
an	,	O
exemplary	CC	O
sequence	JJ	O
of	NN	O
the	.	O
invention,	NN	O
or	IN	O
a	NNP	O
nucleic	NNP	O
acid	DT	O
that	NN	O
encodes	VBZ	O
a	JJ	O
polypeptide	CC	O
of	JJ	O
the	JJ	O
invention.	NNS	O
The	IN	O
stringent	NN	O
conditions	IN	O
can	JJ	O
be	NNS	O
highly	TO	O
stringent	DT	O
conditions,	JJ	O
medium	NN	O
stringent	IN	O
conditions,	DT	O
low	,	O
stringent	CC	O
conditions,	DT	O
including	JJ	O
the	NN	O
high	WDT	O
and	VBZ	O
reduced	DT	O
stringency	NN	O
conditions	IN	O
described	DT	O
herein.	.	O
In	DT	O
one	JJ	O
aspect,	NNS	O
it	MD	O
is	VB	O
the	RB	O
stringency	JJ	O
of	,	O
the	NN	O
wash	NN	O
conditions	,	O
that	JJ	O
set	NN	O
forth	,	O
the	VBG	O
conditions	DT	O
which	JJ	O
determine	CC	O
whether	JJ	O
a	NN	O
nucleic	NNS	O
acid	VBD	O
is	.	O
within	IN	O
the	CD	O
scope	,	O
of	PRP	O
the	VBZ	O
invention,	DT	O
as	NN	O
discussed	IN	O
below.	DT	O
In	NN	O
alternative	NNS	O
embodiments,	WDT	O
nucleic	VBP	O
acids	VBP	O
of	DT	O
the	NNS	O
invention	WDT	O
as	VBP	O
defined	IN	O
by	DT	O
their	JJ	O
ability	NN	O
to	VBZ	O
hybridize	IN	O
under	DT	O
stringent	NN	O
conditions	IN	O
can	DT	O
be	,	O
between	IN	O
about	VBN	O
five	.	O
residues	IN	O
and	JJ	O
the	,	O
full	JJ	O
length	NNS	O
of	IN	O
nucleic	DT	O
acid	NN	O
of	IN	O
the	VBN	O
invention;	IN	O
e.g.,	PRP$	O
they	NN	O
can	TO	O
be	VB	O
at	IN	O
least	JJ	O
5,	NNS	O
10,	MD	O
15,	VB	O
20,	IN	O
25,	RB	O
30,	CD	O
35,	NNS	O
40,	CC	O
50,	DT	O
55,	JJ	O
60,	NN	O
65,	IN	O
70,	JJ	O
75,	NN	O
80,	IN	O
90,	DT	O
100,	:	O
150,	,	O
200,	PRP	O
250,	MD	O
300,	VB	O
350,	IN	O
400,	JJS	O
450,	,	O
500,	,	O
550,	,	O
600,	,	O
650,	,	O
700,	,	O
750,	,	O
800,	,	O
850,	,	O
900,	,	O
950,	,	O
1000,	,	O
or	,	O
more,	,	O
residues	,	O
in	,	O
length.	,	O
Nucleic	,	O
acids	,	O
shorter	,	O
than	,	O
full	,	O
length	,	O
are	,	O
also	,	O
included.	,	O
These	,	O
nucleic	,	O
acids	,	O
can	,	O
be	,	O
useful	,	O
as,	,	O
e.g.,	,	O
hybridization	,	O
probes,	CC	O
labeling	,	O
probes,	NNS	O
PCR	IN	O
oligonucleotide	.	O
probes,	NNP	O
iRNA,	NNS	O
antisense	JJR	O
or	IN	O
sequences	JJ	O
encoding	NN	O
antibody	VBP	O
binding	RB	O
peptides	.	O
(epitopes),	DT	O
motifs,	JJ	O
active	NNS	O
sites	MD	O
and	VB	O
the	JJ	O
like.	,	O
In	,	O
one	NN	O
aspect,	,	O
nucleic	VBG	O
acids	,	O
of	NNP	O
the	IN	O
invention	,	O
are	,	O
defined	NN	O
by	CC	O
their	NNS	O
ability	VBG	O
to	NN	O
hybridize	VBG	O
under	NNS	O
high	,	O
stringency	,	O
comprises	JJ	O
conditions	NNS	O
of	CC	O
about	DT	O
50%	.	O
formamide	IN	O
at	CD	O
about	,	O
37°	JJ	O
C.	NNS	O
to	IN	O
42°	DT	O
C.	NN	O
In	VBP	O
one	VBN	O
aspect,	IN	O
nucleic	PRP$	O
acids	NN	O
of	TO	O
the	VB	O
invention	IN	O
are	JJ	O
defined	NN	O
by	NNS	O
their	NNS	O
ability	IN	O
to	RB	O
hybridize	NN	O
under	NN	O
reduced	IN	O
stringency	IN	O
comprising	CD	O
conditions	NNP	O
in	TO	O
about	CD	O
35%	NNP	O
to	IN	O
25%	CD	O
formamide	,	O
at	JJ	O
about	NNS	O
30°	IN	O
C.	DT	O
to	NN	O
35°	VBP	O
C.	VBN	O
Alternatively,	IN	O
nucleic	PRP$	O
acids	NN	O
of	TO	O
the	VB	O
invention	IN	O
are	JJ	O
defined	NN	O
by	VBG	O
their	NNS	O
ability	IN	O
to	RB	O
hybridize	NN	O
under	TO	O
high	NN	O
stringency	NN	O
comprising	IN	O
conditions	IN	O
at	CD	O
42°	NNP	O
C.	TO	O
in	CD	O
50%	NNP	O
formamide,	,	O
5×SSPE,	JJ	O
0.3%	NNS	O
SDS,	IN	O
and	DT	O
a	NN	O
repetitive	VBP	O
sequence	VBN	O
blocking	IN	O
nucleic	PRP$	O
acid,	NN	O
such	TO	O
as	VB	O
cot-1	IN	O
or	JJ	O
salmon	NN	O
sperm	VBG	O
DNA	NNS	O
(e.g.,	IN	O
200	CD	O
n/ml	NNP	O
sheared	IN	O
and	NN	O
denatured	,	O
salmon	,	O
sperm	NN	O
DNA).	,	O
In	CC	O
one	DT	O
aspect,	JJ	O
nucleic	NN	O
acids	VBG	O
of	JJ	O
the	,	O
invention	JJ	O
are	IN	O
defined	NN	O
by	CC	O
their	JJ	O
ability	NN	O
to	NNP	O
hybridize	,	O
under	CD	O
reduced	NN	O
stringency	VBN	O
conditions	CC	O
comprising	VBN	O
35%	JJ	O
formamide	JJ	O
at	.	O
a	IN	O
reduced	CD	O
temperature	,	O
of	JJ	O
35°	NNS	O
C.	IN	O
Following	DT	O
hybridization,	NN	O
the	VBP	O
filter	VBN	O
may	IN	O
be	PRP$	O
washed	NN	O
with	TO	O
6×SSC,	VB	O
0.5%	IN	O
SDS	JJ	O
at	NN	O
50°	NNS	O
C.	VBG	O
These	NN	O
conditions	NN	O
are	IN	O
considered	DT	O
to	JJ	O
be	NN	O
“moderate”	IN	O
conditions	CD	O
above	NNP	O
25%	NNP	O
formamide	,	O
and	DT	O
“low”	NN	O
conditions	MD	O
below	VB	O
25%	VBN	O
formamide.	IN	O
A	,	O
specific	NN	O
example	NNP	O
of	IN	O
“moderate”	CD	O
hybridization	NNP	O
conditions	DT	O
is	NNS	O
when	VBP	O
the	VBN	O
above	TO	O
hybridization	VB	O
is	JJ	O
conducted	NNS	O
at	IN	O
30%	NN	O
formamide.	NN	O
A	CC	O
specific	JJ	O
example	NNS	O
of	IN	O
“low	NN	O
stringency”	.	O
hybridization	DT	O
conditions	JJ	O
is	NN	O
when	IN	O
the	JJ	O
above	NN	O
hybridization	NNS	O
is	VBZ	O
conducted	WRB	O
at	DT	O
10%	JJ	O
formamide.	NN	O
The	VBZ	O
temperature	VBN	O
range	IN	O
corresponding	NN	O
to	.	O
a	DT	O
particular	JJ	O
level	NN	O
of	IN	O
stringency	JJ	O
can	JJ	O
be	NN	O
further	NNS	O
narrowed	VBZ	O
by	WRB	O
calculating	DT	O
the	JJ	O
purine	NN	O
to	VBZ	O
pyrimidine	VBN	O
ratio	IN	O
of	NN	O
the	.	O
nucleic	DT	O
acid	NN	O
of	NN	O
interest	VBG	O
and	TO	O
adjusting	DT	O
the	JJ	O
temperature	NN	O
accordingly.	IN	O
Nucleic	NN	O
acids	MD	O
of	VB	O
the	JJ	O
invention	VBN	O
are	IN	O
also	VBG	O
defined	DT	O
by	NN	O
their	TO	O
ability	VB	O
to	NN	O
hybridize	IN	O
under	DT	O
high,	JJ	O
medium,	NN	O
and	IN	O
low	NN	O
stringency	CC	O
conditions	VBG	O
as	DT	O
set	NN	O
forth	.	O
in	NNP	O
Ausubel	NNS	O
and	IN	O
Sambrook.	DT	O
Variations	NN	O
on	VBP	O
the	RB	O
above	VBN	O
ranges	IN	O
and	PRP$	O
conditions	NN	O
are	TO	O
well	VB	O
known	IN	O
in	,	O
the	,	O
art.	CC	O
Hybridization	JJ	O
conditions	NN	O
are	NNS	O
discussed	IN	O
further,	NN	O
below.	NN	O
The	IN	O
above	NNP	O
procedure	CC	O
may	.	O
be	NNS	O
modified	IN	O
to	DT	O
identify	JJ	O
nucleic	NNS	O
acids	CC	O
having	NNS	O
decreasing	VBP	O
levels	RB	O
of	VBN	O
homology	IN	O
to	DT	O
the	.	O
probe	NN	O
sequence.	NNS	O
For	VBP	O
example,	VBN	O
to	,	O
obtain	.	O
nucleic	DT	O
acids	JJ	O
of	NN	O
decreasing	MD	O
homology	VB	O
to	VBN	O
the	TO	O
detectable	VB	O
probe,	JJ	O
less	NNS	O
stringent	VBG	O
conditions	VBG	O
may	NNS	O
be	IN	O
used.	NN	O
For	TO	O
example,	DT	O
the	NN	O
hybridization	.	O
temperature	IN	O
may	,	O
be	TO	O
decreased	VB	O
in	JJ	O
increments	NNS	O
of	IN	O
5°	VBG	O
C.	NN	O
from	TO	O
68°	DT	O
C.	JJ	O
to	,	O
42°	RBR	O
C.	JJ	O
in	NNS	O
a	MD	O
hybridization	VB	O
buffer	.	O
having	IN	O
a	,	O
Na+	DT	O
concentration	NN	O
of	NN	O
approximately	MD	O
1M.	VB	O
Following	VBN	O
hybridization,	IN	O
the	NNS	O
filter	IN	O
may	CD	O
be	NNP	O
washed	IN	O
with	CD	O
2×SSC,	NNP	O
0.5%	TO	O
SDS	CD	O
at	NNP	O
the	IN	O
temperature	DT	O
of	NN	O
hybridization.	NN	O
These	VBG	O
conditions	DT	O
are	NNP	O
considered	NN	O
to	IN	O
be	RB	O
“moderate”	.	O
conditions	VBG	O
above	,	O
50°	DT	O
C.	NN	O
and	MD	O
“low”	VB	O
conditions	VBN	O
below	IN	O
50°	,	O
C.	NN	O
A	NNP	O
specific	IN	O
example	DT	O
of	NN	O
“moderate”	IN	O
hybridization	.	O
conditions	DT	O
is	NNS	O
when	VBP	O
the	VBN	O
above	TO	O
hybridization	VB	O
is	JJ	O
conducted	NNS	O
at	IN	O
55°	CD	O
C.	NNP	O
A	CC	O
specific	NNP	O
example	NNS	O
of	IN	O
“low	CD	O
stringency”	NNP	O
hybridization	NNP	O
conditions	JJ	O
is	NN	O
when	IN	O
the	JJ	O
above	NN	O
hybridization	NNS	O
is	VBZ	O
conducted	WRB	O
at	DT	O
45°	JJ	O
C.	NN	O
Alternatively,	VBZ	O
the	VBN	O
hybridization	IN	O
may	CD	O
be	NNP	O
carried	NNP	O
out	JJ	O
in	NN	O
buffers,	IN	O
such	JJ	O
as	JJ	O
6×SSC,	NN	O
containing	NNS	O
formamide	VBZ	O
at	WRB	O
a	DT	O
temperature	JJ	O
of	NN	O
42°	VBZ	O
C.	VBN	O
In	IN	O
this	CD	O
case,	NNP	O
the	,	O
concentration	DT	O
of	NN	O
formamide	MD	O
in	VB	O
the	VBN	O
hybridization	RP	O
buffer	IN	O
may	,	O
be	JJ	O
reduced	IN	O
in	,	O
5%	VBG	O
increments	NN	O
from	IN	O
50%	DT	O
to	NN	O
0%	IN	O
to	CD	O
identify	NNP	O
clones	IN	O
having	DT	O
decreasing	,	O
levels	DT	O
of	NN	O
homology	IN	O
to	NN	O
the	IN	O
probe.	DT	O
Following	NN	O
hybridization,	NN	O
the	MD	O
filter	VB	O
may	VBN	O
be	IN	O
washed	NN	O
with	NNS	O
6×SSC,	IN	O
0.5%	NN	O
SDS	TO	O
at	NN	O
50°	TO	O
C.	VB	O
These	NNS	O
conditions	VBG	O
are	VBG	O
considered	NNS	O
to	IN	O
be	NN	O
“moderate”	TO	O
conditions	DT	O
above	.	O
25%	VBG	O
formamide	,	O
and	DT	O
“low”	NN	O
conditions	MD	O
below	VB	O
25%	VBN	O
formamide.	IN	O
A	,	O
specific	NN	O
example	NNP	O
of	IN	O
“moderate”	CD	O
hybridization	NNP	O
conditions	DT	O
is	NNS	O
when	VBP	O
the	VBN	O
above	TO	O
hybridization	VB	O
is	JJ	O
conducted	NNS	O
at	IN	O
30%	NN	O
formamide.	NN	O
A	CC	O
specific	JJ	O
example	NNS	O
of	IN	O
“low	NN	O
stringency”	.	O
hybridization	DT	O
conditions	JJ	O
is	NN	O
when	IN	O
the	JJ	O
above	NN	O
hybridization	NNS	O
is	VBZ	O
conducted	WRB	O
at	DT	O
10%	JJ	O
formamide.	NN	O
However,	VBZ	O
the	VBN	O
selection	IN	O
of	NN	O
a	.	O
hybridization	DT	O
format	JJ	O
is	NN	O
not	IN	O
critical—it	JJ	O
is	JJ	O
the	NN	O
stringency	NNS	O
of	VBZ	O
the	WRB	O
wash	DT	O
conditions	JJ	O
that	NN	O
set	VBZ	O
forth	VBN	O
the	IN	O
conditions	NN	O
which	.	O
determine	,	O
whether	DT	O
a	NN	O
nucleic	IN	O
acid	DT	O
is	NN	O
within	NN	O
the	VBZ	O
scope	RB	O
of	JJ	O
the	VBZ	O
invention.	DT	O
Wash	NN	O
conditions	IN	O
used	DT	O
to	NN	O
identify	NNS	O
nucleic	WDT	O
acids	VBP	O
within	VBP	O
the	DT	O
scope	NNS	O
of	WDT	O
the	VBP	O
invention	IN	O
include,	DT	O
e.g.:	JJ	O
a	NN	O
salt	VBZ	O
concentration	IN	O
of	DT	O
about	NN	O
0.02	IN	O
molar	DT	O
at	.	O
pH	JJ	O
7	NNS	O
and	VBN	O
a	TO	O
temperature	VB	O
of	JJ	O
at	NNS	O
least	IN	O
about	DT	O
50°	NN	O
C.	IN	O
or	DT	O
about	NN	O
55°	,	O
C.	:	O
to	DT	O
about	JJ	O
60°	NN	O
C.;	IN	O
or,	IN	O
a	CD	O
salt	NN	O
concentration	IN	O
of	NN	O
about	CD	O
0.15	CC	O
M	DT	O
NaCl	NN	O
at	IN	O
72°	IN	O
C.	JJS	O
for	IN	O
about	CD	O
15	NNP	O
minutes;	CC	O
or,	IN	O
a	CD	O
salt	NNP	O
concentration	TO	O
of	IN	O
about	CD	O
0.2×SSC	:	O
at	,	O
a	DT	O
temperature	JJ	O
of	NN	O
at	IN	O
least	IN	O
about	CD	O
50°	NNP	O
C.	NNP	O
or	IN	O
about	CD	O
55°	NNP	O
C.	IN	O
to	RB	O
about	CD	O
60°	:	O
C.	,	O
for	DT	O
about	JJ	O
15	NN	O
to	IN	O
about	RB	O
20	CD	O
minutes;	IN	O
or,	DT	O
the	NN	O
hybridization	IN	O
complex	IN	O
is	JJS	O
washed	IN	O
twice	CD	O
with	NNP	O
a	CC	O
solution	IN	O
with	CD	O
a	NNP	O
salt	TO	O
concentration	IN	O
of	CD	O
about	NNP	O
2×SSC	IN	O
containing	RB	O
0.1%	CD	O
SDS	TO	O
at	IN	O
room	CD	O
temperature	:	O
for	,	O
15	DT	O
minutes	NN	O
and	NN	O
then	VBZ	O
washed	VBN	O
twice	RB	O
by	IN	O
0.1×SSC	DT	O
containing	NN	O
0.1%	IN	O
SDS	DT	O
at	JJ	O
68°	NN	O
C.	IN	O
for	IN	O
15	CD	O
minutes;	VBG	O
or,	NN	O
equivalent	NNP	O
conditions.	IN	O
See	NN	O
Sambrook,	NN	O
Tijssen	IN	O
and	CD	O
Ausubel	NNS	O
for	CC	O
a	RB	O
description	VBD	O
of	RB	O
SSC	IN	O
buffer	CD	O
and	VBG	O
equivalent	NN	O
conditions.	NNP	O
These	IN	O
methods	CD	O
may	NNP	O
be	IN	O
used	CD	O
to	:	O
isolate	,	O
nucleic	JJ	O
acids	.	O
of	VB	O
the	,	O
invention.	NNP	O
Oligonucleotides	CC	O
Probes	NNP	O
and	IN	O
Methods	DT	O
for	NN	O
Using	IN	O
them	NNP	O
The	NN	O
invention	CC	O
also	JJ	O
provides	.	O
nucleic	DT	O
acid	NNS	O
probes	MD	O
that	VB	O
can	VBN	O
be	TO	O
used,	VB	O
e.g.,	JJ	O
for	NNS	O
identifying	IN	O
nucleic	DT	O
acids	.	O
encoding	NNP	O
a	NNP	O
polypeptide	CC	O
with	NNP	O
an	IN	O
amylase	VBG	O
activity	PRP	O
or	DT	O
fragments	NN	O
thereof	RB	O
or	VBZ	O
for	JJ	O
identifying	NN	O
amylase	NNS	O
genes.	WDT	O
In	MD	O
one	VB	O
aspect,	,	O
the	,	O
probe	IN	O
comprises	VBG	O
at	JJ	O
least	NNS	O
10	VBG	O
consecutive	DT	O
bases	NN	O
of	IN	O
a	DT	O
nucleic	NN	O
acid	NN	O
of	CC	O
the	NNS	O
invention.	VBP	O
Alternatively,	CC	O
a	IN	O
probe	VBG	O
of	NN	O
the	.	O
invention	IN	O
can	CD	O
be	,	O
at	DT	O
least	NN	O
about	VBZ	O
5,	IN	O
6,	JJS	O
7,	CD	O
8,	JJ	O
9,	NNS	O
10,	IN	O
15,	DT	O
20,	JJ	O
25,	NN	O
30,	IN	O
35,	DT	O
40,	.	O
45,	,	O
50,	DT	O
60,	NN	O
70,	IN	O
80,	DT	O
90,	NN	O
100,	MD	O
110,	VB	O
120,	IN	O
130,	JJS	O
150	IN	O
or	,	O
about	,	O
10	,	O
to	,	O
50,	,	O
about	,	O
20	,	O
to	,	O
60	,	O
about	,	O
30	,	O
to	,	O
70,	,	O
consecutive	,	O
bases	,	O
of	,	O
a	,	O
sequence	,	O
as	,	O
set	,	O
forth	,	O
in	,	O
a	CD	O
nucleic	CC	O
acid	RB	O
of	CD	O
the	TO	O
invention.	,	O
The	RB	O
probes	CD	O
identify	TO	O
a	CD	O
nucleic	RB	O
acid	CD	O
by	TO	O
binding	,	O
and/or	JJ	O
hybridization.	NNS	O
The	IN	O
probes	DT	O
can	NN	O
be	IN	O
used	VBN	O
in	NN	O
arrays	IN	O
of	DT	O
the	JJ	O
invention,	NN	O
see	IN	O
discussion	DT	O
below,	.	O
including,	DT	O
e.g.,	NNS	O
capillary	VB	O
arrays.	DT	O
The	JJ	O
probes	NN	O
of	IN	O
the	VBG	O
invention	JJ	O
can	.	O
also	DT	O
be	NNS	O
used	MD	O
to	VB	O
isolate	VBN	O
other	IN	O
nucleic	NNS	O
acids	IN	O
or	DT	O
polypeptides.	,	O
The	VBP	O
probes	NN	O
of	,	O
the	,	O
invention	,	O
can	JJ	O
be	.	O
used	DT	O
to	NNS	O
determine	IN	O
whether	DT	O
a	NN	O
biological	MD	O
sample,	RB	O
such	VB	O
as	VBN	O
a	TO	O
soil	VB	O
sample,	JJ	O
contains	JJ	O
an	NNS	O
organism	CC	O
having	.	O
a	DT	O
nucleic	NNS	O
acid	IN	O
sequence	DT	O
of	NN	O
the	MD	O
invention	VB	O
or	VBN	O
an	TO	O
organism	VB	O
from	IN	O
which	DT	O
the	JJ	O
nucleic	,	O
acid	JJ	O
was	IN	O
obtained.	DT	O
In	NN	O
such	,	O
procedures,	VBZ	O
a	DT	O
biological	NN	O
sample	VBG	O
potentially	DT	O
harboring	JJ	O
the	JJ	O
organism	NN	O
from	IN	O
which	DT	O
the	NN	O
nucleic	CC	O
acid	DT	O
was	NN	O
isolated	IN	O
is	WDT	O
obtained	DT	O
and	NN	O
nucleic	NN	O
acids	VBD	O
are	.	O
obtained	IN	O
from	JJ	O
the	,	O
sample.	DT	O
The	JJ	O
nucleic	NN	O
acids	RB	O
are	VBG	O
contacted	DT	O
with	NN	O
the	IN	O
probe	WDT	O
under	DT	O
conditions	NN	O
which	NN	O
permit	VBD	O
the	VBN	O
probe	VBZ	O
to	VBN	O
specifically	CC	O
hybridize	JJ	O
to	NNS	O
any	VBP	O
complementary	VBN	O
sequences	IN	O
present	DT	O
in	.	O
the	DT	O
sample.	JJ	O
Where	NNS	O
necessary,	VBP	O
conditions	VBN	O
which	IN	O
permit	DT	O
the	NN	O
probe	IN	O
to	NNS	O
specifically	WDT	O
hybridize	VBP	O
to	DT	O
complementary	NN	O
sequences	TO	O
may	RB	O
be	VB	O
determined	TO	O
by	DT	O
placing	JJ	O
the	NNS	O
probe	JJ	O
in	IN	O
contact	DT	O
with	.	O
complementary	WRB	O
sequences	,	O
from	NNS	O
samples	WDT	O
known	VBP	O
to	DT	O
contain	NN	O
the	TO	O
complementary	RB	O
sequence,	VB	O
as	TO	O
well	JJ	O
as	NNS	O
control	MD	O
sequences	VB	O
which	VBN	O
do	IN	O
not	VBG	O
contain	DT	O
the	NN	O
complementary	IN	O
sequence.	NN	O
Hybridization	IN	O
conditions,	JJ	O
such	NNS	O
as	IN	O
the	NNS	O
salt	VBN	O
concentration	TO	O
of	VB	O
the	DT	O
hybridization	JJ	O
buffer,	,	O
the	RB	O
formamide	RB	O
concentration	IN	O
of	NN	O
the	NNS	O
hybridization	WDT	O
buffer,	VBP	O
or	RB	O
the	VB	O
hybridization	DT	O
temperature,	JJ	O
may	.	O
be	NN	O
varied	,	O
to	JJ	O
identify	IN	O
conditions	DT	O
which	NN	O
allow	NN	O
the	IN	O
probe	DT	O
to	NN	O
hybridize	,	O
specifically	DT	O
to	JJ	O
complementary	NN	O
nucleic	IN	O
acids	DT	O
(see	NN	O
discussion	,	O
on	CC	O
specific	DT	O
hybridization	NN	O
conditions).	,	O
If	MD	O
the	VB	O
sample	VBN	O
contains	TO	O
the	VB	O
organism	NNS	O
from	WDT	O
which	VBP	O
the	DT	O
nucleic	NN	O
acid	TO	O
was	VB	O
isolated,	RB	O
specific	TO	O
hybridization	VB	O
of	JJ	O
the	NNS	O
probe	VB	O
is	NN	O
then	IN	O
detected.	JJ	O
Hybridization	NN	O
may	.	O
be	IN	O
detected	DT	O
by	NN	O
labeling	VBZ	O
the	DT	O
probe	NN	O
with	IN	O
a	WDT	O
detectable	DT	O
agent	NN	O
such	NN	O
as	VBD	O
a	,	O
radioactive	JJ	O
isotope,	NN	O
a	IN	O
fluorescent	DT	O
dye	NN	O
or	VBZ	O
an	RB	O
enzyme	.	O
capable	NN	O
of	MD	O
catalyzing	VB	O
the	VBN	O
formation	IN	O
of	VBG	O
a	DT	O
detectable	NN	O
product.	IN	O
Many	DT	O
methods	JJ	O
for	NN	O
using	JJ	O
the	IN	O
labeled	DT	O
probes	JJ	O
to	,	O
detect	DT	O
the	JJ	O
presence	NN	O
of	CC	O
complementary	DT	O
nucleic	JJ	O
acids	NN	O
in	IN	O
a	VBG	O
sample	DT	O
are	NN	O
familiar	IN	O
to	DT	O
those	JJ	O
skilled	.	O
in	JJ	O
the	NNS	O
art.	IN	O
These	VBG	O
include	DT	O
Southern	VBN	O
Blots,	NNS	O
Northern	TO	O
Blots,	VB	O
colony	DT	O
hybridization	NN	O
procedures,	IN	O
and	JJ	O
dot	JJ	O
blots.	NNS	O
Protocols	IN	O
for	DT	O
each	NN	O
of	VBP	O
these	JJ	O
procedures	TO	O
are	DT	O
provided	VBN	O
in	IN	O
Ausubel	DT	O
and	.	O
Sambrook.	DT	O
Alternatively,	VBP	O
more	NNP	O
than	,	O
one	NNP	O
probe	,	O
(at	NN	O
least	NN	O
one	,	O
of	CC	O
which	JJ	O
is	.	O
capable	NNS	O
of	IN	O
specifically	DT	O
hybridizing	IN	O
to	DT	O
any	NNS	O
complementary	VBP	O
sequences	VBN	O
which	IN	O
are	NNP	O
present	CC	O
in	.	O
the	,	O
nucleic	JJR	O
acid	IN	O
sample),	CD	O
may	NN	O
be	IN	O
used	JJS	O
in	CD	O
an	IN	O
amplification	WDT	O
reaction	VBZ	O
to	JJ	O
determine	IN	O
whether	RB	O
the	VBG	O
sample	TO	O
contains	DT	O
an	JJ	O
organism	NNS	O
containing	WDT	O
a	VBP	O
nucleic	JJ	O
acid	IN	O
sequence	DT	O
of	JJ	O
the	JJ	O
invention	,	O
(e.g.,	MD	O
an	VB	O
organism	VBN	O
from	IN	O
which	DT	O
the	NN	O
nucleic	NN	O
acid	TO	O
was	VB	O
isolated).	IN	O
In	DT	O
one	NN	O
aspect,	VBZ	O
the	DT	O
probes	NN	O
comprise	VBG	O
oligonucleotides.	DT	O
In	JJ	O
one	JJ	O
aspect,	NN	O
the	IN	O
amplification	DT	O
reaction	NN	O
may	,	O
comprise	DT	O
a	NN	O
PCR	IN	O
reaction.	WDT	O
PCR	DT	O
protocols	NN	O
are	NN	O
described	VBD	O
in	.	O
Ausubel	IN	O
and	CD	O
Sambrook	,	O
(see	DT	O
discussion	NNS	O
on	NN	O
amplification	.	O
reactions).	IN	O
In	CD	O
such	,	O
procedures,	DT	O
the	NN	O
nucleic	NN	O
acids	MD	O
in	VB	O
the	DT	O
sample	NNP	O
are	.	O
contacted	NNP	O
with	NNS	O
the	VBP	O
probes,	VBN	O
the	IN	O
amplification	NNP	O
reaction	CC	O
is	NNP	O
performed,	VB	O
and	NN	O
any	IN	O
resulting	NN	O
amplification	.	O
product	IN	O
is	JJ	O
detected.	,	O
The	DT	O
amplification	JJ	O
product	NNS	O
may	IN	O
be	DT	O
detected	NN	O
by	VBP	O
performing	VBN	O
gel	IN	O
electrophoresis	DT	O
on	,	O
the	DT	O
reaction	NN	O
products	NN	O
and	VBZ	O
staining	,	O
the	CC	O
gel	DT	O
with	JJ	O
an	NN	O
intercalator	NN	O
such	VBZ	O
as	.	O
ethidium	DT	O
bromide.	NN	O
Alternatively,	NN	O
one	MD	O
or	VB	O
more	VBN	O
of	IN	O
the	VBG	O
probes	JJ	O
may	NN	O
be	IN	O
labeled	DT	O
with	NN	O
a	NNS	O
radioactive	CC	O
isotope	VBG	O
and	DT	O
the	NN	O
presence	IN	O
of	DT	O
a	NN	O
radioactive	JJ	O
amplification	IN	O
product	NN	O
may	.	O
be	,	O
detected	CD	O
by	CC	O
autoradiography	JJR	O
after	IN	O
gel	DT	O
electrophoresis.	NNS	O
Probes	MD	O
derived	VB	O
from	VBN	O
sequences	IN	O
near	DT	O
the	JJ	O
3′	NN	O
or	CC	O
5′	DT	O
ends	NN	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
of	MD	O
the	VB	O
invention	VBN	O
can	IN	O
also	NN	O
be	IN	O
used	JJ	O
in	.	O
chromosome	NNS	O
walking	VBN	O
procedures	IN	O
to	NNS	O
identify	IN	O
clones	DT	O
containing	CD	O
additional,	CC	O
e.g.,	CD	O
genomic	NNS	O
sequences.	IN	O
Such	DT	O
methods	JJ	O
allow	JJ	O
the	NN	O
isolation	IN	O
of	DT	O
genes	NN	O
which	MD	O
encode	RB	O
additional	VB	O
proteins	VBN	O
of	IN	O
interest	NN	O
from	NN	O
the	NNS	O
host	TO	O
organism.	VB	O
In	NNS	O
one	VBG	O
aspect,	,	O
nucleic	,	O
acid	JJ	O
sequences	.	O
of	JJ	O
the	NNS	O
invention	VBP	O
are	DT	O
used	NN	O
as	IN	O
probes	NNS	O
to	WDT	O
identify	VBP	O
and	JJ	O
isolate	NNS	O
related	IN	O
nucleic	NN	O
acids.	IN	O
In	DT	O
some	NN	O
aspects,	.	O
the	IN	O
so-identified	CD	O
related	,	O
nucleic	JJ	O
acids	NN	O
may	NNS	O
be	IN	O
cDNAs	DT	O
or	NN	O
genomic	VBP	O
DNAs	VBN	O
from	IN	O
organisms	NNS	O
other	TO	O
than	VB	O
the	CC	O
one	VB	O
from	VBN	O
which	JJ	O
the	.	O
nucleic	IN	O
acid	DT	O
of	,	O
the	DT	O
invention	JJ	O
was	JJ	O
first	JJ	O
isolated.	NNS	O
In	MD	O
such	VB	O
procedures,	NN	O
a	CC	O
nucleic	JJ	O
acid	NNP	O
sample	IN	O
is	IN	O
contacted	JJ	O
with	IN	O
the	DT	O
probe	CD	O
under	IN	O
conditions	WDT	O
which	DT	O
permit	NN	O
the	NN	O
probe	IN	O
to	DT	O
specifically	NN	O
hybridize	VBD	O
to	RB	O
related	.	O
sequences.	IN	O
Hybridization	JJ	O
of	,	O
the	DT	O
probe	JJ	O
to	NN	O
nucleic	NN	O
acids	VBZ	O
from	VBN	O
the	IN	O
related	DT	O
organism	NN	O
is	IN	O
then	NNS	O
detected	WDT	O
using	VBP	O
any	DT	O
of	NN	O
the	TO	O
methods	RB	O
described	VB	O
above.	TO	O
In	JJ	O
nucleic	.	O
acid	NN	O
hybridization	IN	O
reactions,	DT	O
the	NN	O
conditions	TO	O
used	JJ	O
to	NNS	O
achieve	IN	O
a	DT	O
particular	JJ	O
level	NN	O
of	VBZ	O
stringency	RB	O
can	VBN	O
vary,	VBG	O
depending	DT	O
on	IN	O
the	DT	O
nature	NNS	O
of	VBN	O
the	.	O
nucleic	IN	O
acids	JJ	O
being	JJ	O
hybridized.	NN	O
For	,	O
example,	DT	O
the	NNS	O
length,	VBD	O
degree	TO	O
of	VB	O
complementarity,	DT	O
nucleotide	JJ	O
sequence	NN	O
composition	IN	O
(e.g.,	NN	O
GC	MD	O
v.	,	O
AT	VBG	O
content),	IN	O
and	DT	O
nucleic	NN	O
acid	IN	O
type	DT	O
(e.g.,	JJ	O
RNA	NNS	O
v.	VBG	O
DNA)	.	O
of	IN	O
the	,	O
hybridizing	DT	O
regions	,	O
of	NN	O
the	IN	O
nucleic	,	O
acids	JJ	O
can	NN	O
be	NN	O
considered	,	O
in	NNP	O
selecting	NN	O
hybridization	NNP	O
conditions.	,	O
An	CC	O
additional	JJ	O
consideration	NN	O
is	NN	O
whether	,	O
one	NNP	O
of	NNP	O
the	)	O
nucleic	IN	O
acids	DT	O
is	VBG	O
immobilized,	NNS	O
for	IN	O
example,	DT	O
on	JJ	O
a	NNS	O
filter.	MD	O
Hybridization	VB	O
can	VBN	O
be	IN	O
carried	VBG	O
out	NN	O
under	.	O
conditions	DT	O
of	JJ	O
low	NN	O
stringency,	VBZ	O
moderate	IN	O
stringency	CD	O
or	IN	O
high	DT	O
stringency.	JJ	O
As	NNS	O
an	VBZ	O
example	,	O
of	IN	O
nucleic	,	O
acid	IN	O
hybridization,	DT	O
a	.	O
polymer	NN	O
membrane	MD	O
containing	VB	O
immobilized	VBN	O
denatured	RP	O
nucleic	IN	O
acids	NNS	O
is	IN	O
first	JJ	O
prehybridized	,	O
for	JJ	O
30	NN	O
minutes	CC	O
at	JJ	O
45°	.	O
C.	IN	O
in	DT	O
a	NN	O
solution	IN	O
consisting	JJ	O
of	JJ	O
0.9	,	O
M	DT	O
NaCl,	NN	O
50	NN	O
mM	VBG	O
NaH2PO4,	VBN	O
pH	JJ	O
7.0,	JJ	O
5.0	NNS	O
mM	VBZ	O
Na2EDTA,	JJ	O
0.5%	VBN	O
SDS,	IN	O
10×Denhardt's,	CD	O
and	NNS	O
0.5	IN	O
mg/ml	CD	O
polyriboadenylic	NNP	O
acid.	IN	O
Approximately	DT	O
2×107	NN	O
cpm	NN	O
(specific	IN	O
activity	CD	O
4-9×108	NNP	O
cpm/ug)	,	O
of	CD	O
32P	NN	O
end-labeled	,	O
oligonucleotide	NN	O
probe	,	O
can	CD	O
then	NN	O
added	,	O
to	NN	O
the	,	O
solution.	,	O
After	CC	O
12-16	CD	O
hours	NNS	O
of	JJ	O
incubation,	.	O
the	RB	O
membrane	CD	O
is	NN	O
washed	JJ	O
for	NN	O
30	JJ	O
minutes	)	O
at	IN	O
room	CD	O
temperature	JJ	O
(RT)	IN	O
in	NN	O
1×SET	MD	O
(150	RB	O
mM	VB	O
NaCl,	TO	O
20	DT	O
mM	.	O
Tris	IN	O
hydrochloride,	JJ	O
pH	NNS	O
7.8,	IN	O
1	,	O
mM	DT	O
Na2EDTA)	NN	O
containing	VBZ	O
0.5%	VBN	O
SDS,	IN	O
followed	CD	O
by	NNS	O
a	IN	O
30	NN	O
minute	NN	O
wash	)	O
in	IN	O
fresh	CD	O
1×SET	CD	O
at	NN	O
Tm	,	O
−10°	CD	O
C.	NN	O
for	NNP	O
the	,	O
oligonucleotide	NN	O
probe.	,	O
The	CD	O
membrane	NN	O
is	)	O
then	VBG	O
exposed	NN	O
to	,	O
auto-radiographic	VBN	O
film	IN	O
for	DT	O
detection	CD	O
of	NN	O
hybridization	NN	O
signals.	IN	O
By	JJ	O
varying	CD	O
the	IN	O
stringency	NNP	O
of	NNP	O
the	NNP	O
hybridization	IN	O
conditions	DT	O
used	JJ	O
to	.	O
identify	DT	O
nucleic	NN	O
acids,	VBZ	O
such	RB	O
as	VBN	O
cDNAs	TO	O
or	JJ	O
genomic	NN	O
DNAs,	IN	O
which	NN	O
hybridize	IN	O
to	NN	O
the	.	O
detectable	IN	O
probe,	VBG	O
nucleic	DT	O
acids	NN	O
having	IN	O
different	DT	O
levels	NN	O
of	NNS	O
homology	VBD	O
to	TO	O
the	VB	O
probe	JJ	O
can	,	O
be	JJ	O
identified	IN	O
and	NN	O
isolated.	CC	O
Stringency	JJ	O
may	,	O
be	WDT	O
varied	VBP	O
by	TO	O
conducting	DT	O
the	JJ	O
hybridization	,	O
at	JJ	O
varying	NNS	O
temperatures	VBG	O
below	JJ	O
the	NNS	O
melting	IN	O
temperatures	NN	O
of	TO	O
the	DT	O
probes.	NN	O
The	MD	O
melting	VB	O
temperature,	VBN	O
Tm,	CC	O
is	.	O
the	NN	O
temperature	MD	O
(under	VB	O
defined	VBN	O
ionic	IN	O
strength	VBG	O
and	DT	O
pH)	NN	O
at	IN	O
which	VBG	O
50%	NNS	O
of	IN	O
the	DT	O
target	VBG	O
sequence	NNS	O
hybridizes	IN	O
to	DT	O
a	.	O
perfectly	DT	O
complementary	NN	O
probe.	,	O
Very	,	O
stringent	VBZ	O
conditions	DT	O
are	NN	O
selected	IN	O
to	VBN	O
be	JJ	O
equal	NN	O
to	CC	O
or	)	O
about	IN	O
5°	WDT	O
C.	NN	O
lower	IN	O
than	DT	O
the	NN	O
Tm	NN	O
for	VBZ	O
a	TO	O
particular	DT	O
probe.	RB	O
The	JJ	O
melting	.	O
temperature	RB	O
of	JJ	O
the	NNS	O
probe	VBP	O
may	VBN	O
be	TO	O
calculated	VB	O
using	JJ	O
the	TO	O
following	CC	O
exemplary	IN	O
formulas.	CD	O
For	NNP	O
probes	JJR	O
between	IN	O
14	DT	O
and	NNP	O
70	IN	O
nucleotides	DT	O
in	JJ	O
length	.	O
the	DT	O
melting	JJ	O
temperature	NN	O
(Tm)	IN	O
is	DT	O
calculated	NN	O
using	MD	O
the	VB	O
formula:	VBN	O
Tm=81.5+16.6(log	VBG	O
[Na+])+0.41(fraction	DT	O
G+C)−(600/N)	JJ	O
where	JJ	O
N	.	O
is	IN	O
the	NNS	O
length	IN	O
of	CD	O
the	CC	O
probe.	CD	O
If	NNS	O
the	IN	O
hybridization	NN	O
is	DT	O
carried	NN	O
out	NN	O
in	)	O
a	VBZ	O
solution	VBN	O
containing	VBG	O
formamide,	DT	O
the	:	O
melting	JJ	O
temperature	NN	O
may	)	O
be	WRB	O
calculated	NNP	O
using	VBZ	O
the	DT	O
equation:	NN	O
Tm=81.5+16.6(log	IN	O
[Na+])+0.41(fraction	DT	O
G+C)−(0.63%	.	O
formamide)−(600/N)	IN	O
where	DT	O
N	NN	O
is	VBZ	O
the	VBN	O
length	RP	O
of	IN	O
the	DT	O
probe.	NN	O
Prehybridization	VBG	O
may	,	O
be	DT	O
carried	JJ	O
out	NN	O
in	MD	O
6×SSC,	VB	O
5×Denhardt's	VBN	O
reagent,	VBG	O
0.5%	DT	O
SDS,	:	O
100	JJ	O
μg	NN	O
denatured	NN	O
fragmented	)	O
salmon	WRB	O
sperm	NNP	O
DNA	VBZ	O
or	DT	O
6×SSC,	NN	O
5×Denhardt's	IN	O
reagent,	DT	O
0.5%	.	O
SDS,	NN	O
100	MD	O
μg	VB	O
denatured	VBN	O
fragmented	IN	O
salmon	IN	O
sperm	,	O
DNA,	POS	O
50%	,	O
formamide.	NN	O
Formulas	,	O
for	CD	O
SSC	NN	O
and	VBD	O
Denhardt's	JJ	O
and	JJ	O
other	NN	O
solutions	NNP	O
are	CC	O
listed,	,	O
e.g.,	POS	O
in	,	O
Sambrook.	NN	O
Hybridization	,	O
is	CD	O
conducted	NN	O
by	VBD	O
adding	JJ	O
the	JJ	O
detectable	NN	O
probe	,	O
to	NN	O
the	.	O
prehybridization	NNS	O
solutions	IN	O
listed	NNP	O
above.	CC	O
Where	POS	O
the	CC	O
probe	JJ	O
comprises	NNS	O
double	VBP	O
stranded	,	O
DNA,	,	O
it	IN	O
is	.	O
denatured	NN	O
before	VBZ	O
addition	VBN	O
to	IN	O
the	VBG	O
hybridization	DT	O
solution.	JJ	O
The	NN	O
filter	TO	O
is	DT	O
contacted	NN	O
with	NNS	O
the	VBN	O
hybridization	.	O
solution	WRB	O
for	DT	O
a	NN	O
sufficient	VBZ	O
period	RB	O
of	VBN	O
time	,	O
to	PRP	O
allow	VBZ	O
the	VBN	O
probe	IN	O
to	NN	O
hybridize	TO	O
to	DT	O
cDNAs	NN	O
or	.	O
genomic	DT	O
DNAs	NN	O
containing	VBZ	O
sequences	VBN	O
complementary	IN	O
thereto	DT	O
or	NN	O
homologous	NN	O
thereto.	IN	O
For	DT	O
probes	JJ	O
over	NN	O
200	IN	O
nucleotides	NN	O
in	TO	O
length,	VB	O
the	DT	O
hybridization	NN	O
may	TO	O
be	VB	O
carried	TO	O
out	VB	O
at	CC	O
15-25°	VB	O
C.	NNP	O
below	VBG	O
the	NNS	O
Tm.	JJ	O
For	NN	O
shorter	CC	O
probes,	JJ	O
such	.	O
as	IN	O
oligonucleotide	NNS	O
probes,	IN	O
the	CD	O
hybridization	NNS	O
may	IN	O
be	,	O
conducted	DT	O
at	NN	O
5-10°	MD	O
C.	VB	O
below	VBN	O
the	RP	O
Tm.	IN	O
In	JJ	O
one	NNP	O
aspect,	IN	O
hybridizations	DT	O
in	.	O
6×SSC	IN	O
are	JJR	O
conducted	,	O
at	JJ	O
approximately	IN	O
68°	JJ	O
C.	,	O
In	DT	O
one	NN	O
aspect,	MD	O
hybridizations	VB	O
in	VBN	O
50%	IN	O
formamide	JJ	O
containing	NNP	O
solutions	IN	O
are	DT	O
conducted	.	O
at	IN	O
approximately	CD	O
42°	,	O
C.	NNS	O
All	IN	O
of	CD	O
the	VBP	O
foregoing	VBN	O
hybridizations	IN	O
would	RB	O
be	CD	O
considered	NNP	O
to	IN	O
be	CD	O
under	,	O
conditions	NNS	O
of	IN	O
high	NN	O
stringency.	JJ	O
Following	NN	O
hybridization,	NNS	O
the	VBP	O
filter	VBN	O
is	IN	O
washed	RB	O
to	CD	O
remove	NNP	O
any	NNP	O
non-specifically	IN	O
bound	DT	O
detectable	NN	O
probe.	NNS	O
The	MD	O
stringency	VB	O
used	VBN	O
to	TO	O
wash	VB	O
the	IN	O
filters	NNS	O
can	IN	O
also	JJ	O
be	.	O
varied	VBG	O
depending	,	O
on	DT	O
the	NN	O
nature	VBZ	O
of	VBN	O
the	TO	O
nucleic	VB	O
acids	DT	O
being	RB	O
hybridized,	NN	O
the	JJ	O
length	.	O
of	DT	O
the	NN	O
nucleic	VBN	O
acids	TO	O
being	VB	O
hybridized,	DT	O
the	NNS	O
degree	MD	O
of	RB	O
complementarity,	VB	O
the	VBN	O
nucleotide	VBG	O
sequence	IN	O
composition	DT	O
(e.g.,	NN	O
GC	IN	O
v.	DT	O
AT	JJ	O
content),	NNS	O
and	VBG	O
the	,	O
nucleic	DT	O
acid	NN	O
type	IN	O
(e.g.,	DT	O
RNA	JJ	O
v.	NNS	O
DNA).	VBG	O
Examples	,	O
of	DT	O
progressively	NN	O
higher	IN	O
stringency	,	O
condition	DT	O
washes	JJ	O
are	NN	O
as	NN	O
follows:	,	O
2×SSC,	NNP	O
0.1%	NN	O
SDS	NNP	O
at	,	O
room	CC	O
temperature	DT	O
for	JJ	O
15	NN	O
minutes	NN	O
(low	,	O
stringency);	NNP	O
0.1×SSC,	NNP	O
0.5%	.	O
SDS	NNS	O
at	IN	O
room	RB	O
temperature	JJR	O
for	NN	O
30	NN	O
minutes	NNS	O
to	VBP	O
1	IN	O
hour	:	O
(moderate	,	O
stringency);	NN	O
0.1×SSC,	NNP	O
0.5%	IN	O
SDS	NN	O
for	NN	O
15	IN	O
to	CD	O
30	NNS	O
minutes	JJ	O
at	:	O
between	,	O
the	NN	O
hybridization	NNP	O
temperature	IN	O
and	NN	O
68°	NN	O
C.	IN	O
(high	CD	O
stringency);	NNS	O
and	TO	O
0.15M	CD	O
NaCl	NN	O
for	JJ	O
15	:	O
minutes	,	O
at	NN	O
72°	NNP	O
C.	IN	O
(very	CD	O
high	TO	O
stringency).	CD	O
A	NNS	O
final	IN	O
low	IN	O
stringency	DT	O
wash	NN	O
can	NN	O
be	CC	O
conducted	CD	O
in	NNP	O
0.1×SSC	JJ	O
at	:	O
room	CC	O
temperature.	CD	O
The	NNP	O
examples	IN	O
above	CD	O
are	NNS	O
merely	IN	O
illustrative	CD	O
of	NNP	O
one	RB	O
set	JJ	O
of	.	O
conditions	DT	O
that	JJ	O
can	JJ	O
be	NN	O
used	NN	O
to	MD	O
wash	VB	O
filters.	VBN	O
One	IN	O
of	CD	O
skill	IN	O
in	NN	O
the	.	O
art	DT	O
would	NNS	O
know	IN	O
that	VBP	O
there	RB	O
are	JJ	O
numerous	IN	O
recipes	CD	O
for	NN	O
different	IN	O
stringency	NNS	O
washes.	WDT	O
Nucleic	MD	O
acids	VB	O
which	VBN	O
have	TO	O
hybridized	VB	O
to	.	O
the	CD	O
probe	IN	O
can	NN	O
be	IN	O
identified	DT	O
by	NN	O
autoradiography	MD	O
or	VB	O
other	IN	O
conventional	EX	O
techniques.	VBP	O
The	JJ	O
above	NNS	O
procedure	IN	O
may	JJ	O
be	NN	O
modified	.	O
to	NNP	O
identify	NNS	O
nucleic	WDT	O
acids	VBP	O
having	VBN	O
decreasing	TO	O
levels	DT	O
of	NN	O
homology	MD	O
to	VB	O
the	VBN	O
probe	IN	O
sequence.	NN	O
For	CC	O
example,	JJ	O
to	JJ	O
obtain	.	O
nucleic	DT	O
acids	JJ	O
of	NN	O
decreasing	MD	O
homology	VB	O
to	VBN	O
the	TO	O
detectable	VB	O
probe,	JJ	O
less	NNS	O
stringent	VBG	O
conditions	VBG	O
may	NNS	O
be	IN	O
used.	NN	O
For	TO	O
example,	DT	O
the	NN	O
hybridization	.	O
temperature	IN	O
may	,	O
be	TO	O
decreased	VB	O
in	JJ	O
increments	NNS	O
of	IN	O
5°	VBG	O
C.	NN	O
from	TO	O
68°	DT	O
C.	JJ	O
to	,	O
42°	RBR	O
C.	JJ	O
in	NNS	O
a	MD	O
hybridization	VB	O
buffer	.	O
having	IN	O
a	,	O
Na+	DT	O
concentration	NN	O
of	NN	O
approximately	MD	O
1M.	VB	O
Following	VBN	O
hybridization,	IN	O
the	NNS	O
filter	IN	O
may	CD	O
be	NNP	O
washed	IN	O
with	CD	O
2×SSC,	NNP	O
0.5%	TO	O
SDS	CD	O
at	NNP	O
the	IN	O
temperature	DT	O
of	NN	O
hybridization.	NN	O
These	VBG	O
conditions	DT	O
are	NNP	O
considered	NN	O
to	IN	O
be	RB	O
“moderate”	.	O
conditions	VBG	O
above	,	O
50°	DT	O
C.	NN	O
and	MD	O
“low”	VB	O
conditions	VBN	O
below	IN	O
50°	,	O
C.	NN	O
An	NNP	O
example	IN	O
of	DT	O
“moderate”	NN	O
hybridization	IN	O
conditions	.	O
is	DT	O
when	NNS	O
the	VBP	O
above	VBN	O
hybridization	TO	O
is	VB	O
conducted	JJ	O
at	NNS	O
55°	IN	O
C.	CD	O
An	NNP	O
example	CC	O
of	NNP	O
“low	NNS	O
stringency”	IN	O
hybridization	CD	O
conditions	NNP	O
is	DT	O
when	NN	O
the	IN	O
above	JJ	O
hybridization	NN	O
is	NNS	O
conducted	VBZ	O
at	WRB	O
45°	DT	O
C.	JJ	O
Alternatively,	NN	O
the	VBZ	O
hybridization	VBN	O
may	IN	O
be	CD	O
carried	NNP	O
out	DT	O
in	NN	O
buffers,	IN	O
such	JJ	O
as	JJ	O
6×SSC,	NN	O
containing	NNS	O
formamide	VBZ	O
at	WRB	O
a	DT	O
temperature	JJ	O
of	NN	O
42°	VBZ	O
C.	VBN	O
In	IN	O
this	CD	O
case,	NNP	O
the	,	O
concentration	DT	O
of	NN	O
formamide	MD	O
in	VB	O
the	VBN	O
hybridization	RP	O
buffer	IN	O
may	,	O
be	JJ	O
reduced	IN	O
in	,	O
5%	VBG	O
increments	NN	O
from	IN	O
50%	DT	O
to	NN	O
0%	IN	O
to	CD	O
identify	NNP	O
clones	IN	O
having	DT	O
decreasing	,	O
levels	DT	O
of	NN	O
homology	IN	O
to	NN	O
the	IN	O
probe.	DT	O
Following	NN	O
hybridization,	NN	O
the	MD	O
filter	VB	O
may	VBN	O
be	IN	O
washed	NN	O
with	NNS	O
6×SSC,	IN	O
0.5%	NN	O
SDS	TO	O
at	NN	O
50°	TO	O
C.	VB	O
These	NNS	O
conditions	VBG	O
are	VBG	O
considered	NNS	O
to	IN	O
be	NN	O
“moderate”	TO	O
conditions	DT	O
above	.	O
25%	VBG	O
formamide	,	O
and	DT	O
“low”	NN	O
conditions	MD	O
below	VB	O
25%	VBN	O
formamide.	IN	O
A	,	O
specific	NN	O
example	NNP	O
of	IN	O
“moderate”	CD	O
hybridization	NNP	O
conditions	DT	O
is	NNS	O
when	VBP	O
the	VBN	O
above	TO	O
hybridization	VB	O
is	JJ	O
conducted	NNS	O
at	IN	O
30%	NN	O
formamide.	NN	O
A	CC	O
specific	JJ	O
example	NNS	O
of	IN	O
“low	NN	O
stringency”	.	O
hybridization	DT	O
conditions	JJ	O
is	NN	O
when	IN	O
the	JJ	O
above	NN	O
hybridization	NNS	O
is	VBZ	O
conducted	WRB	O
at	DT	O
10%	JJ	O
formamide.	NN	O
These	VBZ	O
probes	VBN	O
and	IN	O
methods	NN	O
of	.	O
the	DT	O
invention	JJ	O
can	NN	O
be	IN	O
used	JJ	O
to	JJ	O
isolate	NN	O
nucleic	NNS	O
acids	VBZ	O
having	WRB	O
a	DT	O
sequence	JJ	O
with	NN	O
at	VBZ	O
least	VBN	O
about	IN	O
50%,	NN	O
51%,	.	O
52%,	DT	O
53%,	NNS	O
54%,	CC	O
55%,	NNS	O
56%,	IN	O
57%,	DT	O
58%,	NN	O
59%,	MD	O
60%,	VB	O
61%,	VBN	O
62%,	TO	O
63%,	VB	O
64%,	JJ	O
65%,	NNS	O
66%,	VBG	O
67%,	DT	O
68%,	NN	O
69%,	IN	O
70%,	IN	O
71%,	JJS	O
72%,	IN	O
73%,	,	O
74%,	,	O
75%,	,	O
76%,	,	O
77%,	,	O
78%,	,	O
79%,	,	O
80%,	,	O
81%,	,	O
82%,	,	O
83%,	,	O
84%,	,	O
85%,	,	O
86%,	,	O
87%,	,	O
88%,	,	O
89%,	,	O
90%,	,	O
91%,	,	O
92%,	,	O
93%,	,	O
94%,	,	O
95%,	,	O
96%,	,	O
97%,	,	O
98%,	,	O
99%	,	O
homology	,	O
to	,	O
a	,	O
nucleic	,	O
acid	,	O
sequence	,	O
of	,	O
the	,	O
invention	,	O
comprising	,	O
at	,	O
least	,	O
about	,	O
10,	,	O
15,	,	O
20,	,	O
25,	,	O
30,	,	O
35,	,	O
40,	,	O
50,	,	O
75,	,	O
100,	NN	O
150,	NN	O
200,	TO	O
250,	DT	O
300,	JJ	O
350,	JJ	O
400,	NN	O
500,	IN	O
550,	DT	O
600,	NN	O
650,	VBG	O
700,	IN	O
750,	JJS	O
800,	IN	O
850,	,	O
900,	,	O
950,	,	O
1000,	,	O
or	,	O
more	,	O
consecutive	,	O
bases	,	O
thereof,	,	O
and	,	O
the	,	O
sequences	,	O
complementary	,	O
thereto.	,	O
Homology	,	O
may	,	O
be	,	O
measured	,	O
using	,	O
an	,	O
alignment	,	O
algorithm,	,	O
as	,	O
discussed	,	O
herein.	,	O
For	,	O
example,	,	O
the	CC	O
homologous	RBR	O
polynucleotides	JJ	O
may	NNS	O
have	,	O
a	CC	O
coding	DT	O
sequence	NNS	O
which	JJ	O
is	.	O
a	NN	O
naturally	MD	O
occurring	VB	O
allelic	VBN	O
variant	VBG	O
of	DT	O
one	NN	O
of	,	O
the	IN	O
coding	VBN	O
sequences	.	O
described	IN	O
herein.	,	O
Such	DT	O
allelic	JJ	O
variants	NNS	O
may	MD	O
have	VB	O
a	DT	O
substitution,	NN	O
deletion	NN	O
or	WDT	O
addition	VBZ	O
of	DT	O
one	RB	O
or	VBG	O
more	JJ	O
nucleotides	NN	O
when	IN	O
compared	CD	O
to	IN	O
a	DT	O
nucleic	NN	O
acid	NNS	O
of	VBD	O
the	.	O
invention.	JJ	O
Additionally,	JJ	O
the	NNS	O
probes	MD	O
and	VB	O
methods	DT	O
of	,	O
the	NN	O
invention	CC	O
can	NN	O
be	IN	O
used	CD	O
to	CC	O
isolate	JJR	O
nucleic	NNS	O
acids	WRB	O
which	VBN	O
encode	TO	O
polypeptides	DT	O
having	JJ	O
at	NN	O
least	IN	O
about	DT	O
50%,	.	O
51%,	,	O
52%,	DT	O
53%,	NNS	O
54%,	CC	O
55%,	NNS	O
56%,	IN	O
57%,	DT	O
58%,	NN	O
59%,	MD	O
60%,	VB	O
61%,	VBN	O
62%,	TO	O
63%,	VB	O
64%,	JJ	O
65%,	NNS	O
66%,	WDT	O
67%,	VBP	O
68%,	NNS	O
69%,	VBG	O
70%,	IN	O
71%,	JJS	O
72%,	IN	O
73%,	,	O
74%,	,	O
75%,	,	O
76%,	,	O
77%,	,	O
78%,	,	O
79%,	,	O
80%,	,	O
81%,	,	O
82%,	,	O
83%,	,	O
84%,	,	O
85%,	,	O
86%,	,	O
87%,	,	O
88%,	,	O
89%,	,	O
90%,	,	O
91%,	,	O
92%,	,	O
93%,	,	O
94%,	,	O
95%,	,	O
96%,	,	O
97%,	,	O
98%,	,	O
99%	,	O
sequence	,	O
identity	,	O
(homology)	,	O
to	,	O
a	,	O
polypeptide	,	O
of	,	O
the	,	O
invention	,	O
comprising	,	O
at	,	O
least	,	O
5,	,	O
10,	,	O
15,	,	O
20,	,	O
25,	,	O
30,	,	O
35,	,	O
40,	,	O
50,	,	O
75,	,	O
100,	NN	O
or	NN	O
150	NN	O
consecutive	)	O
amino	TO	O
acids,	DT	O
as	NN	O
determined	IN	O
using	DT	O
a	NN	O
sequence	VBG	O
alignment	IN	O
algorithm	JJS	O
(e.g.,	,	O
such	,	O
as	,	O
the	,	O
FASTA	,	O
version	,	O
3.0t78	,	O
algorithm	,	O
with	,	O
the	,	O
default	,	O
parameters,	CC	O
or	CD	O
a	JJ	O
BLAST	NN	O
2.2.2	,	O
program	IN	O
with	VBN	O
exemplary	VBG	O
settings	DT	O
as	NN	O
set	NN	O
forth	NN	O
herein).	,	O
Inhibiting	JJ	O
Expression	IN	O
of	DT	O
Amylase	NNP	O
The	NN	O
invention	CD	O
provides	NN	O
nucleic	IN	O
acids	DT	O
complementary	NN	O
to	,	O
(e.g.,	CC	O
antisense	DT	O
sequences	JJ	O
to)	CD	O
the	NN	O
nucleic	IN	O
acid	JJ	O
sequences	NNS	O
of	IN	O
the	NN	O
invention.	NN	O
Antisense	.	O
sequences	VBG	O
are	NN	O
capable	IN	O
of	NNP	O
inhibiting	DT	O
the	NN	O
transport,	VBZ	O
splicing	JJ	O
or	NNS	O
transcription	JJ	O
of	TO	O
amylase-encoding	,	O
genes.	JJ	O
The	NNS	O
inhibition	)	O
can	DT	O
be	JJ	O
effected	NN	O
through	NNS	O
the	IN	O
targeting	DT	O
of	.	O
genomic	NNP	O
DNA	NNS	O
or	VBP	O
messenger	JJ	O
RNA.	IN	O
The	VBG	O
transcription	DT	O
or	,	O
function	VBG	O
of	CC	O
targeted	NN	O
nucleic	IN	O
acid	JJ	O
can	.	O
be	DT	O
inhibited,	NN	O
for	MD	O
example,	VB	O
by	VBN	O
hybridization	IN	O
and/or	DT	O
cleavage.	NN	O
One	IN	O
particularly	JJ	O
useful	NNP	O
set	CC	O
of	JJR	O
inhibitors	.	O
provided	DT	O
by	NN	O
the	CC	O
present	NN	O
invention	IN	O
includes	JJ	O
oligonucleotides	JJ	O
which	NN	O
are	MD	O
able	VB	O
to	,	O
either	IN	O
bind	,	O
amylase	IN	O
gene	NN	O
or	NN	O
message,	.	O
in	CD	O
either	RB	O
case	JJ	O
preventing	NN	O
or	IN	O
inhibiting	NNS	O
the	VBN	O
production	IN	O
or	DT	O
function	JJ	O
of	NN	O
amylase.	VBZ	O
The	IN	O
association	WDT	O
can	VBP	O
be	JJ	O
through	TO	O
sequence	DT	O
specific	NN	O
hybridization.	NN	O
Another	NN	O
useful	CC	O
class	,	O
of	IN	O
inhibitors	DT	O
includes	NN	O
oligonucleotides	VBG	O
which	CC	O
cause	VBG	O
inactivation	DT	O
or	NN	O
cleavage	CC	O
of	NN	O
amylase	IN	O
message.	.	O
The	DT	O
oligonucleotide	NN	O
can	MD	O
have	VB	O
enzyme	IN	O
activity	NN	O
which	JJ	O
causes	.	O
such	DT	O
cleavage,	JJ	O
such	NN	O
as	IN	O
ribozymes.	NNS	O
The	VBZ	O
oligonucleotide	NNS	O
can	WDT	O
be	VBP	O
chemically	NN	O
modified	CC	O
or	NN	O
conjugated	IN	O
to	JJ	O
an	.	O
enzyme	DT	O
or	NN	O
composition	MD	O
capable	VB	O
of	VBN	O
cleaving	NN	O
the	WDT	O
complementary	VBZ	O
nucleic	JJ	O
acid.	,	O
A	JJ	O
pool	IN	O
of	.	O
many	DT	O
different	NN	O
such	MD	O
oligonucleotides	VB	O
can	RB	O
be	VBN	O
screened	CC	O
for	VBN	O
those	TO	O
with	DT	O
the	NN	O
desired	CC	O
activity.	NN	O
Antisense	JJ	O
Oligonucleotides	IN	O
The	VBG	O
invention	DT	O
provides	JJ	O
antisense	NN	O
oligonucleotides	.	O
capable	DT	O
of	NN	O
binding	IN	O
amylase	JJ	O
message	JJ	O
which	JJ	O
can	NNS	O
inhibit	MD	O
proteolytic	VB	O
activity	VBN	O
by	IN	O
targeting	DT	O
mRNA.	IN	O
Strategies	DT	O
for	JJ	O
designing	.	O
antisense	NNP	O
oligonucleotides	VBZ	O
are	DT	O
well	NN	O
described	VBZ	O
in	JJ	O
the	NNS	O
scientific	JJ	O
and	IN	O
patent	VBG	O
literature,	NN	O
and	NN	O
the	WDT	O
skilled	MD	O
artisan	VB	O
can	JJ	O
design	NN	O
such	IN	O
amylase	VBG	O
oligonucleotides	.	O
using	NNS	O
the	IN	O
novel	VBG	O
reagents	NN	O
of	NNS	O
the	VBP	O
invention.	RB	O
For	VBN	O
example,	IN	O
gene	DT	O
walking/RNA	JJ	O
mapping	CC	O
protocols	JJ	O
to	,	O
screen	CC	O
for	DT	O
effective	JJ	O
antisense	NN	O
oligonucleotides	MD	O
are	VB	O
well	JJ	O
known	NN	O
in	NNS	O
the	VBG	O
art,	DT	O
see,	JJ	O
e.g.,	NNS	O
Ho	IN	B
(2000)	DT	I
Methods	.	I
Enzymol.	IN	I
314:168-183,	,	I
describing	NN	O
an	NN	O
RNA	NN	O
mapping	NNS	O
assay,	TO	O
which	VB	O
is	IN	O
based	JJ	O
on	NN	O
standard	NNS	O
molecular	VBP	O
techniques	RB	O
to	VBN	O
provide	IN	O
an	DT	O
easy	,	O
and	,	O
reliable	,	O
method	NNP	O
for	)	O
potent	NNP	O
antisense	.	O
sequence	,	O
selection.	VBG	O
See	DT	O
also	NNP	O
Smith	NN	B
(2000)	,	I
Eur.	WDT	I
J.	VBZ	I
Pharm.	VBN	I
Sci.	IN	I
11:191-198.
Naturally	JJ	O
occurring	NN	O
nucleic	NNS	O
acids	TO	O
are	VB	O
used	DT	O
as	JJ	O
antisense	CC	O
oligonucleotides.	JJ	O
The	NN	O
antisense	IN	O
oligonucleotides	JJ	O
can	JJ	O
be	NN	O
of	.	O
any	NNP	O
length;	RB	O
for	NNP	O
example,	)	O
in	.	O
alternative	NNP	O
aspects,	.	O
the	.	O
antisense	.	O
oligonucleotides	RB	O
are	VBG	O
between	JJ	O
about	NNS	O
5	VBP	O
to	VBN	O
100,	IN	O
about	JJ	O
10	.	O
to	DT	O
80,	NN	O
about	NNS	O
15	MD	O
to	VB	O
60,	IN	O
about	DT	O
18	:	O
to	IN	O
40.	,	O
The	IN	O
optimal	JJ	O
length	,	O
can	DT	O
be	NN	O
determined	NNS	O
by	VBP	O
routine	IN	O
screening.	RB	O
The	CD	O
antisense	TO	O
oligonucleotides	,	O
can	RB	O
be	CD	O
present	TO	O
at	,	O
any	RB	O
concentration.	CD	O
The	TO	O
optimal	,	O
concentration	RB	O
can	CD	O
be	TO	O
determined	.	O
by	DT	O
routine	JJ	O
screening.	NN	O
A	MD	O
wide	VB	O
variety	VBN	O
of	IN	O
synthetic,	JJ	O
non-naturally	.	O
occurring	DT	O
nucleotide	NN	O
and	NNS	O
nucleic	MD	O
acid	VB	O
analogues	JJ	O
are	IN	O
known	DT	O
which	.	O
can	DT	O
address	JJ	O
this	NN	O
potential	MD	O
problem.	VB	O
For	VBN	O
example,	IN	O
peptide	JJ	O
nucleic	.	O
acids	DT	O
(PNAs)	JJ	O
containing	NN	O
non-ionic	IN	O
backbones,	,	O
such	RB	O
as	VBG	O
N-(2-aminoethyl)glycine	NN	O
units	CC	O
can	JJ	O
be	NN	O
used.	NNS	O
Antisense	VBP	O
oligonucleotides	VBN	O
having	WDT	O
phosphorothioate	MD	O
linkages	VB	O
can	DT	O
also	JJ	O
be	.	O
used,	IN	O
as	,	O
described	RB	O
in	JJ	O
WO	NNS	O
97/03211;	)	O
WO	VBG	O
96/39154;	JJ	O
Mata	,	B
(1997)	JJ	I
Toxicol	IN	I
Appl	VBP	I
Pharmacol	NNS	I
144:189-197;	MD	I
Antisense	VB	B
Therapeutics,	.	I
ed.	NNP	I
Agrawal	VBZ	I
(Humana	VBG	I
Press,	JJ	I
Totowa,	NNS	I
N.J.,	MD	I
1996).	RB	I
Antisense	VB	O
oligonucleotides	,	O
having	IN	O
synthetic	VBN	O
DNA	IN	O
backbone	NNP	O
analogues	:	O
provided	NNP	O
by	:	O
the	NNP	O
invention	)	O
can	NNP	O
also	NNP	O
include	NNP	O
phosphoro-dithioate,	:	O
methylphosphonate,	NNP	O
phosphoramidate,	,	O
alkyl	.	O
phosphotriester,	NNP	O
sulfamate,	NNP	O
3′-thioacetal,	,	O
methylene(methylimino),	,	O
3′-N-carbamate,	,	O
and	.	O
morpholino	NNP	O
carbamate	VBZ	O
nucleic	VBG	O
acids,	JJ	O
as	NNP	O
described	NN	O
above.	NNS	O
Combinatorial	VBN	O
chemistry	IN	O
methodology	DT	O
can	NN	O
be	MD	O
used	RB	O
to	VB	O
create	,	O
vast	,	O
numbers	,	O
of	JJ	O
oligonucleotides	,	O
that	,	O
can	,	O
be	,	O
rapidly	,	O
screened	CC	O
for	NN	O
specific	NN	O
oligonucleotides	JJ	O
that	,	O
have	IN	O
appropriate	VBN	O
binding	.	O
affinities	JJ	O
and	NN	O
specificities	NN	O
toward	MD	O
any	VB	O
target,	VBN	O
such	TO	O
as	VB	O
the	JJ	O
sense	NNS	O
and	IN	O
antisense	NNS	O
amylase	WDT	O
sequences	MD	O
of	VB	O
the	RB	O
invention	VBN	O
(see,	IN	O
e.g.,	JJ	O
Gold	NNS	B
(1995)	WDT	I
J.	VBP	I
of	JJ	I
Biol.	NN	I
Chem.	NNS	I
270:13581-13584).Inhibitory	CC	O
Ribozymes	NNS	O
The	IN	O
invention	DT	O
provides	,	O
ribozymes	JJ	O
capable	IN	O
of	DT	O
binding	NN	O
amylase	CC	O
message.	JJ	O
These	NN	O
ribozymes	NNS	O
can	IN	O
inhibit	DT	O
amylase	NN	O
activity	,	O
by,	,	O
e.g.,	NNP	O
targeting	)	O
mRNA.	NNP	O
Strategies	IN	O
for	.	O
designing	.	O
ribozymes	.	O
and	NNP	O
selecting	NNP	O
the	DT	O
amylase-specific	NN	O
antisense	VBZ	O
sequence	NNS	O
for	JJ	O
targeting	IN	O
are	VBG	O
well	JJ	O
described	.	O
in	DT	O
the	NNS	O
scientific	MD	O
and	VB	O
patent	JJ	O
literature,	NN	O
and	,	O
the	,	O
skilled	VBG	O
artisan	.	O
can	NNS	O
design	IN	O
such	VBG	O
ribozymes	NNS	O
using	CC	O
the	VBG	O
novel	DT	O
reagents	JJ	O
of	NN	O
the	NN	O
invention.	IN	O
Ribozymes	VBG	O
act	VBP	O
by	RB	O
binding	VBN	O
to	IN	O
a	DT	O
target	JJ	O
RNA	CC	O
through	JJ	O
the	,	O
target	CC	O
RNA	DT	O
binding	JJ	O
portion	NN	O
of	MD	O
a	VB	O
ribozyme	JJ	O
which	NNS	O
is	VBG	O
held	DT	O
in	JJ	O
close	NNS	O
proximity	IN	O
to	DT	O
an	.	O
enzymatic	NNP	O
portion	NN	O
of	IN	O
the	VBG	O
RNA	TO	O
that	DT	O
cleaves	NN	O
the	NNP	O
target	IN	O
RNA.	DT	O
Thus,	NN	O
the	NNP	O
ribozyme	VBG	O
recognizes	NN	O
and	IN	O
binds	DT	O
a	NN	O
target	WDT	O
RNA	VBZ	O
through	VBN	O
complementary	IN	O
base-pairing,	JJ	O
and	NN	O
once	TO	O
bound	DT	O
to	JJ	O
the	NN	O
correct	IN	O
site,	DT	O
acts	NNP	O
enzymatically	WDT	O
to	VBZ	O
cleave	DT	O
and	NN	O
inactivate	.	O
the	,	O
target	DT	O
RNA.	NN	O
Cleavage	VBZ	O
of	CC	O
a	VBZ	O
target	DT	O
RNA	NN	O
in	NNP	O
such	IN	O
a	JJ	O
manner	,	O
will	CC	O
destroy	RB	O
its	VBN	O
ability	TO	O
to	DT	O
direct	JJ	O
synthesis	,	O
of	VBZ	O
an	RB	O
encoded	TO	O
protein	VB	O
if	CC	O
the	VB	O
cleavage	DT	O
occurs	NN	O
in	.	O
the	NN	O
coding	IN	O
sequence.	DT	O
After	NN	O
a	NNP	O
ribozyme	IN	O
has	JJ	O
bound	DT	O
and	NN	O
cleaved	MD	O
its	VB	O
RNA	PRP$	O
target,	NN	O
it	TO	O
can	JJ	O
be	NN	O
released	IN	O
from	DT	O
that	JJ	O
RNA	NN	O
to	IN	O
bind	DT	O
and	NN	O
cleave	VBZ	O
new	IN	O
targets	DT	O
repeatedly.	NN	O
In	.	O
some	IN	O
circumstances,	DT	O
the	NN	O
enzymatic	VBZ	O
nature	VBN	O
of	CC	O
a	VBN	O
ribozyme	PRP$	O
can	NNP	O
be	,	O
advantageous	PRP	O
over	MD	O
other	VB	O
technologies,	VBN	O
such	IN	O
as	DT	O
antisense	NNP	O
technology	TO	O
(where	VB	O
a	CC	O
nucleic	VB	O
acid	JJ	O
molecule	NNS	O
simply	.	O
binds	IN	O
to	DT	O
a	,	O
nucleic	DT	O
acid	JJ	O
target	NN	O
to	IN	O
block	DT	O
its	NN	O
transcription,	MD	O
translation	VB	O
or	JJ	O
association	IN	O
with	JJ	O
another	,	O
molecule)	JJ	O
as	IN	O
the	JJ	O
effective	NN	O
concentration	WRB	O
of	DT	O
ribozyme	JJ	O
necessary	NN	O
to	NN	O
effect	RB	O
a	VBZ	O
therapeutic	TO	O
treatment	DT	O
can	JJ	O
be	NN	O
lower	NN	O
than	TO	O
that	VB	O
of	PRP$	O
an	,	O
antisense	NN	O
oligonucleotide.	CC	O
This	NN	O
potential	IN	O
advantage	DT	O
reflects	)	O
the	IN	O
ability	DT	O
of	JJ	O
the	NN	O
ribozyme	IN	O
to	JJ	O
act	JJ	O
enzymatically.	TO	O
Thus,	NN	O
a	DT	O
single	JJ	O
ribozyme	NN	O
molecule	MD	O
is	VB	O
able	JJR	O
to	IN	O
cleave	DT	O
many	IN	O
molecules	DT	O
of	JJ	O
target	.	O
RNA.	DT	O
In	JJ	O
addition,	NN	O
a	VBZ	O
ribozyme	DT	O
is	NN	O
typically	IN	O
a	DT	O
highly	NN	O
specific	TO	O
inhibitor,	VB	O
with	.	O
the	,	O
specificity	DT	O
of	JJ	O
inhibition	NN	O
depending	NN	O
not	VBZ	O
only	JJ	O
on	TO	O
the	VB	O
base	JJ	O
pairing	NNS	O
mechanism	IN	O
of	NN	O
binding,	.	O
but	IN	O
also	,	O
on	DT	O
the	NN	O
mechanism	VBZ	O
by	RB	O
which	DT	O
the	RB	O
molecule	JJ	O
inhibits	,	O
the	IN	O
expression	DT	O
of	NN	O
the	IN	O
RNA	NN	O
to	VBG	O
which	RB	O
it	RB	O
binds.	IN	O
That	DT	O
is,	NN	O
the	VBG	O
inhibition	NN	O
is	IN	O
caused	,	O
by	CC	O
cleavage	RB	O
of	IN	O
the	DT	O
RNA	NN	O
target	IN	O
and	WDT	O
so	DT	O
specificity	NN	O
is	VBZ	O
defined	DT	O
as	NN	O
the	IN	O
ratio	DT	O
of	NNP	O
the	TO	O
rate	WDT	O
of	PRP	O
cleavage	.	O
of	DT	O
the	,	O
targeted	DT	O
RNA	NN	O
over	VBZ	O
the	VBN	O
rate	IN	O
of	NN	O
cleavage	IN	O
of	DT	O
non-targeted	NNP	O
RNA.	NN	O
This	CC	O
cleavage	RB	O
mechanism	NN	O
is	VBZ	O
dependent	VBN	O
upon	IN	O
factors	DT	O
additional	NN	O
to	IN	O
those	DT	O
involved	NN	O
in	IN	O
base	NN	O
pairing.	IN	O
Thus,	DT	O
the	JJ	O
specificity	NNP	O
of	IN	O
action	DT	O
of	NN	O
a	IN	O
ribozyme	NN	O
can	IN	O
be	JJ	O
greater	.	O
than	DT	O
that	NN	O
of	NN	O
antisense	VBZ	O
oligonucleotide	JJ	O
binding	IN	O
the	NNS	O
same	JJ	O
RNA	TO	O
site.	DT	O
The	VBN	O
ribozyme	IN	O
of	NN	O
the	.	O
invention,	,	O
e.g.,	DT	O
an	NN	O
enzymatic	IN	O
ribozyme	NN	O
RNA	IN	O
molecule,	DT	O
can	NN	O
be	MD	O
formed	VB	O
in	JJR	O
a	IN	O
hammerhead	DT	O
motif,	IN	O
a	JJ	O
hairpin	IN	O
motif,	VBG	O
as	DT	O
a	JJ	O
hepatitis	NNP	O
delta	.	O
virus	DT	O
motif,	NN	O
a	IN	O
group	DT	O
I	,	O
intron	,	O
motif	DT	O
and/or	JJ	O
an	NN	O
RNaseP-like	NNP	O
RNA	,	O
in	MD	O
association	VB	O
with	VBN	O
an	IN	O
RNA	DT	O
guide	NN	O
sequence.	,	O
Examples	DT	O
of	NN	O
hammerhead	,	O
motifs	IN	O
are	DT	O
described	NN	O
by,	NN	O
e.g.,	NN	O
Rossi	,	B
(1992)	DT	I
Aids	NN	I
Research	PRP	I
and	VBP	I
Human	JJ	I
Retroviruses	IN	I
8:183;	DT	I
hairpin	JJ	O
motifs	NNP	O
by	IN	O
Hampel	NN	B
(1989)	IN	I
Biochemistry	DT	I
28:4929,	NNP	I
and	NN	O
Hampel	.	B
(1990)	NNS	I
Nuc.	IN	I
Acids	JJ	I
Res.	NNS	I
18:299;	VBP	I
the	VBN	O
hepatitis	,	O
delta	,	O
virus	NNP	O
motif	)	O
by	NNP	O
Perrotta	NNP	B
(1992)	CC	I
Biochemistry	NNP	I
31:16;	VBZ	I
the	:	O
RNaseP	VBN	O
motif	NNS	O
by	IN	O
Guerrier-Takada	NNP	B
(1983)	)	I
Cell	NNP	I
35:849;	,	I
and	CC	O
the	NNP	O
group	)	O
I	.	O
intron	NNP	O
by	.	O
Cech	:	O
U.S.	DT	O
Pat.	NN	O
No.	NN	O
4,987,071.	NN	O
The	NN	O
recitation	IN	O
of	NNP	O
these	)	O
specific	NNP	O
motifs	:	O
is	DT	O
not	NNP	O
intended	NN	O
to	IN	O
be	NNP	O
limiting.	)	O
Those	NNP	O
skilled	:	O
in	CC	O
the	DT	O
art	NN	O
will	PRP	O
recognize	VBP	O
that	IN	O
a	NNP	O
ribozyme	NNP	O
of	.	O
the	.	O
invention,	.	O
e.g.,	DT	O
an	NN	O
enzymatic	IN	O
RNA	DT	O
molecule	JJ	O
of	NNS	O
this	VBZ	O
invention,	RB	O
can	VBN	O
have	TO	O
a	VB	O
specific	.	O
substrate	DT	O
binding	VBN	O
site	IN	O
complementary	DT	O
to	NN	O
one	MD	O
or	VB	O
more	IN	O
of	DT	O
the	NN	O
target	IN	O
gene	DT	O
RNA	,	O
regions.	,	O
A	DT	O
ribozyme	JJ	O
of	NNP	O
the	NN	O
invention	IN	O
can	DT	O
have	,	O
a	MD	O
nucleotide	VB	O
sequence	DT	O
within	JJ	O
or	NN	O
surrounding	NN	O
that	NN	O
substrate	JJ	O
binding	TO	O
site	CD	O
which	CC	O
imparts	JJR	O
an	IN	O
RNA	DT	O
cleaving	NN	O
activity	NN	O
to	NNP	O
the	.	O
molecule.	DT	O
RNA	NN	O
Interference	IN	O
(RNAi)	DT	O
In	NN	O
one	MD	O
aspect,	VB	O
the	DT	O
invention	JJ	O
provides	NN	O
an	IN	O
RNA	CC	O
inhibitory	VBG	O
molecule,	IN	O
a	NN	O
so-called	NN	O
“RNAi”	NN	O
molecule,	WDT	O
comprising	VBZ	O
an	DT	O
amylase	NNP	O
sequence	NN	O
of	NN	O
the	TO	O
invention.	DT	O
The	.	O
RNAi	NNP	O
molecule	NNP	O
comprises	)	O
a	IN	O
double-stranded	CD	O
RNA	,	O
(dsRNA)	DT	O
molecule.	NN	O
The	VBZ	O
RNAi	DT	O
can	NNP	O
inhibit	NN	O
expression	,	O
of	DT	O
an	JJ	O
amylase	NN	O
gene.	,	O
In	VBG	O
one	DT	O
aspect,	JJ	O
the	NN	O
RNAi	IN	O
is	DT	O
about	.	O
15,	DT	O
16,	NNP	O
17,	NN	O
18,	VBZ	O
19,	DT	O
20,	JJ	O
21,	NNP	O
22,	)	O
23,	.	O
24,	DT	O
25	NNP	O
or	MD	O
more	VB	O
duplex	NN	O
nucleotides	IN	O
in	DT	O
length.	JJ	O
While	.	O
the	IN	O
invention	CD	O
is	,	O
not	DT	O
limited	NNP	O
by	VBZ	O
any	IN	O
particular	,	O
mechanism	,	O
of	,	O
action,	,	O
the	,	O
RNAi	,	O
can	,	O
enter	,	O
a	,	O
cell	,	O
and	CD	O
cause	CC	O
the	JJR	O
degradation	JJ	O
of	NNS	O
a	IN	O
single-stranded	.	O
RNA	IN	O
(ssRNA)	DT	O
of	NN	O
similar	VBZ	O
or	RB	O
identical	VBN	O
sequences,	IN	O
including	DT	O
endogenous	JJ	O
mRNAs.	NN	O
When	IN	O
a	,	O
cell	DT	O
is	NNP	O
exposed	MD	O
to	VB	O
double-stranded	DT	O
RNA	NN	O
(dsRNA),	CC	O
mRNA	VB	O
from	DT	O
the	NN	O
homologous	IN	O
gene	DT	O
is	JJ	O
selectively	NNP	O
degraded	)	O
by	IN	O
a	JJ	O
process	CC	O
called	JJ	O
RNA	,	O
interference	VBG	O
(RNAi).	JJ	O
A	.	O
possible	WRB	O
basic	DT	O
mechanism	NN	O
behind	VBZ	O
RNAi	VBN	O
is	TO	O
the	JJ	O
breaking	NNP	O
of	,	O
a	RB	O
double-stranded	IN	O
RNA	DT	O
(dsRNA)	JJ	O
matching	NN	O
a	VBZ	O
specific	RB	O
gene	VBN	O
sequence	IN	O
into	DT	O
short	NN	O
pieces	VBN	O
called	NNP	O
short	NN	O
interfering	.	O
RNA,	DT	O
which	JJ	O
trigger	JJ	O
the	NN	O
degradation	IN	O
of	NNP	O
mRNA	VBZ	O
that	DT	O
matches	NN	O
its	IN	O
sequence.	DT	O
In	JJ	O
one	NNP	O
aspect,	)	O
the	VBG	O
RNAi's	DT	O
of	JJ	O
the	NN	O
invention	NN	O
are	IN	O
used	JJ	O
in	NNS	O
gene-silencing	VBN	O
therapeutics,	JJ	O
see,	NN	O
e.g.,	,	O
Shuey	WDT	B
(2002)	VBZ	I
Drug	DT	I
Discov.	NN	I
Today	IN	I
7:1040-1046.	NN	I
In	WDT	O
one	VBZ	O
aspect,	PRP$	O
the	.	O
invention	IN	O
provides	CD	O
methods	,	O
to	DT	O
selectively	POS	O
degrade	IN	O
RNA	DT	O
using	NN	O
the	VBP	O
RNAi's	VBN	O
of	IN	O
the	JJ	O
invention.	,	O
The	,	O
process	,	O
may	NNP	O
be	)	O
practiced	NNP	O
in	.	O
vitro,	NN	O
ex	.	O
vivo	IN	O
or	CD	O
in	,	O
vivo.	DT	O
In	NN	O
one	VBZ	O
aspect,	NNS	O
the	TO	O
RNAi	RB	O
molecules	VB	O
of	NNP	O
the	VBG	O
invention	DT	O
can	POS	O
be	IN	O
used	DT	O
to	.	O
generate	DT	O
a	NN	O
loss-of-function	MD	O
mutation	VB	O
in	VBN	O
a	IN	O
cell,	,	O
an	FW	O
organ	FW	O
or	CC	O
an	IN	O
animal.	.	O
Methods	IN	O
for	CD	O
making	,	O
and	DT	O
using	NNP	O
RNAi	NNS	O
molecules	IN	O
for	DT	O
selectively	NN	O
degrade	MD	O
RNA	VB	O
are	VBN	O
well	TO	O
known	VB	O
in	DT	O
the	JJ	O
art,	NN	O
see,	IN	O
e.g.,	DT	O
U.S.	,	O
Pat.	DT	O
Nos.	NN	O
6,506,559;	CC	O
6,511,824;	DT	O
6,515,109;	.	O
6,489,127.	NNS	O
Modification	IN	O
of	VBG	O
Nucleic	CC	O
Acids	VBG	O
The	NNP	O
invention	NNS	O
provides	IN	O
methods	RB	O
of	JJ	O
generating	NNP	O
variants	VBP	O
of	RB	O
the	VBN	O
nucleic	IN	O
acids	DT	O
of	,	O
the	,	O
invention,	,	O
e.g.,	NNP	O
those	.	O
encoding	.	O
an	:	O
amylase.	:	O
These	:	O
methods	.	O
can	NN	O
be	IN	O
repeated	NNP	O
or	NNP	O
used	DT	O
in	NN	O
various	VBZ	O
combinations	NNS	O
to	IN	O
generate	VBG	O
amylases	NNS	O
having	IN	O
an	DT	O
altered	JJ	O
or	NNS	O
different	IN	O
activity	DT	O
or	,	O
an	,	O
altered	DT	O
or	VBG	O
different	DT	O
stability	.	O
from	DT	O
that	NNS	O
of	MD	O
an	VB	O
amylase	VBN	O
encoded	CC	O
by	VBN	O
the	IN	O
template	JJ	O
nucleic	NNS	O
acid.	TO	O
These	VB	O
methods	NNS	O
also	VBG	O
can	DT	O
be	JJ	O
repeated	CC	O
or	JJ	O
used	NN	O
in	CC	O
various	DT	O
combinations,	JJ	O
e.g.,	CC	O
to	JJ	O
generate	NN	O
variations	IN	O
in	DT	O
gene/message	IN	O
expression,	DT	O
message	NN	O
translation	VBN	O
or	IN	O
message	DT	O
stability.	NN	O
In	JJ	O
another	.	O
aspect,	DT	O
the	NNS	O
genetic	RB	O
composition	MD	O
of	VB	O
a	VBN	O
cell	CC	O
is	VBN	O
altered	IN	O
by,	JJ	O
e.g.,	,	O
modification	,	O
of	TO	O
a	VB	O
homologous	NNS	O
gene	IN	O
ex	NN	O
vivo,	,	O
followed	NN	O
by	NN	O
its	CC	O
reinsertion	NN	O
into	.	O
the	IN	O
cell.	DT	O
A	,	O
nucleic	DT	O
acid	JJ	O
of	NN	O
the	IN	O
invention	DT	O
can	NN	O
be	VBZ	O
altered	VBN	O
by	,	O
any	,	O
means.	NN	O
For	IN	O
example,	DT	O
random	JJ	O
or	NN	O
stochastic	NN	O
methods,	,	O
or,	VBN	O
non-stochastic,	IN	O
or	PRP$	O
“directed	NN	O
evolution,”	IN	O
methods,	DT	O
see,	.	O
e.g.,	DT	O
U.S.	JJ	O
Pat.	NN	O
No.	IN	O
6,361,974.	DT	O
Methods	NN	O
for	MD	O
random	VB	O
mutation	VBN	O
of	IN	O
genes	DT	O
are	.	O
well	IN	O
known	,	O
in	NN	O
the	CC	O
art,	JJ	O
see,	,	O
e.g.,	,	O
U.S.	,	O
Pat.	CC	O
No.	VBN	O
5,830,696.	NNP	O
For	,	O
example,	,	O
mutagens	,	O
can	NNP	O
be	.	O
used	.	O
to	.	O
randomly	NNS	O
mutate	IN	O
a	JJ	O
gene.	NN	O
Mutagens	IN	O
include,	NNS	O
e.g.,	VBP	O
ultraviolet	RB	O
light	VBN	O
or	IN	O
gamma	DT	O
irradiation,	,	O
or	,	O
a	,	O
chemical	NNP	O
mutagen,	.	O
e.g.,	.	O
mitomycin,	.	O
nitrous	IN	O
acid,	,	O
photoactivated	NNS	O
psoralens,	MD	O
alone	VB	O
or	VBN	O
in	TO	O
combination,	VB	O
to	VB	O
induce	DT	O
DNA	.	O
breaks	NNP	O
amenable	,	O
to	,	O
repair	JJ	O
by	NN	O
recombination.	CC	O
Other	JJ	O
chemical	,	O
mutagens	CC	O
include,	DT	O
for	NN	O
example,	,	O
sodium	,	O
bisulfite,	,	O
nitrous	JJ	O
acid,	,	O
hydroxylamine,	VBD	O
hydrazine	,	O
or	RB	O
formic	CC	O
acid.	IN	O
Other	,	O
mutagens	TO	O
are	VB	O
analogues	NNP	O
of	NNS	O
nucleotide	JJ	O
precursors,	TO	O
e.g.,	VB	O
nitrosoguanidine,	IN	O
5-bromouracil,	.	O
2-aminopurine,	JJ	O
or	NN	O
acridine.	NNS	O
These	,	O
agents	IN	O
can	,	O
be	NN	O
added	,	O
to	JJ	O
a	,	O
PCR	,	O
reaction	NN	O
in	CC	O
place	JJ	O
of	.	O
the	JJ	O
nucleotide	NNS	O
precursor	VBP	O
thereby	NNS	O
mutating	IN	O
the	JJ	O
sequence.	,	O
Intercalating	,	O
agents	,	O
such	,	O
as	,	O
proflavine,	CC	O
acriflavine,	.	O
quinacrine	DT	O
and	NNS	O
the	MD	O
like	VB	O
can	VBN	O
also	TO	O
be	DT	O
used.	NNP	O
Any	NN	O
technique	IN	O
in	NN	O
molecular	IN	O
biology	DT	O
can	NN	O
be	NN	O
used,	RB	O
e.g.,	VBG	O
random	DT	O
PCR	.	O
mutagenesis,	VBG	O
see,	NNS	O
e.g.,	JJ	O
Rice	IN	B
(1992)	,	I
Proc.	,	I
Natl.	NN	I
Acad.	CC	I
Sci.	DT	I
USA	JJ	I
89:5467-5471;	MD	I
or,	RB	O
combinatorial	VB	O
multiple	.	O
cassette	DT	O
mutagenesis,	NN	O
see,	IN	O
e.g.,	JJ	O
Crameri	NN	B
(1995)	MD	I
Biotechniques	VB	I
18:194-196.	,	I
Alternatively,	,	O
nucleic	JJ	O
acids,	NNP	O
e.g.,	,	O
genes,	,	O
can	,	O
be	NNP	O
reassembled	)	O
after	.	O
random,	.	O
or	.	O
“stochastic,”	.	O
fragmentation,	NNP	O
see,	:	O
e.g.,	,	O
U.S.	JJ	O
Pat.	NN	O
Nos.	NN	O
6,291,242;	,	O
6,287,862;	,	O
6,287,861;	,	O
5,955,358;	NNP	O
5,830,721;	)	O
5,824,514;	VBZ	O
5,811,238;	.	O
5,605,793.	,	O
In	JJ	O
alternative	,	O
aspects,	,	O
modifications,	,	O
additions	MD	O
or	VB	O
deletions	VBN	O
are	IN	O
introduced	,	O
by	CC	O
error-prone	JJ	O
PCR,	,	O
shuffling,	,	O
oligonucleotide-directed	,	O
mutagenesis,	NNP	O
assembly	.	O
PCR,	.	O
sexual	:	O
PCR	:	O
mutagenesis,	:	O
in	:	O
vivo	:	O
mutagenesis,	:	O
cassette	:	O
mutagenesis,	.	O
recursive	IN	O
ensemble	JJ	O
mutagenesis,	,	O
exponential	,	O
ensemble	NNS	O
mutagenesis,	CC	O
site-specific	NNS	O
mutagenesis,	VBP	O
gene	VBN	O
reassembly,	IN	O
gene	JJ	O
site	,	O
saturated	,	O
mutagenesis	JJ	O
(GSSM),	,	O
synthetic	RB	O
ligation	,	O
reassembly	JJ	O
(SLR),	NNP	O
recombination,	,	O
recursive	IN	O
sequence	JJ	O
recombination,	,	O
phosphothioate-modified	NN	O
DNA	,	O
mutagenesis,	JJ	O
uracil-containing	JJ	O
template	,	O
mutagenesis,	JJ	O
gapped	JJ	O
duplex	,	O
mutagenesis,	JJ	O
point	,	O
mismatch	NN	O
repair	,	O
mutagenesis,	NN	O
repair-deficient	NN	O
host	VBN	O
strain	NN	O
mutagenesis,	,	O
chemical	JJ	O
mutagenesis,	NN	O
radiogenic	RB	O
mutagenesis,	,	O
deletion	,	O
mutagenesis,	JJ	O
restriction-selection	NN	O
mutagenesis,	,	O
restriction-purification	JJ	O
mutagenesis,	NNP	O
artificial	,	O
gene	JJ	O
synthesis,	NN	O
ensemble	,	O
mutagenesis,	VBD	O
chimeric	JJ	O
nucleic	,	O
acid	NN	O
multimer	NN	O
creation,	NN	O
and/or	,	O
a	JJ	O
combination	NN	O
of	NN	O
these	,	O
and	JJ	O
other	,	O
methods.	JJ	O
The	,	O
following	NN	O
publications	,	O
describe	NN	O
a	,	O
variety	NN	O
of	,	O
recursive	JJ	O
recombination	NN	O
procedures	,	O
and/or	JJ	O
methods	,	O
which	JJ	O
can	NN	O
be	NN	O
incorporated	NN	O
into	,	O
the	VBZ	O
methods	DT	O
of	NN	O
the	IN	O
invention:	DT	O
Stemmer	CC	B
(1999)	JJ	I
“Molecular	.	I
breeding	DT	I
of	JJ	I
viruses	NNS	I
for	VBP	I
targeting	DT	I
and	NN	I
other	IN	I
clinical	JJ	I
properties”	NN	I
Tumor	NNS	I
Targeting	VBP	I
4:1-4;	NNS	I
Ness	WDT	B
(1999)	MD	I
Nature	VB	I
Biotechnology	VBN	I
17:893-896;	IN	I
Chang	DT	B
(1999)	NNS	I
“Evolution	IN	I
of	DT	I
a	:	I
cytokine	NNP	I
using	)	I
DNA	JJ	I
family	NN	I
shuffling”	IN	I
Nature	NNS	I
Biotechnology	IN	I
17:793-797;	VBG	I
Minshull	CC	B
(1999)	JJ	I
“Protein	JJ	I
evolution	NNS	I
by	NNP	I
molecular	NNP	I
breeding”	:	I
Current	NNP	I
Opinion	)	I
in	NNP	I
Chemical	NNP	I
Biology	:	I
3:284-290;	NNP	I
Christians	)	B
(1999)	NN	I
“Directed	IN	I
evolution	DT	I
of	NN	I
thymidine	VBG	I
kinase	NNP	I
for	NN	I
AZT	NN	I
phosphorylation	NNP	I
using	NNP	I
DNA	:	I
family	NNP	I
shuffling”	)	I
Nature	FW	I
Biotechnology	NN	I
17:259-264;	IN	I
Crameri	JJ	B
(1998)	NN	I
“DNA	NNP	I
shuffling	NNP	I
of	IN	I
a	NNP	I
family	NNP	I
of	:	I
genes	NNPS	I
from	)	I
diverse	VBD	I
species	NN	I
accelerates	IN	I
directed	JJ	I
evolution”	NN	I
Nature	IN	I
391:288-291;	NNP	I
Crameri	NN	B
(1997)	VBG	I
“Molecular	NNP	I
evolution	NN	I
of	NN	I
an	NNP	I
arsenate	NNP	I
detoxification	:	I
pathway	NNP	I
by	)	I
DNA	NN	I
shuffling,”	NN	I
Nature	IN	I
Biotechnology	DT	I
15:436-438;	NN	I
Zhang	IN	B
(1997)	NNS	I
“Directed	IN	I
evolution	JJ	I
of	NNS	I
an	VBZ	I
effective	JJ	I
fucosidase	JJ	I
from	NNP	I
a	:	I
galactosidase	NNP	I
by	)	I
DNA	JJ	I
shuffling	NN	I
and	IN	I
screening”	DT	I
Proc.	JJ	I
Natl.	NN	I
Acad.	NN	I
Sci.	IN	I
USA	NNP	I
94:4504-4509;	JJ	I
Patten	NNP	B
et	NNP	I
al.	:	I
(1997)	NNP	I
“Applications	)	I
of	VBD	I
DNA	NN	I
Shuffling	IN	I
to	DT	I
Pharmaceuticals	JJ	I
and	NN	I
Vaccines”	IN	I
Current	DT	I
Opinion	NN	I
in	IN	I
Biotechnology	NNP	I
8:724-733;	NN	I
Crameri	CC	B
et	NN	I
al.	.	I
(1996)	.	I
“Construction	.	I
and	.	I
evolution	NNP	I
of	:	I
antibody-phage	NNP	I
libraries	VBZ	I
by	.	I
DNA	)	I
shuffling”	NNS	I
Nature	IN	I
Medicine	NNP	I
2:100-103;	VBG	I
Gates	TO	B
et	NNP	I
al.	CC	I
(1996)	NNP	I
“Affinity	NNP	I
selective	NNP	I
isolation	IN	I
of	NNP	I
ligands	:	I
from	NNP	I
peptide	FW	I
libraries	.	I
through	)	I
display	NN	I
on	CC	I
a	NN	I
lac	IN	I
repressor	JJ	I
‘headpiece	NNS	I
dimer’”	IN	I
Journal	NNP	I
of	JJ	I
Molecular	NNP	I
Biology	NNP	I
255:373-386;	:	I
Stemmer	NNP	B
(1996)	VBP	I
“Sexual	.	I
PCR	)	I
and	NN	I
Assembly	JJ	I
PCR”	NN	I
In:	IN	I
The	NNS	I
Encyclopedia	IN	I
of	NN	I
Molecular	NNS	I
Biology.	IN	I
VCH	NN	I
Publishers,	IN	I
New	DT	I
York.	NN	I
pp.	NN	I
447-457;	NNP	I
Crameri	VBZ	B
and	NNP	I
Stemmer	IN	I
(1995)	NNP	I
“Combinatorial	NNP	I
multiple	:	I
cassette	NNP	I
mutagenesis	)	I
creates	JJ	I
all	NNP	I
the	CC	I
permutations	NNP	I
of	NNP	I
mutant	:	I
and	DT	I
wildtype	NNP	I
cassettes”	IN	I
BioTechniques	NNP	I
18:194-195;	.	I
Stemmer	NNP	B
et	,	I
al.	NNP	I
(1995)	.	I
“Single-step	.	I
assembly	:	I
of	NNP	I
a	CC	I
gene	NNP	I
and	)	I
entire	JJ	I
plasmid	JJ	I
form	NN	I
large	NN	I
numbers	VBZ	I
of	PDT	I
oligodeoxyribonucleotides”	DT	I
Gene,	NNS	I
164:49-53;	IN	I
Stemmer	NN	B
(1995)	CC	I
“The	NN	I
Evolution	NN	I
of	NNP	I
Molecular	:	I
Computation”	NNP	I
Science	FW	I
270:	.	I
1510;	)	I
Stemmer	NN	B
(1995)	NN	I
“Searching	IN	I
Sequence	DT	I
Space”	NN	I
Bio/Technology	CC	I
13:549-553;	JJ	I
Stemmer	NN	B
(1994)	NN	I
“Rapid	JJ	I
evolution	NNS	I
of	IN	I
a	JJ	I
protein	,	I
in	:	I
vitro	NNP	I
by	)	I
DNA	FW	I
shuffling”	NN	I
Nature	IN	I
370:389-391;	NNP	I
and	NNP	O
Stemmer	NNP	B
(1994)	:	I
“DNA	:	I
shuffling	NNP	I
by	)	I
random	VBG	I
fragmentation	NNP	I
and	NNP	I
reassembly:	NNP	I
In	:	I
vitro	NNP	I
recombination	)	I
for	JJ	I
molecular	NN	I
evolution.”	IN	I
Proc.	DT	I
Natl.	NN	I
Acad.	IN	I
Sci.	NN	I
USA	IN	I
91:10747-10751.
Mutational	NNP	O
methods	JJ	O
of	NNP	O
generating	:	O
diversity	CC	O
include,	NNP	O
for	)	O
example,	NN	O
site-directed	VBG	O
mutagenesis	IN	O
Ling	JJ	B
et	NN	I
al.	CC	I
(1997)	:	I
“Approaches	IN	I
to	NN	I
DNA	NN	I
mutagenesis:	IN	I
an	JJ	I
overview”	NN	I
Anal	.	I
Biochem.	.	I
254(2):	.	I
157-178;	.	I
Dale	NNP	B
et	.	I
al.	NNP	I
(1996)	NNS	I
“Oligonucleotide-directed	IN	I
random	VBG	I
mutagenesis	NN	I
using	,	I
the	IN	I
phosphorothioate	,	I
method”	JJ	I
Methods	NN	I
Mol.	VBG	I
Biol.	RB	I
57:369-374;	.	I
Smith	)	B
(1985)	VBZ	I
“In	TO	I
vitro	VB	I
mutagenesis”	:	I
Ann.	DT	I
Rev.	JJ	I
Genet.	NNP	I
19:423-462;	.	I
Botstein	:	B
&	:	I
Shortle	NNP	I
(1985)	FW	I
“Strategies	.	I
and	)	I
applications	JJ	I
of	JJ	I
in	NN	I
vitro	VBG	I
mutagenesis”	DT	I
Science	NN	I
229:1193-1201;	NN	I
Carter	NNP	B
(1986)	.	I
“Site-directed	.	I
mutagenesis”	:	I
Biochem.	NNP	I
J.	)	I
237:1-7;	FW	I
(and	FW	O
Kunkel	FW	B
(1987)	.	I
“The	.	I
efficiency	.	I
of	:	I
oligonucleotide	NNP	I
directed	CC	I
mutagenesis”	NNP	I
in	)	I
Nucleic	NNS	I
Acids	CC	I
&	NNS	I
Molecular	IN	I
Biology	IN	I
(Eckstein,	NN	I
F.	NN	I
and	NNP	I
Lilley,	:	I
D.	NNP	I
M.	)	I
J.	JJ	I
eds.,	NN	I
Springer	.	I
Verlag,	.	I
Berlin));mutagenesis	:	O
using	CC	O
uracil	NNP	O
containing	)	O
templates	FW	O
Kunkel	NN	B
(1985)	IN	I
“Rapid	NN	I
and	VBN	I
efficient	NN	I
site-specific	IN	I
mutagenesis	NNP	I
without	NNP	I
phenotypic	CC	I
selection”	NNP	I
Proc.	NNP	I
Natl.	,	I
Acad.	NNP	I
Sci.	CC	I
USA	,	I
82:488-492;	NNP	I
Kunkel	NNP	B
et	.	I
al.	,	I
(1987)	NNP	I
“Rapid	,	I
and	:	I
efficient	NN	I
site-specific	VBG	I
mutagenesis	JJ	I
without	VBG	I
phenotypic	NNS	I
selection”	NNP	I
Methods	)	I
in	FW	I
Enzymol.	CC	I
154,	JJ	I
367-382;	JJ	I
(and	NN	O
Bass	IN	B
et	NN	I
al.	NN	I
(1988)	.	I
“Mutant	.	I
Tip	.	I
repressors	.	I
with	NNP	I
new	:	I
DNA-binding	NNP	I
specificities”	FW	I
Science	.	I
242:240-245);oligonucleotide-directed	)	O
mutagenesis	FW	O
Methods	CC	B
in	JJ	I
Enzymol.	JJ	I
100:	NN	I
468-500	IN	I
(1983);	NN	I
Methods	NN	B
in	NNP	I
Enzymol.	IN	I
154:	.	I
329-350	,	I
(1987);	:	I
Zoller	CC	B
&	NNP	I
Smith	VBP	I
(1982)	.	I
“Oligonucleotide-directed	)	I
mutagenesis	VBP	I
using	NNP	I
M13-derived	NNS	I
vectors:	IN	I
an	JJ	I
efficient	NNP	I
and	NN	I
general	NNP	I
procedure	:	I
for	JJ	I
the	NN	I
production	NNP	I
of	IN	I
point	.	I
mutations	:	I
in	CD	I
any	:	I
DNA	NNS	I
fragment”	IN	I
Nucleic	.	I
Acids	:	I
Res.	CD	I
10:6487-6500;	:	I
Zoller	NNP	B
&	CC	I
Smith	NNP	I
(1983)	)	I
“Oligonucleotide-directed	JJ	I
mutagenesis	NN	I
of	VBG	I
DNA	JJ	I
fragments	:	I
cloned	DT	I
into	NN	I
M13	CC	I
vectors”	JJ	I
Methods	NN	I
in	IN	I
Enzymol.	DT	I
100:468-500;	NN	I
(and	IN	O
Zoller	NN	B
&	NNS	I
Smith	IN	I
(1987)	DT	I
Oligonucleotide-directed	NNP	I
mutagenesis:	NN	I
a	NNP	I
simple	NNP	I
method	.	I
using	:	I
two	NNP	I
oligonucleotide	CC	I
primers	NNP	I
and	)	I
a	JJ	I
single-stranded	NN	I
DNA	IN	I
template”	NN	I
Methods	NNS	I
in	VBD	I
Enzymol.	IN	I
154:329-350);	NNP	I
phosphorothioate-modified	FW	O
DNA	NNP	O
mutagenesis	IN	O
Taylor	.	B
et	:	I
al.	CC	I
(1985)	NNP	I
“The	CC	I
use	NNP	I
of	)	I
phosphorothioate-modified	JJ	I
DNA	:	I
in	DT	I
restriction	JJ	I
enzyme	NN	I
reactions	VBG	I
to	CD	I
prepare	JJ	I
nicked	NNS	I
DNA”	CC	I
Nucl.	DT	I
Acids	JJ	I
Res.	NNP	I
13:	NN	I
8749-8764;	NNP	I
Taylor	IN	B
et	.	I
al.	:	I
(1985)	JJ	I
“The	NNP	I
rapid	NN	I
generation	NNP	I
of	RB	I
oligonucleotide-directed	.	I
mutations	)	I
at	NN	I
high	NN	I
frequency	IN	I
using	JJ	I
phosphorothioate-modified	NNP	I
DNA”	IN	I
Nucl.	NN	I
Acids	NN	I
Res.	NNS	I
13:	TO	I
8765-8787	VB	I
(1985);	JJ	I
Nakamaye	NNP	B
(1986)	.	I
“Inhibition	NNP	I
of	.	I
restriction	:	I
endonuclease	:	I
Nci	NNP	I
I	FW	I
cleavage	.	I
by	)	I
phosphorothioate	FW	I
groups	JJ	I
and	NN	I
its	IN	I
application	JJ	I
to	NNS	I
oligonucleotide-directed	IN	I
mutagenesis”	JJ	I
Nucl.	NN	I
Acids	VBG	I
Res.	JJ	I
14:	NNP	I
9679-9698;	.	I
Sayers	NNP	B
et	.	I
al.	:	I
(1988)	CD	I
“Y-T	:	I
Exonucleases	NNP	I
in	)	I
phosphorothioate-based	NN	I
oligonucleotide-directed	IN	I
mutagenesis”	NN	I
Nucl.	NN	I
Acids	NNP	I
Res.	PRP	I
16:791-802;	VBP	I
(and	IN	O
Sayers	NN	B
et	NNS	I
al.	CC	I
(1988)	PRP$	I
“Strand	NN	I
specific	TO	I
cleavage	JJ	I
of	NN	I
phosphorothioate-containing	.	I
DNA	NNP	I
by	.	I
reaction	:	I
with	:	I
restriction	NNP	I
endonucleases	VBP	I
in	.	I
the	)	I
presence	NN	I
of	NNS	I
ethidium	IN	I
bromide”	JJ	I
Nucl.	JJ	I
Acids	NN	I
Res.	.	I
16:	NNP	I
803-814);mutagenesis	.	O
using	:	O
gapped	CC	O
duplex	NNP	O
DNA	VBP	O
Kramer	.	B
et	)	I
al.	VBP	I
(1984)	JJ	I
“The	NN	I
gapped	IN	I
duplex	JJ	I
DNA	NN	I
approach	IN	I
to	NN	I
oligonucleotide-directed	IN	I
mutation	NN	I
construction”	NNS	I
Nucl.	IN	I
Acids	DT	I
Res.	NN	I
12:	IN	I
9441-9456;	NN	I
Kramer	NN	B
&	.	I
Fritz	NNP	I
(1987)	.	I
Methods	:	I
in	:	I
Enzymol.	NN	I
“Oligonucleotide-directed	VBG	I
construction	VBD	I
of	JJ	I
mutations	NNP	I
via	NNP	I
gapped	RB	I
duplex	.	I
DNA”	)	I
154:350-367;	NN	I
Kramer	VBD	B
et	JJ	I
al.	NNP	I
(1988)	NN	I
“Improved	TO	I
enzymatic	JJ	I
in	NN	I
vitro	NN	I
reactions	.	I
in	NNP	I
the	.	I
gapped	:	I
duplex	:	I
DNA	NNP	I
approach	CC	I
to	NNP	I
oligonucleotide-directed	)	I
construction	NNS	I
of	IN	I
mutations”	.	I
Nucl.	JJ	I
Acids	NN	I
Res.	IN	I
16:	NNS	I
7207;	IN	I
(and	JJ	O
Fritz	JJ	B
et	NNP	I
al.	:	I
(1988)	NNP	I
“Oligonucleotide-directed	FW	I
construction	.	I
of	)	I
mutations:	VBD	I
a	JJ	I
gapped	IN	I
duplex	JJ	I
DNA	NNS	I
procedure	IN	I
without	DT	I
enzymatic	JJ	I
reactions	NN	I
in	NNP	I
vitro”	NN	I
Nucl.	TO	I
Acids	JJ	I
Res.	NN	I
16:	IN	I
6987-6999).Additional	NN	O
protocols	.	O
that	NNP	O
can	.	O
be	:	O
used	:	O
to	CC	O
practice	NNP	O
the	VBP	O
invention	.	O
include	)	O
point	JJ	O
mismatch	NN	O
repair	IN	O
Kramer	:	B
(1984)	DT	I
“Point	JJ	I
Mismatch	NN	I
Repair”	NNP	I
Cell	NN	I
38:879-887),(	IN	O
mutagenesis	JJ	O
using	NNS	O
repair-deficient	IN	O
host	NN	O
strains	.	O
Carter	NNP	B
et	.	I
al.	:	I
(1985)	.	I
“Improved	NNP	I
oligonucleotide	NNS	I
site-directed	WDT	I
mutagenesis	MD	I
using	VB	I
M13	VBN	I
vectors”	TO	I
Nucl.	NN	I
Acids	DT	I
Res.	NN	I
13:	VBP	I
4431-4443;	NN	I
(and	NN	O
Carter	NN	B
(1987)	NNP	I
“Improved	)	I
oligonucleotide-directed	NN	I
mutagenesis	NNP	I
using	NNP	I
M13	NNP	I
vectors”	,	I
Methods	NN	I
in	VBG	I
Enzymol.	JJ	I
154:	NN	I
382-403),deletion	NNS	O
mutagenesis	NNP	O
Eghtedarzadeh	RB	B
(1986)	.	I
“Use	)	I
of	VBD	I
oligonucleotides	JJ	I
to	JJ	I
generate	NN	I
large	VBG	I
deletions”	NNP	I
Nucl.	NN	I
Acids	.	I
Res.	NNP	I
14:	.	I
5115),(	:	O
restriction-selection	:	O
and	CC	O
restriction-selection	NNP	O
and	)	O
restriction-purification	VBD	O
Wells	JJ	B
et	NN	I
al.	VBG	I
(1986)	NNP	I
“Importance	NN	I
of	NNP	I
hydrogen-bond	IN	I
formation	.	I
in	:	I
stabilizing	,	I
the	NN	I
transition	NN	I
state	NNP	I
of	)	I
subtilisin”	NN	I
Phil.	IN	I
Trans.	NNS	I
R.	TO	I
Soc.	VB	I
Lond.	JJ	I
A	NN	I
317:	.	I
415-423),(	NNP	O
mutagenesis	.	O
by	:	O
total	,	O
gene	JJ	O
synthesis	CC	O
Nambiar	NN	B
et	CC	I
al.	NN	I
(1984)	NNP	I
“Total	VBZ	I
synthesis	.	I
and	)	I
cloning	NN	I
of	IN	I
a	JJ	I
gene	NN	I
coding	IN	I
for	VBG	I
the	DT	I
ribonuclease	NN	I
S	NN	I
protein”	IN	I
Science	NN	I
223:	.	I
1299-1301;	.	I
Sakamar	NNP	B
and	.	I
Khorana	.	I
(1988)	DT	I
“Total	:	I
synthesis	,	I
and	NN	I
expression	IN	I
of	JJ	I
a	NN	I
gene	NN	I
for	NNP	I
the	RB	I
a-subunit	.	I
of	)	I
bovine	JJ	I
rod	NN	I
outer	CC	I
segment	NN	I
guanine	IN	I
nucleotide-binding	DT	I
protein	NN	I
(transducin)”	VBG	I
Nucl.	IN	I
Acids	DT	I
Res.	NN	I
14:	NNP	I
6361-6372;	NN	I
Wells	NNP	B
et	:	I
al.	:	I
(1985)	NNP	I
“Cassette	CC	I
mutagenesis:	NNP	I
an	)	I
efficient	JJ	I
method	NN	I
for	CC	I
generation	NN	I
of	IN	I
multiple	DT	I
mutations	NN	I
at	IN	I
defined	DT	I
sites”	NN	I
Gene	IN	I
34:315-323;	NN	I
(and	NN	O
Grundstrom	NN	B
et	NN	I
al.	NN	I
(1985)	JJ	I
“Oligonucleotide-directed	NN	I
mutagenesis	NN	I
by	.	I
microscale	NNP	I
‘shot-gun’	.	I
gene	:	I
synthesis”	:	I
Nucl.	NNP	I
Acids	VBZ	I
Res.	.	I
13:	)	I
3305-3316),double-strand	NN	O
break	:	O
repair	DT	O
Mandecki	JJ	B
(1986);	NN	I
Arnold	IN	I
(1993)	NN	I
“Protein	IN	I
engineering	JJ	I
for	NNS	I
unusual	IN	I
environments”	VBN	I
Current	JJ	I
Opinion	NNP	I
in	:	I
Biotechnology	CC	I
4:450-455.	NNP	I
“Oligonucleotide-directed	VBP	B
double-strand	.	I
break	)	I
repair	JJ	I
in	NN	I
plasmids	IN	I
of	JJ	I
Escherichia	JJ	I
coli:	NN	I
a	NN	I
method	.	I
for	NNP	I
site-specific	.	I
mutagenesis”	:	I
Proc.	,	I
Natl.	JJ	I
Acad.	NN	I
Sci.	NN	I
USA,	NNP	I
83:7177-7181).(	:	O
Additional	NNP	O
details	)	O
on	FW	O
many	NN	O
of	IN	O
the	JJ	O
above	JJ	O
methods	NNP	O
can	NNP	O
be	IN	O
found	NNP	O
in	.	O
Methods	JJ	O
in	JJ	O
Enzymology	NN	O
Volume	NN	O
154,	IN	O
which	NNS	O
also	IN	O
describes	NNP	O
useful	:	O
controls	DT	O
for	NN	O
trouble-shooting	IN	O
problems	JJ	O
with	NN	O
various	.	O
mutagenesis	.	O
methods.	.	O
Protocols	.	O
that	,	O
can	.	O
be	NNP	O
used	NNS	O
to	IN	O
practice	JJ	O
the	IN	O
invention	DT	O
are	JJ	O
described,	NNS	O
e.g.,	MD	O
in	VB	O
U.S.	VBN	O
Pat.	IN	O
No.	NNP	O
5,605,793	IN	O
to	NNP	O
Stemmer	NN	O
(Feb.	,	O
25,	WDT	O
1997),	RB	O
“Methods	VBZ	O
for	JJ	O
In	NNS	O
Vitro	IN	O
Recombination;”	JJ	O
U.S.	NNS	O
Pat.	IN	O
No.	JJ	O
5,811,238	NN	O
to	.	O
Stemmer	NNS	O
et	WDT	O
al.	MD	O
(Sep.	VB	O
22,	VBN	O
1998)	TO	O
“Methods	NN	O
for	DT	O
Generating	NN	O
Polynucleotides	VBP	O
having	,	O
Desired	,	O
Characteristics	IN	O
by	NNP	O
Iterative	.	O
Selection	.	O
and	CD	O
Recombination;”	TO	O
U.S.	NNP	O
Pat.	NNP	O
No.	,	O
5,830,721	,	O
to	NNS	O
Stemmer	IN	O
et	IN	O
al.	NNP	O
(Nov.	NNP	O
3,	NNP	O
1998),	.	O
“DNA	.	O
Mutagenesis	CD	O
by	TO	O
Random	NNP	O
Fragmentation	FW	O
and	.	O
Reassembly;”	NNP	O
U.S.	,	O
Pat.	)	O
No.	NNS	O
5,834,252	IN	O
to	VBG	O
Stemmer,	NNP	O
et	VBG	O
al.	VBN	O
(Nov.	NNS	O
10,	IN	O
1998)	NNP	O
“End-Complementary	NNP	O
Polymerase	CC	O
Reaction;”	NNP	O
U.S.	NNP	O
Pat.	.	O
No.	.	O
5,837,458	CD	O
to	TO	O
Minshull,	NNP	O
et	FW	O
al.	.	O
(Nov.	NNP	O
17,	,	O
1998),	,	O
“Methods	JJ	O
and	NN	O
Compositions	IN	O
for	NNP	O
Cellular	NNP	O
and	CC	O
Metabolic	NNP	O
Engineering;”	NNP	O
WO	.	O
95/22625,	.	O
Stemmer	CD	O
and	TO	O
Crameri,	,	O
“Mutagenesis	RB	O
by	.	O
Random	NNP	O
Fragmentation	,	O
and	)	O
Reassembly;”	JJ	O
WO	NNP	O
96/33207	NNP	O
by	NNP	O
Stemmer	.	O
and	.	O
Lipschutz	CD	O
“End	TO	O
Complementary	,	O
Polymerase	RB	O
Chain	.	O
Reaction;”	NNP	O
WO	,	O
97/20078	,	O
by	NNS	O
Stemmer	CC	O
and	NNS	O
Crameri	IN	O
“Methods	NNP	O
for	CC	O
Generating	NNP	O
Polynucleotides	NNP	O
having	NNP	O
Desired	,	O
Characteristics	NNP	O
by	CC	O
Iterative	,	O
Selection	NN	O
and	IN	O
Recombination;”	NNP	O
WO	NNP	O
97/35966	CC	O
by	NNP	O
Minshull	NNP	O
and	CD	O
Stemmer,	IN	O
“Methods	NNP	O
and	CC	O
Compositions	NNP	O
for	NNP	O
Cellular	NNP	O
and	NNP	O
Metabolic	NNP	O
Engineering;”	NNP	O
WO	NNP	O
99/41402	CD	O
by	IN	O
Punnonen	NNP	O
et	CC	O
al.	NNP	O
“Targeting	NNS	O
of	IN	O
Genetic	VBG	O
Vaccine	NNP	O
Vectors;”	VBG	O
WO	VBN	O
99/41383	NNS	O
by	IN	O
Punnonen	NNP	O
et	NNP	O
al.	CC	O
“Antigen	NNP	O
Library	NNP	O
Immunization;”	CD	O
WO	IN	O
99/41369	NNP	O
by	CC	O
Punnonen	,	O
et	NNS	O
al.	CC	O
“Genetic	NNS	O
Vaccine	IN	O
Vector	NNP	O
Engineering;”	CC	O
WO	NNP	O
99/41368	NNP	O
by	NNP	O
Punnonen	CD	O
et	IN	O
al.	NNP	O
“Optimization	CC	O
of	.	O
Immunomodulatory	NN	O
Properties	IN	O
of	NNP	O
Genetic	NNP	O
Vaccines;”	NNP	O
EP	NNP	O
752008	CD	O
by	IN	O
Stemmer	NNP	O
and	CC	O
Crameri,	.	O
“DNA	NN	O
Mutagenesis	NNP	O
by	NNP	O
Random	NNP	O
Fragmentation	CD	O
and	IN	O
Reassembly;”	NNP	O
EP	CC	O
0932670	.	O
by	JJ	O
Stemmer	NNP	O
“Evolving	NNP	O
Cellular	NNP	O
DNA	NNP	O
Uptake	CD	O
by	IN	O
Recursive	NNP	O
Sequence	CC	O
Recombination;”	.	O
WO	NN	O
99/23107	IN	O
by	NNP	O
Stemmer	NNP	O
et	IN	O
al.,	NNP	O
“Modification	NNP	O
of	NNP	O
Virus	CD	O
Tropism	IN	O
and	NNP	O
Host	CC	O
Range	,	O
by	JJ	O
Viral	NN	O
Genome	IN	O
Shuffling;”	NNP	O
WO	NNP	O
99/21979	CC	O
by	NNP	O
Apt	NNP	O
et	CD	O
al.,	IN	O
“Human	NNP	O
Papillomavirus	VBG	O
Vectors;”	JJ	O
WO	NNP	O
98/31837	NNP	O
by	IN	O
del	NNP	O
Cardayre	NNP	O
et	NNP	O
al.	NNP	O
“Evolution	CD	O
of	IN	O
Whole	NNP	O
Cells	FW	O
and	,	O
Organisms	NN	O
by	IN	O
Recursive	NNP	O
Sequence	NNP	O
Recombination;”	CC	O
WO	NNP	O
98/27230	NNP	O
by	IN	O
Patten	NNP	O
and	NNP	O
Stemmer,	NNP	O
“Methods	NNP	O
and	CD	O
Compositions	IN	O
for	NNP	O
Polypeptide	FW	O
Engineering;”	,	O
WO	NNP	O
98/27230	NNP	O
by	NNP	O
Stemmer	NNP	O
et	CD	O
al.,	IN	O
“Methods	NN	O
for	NNP	O
Optimization	CC	O
of	.	O
Gene	NN	O
Therapy	IN	O
by	NNP	O
Recursive	NNP	O
Sequence	CC	O
Shuffling	NNP	O
and	IN	O
Selection,”	NNP	O
WO	NNP	O
00/00632,	NNP	O
“Methods	NNP	O
for	CD	O
Generating	IN	O
Highly	NNP	O
Diverse	CC	O
Libraries,”	,	O
WO	NNS	O
00/09679,	CC	O
“Methods	NNP	O
for	IN	O
Obtaining	NNP	O
in	NNP	O
Vitro	NNP	O
Recombined	CD	O
Polynucleotide	IN	O
Sequence	NNP	O
Banks	FW	O
and	,	O
Resulting	NNS	O
Sequences,”	IN	O
WO	NNP	O
98/42832	IN	O
by	NNP	O
Arnold	NNP	O
et	IN	O
al.,	NNP	O
“Recombination	NNP	O
of	NNP	O
Polynucleotide	CC	O
Sequences	NNP	O
Using	NNP	O
Random	,	O
or	NNS	O
Defined	IN	O
Primers,”	VBG	O
WO	NNP	O
99/29902	NNP	O
by	NNP	O
Arnold	NNP	O
et	,	O
al.,	NNS	O
“Method	IN	O
for	VBG	O
Creating	IN	O
Polynucleotide	NNP	O
and	NNP	O
Polypeptide	NNP	O
Sequences,”	NNP	O
WO	NNP	O
98/41653	CC	O
by	NNP	O
Vind,	NNP	O
“An	NNP	O
in	CD	O
Vitro	IN	O
Method	NNP	O
for	FW	O
Construction	,	O
of	NN	O
a	IN	O
DNA	NNP	O
Library,”	NNP	O
WO	NNP	O
98/41622	NNP	O
by	CC	O
Borchert	VBN	O
et	NNP	O
al.,	NNP	O
“Method	CD	O
for	IN	O
Constructing	NNP	O
a	FW	O
Library	,	O
Using	NN	O
DNA	IN	O
Shuffling,”	NNP	O
and	NNP	O
WO	CC	O
98/42727	NNP	O
by	NNP	O
Pati	NNP	O
and	CD	O
Zarling,	IN	O
“Sequence	,	O
Alterations	NNP	O
using	IN	O
Homologous	NNP	O
Recombination.”	NNP	O
Protocols	IN	O
that	NNP	O
can	IN	O
be	DT	O
used	NNP	O
to	NNP	O
practice	NNP	O
the	CD	O
invention	IN	O
(providing	NNP	O
details	FW	O
regarding	,	O
various	NN	O
diversity	IN	O
generating	VBG	O
methods)	DT	O
are	NNP	O
described,	NNP	O
e.g.,	NNP	O
in	NNP	O
U.S.	CC	O
patent	NNP	O
application	CD	O
Ser.	IN	O
No.	NNP	O
09/407,800,	CC	O
“SHUFFLING	,	O
OF	NN	O
CODON	NNS	O
ALTERED	VBG	O
GENES”	NNP	O
by	NNP	O
Patten	NNP	O
et	WDT	O
al.	MD	O
filed	VB	O
Sep.	VBN	O
28,	TO	O
1999;	NN	O
“EVOLUTION	DT	O
OF	NN	O
WHOLE	VBG	O
CELLS	NNS	O
AND	VBG	O
ORGANISMS	JJ	O
BY	NN	O
RECURSIVE	VBG	O
SEQUENCE	)	O
RECOMBINATION”	VBP	O
by	,	O
del	,	O
Cardayre	IN	O
et	NNP	O
al.,	NN	O
U.S.	NN	O
Pat.	.	O
No.	.	O
6,379,964;	,	O
“OLIGONUCLEOTIDE	NN	O
MEDIATED	NNP	O
NUCLEIC	NNP	O
ACID	NNP	O
RECOMBINATION”	NNP	O
by	IN	O
Crameri	NNP	O
et	CC	O
al.,	.	O
U.S.	VBN	O
Pat.	NNP	O
Nos.	,	O
6,319,714;	:	O
6,368,861;	NN	O
6,376,246;	IN	O
6,423,542;	NNP	O
6,426,224	NNP	O
and	NNP	O
PCT/US00/01203;	NNP	O
“USE	NNP	O
OF	NNP	O
CODON-VARIED	NNP	O
OLIGONUCLEOTIDE	NNP	O
SYNTHESIS	IN	O
FOR	NN	O
SYNTHETIC	NNP	O
SHUFFLING”	CC	O
by	,	O
Welch	NNP	O
et	.	O
al.,	.	O
U.S.	:	O
Pat.	NNP	O
No.	NNP	O
6,436,675;	NNP	O
“METHODS	NNP	O
FOR	NNP	O
MAKING	IN	O
CHARACTER	NNP	O
STRINGS,	FW	O
POLYNUCLEOTIDES	,	O
&	NNP	O
POLYPEPTIDES	.	O
HAVING	.	O
DESIRED	:	O
CHARACTERISTICS”	:	O
by	:	O
Selifonov	:	O
et	CD	O
al.,	CC	O
filed	:	O
Jan.	CD	O
18,	IN	O
2000,	NNP	O
(PCT/US00/01202)	NNP	O
and,	NNP	O
e.g.	NNP	O
“METHODS	NNP	O
FOR	NNP	O
MAKING	IN	O
CHARACTER	NNP	O
STRINGS,	FW	O
POLYNUCLEOTIDES	,	O
&	NNP	O
POLYPEPTIDES	.	O
HAVING	.	O
DESIRED	:	O
CHARACTERISTICS”	NN	O
by	IN	O
Selifonov	NNP	O
et	NNP	O
al.,	,	O
filed	NNP	O
Jul.	CC	O
18,	NNP	O
2000	NNP	O
(U.S.	NNP	O
Ser.	NNP	O
No.	IN	O
09/618,579);	NNP	O
“METHODS	FW	O
OF	,	O
POPULATING	VBD	O
DATA	NNP	O
STRUCTURES	,	O
FOR	,	O
USE	)	O
IN	,	O
EVOLUTIONARY	.	O
SIMULATIONS”	NN	O
by	IN	O
Selifonov	NNP	O
and	NNP	O
Stemmer,	,	O
filed	NNP	O
Jan.	CC	O
18,	NNP	O
2000	NNP	O
(PCT/US00/01138);	NNP	O
and	NNP	O
“SINGLE-STRANDED	IN	O
NUCLEIC	NNP	O
ACID	FW	O
TEMPLATE-MEDIATED	,	O
RECOMBINATION	VBD	O
AND	.	O
NUCLEIC	,	O
ACID	CD	O
FRAGMENT	NNP	O
ISOLATION”	.	O
by	.	O
Affholter,	:	O
filed	CD	O
Sep.	IN	O
6,	NNP	O
2000	NNP	O
(U.S.	NNP	O
Ser.	NNP	O
No.	NNP	O
09/656,549);	NNP	O
and	NNP	O
U.S.	NNP	O
Pat.	IN	O
Nos.	NNP	O
6,177,263;	CC	O
6,153,410.	,	O
Non-stochastic,	VBD	O
or	NNP	O
“directed	,	O
evolution,”	CD	O
methods	:	O
include,	CC	O
e.g.,	JJ	O
saturation	NNP	O
mutagenesis	NNP	O
(GSSM),	NNP	O
synthetic	NNP	O
ligation	NNP	O
reassembly	NNP	O
(SLR),	NNP	O
or	NNP	O
a	NNP	O
combination	IN	O
thereof	,	O
are	VBD	O
used	NNP	O
to	,	O
modify	CD	O
the	NNP	O
nucleic	.	O
acids	.	O
of	:	O
the	CC	O
invention	NNP	O
to	.	O
generate	.	O
amylases	:	O
with	.	O
new	,	O
or	CC	O
altered	VBN	O
properties	JJ	O
(e.g.,	NNS	O
activity	,	O
under	,	O
highly	JJ	O
acidic	NN	O
or	,	O
alkaline	JJ	O
conditions,	NN	O
high	RB	O
temperatures,	,	O
and	CC	O
the	DT	O
like).	NN	O
Polypeptides	NN	O
encoded	VBP	O
by	VBN	O
the	TO	O
modified	VB	O
nucleic	DT	O
acids	JJ	O
can	NNS	O
be	IN	O
screened	DT	O
for	NN	O
an	TO	O
activity	VB	O
before	NNS	O
testing	IN	O
for	JJ	O
proteolytic	CC	O
or	JJ	O
other	NNS	O
activity.	,	O
Any	NN	O
testing	IN	O
modality	RB	O
or	JJ	O
protocol	CC	O
can	JJ	O
be	,	O
used,	JJ	O
e.g.,	,	O
using	CC	O
a	DT	O
capillary	.	O
array	NNS	O
platform.	VBN	O
See,	IN	O
e.g.,	DT	O
U.S.	JJ	O
Pat.	JJ	O
Nos.	NNS	O
6,361,974;	MD	O
6,280,926;	VB	O
5,939,250.	VBN	O
Saturation	IN	O
Mutagenesis,	DT	O
or,	NN	O
GSSM	IN	O
In	VBG	O
one	IN	O
aspect,	JJ	O
codon	CC	O
primers	JJ	O
containing	.	O
a	DT	O
degenerate	JJ	O
N,N,G/T	NN	O
sequence	CC	O
are	NN	O
used	MD	O
to	VB	O
introduce	,	O
point	,	O
mutations	VBG	O
into	DT	O
a	JJ	O
polynucleotide,	NN	O
e.g.,	.	O
an	,	O
amylase	,	O
or	NNP	O
an	.	O
antibody	.	O
of	:	O
the	:	O
invention,	.	O
so	NN	O
as	,	O
to	,	O
generate	NNP	O
a	IN	O
set	CD	O
of	,	O
progeny	NN	O
polypeptides	NNS	O
in	VBG	O
which	DT	O
a	NN	O
full	NNP	O
range	NN	O
of	VBP	O
single	VBN	O
amino	TO	O
acid	VB	O
substitutions	NN	O
is	NNS	O
represented	IN	O
at	DT	O
each	,	O
amino	,	O
acid	DT	O
position,	NN	O
e.g.,	CC	O
an	DT	O
amino	NN	O
acid	IN	O
residue	DT	O
in	,	O
an	RB	O
enzyme	IN	O
active	TO	O
site	VB	O
or	DT	O
ligand	NN	O
binding	IN	O
site	NN	O
targeted	NNS	O
to	IN	O
be	WDT	O
modified.	DT	O
These	JJ	O
oligonucleotides	NN	O
can	IN	O
comprise	JJ	O
a	NN	O
contiguous	JJ	O
first	NNS	O
homologous	VBZ	O
sequence,	VBN	O
a	IN	O
degenerate	DT	O
N,N,G/T	NN	O
sequence,	JJ	O
and,	,	O
optionally,	,	O
a	DT	O
second	NN	O
homologous	NN	O
sequence.	NN	O
The	IN	O
downstream	DT	O
progeny	NN	O
translational	JJ	O
products	NN	O
from	CC	O
the	NN	O
use	VBG	O
of	NN	O
such	VBN	O
oligonucleotides	TO	O
include	VB	O
all	.	O
possible	DT	O
amino	NNS	O
acid	MD	O
changes	VB	O
at	DT	O
each	JJ	O
amino	JJ	O
acid	JJ	O
site	,	O
along	DT	O
the	NN	O
polypeptide,	NNP	O
because	,	O
the	,	O
degeneracy	,	O
of	DT	O
the	JJ	O
N,N,G/T	JJ	O
sequence	.	O
includes	DT	O
codons	NN	O
for	VBP	O
all	JJ	O
20	NNS	O
amino	IN	O
acids.	DT	O
In	NN	O
one	IN	O
aspect,	JJ	O
one	NNS	O
such	VBP	O
degenerate	DT	O
oligonucleotide	JJ	O
(comprised	NN	O
of,	NN	O
e.g.,	NNS	O
one	IN	O
degenerate	DT	O
N,N,G/T	NN	O
cassette)	VBZ	O
is	NN	O
used	IN	O
for	DT	O
subjecting	,	O
each	IN	O
original	DT	O
codon	NN	O
in	IN	O
a	DT	O
parental	NNP	O
polynucleotide	NN	O
template	VBZ	O
to	NNS	O
a	IN	O
full	DT	O
range	CD	O
of	NN	O
codon	.	O
substitutions.	IN	O
In	CD	O
another	,	O
aspect,	CD	O
at	JJ	O
least	NN	O
two	NN	O
degenerate	VBN	O
cassettes	,	O
are	,	O
used—either	CD	O
in	NN	O
the	NNP	O
same	)	O
oligonucleotide	VBZ	O
or	VBN	O
not,	IN	O
for	VBG	O
subjecting	DT	O
at	JJ	O
least	NN	O
two	IN	O
original	DT	O
codons	JJ	O
in	NN	O
a	NN	O
parental	TO	O
polynucleotide	DT	O
template	JJ	O
to	NN	O
a	IN	O
full	JJ	O
range	.	O
of	IN	O
codon	DT	O
substitutions.	,	O
For	IN	O
example,	JJS	O
more	CD	O
than	NN	O
one	NNS	O
N,N,G/T	VBP	O
sequence	RB	O
can	IN	O
be	DT	O
contained	JJ	O
in	NN	O
one	CC	O
oligonucleotide	,	O
to	IN	O
introduce	VBG	O
amino	IN	O
acid	JJS	O
mutations	CD	O
at	JJ	O
more	NNS	O
than	IN	O
one	DT	O
site.	JJ	O
This	NN	O
plurality	NN	O
of	TO	O
N,N,G/T	DT	O
sequences	JJ	O
can	NN	O
be	IN	O
directly	JJ	O
contiguous,	.	O
or	IN	O
separated	,	O
by	JJR	O
one	IN	O
or	CD	O
more	NNP	O
additional	NN	O
nucleotide	MD	O
sequence(s).	VB	O
In	VBN	O
another	IN	O
aspect,	CD	O
oligonucleotides	NN	O
serviceable	TO	O
for	VB	O
introducing	JJ	O
additions	JJ	O
and	NNS	O
deletions	IN	O
can	JJR	O
be	IN	O
used	CD	O
either	.	O
alone	DT	O
or	NN	O
in	IN	O
combination	NNP	O
with	NNS	O
the	MD	O
codons	VB	O
containing	RB	O
an	,	O
N,N,G/T	CC	O
sequence,	VBN	O
to	IN	O
introduce	CD	O
any	CC	O
combination	JJR	O
or	JJ	O
permutation	NN	O
of	.	O
amino	IN	O
acid	DT	O
additions,	,	O
deletions,	VBZ	O
and/or	JJ	O
substitutions.	IN	O
In	VBG	O
one	NNS	O
aspect,	CC	O
simultaneous	NNS	O
mutagenesis	MD	O
of	VB	O
two	VBN	O
or	DT	O
more	RB	O
contiguous	CC	O
amino	IN	O
acid	NN	O
positions	IN	O
is	DT	O
done	NNS	O
using	VBG	O
an	DT	O
oligonucleotide	NNP	O
that	,	O
contains	TO	O
contiguous	VB	O
N,N,G/T	DT	O
triplets,	NN	O
i.e.	CC	O
a	NN	O
degenerate	IN	O
(N,N,G/T)n	NN	O
sequence.	NN	O
In	,	O
another	,	O
aspect,	JJ	O
degenerate	.	O
cassettes	IN	O
having	CD	O
less	,	O
degeneracy	JJ	O
than	NN	O
the	IN	O
N,N,G/T	CD	O
sequence	CC	O
are	JJR	O
used.	JJ	O
For	NN	O
example,	NN	O
it	NNS	O
may	VBZ	O
be	VBN	O
desirable	VBG	O
in	DT	O
some	NN	O
instances	WDT	O
to	VBZ	O
use	JJ	O
(e.g.	NNP	O
in	,	O
an	.	O
oligonucleotide)	DT	O
a	NN	O
degenerate	FW	O
triplet	.	O
sequence	IN	O
comprised	DT	O
of	,	O
only	NN	O
one	NNS	O
N,	VBG	O
where	JJR	O
said	NN	O
N	IN	O
can	DT	O
be	NNP	O
in	NN	O
the	VBP	O
first	.	O
second	IN	O
or	,	O
third	PRP	O
position	MD	O
of	VB	O
the	JJ	O
triplet.	IN	O
Any	DT	O
other	NNS	O
bases	TO	O
including	VB	O
any	.	O
combinations	IN	O
and	DT	O
permutations	)	O
thereof	DT	O
can	JJ	O
be	NN	O
used	NN	O
in	VBD	O
the	IN	O
remaining	RB	O
two	CD	O
positions	,	O
of	WRB	O
the	VBD	O
triplet.	NNP	O
Alternatively,	MD	O
it	VB	O
may	IN	O
be	DT	O
desirable	JJ	O
in	NN	O
some	CC	O
instances	JJ	O
to	NN	O
use	IN	O
(e.g.	DT	O
in	.	O
an	DT	O
oligo)	JJ	O
a	NNS	O
degenerate	VBG	O
N,N,N	DT	O
triplet	NNS	O
sequence.	CC	O
In	NNS	O
one	NNS	O
aspect,	MD	O
use	VB	O
of	VBN	O
degenerate	IN	O
triplets	DT	O
(e.g.,	VBG	O
N,N,G/T	CD	O
triplets)	NNS	O
allows	IN	O
for	DT	O
systematic	.	O
and	,	O
easy	PRP	O
generation	MD	O
of	VB	O
a	JJ	O
full	IN	O
range	DT	O
of	NNS	O
possible	TO	O
natural	VB	O
amino	.	O
acids	IN	O
(for	DT	O
a	)	O
total	DT	O
of	NN	O
20	NNP	O
amino	NN	O
acids)	.	O
into	IN	O
each	CD	O
and	,	O
every	NN	O
amino	IN	O
acid	NN	O
position	NNS	O
in	,	O
a	NNP	O
polypeptide	)	O
(in	VBZ	O
alternative	IN	O
aspects,	JJ	O
the	CC	O
methods	JJ	O
also	NN	O
include	IN	O
generation	DT	O
of	JJ	O
less	NN	O
than	IN	O
all	JJ	O
possible	JJ	O
substitutions	NN	O
per	NNS	O
amino	IN	O
acid	DT	O
residue,	NN	O
or	IN	O
codon,	CD	O
position).	JJ	O
For	)	O
example,	IN	O
for	DT	O
a	CC	O
100	DT	O
amino	NN	O
acid	JJ	O
polypeptide,	NN	O
2000	IN	O
distinct	DT	O
species	NN	O
(i.e.	IN	O
20	JJ	O
possible	,	O
amino	DT	O
acids	NNS	O
per	RB	O
position×100	VBP	O
amino	NN	O
acid	IN	O
positions)	JJR	O
can	IN	O
be	DT	O
generated.	JJ	O
Through	NNS	O
the	IN	O
use	NN	O
of	NN	O
an	,	O
oligonucleotide	CC	O
or	,	O
set	.	O
of	IN	O
oligonucleotides	,	O
containing	IN	O
a	DT	O
degenerate	CD	O
N,N,G/T	NN	O
triplet,	NN	O
32	,	O
individual	CD	O
sequences	JJ	O
can	NNS	O
code	.	O
for	CD	O
all	JJ	O
20	NN	O
possible	NNS	O
natural	IN	O
amino	NN	O
acids.	NN	O
Thus,	IN	O
in	)	O
a	MD	O
reaction	VB	O
vessel	.	O
in	IN	O
which	DT	O
a	NN	O
parental	IN	O
polynucleotide	DT	O
sequence	NN	O
is	CC	O
subjected	NN	O
to	IN	O
saturation	NNS	O
mutagenesis	VBG	O
using	DT	O
at	NN	O
least	NNP	O
one	,	O
such	CD	O
oligonucleotide,	JJ	O
there	NNS	O
are	MD	O
generated	VB	O
32	IN	O
distinct	DT	O
progeny	CD	O
polynucleotides	JJ	O
encoding	JJ	O
20	NN	O
distinct	.	O
polypeptides.	,	O
In	IN	O
contrast,	DT	O
the	NN	O
use	NN	O
of	IN	O
a	WDT	O
non-degenerate	DT	O
oligonucleotide	JJ	O
in	NN	O
site-directed	NN	O
mutagenesis	VBZ	O
leads	VBN	O
to	TO	O
only	VB	O
one	NN	O
progeny	VBG	O
polypeptide	IN	O
product	JJS	O
per	CD	O
reaction	JJ	O
vessel.	,	O
Nondegenerate	EX	O
oligonucleotides	VBP	O
can	VBN	O
optionally	CD	O
be	JJ	O
used	NN	O
in	NNS	O
combination	VBG	O
with	CD	O
degenerate	JJ	O
primers	.	O
disclosed;	IN	O
for	,	O
example,	DT	O
nondegenerate	NN	O
oligonucleotides	IN	O
can	DT	O
be	JJ	O
used	NN	O
to	IN	O
generate	JJ	O
specific	NN	O
point	VBZ	O
mutations	TO	O
in	RB	O
a	CD	O
working	NN	O
polynucleotide.	JJ	O
This	NN	O
provides	IN	O
one	NN	O
means	.	O
to	NNP	O
generate	NNS	O
specific	MD	O
silent	RB	O
point	VB	O
mutations,	VBN	O
point	IN	O
mutations	NN	O
leading	IN	O
to	NN	O
corresponding	NNS	O
amino	:	O
acid	IN	O
changes,	,	O
and	JJ	O
point	NNS	O
mutations	MD	O
that	VB	O
cause	VBN	O
the	TO	O
generation	VB	O
of	JJ	O
stop	NN	O
codons	NNS	O
and	IN	O
the	DT	O
corresponding	JJ	O
expression	.	O
of	DT	O
polypeptide	VBZ	O
fragments.	CD	O
In	VBZ	O
one	TO	O
aspect,	VB	O
each	JJ	O
saturation	JJ	O
mutagenesis	NN	O
reaction	,	O
vessel	NN	O
contains	NNS	O
polynucleotides	VBG	O
encoding	TO	O
at	VBG	O
least	JJ	O
20	NN	O
progeny	,	O
polypeptide	CC	O
(e.g.,	NN	O
amylases)	NNS	O
molecules	WDT	O
such	VBP	O
that	DT	O
all	NN	O
20	IN	O
natural	JJ	O
amino	NNS	O
acids	CC	O
are	DT	O
represented	JJ	O
at	NN	O
the	IN	O
one	NN	O
specific	.	O
amino	IN	O
acid	CD	O
position	,	O
corresponding	DT	O
to	NN	O
the	NN	O
codon	NN	O
position	NN	O
mutagenized	VBZ	O
in	NNS	O
the	VBG	O
parental	IN	O
polynucleotide	JJS	O
(other	CD	O
aspects	JJ	O
use	NN	O
less	,	O
than	)	O
all	NNS	O
20	JJ	O
natural	IN	O
combinations).	DT	O
The	CD	O
32-fold	JJ	O
degenerate	NN	O
progeny	NNS	O
polypeptides	VBP	O
generated	VBN	O
from	IN	O
each	DT	O
saturation	CD	O
mutagenesis	NN	O
reaction	NN	O
vessel	JJ	O
can	NN	O
be	VBG	O
subjected	TO	O
to	DT	O
clonal	JJ	O
amplification	NN	O
(e.g.	VBN	O
cloned	IN	O
into	DT	O
a	JJ	O
suitable	NN	O
host,	JJ	O
e.g.,	NNS	O
E.	VBP	O
coli	JJR	O
host,	IN	O
using,	DT	O
e.g.,	CD	O
an	JJ	O
expression	.	O
vector)	DT	O
and	JJ	O
subjected	NN	O
to	NN	O
expression	NNS	O
screening.	VBD	O
When	IN	O
an	DT	O
individual	NN	O
progeny	NN	O
polypeptide	NN	O
is	NN	O
identified	MD	O
by	VB	O
screening	VBN	O
to	TO	O
display	JJ	O
a	NN	O
favorable	.	O
change	VBN	O
in	IN	O
property	DT	O
(when	JJ	O
compared	,	O
to	,	O
the	NNP	O
parental	VBZ	O
polypeptide,	,	O
such	,	O
as	,	O
increased	DT	O
proteolytic	NN	O
activity	)	O
under	CC	O
alkaline	VBN	O
or	TO	O
acidic	VB	O
conditions),	.	O
it	WRB	O
can	DT	O
be	JJ	O
sequenced	NN	O
to	NN	O
identify	VBZ	O
the	VBN	O
correspondingly	IN	O
favorable	VBG	O
amino	TO	O
acid	VB	O
substitution	DT	O
contained	JJ	O
therein.	NN	O
In	IN	O
one	NN	O
aspect,	WRB	O
upon	VBN	O
mutagenizing	TO	O
each	DT	O
and	JJ	O
every	,	O
amino	JJ	O
acid	IN	O
position	JJ	O
in	JJ	O
a	NN	O
parental	IN	O
polypeptide	NN	O
using	CC	O
saturation	JJ	O
mutagenesis	,	O
as	PRP	O
disclosed	MD	O
herein,	VB	O
favorable	VBN	O
amino	TO	O
acid	VB	O
changes	DT	O
may	RB	O
be	JJ	O
identified	NN	O
at	JJ	O
more	NN	O
than	VBD	O
one	.	O
amino	IN	O
acid	CD	O
position.	,	O
One	IN	O
or	VBG	O
more	DT	O
new	CC	O
progeny	DT	O
molecules	NN	O
can	JJ	O
be	NN	O
generated	IN	O
that	DT	O
contain	JJ	O
a	NN	O
combination	VBG	O
of	NN	O
all	NN	O
or	IN	O
part	JJ	O
of	,	O
these	JJ	O
favorable	NN	O
amino	IN	O
acid	NNS	O
substitutions.	MD	O
For	VB	O
example,	VBN	O
if	IN	O
2	JJR	O
specific	IN	O
favorable	CD	O
amino	NN	O
acid	JJ	O
changes	.	O
are	CD	O
identified	CC	O
in	JJR	O
each	JJ	O
of	NN	O
3	NNS	O
amino	MD	O
acid	VB	O
positions	VBN	O
in	DT	O
a	VBP	O
polypeptide,	DT	O
the	NN	O
permutations	IN	O
include	DT	O
3	CC	O
possibilities	NN	O
at	IN	O
each	DT	O
position	JJ	O
(no	NN	O
change	JJ	O
from	.	O
the	IN	O
original	,	O
amino	IN	O
acid,	CD	O
and	JJ	O
each	JJ	O
of	NN	O
two	NN	O
favorable	NNS	O
changes)	VBP	O
and	VBN	O
3	IN	O
positions.	DT	O
Thus,	IN	O
there	CD	O
are	JJ	O
3×3×3	NN	O
or	NNS	O
27	IN	O
total	DT	O
possibilities,	,	O
including	DT	O
7	NNS	O
that	VBP	O
were	CD	O
previously	NNS	O
examined—6	IN	O
single	DT	O
point	NN	O
mutations	DT	O
(i.e.	NN	O
2	IN	O
at	DT	O
each	JJ	O
of	NN	O
three	,	O
positions)	CC	O
and	DT	O
no	IN	O
change	CD	O
at	JJ	O
any	)	O
position.	CC	O
In	CD	O
another	.	O
aspect,	,	O
site-saturation	EX	O
mutagenesis	VBP	O
can	CD	O
be	CC	O
used	CD	O
together	JJ	O
with	,	O
another	VBG	O
stochastic	CD	O
or	WDT	O
non-stochastic	VBD	O
means	RB	O
to	JJ	O
vary	JJ	O
sequence,	NN	O
e.g.,	NNS	O
synthetic	.	O
ligation	CD	O
reassembly	IN	O
(see	DT	O
below),	IN	O
shuffling,	CD	O
chimerization,	)	O
recombination	CC	O
and	DT	O
other	NN	O
mutagenizing	IN	O
processes	DT	O
and	.	O
mutagenizing	IN	O
agents.	DT	O
This	,	O
invention	JJ	O
provides	NN	O
for	MD	O
the	VB	O
use	VBN	O
of	RB	O
any	IN	O
mutagenizing	DT	O
process(es),	JJ	O
including	CC	O
saturation	JJ	O
mutagenesis,	NNS	O
in	TO	O
an	JJ	O
iterative	,	O
manner.	,	O
Synthetic	JJ	O
Ligation	NN	O
Reassembly	RB	O
(SLR)	VB	O
The	,	O
invention	,	O
provides	,	O
a	NN	O
non-stochastic	CC	O
gene	JJ	O
modification	NN	O
system	NNS	O
termed	CC	O
“synthetic	VBG	O
ligation	.	O
reassembly,”	DT	O
or	NN	O
simply	VBZ	O
“SLR,”	IN	O
a	DT	O
“directed	NN	O
evolution	IN	O
process,”	DT	O
to	JJ	O
generate	,	O
polypeptides,	VBG	O
e.g.,	NN	O
amylases	,	O
or	IN	O
antibodies	DT	O
of	JJ	O
the	.	O
invention,	JJ	O
with	NNP	O
new	NNP	O
or	)	O
altered	DT	O
properties.	NN	O
SLR	VBZ	O
is	DT	O
a	JJ	O
method	NN	O
of	NN	O
ligating	NN	O
oligonucleotide	VBD	O
fragments	JJ	O
together	NN	O
non-stochastically.	''	O
This	CC	O
method	RB	O
differs	VB	O
from	DT	O
stochastic	JJ	O
oligonucleotide	NN	O
shuffling	NN	O
in	TO	O
that	VB	O
the	,	O
nucleic	,	O
acid	VBZ	O
building	CC	O
blocks	NNS	O
are	IN	O
not	DT	O
shuffled,	,	O
concatenated	IN	O
or	JJ	O
chimerized	CC	O
randomly,	JJ	O
but	.	O
rather	NNP	O
are	VBZ	O
assembled	DT	O
non-stochastically.	NN	O
See,	IN	O
e.g.,	VBG	O
U.S.	JJ	O
patent	NNS	O
application	RB	O
Ser.	.	O
No.	DT	O
09/332,835	NN	O
entitled	NNS	O
“Synthetic	IN	O
Ligation	JJ	O
Reassembly	NN	O
in	VBG	O
Directed	IN	O
Evolution”	IN	O
and	DT	O
filed	JJ	O
on	NN	O
Jun.	NN	O
14,	NNS	O
1999	VBP	O
(“U.S.	RB	O
Ser.	,	O
No.	VBD	O
09/332,835”).	CC	O
In	VBD	O
one	,	O
aspect,	CC	O
SLR	RB	O
comprises	VBP	O
the	VBN	O
following	.	O
steps:	,	O
(a)	,	O
providing	NNP	O
a	NN	O
template	NN	O
polynucleotide,	.	O
wherein	.	O
the	CD	O
template	VBN	O
polynucleotide	JJ	O
comprises	NNP	O
sequence	NNP	O
encoding	IN	O
a	NNP	O
homologous	NNP	O
gene;	CC	O
(b)	VBN	O
providing	IN	O
a	.	O
plurality	,	O
of	CD	O
building	.	O
block	.	O
polynucleotides,	.	O
wherein	.	O
the	IN	O
building	CD	O
block	,	O
polynucleotides	NNP	O
are	VBZ	O
designed	DT	O
to	JJ	O
cross-over	:	O
reassemble	)	O
with	VBG	O
the	DT	O
template	JJ	O
polynucleotide	,	O
at	VBP	O
a	DT	O
predetermined	NN	O
sequence,	NN	O
and	VBZ	O
a	NN	O
building	VBG	O
block	DT	O
polynucleotide	JJ	O
comprises	:	O
a	)	O
sequence	VBG	O
that	DT	O
is	NN	O
a	IN	O
variant	NN	O
of	NN	O
the	,	O
homologous	VBP	O
gene	DT	O
and	NN	O
a	NN	O
sequence	NNS	O
homologous	VBP	O
to	VBN	O
the	TO	O
template	VB	O
polynucleotide	JJ	O
flanking	IN	O
the	DT	O
variant	NN	O
sequence;	NN	O
(c)	IN	O
combining	DT	O
a	JJ	O
building	,	O
block	CC	O
polynucleotide	DT	O
with	NN	O
a	NN	O
template	NN	O
polynucleotide	VBZ	O
such	DT	O
that	NN	O
the	WDT	O
building	VBZ	O
block	DT	O
polynucleotide	NN	O
cross-over	IN	O
reassembles	DT	O
with	JJ	O
the	NN	O
template	CC	O
polynucleotide	DT	O
to	NN	O
generate	JJ	O
polynucleotides	TO	O
comprising	DT	O
homologous	NN	O
gene	NN	O
sequence	VBG	O
variations.	DT	O
SLR	JJ	O
does	:	O
not	)	O
depend	VBG	O
on	DT	O
the	NN	O
presence	NN	O
of	NN	O
high	IN	O
levels	DT	O
of	JJ	O
homology	NN	O
between	JJ	O
polynucleotides	IN	O
to	DT	O
be	NN	O
rearranged.	NN	O
Thus,	IN	O
this	NN	O
method	NNS	O
can	IN	O
be	DT	O
used	NN	O
to	NN	O
non-stochastically	TO	O
generate	VB	O
libraries	NNS	O
(or	VBG	O
sets)	JJ	O
of	NN	O
progeny	NN	O
molecules	.	O
comprised	NN	O
of	VBZ	O
over	RB	O
10100	VB	O
different	IN	O
chimeras.	DT	O
SLR	NN	O
can	IN	O
be	JJ	O
used	NNS	O
to	IN	O
generate	NN	O
libraries	IN	O
comprised	NNS	O
of	TO	O
over	VB	O
101000	.	O
different	,	O
progeny	DT	O
chimeras.	NN	O
Thus,	MD	O
aspects	VB	O
of	VBN	O
the	TO	O
present	RB	O
invention	VB	O
include	NNS	O
non-stochastic	CC	O
methods	)	O
of	IN	O
producing	NN	O
a	NNS	O
set	VBN	O
of	IN	O
finalized	IN	O
chimeric	CD	O
nucleic	JJ	O
acid	.	O
molecule	NN	O
shaving	MD	O
an	VB	O
overall	VBN	O
assembly	TO	O
order	VB	O
that	NNS	O
is	VBN	O
chosen	IN	O
by	IN	O
design.	CD	O
This	JJ	O
method	NN	O
includes	.	O
the	,	O
steps	NNS	O
of	IN	O
generating	DT	O
by	JJ	O
design	NN	O
a	VBP	O
plurality	JJ	O
of	NNS	O
specific	IN	O
nucleic	VBG	O
acid	DT	O
building	NN	O
blocks	IN	O
having	JJ	O
serviceable	JJ	O
mutually	NN	O
compatible	NN	O
ligatable	NN	O
ends,	VBG	O
and	DT	O
assembling	JJ	O
these	NN	O
nucleic	NN	O
acid	WDT	O
building	VBZ	O
blocks,	VBN	O
such	IN	O
that	.	O
a	DT	O
designed	NN	O
overall	VBZ	O
assembly	DT	O
order	NNS	O
is	IN	O
achieved.	VBG	O
The	IN	O
mutually	NN	O
compatible	DT	O
ligatable	NN	O
ends	IN	O
of	JJ	O
the	JJ	O
nucleic	NN	O
acid	NN	O
building	NNS	O
blocks	VBG	O
to	JJ	O
be	RB	O
assembled	JJ	O
are	JJ	O
considered	,	O
to	CC	O
be	VBG	O
“serviceable”	DT	O
for	JJ	O
this	NN	O
type	NN	O
of	,	O
ordered	JJ	O
assembly	IN	O
if	DT	O
they	VBN	O
enable	JJ	O
the	NN	O
building	NN	O
blocks	VBZ	O
to	.	O
be	DT	O
coupled	RB	O
in	JJ	O
predetermined	JJ	O
orders.	NNS	O
Thus,	IN	O
the	DT	O
overall	JJ	O
assembly	NN	O
order	NN	O
in	NNS	O
which	TO	O
the	VB	O
nucleic	VBN	O
acid	VBP	O
building	VBN	O
blocks	TO	O
can	VB	O
be	VBN	O
coupled	IN	O
is	DT	O
specified	NN	O
by	IN	O
the	VBN	O
design	NN	O
of	IN	O
the	PRP	O
ligatable	VBP	O
ends.	DT	O
If	NN	O
more	NNS	O
than	TO	O
one	VB	O
assembly	VBN	O
step	IN	O
is	JJ	O
to	.	O
be	,	O
used,	DT	O
then	JJ	O
the	NN	O
overall	NN	O
assembly	IN	O
order	WDT	O
in	DT	O
which	NN	O
the	NN	O
nucleic	NN	O
acid	NNS	O
building	MD	O
blocks	VB	O
can	VBN	O
be	VBZ	O
coupled	VBN	O
is	IN	O
also	DT	O
specified	NN	O
by	IN	O
the	DT	O
sequential	JJ	O
order	.	O
of	IN	O
the	JJR	O
assembly	IN	O
step(s).	CD	O
In	JJ	O
one	NN	O
aspect,	VBZ	O
the	TO	O
annealed	VB	O
building	,	O
pieces	RB	O
are	DT	O
treated	JJ	O
with	NN	O
an	NN	O
enzyme,	IN	O
such	WDT	O
as	DT	O
a	NN	O
ligase	NN	O
(e.g.	NN	O
T4	NNS	O
DNA	MD	O
ligase),	VB	O
to	VBN	O
achieve	VBZ	O
covalent	RB	O
bonding	VBN	O
of	IN	O
the	DT	O
building	JJ	O
pieces.	NN	O
In	IN	O
one	DT	O
aspect,	JJ	O
the	.	O
design	IN	O
of	CD	O
the	,	O
oligonucleotide	DT	O
building	JJ	O
blocks	NN	O
is	NNS	O
obtained	VBP	O
by	VBN	O
analyzing	IN	O
a	DT	O
set	,	O
of	JJ	O
progenitor	IN	O
nucleic	DT	O
acid	NN	O
sequence	.	O
templates	NNP	O
that	NNP	O
serve	,	O
as	TO	O
a	VB	O
basis	NN	O
for	NN	O
producing	IN	O
a	DT	O
progeny	NN	O
set	.	O
of	IN	O
finalized	CD	O
chimeric	,	O
polynucleotides.	DT	O
These	NN	O
parental	IN	O
oligonucleotide	DT	O
templates	NN	O
thus	NN	O
serve	NNS	O
as	VBZ	O
a	VBN	O
source	IN	O
of	VBG	O
sequence	DT	O
information	NN	O
that	IN	O
aids	NN	O
in	JJ	O
the	JJ	O
design	NN	O
of	NNS	O
the	WDT	O
nucleic	VBP	O
acid	IN	O
building	DT	O
blocks	NN	O
that	IN	O
are	VBG	O
to	DT	O
be	NN	O
mutagenized,	NN	O
e.g.,	IN	O
chimerized	JJ	O
or	JJ	O
shuffled.	.	O
In	DT	O
one	JJ	O
aspect	NN	O
of	VBZ	O
this	RB	O
method,	VBN	O
the	IN	O
sequences	DT	O
of	NN	O
a	IN	O
plurality	NN	O
of	NN	O
parental	WDT	O
nucleic	VBZ	O
acid	IN	O
templates	DT	O
are	NN	O
aligned	IN	O
in	DT	O
order	JJ	O
to	NN	O
select	NN	O
one	NNS	O
or	WDT	O
more	VBP	O
demarcation	TO	O
points.	VB	O
The	,	O
demarcation	,	O
points	VBD	O
can	CC	O
be	.	O
located	IN	O
at	CD	O
an	NN	O
area	IN	O
of	DT	O
homology,	,	O
and	DT	O
are	NNS	O
comprised	IN	O
of	DT	O
one	NN	O
or	IN	O
more	JJ	O
nucleotides.	JJ	O
These	NN	O
demarcation	NNS	O
points	VBP	O
are	VBN	O
preferably	IN	O
shared	NN	O
by	TO	O
at	VB	O
least	CD	O
two	CC	O
of	JJR	O
the	NN	O
progenitor	.	O
templates.	DT	O
The	NN	O
demarcation	NNS	O
points	MD	O
can	VB	O
thereby	VBN	O
be	IN	O
used	DT	O
to	NN	O
delineate	IN	O
the	,	O
boundaries	CC	O
of	VBP	O
oligonucleotide	VBN	O
building	IN	O
blocks	CD	O
to	CC	O
be	JJR	O
generated	.	O
in	DT	O
order	NN	O
to	NNS	O
rearrange	VBP	O
the	RB	O
parental	VBN	O
polynucleotides.	IN	O
The	IN	O
demarcation	JJS	O
points	CD	O
identified	IN	O
and	DT	O
selected	NN	O
in	.	O
the	DT	O
progenitor	NN	O
molecules	NNS	O
serve	MD	O
as	RB	O
potential	VB	O
chimerization	VBN	O
points	TO	O
in	VB	O
the	DT	O
assembly	NNS	O
of	IN	O
the	JJ	O
final	NN	O
chimeric	NNS	O
progeny	TO	O
molecules.	VB	O
A	VBN	O
demarcation	IN	O
point	NN	O
can	TO	O
be	VB	O
an	DT	O
area	JJ	O
of	.	O
homology	DT	O
(comprised	NN	O
of	NNS	O
at	VBN	O
least	CC	O
one	VBN	O
homologous	IN	O
nucleotide	DT	O
base)	NN	O
shared	VBZ	O
by	VBP	O
at	IN	O
least	JJ	O
two	NN	O
parental	NNS	O
polynucleotide	IN	O
sequences.	DT	O
Alternatively,	NN	O
a	IN	O
demarcation	DT	O
point	JJ	O
can	NN	O
be	NN	O
an	.	O
area	DT	O
of	NN	O
homology	NN	O
that	MD	O
is	VB	O
shared	DT	O
by	NN	O
at	IN	O
least	NN	O
half	VBN	O
of	IN	O
the	IN	O
parental	JJS	O
polynucleotide	CD	O
sequences,	JJ	O
or,	IN	O
it	)	O
can	VBN	O
be	IN	O
an	IN	O
area	JJS	O
of	CD	O
homology	JJ	O
that	NN	O
is	.	O
shared	,	O
by	DT	O
at	NN	O
least	NN	O
two	MD	O
thirds	VB	O
of	DT	O
the	NN	O
parental	IN	O
polynucleotide	NN	O
sequences.	WDT	O
Even	VBZ	O
more	VBN	O
preferably	IN	O
a	IN	O
serviceable	JJS	O
demarcation	NN	O
points	IN	O
is	DT	O
an	JJ	O
area	NN	O
of	,	O
homology	,	O
that	PRP	O
is	MD	O
shared	VB	O
by	DT	O
at	NN	O
least	IN	O
three	NN	O
fourths	WDT	O
of	VBZ	O
the	VBN	O
parental	IN	O
polynucleotide	IN	O
sequences,	JJS	O
or,	CD	O
it	NNS	O
can	IN	O
be	DT	O
shared	JJ	O
by	NN	O
at	.	O
almost	RB	O
all	RBR	O
of	RB	O
the	DT	O
parental	JJ	O
polynucleotide	NN	O
sequences.	NNS	O
In	VBZ	O
one	DT	O
aspect,	NN	O
a	IN	O
demarcation	NN	O
point	WDT	O
is	VBZ	O
an	VBN	O
area	IN	O
of	IN	O
homology	JJS	O
that	CD	O
is	NNS	O
shared	IN	O
by	DT	O
all	JJ	O
of	NN	O
the	,	O
parental	,	O
polynucleotide	PRP	O
sequences.	MD	O
In	VB	O
one	VBN	O
aspect,	IN	O
a	IN	O
ligation	RB	O
reassembly	DT	O
process	IN	O
is	DT	O
performed	JJ	O
exhaustively	NN	O
in	.	O
order	IN	O
to	CD	O
generate	,	O
an	DT	O
exhaustive	NN	O
library	NN	O
of	VBZ	O
progeny	DT	O
chimeric	NN	O
polynucleotides.	IN	O
In	NN	O
other	WDT	O
words,	VBZ	O
all	VBN	O
possible	IN	O
ordered	DT	O
combinations	IN	O
of	DT	O
the	JJ	O
nucleic	NN	O
acid	.	O
building	IN	O
blocks	CD	O
are	,	O
represented	DT	O
in	NN	O
the	RB	O
set	NN	O
of	VBZ	O
finalized	VBN	O
chimeric	RB	O
nucleic	IN	O
acid	NN	O
molecules.	TO	O
At	VB	O
the	DT	O
same	JJ	O
time,	NN	O
in	IN	O
another	NN	O
aspect,	JJ	O
the	.	O
assembly	IN	O
order	JJ	O
(i.e.	,	O
the	DT	O
order	JJ	O
of	JJ	O
assembly	NNS	O
of	IN	O
each	DT	O
building	JJ	O
block	NN	O
in	NN	O
the	NNS	O
5′	VBP	O
to	VBN	O
3	IN	O
sequence	DT	O
of	NN	O
each	IN	O
finalized	JJ	O
chimeric	JJ	O
nucleic	NN	O
acid)	NN	O
in	.	O
each	IN	O
combination	DT	O
is	JJ	O
by	,	O
design	IN	O
(or	DT	O
non-stochastic)	,	O
as	DT	O
described	NN	O
above.	NN	O
Because	.	O
of	DT	O
the	NN	O
non-stochastic	IN	O
nature	NN	O
of	IN	O
this	DT	O
invention,	NN	O
the	NN	O
possibility	IN	O
of	DT	O
unwanted	CD	O
side	TO	O
products	CD	O
is	NN	O
greatly	IN	O
reduced.	DT	O
In	VBN	O
another	NN	O
aspect,	JJ	O
the	)	O
ligation	IN	O
reassembly	DT	O
method	NN	O
is	VBZ	O
performed	IN	O
systematically.	NN	O
For	CC	O
example,	)	O
the	IN	O
method	VBN	O
is	.	O
performed	IN	O
in	IN	O
order	DT	O
to	JJ	O
generate	NN	O
a	IN	O
systematically	DT	O
compartmentalized	,	O
library	DT	O
of	NN	O
progeny	IN	O
molecules,	JJ	O
with	NN	O
compartments	NNS	O
that	VBZ	O
can	RB	O
be	.	O
screened	IN	O
systematically,	DT	O
e.g.	,	O
one	DT	O
by	NN	O
one.	RB	O
In	NN	O
other	VBZ	O
words	VBN	O
this	.	O
invention	IN	O
provides	,	O
that,	DT	O
through	NN	O
the	VBZ	O
selective	VBN	O
and	IN	O
judicious	NN	O
use	TO	O
of	VB	O
specific	DT	O
nucleic	RB	O
acid	JJ	O
building	NN	O
blocks,	IN	O
coupled	NN	O
with	,	O
the	IN	O
selective	NNS	O
and	WDT	O
judicious	MD	O
use	VB	O
of	VBN	O
sequentially	,	O
stepped	.	O
assembly	CD	O
reactions,	IN	O
a	.	O
design	IN	O
can	JJ	O
be	NNS	O
achieved	DT	O
where	NN	O
specific	VBZ	O
sets	,	O
of	IN	O
progeny	DT	O
products	JJ	O
are	CC	O
made	JJ	O
in	NN	O
each	IN	O
of	JJ	O
several	JJ	O
reaction	NN	O
vessels.	NN	O
This	,	O
allows	VBN	O
a	IN	O
systematic	DT	O
examination	JJ	O
and	CC	O
screening	JJ	O
procedure	NN	O
to	IN	O
be	RB	O
performed.	VBN	O
Thus,	NN	O
these	,	O
methods	DT	O
allow	NN	O
a	MD	O
potentially	VB	O
very	VBN	O
large	WRB	O
number	JJ	O
of	NNS	O
progeny	IN	O
molecules	NN	O
to	NNS	O
be	VBP	O
examined	VBN	O
systematically	IN	O
in	DT	O
smaller	IN	O
groups.	JJ	O
Because	NN	O
of	.	O
its	DT	O
ability	VBZ	O
to	DT	O
perform	JJ	O
chimerizations	NN	O
in	CC	O
a	JJ	O
manner	NN	O
that	TO	O
is	VB	O
highly	.	O
flexible	,	O
yet	DT	O
exhaustive	NNS	O
and	VBP	O
systematic	DT	O
as	RB	O
well,	RB	O
particularly	JJ	O
when	NN	O
there	IN	O
is	JJ	O
a	NNS	O
low	TO	O
level	VB	O
of	VBN	O
homology	RB	O
among	IN	O
the	JJR	O
progenitor	.	O
molecules,	IN	O
these	IN	O
methods	PRP$	O
provide	NN	O
for	TO	O
the	VB	O
generation	NNS	O
of	IN	O
a	DT	O
library	NN	O
(or	WDT	O
set)	VBZ	O
comprised	RB	O
of	JJ	O
a	RB	O
large	JJ	O
number	CC	O
of	JJ	O
progeny	RB	O
molecules.	,	O
Because	RB	O
of	WRB	O
the	EX	O
non-stochastic	VBZ	O
nature	DT	O
of	JJ	O
the	NN	O
instant	IN	O
ligation	NN	O
reassembly	IN	O
invention,	DT	O
the	NN	O
progeny	,	O
molecules	DT	O
generated	NNS	O
preferably	VBP	O
comprise	IN	O
a	DT	O
library	NN	O
of	IN	O
finalized	DT	O
chimeric	JJ	O
nucleic	CC	O
acid	)	O
molecules	VBD	O
having	IN	O
an	DT	O
overall	JJ	O
assembly	NN	O
order	IN	O
that	JJ	O
is	.	O
chosen	IN	O
by	IN	O
design.	DT	O
The	JJ	O
saturation	NN	O
mutagenesis	IN	O
and	DT	O
optimized	JJ	O
directed	NN	O
evolution	RB	O
methods	,	O
also	DT	O
can	NN	O
be	NNS	O
used	VBD	O
to	RB	O
generate	VB	O
different	DT	O
progeny	NN	O
molecular	IN	O
species.	JJ	O
It	JJ	O
is	NN	O
appreciated	NN	O
that	NNS	O
the	VBG	O
invention	DT	O
provides	JJ	O
freedom	NN	O
of	NN	O
choice	WDT	O
and	VBZ	O
control	VBN	O
regarding	IN	O
the	.	O
selection	DT	O
of	NN	O
demarcation	NN	O
points,	CC	O
the	VBN	O
size	JJ	O
and	NN	O
number	NNS	O
of	RB	O
the	MD	O
nucleic	VB	O
acid	VBN	O
building	TO	O
blocks,	VB	O
and	JJ	O
the	NNS	O
size	JJ	O
and	.	O
design	PRP	O
of	VBZ	O
the	VBN	O
couplings.	IN	O
It	DT	O
is	NN	O
appreciated,	VBZ	O
furthermore,	NN	O
that	IN	O
the	NN	O
requirement	CC	O
for	NN	O
intermolecular	VBG	O
homology	DT	O
is	NN	O
highly	IN	O
relaxed	NN	O
for	,	O
the	DT	O
operability	NN	O
of	CC	O
this	NN	O
invention.	IN	O
In	DT	O
fact,	JJ	O
demarcation	NN	O
points	NN	O
can	,	O
even	CC	O
be	DT	O
chosen	NN	O
in	CC	O
areas	NN	O
of	IN	O
little	DT	O
or	.	O
no	PRP	O
intermolecular	VBZ	O
homology.	,	O
For	,	O
example,	IN	O
because	DT	O
of	NN	O
codon	IN	O
wobble,	JJ	O
i.e.	NN	O
the	VBZ	O
degeneracy	RB	O
of	VBN	O
codons,	IN	O
nucleotide	DT	O
substitutions	NN	O
can	IN	O
be	DT	O
introduced	.	O
into	IN	O
nucleic	,	O
acid	NN	O
building	NNS	O
blocks	MD	O
without	RB	O
altering	VB	O
the	VBN	O
amino	IN	O
acid	NNS	O
originally	IN	O
encoded	JJ	O
in	CC	O
the	DT	O
corresponding	JJ	O
progenitor	.	O
template.	IN	O
Alternatively,	,	O
a	IN	O
codon	IN	O
can	NN	O
be	,	O
altered	.	O
such	DT	O
that	NN	O
the	IN	O
coding	,	O
for	JJ	O
an	NNS	O
originally	MD	O
amino	VB	O
acid	VBN	O
is	IN	O
altered.	JJ	O
This	NN	O
invention	NN	O
provides	NNS	O
that	IN	O
such	VBG	O
substitutions	DT	O
can	NN	O
be	VBZ	O
introduced	RB	O
into	VBN	O
the	IN	O
nucleic	DT	O
acid	JJ	O
building	NN	O
block	.	O
in	,	O
order	DT	O
to	NN	O
increase	MD	O
the	VB	O
incidence	VBN	O
of	JJ	O
intermolecular	IN	O
homologous	DT	O
demarcation	NN	O
points	IN	O
and	DT	O
thus	RB	O
to	JJ	O
allow	NN	O
an	VBZ	O
increased	.	O
number	DT	O
of	NN	O
couplings	VBZ	O
to	IN	O
be	JJ	O
achieved	NNS	O
among	MD	O
the	VB	O
building	VBN	O
blocks,	IN	O
which	DT	O
in	JJ	O
turn	NN	O
allows	NN	O
a	NN	O
greater	IN	O
number	NN	O
of	TO	O
progeny	VB	O
chimeric	DT	O
molecules	NN	O
to	IN	O
be	JJ	O
generated.	JJ	O
In	NN	O
another	NNS	O
aspect,	CC	O
the	RB	O
synthetic	TO	O
nature	VB	O
of	DT	O
the	JJ	O
step	NN	O
in	IN	O
which	NNS	O
the	TO	O
building	VB	O
blocks	VBN	O
are	IN	O
generated	DT	O
allows	NN	O
the	,	O
design	WDT	O
and	IN	O
introduction	NN	O
of	VBZ	O
nucleotides	DT	O
(e.g.,	JJR	O
one	NN	O
or	IN	O
more	JJ	O
nucleotides,	JJ	O
which	NNS	O
may	TO	O
be,	VB	O
for	.	O
example,	IN	O
codons	DT	O
or	,	O
introns	DT	O
or	JJ	O
regulatory	NN	O
sequences)	IN	O
that	DT	O
can	NN	O
later	IN	O
be	WDT	O
optionally	DT	O
removed	NN	O
in	NNS	O
an	VBP	O
in	VBN	O
vitro	IN	O
process	DT	O
(e.g.	NN	O
by	CC	O
mutagenesis)	NN	O
or	IN	O
in	NNS	O
an	,	O
in	CD	O
vivo	CC	O
process	JJR	O
(e.g.	,	O
by	WDT	O
utilizing	MD	O
the	,	O
gene	IN	O
splicing	,	O
ability	NNS	O
of	CC	O
a	NNS	O
host	CC	O
organism).	JJ	O
It	)	O
is	WDT	O
appreciated	MD	O
that	RB	O
in	VB	O
many	RB	O
instances	VBN	O
the	IN	O
introduction	DT	O
of	IN	O
these	NN	O
nucleotides	NN	O
may	.	O
also	IN	O
be	)	O
desirable	CC	O
for	IN	O
many	DT	O
other	IN	O
reasons	NN	O
in	NN	O
addition	.	O
to	IN	O
the	VBG	O
potential	DT	O
benefit	NN	O
of	VBG	O
creating	NN	O
a	IN	O
serviceable	DT	O
demarcation	NN	O
point.	.	O
In	PRP	O
one	VBZ	O
aspect,	VBN	O
a	IN	O
nucleic	IN	O
acid	JJ	O
building	NNS	O
block	DT	O
is	NN	O
used	IN	O
to	DT	O
introduce	NNS	O
an	MD	O
intron.	RB	O
Thus,	VB	O
functional	JJ	O
introns	IN	O
are	JJ	O
introduced	JJ	O
into	NNS	O
a	IN	O
man-made	NN	O
gene	TO	O
manufactured	DT	O
according	JJ	O
to	NN	O
the	IN	O
methods	VBG	O
described	DT	O
herein.	JJ	O
The	NN	O
artificially	.	O
introduced	IN	O
intron(s)	CD	O
can	,	O
be	DT	O
functional	JJ	O
in	NN	O
a	NN	O
host	NN	O
cells	VBZ	O
for	VBN	O
gene	TO	O
splicing	VB	O
much	DT	O
in	.	O
the	,	O
way	JJ	O
that	NNS	O
naturally-occurring	VBP	O
introns	VBN	O
serve	IN	O
functionally	DT	O
in	JJ	O
gene	NN	O
splicing.	VBD	O
Optimized	VBG	O
Directed	TO	O
Evolution	DT	O
System	NNS	O
The	VBD	O
invention	.	O
provides	DT	O
a	RB	O
non-stochastic	VBN	O
gene	)	O
modification	MD	O
system	VB	O
termed	JJ	O
“optimized	IN	O
directed	DT	O
evolution	NN	O
system”	NNS	O
to	IN	O
generate	NN	O
polypeptides,	VBG	O
e.g.,	JJ	O
amylases	IN	O
or	DT	O
antibodies	NN	O
of	IN	O
the	JJ	O
invention,	NNS	O
with	VBP	O
new	RB	O
or	IN	O
altered	NN	O
properties.	.	O
Optimized	VBN	O
directed	NNP	O
evolution	NNP	O
is	NNP	O
directed	DT	O
to	NN	O
the	VBZ	O
use	DT	O
of	JJ	O
repeated	NN	O
cycles	NN	O
of	NN	O
reductive	VBD	O
reassortment,	VBN	O
recombination	JJ	O
and	NN	O
selection	NN	O
that	TO	O
allow	VB	O
for	,	O
the	,	O
directed	VBZ	O
molecular	CC	O
evolution	NNS	O
of	IN	O
nucleic	DT	O
acids	,	O
through	IN	O
recombination.	JJ	O
Optimized	CC	O
directed	JJ	O
evolution	.	O
allows	VBN	O
generation	JJ	O
of	NN	O
a	VBZ	O
large	VBN	O
population	TO	O
of	DT	O
evolved	NN	O
chimeric	IN	O
sequences,	JJ	O
wherein	NNS	O
the	IN	O
generated	JJ	O
population	,	O
is	NN	O
significantly	CC	O
enriched	NN	O
for	WDT	O
sequences	VBP	O
that	IN	O
have	DT	O
a	JJ	O
predetermined	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events.	NNS	O
A	IN	O
crossover	.	O
event	VBN	O
is	JJ	O
a	NN	O
point	VBZ	O
in	NN	O
a	IN	O
chimeric	DT	O
sequence	JJ	O
where	NN	O
a	IN	O
shift	JJ	O
in	JJ	O
sequence	,	O
occurs	VBP	O
from	DT	O
one	JJ	O
parental	NN	O
variant	VBZ	O
to	RB	O
another	VBN	O
parental	IN	O
variant.	NNS	O
Such	WDT	O
a	VBP	O
point	DT	O
is	JJ	O
normally	NN	O
at	IN	O
the	JJ	O
juncture	.	O
of	DT	O
where	NN	O
oligonucleotides	NN	O
from	VBZ	O
two	DT	O
parents	NN	O
are	IN	O
ligated	DT	O
together	JJ	O
to	NN	O
form	WRB	O
a	DT	O
single	NN	O
sequence.	IN	O
This	NN	O
method	NNS	O
allows	IN	O
calculation	CD	O
of	NN	O
the	NN	O
correct	TO	O
concentrations	DT	O
of	JJ	O
oligonucleotide	.	O
sequences	JJ	O
so	DT	O
that	NN	O
the	VBZ	O
final	RB	O
chimeric	IN	O
population	DT	O
of	NN	O
sequences	IN	O
is	WRB	O
enriched	NNS	O
for	IN	O
the	CD	O
chosen	NNS	O
number	VBP	O
of	VBN	O
crossover	RB	O
events.	TO	O
This	VB	O
provides	DT	O
more	JJ	O
control	.	O
over	DT	O
choosing	NN	O
chimeric	VBZ	O
variants	NN	O
having	IN	O
a	DT	O
predetermined	JJ	O
number	NNS	O
of	IN	O
crossover	JJ	O
events.	NNS	O
In	RB	O
addition,	IN	O
this	DT	O
method	JJ	O
provides	JJ	O
a	NN	O
convenient	IN	O
means	NNS	O
for	VBZ	O
exploring	VBN	O
a	IN	O
tremendous	DT	O
amount	JJ	O
of	NN	O
the	IN	O
possible	JJ	O
protein	.	O
variant	DT	O
space	VBZ	O
in	JJR	O
comparison	NN	O
to	IN	O
other	VBG	O
systems.	JJ	O
Previously,	NNS	O
if	VBG	O
one	DT	O
generated,	JJ	O
for	NN	O
example,	IN	O
1013	JJ	O
chimeric	.	O
molecules	IN	O
during	,	O
a	DT	O
reaction,	NN	O
it	VBZ	O
would	DT	O
be	NN	O
extremely	VBZ	O
difficult	IN	O
to	VBG	O
test	DT	O
such	JJ	O
a	NN	O
high	IN	O
number	DT	O
of	JJ	O
chimeric	NN	O
variants	JJ	O
for	NN	O
a	IN	O
particular	NN	O
activity.	TO	O
Moreover,	JJ	O
a	.	O
significant	,	O
portion	IN	O
of	CD	O
the	,	O
progeny	IN	O
population	,	O
would	CD	O
have	JJ	O
a	NNS	O
very	IN	O
high	DT	O
number	,	O
of	PRP	O
crossover	MD	O
events	VB	O
which	RB	O
resulted	JJ	O
in	TO	O
proteins	VB	O
that	PDT	O
were	DT	O
less	JJ	O
likely	NN	O
to	IN	O
have	JJ	O
increased	NNS	O
levels	IN	O
of	DT	O
a	JJ	O
particular	.	O
activity.	,	O
By	DT	O
using	JJ	O
these	NN	O
methods,	IN	O
the	DT	O
population	JJ	O
of	NN	O
chimerics	MD	O
molecules	VB	O
can	DT	O
be	RB	O
enriched	JJ	O
for	NN	O
those	IN	O
variants	NN	O
that	NNS	O
have	WDT	O
a	VBD	O
particular	IN	O
number	NNS	O
of	WDT	O
crossover	VBD	O
events.	RBR	O
Thus,	JJ	O
although	TO	O
one	VB	O
can	VBN	O
still	NNS	O
generate	IN	O
1013	DT	O
chimeric	JJ	O
molecules	.	O
during	IN	O
a	VBG	O
reaction,	DT	O
each	,	O
of	DT	O
the	NN	O
molecules	IN	O
chosen	NNS	O
for	NNS	O
further	MD	O
analysis	VB	O
most	VBN	O
likely	IN	O
has,	DT	O
for	NNS	O
example,	WDT	O
only	VBP	O
three	DT	O
crossover	JJ	O
events.	NN	O
Because	IN	O
the	JJ	O
resulting	.	O
progeny	,	O
population	IN	O
can	CD	O
be	MD	O
skewed	RB	O
to	VB	O
have	CD	O
a	JJ	O
predetermined	NNS	O
number	IN	O
of	DT	O
crossover	,	O
events,	DT	O
the	IN	O
boundaries	DT	O
on	NNS	O
the	VBN	O
functional	IN	O
variety	JJ	O
between	NN	O
the	RBS	O
chimeric	JJ	O
molecules	,	O
is	IN	O
reduced.	,	O
This	RB	O
provides	CD	O
a	NN	O
more	.	O
manageable	IN	O
number	DT	O
of	VBG	O
variables	JJ	O
when	NN	O
calculating	MD	O
which	VB	O
oligonucleotide	VBN	O
from	TO	O
the	VB	O
original	DT	O
parental	JJ	O
polynucleotides	NN	O
might	IN	O
be	JJ	O
responsible	,	O
for	DT	O
affecting	NNS	O
a	IN	O
particular	DT	O
trait.	JJ	O
One	NN	O
method	IN	O
for	DT	O
creating	JJ	O
a	NNS	O
chimeric	VBZ	O
progeny	.	O
polynucleotide	DT	O
sequence	VBZ	O
is	DT	O
to	RBR	O
create	JJ	O
oligonucleotides	NN	O
corresponding	IN	O
to	NNS	O
fragments	WRB	O
or	VBG	O
portions	WDT	O
of	RB	O
each	IN	O
parental	DT	O
sequence.	JJ	O
Each	JJ	O
oligonucleotide	NNS	O
preferably	MD	O
includes	VB	O
a	JJ	O
unique	IN	O
region	VBG	O
of	DT	O
overlap	JJ	O
so	.	O
that	CD	O
mixing	NN	O
the	IN	O
oligonucleotides	VBG	O
together	DT	O
results	JJ	O
in	NN	O
a	NN	O
new	NN	O
variant	VBZ	O
that	TO	O
has	VB	O
each	NNS	O
oligonucleotide	VBG	O
fragment	TO	O
assembled	NNS	O
in	CC	O
the	NNS	O
correct	IN	O
order.	DT	O
Additional	JJ	O
information	.	O
can	DT	O
also	NN	O
be	RB	O
found,	VBZ	O
e.g.,	DT	O
in	JJ	O
U.S.	NN	O
Ser.	IN	O
No.	NNS	O
09/332,835;	IN	O
U.S.	IN	O
Pat.	VBG	O
No.	DT	O
6,361,974.	NNS	O
The	RB	O
number	NNS	O
of	IN	O
oligonucleotides	DT	O
generated	JJ	O
for	NN	O
each	WDT	O
parental	VBZ	O
variant	DT	O
bears	JJ	O
a	NN	O
relationship	VBN	O
to	IN	O
the	DT	O
total	JJ	O
number	.	O
of	JJ	O
resulting	NN	O
crossovers	MD	O
in	RB	O
the	VB	O
chimeric	,	O
molecule	,	O
that	IN	O
is	NNP	O
ultimately	.	O
created.	.	O
For	:	O
example,	NNP	O
three	.	O
parental	.	O
nucleotide	.	O
sequence	DT	O
variants	NN	O
might	IN	O
be	NNS	O
provided	VBN	O
to	IN	O
undergo	DT	O
a	JJ	O
ligation	NN	O
reaction	VBZ	O
in	DT	O
order	NN	O
to	TO	O
find	DT	O
a	JJ	O
chimeric	NN	O
variant	IN	O
having,	VBG	O
for	NNS	O
example,	IN	O
greater	DT	O
activity	JJ	O
at	NN	O
high	WDT	O
temperature.	VBZ	O
As	RB	O
one	.	O
example,	IN	O
a	,	O
set	CD	O
of	JJ	O
50	RB	O
oligonucleotide	NN	O
sequences	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
corresponding	TO	O
to	VB	O
each	DT	O
portions	NN	O
of	NN	O
each	IN	O
parental	NN	O
variant.	TO	O
Accordingly,	VB	O
during	DT	O
the	JJ	O
ligation	NN	O
reassembly	,	O
process	IN	O
there	,	O
could	JJR	O
be	NN	O
up	IN	O
to	JJ	O
50	.	O
crossover	IN	O
events	CD	O
within	,	O
each	DT	O
of	NN	O
the	IN	O
chimeric	CD	O
sequences.	JJ	O
The	NNS	O
probability	MD	O
that	VB	O
each	VBN	O
of	VBG	O
the	TO	O
generated	DT	O
chimeric	NNS	O
polynucleotides	IN	O
will	DT	O
contain	JJ	O
oligonucleotides	.	O
from	,	O
each	IN	O
parental	DT	O
variant	NN	O
in	RB	O
alternating	NN	O
order	EX	O
is	MD	O
very	VB	O
low.	RB	O
If	TO	O
each	CD	O
oligonucleotide	NN	O
fragment	NNS	O
is	IN	O
present	DT	O
in	IN	O
the	DT	O
ligation	JJ	O
reaction	.	O
in	DT	O
the	NN	O
same	IN	O
molar	DT	O
quantity	IN	O
it	DT	O
is	JJ	O
likely	NN	O
that	NNS	O
in	MD	O
some	VB	O
positions	NNS	O
oligonucleotides	IN	O
from	DT	O
the	JJ	O
same	NN	O
parental	IN	O
polynucleotide	VBG	O
will	NN	O
ligate	VBZ	O
next	RB	O
to	.	O
one	IN	O
another	DT	O
and	NN	O
thus	NN	O
not	VBZ	O
result	JJ	O
in	IN	O
a	DT	O
crossover	NN	O
event.	NN	O
If	IN	O
the	DT	O
concentration	JJ	O
of	JJ	O
each	NN	O
oligonucleotide	PRP	O
from	VBZ	O
each	JJ	O
parent	IN	O
is	IN	O
kept	DT	O
constant	NNS	O
during	IN	O
any	IN	O
ligation	DT	O
step	JJ	O
in	JJ	O
this	NN	O
example,	MD	O
there	VB	O
is	JJ	O
a	TO	O
1/3	CD	O
chance	DT	O
(assuming	CC	O
3	RB	O
parents)	RB	O
that	VB	O
an	IN	O
oligonucleotide	DT	O
from	NN	O
the	.	O
same	IN	O
parental	DT	O
variant	NN	O
will	IN	O
ligate	DT	O
within	NN	O
the	IN	O
chimeric	DT	O
sequence	NN	O
and	VBZ	O
produce	JJ	O
no	JJ	O
crossover.	IN	O
Accordingly,	DT	O
a	JJ	O
probability	NN	O
density	IN	O
function	DT	O
(PDF)	,	O
can	EX	O
be	VBZ	O
determined	DT	O
to	JJ	O
predict	NN	O
the	VBG	O
population	CD	O
of	)	O
crossover	IN	O
events	DT	O
that	NN	O
are	IN	O
likely	DT	O
to	JJ	O
occur	JJ	O
during	NN	O
each	MD	O
step	VB	O
in	IN	O
a	DT	O
ligation	JJ	O
reaction	NN	O
given	CC	O
a	VB	O
set	DT	O
number	.	O
of	,	O
parental	DT	O
variants,	NN	O
a	NN	O
number	NN	O
of	)	O
oligonucleotides	MD	O
corresponding	VB	O
to	VBN	O
each	TO	O
variant,	VB	O
and	DT	O
the	NN	O
concentrations	IN	O
of	NN	O
each	NNS	O
variant	WDT	O
during	VBP	O
each	JJ	O
step	TO	O
in	VB	O
the	IN	O
ligation	DT	O
reaction.	NN	O
The	IN	O
statistics	DT	O
and	NN	O
mathematics	NN	O
behind	VBN	O
determining	DT	O
the	NN	O
PDF	NN	O
is	IN	O
described	JJ	O
below.	,	O
By	DT	O
utilizing	NN	O
these	IN	O
methods,	NNS	O
one	VBG	O
can	TO	O
calculate	DT	O
such	,	O
a	CC	O
probability	DT	O
density	NNS	O
function,	IN	O
and	DT	O
thus	NN	O
enrich	IN	O
the	DT	O
chimeric	NN	O
progeny	IN	O
population	DT	O
for	NN	O
a	.	O
predetermined	DT	O
number	NNS	O
of	CC	O
crossover	NNS	O
events	IN	O
resulting	VBG	O
from	DT	O
a	NNP	O
particular	VBZ	O
ligation	VBN	O
reaction.	.	O
Moreover,	IN	O
a	VBG	O
target	DT	O
number	,	O
of	CD	O
crossover	MD	O
events	VB	O
can	JJ	O
be	DT	O
predetermined,	NN	O
and	NN	O
the	,	O
system	CC	O
then	RB	O
programmed	VB	O
to	DT	O
calculate	JJ	O
the	NN	O
starting	NN	O
quantities	IN	O
of	DT	O
each	JJ	O
parental	NN	O
oligonucleotide	IN	O
during	JJ	O
each	NNS	O
step	VBG	O
in	IN	O
the	DT	O
ligation	JJ	O
reaction	NN	O
to	.	O
result	,	O
in	DT	O
a	NN	O
probability	NN	O
density	IN	O
function	JJ	O
that	NNS	O
centers	MD	O
on	VB	O
the	,	O
predetermined	CC	O
number	DT	O
of	NN	O
crossover	RB	O
events.	VBD	O
These	TO	O
methods	VB	O
are	DT	O
directed	VBG	O
to	NNS	O
the	IN	O
use	DT	O
of	JJ	O
repeated	NN	O
cycles	IN	O
of	DT	O
reductive	NN	O
reassortment,	IN	O
recombination	DT	O
and	NN	O
selection	NN	O
that	TO	O
allow	VB	O
for	IN	O
the	DT	O
directed	NN	O
molecular	NN	O
evolution	NN	O
of	WDT	O
a	VBZ	O
nucleic	IN	O
acid	DT	O
encoding	JJ	O
a	NN	O
polypeptide	IN	O
through	JJ	O
recombination.	.	O
This	DT	O
system	NNS	O
allows	VBP	O
generation	VBN	O
of	TO	O
a	DT	O
large	NN	O
population	IN	O
of	JJ	O
evolved	NNS	O
chimeric	IN	O
sequences,	JJ	O
wherein	,	O
the	NN	O
generated	CC	O
population	NN	O
is	WDT	O
significantly	VBP	O
enriched	IN	O
for	DT	O
sequences	JJ	O
that	JJ	O
have	NN	O
a	IN	O
predetermined	DT	O
number	JJ	O
of	NN	O
crossover	VBG	O
events.	DT	O
A	NN	O
crossover	IN	O
event	.	O
is	DT	O
a	NN	O
point	VBZ	O
in	NN	O
a	IN	O
chimeric	DT	O
sequence	JJ	O
where	NN	O
a	IN	O
shift	JJ	O
in	JJ	O
sequence	,	O
occurs	VBP	O
from	DT	O
one	JJ	O
parental	NN	O
variant	VBZ	O
to	RB	O
another	VBN	O
parental	IN	O
variant.	NNS	O
Such	WDT	O
a	VBP	O
point	DT	O
is	JJ	O
normally	NN	O
at	IN	O
the	JJ	O
juncture	.	O
of	DT	O
where	NN	O
oligonucleotides	NN	O
from	VBZ	O
two	DT	O
parents	NN	O
are	IN	O
ligated	DT	O
together	JJ	O
to	NN	O
form	WRB	O
a	DT	O
single	NN	O
sequence.	IN	O
The	NN	O
method	NNS	O
allows	IN	O
calculation	CD	O
of	NN	O
the	NN	O
correct	TO	O
concentrations	DT	O
of	JJ	O
oligonucleotide	.	O
sequences	JJ	O
so	DT	O
that	NN	O
the	VBZ	O
final	RB	O
chimeric	IN	O
population	DT	O
of	NN	O
sequences	IN	O
is	WRB	O
enriched	NNS	O
for	IN	O
the	CD	O
chosen	NNS	O
number	VBP	O
of	VBN	O
crossover	RB	O
events.	TO	O
This	VB	O
provides	DT	O
more	JJ	O
control	.	O
over	DT	O
choosing	NN	O
chimeric	VBZ	O
variants	NN	O
having	IN	O
a	DT	O
predetermined	JJ	O
number	NNS	O
of	IN	O
crossover	JJ	O
events.	NNS	O
In	RB	O
addition,	IN	O
these	DT	O
methods	JJ	O
provide	JJ	O
a	NN	O
convenient	IN	O
means	NNS	O
for	VBZ	O
exploring	VBN	O
a	IN	O
tremendous	DT	O
amount	JJ	O
of	NN	O
the	IN	O
possible	JJ	O
protein	.	O
variant	DT	O
space	VBZ	O
in	JJR	O
comparison	NN	O
to	IN	O
other	VBG	O
systems.	JJ	O
By	NNS	O
using	VBG	O
the	DT	O
methods	JJ	O
described	NN	O
herein,	IN	O
the	JJ	O
population	.	O
of	IN	O
chimerics	,	O
molecules	DT	O
can	NNS	O
be	VBP	O
enriched	DT	O
for	NN	O
those	VBZ	O
variants	IN	O
that	VBG	O
have	DT	O
a	JJ	O
particular	NN	O
number	IN	O
of	DT	O
crossover	JJ	O
events.	NN	O
Thus,	JJ	O
although	NN	O
one	IN	O
can	NN	O
still	TO	O
generate	JJ	O
1013	.	O
chimeric	IN	O
molecules	VBG	O
during	DT	O
a	NNS	O
reaction,	VBD	O
each	,	O
of	DT	O
the	NN	O
molecules	IN	O
chosen	NNS	O
for	NNS	O
further	MD	O
analysis	VB	O
most	VBN	O
likely	IN	O
has,	DT	O
for	NNS	O
example,	WDT	O
only	VBP	O
three	DT	O
crossover	JJ	O
events.	NN	O
Because	IN	O
the	JJ	O
resulting	.	O
progeny	,	O
population	IN	O
can	CD	O
be	MD	O
skewed	RB	O
to	VB	O
have	CD	O
a	JJ	O
predetermined	NNS	O
number	IN	O
of	DT	O
crossover	,	O
events,	DT	O
the	IN	O
boundaries	DT	O
on	NNS	O
the	VBN	O
functional	IN	O
variety	JJ	O
between	NN	O
the	RBS	O
chimeric	JJ	O
molecules	,	O
is	IN	O
reduced.	,	O
This	RB	O
provides	CD	O
a	NN	O
more	.	O
manageable	IN	O
number	DT	O
of	VBG	O
variables	JJ	O
when	NN	O
calculating	MD	O
which	VB	O
oligonucleotide	VBN	O
from	TO	O
the	VB	O
original	DT	O
parental	JJ	O
polynucleotides	NN	O
might	IN	O
be	JJ	O
responsible	,	O
for	DT	O
affecting	NNS	O
a	IN	O
particular	DT	O
trait.	JJ	O
In	NN	O
one	IN	O
aspect,	DT	O
the	JJ	O
method	NNS	O
creates	VBZ	O
a	.	O
chimeric	DT	O
progeny	VBZ	O
polynucleotide	DT	O
sequence	RBR	O
by	JJ	O
creating	NN	O
oligonucleotides	IN	O
corresponding	NNS	O
to	WRB	O
fragments	VBG	O
or	WDT	O
portions	RB	O
of	IN	O
each	DT	O
parental	JJ	O
sequence.	JJ	O
Each	NNS	O
oligonucleotide	MD	O
preferably	VB	O
includes	JJ	O
a	IN	O
unique	VBG	O
region	DT	O
of	JJ	O
overlap	.	O
so	IN	O
that	CD	O
mixing	,	O
the	DT	O
oligonucleotides	NN	O
together	VBZ	O
results	DT	O
in	JJ	O
a	NN	O
new	NN	O
variant	NN	O
that	IN	O
has	VBG	O
each	NNS	O
oligonucleotide	VBG	O
fragment	TO	O
assembled	NNS	O
in	CC	O
the	NNS	O
correct	IN	O
order.	DT	O
See	JJ	O
also	.	O
U.S.	DT	O
Ser.	NN	O
No.	RB	O
09/332,835.	VBZ	O
Determining	DT	O
Crossover	JJ	O
Events	NN	O
Aspects	IN	O
of	NNS	O
the	IN	O
invention	IN	O
include	VBG	O
a	DT	O
system	NNS	O
and	RB	O
software	NNS	O
that	IN	O
receive	DT	O
a	JJ	O
desired	NN	O
crossover	WDT	O
probability	VBZ	O
density	DT	O
function	JJ	O
(PDF),	NN	O
the	VBN	O
number	IN	O
of	DT	O
parent	JJ	O
genes	.	O
to	NNP	O
be	RB	O
reassembled,	NNP	O
and	.	O
the	.	O
number	.	O
of	VBG	O
fragments	NNP	O
in	NNP	O
the	NNP	O
reassembly	IN	O
as	DT	O
inputs.	NN	O
The	VBP	O
output	DT	O
of	NN	O
this	CC	O
program	NN	O
is	WDT	O
a	VBP	O
“fragment	DT	O
PDF”	JJ	O
that	NN	O
can	NN	O
be	NN	O
used	NN	O
to	,	O
determine	DT	O
a	NN	O
recipe	IN	O
for	NN	O
producing	NNS	O
reassembled	TO	O
genes,	VB	O
and	,	O
the	CC	O
estimated	DT	O
crossover	NN	O
PDF	IN	O
of	NNS	O
those	IN	O
genes.	DT	O
The	NN	O
processing	IN	O
described	.	O
herein	DT	O
is	NN	O
preferably	IN	O
performed	DT	O
in	NN	O
MATLAB™	VBZ	O
(The	DT	O
Mathworks,	JJ	O
Natick,	NNP	O
Mass.)	WDT	O
a	MD	O
programming	VB	O
language	VBN	O
and	TO	O
development	VB	O
environment	DT	O
for	NN	O
technical	IN	O
computing.	VBG	O
Iterative	VBN	O
Processes	,	O
In	CC	O
practicing	DT	O
the	VBN	O
invention,	NN	O
these	NNP	O
processes	IN	O
can	DT	O
be	.	O
iteratively	DT	O
repeated.	NN	O
For	JJ	O
example,	NN	O
a	VBZ	O
nucleic	RB	O
acid	VBN	O
(or,	IN	O
the	NNP	O
nucleic	DT	O
acid)	,	O
responsible	,	O
for	)	O
an	DT	O
altered	JJ	O
or	NN	O
new	CC	O
amylase	NN	O
phenotype	NN	O
is	IN	O
identified,	JJ	O
re-isolated,	.	O
again	JJ	O
modified,	NNS	O
re-tested	IN	O
for	VBG	O
activity.	DT	O
This	,	O
process	DT	O
can	NNS	O
be	MD	O
iteratively	VB	O
repeated	RB	O
until	.	O
a	IN	O
desired	,	O
phenotype	DT	O
is	JJ	O
engineered.	NN	O
For	,	O
example,	DT	O
an	JJ	O
entire	)	O
biochemical	JJ	O
anabolic	IN	O
or	DT	O
catabolic	JJ	O
pathway	CC	O
can	JJ	O
be	NN	O
engineered	NN	O
into	VBZ	O
a	,	O
cell,	,	O
including,	RB	O
e.g.,	,	O
starch	JJ	O
hydrolysis	IN	O
activity.	.	O
Similarly,	DT	O
if	NN	O
it	MD	O
is	VB	O
determined	RB	O
that	VBN	O
a	IN	O
particular	DT	O
oligonucleotide	JJ	O
has	NN	O
no	VBZ	O
affect	.	O
at	IN	O
all	,	O
on	DT	O
the	JJ	O
desired	JJ	O
trait	NN	O
(e.g.,	CC	O
a	JJ	O
new	NN	O
amylase	MD	O
phenotype),	VB	O
it	VBN	O
can	IN	O
be	DT	O
removed	,	O
as	,	O
a	,	O
variable	JJ	O
by	NN	O
synthesizing	.	O
larger	,	O
parental	IN	O
oligonucleotides	PRP	O
that	VBZ	O
include	VBN	O
the	IN	O
sequence	DT	O
to	JJ	O
be	NN	O
removed.	VBZ	O
Since	DT	O
incorporating	NN	O
the	IN	O
sequence	DT	O
within	IN	O
a	DT	O
larger	JJ	O
sequence	NN	O
prevents	,	O
any	DT	O
crossover	JJ	O
events,	NN	O
there	,	O
will	PRP	O
no	MD	O
longer	VB	O
be	VBN	O
any	IN	O
variation	DT	O
of	JJ	O
this	IN	O
sequence	VBG	O
in	JJR	O
the	JJ	O
progeny	NNS	O
polynucleotides.	WDT	O
This	VBP	O
iterative	DT	O
practice	NN	O
of	TO	O
determining	VB	O
which	.	O
oligonucleotides	IN	O
are	VBG	O
most	DT	O
related	NN	O
to	IN	O
the	DT	O
desired	JJR	O
trait,	NN	O
and	NNS	O
which	DT	O
are	NN	O
unrelated,	,	O
allows	EX	O
more	MD	O
efficient	RB	O
exploration	RB	O
all	VB	O
of	DT	O
the	NN	O
possible	IN	O
protein	DT	O
variants	NN	O
that	IN	O
might	DT	O
be	NN	O
provide	.	O
a	DT	O
particular	JJ	O
trait	NN	O
or	IN	O
activity.	VBG	O
In	WDT	O
Vivo	NNS	O
Shuffling	VBP	O
In	RBS	O
vivo	JJ	O
shuffling	TO	O
of	DT	O
molecules	JJ	O
is	,	O
use	CC	O
in	WDT	O
methods	VBP	O
of	,	O
the	VBZ	O
invention	RBR	O
that	JJ	O
provide	NN	O
variants	DT	O
of	IN	O
polypeptides	DT	O
of	JJ	O
the	NN	O
invention,	NNS	O
e.g.,	WDT	O
antibodies,	MD	O
amylases,	VB	O
and	VB	O
the	DT	O
like.	JJ	O
In	NN	O
vivo	CC	O
shuffling	.	O
can	IN	O
be	NNP	O
performed	NNP	O
utilizing	IN	O
the	JJ	O
natural	NN	O
property	IN	O
of	NNS	O
cells	VBZ	O
to	NN	O
recombine	IN	O
multimers.	NNS	O
While	IN	O
recombination	DT	O
in	NN	O
vivo	WDT	O
has	VBP	O
provided	NNS	O
the	IN	O
major	NNS	O
natural	IN	O
route	DT	O
to	,	O
molecular	,	O
diversity,	,	O
genetic	,	O
recombination	CC	O
remains	DT	O
a	.	O
relatively	IN	O
complex	JJ	O
process	NN	O
that	MD	O
involves	VB	O
1)	VBN	O
the	VBG	O
recognition	DT	O
of	JJ	O
homologies;	NN	O
2)	IN	O
strand	NNS	O
cleavage,	TO	O
strand	VB	O
invasion,	.	O
and	IN	O
metabolic	NN	O
steps	IN	O
leading	NN	O
to	VBZ	O
the	VBN	O
production	DT	O
of	JJ	O
recombinant	JJ	O
chiasma;	NN	O
and	TO	O
finally	JJ	O
3)	,	O
the	JJ	O
resolution	NN	O
of	VBZ	O
chiasma	DT	O
into	RB	O
discrete	JJ	O
recombined	NN	O
molecules.	WDT	O
The	VBZ	O
formation	)	O
of	DT	O
the	NN	O
chiasma	IN	O
requires	:	O
the	)	O
recognition	NN	O
of	,	O
homologous	NN	O
sequences.	,	O
In	CC	O
one	JJ	O
aspect,	NNS	O
the	VBG	O
invention	TO	O
provides	DT	O
a	NN	O
method	IN	O
for	JJ	O
producing	:	O
a	CC	O
hybrid	RB	O
polynucleotide	)	O
from	DT	O
at	NN	O
least	IN	O
a	NN	O
first	IN	O
polynucleotide	JJ	O
(e.g.,	VBN	O
an	.	O
amylase	DT	O
of	NN	O
the	IN	O
invention)	DT	O
and	NN	O
a	VBZ	O
second	DT	O
polynucleotide	NN	O
(e.g.,	IN	O
an	JJ	O
enzyme,	.	O
such	IN	O
as	CD	O
an	,	O
amylase	DT	O
of	NN	O
the	VBZ	O
invention	DT	O
or	NN	O
any	IN	O
other	VBG	O
amylase,	DT	O
or,	JJ	O
a	NN	O
tag	IN	O
or	IN	O
an	JJS	O
epitope).	DT	O
The	JJ	O
invention	NN	O
can	,	O
be	DT	O
used	NN	O
to	IN	O
produce	DT	O
a	)	O
hybrid	CC	O
polynucleotide	DT	O
by	JJ	O
introducing	NN	O
at	,	O
least	DT	O
a	,	O
first	JJ	O
polynucleotide	IN	O
and	DT	O
a	NN	O
second	IN	O
polynucleotide	DT	O
which	NN	O
share	CC	O
at	DT	O
least	JJ	O
one	,	O
region	,	O
of	DT	O
partial	NN	O
sequence	CC	O
homology	DT	O
into	.	O
a	DT	O
suitable	NN	O
host	MD	O
cell.	VB	O
The	VBN	O
regions	TO	O
of	VB	O
partial	DT	O
sequence	JJ	O
homology	NN	O
promote	IN	O
processes	VBG	O
which	IN	O
result	JJS	O
in	DT	O
sequence	JJ	O
reorganization	NN	O
producing	CC	O
a	DT	O
hybrid	JJ	O
polynucleotide.	NN	O
The	WDT	O
term	NN	O
“hybrid	IN	O
polynucleotide”,	JJS	O
as	CD	O
used	NN	O
herein,	IN	O
is	JJ	O
any	NN	O
nucleotide	NN	O
sequence	IN	O
which	DT	O
results	JJ	O
from	NN	O
the	.	O
method	DT	O
of	NNS	O
the	IN	O
present	JJ	O
invention	NN	O
and	NN	O
contains	NN	O
sequence	VBZ	O
from	WDT	O
at	NN	O
least	IN	O
two	NN	O
original	NN	O
polynucleotide	VBG	O
sequences.	DT	O
Such	JJ	O
hybrid	.	O
polynucleotides	DT	O
can	NN	O
result	NNP	O
from	,	O
intermolecular	IN	O
recombination	VBN	O
events	,	O
which	VBZ	O
promote	DT	O
sequence	JJ	O
integration	NN	O
between	WDT	O
DNA	NNS	O
molecules.	IN	O
In	DT	O
addition,	NN	O
such	IN	O
hybrid	DT	O
polynucleotides	JJ	O
can	NN	O
result	CC	O
from	NNS	O
intramolecular	NN	O
reductive	IN	O
reassortment	IN	O
processes	JJS	O
which	CD	O
utilize	JJ	O
repeated	NN	O
sequences	.	O
to	JJ	O
alter	JJ	O
a	NNS	O
nucleotide	MD	O
sequence	VB	O
within	IN	O
a	JJ	O
DNA	NN	O
molecule.	NNS	O
Producing	WDT	O
Sequence	VBP	O
Variants	NN	O
The	NN	O
invention	IN	O
also	NNP	O
provides	.	O
additional	IN	O
methods	,	O
for	JJ	O
making	JJ	O
sequence	NNS	O
variants	MD	O
of	VB	O
the	IN	O
nucleic	JJ	O
acid	JJ	O
(e.g.,	NN	O
amylase)	VBZ	O
sequences	WDT	O
of	RB	O
the	VBD	O
invention.	NNS	O
The	TO	O
invention	VB	O
also	DT	O
provides	JJ	O
additional	NN	O
methods	IN	O
for	DT	O
isolating	NN	O
amylases	.	O
using	VBG	O
the	NN	O
nucleic	VBZ	O
acids	DT	O
and	NN	O
polypeptides	RB	O
of	VBZ	O
the	JJ	O
invention.	NNS	O
In	IN	O
one	VBG	O
aspect,	JJ	O
the	NNS	O
invention	IN	O
provides	DT	O
for	JJ	O
variants	NN	O
of	,	O
an	)	O
amylase	NNS	O
coding	IN	O
sequence	DT	O
(e.g.,	.	O
a	DT	O
gene,	NN	O
cDNA	RB	O
or	VBZ	O
message)	JJ	O
of	NNS	O
the	IN	O
invention,	VBG	O
which	NNS	O
can	VBG	O
be	DT	O
altered	JJ	O
by	NNS	O
any	CC	O
means,	NNS	O
including,	IN	O
e.g.,	DT	O
random	.	O
or	IN	O
stochastic	CD	O
methods,	,	O
or,	DT	O
non-stochastic,	NN	O
or	VBZ	O
“directed	IN	O
evolution,”	NNS	O
methods,	IN	O
as	DT	O
described	NN	O
above.	VBG	O
The	NN	O
isolated	,	O
variants	DT	O
may	,	O
be	NN	O
naturally	CC	O
occurring.	)	O
Variant	IN	O
can	DT	O
also	,	O
be	WDT	O
created	MD	O
in	VB	O
vitro.	VBN	O
Variants	IN	O
may	DT	O
be	,	O
created	,	O
using	,	O
genetic	NN	O
engineering	CC	O
techniques	JJ	O
such	,	O
as	,	O
site	,	O
directed	CC	O
mutagenesis,	VBN	O
random	NNP	O
chemical	,	O
mutagenesis,	IN	O
Exonuclease	VBN	O
III	.	O
deletion	DT	O
procedures,	JJ	O
and	NNS	O
standard	MD	O
cloning	VB	O
techniques.	RB	O
Alternatively,	.	O
such	NN	O
variants,	MD	O
fragments,	RB	O
analogs,	VB	O
or	VBN	O
derivatives	IN	O
may	.	O
be	NNS	O
created	MD	O
using	VB	O
chemical	VBN	O
synthesis	VBG	O
or	JJ	O
modification	NN	O
procedures.	NNS	O
Other	JJ	O
methods	IN	O
of	NN	O
making	VBN	O
variants	,	O
are	JJ	O
also	NN	O
familiar	,	O
to	NNP	O
those	NNP	O
skilled	NN	O
in	,	O
the	CC	O
art.	JJ	O
These	NN	O
include	.	O
procedures	,	O
in	JJ	O
which	,	O
nucleic	,	O
acid	,	O
sequences	CC	O
obtained	NNS	O
from	MD	O
natural	VB	O
isolates	VBN	O
are	VBG	O
modified	JJ	O
to	NN	O
generate	CC	O
nucleic	NN	O
acids	.	O
which	JJ	O
encode	NNS	O
polypeptides	IN	O
having	VBG	O
characteristics	NNS	O
which	VBP	O
enhance	RB	O
their	JJ	O
value	TO	O
in	DT	O
industrial	VBN	O
or	IN	O
laboratory	DT	O
applications.	.	O
In	DT	O
such	VBP	O
procedures,	NNS	O
a	IN	O
large	WDT	O
number	JJ	O
of	NN	O
variant	NNS	O
sequences	VBN	O
having	IN	O
one	JJ	O
or	NNS	O
more	VBP	O
nucleotide	VBN	O
differences	TO	O
with	VB	O
respect	JJ	O
to	NNS	O
the	WDT	O
sequence	VBP	O
obtained	NNS	O
from	VBG	O
the	NNS	O
natural	WDT	O
isolate	VBP	O
are	PRP$	O
generated	NN	O
and	IN	O
characterized.	JJ	O
These	CC	O
nucleotide	JJ	O
differences	.	O
can	IN	O
result	JJ	O
in	,	O
amino	DT	O
acid	JJ	O
changes	NN	O
with	IN	O
respect	JJ	O
to	NNS	O
the	VBG	O
polypeptides	CD	O
encoded	CC	O
by	JJR	O
the	JJ	O
nucleic	NNS	O
acids	IN	O
from	NN	O
the	TO	O
natural	DT	O
isolates.	NN	O
For	VBN	O
example,	IN	O
variants	DT	O
may	JJ	O
be	NN	O
created	VBP	O
using	VBN	O
error	CC	O
prone	.	O
PCR.	DT	O
In	JJ	O
error	NNS	O
prone	MD	O
PCR,	VB	O
PCR	IN	O
is	NN	O
performed	NN	O
under	NNS	O
conditions	IN	O
where	NN	O
the	TO	O
copying	DT	O
fidelity	NNS	O
of	VBN	O
the	IN	O
DNA	DT	O
polymerase	JJ	O
is	NNS	O
low,	IN	O
such	DT	O
that	JJ	O
a	.	O
high	IN	O
rate	,	O
of	NNS	O
point	MD	O
mutations	VB	O
is	VBN	O
obtained	VBG	O
along	NN	O
the	NN	O
entire	.	O
length	IN	O
of	NN	O
the	NN	O
PCR	,	O
product.	NNP	O
Error	VBZ	O
prone	VBN	O
PCR	IN	O
is	NNS	O
described,	WRB	O
e.g.,	DT	O
in	NN	O
Leung,	NN	B
D.	IN	I
W.,	DT	I
et	NNP	I
al.,	NN	I
Technique,	VBZ	I
1:11-15,	,	I
1989)	JJ	I
and	IN	O
Caldwell,	DT	B
R.	JJ	I
C.	NN	I
&	IN	I
Joyce	NN	I
G.	NNS	I
F.,	VBZ	I
PCR	VBN	I
Methods	IN	I
Applic.,	DT	I
2:28-33,	JJ	I
1992.	NN	I
Briefly,	IN	O
in	DT	O
such	NNP	O
procedures,	.	O
nucleic	NNP	O
acids	NN	O
to	NNP	O
be	VBZ	O
mutagenized	,	O
are	,	O
mixed	IN	O
with	,	O
PCR	NNP	O
primers,	,	O
reaction	FW	O
buffer,	,	O
MgCl2,	,	O
MnCl2,	,	O
Taq	)	O
polymerase	CC	O
and	,	O
an	NNP	O
appropriate	NNP	O
concentration	CC	O
of	NNP	O
dNTPs	NNP	O
for	,	O
achieving	NNP	O
a	NNP	O
high	,	O
rate	,	O
of	.	O
point	,	O
mutation	IN	O
along	JJ	O
the	,	O
entire	JJ	O
length	NNS	O
of	TO	O
the	VB	O
PCR	VBN	O
product.	VBP	O
For	JJ	O
example,	IN	O
the	NNP	O
reaction	,	O
may	NN	O
be	,	O
performed	,	O
using	,	O
20	NNP	O
fmoles	NN	O
of	CC	O
nucleic	DT	O
acid	JJ	O
to	NN	O
be	IN	O
mutagenized,	NN	O
30	IN	O
pmole	VBG	O
of	DT	O
each	JJ	O
PCR	NN	O
primer,	IN	O
a	NN	O
reaction	NN	O
buffer	IN	O
comprising	DT	O
50	JJ	O
mM	NN	O
KCl,	IN	O
10	DT	O
mM	NNP	O
Tris	.	O
HCl	IN	O
(pH	,	O
8.3)	DT	O
and	NN	O
0.01%	MD	O
gelatin,	VB	O
7	VBN	O
mM	VBG	O
MgCl2,	CD	O
0.5	NNS	O
mM	IN	O
MnCl2,	JJ	O
5	NN	O
units	TO	O
of	VB	O
Taq	,	O
polymerase,	CD	O
0.2	NN	O
mM	IN	O
dGTP,	DT	O
0.2	NNP	O
mM	,	O
dATP,	DT	O
1	NN	O
mM	NN	O
dCTP,	VBG	O
and	CD	O
1	JJ	O
mM	,	O
dTTP.	CD	O
PCR	NN	O
may	NNP	O
be	NNP	O
performed	VB	O
for	)	O
30	CC	O
cycles	NN	O
of	,	O
94°	CD	O
C.	NN	O
for	,	O
1	CD	O
min,	NN	O
45°	,	O
C.	CD	O
for	NNS	O
1	IN	O
min,	NNP	O
and	,	O
72°	CD	O
C.	NN	O
for	,	O
1	CD	O
min.	NN	O
However,	,	O
it	CD	O
will	NN	O
be	,	O
appreciated	CC	O
that	CD	O
these	NN	O
parameters	.	O
may	NN	O
be	MD	O
varied	VB	O
as	VBN	O
appropriate.	IN	O
The	CD	O
mutagenized	NNS	O
nucleic	IN	O
acids	CD	O
are	NNP	O
cloned	IN	O
into	CD	O
an	,	O
appropriate	CD	O
vector	NNP	O
and	IN	O
the	CD	O
activities	,	O
of	CC	O
the	CD	O
polypeptides	NNP	O
encoded	IN	O
by	CD	O
the	.	O
mutagenized	,	O
nucleic	PRP	O
acids	MD	O
is	VB	O
evaluated.	VBN	O
Variants	IN	O
may	DT	O
also	NNS	O
be	MD	O
created	VB	O
using	VBN	O
oligonucleotide	IN	O
directed	.	O
mutagenesis	DT	O
to	JJ	O
generate	JJ	O
site-specific	NNS	O
mutations	VBP	O
in	VBN	O
any	IN	O
cloned	DT	O
DNA	JJ	O
of	NN	O
interest.	CC	O
Oligonucleotide	DT	O
mutagenesis	NNS	O
is	IN	O
described,	DT	O
e.g.,	NNS	O
in	VBN	O
Reidhaar-Olson	IN	B
(1988)	DT	I
Science	JJ	I
241:53-57.	JJ	I
Briefly,	NNS	O
in	VBZ	O
such	.	O
procedures	NNS	O
a	MD	O
plurality	RB	O
of	VB	O
double	VBN	O
stranded	VBG	O
oligonucleotides	RB	O
bearing	VBN	O
one	NN	O
or	TO	O
more	VB	O
mutations	JJ	O
to	NNS	O
be	IN	O
introduced	DT	O
into	JJ	O
the	NN	O
cloned	IN	O
DNA	.	O
are	IN	O
synthesized	NN	O
and	VBZ	O
inserted	,	O
into	,	O
the	IN	O
cloned	NNP	O
DNA	)	O
to	NNP	O
be	.	O
mutagenized.	,	O
Clones	IN	O
containing	JJ	O
the	NNS	O
mutagenized	DT	O
DNA	NN	O
are	IN	O
recovered	JJ	O
and	JJ	O
the	NNS	O
activities	VBG	O
of	CD	O
the	CC	O
polypeptides	JJR	O
they	NNS	O
encode	TO	O
are	VB	O
assessed.	VBN	O
Another	IN	O
method	DT	O
for	VBN	O
generating	NN	O
variants	VBP	O
is	VBN	O
assembly	CC	O
PCR.	VBN	O
Assembly	IN	O
PCR	DT	O
involves	JJ	O
the	NN	O
assembly	TO	O
of	VB	O
a	.	O
PCR	NNS	O
product	VBG	O
from	DT	O
a	VBN	O
mixture	NN	O
of	VBP	O
small	VBN	O
DNA	CC	O
fragments.	DT	O
A	NNS	O
large	IN	O
number	DT	O
of	NNS	O
different	PRP	O
PCR	VBP	O
reactions	VBP	O
occur	.	O
in	DT	O
parallel	NN	O
in	IN	O
the	VBG	O
same	NNS	O
vial,	VBZ	O
with	RB	O
the	.	O
products	RB	O
of	NNP	O
one	VBZ	O
reaction	DT	O
priming	NN	O
the	IN	O
products	DT	O
of	NNP	O
another	NN	O
reaction.	IN	O
Assembly	DT	O
PCR	NN	O
is	IN	O
described	JJ	O
in,	NNP	O
e.g.,	.	O
U.S.	DT	O
Pat.	JJ	O
No.	NN	O
5,965,408.	IN	O
Still	JJ	O
another	NNP	O
method	NNS	O
of	VBP	O
generating	IN	O
variants	NN	O
is	IN	O
sexual	DT	O
PCR	JJ	O
mutagenesis.	,	O
In	IN	O
sexual	DT	O
PCR	NNS	O
mutagenesis,	IN	O
forced	CD	O
homologous	NN	O
recombination	VBG	O
occurs	DT	O
between	NNS	O
DNA	IN	O
molecules	DT	O
of	.	O
different	RB	O
but	NNP	O
highly	VBZ	O
related	VBN	O
DNA	,	O
sequence	,	O
in	NNP	O
vitro,	.	O
as	.	O
a	.	O
result	RB	O
of	DT	O
random	NN	O
fragmentation	IN	O
of	VBG	O
the	NNS	O
DNA	VBZ	O
molecule	JJ	O
based	NNP	O
on	.	O
sequence	IN	O
homology,	JJ	O
followed	NNP	O
by	,	O
fixation	VBD	O
of	JJ	O
the	NN	O
crossover	VBZ	O
by	IN	O
primer	NNP	O
extension	NNS	O
in	IN	O
a	JJ	O
PCR	CC	O
reaction.	RB	O
Sexual	JJ	O
PCR	NNP	O
mutagenesis	NN	O
is	IN	O
described,	,	O
e.g.,	IN	O
in	DT	O
Stemmer	NN	B
(1994)	IN	I
Proc.	JJ	I
Natl.	NN	I
Acad.	IN	I
Sci.	DT	I
USA	NNP	I
91:10747-10751.	NN	I
Briefly,	VBN	O
in	IN	O
such	NN	O
procedures	,	O
a	VBN	O
plurality	IN	O
of	NN	O
nucleic	IN	O
acids	DT	O
to	NN	O
be	IN	O
recombined	JJ	O
are	NN	O
digested	IN	O
with	DT	O
DNase	NNP	O
to	.	O
generate	JJ	O
fragments	NNP	O
having	NN	O
an	VBZ	O
average	,	O
size	,	O
of	IN	O
50-200	NNP	O
nucleotides.	)	O
Fragments	.	O
of	.	O
the	.	O
desired	.	O
average	NNP	O
size	.	O
are	,	O
purified	IN	O
and	JJ	O
resuspended	NNS	O
in	DT	O
a	NN	O
PCR	IN	O
mixture.	JJ	O
PCR	NNS	O
is	TO	O
conducted	VB	O
under	VBN	O
conditions	VBP	O
which	VBN	O
facilitate	IN	O
recombination	NNP	O
between	TO	O
the	VB	O
nucleic	NNS	O
acid	VBG	O
fragments.	DT	O
For	JJ	O
example,	NN	O
PCR	IN	O
may	JJ	O
be	.	O
performed	NNS	O
by	IN	O
resuspending	DT	O
the	JJ	O
purified	JJ	O
fragments	NN	O
at	VBP	O
a	VBN	O
concentration	CC	O
of	VBN	O
10-30	IN	O
ng/:1	DT	O
in	NNP	O
a	.	O
solution	NNP	O
of	VBZ	O
0.2	VBN	O
mM	IN	O
of	NNS	O
each	WDT	O
dNTP,	VBP	O
2.2	NN	O
mM	IN	O
MgCl2,	DT	O
50	JJ	O
mM	NN	O
KCL,	.	O
10	IN	O
mM	,	O
Tris	NNP	O
HCl,	MD	O
pH	VB	O
9.0,	VBN	O
and	IN	O
0.1%	VBG	O
Triton	DT	O
X-100.	JJ	O
2.5	NNS	O
units	IN	O
of	DT	O
Taq	NN	O
polymerase	IN	O
per	JJ	O
100:1	NN	O
of	IN	O
reaction	DT	O
mixture	NN	O
is	IN	O
added	CD	O
and	NNS	O
PCR	IN	O
is	DT	O
performed	,	O
using	CD	O
the	NN	O
following	,	O
regime:	CD	O
94°	NN	O
C.	,	O
for	CD	O
60	NN	O
seconds,	NNP	O
94°	,	O
C.	NN	O
for	,	O
30	CC	O
seconds,	NN	O
50-55°	NNP	O
C.	.	O
for	CD	O
30	NNS	O
seconds,	IN	O
72°	NNP	O
C.	NN	O
for	IN	O
30	CD	O
seconds	IN	O
(30-45	NN	O
times)	NN	O
and	VBZ	O
72°	VBN	O
C.	CC	O
for	NNP	O
5	VBZ	O
minutes.	VBN	O
However,	VBG	O
it	DT	O
will	JJ	O
be	:	O
appreciated	CD	O
that	NNP	O
these	IN	O
parameters	CD	O
may	,	O
be	CD	O
varied	NNP	O
as	IN	O
appropriate.	CD	O
In	,	O
some	JJ	O
aspects,	NNP	O
oligonucleotides	IN	O
may	CD	O
be	,	O
included	CD	O
in	NNP	O
the	IN	O
PCR	CD	O
reactions.	NNS	O
In	JJ	O
other	)	O
aspects,	CC	O
the	CD	O
Klenow	NNP	O
fragment	IN	O
of	CD	O
DNA	.	O
polymerase	,	O
I	PRP	O
may	MD	O
be	VB	O
used	VBN	O
in	IN	O
a	DT	O
first	NNS	O
set	MD	O
of	VB	O
PCR	VBN	O
reactions	IN	O
and	.	O
Taq	IN	O
polymerase	DT	O
may	,	O
be	NNS	O
used	MD	O
in	VB	O
a	VBN	O
subsequent	IN	O
set	DT	O
of	NNP	O
PCR	.	O
reactions.	IN	O
Recombinant	JJ	O
sequences	,	O
are	DT	O
isolated	NNP	O
and	NN	O
the	IN	O
activities	NNP	O
of	NN	O
the	PRP	O
polypeptides	MD	O
they	VB	O
encode	VBN	O
are	IN	O
assessed.	DT	O
Variants	JJ	O
may	NN	O
also	IN	O
be	NNP	O
created	NNS	O
by	CC	O
in	NNP	O
vivo	NN	O
mutagenesis.	MD	O
In	VB	O
some	VBN	O
aspects,	IN	O
random	DT	O
mutations	JJ	O
in	NN	O
a	IN	O
sequence	NNP	O
of	.	O
interest	JJ	O
are	NNS	O
generated	VBP	O
by	VBN	O
propagating	CC	O
the	DT	O
sequence	NNS	O
of	IN	O
interest	DT	O
in	NNS	O
a	PRP	O
bacterial	VBP	O
strain,	VBP	O
such	.	O
as	NNS	O
an	MD	O
E.	RB	O
coli	VB	O
strain,	VBN	O
which	IN	O
carries	IN	O
mutations	JJ	O
in	.	O
one	IN	O
or	DT	O
more	,	O
of	JJ	O
the	NNS	O
DNA	IN	O
repair	DT	O
pathways.	NN	O
Such	IN	O
“mutator”	NN	O
strains	VBP	O
have	VBN	O
a	IN	O
higher	VBG	O
random	DT	O
mutation	NN	O
rate	IN	O
than	NN	O
that	IN	O
of	DT	O
a	JJ	O
wild-type	,	O
parent.	JJ	O
Propagating	IN	O
the	DT	O
DNA	NNP	O
in	NNS	O
one	,	O
of	WDT	O
these	VBZ	O
strains	NNS	O
will	IN	O
eventually	CD	O
generate	CC	O
random	JJR	O
mutations	IN	O
within	DT	O
the	NNP	O
DNA.	NN	O
Mutator	.	O
strains	JJ	O
suitable	NN	O
for	NNS	O
use	VBP	O
for	DT	O
in	JJR	O
vivo	JJ	O
mutagenesis	NN	O
are	NN	O
described,	IN	O
e.g.,	DT	O
in	IN	O
PCT	DT	O
Publication	JJ	O
No.	.	O
WO	VBG	O
91/16427.	DT	O
Variants	NN	O
may	IN	O
also	CD	O
be	IN	O
generated	DT	O
using	NNS	O
cassette	MD	O
mutagenesis.	RB	O
In	VB	O
cassette	NN	O
mutagenesis	NNS	O
a	IN	O
small	DT	O
region	.	O
of	NNP	O
a	VBZ	O
double	JJ	O
stranded	IN	O
DNA	NN	O
molecule	IN	O
is	IN	O
replaced	JJ	O
with	NN	O
a	VBP	O
synthetic	,	O
oligonucleotide	,	O
“cassette”	IN	O
that	NNP	O
differs	NNP	O
from	.	O
the	$	O
native	.	O
sequence.	NNS	O
The	MD	O
oligonucleotide	RB	O
often	VB	O
contains	VBN	O
completely	VBG	O
and/or	JJ	O
partially	.	O
randomized	IN	O
native	NN	O
sequence.	NN	O
Recursive	DT	O
ensemble	JJ	O
mutagenesis	NN	O
may	IN	O
also	DT	O
be	JJ	O
used	JJ	O
to	NN	O
generate	NN	O
variants.	VBZ	O
Recursive	VBN	O
ensemble	IN	O
mutagenesis	DT	O
is	JJ	O
an	NN	O
algorithm	NN	O
for	WDT	O
protein	VBZ	O
engineering	IN	O
(protein	DT	O
mutagenesis)	JJ	O
developed	.	O
to	DT	O
produce	NN	O
diverse	RB	O
populations	VBZ	O
of	RB	O
phenotypically	JJ	O
related	RB	O
mutants	VBN	O
whose	JJ	O
members	.	O
differ	NNP	O
in	JJ	O
amino	NN	O
acid	MD	O
sequence.	RB	O
This	VB	O
method	VBN	O
uses	TO	O
a	VB	O
feedback	.	O
mechanism	NNP	O
to	JJ	O
control	NN	O
successive	VBZ	O
rounds	DT	O
of	NN	O
combinatorial	IN	O
cassette	NN	O
mutagenesis.	NN	O
Recursive	JJ	O
ensemble	)	O
mutagenesis	VBD	O
is	TO	O
described,	VB	O
e.g.,	JJ	O
in	NNS	O
Arkin	IN	B
(1992)	RB	I
Proc.	JJ	I
Natl.	NNS	I
Acad.	WP$	I
Sci.	NNS	I
USA	VBP	I
89:7811-7815.
In	IN	O
some	NN	O
aspects,	NN	O
variants	.	O
are	DT	O
created	NN	O
using	VBZ	O
exponential	DT	O
ensemble	NN	O
mutagenesis.	NN	O
Exponential	TO	O
ensemble	VB	O
mutagenesis	JJ	O
is	NNS	O
a	IN	O
process	JJ	O
for	NN	O
generating	.	O
combinatorial	NNP	O
libraries	JJ	O
with	NN	O
a	VBZ	O
high	,	O
percentage	,	O
of	IN	O
unique	NNP	O
and	)	O
functional	.	O
mutants,	.	O
wherein	.	O
small	.	O
groups	NNP	O
of	.	O
residues	IN	O
are	DT	O
randomized	,	O
in	NNS	O
parallel	VBP	O
to	VBN	O
identify,	VBG	O
at	JJ	O
each	JJ	O
altered	.	O
position,	NNP	O
amino	JJ	O
acids	NN	O
which	VBZ	O
lead	DT	O
to	NN	O
functional	IN	O
proteins.	VBG	O
Exponential	JJ	O
ensemble	NNS	O
mutagenesis	IN	O
is	DT	O
described,	JJ	O
e.g.,	NN	O
in	IN	O
Delegrave	NN	B
(1993)	CC	I
Biotechnology	JJ	I
Res.	,	I
11:1548-1552.	VBP	I
Random	JJ	O
and	NNS	O
site-directed	IN	O
mutagenesis	NNS	O
are	VBP	O
described,	VBN	O
e.g.,	IN	O
in	NN	O
Arnold	TO	B
(1993)	,	I
Current	IN	I
Opinion	DT	I
in	JJ	I
Biotechnology	,	I
4:450-455.
In	NN	O
some	NNS	O
aspects,	WDT	O
the	VBP	O
variants	TO	O
are	JJ	O
created	.	O
using	NNP	O
shuffling	JJ	O
procedures	NN	O
wherein	VBZ	O
portions	,	O
of	,	O
a	IN	O
plurality	NNP	O
of	)	O
nucleic	NNP	O
acids	.	O
which	.	O
encode	NNP	O
distinct	CC	O
polypeptides	JJ	O
are	NN	O
fused	VBP	O
together	,	O
to	,	O
create	IN	O
chimeric	NNP	O
nucleic	)	O
acid	NNP	O
sequences	NNP	O
which	IN	O
encode	NNP	O
chimeric	.	O
polypeptides	IN	O
as	DT	O
described	,	O
in,	DT	O
e.g.,	NNS	O
U.S.	VBP	O
Pat.	VBN	O
Nos.	VBG	O
5,965,408;	VBG	O
5,939,250	NNS	O
(see	JJ	O
also	NNS	O
discussion,	IN	O
above).	DT	O
The	NN	O
invention	IN	O
also	JJ	O
provides	NNS	O
variants	WDT	O
of	VBP	O
polypeptides	JJ	O
of	NNS	O
the	VBP	O
invention	VBN	O
(e.g.,	RB	O
amylases)	TO	O
comprising	VB	O
sequences	JJ	O
in	JJ	O
which	NN	O
one	NNS	O
or	WDT	O
more	VBP	O
of	JJ	O
the	NNS	O
amino	IN	O
acid	NN	O
residues	,	O
(e.g.,	,	O
of	NNP	O
an	.	O
exemplary	.	O
polypeptide	:	O
of	CD	O
the	VB	O
invention)	RB	O
are	,	O
substituted	.	O
with	DT	O
a	NN	O
conserved	RB	O
or	VBZ	O
non-conserved	NNS	O
amino	IN	O
acid	NNS	O
residue	IN	O
(e.g.,	DT	O
a	NN	O
conserved	,	O
amino	)	O
acid	VBG	O
residue)	NNS	O
and	IN	O
such	WDT	O
substituted	CD	O
amino	CC	O
acid	JJR	O
residue	IN	O
may	DT	O
or	NN	O
may	NN	O
not	NNS	O
be	,	O
one	IN	O
encoded	DT	O
by	JJ	O
the	NN	O
genetic	IN	O
code.	DT	O
Conservative	)	O
substitutions	VBP	O
are	VBN	O
those	IN	O
that	DT	O
substitute	JJ	O
a	CC	O
given	JJ	O
amino	NN	O
acid	NN	O
in	NN	O
a	,	O
polypeptide	DT	O
by	VBN	O
another	NN	O
amino	NN	O
acid	)	O
of	CC	O
like	JJ	O
characteristics.	VBN	O
Thus,	NN	O
polypeptides	NNS	O
of	VBP	O
the	MD	O
invention	CC	O
include	MD	O
those	RB	O
with	VB	O
conservative	CD	O
substitutions	VBN	O
of	IN	O
sequences	DT	O
of	JJ	O
the	.	O
invention,	JJ	O
e.g.,	NNS	O
the	VBP	O
exemplary	DT	O
polypeptides	IN	O
of	VBP	O
the	DT	O
invention,	VBN	O
including	NN	O
but	NN	O
not	IN	O
limited	DT	O
to	NN	O
the	IN	O
following	DT	O
replacements:	NN	O
replacements	NN	O
of	IN	O
an	IN	O
aliphatic	.	O
amino	,	O
acid	NNS	O
such	IN	O
as	DT	O
Alanine,	NN	O
Valine,	VBP	O
Leucine	DT	O
and	IN	O
Isoleucine	JJ	O
with	NNS	O
another	IN	O
aliphatic	NNS	O
amino	IN	O
acid;	DT	O
replacement	,	O
of	,	O
a	DT	O
Serine	JJ	O
with	NNS	O
a	IN	O
Threonine	DT	O
or	,	O
vice	VBG	O
versa;	CC	O
replacement	RB	O
of	JJ	O
an	TO	O
acidic	DT	O
residue	JJ	O
such	:	O
as	NNS	O
Aspartic	IN	O
acid	DT	O
and	JJ	O
Glutamic	NN	O
acid	NN	O
with	JJ	O
another	IN	O
acidic	,	O
residue;	,	O
replacement	NNP	O
of	CC	O
a	NNP	O
residue	IN	O
bearing	DT	O
an	JJ	O
amide	NN	O
group,	:	O
such	NN	O
as	IN	O
Asparagine	DT	O
and	NNP	O
Glutamine,	IN	O
with	DT	O
another	NNP	O
residue	CC	O
bearing	NN	O
an	:	O
amide	NN	O
group;	IN	O
exchange	DT	O
of	JJ	O
a	NN	O
basic	JJ	O
residue	IN	O
such	JJ	O
as	NN	O
Lysine	CC	O
and	NNP	O
Arginine	NN	O
with	IN	O
another	DT	O
basic	JJ	O
residue;	:	O
and	NN	O
replacement	IN	O
of	DT	O
an	JJ	O
aromatic	NN	O
residue	DT	O
such	NN	O
as	,	O
Phenylalanine,	JJ	O
Tyrosine	IN	O
with	NNP	O
another	CC	O
aromatic	,	O
residue.	IN	O
Other	DT	O
variants	JJ	O
are	VBG	O
those	DT	O
in	JJ	O
which	:	O
one	NN	O
or	IN	O
more	DT	O
of	JJ	O
the	NN	O
amino	JJ	O
acid	IN	O
residues	NNP	O
of	CC	O
the	NNP	O
polypeptides	IN	O
of	DT	O
the	JJ	O
invention	:	O
includes	CC	O
a	NN	O
substituent	IN	O
group.	DT	O
Other	JJ	O
variants	NN	O
within	JJ	O
the	IN	O
scope	,	O
of	NNP	O
the	IN	O
invention	DT	O
are	JJ	O
those	.	O
in	JJ	O
which	NNS	O
the	VBP	O
polypeptide	DT	O
is	IN	O
associated	WDT	O
with	CD	O
another	CC	O
compound,	JJR	O
such	IN	O
as	DT	O
a	NN	O
compound	NN	O
to	NNS	O
increase	IN	O
the	DT	O
half-life	NNS	O
of	IN	O
the	DT	O
polypeptide,	NN	O
for	VBZ	O
example,	DT	O
polyethylene	NN	O
glycol.	.	O
Additional	JJ	O
variants	NNS	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
those	DT	O
in	IN	O
which	WDT	O
additional	DT	O
amino	NN	O
acids	VBZ	O
are	VBN	O
fused	IN	O
to	DT	O
the	,	O
polypeptide,	JJ	O
such	IN	O
as	DT	O
a	NN	O
leader	TO	O
sequence,	VB	O
a	DT	O
secretory	NN	O
sequence,	IN	O
a	DT	O
proprotein	,	O
sequence	IN	O
or	,	O
a	NN	O
sequence	.	O
which	JJ	O
facilitates	NNS	O
purification,	IN	O
enrichment,	DT	O
or	NN	O
stabilization	IN	O
of	DT	O
the	NN	O
polypeptide.	VBP	O
In	DT	O
some	IN	O
aspects,	WDT	O
the	JJ	O
variants,	NN	O
fragments,	NNS	O
derivatives	VBP	O
and	VBN	O
analogs	TO	O
of	DT	O
the	,	O
polypeptides	JJ	O
of	IN	O
the	DT	O
invention	NN	O
retain	,	O
the	DT	O
same	JJ	O
biological	,	O
function	DT	O
or	JJ	O
activity	NN	O
as	CC	O
the	DT	O
exemplary	NN	O
polypeptides,	WDT	O
e.g.,	VBZ	O
amylase	,	O
activity,	,	O
as	CC	O
described	NN	O
herein.	IN	O
In	DT	O
other	.	O
aspects,	IN	O
the	DT	O
variant,	,	O
fragment,	DT	O
derivative,	,	O
or	,	O
analog	NNS	O
includes	CC	O
a	NNS	O
proprotein,	IN	O
such	DT	O
that	NNS	O
the	IN	O
variant,	DT	O
fragment,	NN	O
derivative,	VBP	O
or	DT	O
analog	JJ	O
can	JJ	O
be	NN	O
activated	CC	O
by	NN	O
cleavage	IN	O
of	DT	O
the	JJ	O
proprotein	,	O
portion	,	O
to	NN	O
produce	,	O
an	IN	O
active	VBN	O
polypeptide.	.	O
Optimizing	IN	O
Codons	JJ	O
to	,	O
Achieve	DT	O
High	,	O
Levels	,	O
of	,	O
Protein	CC	O
Expression	NN	O
in	VBZ	O
Host	DT	O
Cells	,	O
The	JJ	O
invention	IN	O
provides	DT	O
methods	,	O
for	,	O
modifying	,	O
amylase-encoding	CC	O
nucleic	NN	O
acids	MD	O
to	VB	O
modify	VBN	O
codon	IN	O
usage.	NN	O
In	IN	O
one	DT	O
aspect,	NN	O
the	NN	O
invention	TO	O
provides	VB	O
methods	DT	O
for	JJ	O
modifying	.	O
codons	VBG	O
in	NNS	O
a	TO	O
nucleic	NNP	O
acid	NNP	O
encoding	NNP	O
an	IN	O
amylase	NNP	O
to	NNP	O
increase	IN	O
or	NNP	O
decrease	NNP	O
its	DT	O
expression	NN	O
in	VBZ	O
a	NNS	O
host	IN	O
cell.	VBG	O
The	JJ	O
invention	JJ	O
also	NNS	O
provides	TO	O
nucleic	VB	O
acids	JJ	O
encoding	.	O
an	IN	O
amylase	CD	O
modified	,	O
to	DT	O
increase	NN	O
its	VBZ	O
expression	NNS	O
in	IN	O
a	VBG	O
host	NNS	O
cell,	IN	O
amylase	DT	O
so	JJ	O
modified,	NN	O
and	VBG	O
methods	DT	O
of	NN	O
making	TO	O
the	VB	O
modified	CC	O
amylases.	VB	O
The	PRP$	O
method	NN	O
comprises	IN	O
identifying	DT	O
a	NN	O
“non-preferred”	.	O
or	DT	O
a	NN	O
“less	RB	O
preferred”	VBZ	O
codon	JJ	O
in	NNS	O
amylase-encoding	VBG	O
nucleic	DT	O
acid	NN	O
and	VBD	O
replacing	TO	O
one	VB	O
or	PRP$	O
more	NN	O
of	IN	O
these	DT	O
non-preferred	NN	O
or	,	O
less	NN	O
preferred	RB	O
codons	,	O
with	CC	O
a	NNS	O
“preferred	IN	O
codon”	VBG	O
encoding	DT	O
the	JJ	O
same	.	O
amino	DT	O
acid	NN	O
as	VBZ	O
the	VBG	O
replaced	DT	O
codon	JJ	O
and	CC	O
at	DT	O
least	JJ	O
one	NN	O
non-preferred	NN	O
or	IN	O
less	JJ	O
preferred	JJ	O
codon	NN	O
in	CC	O
the	VBG	O
nucleic	CD	O
acid	CC	O
has	JJR	O
been	IN	O
replaced	DT	O
by	JJ	O
a	CC	O
preferred	RBR	O
codon	JJ	O
encoding	NNS	O
the	IN	O
same	DT	O
amino	JJ	O
acid.	NN	O
A	VBG	O
preferred	DT	O
codon	JJ	O
is	NN	O
a	NN	O
codon	IN	O
over-represented	DT	O
in	JJ	O
coding	NN	O
sequences	CC	O
in	IN	O
genes	JJS	O
in	CD	O
the	JJ	O
host	CC	O
cell	RBR	O
and	JJ	O
a	NN	O
non-preferred	IN	O
or	DT	O
less	JJ	O
preferred	NN	O
codon	VBZ	O
is	VBN	O
a	VBN	O
codon	IN	O
under-represented	DT	O
in	JJ	O
coding	NN	O
sequences	VBG	O
in	DT	O
genes	JJ	O
in	NN	O
the	.	O
host	DT	O
cell.	JJ	O
Host	NN	O
cells	VBZ	O
for	DT	O
expressing	JJ	O
the	JJ	O
nucleic	IN	O
acids,	VBG	O
expression	NNS	O
cassettes	IN	O
and	NNS	O
vectors	IN	O
of	DT	O
the	NN	O
invention	NN	O
include	CC	O
bacteria,	DT	O
yeast,	JJ	O
fungi,	CC	O
plant	RBR	O
cells,	JJ	O
insect	NN	O
cells	VBZ	O
and	DT	O
mammalian	JJ	O
cells.	JJ	O
Thus,	IN	O
the	VBG	O
invention	NNS	O
provides	IN	O
methods	NNS	O
for	IN	O
optimizing	DT	O
codon	NN	O
usage	.	O
in	NNP	O
all	NNS	O
of	IN	O
these	VBG	O
cells,	DT	O
codon-altered	JJ	O
nucleic	,	O
acids	NN	O
and	NNS	O
polypeptides	CC	O
made	NNS	O
by	IN	O
the	DT	O
codon-altered	NN	O
nucleic	VBP	O
acids.	,	O
Exemplary	,	O
host	,	O
cells	NN	O
include	,	O
gram	JJ	O
negative	NNS	O
bacteria,	CC	O
such	JJ	O
as	.	O
Escherichia	,	O
coli	DT	O
and	NN	O
Pseudomonas	VBZ	O
fluorescens;	NNS	O
gram	IN	O
positive	VBG	O
bacteria,	JJ	O
such	NN	O
as	IN	O
Streptomyces	DT	O
diversa,	IN	O
Lactobacillus	DT	O
gasseri,	,	O
Lactococcus	JJ	O
lactis,	JJ	O
Lactococcus	NNS	O
cremoris,	CC	O
Bacillus	NNS	O
subtilis.	VBN	O
Exemplary	IN	O
host	DT	O
cells	JJ	O
also	JJ	O
include	.	O
eukaryotic	JJ	O
organisms,	NN	O
e.g.,	NNS	O
various	VBP	O
yeast,	JJ	O
such	JJ	O
as	,	O
Saccharomyces	JJ	O
sp.,	IN	O
including	NNP	O
Saccharomyces	NN	O
cerevisiae,	CC	O
Schizosaccharomyces	NNP	O
pombe,	:	O
Pichia	VB	O
pastoris,	JJ	O
and	,	O
Kluyveromyces	JJ	O
lactis,	IN	O
Hansenula	NNS	O
polymorphs,	,	O
Aspergillus	NNP	O
niger,	,	O
and	NNP	O
mammalian	,	O
cells	NNP	O
and	,	O
cell	NNP	O
lines	.	O
and	JJ	O
insect	NN	O
cells	NNS	O
and	RB	O
cell	VBP	O
lines.	JJ	O
Thus,	,	O
the	,	O
invention	JJ	O
also	,	O
includes	JJ	O
nucleic	IN	O
acids	NNS	O
and	,	O
polypeptides	VBG	O
optimized	NNS	O
for	,	O
expression	NNP	O
in	,	O
these	NNP	O
organisms	,	O
and	CC	O
species.	NNP	O
For	,	O
example,	NNP	O
the	,	O
codons	NNP	O
of	,	O
a	CC	O
nucleic	JJ	O
acid	NNS	O
encoding	CC	O
an	NN	O
amylase	NNS	O
isolated	CC	O
from	JJ	O
a	NNS	O
bacterial	CC	O
cell	NN	O
are	.	O
modified	,	O
such	DT	O
that	NN	O
the	RB	O
nucleic	VBZ	O
acid	JJ	O
is	NNS	O
optimally	CC	O
expressed	NNS	O
in	VBN	O
a	IN	O
bacterial	NN	O
cell	IN	O
different	DT	O
from	NNS	O
the	CC	O
bacteria	.	O
from	IN	O
which	,	O
the	DT	O
amylase	NNS	O
was	IN	O
derived,	DT	O
a	JJ	O
yeast,	NN	O
a	VBG	O
fungi,	DT	O
a	NN	O
plant	VBD	O
cell,	IN	O
an	DT	O
insect	JJ	O
cell	NN	O
or	VBP	O
a	VBN	O
mammalian	JJ	O
cell.	IN	O
Methods	DT	O
for	JJ	O
optimizing	NN	O
codons	VBZ	O
are	RB	O
well	VBN	O
known	IN	O
in	DT	O
the	JJ	O
art,	NN	O
see,	JJ	O
e.g.,	IN	O
U.S.	DT	O
Pat.	NN	O
No.	IN	O
5,795,737;	WDT	O
Baca	DT	B
(2000)	NN	I
Int.	VBD	I
J.	,	I
Parasitol.	DT	I
30:113-118;	,	I
Hale	DT	B
(1998)	,	I
Protein	DT	I
Expr.	NN	I
Purif.	,	I
12:185-188;	DT	I
Narum	NN	B
(2001)	NN	I
Infect.	CC	I
Immun.	DT	I
69:7250-7253.	JJ	I
See	.	O
also	NNS	O
Narum	IN	B
(2001)	VBG	I
Infect.	NNS	I
Immun.	VBP	I
69:7250-7253,	RB	I
describing	VBN	O
optimizing	IN	O
codons	DT	O
in	,	O
mouse	,	O
systems;	,	O
Outchkourov	NNP	B
(2002)	.	I
Protein	.	I
Expr.	:	I
Purif.	NNP	I
24:18-24,	)	I
describing	.	O
optimizing	NNP	O
codons	.	O
in	:	O
yeast;	NNP	O
Feng	)	B
(2000)	NNP	I
Biochemistry	.	I
39:15399-15409,	.	I
describing	:	O
optimizing	NNP	O
codons	)	O
in	.	O
E.	.	O
coli;	.	O
Humphreys	NNP	B
(2000)	RB	I
Protein	NNP	I
Expr.	)	I
Purif.	.	I
20:252-264,	.	I
describing	,	O
optimizing	VBG	O
codon	VBG	O
usage	NNS	O
that	IN	O
affects	NN	O
secretion	:	O
in	NNP	O
E.	)	O
coli.	NNP	O
Transgenic	.	O
Non-Human	.	O
Animals	,	O
The	VBG	O
invention	VBG	O
provides	NNS	O
transgenic	IN	O
non-human	:	O
animals	NNP	O
comprising	)	O
a	NNP	O
nucleic	,	O
acid,	VBG	O
a	VBG	O
polypeptide	NNS	O
(e.g.,	IN	O
an	NNP	O
amylase),	:	O
an	NNP	O
expression	)	O
cassette	NNP	O
or	.	O
vector	.	O
or	,	O
a	VBG	O
transfected	VBG	O
or	JJ	O
transformed	NN	O
cell	WDT	O
of	VBZ	O
the	NN	O
invention.	IN	O
The	NNP	O
invention	.	O
also	JJ	O
provides	JJ	O
methods	NNS	O
of	DT	O
making	NN	O
and	VBZ	O
using	JJ	O
these	JJ	O
transgenic	NNS	O
non-human	VBG	O
animals.	DT	O
The	JJ	O
transgenic	,	O
non-human	DT	O
animals	NN	O
can	,	O
be,	DT	O
e.g.,	,	O
goats,	DT	O
rabbits,	NN	O
sheep,	NN	O
pigs,	CC	O
cows,	NN	O
rats	CC	O
and	DT	O
mice,	JJ	O
comprising	CC	O
the	VBN	O
nucleic	NN	O
acids	IN	O
of	DT	O
the	.	O
invention.	DT	O
These	NN	O
animals	RB	O
can	VBZ	O
be	NNS	O
used,	IN	O
e.g.,	VBG	O
as	CC	O
in	VBG	O
vivo	DT	O
models	JJ	O
to	JJ	O
study	.	O
amylase	DT	O
activity,	JJ	O
or,	JJ	O
as	NNS	O
models	MD	O
to	,	O
screen	,	O
for	,	O
agents	,	O
that	,	O
change	,	O
the	,	O
amylase	NNS	O
activity	CC	O
in	,	O
vivo.	VBG	O
The	DT	O
coding	JJ	O
sequences	NNS	O
for	IN	O
the	DT	O
polypeptides	.	O
to	DT	O
be	NNS	O
expressed	MD	O
in	VB	O
the	,	O
transgenic	,	O
non-human	IN	O
animals	IN	O
can	NN	O
be	NNS	O
designed	TO	O
to	VB	O
be	JJ	O
constitutive,	,	O
or,	,	O
under	IN	O
the	NNS	O
control	TO	O
of	VB	O
tissue-specific,	IN	O
developmental-specific	NNS	O
or	WDT	O
inducible	VBP	O
transcriptional	DT	O
regulatory	NN	O
factors.	NN	O
Transgenic	IN	O
non-human	.	O
animals	DT	O
can	NN	O
be	NNS	O
designed	IN	O
and	DT	O
generated	NNS	O
using	TO	O
any	VB	O
method	VBN	O
known	IN	O
in	DT	O
the	JJ	O
art;	JJ	O
see,	NNS	O
e.g.,	MD	O
U.S.	VB	O
Pat.	VBN	O
Nos.	TO	O
6,211,428;	VB	O
6,187,992;	,	O
6,156,952;	,	O
6,118,044;	IN	O
6,111,166;	DT	O
6,107,541;	NN	O
5,959,171;	IN	O
5,922,854;	,	O
5,892,070;	JJ	O
5,880,327;	CC	O
5,891,698;	JJ	O
5,639,940;	JJ	O
5,573,933;	JJ	O
5,387,742;	.	O
5,087,571,	JJ	O
describing	JJ	O
making	NNS	O
and	MD	O
using	VB	O
transformed	VBN	O
cells	CC	O
and	VBN	O
eggs	VBG	O
and	DT	O
transgenic	NN	O
mice,	VBN	O
rats,	IN	O
rabbits,	DT	O
sheep,	:	O
pigs	,	O
and	,	O
cows.	NNP	O
See	.	O
also,	.	O
e.g.,	:	O
Pollock	:	B
(1999)	:	I
J.	:	I
Immunol.	:	I
Methods	:	I
231:147-157,	:	I
describing	:	O
the	:	O
production	:	O
of	:	O
recombinant	:	O
proteins	:	O
in	:	O
the	,	O
milk	VBG	O
of	NN	O
transgenic	CC	O
dairy	VBG	O
animals;	JJ	O
Baguisi	NNS	B
(1999)	CC	I
Nat.	NNS	I
Biotechnol.	CC	I
17:456-461,	JJ	I
demonstrating	,	O
the	,	O
production	,	O
of	,	O
transgenic	NNS	O
goats.	CC	O
U.S.	.	O
Pat.	NNP	O
No.	,	O
6,211,428,	,	O
describes	NNP	O
making	)	O
and	NNP	O
using	.	O
transgenic	NNS	O
non-human	,	O
mammals	VBG	O
which	DT	O
express	NN	O
in	IN	O
their	JJ	O
brains	NNS	O
a	IN	O
nucleic	DT	O
acid	NN	O
construct	IN	O
comprising	JJ	O
a	NN	O
DNA	:	O
sequence.	NNP	O
U.S.	)	O
Pat.	.	O
No.	.	O
5,387,742,	,	O
describes	VBG	O
injecting	DT	O
cloned	NN	O
recombinant	IN	O
or	JJ	O
synthetic	.	O
DNA	NNP	O
sequences	.	O
into	.	O
fertilized	,	O
mouse	NNS	O
eggs,	VBG	O
implanting	CC	O
the	VBG	O
injected	JJ	O
eggs	JJ	O
in	NNS	O
pseudo-pregnant	WDT	O
females,	VBP	O
and	IN	O
growing	PRP$	O
to	NNS	O
term	DT	O
transgenic	JJ	O
mice	NN	O
whose	NN	O
cells	VBG	O
express	DT	O
proteins	NN	O
related	.	O
to	NNP	O
the	.	O
pathology	.	O
of	,	O
Alzheimer's	VBZ	O
disease.	VBG	O
U.S.	VBN	O
Pat.	NN	O
No.	CC	O
6,187,992,	JJ	O
describes	NN	O
making	NNS	O
and	IN	O
using	VBN	O
a	NN	O
transgenic	,	O
mouse	VBG	O
whose	DT	O
genome	VBN	O
comprises	NNS	O
a	IN	O
disruption	JJ	O
of	,	O
the	CC	O
gene	VBG	O
encoding	TO	O
amyloid	NN	O
precursor	JJ	O
protein	NN	O
(APP).	WP$	O
“Knockout	NNS	O
animals”	VBP	O
can	NNS	O
also	VBN	O
be	TO	O
used	DT	O
to	NN	O
practice	IN	O
the	POS	O
methods	.	O
of	NNP	O
the	.	O
invention.	.	O
For	,	O
example,	NNS	O
in	VBG	O
one	CC	O
aspect,	VBG	O
the	DT	O
transgenic	JJ	O
or	NN	O
modified	WP$	O
animals	NN	O
of	VBZ	O
the	DT	O
invention	NN	O
comprise	IN	O
a	DT	O
“knockout	NN	O
animal,”	VBG	O
e.g.,	JJ	O
a	NN	O
“knockout	NN	O
mouse,”	.	O
engineered	IN	O
not	NN	O
to	MD	O
express	RB	O
an	VB	O
endogenous	VBN	O
gene,	TO	O
which	NN	O
is	DT	O
replaced	NNS	O
with	IN	O
a	DT	O
gene	.	O
expressing	IN	O
an	,	O
amylase	IN	O
of	CD	O
the	,	O
invention,	DT	O
or,	NN	O
a	CC	O
fusion	VBN	O
protein	NNS	O
comprising	IN	O
an	DT	O
amylase	NN	O
of	NN	O
the	DT	O
invention.	NN	O
Transgenic	NNP	O
Plants	,	O
and	DT	O
Seeds	NN	O
The	RB	O
invention	VBD	O
provides	RB	O
transgenic	TO	O
plants	VB	O
and	DT	O
seeds	JJ	O
comprising	,	O
a	WDT	O
nucleic	VBZ	O
acid,	VBN	O
a	IN	O
polypeptide	DT	O
(e.g.,	NN	O
an	VBG	O
amylase,	DT	O
such	NN	O
as	IN	O
an	DT	O
alpha	,	O
amylase),	,	O
an	DT	O
expression	NN	O
cassette	NN	O
or	VBG	O
vector	DT	O
or	NN	O
a	IN	O
transfected	DT	O
or	.	O
transformed	JJ	O
cell	NNS	O
of	CC	O
the	NNP	O
invention.	DT	O
The	NN	O
invention	VBZ	O
also	JJ	O
provides	NNS	O
plant	CC	O
products,	NNS	O
e.g.,	VBG	O
oils,	DT	O
seeds,	JJ	O
leaves,	,	O
extracts	DT	O
and	NN	O
the	,	O
like,	DT	O
comprising	,	O
a	JJ	O
nucleic	IN	O
acid	DT	O
and/or	JJ	O
a	,	O
polypeptide	DT	O
(e.g.,	NN	O
an	NN	O
amylase,	CC	O
such	NN	O
as	CC	O
an	DT	O
alpha	JJ	O
amylase)	CC	O
of	VBN	O
the	NN	O
invention.	IN	O
The	DT	O
transgenic	.	O
plant	DT	O
can	NN	O
be	RB	O
dicotyledonous	VBZ	O
(a	NN	O
dicot)	,	O
or	,	O
monocotyledonous	,	O
(a	,	O
monocot).	,	O
The	NNS	O
invention	CC	O
also	DT	O
provides	,	O
methods	VBG	O
of	DT	O
making	JJ	O
and	NN	O
using	VBZ	O
these	DT	O
transgenic	NN	O
plants	,	O
and	DT	O
seeds.	,	O
The	JJ	O
transgenic	IN	O
plant	DT	O
or	JJ	O
plant	)	O
cell	IN	O
expressing	DT	O
a	.	O
polypeptide	DT	O
of	JJ	O
the	NN	O
present	MD	O
invention	VB	O
may	JJ	O
be	DT	O
constructed	)	O
in	CC	O
accordance	JJ	O
with	DT	O
any	.	O
method	DT	O
known	NN	O
in	RB	O
the	VBZ	O
art.	NNS	O
See,	IN	O
for	VBG	O
example,	CC	O
U.S.	VBG	O
Pat.	DT	O
No.	JJ	O
6,309,872.	NNS	O
Nucleic	CC	O
acids	.	O
and	DT	O
expression	JJ	O
constructs	NN	O
of	CC	O
the	NN	O
invention	NN	O
can	VBG	O
be	DT	O
introduced	NN	O
into	IN	O
a	DT	O
plant	JJ	O
cell	NN	O
by	MD	O
any	VB	O
means.	VBN	O
For	IN	O
example,	NN	O
nucleic	IN	O
acids	DT	O
or	NN	O
expression	VBN	O
constructs	IN	O
can	DT	O
be	.	O
introduced	,	O
into	IN	O
the	,	O
genome	NNP	O
of	.	O
a	.	O
desired	.	O
plant	NNP	O
host,	NNS	O
or,	CC	O
the	NN	O
nucleic	NNS	O
acids	IN	O
or	DT	O
expression	NN	O
constructs	MD	O
can	VB	O
be	VBN	O
episomes.	IN	O
Introduction	DT	O
into	NN	O
the	NN	O
genome	IN	O
of	DT	O
a	.	O
desired	IN	O
plant	,	O
can	JJ	O
be	NNS	O
such	CC	O
that	NN	O
the	NNS	O
host's	MD	O
α-amylase	VB	O
production	VBN	O
is	IN	O
regulated	DT	O
by	NN	O
endogenous	IN	O
transcriptional	DT	O
or	JJ	O
translational	NN	O
control	,	O
elements.	,	O
The	DT	O
invention	JJ	O
also	NNS	O
provides	CC	O
“knockout	NN	O
plants”	NNS	O
where	MD	O
insertion	VB	O
of	.	O
gene	NN	O
sequence	IN	O
by,	DT	O
e.g.,	NN	O
homologous	IN	O
recombination,	DT	O
has	JJ	O
disrupted	NN	O
the	MD	O
expression	VB	O
of	JJ	O
the	IN	O
endogenous	DT	O
gene.	POS	O
Means	JJ	O
to	NN	O
generate	VBZ	O
“knockout”	VBN	O
plants	IN	O
are	JJ	O
well-known	JJ	O
in	CC	O
the	JJ	O
art,	NN	O
see,	.	O
e.g.,	DT	O
Strepp	NN	B
(1998)	RB	I
Proc	VBZ	I
Natl.	IN	I
Acad.	NN	I
Sci.	WRB	I
USA	NN	I
95:4368-4373;	IN	I
Miao	NN	B
(1995)	NN	I
Plant	,	I
J	,	I
7:359-365.	JJ	I
See	,	O
discussion	VBZ	O
on	VBN	O
transgenic	DT	O
plants,	NN	O
below.	IN	O
The	DT	O
nucleic	JJ	O
acids	.	O
of	NNS	O
the	TO	O
invention	VB	O
can	JJ	O
be	NNS	O
used	VBP	O
to	JJ	O
confer	IN	O
desired	DT	O
traits	,	O
on	,	O
essentially	,	O
any	NNP	O
plant,	)	O
e.g.,	NNP	O
on	.	O
starch-producing	.	O
plants,	.	O
such	NNP	O
as	:	O
potato,	NNP	O
wheat,	)	O
rice,	NNP	O
barley,	NNP	O
and	.	O
the	VB	O
like.	NN	O
Nucleic	IN	O
acids	JJ	O
of	,	O
the	.	O
invention	DT	O
can	JJ	O
be	NNS	O
used	IN	O
to	DT	O
manipulate	NN	O
metabolic	MD	O
pathways	VB	O
of	VBN	O
a	TO	O
plant	VB	O
in	JJ	O
order	NNS	O
to	IN	O
optimize	RB	O
or	DT	O
alter	,	O
host's	,	O
expression	IN	O
of	JJ	O
α-amylase.	,	O
The	JJ	O
can	IN	O
change	,	O
the	,	O
ratio	,	O
of	,	O
starch/sugar	CC	O
conversion	DT	O
in	.	O
a	NNP	O
plant.	NNS	O
This	IN	O
can	DT	O
facilitate	NN	O
industrial	MD	O
processing	VB	O
of	VBN	O
a	TO	O
plant.	VB	O
Alternatively,	JJ	O
alpha-amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	IN	O
be	NN	O
used	TO	O
in	VB	O
production	CC	O
of	VB	O
a	POS	O
transgenic	NN	O
plant	IN	O
to	.	O
produce	DT	O
a	MD	O
compound	VB	O
not	DT	O
naturally	NN	O
produced	IN	O
by	NN	O
that	NN	O
plant.	IN	O
This	DT	O
can	.	O
lower	DT	O
production	MD	O
costs	VB	O
or	JJ	O
create	NN	O
a	IN	O
novel	DT	O
product.	.	O
In	,	O
one	NNS	O
aspect,	IN	O
the	DT	O
first	NN	O
step	MD	O
in	VB	O
production	VBN	O
of	IN	O
a	NN	O
transgenic	IN	O
plant	DT	O
involves	JJ	O
making	NN	O
an	TO	O
expression	VB	O
construct	DT	O
for	NN	O
expression	RB	O
in	RB	O
a	VBN	O
plant	IN	O
cell.	DT	O
These	.	O
techniques	DT	O
are	MD	O
well	VB	O
known	NN	O
in	NNS	O
the	CC	O
art.	VB	O
They	DT	O
can	JJ	O
include	.	O
selecting	IN	O
and	CD	O
cloning	,	O
a	DT	O
promoter,	JJ	O
a	NN	O
coding	IN	O
sequence	NN	O
for	IN	O
facilitating	DT	O
efficient	JJ	O
binding	NN	O
of	VBZ	O
ribosomes	VBG	O
to	DT	O
mRNA	NN	O
and	NN	O
selecting	IN	O
the	NN	O
appropriate	IN	O
gene	DT	O
terminator	NN	O
sequences.	.	O
One	DT	O
exemplary	NNS	O
constitutive	VBP	O
promoter	RB	O
is	VBN	O
CaMV35S,	IN	O
from	DT	O
the	.	O
cauliflower	PRP	O
mosaic	MD	O
virus,	VB	O
which	VBG	O
generally	CC	O
results	VBG	O
in	DT	O
a	,	O
high	DT	O
degree	NN	O
of	NN	O
expression	IN	O
in	VBG	O
plants.	JJ	O
Other	NN	O
promoters	IN	O
are	NNS	O
more	TO	O
specific	VB	O
and	CC	O
respond	VBG	O
to	DT	O
cues	JJ	O
in	NN	O
the	NN	O
plant's	.	O
internal	CD	O
or	JJ	O
external	JJ	O
environment.	NN	O
An	VBZ	O
exemplary	,	O
light-inducible	IN	O
promoter	DT	O
is	NN	O
the	NN	O
promoter	,	O
from	WDT	O
the	RB	O
cab	NNS	O
gene,	IN	O
encoding	DT	O
the	JJ	O
major	NN	O
chlorophyll	IN	O
a/b	NN	O
binding	IN	O
protein.	.	O
In	JJ	O
one	NNS	O
aspect,	VBP	O
the	RBR	O
nucleic	JJ	O
acid	CC	O
is	NN	O
modified	TO	O
to	NNS	O
achieve	IN	O
greater	DT	O
expression	POS	O
in	JJ	O
a	CC	O
plant	JJ	O
cell.	.	O
For	DT	O
example,	JJ	O
a	JJ	O
sequence	NN	O
of	VBZ	O
the	DT	O
invention	NN	O
is	IN	O
likely	DT	O
to	NN	O
have	,	O
a	VBG	O
higher	DT	O
percentage	JJ	O
of	NN	O
A-T	NN	O
nucleotide	VBG	O
pairs	.	O
compared	IN	O
to	CD	O
that	,	O
seen	DT	O
in	JJ	O
a	NN	O
plant,	VBZ	O
some	VBN	O
of	TO	O
which	VB	O
prefer	JJR	O
G-C	NN	O
nucleotide	IN	O
pairs.	DT	O
Therefore,	NN	O
A-T	.	O
nucleotides	IN	O
in	,	O
the	DT	O
coding	NN	O
sequence	IN	O
can	DT	O
be	NN	O
substituted	VBZ	O
with	JJ	O
G-C	TO	O
nucleotides	VB	O
without	DT	O
significantly	JJR	O
changing	NN	O
the	IN	O
amino	NNP	O
acid	JJ	O
sequence	NNS	O
to	VBN	O
enhance	TO	O
production	DT	O
of	VBN	O
the	IN	O
gene	DT	O
product	,	O
in	DT	O
plant	IN	O
cells.	WDT	O
Selectable	VBP	O
marker	NNP	O
gene	JJ	O
can	.	O
be	,	O
added	NNP	O
to	NNS	O
the	IN	O
gene	DT	O
construct	NN	O
in	NN	O
order	MD	O
to	VB	O
identify	VBN	O
plant	IN	O
cells	NNP	O
or	NNS	O
tissues	IN	O
that	RB	O
have	VBG	O
successfully	DT	O
integrated	NN	O
the	NN	O
transgene.	NN	O
This	TO	O
may	VB	O
be	NN	O
necessary	IN	O
because	DT	O
achieving	NN	O
incorporation	NN	O
and	IN	O
expression	NN	O
of	.	O
genes	JJ	O
in	NN	O
plant	NN	O
cells	MD	O
is	VB	O
a	VBN	O
rare	TO	O
event,	DT	O
occurring	NN	O
in	NN	O
just	IN	O
a	NN	O
few	TO	O
percent	VB	O
of	NN	O
the	NNS	O
targeted	CC	O
tissues	NNS	O
or	WDT	O
cells.	VBP	O
Selectable	RB	O
marker	VBN	O
genes	DT	O
encode	.	O
proteins	DT	O
that	MD	O
provide	VB	O
resistance	JJ	O
to	IN	O
agents	VBG	O
that	NN	O
are	CC	O
normally	NN	O
toxic	IN	O
to	NNS	O
plants,	IN	O
such	NN	O
as	NNS	O
antibiotics	VBZ	O
or	DT	O
herbicides.	JJ	O
Only	,	O
plant	VBG	O
cells	IN	O
that	RB	O
have	DT	O
integrated	JJ	O
the	NN	O
selectable	IN	O
marker	DT	O
gene	JJ	O
will	NNS	O
survive	CC	O
when	.	O
grown	JJ	O
on	NN	O
a	NNS	O
medium	VBP	O
containing	NNS	O
the	WDT	O
appropriate	VBP	O
antibiotic	NN	O
or	TO	O
herbicide.	NNS	O
As	WDT	O
for	VBP	O
other	RB	O
inserted	JJ	O
genes,	TO	O
marker	,	O
genes	JJ	O
also	IN	O
require	NNS	O
promoter	CC	O
and	.	O
termination	RB	O
sequences	NN	O
for	NNS	O
proper	WDT	O
function.	VBP	O
In	VBN	O
one	DT	O
aspect,	JJ	O
making	NN	O
transgenic	NN	O
plants	MD	O
or	VB	O
seeds	WRB	O
comprises	VBN	O
incorporating	IN	O
sequences	DT	O
of	NN	O
the	VBG	O
invention	DT	O
and,	JJ	O
optionally,	JJ	O
marker	CC	O
genes	.	O
into	IN	O
a	IN	O
target	JJ	O
expression	JJ	O
construct	,	O
(e.g.,	NN	O
a	NNS	O
plasmid),	RB	O
along	VBP	O
with	NN	O
positioning	CC	O
of	NN	O
the	NNS	O
promoter	IN	O
and	JJ	O
the	.	O
terminator	IN	O
sequences.	CD	O
This	,	O
can	VBG	O
involve	JJ	O
transferring	NNS	O
the	CC	O
modified	NNS	O
gene	NNS	O
into	VBG	O
the	NNS	O
plant	IN	O
through	DT	O
a	NN	O
suitable	,	O
method.	,	O
For	JJR	O
example,	NNS	O
a	IN	O
construct	DT	O
may	NN	O
be	NN	O
introduced	NN	O
directly	,	O
into	DT	O
the	,	O
genomic	IN	O
DNA	IN	O
of	NN	O
the	IN	O
plant	DT	O
cell	NN	O
using	CC	O
techniques	DT	O
such	NN	O
as	.	O
electroporation	DT	O
and	MD	O
microinjection	VB	O
of	VBG	O
plant	DT	O
cell	JJ	O
protoplasts,	NN	O
or	IN	O
the	DT	O
constructs	NN	O
can	IN	O
be	DT	O
introduced	JJ	O
directly	.	O
to	IN	O
plant	,	O
tissue	DT	O
using	NN	O
ballistic	MD	O
methods,	VB	O
such	VBN	O
as	RB	O
DNA	IN	O
particle	DT	O
bombardment.	JJ	O
For	NN	O
example,	IN	O
see,	DT	O
e.g.,	NN	O
Christou	NN	B
(1997)	VBG	I
Plant	NNS	I
Mol.	JJ	I
Biol.	IN	I
35:197-203;	NN	I
Pawlowski	CC	B
(1996)	NN	I
Mol.	IN	I
Biotechnol.	NN	I
6:17-30;	NN	I
Klein	,	B
(1987)	CC	I
Nature	DT	I
327:70-73;	NNS	I
Takumi	MD	B
(1997)	VB	I
Genes	VBN	I
Genet.	RB	I
Syst.	TO	I
72:63-69,	NN	I
discussing	NN	O
use	VBG	O
of	JJ	O
particle	,	O
bombardment	JJ	O
to	IN	O
introduce	NNP	O
transgenes	NN	O
into	.	O
wheat;	IN	O
and	,	O
Adam	,	O
(1997)	,	O
supra,	NNP	O
for	)	O
use	NNP	O
of	.	O
particle	.	O
bombardment	:	O
to	NNP	O
introduce	)	O
YACs	.	O
into	.	O
plant	:	O
cells.	NNP	O
For	)	O
example,	NNP	O
Rinehart	:	O
(1997)	NNP	O
supra,	)	O
used	NNPS	O
particle	.	O
bombardment	.	O
to	,	O
generate	VBG	O
transgenic	NN	O
cotton	IN	O
plants.	NN	O
Apparatus	NN	O
for	TO	O
accelerating	VB	O
particles	NNS	O
is	IN	O
described	:	O
U.S.	CC	O
Pat.	NNP	O
No.	)	O
5,015,580;	,	O
and,	IN	O
the	NN	O
commercially	IN	O
available	NN	O
BioRad	NN	O
(Biolistics)	TO	O
PDS-2000	VB	O
particle	NNP	O
acceleration	IN	O
instrument;	NN	O
see	.	O
also,	IN	O
John,	,	O
U.S.	NNP	O
Pat.	)	O
No.	,	O
5,608,148;	VBD	O
and	NN	O
Ellis,	NN	O
U.S.	TO	O
Pat.	VB	O
No.	JJ	O
5,681,730,	NN	O
describing	.	O
particle-mediated	NNP	O
transformation	IN	O
of	VBG	O
gymnosperms.	NNS	O
In	VBZ	O
one	JJ	O
aspect,	NNP	O
protoplasts	.	O
can	.	O
be	:	O
immobilized	,	O
and	DT	O
injected	RB	O
with	JJ	O
a	NNP	O
nucleic	)	O
acids,	CD	O
e.g.,	NN	O
an	NN	O
expression	:	O
construct.	NN	O
Although	,	O
plant	,	O
regeneration	NNP	O
from	.	O
protoplasts	.	O
is	:	O
not	CC	O
easy	,	O
with	NNP	O
cereals,	.	O
plant	.	O
regeneration	,	O
is	VBG	O
possible	JJ	O
in	NN	O
legumes	IN	O
using	.	O
somatic	IN	O
embryogenesis	CD	O
from	,	O
protoplast	NNS	O
derived	MD	O
callus.	VB	O
Organized	VBN	O
tissues	CC	O
can	VBN	O
be	IN	O
transformed	DT	O
with	JJ	O
naked	,	O
DNA	,	O
using	DT	O
gene	NN	O
gun	.	O
technique,	IN	O
where	NN	O
DNA	NN	O
is	IN	O
coated	NNS	O
on	VBZ	O
tungsten	RB	O
microprojectiles,	JJ	O
shot	IN	O
1/100th	,	O
the	NN	O
size	NN	O
of	VBZ	O
cells,	JJ	O
which	IN	O
carry	NNS	O
the	VBG	O
DNA	JJ	O
deep	NN	O
into	IN	O
cells	NN	O
and	VBN	O
organelles.	.	O
Transformed	VBN	O
tissue	NNS	O
is	MD	O
then	VB	O
induced	VBN	O
to	IN	O
regenerate,	JJ	O
usually	NNP	O
by	VBG	O
somatic	NN	O
embryogenesis.	NN	O
This	,	O
technique	WRB	O
has	NN	O
been	VBZ	O
successful	VBN	O
in	IN	O
several	JJ	O
cereal	,	O
species	VBD	O
including	CD	O
maize	DT	O
and	NN	O
rice.	IN	O
Nucleic	,	O
acids,	WDT	O
e.g.,	VBP	O
expression	DT	O
constructs,	NN	O
can	RB	O
also	IN	O
be	NNS	O
introduced	CC	O
in	.	O
to	NNP	O
plant	NN	O
cells	VBZ	O
using	RB	O
recombinant	VBN	O
viruses.	TO	O
Plant	,	O
cells	RB	O
can	IN	O
be	JJ	O
transformed	.	O
using	DT	O
viral	NN	O
vectors,	VBZ	O
such	VBN	O
as,	JJ	O
e.g.,	IN	O
tobacco	JJ	O
mosaic	NN	O
virus	NNS	O
derived	VBG	O
vectors	NN	O
Rouwendal	CC	B
(1997)	.	I
Plant	NNP	I
Mol.	,	I
Biol.	,	I
33:989-999),(	NN	O
see	,	O
Porta	MD	B
(1996)	RB	I
“Use	VB	I
of	VBN	I
viral	IN	I
replicons	TO	I
for	NN	I
the	NNS	I
expression	VBG	I
of	JJ	I
genes	.	I
in	NN	I
plants,”	NNS	I
Mol.	MD	I
Biotechnol.	VB	I
5:209-221.
Alternatively,	VBN	O
nucleic	VBG	O
acids,	JJ	O
e.g.,	,	O
an	JJ	O
expression	,	O
construct,	,	O
can	NN	O
be	NN	O
combined	NN	O
with	VBN	O
suitable	NNS	O
T-DNA	NNP	O
flanking	)	O
regions	NNP	O
and	.	O
introduced	.	O
into	,	O
a	VBP	O
conventional	NNP	O
Agrobacterium	)	O
tumefaciens	NN	O
host	IN	O
vector.	JJ	O
The	NNS	O
virulence	IN	O
functions	DT	O
of	NN	O
the	IN	O
Agrobacterium	NNS	O
tumefaciens	IN	O
host	NNP	O
will	.	O
direct	.	O
the	.	O
insertion	,	O
of	JJ	O
the	,	O
construct	,	O
and	DT	O
adjacent	NN	O
marker	,	O
into	MD	O
the	VB	O
plant	VBN	O
cell	IN	O
DNA	JJ	O
when	JJ	O
the	NN	O
cell	NNS	O
is	CC	O
infected	VBN	O
by	IN	O
the	DT	O
bacteria.	JJ	O
Agrobacterium	NNP	O
tumefaciens-mediated	VBZ	O
transformation	NN	O
techniques,	.	O
including	DT	O
disarming	NN	O
and	NNS	O
use	IN	O
of	DT	O
binary	NNP	O
vectors,	VBZ	O
are	NN	O
well	MD	O
described	VB	O
in	DT	O
the	NN	O
scientific	IN	O
literature.	DT	O
See,	NN	O
e.g.,	CC	O
Horsch	JJ	B
(1984)	NN	I
Science	IN	I
233:496-498;	DT	I
Fraley	NN	B
(1983)	NN	I
Proc.	NNP	I
Natl.	WRB	I
Acad.	DT	I
Sci.	NN	I
USA	VBZ	I
80:4803	VBN	I
(1983);	IN	I
Gene	DT	O
Transfer	.	O
to	NNP	O
Plants,	JJ	O
Potrykus,	NN	O
ed.	,	O
(Springer-Verlag,	VBG	O
Berlin	NN	O
1995).	CC	O
The	NN	O
DNA	IN	O
in	JJ	O
an	,	O
A.	VBP	O
tumefaciens	RB	O
cell	VBN	O
is	IN	O
contained	DT	O
in	JJ	O
the	.	O
bacterial	,	O
chromosome	,	O
as	NNP	O
well	)	O
as	NNP	O
in	:	O
another	NNP	O
structure	)	O
known	.	O
as	.	O
a	.	O
Ti	.	O
(tumor-inducing)	NNP	O
plasmid.	CD	O
The	:	O
Ti	NNP	O
plasmid	NNP	O
contains	TO	O
a	,	O
stretch	,	O
of	.	O
DNA	,	O
termed	NNP	O
T-DNA	.	O
(˜20	DT	O
kb	NN	O
long)	IN	O
that	DT	O
is	NN	O
transferred	NNS	O
to	NN	O
the	VBZ	O
plant	VBN	O
cell	IN	O
in	DT	O
the	JJ	O
infection	NN	O
process	RB	O
and	RB	O
a	IN	O
series	IN	O
of	DT	O
vir	NN	O
(virulence)	VBN	O
genes	IN	O
that	DT	O
direct	NNP	O
the	)	O
infection	.	O
process.	DT	O
A.	NNP	O
tumefaciens	NN	O
can	VBZ	O
only	DT	O
infect	NN	O
a	IN	O
plant	NNP	O
through	VBD	O
wounds:	NNP	O
when	NNP	O
a	NNP	O
plant	)	O
root	WDT	O
or	VBZ	O
stem	VBN	O
is	TO	O
wounded	DT	O
it	NN	O
gives	NN	O
off	IN	O
certain	DT	O
chemical	NN	O
signals,	NN	O
in	CC	O
response	DT	O
to	NN	O
which,	IN	O
the	NN	O
vir	)	O
genes	NNS	O
of	WDT	O
A.	VBP	O
tumefaciens	DT	O
become	NN	O
activated	.	O
and	NN	O
direct	NNS	O
a	MD	O
series	RB	O
of	VB	O
events	DT	O
necessary	NN	O
for	IN	O
the	:	O
transfer	WRB	O
of	DT	O
the	NN	O
T-DNA	NN	O
from	CC	O
the	NN	O
Ti	VBZ	O
plasmid	VBN	O
to	PRP	O
the	VBZ	O
plant's	RP	O
chromosome.	JJ	O
The	NN	O
T-DNA	,	O
then	IN	O
enters	NN	O
the	TO	O
plant	,	O
cell	DT	O
through	NN	O
the	NNS	O
wound.	IN	O
One	NN	O
speculation	NNS	O
is	VBP	O
that	JJ	O
the	CC	O
T-DNA	VB	O
waits	DT	O
until	NN	O
the	IN	O
plant	NNS	O
DNA	JJ	O
is	IN	O
being	DT	O
replicated	NN	O
or	IN	O
transcribed,	DT	O
then	NN	O
inserts	IN	O
itself	DT	O
into	NNP	O
the	NN	O
exposed	TO	O
plant	DT	O
DNA.	POS	O
In	.	O
order	DT	O
to	NNP	O
use	RB	O
A.	VBZ	O
tumefaciens	DT	O
as	NN	O
a	NN	O
transgene	IN	O
vector,	DT	O
the	.	O
tumor-inducing	CD	O
section	NN	O
of	VBZ	O
T-DNA	IN	O
have	DT	O
to	NNP	O
be	NNS	O
removed,	IN	O
while	DT	O
retaining	NN	O
the	NN	O
T-DNA	VBZ	O
border	VBG	O
regions	VBN	O
and	CC	O
the	,	O
vir	RB	O
genes.	VBZ	O
The	PRP	O
transgene	IN	O
is	DT	O
then	JJ	O
inserted	NN	O
between	.	O
the	IN	O
T-DNA	NN	O
border	TO	O
regions,	VB	O
where	NN	O
it	NNS	O
is	IN	O
transferred	DT	O
to	NN	O
the	,	O
plant	DT	O
cell	JJ	O
and	NN	O
becomes	IN	O
integrated	NNP	O
into	VBP	O
the	TO	O
plant's	VB	O
chromosomes.	,	O
The	IN	O
invention	VBG	O
provides	DT	O
for	JJ	O
the	NN	O
transformation	NNS	O
of	CC	O
monocotyledonous	DT	O
plants	NN	O
using	.	O
the	DT	O
nucleic	NN	O
acids	VBZ	O
of	RB	O
the	VBN	O
invention,	IN	O
including	DT	O
important	NNP	O
cereals,	NN	O
see	,	O
Hiei	WRB	B
(1997)	PRP	I
Plant	VBZ	I
Mol.	VBN	I
Biol.	TO	I
35:205-218.	DT	I
See	NN	O
also,	NN	O
e.g.,	CC	O
Horsch,	VBZ	B
Science	VBN	I
(1984)	IN	I
233:496;	DT	I
Fraley	POS	B
(1983)	.	I
Proc.	DT	I
Natl.	NN	I
Acad.	VBZ	I
Sci.	IN	I
USA	DT	I
80:4803;	NN	I
Thykjaer	IN	O
(1997)	JJ	O
supra;	NNS	O
Park	VBG	B
(1996)	DT	I
Plant	JJ	I
Mol.	NNS	I
Biol.	IN	I
32:1135-1148,	DT	I
discussing	,	O
T-DNA	VBG	O
integration	JJ	O
into	,	O
genomic	VBP	O
DNA.	NNP	O
See	)	O
also	NNP	O
D'Halluin,	.	O
U.S.	.	O
Pat.	.	O
No.	NNP	O
5,712,135,	,	O
describing	,	O
a	,	O
process	NNP	O
for	)	O
the	:	O
stable	NNP	O
integration	)	O
of	.	O
a	.	O
DNA	.	O
comprising	.	O
a	NNP	O
gene	:	O
that	NNP	O
is	)	O
functional	:	O
in	NNP	O
a	)	O
cell	NNP	O
of	.	O
a	.	O
cereal,	,	O
or	VBG	O
other	JJ	O
monocotyledonous	NN	O
plant.	IN	O
In	JJ	O
one	.	O
aspect,	NNP	O
the	RB	O
third	,	O
step	NNP	O
can	.	O
involve	.	O
selection	,	O
and	VBG	O
regeneration	DT	O
of	NN	O
whole	IN	O
plants	DT	O
capable	JJ	O
of	NN	O
transmitting	IN	O
the	DT	O
incorporated	NN	O
target	VBG	O
gene	DT	O
to	NN	O
the	WDT	O
next	VBZ	O
generation.	JJ	O
Such	IN	O
regeneration	DT	O
techniques	NN	O
rely	IN	O
on	DT	O
manipulation	,	O
of	CC	O
certain	JJ	O
phytohormones	JJ	O
in	.	O
a	IN	O
tissue	CD	O
culture	,	O
growth	DT	O
medium,	JJ	O
typically	NN	O
relying	MD	O
on	VB	O
a	NN	O
biocide	CC	O
and/or	NN	O
herbicide	IN	O
marker	JJ	O
that	NNS	O
has	JJ	O
been	IN	O
introduced	VBG	O
together	DT	O
with	VBN	O
the	NN	O
desired	NN	O
nucleotide	TO	O
sequences.	DT	O
Plant	JJ	O
regeneration	.	O
from	JJ	O
cultured	NN	O
protoplasts	NNS	O
is	VBP	O
described	IN	O
in	NN	O
Evans	IN	B
et	JJ	I
al.,	NNS	I
Protoplasts	IN	I
Isolation	DT	I
and	NN	I
Culture,	NN	I
Handbook	NN	I
of	,	I
Plant	RB	I
Cell	VBG	I
Culture,	IN	I
pp.	DT	I
124-176,	JJ	I
MacMillilan	NN	I
Publishing	NN	I
Company,	NN	I
New	WDT	I
York,	VBZ	I
1983;	VBN	I
and	VBN	O
Binding,	RB	B
Regeneration	IN	I
of	DT	I
Plants,	JJ	I
Plant	JJ	I
Protoplasts,	.	I
pp.	JJ	I
21-73,	NN	I
CRC	IN	I
Press,	JJ	I
Boca	NNS	I
Raton,	VBZ	I
1985.	VBN	I
Regeneration	IN	O
can	NNP	O
also	CC	O
be	,	O
obtained	NNPS	O
from	NNP	O
plant	CC	O
callus,	,	O
explants,	NNP	O
organs,	IN	O
or	NNP	O
parts	NNP	O
thereof.	,	O
Such	.	O
regeneration	,	O
techniques	NNP	O
are	NNP	O
described	,	O
generally	NNP	O
in	,	O
Klee	:	B
(1987)	CC	I
Ann.	,	I
Rev.	NNP	I
of	IN	I
Plant	,	I
Phys.	NNP	I
38:467-486.	,	I
To	.	O
obtain	,	O
whole	NNP	O
plants	,	O
from	NNP	O
transgenic	,	O
tissues	.	O
such	NN	O
as	MD	O
immature	RB	O
embryos,	VB	O
they	VBN	O
can	IN	O
be	NN	O
grown	,	O
under	,	O
controlled	,	O
environmental	CC	O
conditions	NNS	O
in	.	O
a	JJ	O
series	NN	O
of	NNS	O
media	VBP	O
containing	VBN	O
nutrients	RB	O
and	IN	O
hormones,	NNP	O
a	)	O
process	.	O
known	.	O
as	IN	O
tissue	NNP	O
culture.	.	O
Once	.	O
whole	TO	O
plants	VB	O
are	JJ	O
generated	NNS	O
and	IN	O
produce	JJ	O
seed,	NNS	O
evaluation	JJ	O
of	IN	O
the	NN	O
progeny	,	O
begins.	PRP	O
After	MD	O
the	VB	O
expression	VBN	O
cassette	IN	O
is	JJ	O
stably	JJ	O
incorporated	NNS	O
in	IN	O
transgenic	DT	O
plants,	NN	O
it	IN	O
can	NNS	O
be	VBG	O
introduced	NNS	O
into	CC	O
other	,	O
plants	DT	O
by	NN	O
sexual	VBN	O
crossing.	IN	O
Any	NN	O
of	.	O
a	RB	O
number	JJ	O
of	NNS	O
standard	VBP	O
breeding	VBN	O
techniques	CC	O
can	VBP	O
be	,	O
used,	NN	O
depending	IN	O
upon	DT	O
the	NN	O
species	.	O
to	IN	O
be	DT	O
crossed.	NN	O
Since	NN	O
transgenic	VBZ	O
expression	RB	O
of	VBN	O
the	IN	O
nucleic	JJ	O
acids	,	O
of	PRP	O
the	MD	O
invention	VB	O
leads	VBN	O
to	IN	O
phenotypic	JJ	O
changes,	NNS	O
plants	IN	O
comprising	JJ	O
the	.	O
recombinant	DT	O
nucleic	IN	O
acids	DT	O
of	NN	O
the	IN	O
invention	JJ	O
can	VBG	O
be	NNS	O
sexually	MD	O
crossed	VB	O
with	,	O
a	VBG	O
second	IN	O
plant	DT	O
to	NNS	O
obtain	TO	O
a	VB	O
final	.	O
product.	IN	O
Thus,	JJ	O
the	NN	O
seed	IN	O
of	DT	O
the	JJ	O
invention	NNS	O
can	IN	O
be	DT	O
derived	NN	O
from	VBZ	O
a	TO	O
cross	VB	O
between	,	O
two	NNS	O
transgenic	VBG	O
plants	DT	O
of	JJ	O
the	JJ	O
invention,	NNS	O
or	IN	O
a	DT	O
cross	NN	O
between	MD	O
a	VB	O
plant	RB	O
of	VBN	O
the	IN	O
invention	DT	O
and	JJ	O
another	NN	O
plant.	TO	O
The	VB	O
desired	DT	O
effects	JJ	O
(e.g.,	.	O
expression	,	O
of	DT	O
the	NN	O
polypeptides	IN	O
of	DT	O
the	NN	O
invention	MD	O
to	VB	O
produce	VBN	O
a	IN	O
plant	DT	O
in	NN	O
which	IN	O
flowering	CD	O
behavior	JJ	O
is	NNS	O
altered)	IN	O
can	DT	O
be	,	O
enhanced	CC	O
when	DT	O
both	NN	O
parental	IN	O
plants	DT	O
express	NN	O
the	IN	O
polypeptides	DT	O
(e.g.,	NN	O
an	CC	O
amylase,	DT	O
such	.	O
as	DT	O
an	JJ	O
alpha	NNS	O
amylase)	,	O
of	NN	O
the	IN	O
invention.	DT	O
The	NNS	O
desired	IN	O
effects	DT	O
can	NN	O
be	TO	O
passed	VB	O
to	DT	O
future	NN	O
plant	IN	O
generations	WDT	O
by	VBG	O
standard	NN	O
propagation	VBZ	O
means.	)	O
The	MD	O
nucleic	VB	O
acids	VBN	O
and	WRB	O
polypeptides	DT	O
of	JJ	O
the	NNS	O
invention	VB	O
are	DT	O
expressed	NNS	O
in	,	O
or	DT	O
inserted	,	O
in	JJ	O
any	IN	O
plant	DT	O
or	JJ	O
seed.	)	O
Transgenic	IN	O
plants	DT	O
of	.	O
the	DT	O
invention	JJ	O
can	NNS	O
be	MD	O
dicotyledonous	VB	O
or	VBN	O
monocotyledonous.	TO	O
Examples	VB	O
of	NN	O
monocot	NNS	O
transgenic	IN	O
plants	JJ	O
of	NN	O
the	.	O
invention	DT	O
are	JJ	O
grasses,	NNS	O
such	CC	O
as	NNS	O
meadow	IN	O
grass	DT	O
(blue	NN	O
grass,	VBP	O
Poa),	VBN	O
forage	IN	O
grass	CC	O
such	VBN	O
as	IN	O
festuca,	DT	O
lolium,	NN	O
temperate	CC	O
grass,	.	O
such	JJ	O
as	NNS	O
Agrostis,	IN	O
and	DT	O
cereals,	NN	O
e.g.,	MD	O
wheat,	VB	O
oats,	JJ	O
rye,	CC	O
barley,	.	O
rice,	NNS	O
sorghum,	IN	O
and	NN	O
maize	JJ	O
(corn).	NNS	O
Examples	IN	O
of	DT	O
dicot	NN	O
transgenic	VBP	O
plants	,	O
of	JJ	O
the	IN	O
invention	JJ	O
are	NN	O
tobacco,	JJ	O
legumes,	,	O
such	,	O
as	JJ	O
lupins,	NN	O
potato,	JJ	O
sugar	IN	O
beet,	,	O
pea,	,	O
bean	JJ	O
and	,	O
soybean,	JJ	O
and	IN	O
cruciferous	,	O
plants	CC	O
(family	,	O
Brassicaceae),	,	O
such	,	O
as	,	O
cauliflower,	,	O
rape	,	O
seed,	,	O
and	,	O
the	CC	O
closely	NN	O
related	.	O
model	NNS	O
organism	IN	O
Arabidopsis	JJ	O
thaliana.	JJ	O
Thus,	NNS	O
the	IN	O
transgenic	DT	O
plants	NN	O
and	VBP	O
seeds	,	O
of	,	O
the	JJ	O
invention	IN	O
include	,	O
a	,	O
broad	NN	O
range	,	O
of	,	O
plants,	NN	O
including,	CC	O
but	,	O
not	CC	O
limited	JJ	O
to,	NNS	O
species	NN	O
from	,	O
the	JJ	O
genera	IN	O
Anacardium,	,	O
Arachis,	NN	O
Asparagus,	,	O
Atropa,	CC	O
Avena,	DT	O
Brassica,	RB	O
Citrus,	JJ	O
Citrullus,	NN	O
Capsicum,	NN	O
Carthamus,	NNP	O
Cocos,	.	O
Coffea,	,	O
Cucumis,	DT	O
Cucurbita,	JJ	O
Daucus,	NNS	O
Elaeis,	CC	O
Fragaria,	NNS	O
Glycine,	IN	O
Gossypium,	DT	O
Helianthus,	NN	O
Heterocallis,	VBP	O
Hordeum,	DT	O
Hyoscyamus,	JJ	O
Lactuca,	NN	O
Linum,	IN	O
Lolium,	,	O
Lupinus,	,	O
Lycopersicon,	CC	O
Malus,	RB	O
Manihot,	JJ	O
Majorana,	,	O
Medicago,	NNS	O
Nicotiana,	IN	O
Olea,	DT	O
Oryza,	NN	O
Panieum,	,	O
Pannisetum,	,	O
Persea,	,	O
Phaseolus,	,	O
Pistachia,	,	O
Pisum,	,	O
Pyrus,	,	O
Prunus,	,	O
Raphanus,	,	O
Ricinus,	,	O
Secale,	,	O
Senecio,	,	O
Sinapis,	,	O
Solanum,	,	O
Sorghum,	,	O
Theobromus,	,	O
Trigonella,	,	O
Triticum,	,	O
Vicia,	,	O
Vitis,	,	O
Vigna,	,	O
and	,	O
Zea.	,	O
In	,	O
alternative	,	O
embodiments,	,	O
the	,	O
nucleic	,	O
acids	,	O
of	,	O
the	,	O
invention	,	O
are	,	O
expressed	,	O
in	,	O
plants	,	O
which	,	O
contain	,	O
fiber	,	O
cells,	,	O
including,	,	O
e.g.,	,	O
cotton,	,	O
silk	,	O
cotton	,	O
tree	,	O
(Kapok,	,	O
Ceiba	,	O
pentandra),	,	O
desert	,	O
willow,	,	O
creosote	,	O
bush,	,	O
winterfat,	,	O
balsa,	,	O
ramie,	,	O
kenaf,	CC	O
hemp,	.	O
roselle,	IN	O
jute,	JJ	O
sisal	,	O
abaca	DT	O
and	JJ	O
flax.	NNS	O
In	IN	O
alternative	DT	O
embodiments,	NN	O
the	VBP	O
transgenic	VBN	O
plants	IN	O
of	NNS	O
the	WDT	O
invention	VBP	O
can	JJ	O
be	,	O
members	,	O
of	,	O
the	,	O
genus	JJ	O
Gossypium,	NN	O
including	NN	O
members	,	O
of	NNP	O
any	,	O
Gossypium	JJ	O
species,	,	O
such	NN	O
as	,	O
G.	,	O
arboreum;	,	O
G.	,	O
herbaceum,	,	O
G.	,	O
barbadense,	,	O
and	,	O
G.	JJ	O
hirsutum.	NN	O
The	CC	O
invention	.	O
also	IN	O
provides	JJ	O
for	,	O
transgenic	DT	O
plants	JJ	O
to	NNS	O
be	IN	O
used	DT	O
for	NN	O
producing	MD	O
large	VB	O
amounts	NNS	O
of	IN	O
the	DT	O
polypeptides	NN	O
(e.g.,	,	O
an	VBG	O
amylase,	NNS	O
such	IN	O
as	DT	O
an	NNP	O
alpha	,	O
amylase)	JJ	O
of	IN	O
the	NNP	O
invention.	:	O
For	NNP	O
example,	,	O
see	NNP	O
Palmgren	,	B
(1997)	CC	I
Trends	NNP	I
Genet.	.	I
13:348;	DT	I
Chong	NN	B
(1997)	RB	I
Transgenic	VBZ	I
Res.	IN	I
6:289-296	JJ	I
(producing	NNS	O
human	TO	O
milk	VB	O
protein	VBN	O
beta-casein	IN	O
in	VBG	O
transgenic	JJ	O
potato	NNS	O
plants	IN	O
using	DT	O
an	NNS	O
auxin-inducible,	,	O
bidirectional	DT	O
mannopine	,	O
synthase	JJ	O
(mas1′,2′)	IN	O
promoter	DT	O
with	JJ	O
Agrobacterium	)	O
tumefaciens-mediated	IN	O
leaf	DT	O
disc	.	O
transformation	IN	O
methods).	,	O
Using	VBP	O
known	NNP	O
procedures,	)	O
one	NNPS	O
of	.	O
skill	:	O
can	NNP	O
screen	)	O
for	NNP	O
plants	.	O
of	JJ	O
the	VBG	O
invention	JJ	O
by	NN	O
detecting	NN	O
the	NN	O
increase	IN	O
or	JJ	O
decrease	NN	O
of	NNS	O
transgene	VBG	O
mRNA	DT	O
or	,	O
protein	JJ	O
in	NN	O
transgenic	NN	O
plants.	)	O
Means	NN	O
for	IN	O
detecting	NNP	O
and	JJ	O
quantitation	NN	O
of	NN	O
mRNAs	NN	O
or	.	O
proteins	VBG	O
are	VBN	O
well	,	O
known	CD	O
in	IN	O
the	NN	O
art.	MD	O
Polypeptides	VB	O
and	IN	O
Peptides	NNS	O
In	IN	O
one	DT	O
aspect,	NN	O
the	IN	O
invention	VBG	O
provides	DT	O
isolated	NN	O
or	CC	O
recombinant	NN	O
polypeptides	IN	O
having	JJ	O
a	NN	O
sequence	CC	O
identity	NN	O
(e.g.,	IN	O
at	JJ	O
least	.	O
about	NNS	O
50%,	IN	O
51%,	VBG	O
52%,	CC	O
53%,	NN	O
54%,	IN	O
55%,	NN	O
56%,	CC	O
57%,	NNS	O
58%,	VBP	O
59%,	RB	O
60%,	VBN	O
61%,	IN	O
62%,	DT	O
63%,	.	O
64%,	NNS	O
65%,	CC	O
66%,	NNP	O
67%,	IN	O
68%,	CD	O
69%,	,	O
70%,	DT	O
71%,	NN	O
72%,	VBZ	O
73%,	JJ	O
74%,	CC	O
75%,	JJ	O
76%,	NNS	O
77%,	VBG	O
78%,	DT	O
79%,	NN	O
80%,	NN	O
81%,	,	O
82%,	IN	O
83%,	JJS	O
84%,	IN	O
85%,	,	O
86%,	,	O
87%,	,	O
88%,	,	O
89%,	,	O
90%,	,	O
91%,	,	O
92%,	,	O
93%,	,	O
94%,	,	O
95%,	,	O
96%,	,	O
97%,	,	O
98%,	,	O
99%,	,	O
or	,	O
more,	,	O
or	,	O
complete	,	O
(100%)	,	O
sequence	,	O
identity)	,	O
to	,	O
an	,	O
exemplary	,	O
sequence	,	O
of	,	O
the	,	O
invention,	,	O
e.g.,	,	O
SEQ	,	O
ID	,	O
NO:2	,	O
and	,	O
subsequences	,	O
thereof	,	O
and	,	O
variants	,	O
thereof.	,	O
In	,	O
one	,	O
aspect,	,	O
the	,	O
polypeptide	,	O
has	,	O
an	,	O
amylase	,	O
activity,	,	O
e.g.,	,	O
an	,	O
alpha	CC	O
amylase	,	O
activity.	CC	O
The	JJ	O
identity	)	O
can	NN	O
be	)	O
over	TO	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
the	DT	O
polypeptide,	,	O
or,	,	O
the	NNP	O
identity	NNP	O
can	NNP	O
be	CC	O
over	NNS	O
a	NN	O
region	CC	O
of	NNS	O
at	.	O
least	IN	O
about	CD	O
50,	,	O
60,	DT	O
70,	NN	O
80,	VBZ	O
90,	DT	O
100,	NN	O
150,	,	O
200,	,	O
250,	DT	O
300,	JJ	O
350,	NN	O
400,	.	O
450,	DT	O
500,	NN	O
550,	MD	O
600,	VB	O
650,	IN	O
700	DT	O
or	JJ	O
more	NN	O
residues.	IN	O
Polypeptides	DT	O
of	,	O
the	,	O
invention	DT	O
can	NN	O
also	MD	O
be	VB	O
shorter	IN	O
than	DT	O
the	NN	O
full	IN	O
length	IN	O
of	JJS	O
exemplary	IN	O
polypeptides.	,	O
In	,	O
alternative	,	O
aspects,	,	O
the	,	O
invention	,	O
provides	,	O
polypeptides	,	O
(peptides,	,	O
fragments)	,	O
ranging	,	O
in	,	O
size	,	O
between	,	O
about	,	O
5	,	O
and	,	O
the	CD	O
full	CC	O
length	JJR	O
of	.	O
a	NNS	O
polypeptide,	IN	O
e.g.,	DT	O
an	NN	O
enzyme,	MD	O
such	RB	O
as	VB	O
an	JJR	O
amylase;	IN	O
exemplary	DT	O
sizes	JJ	O
being	NN	O
of	IN	O
about	JJ	O
5,	.	O
10,	IN	O
15,	JJ	O
20,	,	O
25,	DT	O
30,	NN	O
35,	VBZ	O
40,	NNS	O
45,	,	O
50,	)	O
55,	VBG	O
60,	IN	O
65,	NN	O
70,	IN	O
75,	IN	O
80,	CD	O
85,	CC	O
90,	DT	O
100,	JJ	O
125,	NN	O
150,	IN	O
175,	DT	O
200,	,	O
250,	,	O
300,	DT	O
350,	,	O
400,	JJ	O
450,	IN	O
500,	DT	O
550,	:	O
600,	JJ	O
650,	NNS	O
700,	VBG	O
or	IN	O
more	IN	O
residues,	,	O
e.g.,	,	O
contiguous	,	O
residues	,	O
of	,	O
an	,	O
exemplary	,	O
amylase	,	O
of	,	O
the	,	O
invention.	,	O
Peptides	,	O
of	,	O
the	,	O
invention	,	O
can	,	O
be	,	O
useful	,	O
as,	,	O
e.g.,	,	O
labeling	,	O
probes,	,	O
antigens,	,	O
toleragens,	,	O
motifs,	,	O
amylase	,	O
active	,	O
sites.	,	O
Polypeptides	,	O
and	,	O
peptides	,	O
of	,	O
the	,	O
invention	CC	O
can	JJR	O
be	,	O
isolated	,	O
from	JJ	O
natural	NNS	O
sources,	IN	O
be	DT	O
synthetic,	JJ	O
or	NN	O
be	IN	O
recombinantly	DT	O
generated	.	O
polypeptides.	NNS	O
Peptides	IN	O
and	DT	O
proteins	NN	O
can	MD	O
be	VB	O
recombinantly	JJ	O
expressed	,	O
in	,	O
vitro	VBG	O
or	,	O
in	,	O
vivo.	,	O
The	,	O
peptides	RB	O
and	JJ	O
polypeptides	.	O
of	NNS	O
the	CC	O
invention	NNS	O
can	IN	O
be	DT	O
made	NN	O
and	MD	O
isolated	VB	O
using	VBN	O
any	IN	O
method	JJ	O
known	,	O
in	VB	O
the	,	O
art.	CC	O
Polypeptide	VB	O
and	RB	O
peptides	VBN	O
of	.	O
the	NNS	O
invention	CC	O
can	NNS	O
also	MD	O
be	VB	O
synthesized,	RB	O
whole	VBN	O
or	IN	O
in	NN	O
part,	CC	O
using	IN	O
chemical	.	O
methods	DT	O
well	NNS	O
known	CC	O
in	NNS	O
the	IN	O
art.	DT	O
See	NN	O
e.g.,	MD	O
Caruthers	VB	B
(1980)	VBN	I
Nucleic	CC	I
Acids	JJ	I
Res.	VBG	I
Symp.	DT	I
Ser.	NN	I
215-223;	VBN	I
Horn	IN	B
(1980)	DT	I
Nucleic	.	I
Acids	NNP	I
Res.	CC	I
Symp.	NNS	I
Ser.	IN	I
225-232;	DT	I
Banga,	NN	B
A.	MD	I
K.,	RB	I
Therapeutic	VB	I
Peptides	,	I
and	JJ	I
Proteins,	CC	I
Formulation,	IN	I
Processing	,	I
and	VBG	I
Delivery	NN	I
Systems	NNS	I
(1995)	RB	I
Technomic	VBN	I
Publishing	IN	I
Co.,	DT	I
Lancaster,	.	I
Pa.	VB	I
For	,	O
example,	NNP	O
peptide	)	O
synthesis	NNP	O
can	NNP	O
be	.	O
performed	.	O
using	.	O
various	:	O
solid-phase	NNP	O
techniques	)	O
(see	NNP	O
e.g.,	NNP	O
Roberge	.	B
(1995)	.	I
Science	.	I
269:202;	:	I
Merrifield	,	B
(1997)	NNP	I
Methods	,	I
Enzymol.	NNP	I
289:3-13)	NNP	I
and	CC	O
automated	,	O
synthesis	,	O
may	NNP	O
be	CC	O
achieved,	NNP	O
e.g.,	NNP	O
using	)	O
the	NNP	O
ABI	NNP	O
431A	,	O
Peptide	,	O
Synthesizer	NNP	O
(Perkin	IN	O
Elmer)	,	O
in	IN	O
accordance	NN	O
with	MD	O
the	VB	O
instructions	VBN	O
provided	VBG	O
by	JJ	O
the	JJ	O
manufacturer.	NNS	O
The	VB	O
peptides	,	O
and	NNP	O
polypeptides	)	O
of	NN	O
the	:	O
invention	NNP	O
can	)	O
also	NNP	O
be	.	O
glycosylated.	)	O
The	CC	O
glycosylation	VBN	O
can	NN	O
be	MD	O
added	VB	O
post-translationally	,	O
either	,	O
chemically	VBG	O
or	DT	O
by	NNP	O
cellular	CD	O
biosynthetic	NNP	O
mechanisms,	NNP	O
wherein	NNP	O
the	)	O
later	IN	O
incorporates	NN	O
the	IN	O
use	DT	O
of	NNS	O
known	VBN	O
glycosylation	IN	O
motifs,	DT	O
which	.	O
can	DT	O
be	NNS	O
native	CC	O
to	NNS	O
the	IN	O
sequence	DT	O
or	NN	O
can	MD	O
be	RB	O
added	VB	O
as	.	O
a	DT	O
peptide	NN	O
or	MD	O
added	VB	O
in	VBN	O
the	RB	O
nucleic	DT	O
acid	RB	O
coding	CC	O
sequence.	IN	O
The	JJ	O
glycosylation	JJ	O
can	,	O
be	VBP	O
O-linked	DT	O
or	NN	O
N-linked.	VBZ	O
The	DT	O
peptides	NN	O
and	IN	O
polypeptides	VBN	O
of	NN	O
the	,	O
invention,	WDT	O
as	MD	O
defined	VB	O
above,	JJ	O
include	TO	O
all	DT	O
“mimetic”	NN	O
and	CC	O
“peptidomimetic”	MD	O
forms.	VB	O
The	VBN	O
terms	IN	O
“mimetic”	DT	O
and	NN	O
“peptidomimetic”	CC	O
refer	VBN	O
to	IN	O
a	DT	O
synthetic	JJ	O
chemical	NN	O
compound	VBG	O
which	.	O
has	DT	O
substantially	NN	O
the	MD	O
same	VB	O
structural	JJ	O
and/or	CC	O
functional	.	O
characteristics	DT	O
of	NNS	O
the	CC	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention.	,	O
The	IN	O
mimetic	VBN	O
can	,	O
be	VBP	O
either	DT	O
entirely	NNP	O
composed	CC	O
of	NNP	O
synthetic,	.	O
non-natural	DT	O
analogues	NNS	O
of	VBP	O
amino	CC	O
acids,	VBP	O
or,	VBP	O
is	TO	O
a	DT	O
chimeric	JJ	O
molecule	NN	O
of	NN	O
partly	WDT	O
natural	VBZ	O
peptide	RB	O
amino	DT	O
acids	JJ	O
and	JJ	O
partly	IN	O
non-natural	JJ	O
analogs	NNS	O
of	IN	O
amino	DT	O
acids.	NNS	O
The	IN	O
mimetic	DT	O
can	.	O
also	DT	O
incorporate	JJ	O
any	MD	O
amount	VB	O
of	RB	O
natural	RB	O
amino	VBN	O
acid	IN	O
conservative	,	O
substitutions	JJ	O
as	NNS	O
long	IN	O
as	NN	O
such	,	O
substitutions	,	O
also	VBZ	O
do	DT	O
not	JJ	O
substantially	NN	O
alter	IN	O
the	RB	O
mimetic's	JJ	O
structure	NN	O
and/or	NN	O
activity.	NNS	O
As	CC	O
with	RB	O
polypeptides	JJ	O
of	NNS	O
the	IN	O
invention	JJ	O
which	.	O
are	DT	O
conservative	NN	O
variants,	MD	O
routine	RB	O
experimentation	VB	O
will	DT	O
determine	NN	O
whether	IN	O
a	JJ	O
mimetic	JJ	O
is	NN	O
within	JJ	O
the	NNS	O
scope	RB	O
of	RB	O
the	IN	O
invention,	JJ	O
i.e.,	NNS	O
that	RB	O
its	VBP	O
structure	RB	O
and/or	RB	O
function	VB	O
is	DT	O
not	POS	O
substantially	NN	O
altered.	NN	O
Thus,	.	O
in	IN	O
one	IN	O
aspect,	NNS	O
a	IN	O
mimetic	DT	O
composition	NN	O
is	WDT	O
within	VBP	O
the	JJ	O
scope	,	O
of	JJ	O
the	NN	O
invention	MD	O
if	VB	O
it	IN	O
has	DT	O
an	JJ	O
amylase	VBZ	O
activity.	IN	O
Polypeptide	DT	O
mimetic	NN	O
compositions	IN	O
of	DT	O
the	,	O
invention	,	O
can	IN	O
contain	PRP$	O
any	NN	O
combination	NN	O
of	NN	O
non-natural	VBZ	O
structural	RB	O
components.	RB	O
In	.	O
alternative	,	O
aspect,	IN	O
mimetic	CD	O
compositions	,	O
of	DT	O
the	JJ	O
invention	NN	O
include	VBZ	O
one	IN	O
or	DT	O
all	NN	O
of	IN	O
the	DT	O
following	NN	O
three	IN	O
structural	PRP	O
groups:	VBZ	O
a)	DT	O
residue	NN	O
linkage	.	O
groups	NNP	O
other	JJ	O
than	NNS	O
the	IN	O
natural	DT	O
amide	NN	O
bond	MD	O
(“peptide	VB	O
bond”)	DT	O
linkages;	NN	O
b)	IN	O
non-natural	JJ	O
residues	JJ	O
in	.	O
place	IN	O
of	JJ	O
naturally	,	O
occurring	JJ	O
amino	NNS	O
acid	IN	O
residues;	DT	O
or	NN	O
c)	VBP	O
residues	CD	O
which	CC	O
induce	DT	O
secondary	IN	O
structural	DT	O
mimicry,	JJ	O
i.e.,	CD	O
to	JJ	O
induce	:	O
or	)	O
stabilize	JJ	O
a	NN	O
secondary	NNS	O
structure,	JJ	O
e.g.,	IN	O
a	DT	O
beta	JJ	O
turn,	NN	O
gamma	NN	O
turn,	JJ	O
beta	)	O
sheet,	:	O
alpha	)	O
helix	JJ	O
conformation,	NNS	O
and	IN	O
the	NN	O
like.	IN	O
For	RB	O
example,	VBG	O
a	NN	O
polypeptide	NN	O
of	:	O
the	CC	O
invention	)	O
can	NNS	O
be	WDT	O
characterized	VBP	O
as	JJ	O
a	JJ	O
mimetic	,	O
when	,	O
all	TO	O
or	VB	O
some	CC	O
of	VB	O
its	DT	O
residues	JJ	O
are	,	O
joined	,	O
by	DT	O
chemical	NN	O
means	,	O
other	JJ	O
than	,	O
natural	JJ	O
peptide	,	O
bonds.	JJ	O
Individual	NN	O
peptidomimetic	,	O
residues	CC	O
can	DT	O
be	.	O
joined	IN	O
by	,	O
peptide	DT	O
bonds,	NN	O
other	IN	O
chemical	DT	O
bonds	NN	O
or	MD	O
coupling	VB	O
means,	VBN	O
such	IN	O
as,	DT	O
e.g.,	JJ	O
glutaraldehyde,	WRB	O
N-hydroxysuccinimide	DT	O
esters,	CC	O
bifunctional	DT	O
maleimides,	IN	O
N,N′-dicyclohexylcarbodiimide	PRP$	O
(DCC)	NNS	O
or	VBP	O
N,N′-diisopropylcarbodiimide	VBN	O
(DIC).	IN	O
Linking	NN	O
groups	NNS	O
that	JJ	O
can	IN	O
be	JJ	O
an	JJ	O
alternative	.	O
to	NNP	O
the	JJ	O
traditional	NNS	O
amide	MD	O
bond	VB	O
(“peptide	VBN	O
bond”)	IN	O
linkages	NN	O
include,	,	O
e.g.,	JJ	O
ketomethylene	JJ	O
(e.g.,	NNS	O
—C(═O)—CH2—	CC	O
for	NN	O
—C(═O)—NH—),	,	O
aminomethylene	JJ	O
(CH2—NH),	,	O
ethylene,	,	O
olefin	,	O
(CH═CH),	JJ	O
ether	,	O
(CH2—O),	JJ	O
thioether	,	O
(CH2—S),	NNP	O
tetrazole	)	O
(CN4—),	CC	O
thiazole,	NNP	O
retroamide,	.	O
thioamide,	VBG	O
or	NNS	O
ester	WDT	O
(see,	MD	O
e.g.,	VB	O
Spatola	DT	B
(1983)	JJ	I
in	TO	I
Chemistry	DT	I
and	JJ	I
Biochemistry	NN	I
of	NN	I
Amino	JJ	I
Acids,	)	I
Peptides	VBZ	I
and	,	I
Proteins,	,	I
Vol.	NN	I
7,	,	I
pp	NN	I
267-357,	IN	I
“Peptide	,	I
Backbone	NN	I
Modifications,”	,	I
Marcell	,	I
Dekker,	FW	I
NY).A	,	O
polypeptide	RB	O
of	,	O
the	RB	O
invention	,	O
can	JJ	O
also	,	O
be	,	O
characterized	,	O
as	,	O
a	CC	O
mimetic	NN	O
by	,	O
containing	,	O
all	NNP	O
or	)	O
some	IN	O
non-natural	NNP	O
residues	CC	O
in	NNP	O
place	IN	O
of	NNP	O
naturally	,	O
occurring	NNP	O
amino	CC	O
acid	,	O
residues.	.	O
Non-natural	,	O
residues	JJ	O
are	,	O
well	JJ	O
described	NNP	O
in	NNP	O
the	NNP	O
scientific	,	O
and	.	O
patent	DT	O
literature;	NN	O
a	IN	O
few	DT	O
exemplary	NN	O
non-natural	MD	O
compositions	RB	O
useful	VB	O
as	VBN	O
mimetics	IN	O
of	DT	O
natural	JJ	O
amino	IN	O
acid	VBG	O
residues	DT	O
and	CC	O
guidelines	DT	O
are	JJ	O
described	NNS	O
below.	IN	O
Mimetics	NN	O
of	IN	O
aromatic	RB	O
amino	VBG	O
acids	NN	O
can	NN	O
be	.	O
generated	JJ	O
by	NNS	O
replacing	VBP	O
by,	RB	O
e.g.,	VBN	O
D-	IN	O
or	DT	O
L-naphylalanine;	JJ	O
D-	CC	O
or	JJ	O
L-phenylglycine;	:	O
D-	DT	O
or	JJ	O
L-2	JJ	O
thieneylalanine;	JJ	O
D-	NNS	O
or	JJ	O
L-1,	IN	O
-2,	NNS	O
3-,	IN	O
or	JJ	O
4-pyreneylalanine;	NN	O
D-	NN	O
or	NNS	O
L-3	CC	O
thieneylalanine;	NNS	O
D-	VBP	O
or	VBN	O
L-(2-pyridinyl)-alanine;	.	O
D-	NNS	O
or	IN	O
L-(3-pyridinyl)-alanine;	JJ	O
D-	NN	O
or	NNS	O
L-(2-pyrazinyl)-alanine;	MD	O
D-	VB	O
or	VBN	O
L-(4-isopropyl)-phenylglycine;	IN	O
D-(trifluoromethyl)-phenylglycine;	VBG	O
D-(trifluoromethyl)-phenylalanine;	,	O
D-p-fluoro-phenylalanine;	,	O
D-	NNP	O
or	CC	O
L-p-biphenylphenylalanine;	:	O
D-	NNP	O
or	CC	O
L-p-methoxy-biphenylphenylalanine;	:	O
D-	NNP	O
or	CC	O
L-2-indole(alkyl)alanines;	NNP	O
and,	:	O
D-	NNP	O
or	CC	O
L-alkylainines,	,	O
where	,	O
alkyl	,	O
can	CC	O
be	:	O
substituted	NNP	O
or	CC	O
unsubstituted	NNP	O
methyl,	:	O
ethyl,	NNP	O
propyl,	CC	O
hexyl,	:	O
butyl,	NNP	O
pentyl,	CC	O
isopropyl,	:	O
iso-butyl,	NNP	O
sec-isotyl,	CC	O
iso-pentyl,	:	O
or	NNP	O
a	CC	O
non-acidic	:	O
amino	:	O
acids.	:	O
Aromatic	:	O
rings	NNP	O
of	CC	O
a	:	O
non-natural	NNP	O
amino	CC	O
acid	:	O
include,	NNP	O
e.g.,	CC	O
thiazolyl,	:	O
thiophenyl,	,	O
pyrazolyl,	NNP	O
benzimidazolyl,	CC	O
naphthyl,	,	O
furanyl,	WRB	O
pyrrolyl,	NN	O
and	MD	O
pyridyl	VB	O
aromatic	VBN	O
rings.	CC	O
Mimetics	JJ	O
of	,	O
acidic	,	O
amino	,	O
acids	,	O
can	,	O
be	,	O
generated	,	O
by	,	O
substitution	,	O
by,	,	O
e.g.,	CC	O
non-carboxylate	DT	O
amino	JJ	O
acids	NN	O
while	.	O
maintaining	JJ	O
a	NNS	O
negative	IN	O
charge;	DT	O
(phosphono)alanine;	JJ	O
sulfated	NN	O
threonine.	NN	O
Carboxyl	,	O
side	,	O
groups	,	O
(e.g.,	,	O
aspartyl	,	O
or	,	O
glutamyl)	,	O
can	,	O
also	,	O
be	CC	O
selectively	RB	O
modified	JJ	O
by	.	O
reaction	NNS	O
with	IN	O
carbodiimides	JJ	O
(R′—N—C—N—R′)	JJ	O
such	NNS	O
as,	MD	O
e.g.,	VB	O
1-cyclohexyl-3(2-morpholinyl-(4-ethyl)carbodiimide	VBN	O
or	IN	O
1-ethyl-3(4-azonia-4,4-dimetholpentyl)carbodiimide.	NN	O
Aspartyl	,	O
or	,	O
glutamyl	JJ	O
can	NN	O
also	NNS	O
be	IN	O
converted	VBG	O
to	DT	O
asparaginyl	JJ	O
and	:	O
glutaminyl	:	O
residues	VBN	O
by	.	O
reaction	NNP	O
with	NN	O
ammonium	NNS	O
ions.	,	O
Mimetics	NN	O
of	CC	O
basic	)	O
amino	MD	O
acids	RB	O
can	VB	O
be	RB	O
generated	VBN	O
by	IN	O
substitution	NN	O
with,	IN	O
e.g.,	NNS	O
(in	)	O
addition	JJ	O
to	,	O
lysine	,	O
and	NN	O
arginine)	CC	O
the	.	O
amino	NNP	O
acids	CC	O
ornithine,	NN	O
citrulline,	MD	O
or	RB	O
(guanidino)-acetic	VB	O
acid,	VBN	O
or	TO	O
(guanidino)alkyl-acetic	VB	O
acid,	CC	O
where	VB	O
alkyl	NNS	O
is	IN	O
defined	NN	O
above.	IN	O
Nitrile	NN	O
derivative	.	O
(e.g.,	NNS	O
containing	IN	O
the	JJ	O
CN-moiety	NN	O
in	NNS	O
place	MD	O
of	VB	O
COOH)	VBN	O
can	IN	O
be	NN	O
substituted	,	O
for	,	O
asparagine	IN	O
or	NN	O
glutamine.	TO	O
Asparaginyl	VB	O
and	CC	O
glutaminyl	)	O
residues	DT	O
can	NN	O
be	NNS	O
deaminated	,	O
to	,	O
the	CC	O
corresponding	JJ	O
aspartyl	,	O
or	CC	O
glutamyl	JJ	O
residues.	,	O
Arginine	WRB	O
residue	NN	O
mimetics	VBZ	O
can	VBN	O
be	.	O
generated	NNP	O
by	NN	O
reacting	,	O
arginyl	VBG	O
with,	DT	O
e.g.,	NN	O
one	IN	O
or	NN	O
more	IN	O
conventional	)	O
reagents,	MD	O
including,	VB	O
e.g.,	VBN	O
phenylglyoxal,	IN	O
2,3-butanedione,	NN	O
1,2-cyclo-hexanedione,	CC	O
or	.	O
ninhydrin,	NNP	O
preferably	CC	O
under	NN	O
alkaline	NNS	O
conditions.	MD	O
Tyrosine	VB	O
residue	VBN	O
mimetics	TO	O
can	DT	O
be	JJ	O
generated	NN	O
by	CC	O
reacting	NN	O
tyrosyl	.	O
with,	NNP	O
e.g.,	JJ	O
aromatic	NNS	O
diazonium	MD	O
compounds	VB	O
or	VBN	O
tetranitromethane.	IN	O
N-acetylimidizol	VBG	O
and	NN	O
tetranitromethane	,	O
can	,	O
be	CD	O
used	CC	O
to	JJR	O
form	JJ	O
O-acetyl	,	O
tyrosyl	,	O
species	,	O
and	,	O
3-nitro	,	O
derivatives,	,	O
respectively.	CC	O
Cysteine	,	O
residue	RB	O
mimetics	IN	O
can	JJ	O
be	.	O
generated	NNP	O
by	JJ	O
reacting	NNS	O
cysteinyl	MD	O
residues	VB	O
with,	VBN	O
e.g.,	IN	O
alpha-haloacetates	VBG	O
such	NN	O
as	,	O
2-chloroacetic	,	O
acid	JJ	O
or	NN	O
chloroacetamide	NNS	O
and	CC	O
corresponding	.	O
amines;	NNP	O
to	CC	O
give	NN	O
carboxymethyl	MD	O
or	VB	O
carboxyamidomethyl	VBN	O
derivatives.	TO	O
Cysteine	VB	O
residue	NNP	O
mimetics	NN	O
can	NNS	O
also	CC	O
be	JJ	O
generated	,	O
by	.	O
reacting	NNP	O
cysteinyl	JJ	O
residues	NNS	O
with,	MD	O
e.g.,	VB	O
bromo-trifluoroacetone,	VBN	O
alpha-bromo-beta-(5-imidozoyl)propionic	IN	O
acid;	VBG	O
chloroacetyl	NN	O
phosphate,	NNS	O
N-alkylmaleimides,	,	O
3-nitro-2-pyridyl	,	O
disulfide;	NNS	O
methyl	JJ	O
2-pyridyl	IN	O
disulfide;	JJ	O
p-chloromercuribenzoate;	NN	O
2-chloromercuri-4	CC	O
nitrophenol;	NN	O
or,	CC	O
chloro-7-nitrobenzo-oxa-1,3-diazole.	JJ	O
Lysine	:	O
mimetics	TO	O
can	VB	O
be	NN	O
generated	CC	O
(and	NN	O
amino	.	O
terminal	NNP	O
residues	JJ	O
can	NNS	O
be	MD	O
altered)	RB	O
by	VB	O
reacting	VBN	O
lysinyl	IN	O
with,	VBG	O
e.g.,	NN	O
succinic	NNS	O
or	,	O
other	,	O
carboxylic	,	O
acid	JJ	O
anhydrides.	:	O
Lysine	JJ	O
and	,	O
other	,	O
alpha-amino-containing	JJ	O
residue	:	O
mimetics	CC	O
can	JJ	O
also	:	O
be	:	O
generated	JJ	O
by	:	O
reaction	,	O
with	.	O
imidoesters,	JJ	O
such	NNS	O
as	MD	O
methyl	VB	O
picolinimidate,	VBN	O
pyridoxal	CC	O
phosphate,	VBZ	O
pyridoxal,	JJ	O
chloroborohydride,	NNS	O
trinitro-benzenesulfonic	MD	O
acid,	VB	O
O-methylisourea,	)	O
2,4,	IN	O
pentanedione,	VBG	O
and	NN	O
transamidase-catalyzed	,	O
reactions	,	O
with	JJ	O
glyoxylate.	CC	O
Mimetics	JJ	O
of	JJ	O
methionine	NN	O
can	.	O
be	NNP	O
generated	CC	O
by	JJ	O
reaction	JJ	O
with,	JJ	O
e.g.,	NNS	O
methionine	MD	O
sulfoxide.	RB	O
Mimetics	VB	O
of	VBN	O
proline	IN	O
include,	NN	O
e.g.,	IN	O
pipecolic	,	O
acid,	JJ	O
thiazolidine	IN	O
carboxylic	NN	O
acid,	,	O
3-	NN	O
or	,	O
4-hydroxy	,	O
proline,	,	O
dehydroproline,	JJ	O
3-	,	O
or	,	O
4-methylproline,	,	O
or	,	O
3,3,-dimethylproline.	CC	O
Histidine	JJ	O
residue	NNS	O
mimetics	IN	O
can	.	O
be	NNS	O
generated	IN	O
by	NN	O
reacting	MD	O
histidyl	VB	O
with,	VBN	O
e.g.,	IN	O
diethylprocarbonate	NN	O
or	,	O
para-bromophenacyl	,	O
bromide.	JJ	O
Other	.	O
mimetics	NNS	O
include,	IN	O
e.g.,	NN	O
those	,	O
generated	,	O
by	JJ	O
hydroxylation	,	O
of	JJ	O
proline	JJ	O
and	,	O
lysine;	JJ	O
phosphorylation	CC	O
of	JJ	O
the	,	O
hydroxyl	,	O
groups	JJ	O
of	CC	O
seryl	,	O
or	CC	O
threonyl	.	O
residues;	NNP	O
methylation	JJ	O
of	NNS	O
the	MD	O
alpha-amino	VB	O
groups	VBN	O
of	IN	O
lysine,	VBG	O
arginine	NN	O
and	,	O
histidine;	,	O
acetylation	NN	O
of	CC	O
the	JJ	O
N-terminal	.	O
amine;	JJ	O
methylation	NNS	O
of	,	O
main	,	O
chain	DT	O
amide	VBN	O
residues	IN	O
or	NN	O
substitution	IN	O
with	NN	O
N-methyl	CC	O
amino	:	O
acids;	NN	O
or	IN	O
amidation	DT	O
of	NN	O
C-terminal	NNS	O
carboxyl	IN	O
groups.	NN	O
A	CC	O
residue,	NN	O
e.g.,	:	O
an	NN	O
amino	IN	O
acid,	DT	O
of	JJ	O
a	NNS	O
polypeptide	IN	O
of	,	O
the	NN	O
invention	CC	O
can	:	O
also	NN	O
be	IN	O
replaced	DT	O
by	JJ	O
an	:	O
amino	NN	O
acid	IN	O
(or	JJ	O
peptidomimetic	NN	O
residue)	IN	O
of	NNS	O
the	CC	O
opposite	NN	O
chirality.	IN	O
Thus,	NNP	O
any	NN	O
amino	:	O
acid	CC	O
naturally	NN	O
occurring	IN	O
in	JJ	O
the	NN	O
L-configuration	.	O
(which	DT	O
can	,	O
also	,	O
be	DT	O
referred	NN	O
to	,	O
as	IN	O
the	DT	O
R	NN	O
or	IN	O
S,	DT	O
depending	NN	O
upon	MD	O
the	RB	O
structure	VB	O
of	VBN	O
the	IN	O
chemical	DT	O
entity)	NN	O
can	NN	O
be	CC	O
replaced	JJ	O
with	)	O
the	IN	O
amino	DT	O
acid	JJ	O
of	.	O
the	,	O
same	DT	O
chemical	JJ	O
structural	NN	O
type	RB	O
or	VBG	O
a	IN	O
peptidomimetic,	DT	O
but	NNP	O
of	WDT	O
the	MD	O
opposite	RB	O
chirality,	VB	O
referred	VBN	O
to	TO	O
as	IN	O
the	DT	O
D-amino	NNP	O
acid,	CC	O
but	,	O
also	VBG	O
can	IN	O
be	DT	O
referred	NN	O
to	IN	O
as	DT	O
the	NN	O
R-	)	O
or	MD	O
S-form.	VB	O
The	VBN	O
invention	IN	O
also	DT	O
provides	NN	O
methods	NN	O
for	IN	O
modifying	DT	O
the	JJ	O
polypeptides	JJ	O
of	JJ	O
the	NN	O
invention	CC	O
by	DT	O
either	,	O
natural	CC	O
processes,	IN	O
such	DT	O
as	JJ	O
post-translational	,	O
processing	VBD	O
(e.g.,	TO	O
phosphorylation,	IN	O
acylation,	DT	O
etc),	NNP	O
or	,	O
by	CC	O
chemical	RB	O
modification	MD	O
techniques,	VB	O
and	VBN	O
the	TO	O
resulting	IN	O
modified	DT	O
polypeptides.	NNP	O
Modifications	CC	O
can	.	O
occur	DT	O
anywhere	NN	O
in	RB	O
the	VBZ	O
polypeptide,	NNS	O
including	IN	O
the	VBG	O
peptide	DT	O
backbone,	NNS	O
the	IN	O
amino	DT	O
acid	NN	O
side-chains	IN	O
and	DT	O
the	JJ	O
amino	,	O
or	JJ	O
carboxyl	IN	O
termini.	JJ	O
It	NN	O
will	,	O
be	,	O
appreciated	,	O
that	,	O
the	CC	O
same	IN	O
type	JJ	O
of	NN	O
modification	,	O
may	CC	O
be	DT	O
present	VBG	O
in	JJ	O
the	.	O
same	NNS	O
or	MD	O
varying	VB	O
degrees	RB	O
at	IN	O
several	DT	O
sites	,	O
in	VBG	O
a	DT	O
given	NN	O
polypeptide.	,	O
Also	DT	O
a	NN	O
given	JJ	O
polypeptide	NNS	O
may	CC	O
have	DT	O
many	NN	O
types	CC	O
of	NN	O
modifications.	.	O
Modifications	PRP	O
include	MD	O
acetylation,	VB	O
acylation,	VBN	O
ADP-ribosylation,	IN	O
amidation,	DT	O
covalent	JJ	O
attachment	NN	O
of	IN	O
flavin,	NN	O
covalent	MD	O
attachment	VB	O
of	JJ	O
a	IN	O
heme	DT	O
moiety,	JJ	O
covalent	CC	O
attachment	VBG	O
of	NNS	O
a	IN	O
nucleotide	JJ	O
or	NNS	O
nucleotide	IN	O
derivative,	DT	O
covalent	VBN	O
attachment	.	O
of	RB	O
a	DT	O
lipid	VBN	O
or	NN	O
lipid	MD	O
derivative,	VB	O
covalent	JJ	O
attachment	NNS	O
of	IN	O
a	.	O
phosphatidylinositol,	NNS	O
cross-linking	VBP	O
cyclization,	,	O
disulfide	,	O
bond	,	O
formation,	,	O
demethylation,	JJ	O
formation	NN	O
of	IN	O
covalent	,	O
cross-links,	JJ	O
formation	NN	O
of	IN	O
cysteine,	DT	O
formation	NN	O
of	,	O
pyroglutamate,	JJ	O
formylation,	NN	O
gamma-carboxylation,	IN	O
glycosylation,	DT	O
GPI	NN	O
anchor	CC	O
formation,	RB	O
hydroxylation,	,	O
iodination,	JJ	O
methylation,	NN	O
myristolyation,	IN	O
oxidation,	DT	O
pegylation,	JJ	O
proteolytic	CC	O
processing,	JJ	O
phosphorylation,	,	O
prenylation,	JJ	O
racemization,	NN	O
selenoylation,	IN	O
sulfation,	DT	O
and	,	O
transfer-RNA	JJ	O
mediated	,	O
addition	JJ	O
of	NN	O
amino	,	O
acids	,	O
to	NN	O
protein	IN	O
such	JJ	O
as	,	O
arginylation.	NN	O
See,	IN	O
e.g.,	,	O
Creighton,	NN	B
T.	IN	I
E.,	,	I
Proteins—Structure	,	I
and	,	I
Molecular	,	I
Properties	NNP	I
2nd	NN	I
Ed.,	,	I
W.H.	,	I
Freeman	,	I
and	,	I
Company,	,	I
New	,	I
York	,	I
(1993);	JJ	I
Posttranslational	,	B
Covalent	,	I
Modification	,	I
of	,	I
Proteins,	,	I
B.	,	I
C.	CC	I
Johnson,	JJ	I
Ed.,	JJ	I
Academic	NN	I
Press,	IN	I
New	NN	I
York,	NNS	I
pp.	TO	I
1-12	VB	I
(1983).
Solid-phase	JJ	O
chemical	IN	O
peptide	.	O
synthesis	,	O
methods	,	O
can	,	O
also	NNP	O
be	,	O
used	NNP	O
to	CC	O
synthesize	NNP	O
the	NNP	O
polypeptide	CD	O
or	,	O
fragments	.	O
of	NNP	O
the	CC	O
invention.	,	O
Such	NNP	O
method	NNP	O
have	:	O
been	NNP	O
known	NNP	O
in	NNP	O
the	IN	O
art	,	O
since	NNP	O
the	NNP	O
early	,	O
1960's	,	O
Merrifield,	NNP	B
R.	,	I
B.,	NNP	I
J.	,	I
Am.	.	I
Chem.	CD	I
Soc.,	.	I
85:2149-2154,	JJ	I
1963)	NN	I
((See	NN	O
also	NN	O
Stewart,	NNS	B
J.	MD	I
M.	RB	I
and	VB	I
Young,	VBN	I
J.	TO	I
D.,	VB	I
Solid	DT	I
Phase	NN	I
Peptide	CC	I
Synthesis,	NNS	I
2nd	IN	I
Ed.,	DT	I
Pierce	.	I
Chemical	JJ	I
Co.,	NNS	I
Rockford,	VBP	I
Ill.,	VBN	I
pp.	VBN	I
11-12))and	IN	O
have	DT	O
recently	NN	O
been	IN	O
employed	DT	O
in	JJ	O
commercially	POS	O
available	,	O
laboratory	NNP	O
peptide	,	O
design	.	O
and	.	O
synthesis	.	O
kits	,	O
(Cambridge	,	O
Research	)	O
Biochemicals).	NNP	O
Such	RB	O
commercially	,	O
available	NNP	O
laboratory	NNP	O
kits	CC	O
have	,	O
generally	NNP	O
utilized	,	O
the	NNP	O
teachings	NNP	O
of	NNP	O
H.	,	B
M.	CD	I
Geysen	,	I
et	NNP	I
al,	NNP	I
Proc.	,	I
Natl.	,	I
Acad.	,	I
Sci.,	.	I
USA,	)	I
81:3998	CC	I
(1984)	VBP	I
and	RB	O
provide	VBN	O
for	VBN	O
synthesizing	IN	O
peptides	RB	O
upon	JJ	O
the	NN	O
tips	NN	O
of	NN	O
a	CC	O
multitude	NN	O
of	NNS	O
“rods”	NNP	O
or	NNP	O
“pins”	.	O
all	JJ	O
of	RB	O
which	JJ	O
are	NN	O
connected	NNS	O
to	VBP	O
a	RB	O
single	VBN	O
plate.	DT	O
When	NNS	O
such	IN	O
a	NNP	O
system	NNP	O
is	NNP	O
utilized,	FW	O
a	,	O
plate	.	O
of	.	O
rods	.	O
or	,	O
pins	,	O
is	CD	O
inverted	)	O
and	CC	O
inserted	VB	O
into	IN	O
a	VBG	O
second	NNS	O
plate	IN	O
of	DT	O
corresponding	NNS	O
wells	IN	O
or	DT	O
reservoirs,	NN	O
which	IN	O
contain	NN	O
solutions	CC	O
for	VB	O
attaching	DT	O
or	IN	O
anchoring	WDT	O
an	VBP	O
appropriate	VBN	O
amino	TO	O
acid	DT	O
to	JJ	O
the	.	O
pin's	WRB	O
or	PDT	O
rod's	DT	O
tips.	NN	O
By	VBZ	O
repeating	,	O
such	DT	O
a	NN	O
process	IN	O
step,	NNS	O
i.e.,	CC	O
inverting	NNS	O
and	VBZ	O
inserting	VBN	O
the	CC	O
rod's	VBN	O
and	IN	O
pin's	DT	O
tips	JJ	O
into	NN	O
appropriate	IN	O
solutions,	VBG	O
amino	NNS	O
acids	CC	O
are	,	O
built	WDT	O
into	VBP	O
desired	NNS	O
peptides.	IN	O
In	VBG	O
addition,	CC	O
a	VBG	O
number	DT	O
of	JJ	O
available	NN	O
FMOC	NN	O
peptide	TO	O
synthesis	DT	O
systems	POS	O
are	CC	O
available.	POS	O
For	.	O
example,	IN	O
assembly	VBG	O
of	JJ	O
a	DT	O
polypeptide	JJ	O
or	,	O
fragment	,	O
can	VBG	O
be	CC	O
carried	VBG	O
out	DT	O
on	POS	O
a	CC	O
solid	POS	O
support	NNS	O
using	IN	O
an	JJ	O
Applied	,	O
Biosystems,	JJ	O
Inc.	NNS	O
Model	VBP	O
431A™	VBN	O
automated	IN	O
peptide	JJ	O
synthesizer.	.	O
Such	IN	O
equipment	,	O
provides	DT	O
ready	NN	O
access	IN	O
to	JJ	O
the	NNP	O
peptides	NN	O
of	NN	O
the	NNS	O
invention,	VBP	O
either	.	O
by	IN	O
direct	,	O
synthesis	NN	O
or	IN	O
by	DT	O
synthesis	NN	O
of	CC	O
a	NN	O
series	MD	O
of	VB	O
fragments	VBN	O
that	RP	O
can	IN	O
be	DT	O
coupled	JJ	O
using	NN	O
other	VBG	O
known	DT	O
techniques.	NNP	O
The	,	O
invention	NNP	O
provides	NNP	O
novel	CD	O
amylases	VBD	O
(e.g.,	JJ	O
alpha	.	O
amylases),	JJ	O
including	NN	O
the	VBZ	O
exemplary	JJ	O
enzymes	NN	O
of	TO	O
the	DT	O
invention,	NNS	O
nucleic	IN	O
acids	DT	O
encoding	,	O
them,	RB	O
antibodies	IN	O
that	JJ	O
bind	NN	O
them,	CC	O
and	IN	O
methods	NN	O
for	IN	O
making	DT	O
and	NN	O
using	IN	O
them.	NNS	O
In	WDT	O
one	MD	O
aspect,	VB	O
the	VBN	O
polypeptides	VBG	O
of	JJ	O
the	VBN	O
invention	.	O
have	DT	O
an	NN	O
amylase	VBZ	O
activity,	JJ	O
as	NNS	O
described	,	O
herein,	JJ	O
including,	,	O
e.g.,	VBG	O
the	DT	O
ability	JJ	O
to	NNS	O
hydrolyze	IN	O
starches	DT	O
into	,	O
sugars.	JJ	O
In	NNS	O
one	VBG	O
aspect,	,	O
the	VBZ	O
polypeptides	IN	O
of	VB	O
the	,	O
invention	CC	O
have	NNS	O
an	IN	O
alpha	VBG	O
amylase	CC	O
activity.	VBG	O
In	.	O
alternative	IN	O
aspects,	CD	O
the	,	O
amylases	DT	O
of	NNS	O
the	IN	O
invention	DT	O
have	NN	O
activities	VBP	O
that	DT	O
have	NN	O
been	,	O
modified	IN	O
from	VBN	O
those	,	O
of	,	O
the	,	O
exemplary	DT	O
amylases	NN	O
described	TO	O
herein.	VB	O
The	NNS	O
invention	IN	O
includes	.	O
amylases	IN	O
of	CD	O
the	,	O
invention	DT	O
with	NNS	O
and	IN	O
without	DT	O
signal	NN	O
sequences	VBP	O
(including	DT	O
signal	JJ	O
sequence	NN	O
of	.	O
the	IN	O
invention,	JJ	O
or	,	O
other	DT	O
signal	NNS	O
sequences)	IN	O
and	DT	O
the	NN	O
signal	VBP	O
sequences	NNS	O
themselves.	WDT	O
The	VBP	O
invention	VBN	O
also	VBN	O
include	IN	O
polypeptides	DT	O
(e.g.,	IN	O
fusion	DT	O
proteins)	JJ	O
comprising	NNS	O
a	VBD	O
signal	.	O
sequence	DT	O
of	NN	O
the	VBZ	O
invention.	NNS	O
The	IN	O
polypeptide	DT	O
comprising	NN	O
a	IN	O
signal	CC	O
sequence	IN	O
of	JJ	O
the	NNS	O
invention	VBG	O
can	JJ	O
be	NN	O
an	IN	O
amylase	DT	O
of	,	O
the	CC	O
invention	JJ	O
or	JJ	O
another	)	O
amylase	CC	O
or	DT	O
another	JJ	O
enzyme	NNS	O
or	.	O
other	DT	O
polypeptide.	NN	O
The	RB	O
invention	VBP	O
includes	NNS	O
immobilized	,	O
amylases,	NN	O
anti-amylase	)	O
antibodies	VBG	O
and	DT	O
fragments	JJ	O
thereof.	NN	O
The	IN	O
invention	DT	O
provides	.	O
methods	DT	O
for	NN	O
inhibiting	VBG	O
amylase	DT	O
activity,	JJ	O
e.g,	NN	O
using	IN	O
dominant	DT	O
negative	NN	O
mutants	MD	O
or	VB	O
anti-amylase	DT	O
antibodies	NN	O
of	IN	O
the	DT	O
invention.	NN	O
The	CC	O
invention	DT	O
includes	NN	O
heterocomplexes,	CC	O
e.g.,	DT	O
fusion	NN	O
proteins,	CC	O
heterodimers,	JJ	O
etc.,	.	O
comprising	DT	O
the	NN	O
amylases	VBZ	O
of	JJ	O
the	,	O
invention.	JJ	O
In	NNS	O
one	CC	O
aspect,	NNS	O
amylases	.	O
(e.g.,	DT	O
alpha	NN	O
amylases)	VBZ	O
of	NNS	O
the	IN	O
invention	VBG	O
hydrolyze	NN	O
internal	,	O
polysaccharide	,	O
bonds,	VBG	O
e.g.,	JJ	O
α-1,4-	JJ	O
and	NNS	O
1,6-glucosidic	CC	O
bonds	JJ	O
in	NNS	O
starch	IN	O
to	DT	O
produce	.	O
smaller	DT	O
molecular	NN	O
weight	VBZ	O
maltodextrines.	,	O
In	,	O
one	NN	O
aspect,	,	O
this	,	O
hydrolysis	,	O
is	VBG	O
largely	DT	O
at	NNS	O
random.	IN	O
Thus,	DT	O
the	.	O
invention	IN	O
provides	CD	O
methods	,	O
for	NNS	O
producing	,	O
smaller	JJ	O
molecular	)	O
weight	IN	O
maltodextrines.	DT	O
Amylases	NN	O
of	VBD	O
the	JJ	O
invention	NN	O
can	,	O
be	,	O
used	JJ	O
in	CC	O
laboratory	JJ	O
and	NNS	O
industrial	IN	O
settings	NN	O
to	TO	O
hydrolyze	VB	O
starch	JJR	O
or	JJ	O
any	NN	O
maltodextrine-comprising	.	O
compound	IN	O
for	CD	O
a	,	O
variety	DT	O
of	NN	O
purposes.	VBZ	O
These	RB	O
amylases	IN	O
can	.	O
be	,	O
used	DT	O
alone	NN	O
to	VBZ	O
provide	NNS	O
specific	IN	O
hydrolysis	VBG	O
or	JJR	O
can	JJ	O
be	NN	O
combined	.	O
with	NNS	O
other	IN	O
amylases	DT	O
to	NN	O
provide	MD	O
a	VB	O
“cocktail”	VBN	O
with	IN	O
a	NN	O
broad	CC	O
spectrum	JJ	O
of	NNS	O
activity.	TO	O
Exemplary	VB	O
uses	NN	O
include	CC	O
the	DT	O
removal	JJ	O
or	NN	O
partial	IN	O
or	DT	O
complete	NN	O
hydrolysis	IN	O
of	.	O
starch	DT	O
or	NNS	O
any	MD	O
maltodextrine-comprising	VB	O
compound	VBN	O
from	RB	O
biological,	TO	O
food,	VB	O
animal	JJ	O
feed,	NN	O
pharmaceutical	CC	O
or	MD	O
industrial	VB	O
samples.	VBN	O
For	IN	O
example,	JJ	O
the	NNS	O
amylases	TO	O
of	VB	O
the	DT	O
present	NN	O
invention	IN	O
can	DT	O
be	JJ	O
formulated	NN	O
in	IN	O
laundry	.	O
detergents	JJ	O
to	NNS	O
aid	VBP	O
in	DT	O
the	NN	O
removal	CC	O
of	JJ	O
starch-containing	CC	O
stains.	JJ	O
Amylases	NN	O
of	IN	O
the	NN	O
invention	CC	O
can	DT	O
be	JJ	O
used	NN	O
as	IN	O
cleaning	,	O
agents	,	O
in	NN	O
detergent	,	O
matrices	JJ	O
(see	CC	O
industrial	JJ	O
applications	.	O
below).	IN	O
The	,	O
amylases	DT	O
of	NNS	O
the	IN	O
present	DT	O
invention	JJ	O
can	NN	O
be	MD	O
used	VB	O
in	VBN	O
the	IN	O
initial	JJ	O
stages	NNS	O
(liquefaction)	TO	O
of	VB	O
starch	IN	O
processing,	DT	O
in	NN	O
wet	IN	O
corn	JJ	O
milling,	.	O
in	NNS	O
alcohol	IN	O
production,	DT	O
in	NN	O
the	MD	O
textile	VB	O
industry	VBN	O
for	IN	O
starch	NN	O
desizing,	NNS	O
in	IN	O
baking	NN	O
applications,	NNS	O
in	VB	O
the	JJ	O
beverage	NNS	O
industry,	.	O
in	DT	O
oilfields	NNS	O
in	IN	O
drilling	DT	O
processes;	JJ	O
in	NN	O
inking	MD	O
of	VB	O
recycled	VBN	O
paper;	IN	O
and	DT	O
in	JJ	O
animal	NNS	O
feed.	)	O
Amylases	IN	O
of	NN	O
the	,	O
invention	IN	O
can	JJ	O
have	NN	O
an	,	O
amylase	IN	O
activity	NN	O
under	,	O
various	IN	O
conditions,	DT	O
e.g.,	NN	O
extremes	NN	O
in	IN	O
pH	NN	O
and/or	,	O
temperature,	IN	O
oxidizing	VBG	O
agents,	,	O
and	IN	O
the	DT	O
like.	NN	O
The	,	O
invention	IN	O
provides	NNS	O
methods	IN	O
leading	NN	O
to	:	O
alternative	IN	O
amylase	NN	O
preparations	IN	O
with	JJ	O
different	:	O
catalytic	CC	O
efficiencies	IN	O
and	JJ	O
stabilities,	.	O
e.g.,	NNS	O
towards	IN	O
temperature,	DT	O
oxidizing	NN	O
agents	MD	O
and	VB	O
changing	DT	O
wash	NN	O
conditions.	NN	O
In	IN	O
one	JJ	O
aspect,	,	O
amylase	,	O
variants	RB	O
can	IN	O
be	NN	O
produced	NN	O
using	,	O
techniques	VBG	O
of	,	O
site-directed	CC	O
mutagenesis	DT	O
and/or	.	O
random	DT	O
mutagenesis.	NN	O
In	VBZ	O
one	NNS	O
aspect,	VBG	O
directed	TO	O
evolution	JJ	O
can	NN	O
be	NNS	O
used	IN	O
to	JJ	O
produce	JJ	O
a	NNS	O
great	CC	O
variety	,	O
of	,	O
amylase	NNS	O
variants	,	O
with	VBG	O
alternative	NNS	O
specificities	CC	O
and	VBG	O
stability.	JJ	O
The	.	O
proteins	IN	O
of	CD	O
the	,	O
invention	NN	O
are	NNS	O
also	MD	O
useful	VB	O
as	VBN	O
research	VBG	O
reagents	NNS	O
to	IN	O
identify	JJ	O
amylase	NN	O
modulators,	NN	O
e.g.,	JJ	O
activators	.	O
or	IN	O
inhibitors	CD	O
of	,	O
amylase	VBN	O
activity.	NN	O
Briefly,	MD	O
test	VB	O
samples	VBN	O
(compounds,	TO	O
broths,	VB	O
extracts,	DT	O
and	JJ	O
the	NN	O
like)	IN	O
are	JJ	O
added	NNS	O
to	IN	O
amylase	JJ	O
assays	NNS	O
to	CC	O
determine	.	O
their	DT	O
ability	NNS	O
to	IN	O
inhibit	DT	O
substrate	NN	O
cleavage.	VBP	O
Inhibitors	RB	O
identified	JJ	O
in	IN	O
this	NN	O
way	NNS	O
can	TO	O
be	VB	O
used	JJ	O
in	,	O
industry	,	O
and	NNS	O
research	CC	O
to	NNS	O
reduce	IN	O
or	NN	O
prevent	.	O
undesired	,	O
proteolysis.	NN	O
As	NNS	O
with	,	O
amylases,	,	O
inhibitors	,	O
can	CC	O
be	DT	O
combined	)	O
to	VBP	O
increase	VBN	O
the	TO	O
spectrum	VB	O
of	NNS	O
activity.	TO	O
The	VB	O
invention	PRP$	O
also	NN	O
provides	TO	O
methods	VB	O
of	JJ	O
discovering	.	O
new	NNS	O
amylases	VBN	O
using	IN	O
the	DT	O
nucleic	NN	O
acids,	MD	O
polypeptides	VB	O
and	VBN	O
antibodies	IN	O
of	NN	O
the	CC	O
invention.	NN	O
In	TO	O
one	VB	O
aspect,	CC	O
lambda	VB	O
phage	JJ	O
libraries	.	O
are	IN	O
screened	IN	O
for	,	O
expression-based	NNS	O
discovery	MD	O
of	VB	O
amylases.	VBN	O
In	TO	O
one	VB	O
aspect,	DT	O
the	NN	O
invention	IN	O
uses	.	O
lambda	DT	O
phage	NN	O
libraries	RB	O
in	VBZ	O
screening	NNS	O
to	IN	O
allow	VBG	O
detection	JJ	O
of	NNS	O
toxic	VBG	O
clones;	DT	O
improved	JJ	O
access	,	O
to	NNS	O
substrate;	CC	O
reduced	NNS	O
need	IN	O
for	DT	O
engineering	.	O
a	IN	O
host,	CD	O
by-passing	,	O
the	JJ	O
potential	NN	O
for	NNS	O
any	VBP	O
bias	VBN	O
resulting	IN	O
from	JJ	O
mass	NN	O
excision	IN	O
of	.	O
the	IN	O
library;	CD	O
and,	,	O
faster	DT	O
growth	NN	O
at	VBZ	O
low	JJ	O
clone	NN	O
densities.	NNS	O
Screening	IN	O
of	VBG	O
lambda	TO	O
phage	VB	O
libraries	NN	O
can	IN	O
be	JJ	O
in	:	O
liquid	VBN	O
phase	NN	O
or	TO	O
in	:	O
solid	VBN	O
phase.	NN	O
In	IN	O
one	NN	O
aspect,	DT	O
the	,	O
invention	VBG	O
provides	DT	O
screening	NN	O
in	IN	O
liquid	DT	O
phase.	JJ	O
This	VBG	O
gives	IN	O
a	NN	O
greater	NN	O
flexibility	IN	O
in	DT	O
assay	:	O
conditions;	,	O
additional	JJR	O
substrate	NN	O
flexibility;	IN	O
higher	JJ	O
sensitivity	NN	O
for	.	O
weak	VBG	O
clones;	IN	O
and	JJ	O
ease	NN	O
of	NNS	O
automation	MD	O
over	VB	O
solid	IN	O
phase	JJ	O
screening.	NN	O
The	CC	O
invention	IN	O
provides	JJ	O
screening	.	O
methods	IN	O
using	CD	O
the	,	O
proteins	DT	O
and	NN	O
nucleic	VBZ	O
acids	VBG	O
of	IN	O
the	JJ	O
invention	.	O
and	DT	O
robotic	VBZ	O
automation	DT	O
to	JJR	O
enable	NN	O
the	IN	O
execution	JJ	O
of	:	O
many	JJ	O
thousands	NN	O
of	:	O
biocatalytic	JJR	O
reactions	NN	O
and	IN	O
screening	JJ	O
assays	:	O
in	CC	O
a	NN	O
short	IN	O
period	NN	O
of	IN	O
time,	JJ	O
e.g.,	NN	O
per	.	O
day,	DT	O
as	NN	O
well	VBZ	O
as	VBG	O
ensuring	NNS	O
a	VBG	O
high	DT	O
level	NNS	O
of	CC	O
accuracy	JJ	O
and	NNS	O
reproducibility	IN	O
(see	DT	O
discussion	NN	O
of	CC	O
arrays,	JJ	O
below).	NN	O
As	TO	O
a	VB	O
result,	DT	O
a	NN	O
library	IN	O
of	JJ	O
derivative	NNS	O
compounds	IN	O
can	JJ	O
be	NNS	O
produced	CC	O
in	VBG	O
a	NNS	O
matter	IN	O
of	DT	O
weeks.	JJ	O
For	NN	O
further	IN	O
teachings	,	O
on	,	O
modification	IN	O
of	,	O
molecules,	RB	O
including	RB	O
small	IN	O
molecules,	VBG	O
see	DT	O
PCT/US94/09174.	JJ	O
The	NN	O
present	IN	O
invention	NN	O
includes	CC	O
amylase	NN	O
enzymes	VB	O
which	NN	O
are	IN	O
non-naturally	,	O
occurring	.	O
carbonyl	IN	O
hydrolase	DT	O
variants	,	O
(e.g.,	DT	O
amylase	NN	O
variants)	IN	O
having	JJ	O
a	NNS	O
different	MD	O
proteolytic	VB	O
activity,	VBN	O
stability,	IN	O
substrate	DT	O
specificity,	NN	O
pH	IN	O
profile	.	O
and/or	IN	O
performance	JJ	O
characteristic	NNS	O
as	IN	O
compared	NN	O
to	IN	O
the	,	O
precursor	VBG	O
carbonyl	JJ	O
hydrolase	,	O
from	VBP	O
which	.	O
the	DT	O
amino	JJ	O
acid	NN	O
sequence	VBZ	O
of	NN	O
the	NNS	O
variant	WDT	O
is	VBP	O
derived.	RB	O
Specifically,	VBG	O
such	JJ	O
amylase	NN	O
variants	NNS	O
have	,	O
an	JJ	O
amino	)	O
acid	VBG	O
sequence	DT	O
not	JJ	O
found	JJ	O
in	,	O
nature,	,	O
which	JJ	O
is	,	O
derived	NN	O
by	NN	O
substitution	JJ	O
of	NN	O
a	NN	O
plurality	IN	O
of	VBN	O
amino	TO	O
acid	DT	O
residues	NN	O
of	NN	O
a	NN	O
precursor	IN	O
amylase	WDT	O
with	DT	O
different	NN	O
amino	JJ	O
acids.	NN	O
The	IN	O
precursor	DT	O
amylase	NN	O
may	VBZ	O
be	.	O
a	,	O
naturally-occurring	JJ	O
amylase	NN	O
or	NNS	O
a	VBP	O
recombinant	DT	O
amylase.	NN	O
The	NN	O
useful	NN	O
amylase	RB	O
variants	VBN	O
encompass	IN	O
the	,	O
substitution	WDT	O
of	VBZ	O
any	VBN	O
of	IN	O
the	NN	O
naturally	IN	O
occurring	DT	O
L-amino	NN	O
acids	IN	O
at	NN	O
the	NN	O
designated	NNS	O
amino	IN	O
acid	DT	O
residue	NN	O
positions.	NN	O
Amylase	IN	O
Signal	JJ	O
Sequences	NN	O
The	.	O
invention	DT	O
provides	NN	O
amylase	NN	O
signal	MD	O
sequences	VB	O
and	DT	O
nucleic	JJ	O
acids	NN	O
encoding	CC	O
these	DT	O
signal	JJ	O
sequences,	.	O
e.g.,	DT	O
the	JJ	O
amino	NN	O
terminal	NNS	O
13	VBP	O
to	DT	O
36	NN	O
residues	IN	O
of	DT	O
SEQ	IN	O
ID	DT	O
NO:2.	RB	O
The	VBG	O
amylase	JJ	O
signal	NNS	O
sequences	IN	O
of	DT	O
the	JJ	O
invention	NN	O
can	NN	O
be	JJ	O
isolated	.	O
peptides,	NNP	O
or,	NNP	O
sequences	VBZ	O
joined	DT	O
to	NN	O
another	VBZ	O
amylase	JJ	O
or	JJ	O
a	NNS	O
non-amylase	CC	O
polypeptide,	JJ	O
e.g.,	NNS	O
as	VBG	O
a	DT	O
fusion	JJ	O
protein.	,	O
In	,	O
one	DT	O
aspect,	JJ	O
the	JJ	O
invention	CD	O
provides	TO	O
polypeptides	CD	O
comprising	NNS	O
amylase	IN	O
signal	NNP	O
sequences	NNP	O
of	.	O
the	DT	O
invention.	JJ	O
In	JJ	O
one	NNS	O
aspect,	IN	O
polypeptides	DT	O
comprising	NN	O
amylase	MD	O
signal	VB	O
sequences	VBN	O
of	,	O
the	,	O
invention	NNS	O
comprise	VBD	O
sequences	TO	O
heterologous	DT	O
to	NN	O
an	CC	O
amylase	DT	O
of	JJ	O
the	,	O
invention	,	O
(e.g.,	IN	O
a	DT	O
fusion	NN	O
protein	.	O
comprising	IN	O
an	CD	O
amylase	,	O
signal	DT	O
sequence	NN	O
of	VBZ	O
the	IN	O
invention	VBG	O
and	JJ	O
sequences	JJ	O
from	NNS	O
another	IN	O
amylase	DT	O
or	.	O
a	IN	O
non-amylase	CD	O
protein).	,	O
In	NNS	O
one	VBG	O
aspect,	JJ	O
the	JJ	O
invention	NNS	O
provides	IN	O
amylases	DT	O
of	NN	O
the	NN	O
invention	VBZ	O
with	JJ	O
heterologous	TO	O
signal	DT	O
sequences,	NN	O
e.g.,	IN	O
sequences	DT	O
with	NN	O
a	,	O
yeast	DT	O
signal	NN	O
sequence.	NN	O
For	VBG	O
example,	DT	O
an	JJ	O
amylase	JJ	O
of	NN	O
the	IN	O
invention	DT	O
comprising	NN	O
a	CC	O
heterologous	NNS	O
signal	IN	O
sequence	DT	O
in	NN	O
a	CC	O
vectors,	DT	O
e.g.,	JJ	O
a	.	O
pPIC	IN	O
series	CD	O
vector	,	O
(Invitrogen,	DT	O
Carlsbad,	NN	O
Calif.).	VBZ	O
In	NNS	O
one	IN	O
aspect,	DT	O
the	NN	O
signal	IN	O
sequences	JJ	O
of	JJ	O
the	,	O
invention	,	O
are	NNS	O
identified	IN	O
following	DT	O
identification	JJ	O
of	JJ	O
novel	.	O
amylase	IN	O
polypeptides.	,	O
The	DT	O
pathways	NN	O
by	IN	O
which	DT	O
proteins	NN	O
are	VBG	O
sorted	DT	O
and	JJ	O
transported	JJ	O
to	NN	O
their	IN	O
proper	DT	O
cellular	,	O
location	,	O
are	DT	O
often	JJ	O
referred	NN	O
to	NN	O
as	,	O
protein	,	O
targeting	.	O
pathways.	IN	O
One	CD	O
of	,	O
the	DT	O
most	JJ	O
important	NNS	O
elements	IN	O
in	DT	O
all	NN	O
of	VBP	O
these	VBN	O
targeting	VBG	O
systems	NN	O
is	IN	O
a	JJ	O
short	NN	O
amino	.	O
acid	DT	O
sequence	NNS	O
at	IN	O
the	WDT	O
amino	NNS	O
terminus	VBP	O
of	VBN	O
a	CC	O
newly	VBN	O
synthesized	TO	O
polypeptide	PRP$	O
called	JJ	O
the	JJ	O
signal	NN	O
sequence.	VBP	O
This	RB	O
signal	VBN	O
sequence	TO	O
directs	IN	O
a	NN	O
protein	VBG	O
to	.	O
its	CD	O
appropriate	IN	O
location	DT	O
in	RBS	O
the	JJ	O
cell	NNS	O
and	IN	O
is	DT	O
removed	IN	O
during	DT	O
transport	VBG	O
or	NNS	O
when	VBZ	O
the	DT	O
protein	JJ	O
reaches	NN	O
its	JJ	O
final	NN	O
destination.	IN	O
Most	DT	O
lysosomal,	NN	O
membrane,	NN	O
or	IN	O
secreted	DT	O
proteins	RB	O
have	VBN	O
an	NN	O
amino-terminal	VBD	O
signal	DT	O
sequence	NN	O
that	.	O
marks	DT	O
them	JJ	O
for	NN	O
translocation	VBZ	O
into	DT	O
the	NN	O
lumen	TO	O
of	PRP$	O
the	JJ	O
endoplasmic	NN	O
reticulum.	IN	O
More	DT	O
than	NN	O
100	CC	O
signal	VBZ	O
sequences	VBN	O
for	IN	O
proteins	NN	O
in	CC	O
this	WRB	O
group	DT	O
have	NN	O
been	VBZ	O
determined.	PRP$	O
The	JJ	O
signal	.	O
sequences	JJS	O
can	,	O
vary	,	O
in	CC	O
length	VBN	O
from	NNS	O
13	VBP	O
to	DT	O
36	JJ	O
amino	NN	O
acid	NN	O
residues.	WDT	O
Various	VBZ	O
methods	PRP	O
of	IN	O
recognition	NN	O
of	IN	O
signal	DT	O
sequences	NNS	O
are	IN	O
known	DT	O
to	JJ	O
those	.	O
of	JJR	O
skill	IN	O
in	CD	O
the	JJ	O
art.	NNS	O
For	IN	O
example,	NNS	O
in	IN	O
one	DT	O
aspect,	NN	O
novel	VBP	O
amylase	VBN	O
signal	.	O
peptides	DT	O
are	JJ	O
identified	NNS	O
by	MD	O
a	VB	O
method	IN	O
referred	NN	O
to	IN	O
as	CD	O
SignalP.	TO	O
SignalP	CD	O
uses	NN	O
a	NN	O
combined	.	O
neural	JJ	O
network	NNS	O
which	IN	O
recognizes	NN	O
both	IN	O
signal	JJ	O
peptides	NNS	O
and	VBP	O
their	VBN	O
cleavage	TO	O
sites.	DT	O
Nielsen,	IN	B
et	NN	I
al.,	IN	I
“Identification	DT	I
of	.	I
prokaryotic	IN	I
and	,	I
eukaryotic	IN	I
signal	CD	I
peptides	,	I
and	JJ	I
prediction	JJ	I
of	NN	I
their	NNS	I
cleavage	VBP	I
sites.”	VBN	I
Protein	IN	I
Engineering,	DT	I
vol.	NN	I
10,	VBD	I
no.	TO	I
1,	IN	I
p.	.	I
1-6	NNP	I
(1997).
(	VBZ	O
It	DT	O
should	JJ	O
be	JJ	O
understood	NN	O
that	WDT	O
in	VBZ	O
some	DT	O
aspects	JJ	O
amylases	NNS	O
of	CC	O
the	PRP$	O
invention	NN	O
may	.	O
not	,	O
have	FW	O
signal	,	O
sequences.	NN	O
In	IN	O
one	JJ	O
aspect,	CC	O
the	JJ	O
invention	NN	O
provides	NNS	O
the	CC	O
amylases	NN	O
of	IN	O
the	PRP$	O
invention	NN	O
lacking	NN	O
all	NNP	O
or	,	O
part	.	O
of	,	O
a	.	O
signal	,	O
sequence,	JJ	O
e.g.	CD	O
the	.	O
signal	PRP	O
sequences	MD	O
of	VB	O
the	JJ	O
invention.	IN	O
In	IN	O
one	DT	O
aspect,	NNS	O
the	NNS	O
invention	IN	O
provides	DT	O
a	NN	O
nucleic	MD	O
acid	RB	O
sequence	VB	O
encoding	JJ	O
a	.	O
signal	IN	O
sequence	CD	O
from	,	O
one	DT	O
amylase	NN	O
operably	VBZ	O
linked	DT	O
to	NNS	O
a	IN	O
nucleic	DT	O
acid	NN	O
sequence	VBG	O
of	DT	O
a	CC	O
different	NN	O
amylase	IN	O
or,	DT	O
optionally,	JJ	O
a	,	O
signal	.	O
sequence	DT	O
from	JJ	O
a	NNS	O
non-amylase	IN	O
protein	DT	O
may	.	O
be	IN	O
desired.	CD	O
Hybrid	,	O
Amylases	DT	O
and	NN	O
Peptide	VBZ	O
Libraries	DT	O
In	JJ	O
one	NN	O
aspect,	NN	O
the	VBG	O
invention	DT	O
provides	JJ	O
hybrid	NN	O
amylases	IN	O
and	CD	O
fusion	NN	O
proteins,	RB	O
including	VBD	O
peptide	TO	O
libraries,	DT	O
comprising	JJ	O
sequences	JJ	O
of	NN	O
the	IN	O
invention.	DT	O
The	JJ	O
peptide	NN	O
libraries	,	O
of	,	O
the	DT	O
invention	JJ	O
can	NN	O
be	IN	O
used	DT	O
to	JJ	O
isolate	NN	O
peptide	MD	O
modulators	VB	O
(e.g.,	.	O
activators	JJ	O
or	NNS	O
inhibitors)	CC	O
of	NNP	O
targets,	NNP	O
such	IN	O
as	CD	O
amylase	,	O
substrates,	DT	O
receptors,	NN	O
enzymes.	VBZ	O
The	JJ	O
peptide	NNS	O
libraries	CC	O
of	NN	O
the	,	O
invention	VBG	O
can	JJ	O
be	,	O
used	VBG	O
to	NNS	O
identify	IN	O
formal	DT	O
binding	.	O
partners	DT	O
of	JJ	O
targets,	NNS	O
such	IN	O
as	DT	O
ligands,	NN	O
e.g.,	MD	O
cytokines,	VB	O
hormones	VBN	O
and	TO	O
the	VB	O
like.	JJ	O
In	NNS	O
one	,	O
aspect,	NNS	O
the	CC	O
fusion	)	O
proteins	IN	O
of	,	O
the	JJ	O
invention	IN	O
(e.g.,	NN	O
the	,	O
peptide	,	O
moiety)	.	O
are	DT	O
conformationally	JJ	O
stabilized	NNS	O
(relative	IN	O
to	DT	O
linear	NN	O
peptides)	MD	O
to	VB	O
allow	VBN	O
a	TO	O
higher	VB	O
binding	JJ	O
affinity	VBG	O
for	NNS	O
targets.	IN	O
The	,	O
invention	JJ	O
provides	IN	O
fusions	,	O
of	,	O
amylases	,	O
of	NNS	O
the	CC	O
invention	DT	O
and	.	O
other	IN	O
peptides,	CD	O
including	,	O
known	DT	O
and	NN	O
random	NNS	O
peptides.	IN	O
They	DT	O
can	NN	O
be	,	O
fused	DT	O
in	JJ	O
such	)	O
a	VBP	O
manner	RB	O
that	VBN	O
the	JJ	O
structure	TO	O
of	VB	O
the	)	O
amylases	TO	O
is	VB	O
not	DT	O
significantly	JJR	O
perturbed	NN	O
and	NN	O
the	IN	O
peptide	.	O
is	DT	O
metabolically	NN	O
or	VBZ	O
structurally	NNS	O
conformationally	IN	O
stabilized.	NNS	O
This	IN	O
allows	DT	O
the	NN	O
creation	CC	O
of	JJ	O
a	,	O
peptide	VBG	O
library	VBN	O
that	CC	O
is	JJ	O
easily	.	O
monitored	PRP	O
both	MD	O
for	VB	O
its	VBN	O
presence	IN	O
within	JJ	O
cells	DT	O
and	NN	O
its	IN	O
quantity.	DT	O
Amino	NN	O
acid	IN	O
sequence	DT	O
variants	NNS	O
of	VBZ	O
the	RB	O
invention	RB	O
can	VBN	O
be	CC	O
characterized	DT	O
by	NN	O
a	VBZ	O
predetermined	RB	O
nature	CC	O
of	RB	O
the	RB	O
variation,	.	O
a	DT	O
feature	VBZ	O
that	DT	O
sets	NN	O
them	IN	O
apart	DT	O
from	JJ	O
a	NN	O
naturally	WDT	O
occurring	VBZ	O
form,	RB	O
e.g,	VBN	O
an	DT	O
allelic	IN	O
or	PRP$	O
interspecies	NN	O
variation	IN	O
of	NNS	O
an	CC	O
amylase	PRP$	O
sequence.	.	O
In	NNP	O
one	JJ	O
aspect,	NN	O
the	NNS	O
variants	IN	O
of	DT	O
the	NN	O
invention	MD	O
exhibit	VB	O
the	VBN	O
same	IN	O
qualitative	DT	O
biological	JJ	O
activity	NN	O
as	IN	O
the	DT	O
naturally	,	O
occurring	DT	O
analogue.	NN	O
Alternatively,	WDT	O
the	VBZ	O
variants	PRP	O
can	RB	O
be	IN	O
selected	DT	O
for	RB	O
having	VBG	O
modified	,	O
characteristics.	,	O
In	DT	O
one	NN	O
aspect,	CC	O
while	NNS	O
the	NN	O
site	IN	O
or	DT	O
region	NN	O
for	.	O
introducing	IN	O
an	CD	O
amino	,	O
acid	DT	O
sequence	NNS	O
variation	IN	O
is	DT	O
predetermined,	NN	O
the	VBZ	O
mutation	DT	O
per	JJ	O
se	JJ	O
need	JJ	O
not	NN	O
be	IN	O
predetermined.	DT	O
For	RB	O
example,	VBG	O
in	.	O
order	,	O
to	DT	O
optimize	NNS	O
the	MD	O
performance	VB	O
of	VBN	O
a	IN	O
mutation	VBG	O
at	VBN	O
a	.	O
given	IN	O
site,	CD	O
random	,	O
mutagenesis	IN	O
may	DT	O
be	NN	O
conducted	CC	O
at	NN	O
the	IN	O
target	VBG	O
codon	DT	O
or	NN	O
region	NN	O
and	NN	O
the	NN	O
expressed	VBZ	O
amylase	,	O
variants	DT	O
screened	NN	O
for	IN	O
the	FW	O
optimal	MD	O
combination	RB	O
of	VB	O
desired	.	O
activity.	IN	O
Techniques	,	O
for	IN	O
making	NN	O
substitution	TO	O
mutations	VB	O
at	DT	O
predetermined	NN	O
sites	IN	O
in	DT	O
DNA	NN	O
having	IN	O
a	DT	O
known	VBN	O
sequence	,	O
are	JJ	O
well	NN	O
known,	MD	O
as	VB	O
discussed	VBN	O
herein	IN	O
for	DT	O
example,	NN	O
M13	NN	O
primer	CC	O
mutagenesis	NN	O
and	CC	O
PCR	DT	O
mutagenesis.	JJ	O
Screening	NN	O
of	NNS	O
the	VBD	O
mutants	IN	O
can	DT	O
be	JJ	O
done	NN	O
using	IN	O
assays	JJ	O
of	.	O
proteolytic	NNS	O
activities.	IN	O
In	VBG	O
alternative	NN	O
aspects,	NNS	O
amino	IN	O
acid	VBN	O
substitutions	NNS	O
can	IN	O
be	NNP	O
single	VBG	O
residues;	DT	O
insertions	VBN	O
can	NN	O
be	VBP	O
on	RB	O
the	,	O
order	IN	O
of	VBN	O
from	NN	O
about	IN	O
1	,	O
to	NNP	O
20	NN	O
amino	NN	O
acids,	CC	O
although	NNP	O
considerably	.	O
larger	NN	O
insertions	IN	O
can	DT	O
be	NNS	O
done.	MD	O
Deletions	VB	O
can	VBN	O
range	VBG	O
from	NNS	O
about	IN	O
1	JJ	O
to	.	O
about	IN	O
20,	JJ	O
30,	,	O
40,	NN	O
50,	JJ	O
60,	NNS	O
70	MD	O
residues	VB	O
or	JJ	O
more.	:	O
To	NNS	O
obtain	MD	O
a	VB	O
final	IN	O
derivative	DT	O
with	NN	O
the	IN	O
optimal	IN	O
properties,	IN	O
substitutions,	CD	O
deletions,	TO	O
insertions	CD	O
or	NN	O
any	,	O
combination	IN	O
thereof	RB	O
may	JJR	O
be	NNS	O
used.	MD	O
Generally,	VB	O
these	.	O
changes	NNS	O
are	MD	O
done	VB	O
on	IN	O
a	RB	O
few	CD	O
amino	TO	O
acids	IN	O
to	,	O
minimize	,	O
the	,	O
alteration	,	O
of	,	O
the	CD	O
molecule.	NNS	O
However,	CC	O
larger	.	O
changes	TO	O
may	VB	O
be	DT	O
tolerated	JJ	O
in	NN	O
certain	IN	O
circumstances.	DT	O
The	JJ	O
invention	,	O
provides	,	O
amylases	,	O
where	NNS	O
the	CC	O
structure	DT	O
of	NN	O
the	NN	O
polypeptide	MD	O
backbone,	VB	O
the	.	O
secondary	,	O
or	DT	O
the	NNS	O
tertiary	VBP	O
structure,	VBN	O
e.g.,	IN	O
an	DT	O
alpha-helical	JJ	O
or	NN	O
beta-sheet	NNS	O
structure,	TO	O
has	VB	O
been	DT	O
modified.	NN	O
In	IN	O
one	DT	O
aspect,	.	O
the	,	O
charge	JJR	O
or	NNS	O
hydrophobicity	MD	O
has	VB	O
been	VBN	O
modified.	IN	O
In	JJ	O
one	.	O
aspect,	DT	O
the	NN	O
bulk	VBZ	O
of	NNS	O
a	WRB	O
side	DT	O
chain	NN	O
has	IN	O
been	DT	O
modified.	NN	O
Substantial	,	O
changes	DT	O
in	JJ	O
function	CC	O
or	DT	O
immunological	JJ	O
identity	,	O
are	,	O
made	DT	O
by	JJ	O
selecting	CC	O
substitutions	JJ	O
that	,	O
are	VBZ	O
less	VBN	O
conservative.	.	O
For	IN	O
example,	CD	O
substitutions	,	O
can	DT	O
be	NN	O
made	CC	O
which	NN	O
more	VBZ	O
significantly	VBN	O
affect:	.	O
the	IN	O
structure	CD	O
of	,	O
the	DT	O
polypeptide	NN	O
backbone	IN	O
in	DT	O
the	NN	O
area	NN	O
of	VBZ	O
the	VBN	O
alteration,	.	O
for	JJ	O
example	NNS	O
a	IN	O
alpha-helical	NN	O
or	CC	O
a	JJ	O
beta-sheet	NN	O
structure;	VBP	O
a	VBN	O
charge	IN	O
or	VBG	O
a	NNS	O
hydrophobic	WDT	O
site	VBP	O
of	RBR	O
the	.	O
molecule,	IN	O
which	,	O
can	NNS	O
be	MD	O
at	VB	O
an	VBN	O
active	WDT	O
site;	RBR	O
or	RB	O
a	:	O
side	DT	O
chain.	NN	O
The	IN	O
invention	DT	O
provides	NN	O
substitutions	NN	O
in	IN	O
polypeptide	DT	O
of	NN	O
the	IN	O
invention	DT	O
where	,	O
(a)	IN	O
a	NN	O
hydrophilic	DT	O
residues,	JJ	O
e.g.	CC	O
seryl	DT	O
or	JJ	O
threonyl,	:	O
is	DT	O
substituted	NN	O
for	CC	O
(or	DT	O
by)	JJ	O
a	NN	O
hydrophobic	IN	O
residue,	DT	O
e.g.	,	O
leucyl,	WDT	O
isoleucyl,	MD	O
phenylalanyl,	VB	O
valyl	IN	O
or	DT	O
alanyl;	JJ	O
(b)	:	O
a	CC	O
cysteine	DT	O
or	NN	O
proline	.	O
is	DT	O
substituted	NN	O
for	VBZ	O
(or	NNS	O
by)	IN	O
any	NN	O
other	IN	O
residue;	DT	O
(c)	NN	O
a	WRB	O
residue	)	O
having	DT	O
an	JJ	O
electropositive	,	O
side	.	O
chain,	NN	O
e.g.	CC	O
lysyl,	,	O
arginyl,	VBZ	O
or	VBN	O
histidyl,	IN	O
is	CC	O
substituted	)	O
for	DT	O
(or	JJ	O
by)	,	O
an	.	O
electronegative	,	O
residue,	,	O
e.g.	,	O
glutamyl	NN	O
or	CC	O
aspartyl;	:	O
or	)	O
(d)	DT	O
a	NN	O
residue	CC	O
having	NN	O
a	VBZ	O
bulky	VBN	O
side	IN	O
chain,	CC	O
e.g.	)	O
phenylalanine,	DT	O
is	JJ	O
substituted	:	O
for	)	O
(or	DT	O
by)	JJ	O
one	VBG	O
not	DT	O
having	JJ	O
a	NN	O
side	,	O
chain,	.	O
e.g.	,	O
glycine.	,	O
The	CC	O
variants	,	O
can	VBZ	O
exhibit	VBN	O
the	IN	O
same	CC	O
qualitative	)	O
biological	DT	O
activity	JJ	O
(i.e.	,	O
amylase	.	O
activity)	NN	O
although	CC	O
variants	:	O
can	CC	O
be	)	O
selected	DT	O
to	JJ	O
modify	VBG	O
the	DT	O
characteristics	JJ	O
of	NN	O
the	,	O
amylases	.	O
as	,	O
needed.	VBZ	O
In	VBN	O
one	IN	O
aspect,	CC	O
amylases	)	O
of	CD	O
the	RB	O
invention	VBG	O
comprise	DT	O
epitopes	NN	O
or	,	O
purification	.	O
tags,	.	O
signal	DT	O
sequences	NNS	O
or	MD	O
other	VB	O
fusion	DT	O
sequences,	JJ	O
etc.	JJ	O
In	JJ	O
one	NN	O
aspect,	.	O
the	NN	O
amylases	)	O
of	IN	O
the	NNS	O
invention	MD	O
can	VB	O
be	VBN	O
fused	TO	O
to	VB	O
a	DT	O
random	NNS	O
peptide	IN	O
to	DT	O
form	NNS	O
a	IN	O
fusion	.	O
polypeptide.	IN	O
By	CD	O
“fused”	,	O
or	NNS	O
“operably	IN	O
linked”	DT	O
herein	NN	O
is	NN	O
meant	VBZ	O
that	CC	O
the	NN	O
random	,	O
peptide	JJ	O
and	NNS	O
the	CC	O
amylase	JJ	O
are	NN	O
linked	,	O
together,	.	O
in	IN	O
such	CD	O
a	,	O
manner	DT	O
as	NNS	O
to	IN	O
minimize	DT	O
the	NN	O
disruption	MD	O
to	VB	O
the	VBN	O
stability	TO	O
of	DT	O
the	JJ	O
amylase	NN	O
structure,	TO	O
e.g.,	VB	O
it	DT	O
retains	NN	O
amylase	.	O
activity.	IN	O
The	NNP	O
fusion	CC	O
polypeptide	RB	O
(or	JJ	O
fusion	NN	O
polynucleotide	VBZ	O
encoding	VBN	O
the	IN	O
fusion	DT	O
polypeptide)	NN	O
can	NN	O
comprise	CC	O
further	DT	O
components	NN	O
as	VBP	O
well,	VBN	O
including	,	O
multiple	IN	O
peptides	PDT	O
at	DT	O
multiple	NN	O
loops.	IN	O
In	TO	O
one	VB	O
aspect,	DT	O
the	NN	O
peptides	TO	O
and	DT	O
nucleic	NN	O
acids	IN	O
encoding	DT	O
them	NN	O
are	,	O
randomized,	,	O
either	PRP	O
fully	VBZ	O
randomized	JJ	O
or	.	O
they	DT	O
are	NN	O
biased	NN	O
in	CC	O
their	NN	O
randomization,	IN	O
e.g.	VBG	O
in	DT	O
nucleotide/residue	NN	O
frequency	)	O
generally	MD	O
or	VB	O
per	JJ	O
position.	NNS	O
“Randomized”	IN	O
means	,	O
that	VBG	O
each	JJ	O
nucleic	NNS	O
acid	IN	O
and	JJ	O
peptide	.	O
consists	IN	O
of	CD	O
essentially	,	O
random	DT	O
nucleotides	NNS	O
and	CC	O
amino	JJ	O
acids,	NNS	O
respectively.	VBG	O
In	PRP	O
one	VBP	O
aspect,	,	O
the	DT	O
nucleic	RB	O
acids	VBN	O
which	CC	O
give	PRP	O
rise	VBP	O
to	VBN	O
the	IN	O
peptides	PRP$	O
can	,	O
be	.	O
chemically	IN	O
synthesized,	JJ	O
and	NN	O
thus	RB	O
may	CC	O
incorporate	IN	O
any	.	O
nucleotide	NN	O
at	VBZ	O
any	IN	O
position.	DT	O
Thus,	JJ	O
when	NN	O
the	CC	O
nucleic	NN	O
acids	NNS	O
are	IN	O
expressed	RB	O
to	JJ	O
form	NNS	O
peptides,	CC	O
any	JJ	O
amino	,	O
acid	.	O
residue	IN	O
may	CD	O
be	,	O
incorporated	DT	O
at	NN	O
any	NNS	O
position.	WDT	O
The	VBP	O
synthetic	NN	O
process	TO	O
can	DT	O
be	NNS	O
designed	MD	O
to	VB	O
generate	RB	O
randomized	,	O
nucleic	CC	O
acids,	RB	O
to	MD	O
allow	VB	O
the	DT	O
formation	NN	O
of	IN	O
all	DT	O
or	.	O
most	,	O
of	WRB	O
the	DT	O
possible	JJ	O
combinations	NNS	O
over	VBP	O
the	VBN	O
length	TO	O
of	VB	O
the	,	O
nucleic	DT	O
acid,	JJ	O
thus	NNS	O
forming	JJ	O
a	MD	O
library	VB	O
of	VBN	O
randomized	IN	O
nucleic	DT	O
acids.	.	O
The	DT	O
library	JJ	O
can	NN	O
provide	MD	O
a	VB	O
sufficiently	VBN	O
structurally	TO	O
diverse	VB	O
population	JJ	O
of	JJ	O
randomized	,	O
expression	TO	O
products	VB	O
to	DT	O
affect	NN	O
a	IN	O
probabilistically	DT	O
sufficient	CC	O
range	JJS	O
of	IN	O
cellular	DT	O
responses	JJ	O
to	NNS	O
provide	IN	O
one	DT	O
or	NN	O
more	IN	O
cells	DT	O
exhibiting	JJ	O
a	,	O
desired	RB	O
response.	VBG	O
Thus,	DT	O
the	NN	O
invention	IN	O
provides	JJ	O
an	JJ	O
interaction	.	O
library	DT	O
large	NN	O
enough	MD	O
so	VB	O
that	DT	O
at	RB	O
least	RB	O
one	JJ	O
of	NN	O
its	IN	O
members	JJ	O
will	NN	O
have	NNS	O
a	TO	O
structure	VB	O
that	DT	O
gives	RB	O
it	JJ	O
affinity	NN	O
for	IN	O
some	JJ	O
molecule,	NNS	O
protein,	TO	O
or	VB	O
other	CD	O
factor.	CC	O
Screening	JJR	O
Methodologies	NNS	O
and	VBG	O
“On-Line”	DT	O
Monitoring	JJ	O
Devices	.	O
In	,	O
practicing	DT	O
the	NN	O
methods	VBZ	O
of	DT	O
the	NN	O
invention,	JJ	O
a	JJ	O
variety	RB	O
of	IN	O
apparatus	DT	O
and	IN	O
methodologies	JJS	O
can	CD	O
be	IN	O
used	PRP$	O
to	NNS	O
in	MD	O
conjunction	VB	O
with	DT	O
the	NN	O
polypeptides	WDT	O
and	VBZ	O
nucleic	PRP	O
acids	NN	O
of	IN	O
the	DT	O
invention,	,	O
e.g.,	,	O
to	CC	O
screen	JJ	O
polypeptides	.	O
for	VBG	O
amylase	NNS	O
activity,	CC	O
to	JJ	O
screen	NNP	O
compounds	NNPS	O
as	IN	O
potential	VBG	O
modulators,	DT	O
e.g.,	NNS	O
activators	IN	O
or	DT	O
inhibitors,	,	O
of	DT	O
an	NN	O
amylase	IN	O
activity,	NN	O
for	CC	O
antibodies	NNS	O
that	MD	O
bind	VB	O
to	VBN	O
a	TO	O
polypeptide	IN	O
of	NN	O
the	IN	O
invention,	DT	O
for	NNS	O
nucleic	CC	O
acids	JJ	O
that	NNS	O
hybridize	IN	O
to	DT	O
a	,	O
nucleic	,	O
acid	TO	O
of	VB	O
the	NNS	O
invention,	IN	O
to	NN	O
screen	,	O
for	TO	O
cells	VB	O
expressing	NNS	O
a	IN	O
polypeptide	JJ	O
of	,	O
the	,	O
invention	NNS	O
and	CC	O
the	,	O
like.	IN	O
Capillary	DT	O
Arrays	NN	O
Capillary	,	O
arrays,	IN	O
such	NNS	O
as	WDT	O
the	VBP	O
GIGAMATRIX™,	TO	O
Diversa	DT	O
Corporation,	NN	O
San	IN	O
Diego,	DT	O
Calif.,	,	O
can	IN	O
be	JJ	O
used	NNS	O
to	WDT	O
in	VBP	O
the	TO	O
methods	DT	O
of	JJ	O
the	NN	O
invention.	IN	O
Nucleic	DT	O
acids	,	O
or	TO	O
polypeptides	VB	O
of	IN	O
the	NNS	O
invention	VBG	O
can	DT	O
be	NN	O
immobilized	IN	O
to	DT	O
or	NN	O
applied	CC	O
to	DT	O
an	.	O
array,	NNP	O
including	NNP	O
capillary	NNP	O
arrays.	,	O
Arrays	JJ	O
can	IN	O
be	DT	O
used	,	O
to	NNP	O
screen	,	O
for	NNP	O
or	,	O
monitor	,	O
libraries	MD	O
of	VB	O
compositions	VBN	O
(e.g.,	TO	O
small	IN	O
molecules,	DT	O
antibodies,	NNS	O
nucleic	IN	O
acids,	DT	O
etc.)	.	O
for	NNP	O
their	NNS	O
ability	CC	O
to	NNS	O
bind	IN	O
to	DT	O
or	NN	O
modulate	MD	O
the	VB	O
activity	VBN	O
of	TO	O
a	CC	O
nucleic	VBN	O
acid	TO	O
or	DT	O
a	,	O
polypeptide	VBG	O
of	JJ	O
the	.	O
invention.	NNS	O
Capillary	MD	O
arrays	VB	O
provide	VBN	O
another	TO	O
system	VB	O
for	IN	O
holding	CC	O
and	VB	O
screening	NNS	O
samples.	IN	O
For	NNS	O
example,	,	O
a	JJ	O
sample	,	O
screening	,	O
apparatus	JJ	O
can	,	O
include	)	O
a	IN	O
plurality	PRP$	O
of	NN	O
capillaries	TO	O
formed	VB	O
into	TO	O
an	CC	O
array	VB	O
of	DT	O
adjacent	NN	O
capillaries,	IN	O
wherein	DT	O
each	JJ	O
capillary	NN	O
comprises	CC	O
at	DT	O
least	NN	O
one	IN	O
wall	DT	O
defining	.	O
a	NNP	O
lumen	NNS	O
for	VBP	O
retaining	DT	O
a	NN	O
sample.	IN	O
The	VBG	O
apparatus	CC	O
can	VBG	O
further	.	O
include	IN	O
interstitial	,	O
material	DT	O
disposed	NN	O
between	VBG	O
adjacent	NN	O
capillaries	MD	O
in	VB	O
the	DT	O
array,	NN	O
and	IN	O
one	NNS	O
or	VBN	O
more	IN	O
reference	DT	O
indicia	NN	O
formed	IN	O
within	JJ	O
of	,	O
the	VBP	O
interstitial	DT	O
material.	JJ	O
A	NNS	O
capillary	IN	O
for	JJS	O
screening	CD	O
a	NN	O
sample,	VBG	O
wherein	DT	O
the	NN	O
capillary	IN	O
is	VBG	O
adapted	DT	O
for	.	O
being	DT	O
bound	NN	O
in	MD	O
an	VB	O
array	VB	O
of	JJ	O
capillaries,	NN	O
can	VBD	O
include	IN	O
a	JJ	O
first	NNS	O
wall	IN	O
defining	DT	O
a	,	O
lumen	CC	O
for	CD	O
retaining	CC	O
the	JJR	O
sample,	NN	O
and	NN	O
a	VBD	O
second	IN	O
wall	IN	O
formed	DT	O
of	JJ	O
a	.	O
filtering	DT	O
material,	NN	O
for	IN	O
filtering	VBG	O
excitation	DT	O
energy	,	O
provided	VBP	O
to	DT	O
the	NN	O
lumen	VBZ	O
to	VBN	O
excite	IN	O
the	VBG	O
sample.	VBN	O
A	IN	O
polypeptide	DT	O
or	NN	O
nucleic	IN	O
acid,	,	O
e.g.,	MD	O
a	VB	O
ligand,	DT	O
can	JJ	O
be	NN	O
introduced	VBG	O
into	DT	O
a	NN	O
first	IN	O
component	VBG	O
into	DT	O
at	,	O
least	CC	O
a	DT	O
portion	JJ	O
of	NN	O
a	VBN	O
capillary	IN	O
of	DT	O
a	JJ	O
capillary	,	O
array.	IN	O
Each	VBG	O
capillary	NN	O
of	NN	O
the	VBD	O
capillary	TO	O
array	DT	O
can	NNS	O
comprise	TO	O
at	VB	O
least	DT	O
one	.	O
wall	DT	O
defining	NN	O
a	CC	O
lumen	JJ	O
for	,	O
retaining	,	O
the	DT	O
first	,	O
component.	MD	O
An	VB	O
air	VBN	O
bubble	IN	O
can	DT	O
be	JJ	O
introduced	NN	O
into	IN	O
the	IN	O
capillary	JJS	O
behind	DT	O
the	NN	O
first	IN	O
component.	DT	O
A	NN	O
second	IN	O
component	DT	O
can	JJ	O
be	.	O
introduced	DT	O
into	NN	O
the	IN	O
capillary,	DT	O
wherein	JJ	O
the	NN	O
second	MD	O
component	VB	O
is	IN	O
separated	JJS	O
from	CD	O
the	NN	O
first	VBG	O
component	DT	O
by	NN	O
the	IN	O
air	VBG	O
bubble.	DT	O
A	JJ	O
sample	.	O
of	DT	O
interest	NN	O
can	JJ	O
be	MD	O
introduced	VB	O
as	VBN	O
a	IN	O
first	DT	O
liquid	JJ	O
labeled	IN	O
with	DT	O
a	JJ	O
detectable	.	O
particle	DT	O
into	JJ	O
a	NN	O
capillary	MD	O
of	VB	O
a	VBN	O
capillary	IN	O
array,	DT	O
wherein	,	O
each	VBD	O
capillary	DT	O
of	JJ	O
the	NN	O
capillary	VBZ	O
array	VBN	O
comprises	IN	O
at	DT	O
least	JJ	O
one	NN	O
wall	IN	O
defining	DT	O
a	NN	O
lumen	.	O
for	DT	O
retaining	NN	O
the	IN	O
first	NN	O
liquid	MD	O
and	VB	O
the	VBN	O
detectable	IN	O
particle,	DT	O
and	JJ	O
wherein	NN	O
the	VBN	O
at	IN	O
least	DT	O
one	JJ	O
wall	NN	O
is	IN	O
coated	DT	O
with	NN	O
a	IN	O
binding	DT	O
material	JJ	O
for	,	O
binding	WP	O
the	DT	O
detectable	NN	O
particle	IN	O
to	DT	O
the	JJ	O
at	NN	O
least	NNS	O
one	IN	O
wall.	JJS	O
The	CD	O
method	NN	O
can	VBG	O
further	DT	O
include	NN	O
removing	IN	O
the	VBG	O
first	DT	O
liquid	JJ	O
from	NN	O
the	CC	O
capillary	DT	O
tube,	JJ	O
wherein	,	O
the	CC	O
bound	VBD	O
detectable	DT	O
particle	IN	O
is	JJS	O
maintained	CD	O
within	NN	O
the	VBZ	O
capillary,	VBN	O
and	IN	O
introducing	DT	O
a	VBG	O
second	NN	O
liquid	IN	O
into	VBG	O
the	DT	O
capillary	JJ	O
tube.	NN	O
The	TO	O
capillary	DT	O
array	IN	O
can	JJS	O
include	CD	O
a	.	O
plurality	DT	O
of	NN	O
individual	MD	O
capillaries	VB	O
comprising	VB	O
at	VBG	O
least	DT	O
one	JJ	O
outer	NN	O
wall	IN	O
defining	DT	O
a	JJ	O
lumen.	,	O
The	VBP	O
outer	DT	O
wall	NN	O
of	JJ	O
the	NN	O
capillary	VBZ	O
can	VBN	O
be	IN	O
one	DT	O
or	,	O
more	CC	O
walls	VBG	O
fused	DT	O
together.	JJ	O
Similarly,	NN	O
the	IN	O
wall	DT	O
can	JJ	O
define	.	O
a	DT	O
lumen	JJ	O
that	NN	O
is	MD	O
cylindrical,	VB	O
square,	DT	O
hexagonal	NN	O
or	IN	O
any	JJ	O
other	NNS	O
geometric	VBG	O
shape	IN	O
so	JJS	O
long	CD	O
as	NN	O
the	NN	O
walls	VBG	O
form	DT	O
a	.	O
lumen	DT	O
for	NN	O
retention	NN	O
of	IN	O
a	DT	O
liquid	NN	O
or	MD	O
sample.	VB	O
The	CD	O
capillaries	CC	O
of	JJR	O
the	NNS	O
capillary	VBN	O
array	.	O
can	,	O
be	DT	O
held	NN	O
together	MD	O
in	VB	O
close	DT	O
proximity	NNS	O
to	WDT	O
form	VBZ	O
a	,	O
planar	,	O
structure.	JJ	O
The	CC	O
capillaries	DT	O
can	JJ	O
be	JJ	O
bound	NN	O
together,	RB	O
by	RB	O
being	IN	O
fused	DT	O
(e.g.,	NNS	O
where	VBP	O
the	DT	O
capillaries	NNS	O
are	IN	O
made	NN	O
of	IN	O
glass),	DT	O
glued,	NN	O
bonded,	CC	O
or	.	O
clamped	DT	O
side-by-side.	NNS	O
The	IN	O
capillary	DT	O
array	JJ	O
can	NN	O
be	MD	O
formed	VB	O
of	VBN	O
any	RB	O
number	IN	O
of	JJ	O
individual	NN	O
capillaries,	TO	O
for	VB	O
example,	DT	O
a	NN	O
range	.	O
from	DT	O
100	NNS	O
to	MD	O
4,000,000	VB	O
capillaries.	VBN	O
A	,	O
capillary	IN	O
array	VBG	O
can	VBN	O
form	,	O
a	WRB	O
micro	DT	O
titer	NNS	O
plate	VBP	O
having	VBN	O
about	IN	O
100,000	,	O
or	,	O
more	,	O
individual	CC	O
capillaries	VBD	O
bound	.	O
together.	DT	O
Arrays,	JJ	O
or	NN	O
“Biochips”	MD	O
Nucleic	VB	O
acids	VBN	O
or	IN	O
polypeptides	DT	O
of	NN	O
the	IN	O
invention	JJ	O
can	,	O
be	IN	O
immobilized	,	O
to	DT	O
or	NN	O
applied	IN	O
to	CD	O
an	TO	O
array.	CD	O
Arrays	.	O
can	DT	O
be	JJ	O
used	NN	O
to	MD	O
screen	VB	O
for	DT	O
or	NN	O
monitor	NN	O
libraries	NN	O
of	VBG	O
compositions	IN	O
(e.g.,	CD	O
small	CC	O
molecules,	JJR	O
antibodies,	JJ	O
nucleic	NNS	O
acids,	IN	O
etc.)	.	O
for	,	O
their	CC	O
ability	VB	O
to	NNP	O
bind	NNS	O
to	CC	O
or	NNS	O
modulate	IN	O
the	DT	O
activity	NN	O
of	MD	O
a	VB	O
nucleic	VBN	O
acid	TO	O
or	CC	O
a	VBN	O
polypeptide	TO	O
of	DT	O
the	.	O
invention.	NNS	O
For	MD	O
example,	VB	O
in	VBN	O
one	TO	O
aspect	VB	O
of	IN	O
the	CC	O
invention,	VB	O
a	NNS	O
monitored	IN	O
parameter	NNS	O
is	,	O
transcript	JJ	O
expression	,	O
of	,	O
an	JJ	O
amylase	,	O
gene.	)	O
One	IN	O
or	PRP$	O
more,	NN	O
or,	TO	O
all	VB	O
the	TO	O
transcripts	CC	O
of	VB	O
a	DT	O
cell	NN	O
can	IN	O
be	DT	O
measured	JJ	O
by	NN	O
hybridization	CC	O
of	DT	O
a	NN	O
sample	IN	O
comprising	DT	O
transcripts	.	O
of	IN	O
the	,	O
cell,	IN	O
or,	CD	O
nucleic	NN	O
acids	IN	O
representative	DT	O
of	,	O
or	DT	O
complementary	JJ	O
to	NN	O
transcripts	VBZ	O
of	JJ	O
a	NN	O
cell,	IN	O
by	DT	O
hybridization	JJ	O
to	.	O
immobilized	CD	O
nucleic	CC	O
acids	,	O
on	,	O
an	PDT	O
array,	DT	O
or	NNS	O
“biochip.”	IN	O
By	DT	O
using	NN	O
an	MD	O
“array”	VB	O
of	VBN	O
nucleic	IN	O
acids	NN	O
on	IN	O
a	DT	O
microchip,	NN	O
some	VBG	O
or	NNS	O
all	IN	O
of	DT	O
the	,	O
transcripts	,	O
of	JJ	O
a	NNS	O
cell	NN	O
can	IN	O
be	CC	O
simultaneously	JJ	O
quantified.	TO	O
Alternatively,	NNS	O
arrays	IN	O
comprising	DT	O
genomic	,	O
nucleic	IN	O
acid	NN	O
can	TO	O
also	VB	O
be	JJ	O
used	NNS	O
to	IN	O
determine	DT	O
the	,	O
genotype	CC	O
of	NN	O
a	IN	O
newly	VBG	O
engineered	DT	O
strain	NN	O
made	IN	O
by	JJ	O
the	NNS	O
methods	IN	O
of	DT	O
the	,	O
invention.	DT	O
Polypeptide	CC	O
arrays”	DT	O
can	IN	O
also	DT	O
be	NNS	O
used	IN	O
to	DT	O
simultaneously	NN	O
quantify	MD	O
a	VB	O
plurality	RB	O
of	.	O
proteins.	,	O
The	NNS	O
present	VBG	O
invention	JJ	O
can	JJ	O
be	NN	O
practiced	MD	O
with	RB	O
any	VB	O
known	VBN	O
“array,”	TO	O
also	VB	O
referred	DT	O
to	NN	O
as	IN	O
a	DT	O
“microarray”	RB	O
or	VBN	O
“nucleic	NN	O
acid	VBN	O
array”	IN	O
or	DT	O
“polypeptide	NNS	O
array”	IN	O
or	DT	O
“antibody	.	O
array”	NNP	O
or	NN	O
“biochip,”	MD	O
or	RB	O
variation	VB	O
thereof.	VBN	O
Arrays	TO	O
are	RB	O
generically	VB	O
a	DT	O
plurality	NN	O
of	IN	O
“spots”	.	O
or	DT	O
“target	JJ	O
elements,”	NN	O
each	MD	O
target	VB	O
element	VBN	O
comprising	IN	O
a	DT	O
defined	JJ	O
amount	NNP	O
of	RB	O
one	VBD	O
or	TO	O
more	IN	O
biological	DT	O
molecules,	NN	O
e.g.,	CC	O
oligonucleotides,	JJ	O
immobilized	JJ	O
onto	NN	O
a	CC	O
defined	VB	O
area	NN	O
of	CC	O
a	NN	O
substrate	NN	O
surface	CC	O
for	''	O
specific	CC	O
binding	NN	O
to	.	O
a	NNS	O
sample	VBP	O
molecule,	RB	O
e.g.,	DT	O
mRNA	NN	O
transcripts.	IN	O
In	NN	O
practicing	CC	O
the	NN	O
methods	NNP	O
of	DT	O
the	NN	O
invention,	NN	O
any	VBG	O
known	DT	O
array	JJ	O
and/or	NN	O
method	IN	O
of	CD	O
making	CC	O
and	JJR	O
using	JJ	O
arrays	,	O
can	,	O
be	,	O
incorporated	VBN	O
in	IN	O
whole	DT	O
or	JJ	O
in	NN	O
part,	IN	O
or	DT	O
variations	JJ	O
thereof,	NN	O
as	IN	O
described,	JJ	O
for	VBG	O
example,	TO	O
in	DT	O
U.S.	NN	O
Pat.	,	O
Nos.	,	O
6,277,628;	NN	O
6,277,489;	.	O
6,261,776;	IN	O
6,258,606;	VBG	O
6,054,270;	DT	O
6,048,695;	NNS	O
6,045,996;	IN	O
6,022,963;	DT	O
6,013,440;	,	O
5,965,452;	DT	O
5,959,098;	JJ	O
5,856,174;	NN	O
5,830,645;	NN	O
5,770,456;	NN	O
5,632,957;	IN	O
5,556,752;	VBG	O
5,143,854;	CC	O
5,807,522;	VBG	O
5,800,992;	NNS	O
5,744,305;	MD	O
5,700,637;	VB	O
5,556,752;	VBN	O
5,434,049;	IN	O
see	JJ	O
also,	CC	O
e.g.,	IN	O
WO	,	O
99/51773;	CC	O
WO	NNS	O
99/09217;	,	O
WO	IN	O
97/46313;	,	O
WO	IN	O
96/17958;	,	O
see	IN	O
also,	NNP	O
e.g.,	.	O
Johnston	.	B
(1998)	:	I
Curr.	:	I
Biol.	:	I
8:R171-R174;	:	I
Schummer	:	B
(1997)	:	I
Biotechniques	:	I
23:1087-1092;	:	I
Kern	:	B
(1997)	:	I
Biotechniques	:	I
23:120-124;	:	I
Solinas-Toldo	:	B
(1997)	:	I
Genes,	:	I
Chromosomes	:	I
&	:	I
Cancer	:	I
20:399-407;	:	I
Bowtell	:	B
(1999)	:	I
Nature	:	I
Genetics	:	I
Supp.	NN	I
21:25-32.	,	I
See	,	O
also	NNP	O
published	:	O
U.S.	NNP	O
patent	:	O
applications	NNP	O
Nos.	:	O
20010018642;	NNP	O
20010019827;	:	O
20010016322;	NN	O
20010014449;	,	O
20010014448;	,	O
20010012537;	NNP	O
20010008765.	)	O
Antibodies	.	O
and	.	O
Antibody-Based	:	O
Screening	NNP	O
Methods	)	O
The	NNP	O
invention	:	O
provides	NNP	O
isolated	)	O
or	NNP	O
recombinant	:	O
antibodies	NNP	O
that	)	O
specifically	,	O
bind	NNP	O
to	CC	O
an	NNP	O
amylase	:	O
of	NNP	O
the	)	O
invention.	NN	O
These	NNP	O
antibodies	.	O
can	.	O
be	NNP	O
used	RB	O
to	VBD	O
isolate,	NNP	O
identify	NN	O
or	NNS	O
quantify	.	O
the	:	O
amylases	:	O
of	:	O
the	:	O
invention	:	O
or	:	O
related	.	O
polypeptides.	NNS	O
These	CC	O
antibodies	JJ	O
can	NNP	O
be	NNP	O
used	DT	O
to	NN	O
isolate	VBZ	O
other	JJ	O
polypeptides	CC	O
within	JJ	O
the	NNS	O
scope	WDT	O
the	RB	O
invention	VBP	O
or	TO	O
other	DT	O
related	NN	O
amylases.	IN	O
The	DT	O
antibodies	.	O
can	DT	O
be	NNS	O
designed	MD	O
to	VB	O
bind	VBN	O
to	TO	O
an	,	O
active	VB	O
site	CC	O
of	VB	O
an	DT	O
amylase.	NNS	O
Thus,	IN	O
the	DT	O
invention	NN	O
provides	CC	O
methods	VBN	O
of	.	O
inhibiting	DT	O
amylases	NNS	O
using	MD	O
the	VB	O
antibodies	VBN	O
of	TO	O
the	VB	O
invention.	JJ	O
The	NNS	O
antibodies	IN	O
can	DT	O
be	NN	O
used	DT	O
in	NN	O
immunoprecipitation,	CC	O
staining,	JJ	O
immunoaffinity	JJ	O
columns,	.	O
and	DT	O
the	NNS	O
like.	MD	O
If	VB	O
desired,	VBN	O
nucleic	TO	O
acid	VB	O
sequences	TO	O
encoding	DT	O
for	JJ	O
specific	NN	O
antigens	IN	O
can	DT	O
be	.	O
generated	,	O
by	DT	O
immunization	NN	O
followed	VBZ	O
by	NNS	O
isolation	IN	O
of	VBG	O
polypeptide	NNS	O
or	VBG	O
nucleic	DT	O
acid,	NNS	O
amplification	IN	O
or	DT	O
cloning	.	O
and	DT	O
immobilization	NNS	O
of	MD	O
polypeptide	VB	O
onto	VBN	O
an	IN	O
array	,	O
of	,	O
the	NN	O
invention.	,	O
Alternatively,	CC	O
the	DT	O
methods	.	O
of	IN	O
the	,	O
invention	JJ	O
can	NN	O
be	NNS	O
used	VBG	O
to	IN	O
modify	JJ	O
the	NNS	O
structure	MD	O
of	VB	O
an	VBN	O
antibody	IN	O
produced	NN	O
by	VBN	O
a	IN	O
cell	NN	O
to	IN	O
be	NN	O
modified,	CC	O
e.g.,	JJ	O
an	,	O
antibody's	NN	O
affinity	CC	O
can	NN	O
be	CC	O
increased	NN	O
or	IN	O
decreased.	NN	O
Furthermore,	IN	O
the	DT	O
ability	NN	O
to	IN	O
make	DT	O
or	.	O
modify	,	O
antibodies	DT	O
can	NNS	O
be	IN	O
a	DT	O
phenotype	NN	O
engineered	MD	O
into	VB	O
a	VBN	O
cell	TO	O
by	VB	O
the	DT	O
methods	NN	O
of	IN	O
the	DT	O
invention.	NN	O
Methods	VBN	O
of	IN	O
immunization,	DT	O
producing	NN	O
and	TO	O
isolating	VB	O
antibodies	,	O
(polyclonal	,	O
and	DT	O
monoclonal)	POS	O
are	NN	O
known	MD	O
to	VB	O
those	VBN	O
of	CC	O
skill	.	O
in	,	O
the	DT	O
art	NN	O
and	TO	O
described	VB	O
in	CC	O
the	VB	O
scientific	NNS	O
and	MD	O
patent	VB	O
literature,	DT	O
see,	NN	O
e.g.,	VBN	O
Coligan,	IN	B
CURRENT	DT	I
PROTOCOLS	NN	I
IN	IN	I
IMMUNOLOGY,	DT	I
Wiley/Greene,	NNS	I
NY	IN	I
(1991);	DT	I
Stites	.	O
(eds.)	NNS	O
BASIC	IN	O
AND	,	O
CLINICAL	VBG	O
IMMUNOLOGY	CC	O
(7th	VBG	O
ed.)	NNS	O
Lange	JJ	O
Medical	CC	O
Publications,	)	O
Los	VBP	O
Altos,	VBN	O
Calif.	TO	O
(“Stites”);	DT	O
Goding,	IN	O
MONOCLONAL	NN	O
ANTIBODIES:	IN	O
PRINCIPLES	DT	O
AND	NN	O
PRACTICE	CC	O
(2d	VBN	O
ed.)	IN	O
Academic	DT	O
Press,	JJ	O
New	CC	O
York,	JJ	O
N.Y.	,	O
(1986);	,	O
Kohler	,	B
(1975)	,	I
Nature	NNP	I
256:495;	NNP	I
Harlow	NNP	B
(1988)	,	I
ANTIBODIES,	,	I
A	NNP	I
LABORATORY	:	I
MANUAL,	NNP	I
Cold	)	I
Spring	NNP	I
Harbor	CC	I
Publications,	NNP	I
New	NNP	I
York.	CD	I
Antibodies	)	O
also	NNP	O
can	NNP	O
be	,	O
generated	NNP	O
in	,	O
vitro,	NNP	O
e.g.,	:	O
using	,	O
recombinant	NNP	O
antibody	:	O
binding	NN	O
site	CC	O
expressing	NNP	O
phage	CD	O
display	)	O
libraries,	NNP	O
in	,	O
addition	NNP	O
to	,	O
the	NNP	O
traditional	:	O
in	NNP	O
vivo	)	O
methods	NN	O
using	:	O
animals.	NNP	O
See,	)	O
e.g.,	,	O
Hoogenboom	NNP	B
(1997)	NNP	I
Trends	,	I
Biotechnol.	NNP	I
15:62-70;	NNP	I
Katz	NNP	B
(1997)	,	I
Annu.	NNP	I
Rev.	.	I
Biophys.	NNS	I
Biomol.	RB	I
Struct.	MD	I
26:27-45.
Polypeptides	VB	O
or	VBN	O
peptides	IN	O
can	,	O
be	,	O
used	VBG	O
to	JJ	O
generate	NN	O
antibodies	VBG	O
which	NN	O
bind	VBG	O
specifically	NN	O
to	NN	O
the	,	O
polypeptides,	IN	O
e.g.,	NN	O
the	TO	O
amylases,	DT	O
of	JJ	O
the	IN	O
invention.	NN	O
The	NNS	O
resulting	VBG	O
antibodies	.	O
may	,	O
be	,	O
used	NNP	O
in	)	O
immunoaffinity	VBZ	O
chromatography	.	O
procedures	:	O
to	NNP	O
isolate	)	O
or	.	O
purify	.	O
the	.	O
polypeptide	.	O
or	.	O
to	.	O
determine	NNS	O
whether	CC	O
the	NNS	O
polypeptide	MD	O
is	VB	O
present	VBN	O
in	TO	O
a	VB	O
biological	NNS	O
sample.	WDT	O
In	VBP	O
such	RB	O
procedures,	TO	O
a	DT	O
protein	,	O
preparation,	,	O
such	DT	O
as	,	O
an	IN	O
extract,	DT	O
or	.	O
a	DT	O
biological	VBG	O
sample	NNS	O
is	MD	O
contacted	VB	O
with	VBN	O
an	IN	O
antibody	NN	O
capable	NN	O
of	NNS	O
specifically	TO	O
binding	VB	O
to	CC	O
one	VB	O
of	DT	O
the	NN	O
polypeptides	CC	O
of	TO	O
the	VB	O
invention.	IN	O
In	DT	O
immunoaffinity	NN	O
procedures,	VBZ	O
the	JJ	O
antibody	IN	O
is	DT	O
attached	JJ	O
to	.	O
a	IN	O
solid	JJ	O
support,	,	O
such	DT	O
as	NN	O
a	,	O
bead	JJ	O
or	IN	O
other	DT	O
column	,	O
matrix.	CC	O
The	DT	O
protein	JJ	O
preparation	NN	O
is	VBZ	O
placed	VBN	O
in	IN	O
contact	DT	O
with	NN	O
the	JJ	O
antibody	IN	O
under	RB	O
conditions	VBG	O
in	TO	O
which	CD	O
the	IN	O
antibody	DT	O
specifically	NNS	O
binds	IN	O
to	DT	O
one	.	O
of	IN	O
the	NN	O
polypeptides	,	O
of	DT	O
the	NN	O
invention.	VBZ	O
After	VBN	O
a	TO	O
wash	DT	O
to	JJ	O
remove	,	O
non-specifically	JJ	O
bound	IN	O
proteins,	DT	O
the	NN	O
specifically	CC	O
bound	JJ	O
polypeptides	NN	O
are	.	O
eluted.	DT	O
The	NN	O
ability	NN	O
of	VBZ	O
proteins	VBN	O
in	IN	O
a	NN	O
biological	IN	O
sample	DT	O
to	NN	O
bind	IN	O
to	NNS	O
the	IN	O
antibody	WDT	O
may	DT	O
be	NN	O
determined	RB	O
using	VBZ	O
any	TO	O
of	CD	O
a	IN	O
variety	DT	O
of	NNS	O
procedures	IN	O
familiar	DT	O
to	.	O
those	IN	O
skilled	DT	O
in	NN	O
the	TO	O
art.	VB	O
For	RB	O
example,	JJ	O
binding	,	O
may	DT	O
be	RB	O
determined	JJ	O
by	NNS	O
labeling	VBP	O
the	.	O
antibody	DT	O
with	NN	O
a	IN	O
detectable	NNS	O
label	IN	O
such	DT	O
as	JJ	O
a	NN	O
fluorescent	TO	O
agent,	VB	O
an	TO	O
enzymatic	DT	O
label,	NN	O
or	MD	O
a	VB	O
radioisotope.	VBN	O
Alternatively,	VBG	O
binding	DT	O
of	IN	O
the	DT	O
antibody	NN	O
to	IN	O
the	NNS	O
sample	JJ	O
may	TO	O
be	DT	O
detected	VBN	O
using	IN	O
a	DT	O
secondary	.	O
antibody	IN	O
having	,	O
such	NN	O
a	MD	O
detectable	VB	O
label	VBN	O
thereon.	IN	O
Particular	VBG	O
assays	DT	O
include	NN	O
ELISA	IN	O
assays,	DT	O
sandwich	JJ	O
assays,	NN	O
radioimmunoassays,	JJ	O
and	IN	O
Western	DT	O
Blots.	NN	O
Polyclonal	,	O
antibodies	DT	O
generated	JJ	O
against	,	O
the	CC	O
polypeptides	DT	O
of	.	O
the	,	O
invention	NN	O
can	IN	O
be	DT	O
obtained	NN	O
by	TO	O
direct	DT	O
injection	NN	O
of	MD	O
the	VB	O
polypeptides	VBN	O
into	VBG	O
an	DT	O
animal	JJ	O
or	NN	O
by	VBG	O
administering	JJ	O
the	DT	O
polypeptides	JJ	O
to	NN	O
a	.	O
non-human	JJ	O
animal.	NNS	O
The	VBP	O
antibody	NNP	O
so	,	O
obtained	JJ	O
will	,	O
then	,	O
bind	CC	O
the	JJ	O
polypeptide	.	O
itself.	NNP	O
In	NNS	O
this	VBD	O
manner,	IN	O
even	DT	O
a	NNS	O
sequence	IN	O
encoding	DT	O
only	NN	O
a	MD	O
fragment	VB	O
of	VBN	O
the	IN	O
polypeptide	JJ	O
can	NN	O
be	IN	O
used	DT	O
to	NNS	O
generate	IN	O
antibodies	DT	O
which	NN	O
may	CC	O
bind	IN	O
to	VBG	O
the	DT	O
whole	NNS	O
native	TO	O
polypeptide.	DT	O
Such	JJ	O
antibodies	.	O
can	DT	O
then	NN	O
be	RB	O
used	VBN	O
to	MD	O
isolate	RB	O
the	VB	O
polypeptide	DT	O
from	NN	O
cells	.	O
expressing	IN	O
that	DT	O
polypeptide.	,	O
For	RB	O
preparation	DT	O
of	NN	O
monoclonal	VBG	O
antibodies,	RB	O
any	DT	O
technique	NN	O
which	IN	O
provides	DT	O
antibodies	NN	O
produced	MD	O
by	VB	O
continuous	VBN	O
cell	TO	O
line	VB	O
cultures	NNS	O
can	WDT	O
be	MD	O
used.	VB	O
Examples	TO	O
include	DT	O
the	JJ	O
hybridoma	JJ	O
technique,	.	O
the	JJ	O
trioma	NNS	O
technique,	MD	O
the	RB	O
human	VB	O
B-cell	VBN	O
hybridoma	TO	O
technique,	VB	O
and	DT	O
the	NN	O
EBV-hybridoma	IN	O
technique	NNS	O
(see,	VBG	O
e.g.,	IN	O
Cole	.	B
(1985)	IN	I
in	NN	I
Monoclonal	IN	I
Antibodies	JJ	I
and	,	I
Cancer	DT	I
Therapy,	NN	I
Alan	WDT	I
R.	VBZ	I
Liss,	NNS	I
Inc.,	VBN	I
pp.	IN	I
77-96).Techniques	JJ	O
described	NN	O
for	NN	O
the	NNS	O
production	MD	O
of	VB	O
single	.	O
chain	NNS	O
antibodies	VBP	O
(see,	DT	O
e.g.,	NN	O
U.S.	,	O
Pat.	DT	O
No.	NN	O
4,946,778)	,	O
can	DT	O
be	JJ	O
adapted	NNP	O
to	NN	O
produce	,	O
single	CC	O
chain	DT	O
antibodies	NNP	O
to	NN	O
the	,	O
polypeptides	,	O
of	NNP	O
the	)	O
invention.	IN	O
Alternatively,	NNP	O
transgenic	NNPS	O
mice	CC	O
may	NNP	O
be	,	O
used	NNP	O
to	NNP	O
express	,	O
humanized	,	O
antibodies	.	O
to	.	O
these	NNS	O
polypeptides	VBN	O
or	IN	O
fragments	DT	O
thereof.	NN	O
Antibodies	IN	O
generated	JJ	O
against	NN	O
the	NNS	O
polypeptides	,	O
of	,	O
the	NNP	O
invention	.	O
may	.	O
be	)	O
used	MD	O
in	VB	O
screening	VBN	O
for	TO	O
similar	VB	O
polypeptides	JJ	O
(e.g.,	NN	O
amylases)	NNS	O
from	TO	O
other	DT	O
organisms	NNS	O
and	IN	O
samples.	DT	O
In	.	O
such	,	O
techniques,	JJ	O
polypeptides	NN	O
from	MD	O
the	VB	O
organism	VBN	O
are	TO	O
contacted	VB	O
with	JJ	O
the	NNS	O
antibody	TO	O
and	DT	O
those	NNS	O
polypeptides	CC	O
which	NNS	O
specifically	.	O
bind	NNS	O
the	VBN	O
antibody	IN	O
are	DT	O
detected.	NNS	O
Any	IN	O
of	DT	O
the	NN	O
procedures	MD	O
described	VB	O
above	VBN	O
may	IN	O
be	VBG	O
used	IN	O
to	JJ	O
detect	NNS	O
antibody	,	O
binding.	)	O
Kits	IN	O
The	JJ	O
invention	NNS	O
provides	CC	O
kits	.	O
comprising	IN	O
the	JJ	O
compositions,	,	O
e.g.,	NNS	O
nucleic	IN	O
acids,	DT	O
expression	NN	O
cassettes,	VBP	O
vectors,	VBN	O
cells,	IN	O
transgenic	DT	O
seeds	NN	O
or	CC	O
plants	DT	O
or	NNS	O
plant	WDT	O
parts,	RB	O
polypeptides	VBP	O
(e.g.,	DT	O
amylases)	NN	O
and/or	VBP	O
antibodies	.	O
of	DT	O
the	IN	O
invention.	DT	O
The	NNS	O
kits	VBN	O
also	IN	O
can	MD	O
contain	VB	O
instructional	VBN	O
material	TO	O
teaching	VB	O
the	NN	O
methodologies	.	O
and	VBZ	O
industrial	DT	O
uses	NN	O
of	VBZ	O
the	NNS	O
invention,	VBG	O
as	DT	O
described	,	O
herein.	,	O
Measuring	JJ	O
Metabolic	,	O
Parameters	NN	O
The	,	O
methods	,	O
of	,	O
the	JJ	O
invention	NNS	O
provide	CC	O
whole	NNS	O
cell	CC	O
evolution,	NN	O
or	,	O
whole	NNS	O
cell	,	O
engineering,	)	O
of	VBP	O
a	NNS	O
cell	IN	O
to	DT	O
develop	.	O
a	DT	O
new	NNS	O
cell	RB	O
strain	MD	O
having	VB	O
a	JJ	O
new	NN	O
phenotype,	VBG	O
e.g.,	DT	O
a	NNS	O
new	CC	O
or	JJ	O
modified	NNS	O
amylase	IN	O
activity,	DT	O
by	,	O
modifying	IN	O
the	VBN	O
genetic	.	O
composition	VBG	O
of	NNP	O
the	NNPS	O
cell.	DT	O
The	NNS	O
genetic	IN	O
composition	DT	O
can	NN	O
be	VBP	O
modified	JJ	O
by	NN	O
addition	,	O
to	CC	O
the	JJ	O
cell	NN	O
of	,	O
a	IN	O
nucleic	DT	O
acid	NN	O
of	TO	O
the	VB	O
invention.	DT	O
To	JJ	O
detect	NN	O
the	NN	O
new	VBG	O
phenotype,	DT	O
at	JJ	O
least	,	O
one	,	O
metabolic	DT	O
parameter	JJ	O
of	CC	O
a	JJ	O
modified	NN	O
cell	,	O
is	IN	O
monitored	VBG	O
in	DT	O
the	JJ	O
cell	NN	O
in	IN	O
a	DT	O
“real	.	O
time”	DT	O
or	JJ	O
“on-line”	NN	O
time	MD	O
frame.	VB	O
In	VBN	O
one	IN	O
aspect,	NN	O
a	TO	O
plurality	DT	O
of	NN	O
cells,	IN	O
such	DT	O
as	JJ	O
a	NN	O
cell	IN	O
culture,	DT	O
is	.	O
monitored	TO	O
in	VB	O
“real	DT	O
time”	JJ	O
or	,	O
“on-line.”	IN	O
In	JJS	O
one	CD	O
aspect,	JJ	O
a	NN	O
plurality	IN	O
of	DT	O
metabolic	VBN	O
parameters	NN	O
is	VBZ	O
monitored	VBN	O
in	IN	O
“real	DT	O
time”	NN	O
or	IN	O
“on-line.”	DT	O
Metabolic	JJ	O
parameters	NN	O
can	CC	O
be	JJ	O
monitored	NN	O
using	.	O
the	IN	O
amylases	CD	O
of	,	O
the	DT	O
invention.	NN	O
Metabolic	IN	O
flux	,	O
analysis	JJ	O
(MFA)	IN	O
is	DT	O
based	NN	O
on	,	O
a	VBZ	O
known	VBN	O
biochemistry	IN	O
framework.	JJ	O
A	NN	O
linearly	CC	O
independent	NN	O
metabolic	IN	O
matrix	CD	O
is	,	O
constructed	DT	O
based	NN	O
on	IN	O
the	JJ	O
law	NNS	O
of	VBZ	O
mass	VBN	O
conservation	IN	O
and	JJ	O
on	NN	O
the	CC	O
pseudo-steady	JJ	O
state	JJ	O
hypothesis	NNS	O
(PSSH)	MD	O
on	VB	O
the	VBN	O
intracellular	VBG	O
metabolites.	DT	O
In	NNS	O
practicing	IN	O
the	DT	O
methods	.	O
of	NNP	O
the	NN	O
invention,	NN	O
metabolic	)	O
networks	VBZ	O
are	VBN	O
established,	IN	O
including	DT	O
the:	VBN	O
Once	NN	O
the	.	O
metabolic	DT	O
network	JJ	O
for	JJ	O
a	JJ	O
given	NN	O
strain	VBZ	O
is	VBN	O
built,	VBN	O
mathematic	IN	O
presentation	DT	O
by	NN	O
matrix	IN	O
notion	NN	O
can	NN	O
be	CC	O
introduced	IN	O
to	DT	O
estimate	JJ	O
the	NN	O
intracellular	NN	O
metabolic	)	O
fluxes	IN	O
if	DT	O
the	JJ	O
on-line	.	O
metabolome	IN	O
data	VBG	O
is	DT	O
available.	NNS	O
Metabolic	IN	O
phenotype	DT	O
relies	,	O
on	JJ	O
the	NNS	O
changes	VBP	O
of	,	O
the	VBG	O
whole	:	O
metabolic	RB	O
network	DT	O
within	NN	O
a	NN	O
cell.	IN	O
Metabolic	DT	O
phenotype	VBN	O
relies	NN	O
on	VBZ	O
the	,	O
change	JJ	O
of	NN	O
pathway	IN	O
utilization	JJ	O
with	NN	O
respect	MD	O
to	VB	O
environmental	VBN	O
conditions,	TO	O
genetic	VB	O
regulation,	DT	O
developmental	JJ	O
state	NN	O
and	NNS	O
the	IN	O
genotype,	DT	O
etc.	JJ	O
In	NN	O
one	NNS	O
aspect	VBZ	O
of	.	O
the	NNP	O
methods	NN	O
of	NNS	O
the	IN	O
invention,	DT	O
after	NNS	O
the	IN	O
on-line	DT	O
MFA	JJ	O
calculation,	NN	O
the	NN	O
dynamic	IN	O
behavior	DT	O
of	.	O
the	NNP	O
cells,	NN	O
their	NNS	O
phenotype	IN	O
and	DT	O
other	NN	O
properties	IN	O
are	NN	O
analyzed	NN	O
by	IN	O
investigating	NN	O
the	TO	O
pathway	JJ	O
utilization.	,	O
For	JJ	O
example,	,	O
if	JJ	O
the	NN	O
glucose	CC	O
supply	DT	O
is	,	O
increased	.	O
and	IN	O
the	CD	O
oxygen	NN	O
decreased	IN	O
during	DT	O
the	NNS	O
yeast	IN	O
fermentation,	DT	O
the	,	O
utilization	IN	O
of	DT	O
respiratory	JJ	O
pathways	NNP	O
will	,	O
be	DT	O
reduced	JJ	O
and/or	NN	O
stopped,	IN	O
and	DT	O
the	,	O
utilization	PRP$	O
of	NN	O
the	CC	O
fermentative	JJ	O
pathways	NNS	O
will	VBP	O
dominate.	VBN	O
Control	IN	O
of	VBG	O
physiological	DT	O
state	NN	O
of	.	O
cell	IN	O
cultures	,	O
will	IN	O
become	DT	O
possible	JJ	O
after	NN	O
the	VBZ	O
pathway	VBN	O
analysis.	CC	O
The	DT	O
methods	NN	O
of	VBD	O
the	IN	O
invention	DT	O
can	JJ	O
help	,	O
determine	DT	O
how	NN	O
to	IN	O
manipulate	NN	O
the	NNS	O
fermentation	MD	O
by	VB	O
determining	VBN	O
how	JJ	O
to	,	O
change	CC	O
the	DT	O
substrate	NN	O
supply,	IN	O
temperature,	DT	O
use	JJ	O
of	NNS	O
inducers,	MD	O
etc.	.	O
to	NN	O
control	IN	O
the	JJ	O
physiological	NN	O
state	IN	O
of	NN	O
cells	NNS	O
to	MD	O
move	VB	O
along	JJ	O
desirable	IN	O
direction.	DT	O
In	NN	O
practicing	.	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention,	NN	O
the	MD	O
MFA	VB	O
results	VB	O
can	WRB	O
also	TO	O
be	VB	O
compared	DT	O
with	NN	O
transcriptome	IN	O
and	VBG	O
proteome	WRB	O
data	TO	O
to	VB	O
design	DT	O
experiments	NN	O
and	,	O
protocols	,	O
for	NN	O
metabolic	IN	O
engineering	,	O
or	.	O
gene	TO	O
shuffling,	VB	O
etc.	DT	O
In	JJ	O
practicing	NN	O
the	IN	O
methods	NNS	O
of	TO	O
the	VB	O
invention,	RB	O
any	JJ	O
modified	.	O
or	IN	O
new	VBG	O
phenotype	DT	O
can	NNS	O
be	IN	O
conferred	DT	O
and	,	O
detected,	DT	O
including	NNP	O
new	NNS	O
or	MD	O
improved	RB	O
characteristics	VB	O
in	VBN	O
the	IN	O
cell.	NN	O
Any	CC	O
aspect	VB	O
of	NNS	O
metabolism	TO	O
or	VB	O
growth	NNS	O
can	CC	O
be	NNS	O
monitored.	IN	O
Monitoring	JJ	O
Expression	NN	O
of	CC	O
an	NN	O
mRNA	,	O
Transcript	.	O
In	IN	O
one	VBG	O
aspect	DT	O
of	NNS	O
the	IN	O
invention,	DT	O
the	,	O
engineered	DT	O
phenotype	VBD	O
comprises	CC	O
increasing	JJ	O
or	NN	O
decreasing	MD	O
the	VB	O
expression	VBN	O
of	CC	O
an	,	O
mRNA	VBG	O
transcript	JJ	O
(e.g.,	CC	O
an	JJ	O
amylase	NNS	O
message)	IN	O
or	DT	O
generating	.	O
new	DT	O
(e.g.,	NN	O
amylase)	IN	O
transcripts	NN	O
in	CC	O
a	NN	O
cell.	MD	O
This	VB	O
increased	.	O
or	VBG	O
decreased	NNP	O
expression	IN	O
can	DT	O
be	NN	O
traced	NN	O
by	IN	O
testing	CD	O
for	NN	O
the	IN	O
presence	DT	O
of	,	O
an	DT	O
amylase	JJ	O
of	NN	O
the	VBZ	O
invention	VBG	O
or	CC	O
by	VBG	O
amylase	DT	O
activity	NN	O
assays.	IN	O
mRNA	DT	O
transcripts,	NN	O
or	NN	O
messages,	,	O
also	DT	O
can	JJ	O
be	)	O
detected	CC	O
and	VBG	O
quantified	JJ	O
by	,	O
any	)	O
method	NNS	O
known	IN	O
in	DT	O
the	.	O
art,	DT	O
including,	VBD	O
e.g.,	CC	O
Northern	JJ	O
blots,	NN	O
quantitative	MD	O
amplification	VB	O
reactions,	VBN	O
hybridization	IN	O
to	VBG	O
arrays,	IN	O
and	DT	O
the	NN	O
like.	IN	O
Quantitative	DT	O
amplification	NN	O
reactions	IN	O
include,	DT	O
e.g.,	NN	O
quantitative	CC	O
PCR,	IN	O
including,	JJ	O
e.g.,	NN	O
quantitative	.	O
reverse	NN	O
transcription	,	O
polymerase	CC	O
chain	,	O
reaction,	RB	O
or	MD	O
RT-PCR;	VB	O
quantitative	VBN	O
real	CC	O
time	VBN	O
RT-PCR,	IN	O
or	DT	O
“real-time	NN	O
kinetic	VBN	O
RT-PCR”	IN	O
(see,	DT	O
e.g.,	,	O
Kreuzer	,	B
(2001)	,	I
Br.	NNP	I
J.	,	I
Haematol.	JJ	I
114:313-318;	NN	I
Xia	,	B
(2001)	NN	I
Transplantation	TO	I
72:907-914).In	,	O
one	CC	O
aspect	DT	O
of	.	O
the	JJ	O
invention,	NN	O
the	NNS	O
engineered	,	O
phenotype	,	O
is	JJ	O
generated	,	O
by	,	O
knocking	,	O
out	JJ	O
expression	NN	O
of	NN	O
a	NN	O
homologous	NN	O
gene.	,	O
The	CC	O
gene's	:	O
coding	JJ	O
sequence	JJ	O
or	NN	O
one	,	O
or	CC	O
more	JJ	O
transcriptional	JJ	O
control	NNP	O
elements	,	O
can	,	O
be	NNP	O
knocked	)	O
out,	.	O
e.g.,	NNP	O
promoters	.	O
or	:	O
enhancers.	NNP	O
Thus,	)	O
the	NNP	O
expression	.	O
of	IN	O
a	CD	O
transcript	NN	O
can	IN	O
be	DT	O
completely	,	O
ablated	DT	O
or	JJ	O
only	NN	O
decreased.	VBZ	O
In	VBN	O
one	IN	O
aspect	VBG	O
of	RP	O
the	NN	O
invention,	IN	O
the	DT	O
engineered	JJ	O
phenotype	.	O
comprises	DT	O
increasing	POS	O
the	VBG	O
expression	NN	O
of	CC	O
a	CD	O
homologous	CC	O
gene.	JJR	O
This	JJ	O
can	NN	O
be	NNS	O
effected	MD	O
by	VB	O
knocking	VBN	O
out	,	O
of	,	O
a	NNS	O
negative	CC	O
control	.	O
element,	,	O
including	DT	O
a	NN	O
transcriptional	IN	O
regulatory	DT	O
element	NN	O
acting	MD	O
in	VB	O
cis-	RB	O
or	VBN	O
trans-,	CC	O
or,	RB	O
mutagenizing	.	O
a	IN	O
positive	CD	O
control	NN	O
element.	IN	O
One	DT	O
or	,	O
more,	DT	O
or,	JJ	O
all	NN	O
the	NNS	O
transcripts	VBG	O
of	DT	O
a	NN	O
cell	IN	O
can	DT	O
be	JJ	O
measured	.	O
by	DT	O
hybridization	MD	O
of	VB	O
a	VBN	O
sample	IN	O
comprising	VBG	O
transcripts	IN	O
of	IN	O
the	DT	O
cell,	JJ	O
or,	NN	O
nucleic	,	O
acids	VBG	O
representative	DT	O
of	JJ	O
or	JJ	O
complementary	NN	O
to	VBG	O
transcripts	IN	O
of	JJ	O
a	CC	O
cell,	,	O
by	,	O
hybridization	VBG	O
to	DT	O
immobilized	JJ	O
nucleic	NN	O
acids	.	O
on	CD	O
an	CC	O
array.	,	O
Monitoring	,	O
Expression	PDT	O
of	DT	O
a	NNS	O
Polypeptides,	IN	O
Peptides	DT	O
and	NN	O
Amino	MD	O
Acids	VB	O
In	VBN	O
one	IN	O
aspect	NN	O
of	IN	O
the	DT	O
invention,	NN	O
the	VBG	O
engineered	NNS	O
phenotype	IN	O
comprises	DT	O
increasing	,	O
or	,	O
decreasing	JJ	O
the	NNS	O
expression	NN	O
of	IN	O
a	CC	O
polypeptide	JJ	O
(e.g.,	TO	O
an	NNS	O
amylase)	IN	O
or	DT	O
generating	,	O
new	IN	O
polypeptides	NN	O
in	TO	O
a	VB	O
cell.	JJ	O
This	NNS	O
increased	IN	O
or	DT	O
decreased	.	O
expression	VBG	O
can	NNP	O
be	IN	O
traced	DT	O
by	,	O
determining	NNP	O
the	CC	O
amount	NNP	O
of	NNP	O
amylase	IN	O
present	CD	O
or	NN	O
by	IN	O
amylase	DT	O
activity	,	O
assays.	DT	O
Polypeptides,	JJ	O
peptides	NN	O
and	VBZ	O
amino	VBG	O
acids	CC	O
also	VBG	O
can	DT	O
be	NN	O
detected	IN	O
and	DT	O
quantified	NN	O
by	,	O
any	DT	O
method	)	O
known	CC	O
in	VBG	O
the	JJ	O
art,	NNS	O
including,	IN	O
e.g.,	DT	O
nuclear	.	O
magnetic	DT	O
resonance	VBD	O
(NMR),	CC	O
spectrophotometry,	JJ	O
radiography	NN	O
(protein	MD	O
radiolabeling),	VB	O
electrophoresis,	VBN	O
capillary	IN	O
electrophoresis,	VBG	O
high	DT	O
performance	NN	O
liquid	IN	O
chromatography	JJ	O
(HPLC),	NN	O
thin	CC	O
layer	IN	O
chromatography	JJ	O
(TLC),	NN	O
hyperdiffusion	.	O
chromatography,	,	O
various	NNS	O
immunological	CC	O
methods,	NN	O
e.g.	NNS	O
immunoprecipitation,	RB	O
immunodiffusion,	MD	O
immuno-electrophoresis,	VB	O
radioimmunoassays	VBN	O
(RIAs),	CC	O
enzyme-linked	VBN	O
immunosorbent	IN	O
assays	DT	O
(ELISAs),	NN	O
immuno-fluorescent	VBN	O
assays,	IN	O
gel	DT	O
electrophoresis	,	O
(e.g.,	,	O
SDS-PAGE),	,	O
staining	JJ	O
with	JJ	O
antibodies,	NN	O
fluorescent	,	O
activated	,	O
cell	NN	O
sorter	IN	O
(FACS),	,	O
pyrolysis	,	O
mass	JJ	O
spectrometry,	,	O
Fourier-Transform	JJ	O
Infrared	NN	O
Spectrometry,	NN	O
Raman	NN	O
spectrometry,	,	O
GC-MS,	JJ	O
and	NN	O
LC-Electrospray	NN	O
and	,	O
cap-LC-tandem-electrospray	NN	O
mass	,	O
spectrometries,	JJ	O
and	JJ	O
the	,	O
like.	.	O
Novel	,	O
bioactivities	,	O
can	,	O
also	NNS	O
be	,	O
screened	JJ	O
using	NN	O
methods,	NNS	O
or	,	O
variations	JJ	O
thereof,	,	O
described	JJ	O
in	NN	O
U.S.	,	O
Pat.	,	O
No.	VBG	O
6,057,103.	IN	O
Furthermore,	,	O
as	NN	O
discussed	VBD	O
below	NN	O
in	NN	O
detail,	,	O
one	JJ	O
or	NN	O
more,	,	O
or,	NNP	O
all	NNP	O
the	,	O
polypeptides	NNP	O
of	,	O
a	,	O
cell	CC	O
can	NNP	O
be	CC	O
measured	JJ	O
using	NN	O
a	,	O
protein	CC	O
array.	DT	O
Industrial	.	O
Applications	NNP	O
Detergent	NNS	O
Compositions	MD	O
The	RB	O
invention	VB	O
provides	VBN	O
detergent	VBG	O
compositions	,	O
comprising	CC	O
one	NNS	O
or	,	O
more	VBN	O
polypeptides	IN	O
of	NNP	O
the	.	O
invention,	.	O
and	.	O
methods	,	O
of	IN	O
making	VBN	O
and	IN	O
using	IN	O
these	,	O
compositions.	CD	O
The	CC	O
invention	,	O
incorporates	,	O
all	PDT	O
methods	DT	O
of	NNS	O
making	IN	O
and	DT	O
using	NN	O
detergent	MD	O
compositions,	VB	O
see,	VBN	O
e.g.,	VBG	O
U.S.	DT	O
Pat.	JJ	O
Nos.	.	O
6,413,928;	NNP	O
6,399,561;	NNP	O
6,365,561;	NNP	O
6,380,147.	NNP	O
The	DT	O
detergent	NN	O
compositions	VBZ	O
can	JJ	O
be	NNS	O
a	VBG	O
one	CD	O
and	CC	O
two	JJR	O
part	NNS	O
aqueous	IN	O
composition,	DT	O
a	,	O
non-aqueous	CC	O
liquid	NNS	O
composition,	IN	O
a	VBG	O
cast	CC	O
solid,	VBG	O
a	DT	O
granular	.	O
form,	DT	O
a	NN	O
particulate	VBZ	O
form,	DT	O
a	NNS	O
compressed	IN	O
tablet,	VBG	O
a	CC	O
gel	VBG	O
and/or	JJ	O
a	,	O
paste	,	O
and	,	O
a	NNP	O
slurry	.	O
form.	.	O
The	:	O
invention	:	O
also	:	O
provides	.	O
methods	DT	O
capable	NN	O
of	NNS	O
a	MD	O
rapid	VB	O
removal	DT	O
of	CD	O
gross	CC	O
food	CD	O
soils,	NN	O
films	JJ	O
of	,	O
food	DT	O
residue	JJ	O
and	NN	O
other	,	O
minor	DT	O
food	NN	O
compositions	,	O
using	DT	O
these	JJ	O
detergent	,	O
compositions.	DT	O
Amylases	JJ	O
of	,	O
the	DT	O
invention	JJ	O
can	,	O
facilitate	DT	O
the	NN	O
removal	VBZ	O
of	DT	O
starchy	NN	O
stains	CC	O
by	DT	O
means	JJ	O
of	.	O
catalytic	DT	O
hydrolysis	NN	O
of	RB	O
the	VBZ	O
starch	NNS	O
polysaccharide.	JJ	O
Amylases	IN	O
of	DT	O
the	JJ	O
invention	NN	O
can	IN	O
be	JJ	O
used	NN	O
in	,	O
dishwashing	NNS	O
detergents	IN	O
in	NN	O
textile	NNS	O
laundering	CC	O
detergents.	JJ	O
The	JJ	O
actual	NN	O
active	NNS	O
enzyme	VBG	O
content	DT	O
depends	JJ	O
upon	.	O
the	NNS	O
method	IN	O
of	DT	O
manufacture	NN	O
of	MD	O
a	VB	O
detergent	DT	O
composition	NN	O
and	IN	O
is	NN	O
not	NNS	O
critical,	IN	O
assuming	NNS	O
the	IN	O
detergent	JJ	O
solution	NN	O
has	IN	O
the	DT	O
desired	NN	O
enzymatic	.	O
activity.	NNS	O
In	IN	O
one	DT	O
aspect,	NN	O
the	MD	O
amount	VB	O
of	VBN	O
amylase	IN	O
present	VBG	O
in	NNS	O
the	IN	O
final	NN	O
solution	NN	O
ranges	.	O
from	DT	O
about	JJ	O
0.001	JJ	O
mg	NN	O
to	NN	O
0.5	VBZ	O
mg	IN	O
per	DT	O
gram	NN	O
of	IN	O
the	NN	O
detergent	IN	O
composition.	DT	O
The	JJ	O
particular	NN	O
enzyme	CC	O
chosen	VBZ	O
for	RB	O
use	,	O
in	VBG	O
the	DT	O
process	NN	O
and	NN	O
products	VBZ	O
of	DT	O
this	VBN	O
invention	JJ	O
depends	.	O
upon	IN	O
the	CD	O
conditions	,	O
of	DT	O
final	NN	O
utility,	IN	O
including	NN	O
the	NN	O
physical	IN	O
product	DT	O
form,	JJ	O
use	NN	O
pH,	VBZ	O
use	IN	O
temperature,	IN	O
and	CD	O
soil	NNS	O
types	TO	O
to	CD	O
be	NNS	O
degraded	IN	O
or	NN	O
altered.	IN	O
The	DT	O
enzyme	NN	O
can	.	O
be	DT	O
chosen	JJ	O
to	NN	O
provide	NN	O
optimum	IN	O
activity	NN	O
and	IN	O
stability	DT	O
for	NN	O
any	CC	O
given	NNS	O
set	IN	O
of	DT	O
utility	NN	O
conditions.	VBZ	O
In	IN	O
one	DT	O
aspect,	NNS	O
the	IN	O
polypeptides	JJ	O
of	,	O
the	VBG	O
present	DT	O
invention	JJ	O
are	NN	O
active	,	O
in	NN	O
the	,	O
pH	NN	O
ranges	,	O
of	CC	O
from	NN	O
about	NNS	O
4	TO	O
to	VB	O
about	VBN	O
12	CC	O
and	.	O
in	DT	O
the	NN	O
temperature	MD	O
range	VB	O
of	VBN	O
from	TO	O
about	VB	O
20°	JJ	O
C.	NN	O
to	CC	O
about	NN	O
95°	IN	O
C.	DT	O
The	VBN	O
detergents	NN	O
of	IN	O
the	NN	O
invention	.	O
can	IN	O
comprise	CD	O
cationic,	,	O
semi-polar	DT	O
nonionic	NNS	O
or	IN	O
zwitterionic	DT	O
surfactants;	JJ	O
or,	NN	O
mixtures	VBP	O
thereof.	JJ	O
Amylases	IN	O
of	DT	O
the	NN	O
present	VBZ	O
invention	IN	O
can	IN	O
be	IN	O
formulated	CD	O
into	TO	O
powdered	IN	O
and	CD	O
liquid	CC	O
detergents	IN	O
having	DT	O
pH	NN	O
between	NN	O
4.0	IN	O
and	IN	O
12.0	IN	O
at	CD	O
levels	NNP	O
of	TO	O
about	IN	O
0.01	CD	O
to	NNP	O
about	DT	O
5%	NNS	O
(preferably	IN	O
0.1%	DT	O
to	NN	O
0.5%)	MD	O
by	VB	O
weight.	,	O
These	JJ	O
detergent	NN	O
compositions	CC	O
can	JJ	O
also	:	O
include	,	O
other	NNS	O
enzymes	.	O
such	NNS	O
as	IN	O
known	DT	O
proteases,	JJ	O
cellulases,	NN	O
lipases	MD	O
or	VB	O
endoglycosidases,	VBN	O
as	IN	O
well	JJ	O
as	CC	O
builders	JJ	O
and	NNS	O
stabilizers.	VBG	O
The	NN	O
addition	IN	O
of	CD	O
amylases	CC	O
of	CD	O
the	IN	O
invention	NNS	O
to	IN	O
conventional	RB	O
cleaning	CD	O
compositions	TO	O
does	IN	O
not	NN	O
create	RB	O
any	NN	O
special	TO	O
use	)	O
limitation.	IN	O
In	.	O
other	DT	O
words,	JJ	O
any	NNS	O
temperature	MD	O
and	RB	O
pH	VB	O
suitable	JJ	O
for	NNS	O
the	JJ	O
detergent	IN	O
is	JJ	O
also	,	O
suitable	,	O
for	VBZ	O
the	CC	O
present	,	O
compositions	RB	O
as	RB	O
long	IN	O
as	NNS	O
the	CC	O
pH	.	O
is	DT	O
within	NN	O
the	IN	O
above	NNS	O
range,	IN	O
and	DT	O
the	NN	O
temperature	TO	O
is	JJ	O
below	JJ	O
the	NNS	O
described	VBZ	O
enzyme's	RB	O
denaturing	VB	O
temperature.	DT	O
In	JJ	O
addition,	NN	O
the	.	O
polypeptides	IN	O
of	JJ	O
the	,	O
invention	DT	O
can	NN	O
be	CC	O
used	NN	O
in	NN	O
a	IN	O
cleaning	DT	O
composition	NN	O
without	VBZ	O
detergents,	RB	O
again	JJ	O
either	IN	O
alone	DT	O
or	JJ	O
in	NNS	O
combination	RB	O
with	RB	O
builders	IN	O
and	DT	O
stabilizers.	NN	O
The	VBZ	O
present	IN	O
invention	DT	O
provides	JJ	O
cleaning	,	O
compositions	CC	O
including	DT	O
detergent	NN	O
compositions	VBZ	O
for	IN	O
cleaning	DT	O
hard	JJ	O
surfaces,	POS	O
detergent	JJ	O
compositions	.	O
for	IN	O
cleaning	,	O
fabrics,	DT	O
dishwashing	NNS	O
compositions,	IN	O
oral	DT	O
cleaning	NN	O
compositions,	MD	O
denture	VB	O
cleaning	VBN	O
compositions,	IN	O
and	DT	O
contact	NN	O
lens	NN	O
cleaning	IN	O
solutions.	,	O
In	RB	O
one	CC	O
aspect,	RB	O
the	CC	O
invention	IN	O
provides	NN	O
a	IN	O
method	NNS	O
for	CC	O
washing	.	O
an	DT	O
object	JJ	O
comprising	NN	O
contacting	VBZ	O
the	JJ	O
object	NNS	O
with	VBG	O
a	NN	O
polypeptide	NNS	O
of	IN	O
the	VBG	O
invention	JJ	O
under	,	O
conditions	NN	O
sufficient	NNS	O
for	IN	O
washing.	VBG	O
A	,	O
polypeptide	VBG	O
of	,	O
the	JJ	O
invention	NN	O
may	,	O
be	NN	O
included	NN	O
as	,	O
a	CC	O
detergent	NN	O
additive.	NNS	O
The	VBG	O
detergent	.	O
composition	IN	O
of	CD	O
the	,	O
invention	DT	O
may,	NN	O
for	VBZ	O
example,	DT	O
be	NN	O
formulated	IN	O
as	VBG	O
a	DT	O
hand	JJ	O
or	NN	O
machine	VBG	O
laundry	DT	O
detergent	NN	O
composition	IN	O
comprising	DT	O
a	NN	O
polypeptide	IN	O
of	DT	O
the	NN	O
invention.	IN	O
A	NNS	O
laundry	JJ	O
additive	IN	O
suitable	.	O
for	DT	O
pre-treatment	NN	O
of	IN	O
stained	DT	O
fabrics	NN	O
can	MD	O
comprise	VB	O
a	VBN	O
polypeptide	IN	O
of	DT	O
the	NN	O
invention.	.	O
A	DT	O
fabric	JJ	O
softener	NN	O
composition	IN	O
can	DT	O
comprise	NN	O
a	,	O
polypeptide	IN	O
of	,	O
the	VB	O
invention.	VBN	O
Alternatively,	IN	O
a	DT	O
polypeptide	NN	O
of	CC	O
the	NN	O
invention	JJ	O
can	NN	O
be	NN	O
formulated	VBG	O
as	DT	O
a	NN	O
detergent	IN	O
composition	DT	O
for	.	O
use	DT	O
in	JJ	O
general	NN	O
household	NN	O
hard	IN	O
surface	NN	O
cleaning	IN	O
operations.	JJ	O
In	NNS	O
alternative	MD	O
aspects,	VB	O
detergent	DT	O
additives	NN	O
and	IN	O
detergent	DT	O
compositions	.	O
of	DT	O
the	JJ	O
invention	NN	O
may	NN	O
comprise	MD	O
one	VB	O
or	DT	O
more	NN	O
other	IN	O
enzymes	DT	O
such	.	O
as	,	O
a	DT	O
protease,	NN	O
a	IN	O
lipase,	DT	O
a	NN	O
cutinase,	MD	O
another	VB	O
amylase,	VBN	O
a	IN	O
carbohydrase,	DT	O
a	NN	O
cellulase,	NN	O
a	IN	O
pectinase,	NN	O
a	IN	O
mannanase,	JJ	O
an	NN	O
arabinase,	JJ	O
a	NN	O
galactanase,	VBG	O
a	.	O
xylanase,	IN	O
an	JJ	O
oxidase,	,	O
e.g.,	NN	O
a	NNS	O
lactase,	CC	O
and/or	JJ	O
a	NNS	O
peroxidase.	IN	O
The	DT	O
properties	NN	O
of	MD	O
the	VB	O
enzyme(s)	CD	O
of	CC	O
the	JJR	O
invention	JJ	O
are	NNS	O
chosen	JJ	O
to	IN	O
be	DT	O
compatible	,	O
with	DT	O
the	,	O
selected	DT	O
detergent	,	O
(i.e.	DT	O
pH-optimum,	,	O
compatibility	DT	O
with	,	O
other	DT	O
enzymatic	,	O
and	DT	O
non-enzymatic	,	O
ingredients,	DT	O
etc.)	,	O
and	DT	O
the	,	O
enzyme(s)	DT	O
is	,	O
present	DT	O
in	,	O
effective	DT	O
amounts.	,	O
In	,	O
one	DT	O
aspect,	,	O
amylase	VBZ	O
enzymes	DT	O
of	.	O
the	DT	O
invention	NNS	O
are	IN	O
used	DT	O
to	)	O
remove	IN	O
malodorous	DT	O
materials	NN	O
from	VBP	O
fabrics.	VBN	O
Various	TO	O
detergent	VB	O
compositions	JJ	O
and	IN	O
methods	DT	O
for	VBN	O
making	NN	O
them	.	O
that	,	O
can	NN	O
be	IN	O
used	JJ	O
in	JJ	O
practicing	CC	O
the	JJ	O
invention	,	O
are	)	O
described	CC	O
in,	DT	O
e.g.,	)	O
U.S.	VBZ	O
Pat.	JJ	O
Nos.	IN	O
6,333,301;	JJ	O
6,329,333;	.	O
6,326,341;	IN	O
6,297,038;	CD	O
6,309,871;	,	O
6,204,232;	NN	O
6,197,070;	NNS	O
5,856,164.	IN	O
Treating	DT	O
Fabrics	NN	O
The	VBP	O
invention	VBN	O
provides	TO	O
methods	VB	O
of	JJ	O
treating	NNS	O
fabrics	IN	O
using	.	O
one	JJ	O
or	NN	O
more	NNS	O
polypeptides	CC	O
of	NNS	O
the	IN	O
invention.	VBG	O
The	PRP	O
polypeptides	WDT	O
of	MD	O
the	VB	O
invention	VBN	O
can	IN	O
be	VBG	O
used	DT	O
in	NN	O
any	VBP	O
fabric-treating	VBN	O
method,	,	O
which	,	O
are	NNP	O
well	.	O
known	.	O
in	:	O
the	:	O
art,	:	O
see,	:	O
e.g.,	:	O
U.S.	:	O
Pat.	:	O
No.	.	O
6,077,316.	VBG	O
For	NNS	O
example,	DT	O
in	NN	O
one	VBZ	O
aspect,	NNS	O
the	IN	O
feel	VBG	O
and	NNS	O
appearance	VBG	O
of	CD	O
a	CC	O
fabric	JJR	O
is	NNS	O
improved	IN	O
by	DT	O
a	.	O
method	DT	O
comprising	NNS	O
contacting	IN	O
the	DT	O
fabric	NN	O
with	MD	O
an	VB	O
amylase	VBN	O
of	IN	O
the	DT	O
invention	JJ	O
in	,	O
a	WDT	O
solution.	VBP	O
In	RB	O
one	VBN	O
aspect,	IN	O
the	DT	O
fabric	,	O
is	,	O
treated	,	O
with	NNP	O
the	.	O
solution	.	O
under	.	O
pressure.	IN	O
In	,	O
one	IN	O
aspect,	CD	O
the	,	O
enzymes	DT	O
of	NN	O
the	CC	O
invention	NN	O
are	IN	O
applied	DT	O
during	NN	O
or	VBZ	O
after	VBN	O
the	IN	O
weaving	DT	O
of	NN	O
textiles,	VBG	O
or	VBG	O
during	DT	O
the	NN	O
desizing	IN	O
stage,	DT	O
or	NN	O
one	IN	O
or	DT	O
more	NN	O
additional	IN	O
fabric	DT	O
processing	.	O
steps.	IN	O
During	CD	O
the	,	O
weaving	DT	O
of	NN	O
textiles,	VBZ	O
the	VBN	O
threads	IN	O
are	DT	O
exposed	NN	O
to	IN	O
considerable	.	O
mechanical	IN	O
strain.	CD	O
Prior	,	O
to	DT	O
weaving	NNS	O
on	IN	O
mechanical	DT	O
looms,	NN	O
warp	VBP	O
yarns	VBN	O
are	IN	O
often	CC	O
coated	IN	O
with	DT	O
sizing	NN	O
starch	IN	O
or	,	O
starch	CC	O
derivatives	IN	O
in	DT	O
order	NN	O
to	,	O
increase	CC	O
their	CD	O
tensile	CC	O
strength	JJR	O
and	JJ	O
to	NN	O
prevent	NN	O
breaking.	.	O
The	IN	O
enzymes	DT	O
of	NN	O
the	IN	O
invention	,	O
can	DT	O
be	NNS	O
applied	VBP	O
to	VBN	O
remove	TO	O
these	JJ	O
sizing	JJ	O
starch	.	O
or	RB	O
starch	TO	O
derivatives.	VBG	O
After	IN	O
the	JJ	O
textiles	,	O
have	NN	O
been	NNS	O
woven,	VBP	O
a	RB	O
fabric	VBN	O
can	IN	O
proceed	VBG	O
to	NN	O
a	CC	O
desizing	NN	O
stage.	NNS	O
This	IN	O
can	NN	O
be	TO	O
followed	VB	O
by	PRP$	O
one	JJ	O
or	NN	O
more	CC	O
additional	TO	O
fabric	VB	O
processing	.	O
steps.	DT	O
Desizing	NNS	O
is	IN	O
the	DT	O
act	NN	O
of	MD	O
removing	VB	O
size	VBN	O
from	TO	O
textiles.	VB	O
After	DT	O
weaving,	VBG	O
the	NN	O
size	CC	O
coating	NN	O
must	.	O
be	IN	O
removed	DT	O
before	NNS	O
further	VBP	O
processing	VBN	O
the	,	O
fabric	DT	O
in	NN	O
order	MD	O
to	VB	O
ensure	TO	O
a	DT	O
homogeneous	NN	O
and	.	O
wash-proof	DT	O
result.	MD	O
The	VB	O
invention	VBN	O
provides	IN	O
a	CD	O
method	CC	O
of	JJR	O
desizing	JJ	O
comprising	NN	O
enzymatic	NN	O
hydrolysis	.	O
of	NN	O
the	VBZ	O
size	DT	O
by	NN	O
the	IN	O
action	VBG	O
of	NN	O
an	IN	O
enzyme	.	O
of	IN	O
the	,	O
invention.	DT	O
The	NN	O
enzymes	NN	O
of	MD	O
the	VB	O
invention	VBN	O
can	IN	O
be	JJ	O
used	VBG	O
to	DT	O
desize	NN	O
fabrics,	IN	O
including	NN	O
cotton-containing	TO	O
fabrics,	VB	O
as	DT	O
detergent	JJ	O
additives,	CC	O
e.g.,	JJ	O
in	.	O
aqueous	DT	O
compositions.	NN	O
The	VBZ	O
invention	DT	O
provides	NN	O
methods	IN	O
for	VBG	O
producing	VBG	O
a	JJ	O
stonewashed	NN	O
look	IN	O
on	DT	O
indigo-dyed	NN	O
denim	IN	O
fabric	DT	O
and	NN	O
garments.	IN	O
For	DT	O
the	NN	O
manufacture	IN	O
of	DT	O
clothes,	.	O
the	DT	O
fabric	NNS	O
can	IN	O
be	DT	O
cut	NN	O
and	MD	O
sewn	VB	O
into	VBN	O
clothes	TO	O
or	VB	O
garments,	,	O
which	VBG	O
is	JJ	O
afterwards	,	O
finished.	IN	O
In	NN	O
particular,	,	O
for	,	O
the	IN	O
manufacture	JJ	O
of	.	O
denim	DT	O
jeans,	NN	O
different	VBZ	O
enzymatic	NNS	O
finishing	IN	O
methods	VBG	O
have	DT	O
been	JJ	O
developed.	NN	O
The	IN	O
finishing	JJ	O
of	NN	O
denim	NN	O
garment	CC	O
normally	.	O
is	IN	O
initiated	DT	O
with	NN	O
an	IN	O
enzymatic	,	O
desizing	DT	O
step,	NN	O
during	MD	O
which	VB	O
garments	VBN	O
are	CC	O
subjected	VBN	O
to	IN	O
the	NNS	O
action	CC	O
of	,	O
amylolytic	WDT	O
enzymes	VBZ	O
in	NNS	O
order	.	O
to	IN	O
provide	,	O
softness	IN	O
to	DT	O
the	NN	O
fabric	IN	O
and	JJ	O
make	,	O
the	JJ	O
cotton	JJ	O
more	NN	O
accessible	NNS	O
to	VBP	O
the	VBN	O
subsequent	.	O
enzymatic	DT	O
finishing	NN	O
steps.	IN	O
The	JJ	O
invention	NN	O
provides	RB	O
methods	VBZ	O
of	VBN	O
finishing	IN	O
denim	DT	O
garments	JJ	O
(e.g.,	NN	O
a	,	O
“bio-stoning	IN	O
process”),	WDT	O
enzymatic	NNS	O
desizing	VBP	O
and	VBN	O
providing	TO	O
softness	DT	O
to	NN	O
fabrics	IN	O
using	JJ	O
the	NNS	O
amylases	IN	O
of	NN	O
the	TO	O
invention.	VB	O
The	NN	O
invention	TO	O
provides	DT	O
methods	NN	O
for	CC	O
quickly	VB	O
softening	DT	O
denim	NN	O
garments	RBR	O
in	JJ	O
a	TO	O
desizing	DT	O
and/or	JJ	O
finishing	JJ	O
process.	NN	O
Foods	.	O
and	DT	O
Food	NN	O
Processing	VBZ	O
The	NNS	O
enzymes	IN	O
of	VBG	O
the	JJ	O
invention	NNS	O
have	,	O
numerous	DT	O
applications	JJ	O
in	,	O
food	JJ	O
processing	NN	O
industry.	CC	O
The	VBG	O
amylases	NN	O
of	TO	O
the	NNS	O
invention	VBG	O
are	DT	O
used	NNS	O
in	IN	O
starch	DT	O
to	.	O
fructose	DT	O
processing.	NN	O
Starch	VBZ	O
to	NNS	O
fructose	IN	O
processing	RB	O
can	VBG	O
consist	JJ	O
of	NNS	O
four	IN	O
steps:	DT	O
liquefaction	NN	O
of	RP	O
granular	VBG	O
starch,	.	O
saccharification	NNS	O
of	CC	O
the	NNP	O
liquefied	NNP	O
starch	DT	O
into	NNS	O
dextrose,	IN	O
purification,	DT	O
and	NN	O
isomerization	VBP	O
to	JJ	O
fructose.	NNS	O
The	IN	O
invention	NN	O
provides	NN	O
methods	.	O
of	DT	O
starch	NNS	O
liquefaction	IN	O
using	DT	O
the	NN	O
enzymes	VBP	O
of	VBN	O
the	IN	O
invention.	NN	O
Concentrated	TO	O
suspensions	VB	O
of	.	O
starch	NN	O
polymer	TO	O
granules	VB	O
are	NN	O
converted	MD	O
into	VB	O
a	IN	O
solution	CD	O
of	:	O
soluble	NN	O
shorter	IN	O
chain	JJ	O
length	,	O
dextrins	NN	O
of	IN	O
low	DT	O
viscosity.	JJ	O
This	NN	O
step	IN	O
is	,	O
useful	,	O
for	CC	O
convenient	NN	O
handling	TO	O
with	.	O
standard	DT	O
equipment	NN	O
and	VBZ	O
for	NNS	O
efficient	IN	O
conversion	NN	O
to	NN	O
glucose	VBG	O
or	DT	O
103	NNS	O
other	IN	O
sugars.	DT	O
In	.	O
one	JJ	O
aspect,	NNS	O
the	IN	O
granular	NN	O
starch	NN	O
is	NNS	O
liquefied	VBP	O
by	VBN	O
gelatinizing	IN	O
the	DT	O
granules	NN	O
by	IN	O
raising	JJ	O
the	NN	O
temperature	NN	O
of	NN	O
the	NNS	O
granular	IN	O
starch	JJ	O
to	.	O
over	DT	O
about	NN	O
72°	VBZ	O
C.	JJ	O
The	IN	O
heating	NN	O
process	VBG	O
instantaneously	IN	O
disrupts	JJ	O
the	NN	O
insoluble	CC	O
starch	IN	O
granules	JJ	O
to	NN	O
produce	TO	O
a	VB	O
water	CC	O
soluble	CD	O
starch	JJ	O
solution.	.	O
The	IN	O
solubilized	CD	O
starch	,	O
solution	DT	O
can	JJ	O
then	NN	O
be	VBZ	O
liquefied	VBN	O
by	IN	O
an	VBG	O
amylase	DT	O
of	NNS	O
the	IN	O
invention.	VBG	O
Thus,	DT	O
the	NN	O
invention	IN	O
provides	DT	O
enzymatic	JJ	O
starch	NN	O
liquefaction	TO	O
processes	VB	O
using	IN	O
an	CD	O
amylase	NNP	O
of	DT	O
the	NN	O
invention.	NN	O
An	RB	O
exemplary	VBZ	O
enzymatic	DT	O
liquefaction	JJ	O
process	NN	O
involves	NNS	O
adjusting	TO	O
the	VB	O
pH	DT	O
of	NN	O
a	JJ	O
granular	NN	O
starch	.	O
slurry	DT	O
to	VBN	O
between	NN	O
6.0	NN	O
and	MD	O
6.5	RB	O
and	VB	O
the	VBN	O
addition	IN	O
of	DT	O
calcium	NN	O
hydroxide,	IN	O
sodium	DT	O
hydroxide	.	O
or	,	O
sodium	DT	O
carbonate.	NN	O
In	VBZ	O
one	JJ	O
aspect,	NN	O
calcium	NN	O
hydroxide	VBZ	O
is	VBG	O
added.	DT	O
This	NN	O
provides	IN	O
calcium	DT	O
ions	.	O
to	DT	O
stabilize	JJ	O
the	JJ	O
glucoamylase	NN	O
of	NN	O
the	VBZ	O
invention	VBG	O
against	DT	O
inactivation.	NN	O
In	IN	O
one	DT	O
aspect,	JJ	O
upon	NN	O
addition	NN	O
of	TO	O
amylase,	IN	O
the	CD	O
suspension	CC	O
is	CD	O
pumped	CC	O
through	DT	O
a	NN	O
steam	IN	O
jet	NN	O
to	,	O
instantaneously	NN	O
raise	NN	O
the	CC	O
temperature	NN	O
to	.	O
between	IN	O
80°-115°	CD	O
C.	,	O
In	NN	O
one	NN	O
aspect,	VBZ	O
the	.	O
starch	DT	O
is	VBZ	O
immediately	NN	O
gelatinized	NNS	O
and,	TO	O
due	VB	O
to	DT	O
the	NN	O
presence	IN	O
of	DT	O
amylase,	NN	O
depolymerized	IN	O
through	.	O
random	IN	O
hydrolysis	CD	O
of	,	O
α-1,4-glycosidic	IN	O
bonds	NN	O
by	IN	O
amylase	,	O
to	DT	O
a	NN	O
fluid	VBZ	O
mass.	VBN	O
The	IN	O
fluid	DT	O
mass	NN	O
can	NN	O
be	TO	O
easily	RB	O
pumped.	VB	O
The	DT	O
invention	NN	O
provides	TO	O
various	IN	O
enzymatic	JJ	O
starch	NNP	O
liquefaction	IN	O
processes	CD	O
using	,	O
an	DT	O
amylase	NN	O
of	VBZ	O
the	RB	O
invention.	VBN	O
In	,	O
one	JJ	O
aspect	TO	O
of	DT	O
the	NN	O
liquefaction	IN	O
process	,	O
of	VBN	O
the	IN	O
invention,	JJ	O
an	NN	O
amylase	IN	O
is	JJ	O
added	NNS	O
to	IN	O
the	NN	O
starch	TO	O
suspension	DT	O
and	JJ	O
the	.	O
suspension	DT	O
is	JJ	O
held	NN	O
at	MD	O
a	VB	O
temperature	RB	O
of	.	O
between	DT	O
about	NN	O
80°-100°	VBZ	O
C.	JJ	O
to	JJ	O
partially	NN	O
hydrolyze	NN	O
the	VBZ	O
starch	VBG	O
granules.	DT	O
In	NN	O
one	IN	O
aspect,	DT	O
the	.	O
partially	IN	O
hydrolyzed	CD	O
starch	NN	O
suspension	IN	O
is	DT	O
pumped	NN	O
through	NN	O
a	IN	O
jet	DT	O
at	,	O
temperatures	DT	O
in	NN	O
excess	VBZ	O
of	VBN	O
about	TO	O
105°	DT	O
C.	NN	O
to	NN	O
thoroughly	CC	O
gelatinize	DT	O
any	NN	O
remaining	VBZ	O
granular	VBN	O
structure.	IN	O
In	DT	O
one	NN	O
aspect,	IN	O
after	IN	O
cooling	IN	O
the	JJ	O
gelatinized	NNP	O
starch,	TO	O
a	RB	O
second	VB	O
addition	DT	O
of	NN	O
amylase	.	O
is	IN	O
made	CD	O
to	,	O
further	DT	O
hydrolyze	RB	O
the	VBN	O
starch.	NN	O
The	NN	O
invention	VBZ	O
provides	VBN	O
enzymatic	IN	O
dry	DT	O
milling	NN	O
processes	IN	O
using	NNS	O
an	IN	O
amylase	NN	O
of	IN	O
the	IN	O
invention.	CD	O
In	NNP	O
dry	TO	O
milling,	VB	O
whole	VB	O
grain	DT	O
is	VBG	O
ground	JJ	O
and	.	O
combined	IN	O
with	CD	O
water.	,	O
The	IN	O
germ	VBG	O
is	DT	O
optionally	VBN	O
removed	,	O
by	DT	O
flotation	JJ	O
separation	NN	O
or	IN	O
equivalent	NN	O
techniques.	VBZ	O
The	VBN	O
resulting	TO	O
mixture,	RBR	O
which	VB	O
contains	DT	O
starch,	.	O
fiber,	DT	O
protein	NN	O
and	VBZ	O
other	JJ	O
components	JJ	O
of	NN	O
the	VBZ	O
grain,	VBG	O
is	DT	O
liquefied	NN	O
using	IN	O
amylase.	DT	O
In	.	O
one	IN	O
aspect,	JJ	O
enzymatic	,	O
liquefaction	JJ	O
is	NN	O
done	VBZ	O
at	NN	O
lower	CC	O
temperatures	VBN	O
than	IN	O
the	.	O
starch	DT	O
liquification	NN	O
processes	VBZ	O
discussed	RB	O
above.	VBN	O
In	IN	O
one	NN	O
aspect,	NN	O
after	CC	O
gelatinization	JJ	O
the	.	O
starch	DT	O
solution	JJ	O
is	,	O
held	WDT	O
at	VBZ	O
an	,	O
elevated	,	O
temperature	NN	O
in	CC	O
the	JJ	O
presence	NNS	O
of	IN	O
amylase	DT	O
until	,	O
a	VBZ	O
DE	VBN	O
of	VBG	O
10-20	.	O
is	IN	O
achieved.	CD	O
In	,	O
one	JJ	O
aspect,	NN	O
this	VBZ	O
is	VBN	O
a	IN	O
period	JJR	O
of	NNS	O
about	IN	O
1-3	DT	O
hours.	JJ	O
Dextrose	NN	O
equivalent	NNS	O
(DE)	VBN	O
is	.	O
the	IN	O
industry	CD	O
standard	,	O
for	IN	O
measuring	NN	O
the	DT	O
concentration	NN	O
of	NN	O
total	VBZ	O
reducing	VBN	O
sugars,	IN	O
calculated	DT	O
as	JJ	O
D-glucose	NN	O
on	IN	O
a	DT	O
dry	NN	O
weight	IN	O
basis.	NN	O
Unhydrolyzed	IN	O
granular	DT	O
starch	NNP	O
has	IN	O
a	JJ	O
DE	VBZ	O
of	.	O
virtually	IN	O
zero,	CD	O
whereas	,	O
the	DT	O
DE	VBZ	O
of	DT	O
D-glucose	NN	O
is	IN	O
defined	IN	O
as	JJ	O
100.	.	O
The	NNP	O
invention	JJ	O
provides	)	O
wet	VBZ	O
milling	DT	O
processes,	NN	O
e.g.,	NN	O
corn	IN	O
wet	VBG	O
milling,	DT	O
using	NN	O
an	IN	O
amylase	JJ	O
of	VBG	O
the	,	O
invention.	VBD	O
Corn	IN	O
wet	NNP	O
milling	IN	O
is	DT	O
a	JJ	O
process	JJ	O
which	.	O
produces	VBN	O
corn	JJ	O
oil,	NN	O
gluten	VBZ	O
meal,	DT	O
gluten	NNP	O
feed	IN	O
and	RB	O
starch.	,	O
Thus,	IN	O
the	DT	O
invention	NNP	O
provides	IN	O
methods	NNP	O
of	VBZ	O
making	VBN	O
corn	IN	O
oil,	.	O
gluten	DT	O
meal,	NN	O
gluten	VBZ	O
feed	JJ	O
and	NN	O
starch	,	O
using	,	O
an	NN	O
enzyme	NN	O
of	,	O
the	VBG	O
invention.	DT	O
In	NN	O
one	IN	O
aspect,	DT	O
an	.	O
alkaline-amylase	NNP	O
of	NN	O
the	NN	O
invention	VBZ	O
is	DT	O
used	NN	O
in	WDT	O
the	VBZ	O
liquefaction	NN	O
of	,	O
starch.	VB	O
In	,	O
one	VBP	O
aspect,	NN	O
glucoamylase	CC	O
is	.	O
used	,	O
in	DT	O
saccharification	NN	O
to	VBZ	O
produce	NNS	O
glucose.	IN	O
In	VBG	O
one	NN	O
aspect,	,	O
corn	VB	O
(a	,	O
kernel	VBP	O
that	NN	O
consists	CC	O
of	NN	O
a	VBG	O
outer	DT	O
seed	NN	O
coat	IN	O
(fiber),	DT	O
starch,	.	O
a	IN	O
combination	CD	O
of	,	O
starch	DT	O
and	NN	O
glucose	IN	O
and	DT	O
the	NN	O
inner	VBZ	O
germ),	VBN	O
is	IN	O
subjected	DT	O
to	NN	O
a	IN	O
four	.	O
step	IN	O
process,	CD	O
which	,	O
results	NN	O
in	VBZ	O
the	VBN	O
production	IN	O
of	NN	O
starch.	TO	O
In	VB	O
one	.	O
aspect,	IN	O
the	CD	O
corn	,	O
is	NN	O
steeped,	DT	O
de-germed,	NN	O
de-fibered,	IN	O
and	VBZ	O
the	IN	O
gluten	DT	O
is	NN	O
separated.	NN	O
In	NN	O
a	,	O
steeping	,	O
process	DT	O
the	NN	O
solubles	IN	O
are	NN	O
taken	CC	O
out.	NN	O
The	CC	O
product	DT	O
remaining	JJ	O
after	,	O
removal	VBZ	O
of	VBN	O
the	TO	O
solubles	DT	O
is	CD	O
de-germed,	NN	O
resulting	,	O
in	WDT	O
production	NNS	O
of	IN	O
corn	DT	O
oil	NN	O
and	IN	O
production	.	O
of	IN	O
an	CD	O
oil	,	O
cake,	DT	O
which	NN	O
is	VBZ	O
added	,	O
to	,	O
the	,	O
solubles	CC	O
from	DT	O
the	NN	O
steeping	VBZ	O
step.	.	O
The	IN	O
remaining	DT	O
product	NN	O
is	NN	O
de-fibered	DT	O
and	NNS	O
the	VBP	O
fiber	VBN	O
solids	.	O
are	DT	O
added	NN	O
to	VBG	O
the	IN	O
oil	NN	O
cake/solubles	IN	O
mixture.	DT	O
This	NNS	O
mixture	VBZ	O
of	,	O
fiber	VBG	O
solids,	IN	O
oil	NN	O
cake	IN	O
and	NN	O
solubles	NN	O
forms	CC	O
a	NN	O
gluten	IN	O
feed.	DT	O
After	NN	O
de-fibering,	,	O
the	WDT	O
remaining	VBZ	O
product	VBN	O
is	TO	O
subjected	DT	O
to	NNS	O
gluten	IN	O
separation.	DT	O
This	VBG	O
separation	.	O
results	DT	O
in	VBG	O
a	NN	O
gluten	VBZ	O
meal	JJ	O
and	CC	O
starch.	DT	O
The	NN	O
starch	NNS	O
is	VBP	O
then	VBN	O
subjected	TO	O
to	DT	O
liquefaction	NN	O
and	VBZ	O
saccharification	.	O
using	DT	O
polypeptides	NN	O
of	IN	O
the	NN	O
invention	,	O
to	NN	O
produce	NN	O
glucose.	CC	O
The	NNS	O
invention	VBZ	O
provides	DT	O
anti-staling	JJ	O
processes	.	O
(e.g.,	IN	O
of	,	O
baked	DT	O
products	VBG	O
such	NN	O
as	VBZ	O
bread)	VBN	O
using	TO	O
an	VB	O
amylase	.	O
of	DT	O
the	NN	O
invention.	NNS	O
The	IN	O
invention	DT	O
provides	JJ	O
methods	NN	O
to	CC	O
slow	.	O
the	DT	O
increase	NN	O
of	VBZ	O
the	RB	O
firmness	VBN	O
of	TO	O
the	NN	O
crumb	CC	O
(of	NN	O
the	VBG	O
baked	NNS	O
product)	IN	O
and	DT	O
a	NN	O
decrease	TO	O
of	VB	O
the	.	O
elasticity	DT	O
of	NN	O
the	VBZ	O
crumb	JJ	O
using	NNS	O
an	,	O
amylase	IN	O
of	JJ	O
the	NNS	O
invention.	JJ	O
Staling	IN	O
of	)	O
baked	VBG	O
products	DT	O
(such	NN	O
as	IN	O
bread)	DT	O
is	.	O
more	DT	O
serious	NN	O
as	VBZ	O
time	NNS	O
passes	TO	O
between	VB	O
the	DT	O
moment	NN	O
of	IN	O
preparation	DT	O
of	NN	O
the	IN	O
bread	DT	O
product	NN	O
and	IN	O
the	DT	O
moment	JJ	O
of	)	O
consumption.	CC	O
The	DT	O
term	NN	O
staling	IN	O
is	DT	O
used	NN	O
to	IN	O
describe	DT	O
changes	NN	O
undesirable	VBG	O
to	DT	O
the	NN	O
consumer	IN	O
in	DT	O
the	.	O
properties	VBG	O
of	IN	O
the	JJ	O
bread	NNS	O
product	JJ	O
after	IN	O
leaving	)	O
the	VBZ	O
oven,	RBR	O
such	JJ	O
as	IN	O
an	NN	O
increase	NNS	O
of	IN	O
the	DT	O
firmness	NN	O
of	IN	O
the	NN	O
crumb,	IN	O
a	DT	O
decrease	JJ	O
of	NN	O
the	CC	O
elasticity	DT	O
of	NN	O
the	IN	O
crumb,	.	O
and	DT	O
changes	NN	O
in	NN	O
the	VBZ	O
crust,	VBN	O
which	TO	O
becomes	VB	O
tough	NNS	O
and	JJ	O
leathery.	TO	O
The	DT	O
firmness	NN	O
of	IN	O
the	DT	O
bread	NNS	O
crumb	IN	O
increases	DT	O
further	JJ	O
during	NN	O
storage	IN	O
up	VBG	O
to	DT	O
a	,	O
level,	JJ	O
which	IN	O
is	DT	O
considered	NN	O
as	IN	O
negative.	DT	O
Amylases	NN	O
of	IN	O
the	DT	O
invention	,	O
are	DT	O
used	NN	O
to	IN	O
retard	DT	O
staling	NN	O
of	IN	O
the	DT	O
bread	,	O
as	CC	O
described	NNS	O
e.g.,	IN	O
in	DT	O
U.S.	,	O
Pat.	WDT	O
Nos.	VBZ	O
6,197,352;	JJ	O
2,615,810	CC	O
and	.	O
3,026,205;	DT	O
Silberstein	NN	O
(1964)	IN	O
Baker's	DT	O
Digest	NN	O
38:66-72.	NN	O
In	VBZ	O
one	RBR	O
aspect,	IN	O
an	NN	O
enzyme	RB	O
of	TO	O
the	DT	O
invention	,	O
is	WDT	O
used	VBZ	O
to	VBN	O
retard	IN	O
the	.	O
staling	NNS	O
of	IN	O
baked	DT	O
products	NN	O
while	VBP	O
not	VBN	O
hydrolyzing	TO	O
starch	VB	O
into	NN	O
the	IN	O
branched	DT	O
dextrins.	NN	O
Branched	IN	O
dextrins	JJ	O
are	,	O
formed	IN	O
by	NNP	O
cleaving	.	O
off	.	O
the	:	O
branched	CD	O
chains	CC	O
of	:	O
the	NNP	O
dextrins	)	O
generated	POS	O
by	NNP	O
α-amylase	.	O
hydrolysis	IN	O
which	CD	O
cannot	,	O
be	DT	O
degraded	NN	O
further	IN	O
by	DT	O
the	NN	O
α-amylase.	VBZ	O
This	VBN	O
can	TO	O
produce	VB	O
a	DT	O
gummy	NN	O
crumb	IN	O
in	JJ	O
the	NNS	O
resulting	IN	O
bread.	RB	O
Accordingly,	VBG	O
the	NN	O
invention	IN	O
provides	DT	O
a	JJ	O
process	.	O
for	VBN	O
retarding	NNS	O
the	VBP	O
staling	VBN	O
of	IN	O
baked	VBG	O
products	RP	O
(e.g.,	DT	O
leavened	JJ	O
baked	NNS	O
products)	IN	O
comprising	DT	O
adding	NNS	O
an	VBN	O
enzyme	IN	O
of	JJ	O
the	NN	O
invention	WDT	O
comprising	RB	O
exoamylase	VB	O
activity	VBN	O
to	RB	O
a	IN	O
flour	DT	O
or	.	O
a	DT	O
dough	MD	O
used	VB	O
for	DT	O
producing	NN	O
a	NN	O
baked	IN	O
product.	DT	O
Exoamylases	VBG	O
of	.	O
the	,	O
invention	DT	O
can	NN	O
have	VBZ	O
glucoamylase,	DT	O
β-amylase	NN	O
(which	IN	O
releases	VBG	O
maltose	DT	O
in	NN	O
the	IN	O
beta-configuration)	JJ	O
and/or	NNS	O
maltogenic	,	O
amylase	VBD	O
activity.	JJ	O
The	)	O
invention	VBG	O
also	VBG	O
provides	DT	O
a	NN	O
process	IN	O
for	DT	O
preparing	NN	O
a	VBG	O
dough	NN	O
or	NN	O
a	TO	O
baked	DT	O
product	NN	O
prepared	CC	O
from	DT	O
the	NN	O
dough	VBN	O
which	IN	O
comprises	VBG	O
adding	DT	O
an	JJ	O
amylase	.	O
of	NNS	O
the	IN	O
invention	DT	O
to	NN	O
the	MD	O
dough	VB	O
in	,	O
an	NNP	O
amount	WDT	O
which	VBZ	O
is	NN	O
effective	IN	O
to	DT	O
retard	)	O
the	VBZ	O
staling	JJ	O
of	NN	O
the	.	O
bread.	DT	O
The	NN	O
invention	RB	O
also	VBZ	O
provides	DT	O
a	NN	O
dough	IN	O
comprising	VBG	O
said	DT	O
amylase	NN	O
and	CC	O
a	DT	O
premix	JJ	O
comprising	NN	O
flour	VBN	O
together	IN	O
with	DT	O
said	NN	O
amylase.	WDT	O
Finally,	VBZ	O
the	VBG	O
invention	DT	O
provides	NN	O
an	IN	O
enzymatic	DT	O
baking	NN	O
additive,	TO	O
which	DT	O
contains	NN	O
said	IN	O
amylase.	DT	O
The	NN	O
invention	WDT	O
also	VBZ	O
provides	JJ	O
a	TO	O
high	VB	O
yield	DT	O
process	NN	O
for	IN	O
producing	DT	O
high	.	O
quality	DT	O
corn	NN	O
fiber	RB	O
gum	VBZ	O
by	DT	O
treatment	NN	O
of	NN	O
corn	VBD	O
fiber	NN	O
with	CC	O
an	DT	O
enzyme	NN	O
of	VBG	O
the	PRP$	O
invention	NN	O
followed	IN	O
by	VBD	O
hydrogen	.	O
peroxide	,	O
treatment	DT	O
to	NN	O
obtain	VBZ	O
an	DT	O
extract	JJ	O
of	NN	O
milled	,	O
corn	WDT	O
fiber.	VBZ	O
See,	VBD	O
e.g.,	.	O
U.S.	DT	O
Pat.	NN	O
No.	RB	O
6,147,206.	VBZ	O
Animal	DT	O
Feeds	JJ	O
and	NN	O
Additives	NN	O
The	IN	O
invention	VBG	O
provides	JJ	O
methods	NN	O
for	NN	O
treating	NN	O
animal	NN	O
feeds	IN	O
and	NN	O
additives	IN	O
using	NN	O
amylase	NN	O
enzymes	IN	O
of	DT	O
the	NN	O
invention.	IN	O
The	DT	O
invention	NN	O
provides	VBN	O
animal	IN	O
feeds	NN	O
and	NN	O
additives	NN	O
comprising	TO	O
amylases	VB	O
of	DT	O
the	NN	O
invention.	IN	O
In	JJ	O
one	NN	O
aspect,	.	O
treating	,	O
animal	,	O
feeds	NNP	O
and	.	O
additives	.	O
using	.	O
amylase	NNP	O
enzymes	NNP	O
of	CC	O
the	VBZ	O
invention	DT	O
can	NN	O
help	VBZ	O
in	NNS	O
the	IN	O
availability	VBG	O
of	JJ	O
starch	NNS	O
in	CC	O
the	NNS	O
animal	VBG	O
feed	JJ	O
or	NNS	O
additive.	IN	O
This	DT	O
can	.	O
result	DT	O
in	NN	O
release	VBZ	O
of	JJ	O
readily	NNS	O
digestible	CC	O
and	NNS	O
easily	VBG	O
absorbed	NNS	O
sugars.	IN	O
Use	DT	O
of	.	O
an	IN	O
amylase	CD	O
of	,	O
the	VBG	O
invention	JJ	O
can	NNS	O
increase	CC	O
the	NNS	O
digestive	VBG	O
capacity	JJ	O
of	NNS	O
animals	IN	O
and	DT	O
birds.	NN	O
Use	MD	O
of	VB	O
an	IN	O
amylase	DT	O
of	NN	O
the	IN	O
invention	NN	O
can	IN	O
ensure	DT	O
availability	JJ	O
of	NN	O
an	CC	O
adequate	.	O
nutrient	DT	O
supply	MD	O
for	VB	O
better	IN	O
growth	NN	O
and	IN	O
performance.	RB	O
In	JJ	O
one	CC	O
aspect,	RB	O
the	JJ	O
enzymes	.	O
of	NNP	O
the	IN	O
invention	DT	O
can	NN	O
be	IN	O
added	DT	O
as	NN	O
feed	MD	O
additives	VB	O
for	DT	O
animals.	JJ	O
In	NN	O
another	IN	O
aspect,	NNS	O
the	CC	O
animal	.	O
feed	NNP	O
can	IN	O
be	DT	O
treated	NN	O
with	IN	O
amylases	DT	O
prior	NN	O
to	MD	O
animal	VB	O
consumption.	NN	O
In	IN	O
another	DT	O
aspect,	JJ	O
the	NN	O
amylases	NN	O
may	IN	O
be	JJR	O
supplied	NN	O
by	CC	O
expressing	.	O
the	IN	O
enzymes	CD	O
directly	,	O
in	DT	O
transgenic	NNS	O
feed	IN	O
crops	DT	O
(as,	NN	O
e.g.,	MD	O
transgenic	VB	O
plants,	VBN	O
seeds	IN	O
and	NN	O
the	NNS	O
like),	IN	O
such	.	O
as	IN	O
corn.	DT	O
As	,	O
discussed	DT	O
above,	JJ	O
the	NN	O
invention	MD	O
provides	VB	O
transgenic	VBN	O
plants,	IN	O
plant	NNS	O
parts	RB	O
and	TO	O
plant	VB	O
cells	.	O
comprising	IN	O
a	DT	O
nucleic	,	O
acid	DT	O
sequence	NNS	O
encoding	MD	O
a	VB	O
polypeptide	VBN	O
of	IN	O
the	VBG	O
invention.	DT	O
In	NNS	O
one	RB	O
aspect,	IN	O
the	JJ	O
nucleic	NN	O
acid	NNS	O
is	,	O
expressed	,	O
such	JJ	O
that	,	O
the	NNS	O
amylase	CC	O
is	DT	O
produced	,	O
in	JJ	O
recoverable	IN	O
quantities.	.	O
The	IN	O
amylase	VBN	O
can	,	O
be	DT	O
recovered	NN	O
from	VBZ	O
any	JJ	O
plant	,	O
or	NN	O
plant	NNS	O
part.	CC	O
Alternatively,	NN	O
the	NNS	O
plant	VBG	O
or	DT	O
plant	JJ	O
part	NN	O
containing	NN	O
the	VBG	O
recombinant	DT	O
polypeptide	NN	O
can	IN	O
be	DT	O
used	.	O
as	IN	O
such	CD	O
for	,	O
improving	DT	O
the	JJ	O
quality	NN	O
of	VBZ	O
a	VBN	O
food	JJ	O
or	IN	O
feed,	DT	O
e.g.,	NN	O
improving	VBZ	O
nutritional	VBN	O
value,	IN	O
palatability,	JJ	O
and	.	O
rheological	DT	O
properties,	NN	O
or	MD	O
to	VB	O
destroy	VBN	O
an	IN	O
antinutritive	DT	O
factor.	NN	O
Paper	CC	O
or	NN	O
Pulp	.	O
Treatment	,	O
The	DT	O
enzymes	NN	O
of	CC	O
the	NN	O
invention	NN	O
can	VBG	O
be	DT	O
in	JJ	O
paper	NN	O
or	MD	O
pulp	VB	O
treatment	VBN	O
or	IN	O
paper	JJ	O
deinking.	IN	O
For	VBG	O
example,	DT	O
in	NN	O
one	IN	O
aspect,	DT	O
the	NN	O
invention	CC	O
provides	,	O
a	,	O
paper	VBG	O
treatment	JJ	O
process	,	O
using	,	O
amylases	CC	O
of	JJ	O
the	,	O
invention.	CC	O
In	TO	O
one	VB	O
aspect,	DT	O
the	JJ	O
enzymes	.	O
of	NN	O
the	CC	O
invention	NNP	O
can	NNP	O
be	DT	O
used	NNS	O
to	IN	O
modify	DT	O
starch	NN	O
in	MD	O
the	VB	O
paper	IN	O
thereby	NN	O
converting	CC	O
it	NN	O
into	NN	O
a	CC	O
liquefied	NN	O
form.	.	O
In	IN	O
another	,	O
aspect,	IN	O
paper	CD	O
components	,	O
of	DT	O
recycled	NN	O
photocopied	VBZ	O
paper	DT	O
during	NN	O
chemical	NN	O
and	NN	O
enzymatic	VBG	O
deinking	NNS	O
processes.	IN	O
In	DT	O
one	.	O
aspect,	IN	O
amylases	CD	O
of	,	O
the	DT	O
invention	NNS	O
can	IN	O
be	DT	O
used	NN	O
in	MD	O
combination	VB	O
with	VBN	O
cellulases.	TO	O
The	VB	O
paper	NN	O
can	IN	O
be	DT	O
treated	NN	O
by	RB	O
the	VBG	O
following	PRP	O
three	IN	O
processes:	DT	O
1)	JJ	O
disintegration	.	O
in	IN	O
the	DT	O
presence	,	O
of	NN	O
an	NNS	O
enzyme	IN	O
of	JJ	O
the	JJ	O
invention,	NN	O
2)	IN	O
disintegration	NN	O
with	CC	O
a	JJ	O
deinking	NN	O
chemical	.	O
and	IN	O
an	CD	O
enzyme	,	O
of	NNS	O
the	IN	O
invention,	DT	O
and/or	NN	O
3)	MD	O
disintegration	VB	O
after	VBN	O
soaking	IN	O
with	NN	O
an	IN	O
enzyme	.	O
of	DT	O
the	NN	O
invention.	MD	O
The	VB	O
recycled	VBN	O
paper	IN	O
treated	DT	O
with	JJ	O
amylase	CD	O
can	:	O
have	)	O
a	NN	O
higher	IN	O
brightness	DT	O
due	NN	O
to	IN	O
removal	DT	O
of	NN	O
toner	IN	O
particles	DT	O
as	,	O
compared	)	O
to	NN	O
the	IN	O
paper	DT	O
treated	VBG	O
with	NN	O
just	CC	O
cellulase.	DT	O
While	NN	O
the	IN	O
invention	DT	O
is	,	O
not	RB	O
limited	)	O
by	NN	O
any	IN	O
particular	VBG	O
mechanism,	IN	O
the	DT	O
effect	NN	O
of	IN	O
an	DT	O
amylase	.	O
of	DT	O
the	JJ	O
invention	NN	O
may	VBN	O
be	IN	O
due	NN	O
to	MD	O
its	VB	O
behavior	DT	O
as	JJR	O
surface-active	NN	O
agents	JJ	O
in	TO	O
pulp	VB	O
suspension.	IN	O
The	NN	O
invention	NNS	O
provides	IN	O
methods	VBN	O
of	TO	O
treating	DT	O
paper	NN	O
and	VBN	O
paper	IN	O
pulp	RB	O
using	.	O
one	IN	O
or	DT	O
more	NN	O
polypeptides	VBZ	O
of	RB	O
the	VBN	O
invention.	IN	O
The	DT	O
polypeptides	JJ	O
of	,	O
the	DT	O
invention	NN	O
can	IN	O
be	DT	O
used	NN	O
in	IN	O
any	DT	O
paper-	NN	O
or	MD	O
pulp-treating	VB	O
method,	JJ	O
which	TO	O
are	PRP$	O
well	NN	O
known	IN	O
in	JJ	O
the	NNS	O
art,	IN	O
see,	NN	O
e.g.,	.	O
U.S.	DT	O
Pat.	NN	O
Nos.	VBZ	O
6,241,849;	NNS	O
6,066,233;	IN	O
5,582,681.	VBG	O
For	NN	O
example,	CC	O
in	NN	O
one	NN	O
aspect,	VBG	O
the	CD	O
invention	CC	O
provides	JJR	O
a	NNS	O
method	IN	O
for	DT	O
deinking	.	O
and	DT	O
decolorizing	NNS	O
a	IN	O
printed	DT	O
paper	NN	O
containing	MD	O
a	VB	O
dye,	VBN	O
comprising	IN	O
pulping	DT	O
a	JJ	O
printed	CC	O
paper	JJ	O
to	,	O
obtain	WDT	O
a	VBP	O
pulp	RB	O
slurry,	VBN	O
and	IN	O
dislodging	DT	O
an	,	O
ink	,	O
from	,	O
the	NNP	O
pulp	.	O
slurry	.	O
in	:	O
the	:	O
presence	.	O
of	IN	O
an	,	O
enzyme	IN	O
of	CD	O
the	,	O
invention	DT	O
(other	NN	O
enzymes	VBZ	O
can	DT	O
also	NN	O
be	IN	O
added).	VBG	O
In	CC	O
another	VBG	O
aspect,	DT	O
the	JJ	O
invention	NN	O
provides	VBG	O
a	DT	O
method	,	O
for	VBG	O
enhancing	VBG	O
the	DT	O
freeness	JJ	O
of	NN	O
pulp,	TO	O
e.g.,	VB	O
pulp	DT	O
made	NN	O
from	,	O
secondary	CC	O
fiber,	VBG	O
by	DT	O
adding	NN	O
an	IN	O
enzymatic	DT	O
mixture	NN	O
comprising	NN	O
an	IN	O
enzyme	DT	O
of	NN	O
the	IN	O
invention	DT	O
(can	NN	O
also	IN	O
include	DT	O
other	NN	O
enzymes,	JJ	O
e.g.,	NNS	O
pectinase	MD	O
enzymes)	RB	O
to	VB	O
the	.	O
pulp	IN	O
and	DT	O
treating	,	O
under	DT	O
conditions	NN	O
to	VBZ	O
cause	DT	O
a	NN	O
reaction	IN	O
to	VBG	O
produce	DT	O
an	NN	O
enzymatically	IN	O
treated	,	O
pulp.	,	O
The	NN	O
freeness	VBN	O
of	IN	O
the	JJ	O
enzymatically	,	O
treated	IN	O
pulp	VBG	O
is	DT	O
increased	JJ	O
from	NN	O
the	VBG	O
initial	DT	O
freeness	NN	O
of	IN	O
the	DT	O
secondary	NN	O
fiber	MD	O
pulp	RB	O
without	VB	O
a	JJ	O
loss	,	O
in	,	O
brightness.	NN	O
Repulping:	)	O
Treatment	TO	O
of	DT	O
Lignocellulosic	NN	O
Materials	CC	O
The	VBG	O
invention	IN	O
also	NNS	O
provides	TO	O
a	VB	O
method	DT	O
for	NN	O
the	TO	O
treatment	VB	O
of	DT	O
lignocellulosic	RB	O
fibers,	JJ	O
wherein	.	O
the	DT	O
fibers	NN	O
are	IN	O
treated	DT	O
with	RB	O
a	JJ	O
polypeptide	NN	O
of	VBZ	O
the	VBN	O
invention,	IN	O
in	DT	O
an	JJ	O
amount	NN	O
which	IN	O
is	DT	O
efficient	JJ	O
for	NN	O
improving	NN	O
the	IN	O
fiber	DT	O
properties.	NN	O
The	IN	O
amylases	.	O
of	:	O
the	NN	O
invention	IN	O
may	JJ	O
also	NNPS	O
be	DT	O
used	NN	O
in	RB	O
the	VBZ	O
production	DT	O
of	NN	O
lignocellulosic	IN	O
materials	DT	O
such	NN	O
as	IN	O
pulp,	JJ	O
paper	,	O
and	VBP	O
cardboard,	DT	O
from	NNS	O
starch	VBP	O
reinforced	VBN	O
waste	IN	O
paper	DT	O
and	NN	O
cardboard,	IN	O
especially	DT	O
where	,	O
repulping	IN	O
occurs	DT	O
at	NN	O
pH	WDT	O
above	VBZ	O
7	JJ	O
and	IN	O
where	VBG	O
amylases	DT	O
can	NN	O
facilitate	.	O
the	DT	O
disintegration	NNS	O
of	IN	O
the	DT	O
waste	NN	O
material	MD	O
through	RB	O
degradation	VB	O
of	VBN	O
the	IN	O
reinforcing	DT	O
starch.	NN	O
The	IN	O
amylases	JJ	O
of	NNS	O
the	JJ	O
invention	IN	O
can	,	O
be	NN	O
useful	CC	O
in	,	O
a	IN	O
process	NN	O
for	VBN	O
producing	NN	O
a	NN	O
papermaking	CC	O
pulp	,	O
from	RB	O
starch-coated	WRB	O
printed	VBG	O
paper.	NNS	O
The	IN	O
process	NNS	O
may	IN	O
be	CD	O
performed	CC	O
as	WRB	O
described	NNS	O
in,	MD	O
e.g.,	VB	O
WO	DT	O
95/14807.	NN	O
An	IN	O
exemplary	DT	O
process	NN	O
comprises	NN	O
disintegrating	IN	O
the	NN	O
paper	IN	O
to	DT	O
produce	NN	O
a	.	O
pulp,	DT	O
treating	NNS	O
with	IN	O
a	DT	O
starch-degrading	NN	O
enzyme	MD	O
before,	VB	O
during	JJ	O
or	IN	O
after	DT	O
the	NN	O
disintegrating,	IN	O
and	VBG	O
separating	DT	O
ink	VBG	O
particles	NN	O
from	IN	O
the	JJ	O
pulp	JJ	O
after	.	O
disintegrating	DT	O
and	NN	O
enzyme	MD	O
treatment.	VB	O
See	VBN	O
also	IN	O
U.S.	NN	O
Pat.	,	O
No.	,	O
6,309,871	NNP	O
and	.	O
other	DT	O
US	JJ	O
patents	NN	O
cited	NNS	O
herein.	VBG	O
Thus,	DT	O
the	NN	O
invention	TO	O
includes	VB	O
a	DT	O
method	,	O
for	VBG	O
enzymatic	IN	O
deinking	DT	O
of	JJ	O
recycled	NN	O
paper	,	O
pulp,	IN	O
wherein	CC	O
the	IN	O
polypeptide	DT	O
is	,	O
applied	CC	O
in	VBG	O
an	NN	O
amount	NNS	O
which	IN	O
is	DT	O
efficient	NN	O
for	IN	O
effective	VBG	O
de-inking	CC	O
of	JJ	O
the	.	O
fiber	NNP	O
surface.	RB	O
Waste	NNP	O
Treatment	.	O
The	.	O
enzymes	CD	O
of	CC	O
the	JJ	O
invention	NNP	O
can	NNS	O
be	VBD	O
used	.	O
in	,	O
a	DT	O
variety	NN	O
of	VBZ	O
other	DT	O
industrial	NN	O
applications,	IN	O
e.g.,	JJ	O
in	NN	O
waste	IN	O
treatment.	JJ	O
For	NN	O
example,	,	O
in	VBP	O
one	DT	O
aspect,	NN	O
the	VBZ	O
invention	VBN	O
provides	IN	O
a	DT	O
solid	NN	O
waste	WDT	O
digestion	VBZ	O
process	JJ	O
using	IN	O
enzymes	JJ	O
of	NN	O
the	IN	O
invention.	DT	O
The	NN	O
methods	.	O
can	NNP	O
comprise	NNP	O
reducing	DT	O
the	NNS	O
mass	IN	O
and	DT	O
volume	NN	O
of	MD	O
substantially	VB	O
untreated	VBN	O
solid	IN	O
waste.	DT	O
Solid	NN	O
waste	IN	O
can	JJ	O
be	JJ	O
treated	,	O
with	,	O
an	IN	O
enzymatic	NN	O
digestive	.	O
process	IN	O
in	,	O
the	IN	O
presence	CD	O
of	,	O
an	DT	O
enzymatic	NN	O
solution	VBZ	O
(including	DT	O
an	JJ	O
enzyme	NN	O
of	NN	O
the	NN	O
invention)	VBG	O
at	NNS	O
a	IN	O
controlled	DT	O
temperature.	.	O
This	DT	O
results	NNS	O
in	MD	O
a	VB	O
reaction	VBG	O
without	DT	O
appreciable	NN	O
bacterial	CC	O
fermentation	NN	O
from	IN	O
added	RB	O
microorganisms.	JJ	O
The	JJ	O
solid	.	O
waste	JJ	O
is	NN	O
converted	MD	O
into	VB	O
a	VBN	O
liquefied	IN	O
waste	DT	O
and	JJ	O
any	NN	O
residual	NN	O
solid	IN	O
waste.	DT	O
The	NN	O
resulting	IN	O
liquefied	DT	O
waste	JJ	O
can	NN	O
be	VBG	O
separated	DT	O
from	NN	O
said	IN	O
any	DT	O
residual	)	O
solidified	IN	O
waste.	DT	O
See	JJ	O
e.g.,	.	O
U.S.	DT	O
Pat.	NNS	O
No.	IN	O
5,709,796.	DT	O
Oral	NN	O
Care	IN	O
Products	JJ	O
The	JJ	O
invention	NN	O
provides	IN	O
oral	VBN	O
care	.	O
product	DT	O
comprising	JJ	O
an	NN	O
amylase	VBZ	O
of	VBN	O
the	IN	O
invention.	DT	O
Exemplary	JJ	O
oral	NN	O
care	CC	O
products	DT	O
include	JJ	O
toothpastes,	JJ	O
dental	.	O
creams,	DT	O
gels	VBG	O
or	JJ	O
tooth	NN	O
powders,	MD	O
odontics,	VB	O
mouth	VBN	O
washes,	IN	O
pre-	VBD	O
or	DT	O
post	JJ	O
brushing	JJ	O
rinse	.	O
formulations,	VB	O
chewing	,	O
gums,	NNP	O
lozenges,	.	O
or	.	O
candy.	.	O
See,	NNP	O
e.g.,	NNP	O
U.S.	VBZ	O
Pat.	DT	O
No.	NN	O
6,264,925.	VBZ	O
Brewing	JJ	O
and	NN	O
Fermenting	NN	O
The	VBG	O
invention	DT	O
provides	NN	O
methods	IN	O
of	DT	O
brewing	.	O
(e.g.,	JJ	O
fermenting)	JJ	O
beer	NN	O
comprising	NNS	O
an	VBP	O
amylase	,	O
of	JJ	O
the	,	O
invention.	NNS	O
In	CC	O
one	JJ	O
exemplary	,	O
process,	,	O
starch-containing	NN	O
raw	,	O
materials	NN	O
are	CC	O
disintegrated	NN	O
and	NN	O
processed	NN	O
to	,	O
form	VBG	O
a	,	O
malt.	,	O
An	CC	O
amylase	.	O
of	,	O
the	,	O
invention	NNP	O
is	.	O
used	.	O
at	.	O
any	NN	O
point	CC	O
in	VBG	O
the	DT	O
fermentation	NN	O
process.	VBZ	O
For	NNS	O
example,	IN	O
amylases	NN	O
of	,	O
the	)	O
invention	NN	O
can	VBG	O
be	DT	O
used	NN	O
in	IN	O
the	DT	O
processing	.	O
of	IN	O
barley	CD	O
malt.	JJ	O
The	,	O
major	JJ	O
raw	JJ	O
material	NNS	O
of	VBP	O
beer	VBN	O
brewing	CC	O
is	VBN	O
barley	TO	O
malt.	VB	O
This	DT	O
can	.	O
be	DT	O
a	NN	O
three	IN	O
stage	DT	O
process.	NN	O
First,	VBZ	O
the	VBN	O
barley	IN	O
grain	DT	O
can	NN	O
be	IN	O
steeped	DT	O
to	NN	O
increase	.	O
water	IN	O
content,	,	O
e.g.,	NNS	O
to	IN	O
around	DT	O
about	NN	O
40%.	MD	O
Second,	VB	O
the	VBN	O
grain	IN	O
can	DT	O
be	NN	O
germinated	IN	O
by	NN	O
incubation	.	O
at	DT	O
15-25°	JJ	O
C.	JJ	O
for	NN	O
3	IN	O
to	NN	O
6	NN	O
days	VBZ	O
when	JJ	O
enzyme	.	O
synthesis	DT	O
is	MD	O
stimulated	VB	O
under	DT	O
the	CD	O
control	NN	O
of	.	O
gibberellins.	,	O
During	DT	O
this	NN	O
time	NN	O
amylase	MD	O
levels	VB	O
rise	VBN	O
significantly.	TO	O
In	VB	O
one	NN	O
aspect,	,	O
amylases	,	O
of	TO	O
the	IN	O
invention	RB	O
are	.	O
added	,	O
at	DT	O
this	NN	O
(or	MD	O
any	VB	O
other)	VBN	O
stage	IN	O
of	NN	O
the	IN	O
process.	JJ	O
The	NNP	O
action	IN	O
of	CD	O
the	TO	O
amylase	CD	O
results	NNS	O
in	WRB	O
an	JJ	O
increase	NN	O
in	VBZ	O
fermentable	VBN	O
reducing	IN	O
sugars.	DT	O
This	NN	O
can	IN	O
be	.	O
expressed	IN	O
as	DT	O
the	NN	O
diastatic	NN	O
power,	NNS	O
DP,	VBP	O
which	.	O
can	IN	O
rise	CD	O
from	,	O
around	NNS	O
80	IN	O
to	DT	O
190	NN	O
in	VBP	O
5	VBN	O
days	IN	O
at	DT	O
12°	CC	O
C.	DT	O
Amylases	)	O
of	NN	O
the	IN	O
invention	DT	O
can	.	O
be	DT	O
used	NN	O
in	IN	O
any	DT	O
beer	NN	O
producing	NNS	O
process,	IN	O
as	DT	O
described,	NN	O
e.g.,	IN	O
in	JJ	O
U.S.	VBG	O
Pat.	.	O
Nos.	DT	O
5,762,991;	MD	O
5,536,650;	VB	O
5,405,624;	VBN	O
5,021,246;	IN	O
4,788,066.	DT	O
Other	JJ	O
Industrial	,	O
Applications	,	O
The	WDT	O
invention	MD	O
also	VB	O
includes	IN	O
a	RB	O
method	CD	O
of	TO	O
increasing	CD	O
the	IN	O
flow	CD	O
of	NNS	O
production	IN	O
fluids	CD	O
from	NNP	O
a	NNP	O
subterranean	IN	O
formation	DT	O
by	NN	O
removing	MD	O
a	VB	O
viscous,	VBN	O
starch-containing,	IN	O
damaging	DT	O
fluid	NN	O
formed	VBG	O
during	,	O
production	IN	O
operations	,	O
and	,	O
found	IN	O
within	NNP	O
the	.	O
subterranean	.	O
formation	:	O
which	:	O
surrounds	:	O
a	:	O
completed	.	O
well	JJ	O
bore	NNP	O
comprising	NNP	O
allowing	DT	O
production	NN	O
fluids	RB	O
to	VBZ	O
flow	DT	O
from	NN	O
the	IN	O
well	VBG	O
bore;	DT	O
reducing	NN	O
the	IN	O
flow	NN	O
of	NNS	O
production	IN	O
fluids	DT	O
from	JJ	O
the	NN	O
formation	IN	O
below	VBG	O
expected	DT	O
flow	,	O
rates;	,	O
formulating	JJ	O
an	NN	O
enzyme	VBD	O
treatment	IN	O
by	NN	O
blending	NNS	O
together	CC	O
an	VBN	O
aqueous	IN	O
fluid	DT	O
and	JJ	O
a	NN	O
polypeptide	WDT	O
of	VBZ	O
the	DT	O
invention;	VBN	O
pumping	RB	O
the	RB	O
enzyme	VBG	O
treatment	VBG	O
to	NN	O
a	NNS	O
desired	TO	O
location	VB	O
within	IN	O
the	DT	O
well	NN	O
bore;	:	O
allowing	VBG	O
the	DT	O
enzyme	NN	O
treatment	IN	O
to	NN	O
degrade	NNS	O
the	IN	O
viscous,	DT	O
starch-containing,	NN	O
damaging	IN	O
fluid,	VBN	O
whereby	NN	O
the	:	O
fluid	VBG	O
can	DT	O
be	NN	O
removed	NN	O
from	IN	O
the	VBG	O
subterranean	RB	O
formation	DT	O
to	JJ	O
the	NN	O
well	CC	O
surface;	DT	O
and	NN	O
wherein	IN	O
the	DT	O
enzyme	:	O
treatment	VBG	O
is	DT	O
effective	NN	O
to	NN	O
attack	TO	O
the	DT	O
alpha	VBN	O
glucosidic	NN	O
linkages	IN	O
in	DT	O
the	NN	O
starch-containing	:	O
fluid.	VBG	O
In	DT	O
summary,	NN	O
the	NN	O
invention	TO	O
provides	VB	O
enzymes	DT	O
and	,	O
processes	,	O
for	JJ	O
hydrolyzing	,	O
liquid	WRB	O
(liquefied)	DT	O
and	NN	O
granular	MD	O
starch.	VB	O
Such	VBN	O
starch	IN	O
can	DT	O
be	JJ	O
derived	NN	O
from	TO	O
any	DT	O
source,	NN	O
e.g.,	:	O
corn,	CC	O
wheat,	VB	O
milo,	DT	O
sorghum,	NN	O
rye	NN	O
or	VBZ	O
bulgher.	JJ	O
The	TO	O
invention	VB	O
applies	DT	O
to	NN	O
any	JJ	O
grain	NNS	O
starch	IN	O
source	DT	O
which	JJ	O
is	.	O
useful	IN	O
in	,	O
liquefaction,	DT	O
e.g.,	NN	O
any	VBZ	O
other	NNS	O
grain	CC	O
or	NNS	O
vegetable	IN	O
source	VBG	O
known	NN	O
to	)	O
produce	CC	O
starch	JJ	O
suitable	.	O
for	JJ	O
liquefaction.	NN	O
The	MD	O
methods	VB	O
of	VBN	O
the	IN	O
invention	DT	O
comprise	,	O
liquefying	,	O
starch	,	O
from	,	O
any	,	O
natural	,	O
material,	NN	O
such	CC	O
as	.	O
rice,	DT	O
germinated	NN	O
rice,	NNS	O
corn,	TO	O
barley,	DT	O
milo,	NN	O
wheat,	NN	O
legumes	NN	O
and	WDT	O
sweet	VBZ	O
potato.	JJ	O
The	IN	O
liquefying	,	O
process	,	O
can	DT	O
substantially	JJ	O
hydrolyze	NN	O
the	CC	O
starch	JJ	O
to	NN	O
produce	VBN	O
a	TO	O
syrup.	VB	O
The	NN	O
temperature	JJ	O
range	IN	O
of	.	O
the	DT	O
liquefaction	NNS	O
can	IN	O
be	DT	O
any	NN	O
liquefaction	NN	O
temperature	VBG	O
which	NN	O
is	IN	O
known	DT	O
to	JJ	O
be	,	O
effective	JJ	O
in	IN	O
liquefying	,	O
starch.	VBN	O
For	,	O
example,	,	O
the	,	O
temperature	,	O
of	,	O
the	NNS	O
starch	CC	O
can	JJ	O
be	.	O
between	DT	O
about	VBG	O
80°	NN	O
C.	MD	O
to	RB	O
about	VB	O
115°	DT	O
C.,	NN	O
between	TO	O
about	VB	O
100°	DT	O
C.	.	O
to	DT	O
about	NN	O
110°	NN	O
C.,	IN	O
and	DT	O
from	NN	O
about	MD	O
105°	VB	O
C.	DT	O
to	NN	O
about	NN	O
108°	WDT	O
C.	VBZ	O
In	VBN	O
one	TO	O
aspect,	VB	O
the	JJ	O
invention	IN	O
includes	VBG	O
a	.	O
method	IN	O
for	,	O
liquefying	DT	O
a	NN	O
starch	IN	O
containing	DT	O
composition	NN	O
comprising	MD	O
contacting	VB	O
the	IN	O
starch	RB	O
with	CD	O
a	NNP	O
polypeptide	TO	O
of	IN	O
the	CD	O
invention	,	O
(e.g.,	IN	O
a	IN	O
purified	CD	O
polypeptide	NNP	O
selected	TO	O
from	IN	O
polypeptides	CD	O
having	,	O
an	CC	O
amino	IN	O
acid	IN	O
sequence	CD	O
selected	NNP	O
from	TO	O
the	IN	O
group	CD	O
consisting	NNP	O
of:	IN	O
SEQ	CD	O
ID	,	O
NO:2;	DT	O
variants	NN	O
having	VBZ	O
at	DT	O
least	NN	O
about	IN	O
50%	VBG	O
homology	DT	O
to	NN	O
at	VBG	O
least	NN	O
one	VBG	O
of	VBG	O
SEQ	DT	O
ID	NN	O
NO:2,	IN	O
over	DT	O
a	NN	O
region	IN	O
of	DT	O
at	NN	O
least	,	O
about	DT	O
100	JJ	O
residues,	NN	O
as	VBN	O
determined	IN	O
by	NNS	O
analysis	VBG	O
with	DT	O
a	NN	O
sequence	NN	O
comparison	NN	O
algorithm	VBN	O
or	IN	O
by	DT	O
visual	NN	O
inspection;	VBG	O
sequences	:	O
complementary	NNP	O
to	NNP	O
SEQ	:	O
ID	NNS	O
NO:2;	VBG	O
and	IN	O
sequences	JJS	O
complementary	IN	O
to	NN	O
variants	NN	O
having	TO	O
at	IN	O
least	JJS	O
about	CD	O
50%	IN	O
homology	NNP	O
to	NNP	O
SEQ	,	O
ID	IN	O
NO:2	DT	O
over	NN	O
a	IN	O
region	IN	O
of	JJS	O
at	IN	O
least	CD	O
about	,	O
100	IN	O
residues,	VBN	O
as	IN	O
determined	NN	O
by	IN	O
analysis	DT	O
with	NN	O
a	NN	O
sequence	NN	O
comparison	CC	O
algorithm	IN	O
or	JJ	O
by	:	O
visual	NNS	O
inspection;	VBP	O
and	TO	O
polypeptides	NNP	O
having	NNP	O
at	:	O
least	CC	O
10	NNS	O
consecutive	VBP	O
amino	TO	O
acids	NNS	O
of	VBG	O
a	IN	O
polypeptide	JJS	O
having	IN	O
a	NN	O
sequence	NN	O
selected	TO	O
from	NNP	O
the	NNP	O
group	NNP	O
consisting	IN	O
of	DT	O
SEQ	NN	O
ID	IN	O
NO:2).	IN	O
In	JJS	O
one	IN	O
aspect,	CD	O
the	,	O
polypeptide	IN	O
is	VBN	O
set	IN	O
forth	NN	O
in	IN	O
SEQ	DT	O
ID	NN	O
NO:2.	NN	O
The	NN	O
starch	CC	O
may	IN	O
be	JJ	O
from	:	O
a	CC	O
material	NNS	O
selected	VBG	O
from	IN	O
rice,	JJS	O
germinated	CD	O
rice,	JJ	O
corn,	NN	O
barley,	NNS	O
wheat,	IN	O
legumes	DT	O
and	NN	O
sweet	VBG	O
potato.	DT	O
A	NN	O
glucose	VBN	O
syrup	IN	O
produced	DT	O
by	NN	O
the	VBG	O
method	IN	O
of	NNP	O
the	NNP	O
invention	.	O
is	IN	O
included	CD	O
herein	,	O
and	DT	O
is	NN	O
described	VBZ	O
in	VBN	O
the	NN	O
examples.	IN	O
Such	NNP	O
a	NNP	O
syrup	.	O
can	DT	O
be	NN	O
a	MD	O
maltose	VB	O
syrup,	IN	O
a	DT	O
glucose	NN	O
syrup,	VBN	O
or	IN	O
a	,	O
combination	VBN	O
thereof.	,	O
In	,	O
particular,	,	O
the	,	O
syrups	NNS	O
produced	CC	O
using	JJ	O
the	.	O
amylases	DT	O
of	JJ	O
the	NN	O
invention	VBN	O
there	IN	O
is	DT	O
a	NN	O
higher	IN	O
level	DT	O
of	NN	O
DP2	VBZ	O
fraction	VBN	O
and	NN	O
a	CC	O
higher	VBZ	O
level	VBN	O
of	IN	O
DP3	DT	O
(maltotriose	.	O
and/or	JJ	O
panose)	DT	O
and	NN	O
less	MD	O
of	VB	O
the	DT	O
greater	JJ	O
than	,	O
DP7	DT	O
fragments	JJ	O
as	,	O
compared	CC	O
to	DT	O
the	NN	O
syrups	.	O
produced	IN	O
by	,	O
commercial	DT	O
enzymes.	NNS	O
This	VBD	O
is	VBG	O
consistent	DT	O
with	NNS	O
the	IN	O
liquefaction	DT	O
profile	NN	O
since	EX	O
less	VBZ	O
of	DT	O
the	JJR	O
large	NN	O
fragments	IN	O
are	NNP	O
in	NN	O
the	CC	O
invention	DT	O
liquefied	JJR	O
syrups.	NN	O
The	IN	O
invention	NNP	O
also	JJ	O
provides	NNS	O
a	)	O
method	CC	O
for	JJR	O
removing	IN	O
starch	DT	O
containing	JJR	O
stains	IN	O
from	NNP	O
a	NNS	O
material	IN	O
comprising	VBN	O
contacting	TO	O
the	DT	O
material	NNS	O
with	VBN	O
a	IN	O
polypeptide	JJ	O
of	.	O
the	DT	O
invention.	VBZ	O
In	JJ	O
one	IN	O
aspect,	DT	O
the	NN	O
invention	NN	O
provides	IN	O
a	JJR	O
method	IN	O
for	DT	O
washing	JJ	O
an	NNS	O
object	VBP	O
comprising	IN	O
contacting	DT	O
the	NN	O
object	VBD	O
with	.	O
a	DT	O
polypeptide	NN	O
of	RB	O
the	VBZ	O
invention	DT	O
under	NN	O
conditions	IN	O
sufficient	VBG	O
for	NN	O
washing.	VBG	O
A	NNS	O
polypeptide	IN	O
of	DT	O
the	NN	O
invention	VBG	O
may	VBG	O
be	DT	O
included	NN	O
as	IN	O
a	DT	O
detergent	NN	O
additive	IN	O
for	DT	O
example.	.	O
The	IN	O
invention	CD	O
also	,	O
includes	DT	O
a	NN	O
method	VBZ	O
for	DT	O
textile	NN	O
desizing	IN	O
comprising	VBG	O
contacting	DT	O
the	JJ	O
textile	NN	O
with	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
under	IN	O
conditions	DT	O
sufficient	NN	O
for	IN	O
desizing.	NNS	O
The	JJ	O
invention	IN	O
also	.	O
provides	DT	O
a	NN	O
method	IN	O
of	DT	O
reducing	NN	O
the	MD	O
staling	VB	O
of	VBN	O
bakery	IN	O
products	DT	O
comprising	NN	O
addition	NN	O
of	IN	O
a	.	O
polypeptide	DT	O
of	NN	O
the	RB	O
invention	VBZ	O
to	DT	O
the	NN	O
bakery	IN	O
product,	NN	O
prior	VBG	O
to	VBG	O
baking.	VBG	O
The	DT	O
invention	NN	O
also	IN	O
provides	DT	O
a	NN	O
method	IN	O
for	DT	O
the	NN	O
treatment	IN	O
of	NNS	O
lignocellulosic	JJ	O
fibers,	IN	O
wherein	.	O
the	DT	O
fibers	NN	O
are	RB	O
treated	VBZ	O
with	DT	O
a	NN	O
polypeptide	IN	O
of	VBG	O
the	DT	O
invention,	NN	O
in	IN	O
an	NN	O
amount	NNS	O
which	VBG	O
is	NN	O
efficient	IN	O
for	DT	O
improving	NN	O
the	IN	O
fiber	DT	O
properties.	NN	O
The	TO	O
invention	DT	O
includes	NN	O
a	,	O
method	RB	O
for	TO	O
enzymatic	.	O
deinking	DT	O
of	NN	O
recycled	RB	O
paper	VBZ	O
pulp,	DT	O
wherein	NN	O
the	IN	O
polypeptide	DT	O
is	NN	O
applied	IN	O
in	JJ	O
an	,	O
amount	VBP	O
which	DT	O
is	NNS	O
efficient	VBP	O
for	VBN	O
effective	IN	O
deinking	DT	O
of	NN	O
the	IN	O
fiber	DT	O
surface.	,	O
Any	IN	O
of	DT	O
the	NN	O
methods	WDT	O
described	VBZ	O
herein	JJ	O
include	IN	O
the	VBG	O
possibility	DT	O
of	NN	O
the	.	O
addition	DT	O
of	NN	O
a	VBZ	O
second	DT	O
alpha	NN	O
amylase	IN	O
or	JJ	O
a	NN	O
beta	IN	O
amylase	JJ	O
or	NN	O
a	,	O
combination	VBP	O
thereof.	DT	O
Commercial	NN	O
amylases	VBZ	O
or	VBN	O
other	IN	O
enzymes	DT	O
suitable	NN	O
for	WDT	O
use	VBZ	O
in	JJ	O
combination	IN	O
with	JJ	O
an	NN	O
enzyme	IN	O
of	DT	O
the	NN	O
invention	.	O
are	DT	O
known	IN	O
to	DT	O
those	NNS	O
of	VBD	O
skill	JJ	O
in	VBP	O
the	DT	O
art.	NN	O
The	IN	O
invention	DT	O
also	NN	O
includes	IN	O
a	DT	O
method	JJ	O
of	JJ	O
increasing	NN	O
the	CC	O
flow	DT	O
of	JJ	O
production	NN	O
fluids	CC	O
from	DT	O
a	NN	O
subterranean	.	O
formation	JJ	O
by	NNS	O
removing	CC	O
a	JJ	O
viscous,	NNS	O
starch-containing,	JJ	O
damaging	IN	O
fluid	NN	O
formed	IN	O
during	NN	O
production	IN	O
operations	DT	O
and	NN	O
found	IN	O
within	DT	O
the	NN	O
subterranean	VBP	O
formation	VBN	O
which	TO	O
surrounds	DT	O
a	IN	O
completed	NN	O
well	IN	O
bore	DT	O
comprising	.	O
allowing	DT	O
production	NN	O
fluids	RB	O
to	VBZ	O
flow	DT	O
from	NN	O
the	IN	O
well	VBG	O
bore;	DT	O
reducing	NN	O
the	IN	O
flow	NN	O
of	NNS	O
production	IN	O
fluids	DT	O
from	JJ	O
the	NN	O
formation	IN	O
below	VBG	O
expected	DT	O
flow	,	O
rates;	,	O
formulating	JJ	O
an	NN	O
enzyme	VBD	O
treatment	IN	O
by	NN	O
blending	NNS	O
together	CC	O
an	VBN	O
aqueous	IN	O
fluid	DT	O
and	JJ	O
a	NN	O
polypeptide	WDT	O
of	VBZ	O
the	DT	O
invention;	VBN	O
pumping	RB	O
the	RB	O
enzyme	VBG	O
treatment	VBG	O
to	NN	O
a	NNS	O
desired	TO	O
location	VB	O
within	IN	O
the	DT	O
well	NN	O
bore;	:	O
allowing	VBG	O
the	DT	O
enzyme	NN	O
treatment	IN	O
to	NN	O
degrade	NNS	O
the	IN	O
viscous,	DT	O
starch-containing,	NN	O
damaging	IN	O
fluid,	VBN	O
whereby	NN	O
the	:	O
fluid	VBG	O
can	DT	O
be	NN	O
removed	NN	O
from	IN	O
the	VBG	O
subterranean	RB	O
formation	DT	O
to	JJ	O
the	NN	O
well	CC	O
surface;	DT	O
and	NN	O
wherein	IN	O
the	DT	O
enzyme	:	O
treatment	VBG	O
is	DT	O
effective	NN	O
to	NN	O
attack	TO	O
the	DT	O
alpha	VBN	O
glucosidic	NN	O
linkages	IN	O
in	DT	O
the	NN	O
starch-containing	:	O
fluid.	VBG	O
The	DT	O
present	NN	O
invention	NN	O
exploits	TO	O
the	VB	O
unique	DT	O
catalytic	,	O
properties	,	O
of	JJ	O
enzymes.	,	O
Whereas	WRB	O
the	DT	O
use	NN	O
of	MD	O
biocatalysts	VB	O
(i.e.,	VBN	O
purified	IN	O
or	DT	O
crude	JJ	O
enzymes,	NN	O
non-living	TO	O
or	DT	O
living	NN	O
cells)	:	O
in	CC	O
chemical	VB	O
transformations	DT	O
normally	NN	O
requires	NN	O
the	VBZ	O
identification	JJ	O
of	TO	O
a	VB	O
particular	DT	O
biocatalyst	NN	O
that	JJ	O
reacts	NNS	O
with	IN	O
a	DT	O
specific	JJ	O
starting	.	O
compound,	DT	O
the	JJ	O
present	NN	O
invention	VBZ	O
uses	DT	O
selected	JJ	O
biocatalysts	JJ	O
and	NNS	O
reaction	IN	O
conditions	.	O
that	IN	O
are	DT	O
specific	NN	O
for	IN	O
functional	NNS	O
groups	,	O
that	VBD	O
are	CC	O
present	JJ	O
in	,	O
many	JJ	O
starting	CC	O
compounds.	JJ	O
Each	)	O
biocatalyst	IN	O
is	NN	O
specific	NNS	O
for	RB	O
one	VBZ	O
functional	DT	O
group,	NN	O
or	IN	O
several	DT	O
related	JJ	O
functional	NN	O
groups,	WDT	O
and	VBZ	O
can	IN	O
react	DT	O
with	JJ	O
many	VBG	O
starting	,	O
compounds	DT	O
containing	JJ	O
this	NN	O
functional	VBZ	O
group.	VBN	O
The	NNS	O
biocatalytic	CC	O
reactions	NN	O
produce	NNS	O
a	WDT	O
population	VBP	O
of	JJ	O
derivatives	IN	O
from	JJ	O
a	NNS	O
single	WDT	O
starting	VBP	O
compound.	JJ	O
These	IN	O
derivatives	JJ	O
can	VBG	O
be	.	O
subjected	DT	O
to	NN	O
another	VBZ	O
round	JJ	O
of	IN	O
biocatalytic	CD	O
reactions	JJ	O
to	,	O
produce	CC	O
a	JJ	O
second	JJ	O
population	JJ	O
of	,	O
derivative	CC	O
compounds.	MD	O
Thousands	VB	O
of	IN	O
variations	JJ	O
of	VBG	O
the	NNS	O
original	VBG	O
compound	DT	O
can	JJ	O
be	.	O
produced	DT	O
with	JJ	O
each	NNS	O
iteration	VBP	O
of	DT	O
biocatalytic	NN	O
derivatization.	IN	O
Enzymes	NNS	O
react	IN	O
at	DT	O
specific	JJ	O
sites	NN	O
of	.	O
a	DT	O
starting	NNS	O
compound	MD	O
without	VB	O
affecting	VBN	O
the	TO	O
rest	DT	O
of	NN	O
the	IN	O
molecule,	JJ	O
a	NNS	O
process	TO	O
which	VB	O
is	DT	O
very	JJ	O
difficult	NN	O
to	IN	O
achieve	JJ	O
using	.	O
traditional	NNS	O
chemical	IN	O
methods.	NNS	O
This	IN	O
high	DT	O
degree	JJ	O
of	NN	O
biocatalytic	MD	O
specificity	VB	O
provides	VBN	O
the	IN	O
means	DT	O
to	NN	O
identify	IN	O
a	JJ	O
single	.	O
active	NNS	O
compound	VBP	O
within	IN	O
the	JJ	O
library.	NNS	O
The	IN	O
library	DT	O
is	VBG	O
characterized	NN	O
by	IN	O
the	VBG	O
series	DT	O
of	NN	O
biocatalytic	IN	O
reactions	DT	O
used	,	O
to	DT	O
produce	NN	O
it,	WDT	O
a	VBZ	O
so-called	RB	O
“biosynthetic	JJ	O
history”.	TO	O
Screening	VB	O
the	VBG	O
library	JJ	O
for	NN	O
biological	.	O
activities	DT	O
and	JJ	O
tracing	NN	O
the	IN	O
biosynthetic	JJ	O
history	NN	O
identifies	VBZ	O
the	DT	O
specific	NNS	O
reaction	TO	O
sequence	VB	O
producing	DT	O
the	JJ	O
active	JJ	O
compound.	NN	O
The	IN	O
reaction	DT	O
sequence	.	O
is	DT	O
repeated	NN	O
and	VBZ	O
the	VBN	O
structure	IN	O
of	DT	O
the	NN	O
synthesized	IN	O
compound	JJ	O
determined.	NNS	O
This	VBN	O
mode	TO	O
of	VB	O
identification,	,	O
unlike	DT	O
other	JJ	O
synthesis	JJ	O
and	.	O
screening	VBG	O
approaches,	DT	O
does	NN	O
not	IN	O
require	JJ	O
immobilization	NNS	O
technologies,	CC	O
and	VBG	O
compounds	DT	O
can	JJ	O
be	NN	O
synthesized	NNS	O
and	DT	O
tested	JJ	O
free	NN	O
in	NN	O
solution	VBG	O
using	DT	O
virtually	JJ	O
any	.	O
type	DT	O
of	NN	O
screening	NN	O
assay.	VBZ	O
It	VBN	O
is	CC	O
important	DT	O
to	NN	O
note,	IN	O
that	DT	O
the	VBN	O
high	NN	O
degree	.	O
of	DT	O
specificity	NN	O
of	IN	O
enzyme	,	O
reactions	IN	O
on	JJ	O
functional	NN	O
groups	CC	O
allows	NN	O
for	,	O
the	VBZ	O
“tracking”	RB	O
of	VB	O
specific	NN	O
enzymatic	,	O
reactions	CC	O
that	NNS	O
make	MD	O
up	VB	O
the	VBN	O
biocatalytically	CC	O
produced	VBN	O
library.	JJ	O
Many	IN	O
of	NN	O
the	VBG	O
procedural	RB	O
steps	DT	O
are	NN	O
performed	IN	O
using	VBG	O
robotic	.	O
automation	PRP	O
enabling	VBZ	O
the	JJ	O
execution	TO	O
of	,	O
many	IN	O
thousands	DT	O
of	JJ	O
biocatalytic	NN	O
reactions	IN	O
and	NN	O
screening	IN	O
assays	JJ	O
per	NNS	O
day	IN	O
as	JJ	O
well	NNS	O
as	VBZ	O
ensuring	IN	O
a	DT	O
high	NN	O
level	IN	O
of	JJ	O
accuracy	JJ	O
and	NNS	O
reproducibility.	WDT	O
As	VBP	O
a	RP	O
result,	DT	O
a	RB	O
library	VBN	O
of	.	O
derivative	JJ	O
compounds	IN	O
can	DT	O
be	JJ	O
produced	NNS	O
in	VBP	O
a	VBN	O
matter	VBG	O
of	JJ	O
weeks	NN	O
which	VBG	O
would	DT	O
take	NN	O
years	IN	O
to	JJ	O
produce	NNS	O
using	IN	O
current	JJ	O
chemical	NNS	O
methods.	CC	O
(For	VBG	O
further	NNS	O
teachings	RB	O
on	NN	O
modification	RB	O
of	RB	O
molecules,	IN	O
including	VBG	O
small	DT	O
molecules,	JJ	O
see,	NN	O
e.g.,	IN	O
PCT/US94/09174).	NN	O
The	CC	O
invention	.	O
will	IN	O
be	DT	O
further	,	O
described	DT	O
with	NN	O
reference	IN	O
to	JJ	O
the	NNS	O
following	MD	O
examples;	VB	O
however,	VBN	O
it	IN	O
is	DT	O
to	NN	O
be	IN	O
understood	NNS	O
that	WDT	O
the	MD	O
invention	VB	O
is	NNS	O
not	TO	O
limited	VB	O
to	VBG	O
such	JJ	O
examples.	NN	O
EXAMPLES	.	O
Example	IN	O
1	JJ	O
Identification	NNS	O
and	IN	O
Characterization	NN	O
of	IN	O
Thermostable	,	O
α-Amylases	VBG	O
The	JJ	O
following	,	O
example	,	O
describes	,	O
an	.	O
exemplary	DT	O
method	NN	O
for	MD	O
determining	VB	O
if	JJ	O
a	VBN	O
polypeptide	IN	O
is	NN	O
within	TO	O
the	DT	O
scope	JJ	O
of	:	O
the	,	O
invention.	PRP	O
This	VBZ	O
example	TO	O
describes	VB	O
the	JJ	O
identification	IN	O
of	DT	O
novel	NN	O
amylases.	VBZ	O
A	RB	O
screening	VBN	O
program	TO	O
can	JJ	O
be	.	O
carried	NNP	O
out	NNP	O
under	CD	O
neutral	NNP	O
and/or	CC	O
low	NNP	O
pH	IN	O
conditions.	NNP	O
DNA	VBZ	O
libraries	DT	O
generated	JJ	O
from	NN	O
low	VBZ	O
pH	DT	O
samples	JJ	O
can	NN	O
be	IN	O
targeted	VBG	O
for	IN	O
discovery.	DT	O
Biochemical	NN	O
Studies	VBZ	O
Biochemical	IN	O
analysis	DT	O
of	NN	O
genomic	IN	O
clones	DT	O
can	.	O
show	DT	O
if	NN	O
any	VBZ	O
have	DT	O
pH	NN	O
optima	IN	O
of	JJ	O
less	.	O
than	DT	O
pH	JJ	O
6.	NN	O
Lysates	MD	O
of	VB	O
these	VBN	O
genomic	RP	O
clones	IN	O
can	JJ	O
be	NN	O
tested	JJ	O
for	NN	O
thermal	.	O
tolerance	NN	O
by	NNS	O
incubation	VBD	O
at	IN	O
70°	JJ	O
C.,	NN	O
80°	NNS	O
C.,	MD	O
90°	VB	O
C.	VBN	O
or	IN	O
100°	.	O
C.	JJ	O
for	NNP	O
10	NNP	O
minutes	NN	O
and	IN	O
measurement	JJ	O
of	NNS	O
residual	MD	O
activity	VB	O
at	IN	O
pH	DT	O
4.5.	VBP	O
Those	VBN	O
clones	NN	O
retaining	IN	O
>50%	JJR	O
activity	IN	O
after	NN	O
heat	.	O
treatment	NNS	O
at	IN	O
80°	DT	O
C.	JJ	O
can	NNS	O
be	MD	O
chosen	VB	O
for	VBN	O
further	IN	O
analysis.	JJ	O
These	NN	O
clones	IN	O
can	NN	O
be	IN	O
incubated	CD	O
at	,	O
90°	CD	O
C.	,	O
for	CD	O
10	NNP	O
minutes	CC	O
at	CD	O
pH	NNP	O
6.0	IN	O
and	CD	O
4.5	NNS	O
and	CC	O
tested	NN	O
for	IN	O
residual	JJ	O
activity	NN	O
at	IN	O
pH	NN	O
4.5.	.	O
Thermal	DT	O
activity	NNS	O
of	VBG	O
the	NN	O
clones	NN	O
with	IN	O
residual	NN	O
activity	NN	O
after	IN	O
heat	CD	O
treatment	NNP	O
at	MD	O
90°	VB	O
C.	VBN	O
at	IN	O
pH	JJ	O
4.5	.	O
can	DT	O
be	NNS	O
measured	MD	O
at	VB	O
room	VBN	O
temperature,	IN	O
70°	CD	O
C.	NNP	O
and	IN	O
90°	CD	O
C.	NNS	O
at	IN	O
pH	NN	O
4.5.	CD	O
Example	CC	O
2	CD	O
Thermostable	CC	O
Amylases	VBD	O
Active	IN	O
at	JJ	O
Alkaline	NN	O
pH	IN	O
The	NN	O
following	.	O
example	JJ	O
describes	NN	O
an	IN	O
exemplary	DT	O
method	NNS	O
for	IN	O
determining	JJ	O
if	NN	O
a	IN	O
polypeptide	NN	O
is	NN	O
within	IN	O
the	CD	O
scope	NNP	O
of	IN	O
the	RB	O
invention,	CD	O
e.g.,	MD	O
is	VB	O
a	VBN	O
thermostable	IN	O
amylase.	NN	O
Biochemical	,	O
Studies	CD	O
Soluble,	NNP	O
active	CC	O
protein	CD	O
can	NNP	O
be	IN	O
successfully	NN	O
purified	.	O
to	RB	O
homogeneity	CD	O
and	JJ	O
measured	NNS	O
at	VBP	O
pH	IN	O
8	NNP	O
and	VBP	O
pH	DT	O
10	JJ	O
(40°	NN	O
C.	VBZ	O
and	DT	O
50°	JJ	O
C.)	NN	O
using	IN	O
2%	VBG	O
starch	IN	O
in	DT	O
buffer.	NN	O
Stability	VBZ	O
Activity	IN	O
can	DT	O
be	NN	O
measured	IN	O
at	DT	O
pH	,	O
8	,	O
and	VBZ	O
50°	DT	O
C.	JJ	O
after	.	O
a	JJ	O
30	NNP	O
minute	,	O
incubation	JJ	O
at	NN	O
50°	MD	O
C.	VB	O
in	RB	O
the	VBN	O
presence	TO	O
of	NN	O
various	CC	O
components	VBN	O
of	IN	O
an	NN	O
ADW	CD	O
formulation;	CC	O
pH	VB	O
8,	CD	O
pH	CD	O
10.8,	NNP	O
ADW	CC	O
solution	CD	O
(with	)	O
bleach)	VBG	O
and	NN	O
ADW	NN	O
solution	IN	O
(without	.	O
bleach).	NN	O
The	NNP	O
measured	MD	O
activity	VB	O
after	VBN	O
the	IN	O
incubation	NN	O
can	CD	O
be	CC	O
expressed	CD	O
as	NNP	O
a	IN	O
percentage	DT	O
of	CD	O
the	NN	O
original	NN	O
activity.	IN	O
Wash	CD	O
Tests	NNP	O
Wash	IN	O
tests	DT	O
using	NN	O
starch	IN	O
coated	JJ	O
slides	NNS	O
can	IN	O
be	DT	O
carried	NNP	O
out	:	O
to	CC	O
gauge	,	O
the	NN	O
performance	,	O
of	NNP	O
each	NN	O
of	IN	O
the	)	O
purified	CC	O
enzymes	NNP	O
as	NN	O
compared	IN	O
to	.	O
the	DT	O
commercial	VBN	O
amylase.	NN	O
The	IN	O
spaghetti	DT	O
starch	NN	O
coated	MD	O
slides	VB	O
can	VBN	O
be	IN	O
prepared	DT	O
according	NN	O
to	IN	O
manufacturer's	DT	O
protocol.	JJ	O
Two	.	O
pre-weighed	JJ	O
starch	NNS	O
coated	VBP	O
slides	NNS	O
can	VBG	O
be	NN	O
placed	VBD	O
back	NNS	O
to	MD	O
back	VB	O
in	VBN	O
a	IN	O
50	TO	O
mL	VB	O
conical	DT	O
tube	NN	O
and	IN	O
25	DT	O
mL	IN	O
of	DT	O
ADW	JJ	O
solution,	NNS	O
+/−enzyme	IN	O
were	VBN	O
added	TO	O
per	DT	O
tube.	JJ	O
The	.	O
tubes	DT	O
can	NNS	O
be	VBP	O
incubated	VBN	O
for	NNS	O
20	MD	O
minutes	VB	O
at	VBN	O
50°	VBG	O
C.	TO	O
with	POS	O
gentle	.	O
rotation	CD	O
on	JJ	O
a	NN	O
vertical	VBD	O
carousel.	NNS	O
Following	MD	O
the	VB	O
incubation	VBN	O
period,	RB	O
the	TO	O
slides	VB	O
are	IN	O
immediately	DT	O
rinsed	CD	O
in	NN	O
water	JJ	O
and	NN	O
oven	CC	O
dried	CD	O
overnight.	NN	O
Trials	IN	O
can	NNP	O
be	,	O
run	EX	O
in	VBD	O
duplicate	VBN	O
and	IN	O
a	.	O
commercial	DT	O
enzyme	NNS	O
can	MD	O
be	VB	O
run	VBN	O
as	IN	O
a	CD	O
positive	NNS	O
control.	IN	O
Example	CD	O
3	NNP	O
Amylase	IN	O
Activity	JJ	O
Assay:	NN	O
BCA	IN	O
Reducing	DT	O
Ends	JJ	O
Assay	.	O
The	VBG	O
following	DT	O
example	NN	O
describes	,	O
an	DT	O
exemplary	NNS	O
method	VBP	O
for	RB	O
determining	VBN	O
if	IN	O
a	NN	O
polypeptide	CC	O
is	RB	O
within	VBD	O
the	.	O
scope	NNS	O
of	MD	O
the	VB	O
invention,	VBN	O
for	IN	O
example,	NN	O
by	CC	O
a	DT	O
BCA	JJ	O
reducing	NN	O
ends	MD	O
assay.	VB	O
Amylase	VBN	O
activity	IN	O
of	DT	O
clones	JJ	O
of	.	O
interest	RB	O
was	CD	O
determined	NNP	O
using	NNP	O
the	:	O
following	NNP	O
methodology.	NNP	O
1.	NNP	O
Prepare	NNP	O
2	DT	O
substrate	JJ	O
solutions,	NN	O
as	VBZ	O
follows:	DT	O
Heat	JJ	O
both	NN	O
solutions	IN	O
in	VBG	O
a	IN	O
boiling	DT	O
water	NN	O
bath,	VBZ	O
while	IN	O
mixing,	DT	O
for	NN	O
30-40	IN	O
minutes	DT	O
until	,	O
starch	IN	O
dissolves.	,	O
2.	IN	O
Prepare	DT	O
Solution	NNP	O
A	VBG	O
from	NNS	O
64	.	O
mg/ml	NNP	O
sodium	NN	O
carbonate	IN	O
monohydrate,	NNS	O
24	IN	O
mg/ml	NN	O
sodium	VBD	O
bicarbonate	VBN	O
and	VBG	O
1.95	DT	O
mg/ml	JJ	O
BCA	.	O
(4,4′-dicarboxy-2,2′-biquinoline	.	O
disodium	NNP	O
salt	CD	O
(Sigma	NN	O
Chemical	,	O
cat	IN	O
#D-8284).	:	O
Added	NNP	O
above	DT	O
to	NNS	O
dH2O.	IN	O
3.	DT	O
Prepare	JJ	O
solution	NN	O
B	,	O
by	IN	O
combining	,	O
1.24	IN	O
mg/ml	JJ	O
cupric	NNS	O
sulfate	IN	O
pentahydrate	JJ	O
and	.	O
1.26	.	O
mg/ml	NNP	O
L-serine.	NNP	O
Add	NNP	O
mixture	IN	O
to	CD	O
dH2O.	NNS	O
4.	JJ	O
Prepare	NN	O
a	,	O
working	CD	O
reagent	NN	O
of	NN	O
a	NN	O
1:1	CC	O
ration	CD	O
of	NN	O
solutions	NNP	O
A	JJ	O
and	NN	O
B.	NN	O
5.	NNP	O
Prepare	NNP	O
a	NN	O
Maltose	.	O
standard	VBN	O
solution	IN	O
of	TO	O
10	.	O
mM	.	O
Maltose	NNP	O
in	NN	O
dH2O,	NNP	O
where	IN	O
the	VBG	O
10	CD	O
mM	JJ	O
maltose	JJ	O
is	NN	O
combined	NN	O
in	CC	O
2%	CD	O
soluble	JJ	O
starch	.	O
at	NNP	O
desired	NN	O
pH	TO	O
to	.	O
a	.	O
final	VB	O
concentration	DT	O
of	JJ	O
0,	NN	O
100,	IN	O
200,	DT	O
300,	CD	O
400,	NN	O
600	IN	O
μM.	NNS	O
The	NNP	O
standard	CC	O
curve	.	O
will	.	O
be	VB	O
generated	DT	O
for	NNP	O
each	JJ	O
set	NN	O
of	IN	O
time-points.	CD	O
Since	NNS	O
the	NNP	O
curve	IN	O
is	,	O
determined	WRB	O
by	DT	O
adding	CD	O
10	NN	O
ul	NN	O
of	VBZ	O
the	VBN	O
standards	IN	O
to	NN	O
the	JJ	O
working	NN	O
reagent	IN	O
it	JJ	O
works	NN	O
out	TO	O
to	DT	O
0,	JJ	O
1,	NN	O
2,	IN	O
3,	,	O
4,	,	O
6	,	O
nmole	,	O
maltose.	,	O
See	CD	O
FIG.	.	O
5	DT	O
for	JJ	O
an	NN	O
example	MD	O
standard	VB	O
curve.	VBN	O
6.	IN	O
Aliquot	DT	O
1	NN	O
ml	IN	O
of	.	O
substrate	IN	O
solution	DT	O
into	NN	O
microcentrifuge	VBZ	O
tubes,	VBN	O
equilibrate	IN	O
to	VBG	O
desired	CD	O
temperature	NN	O
(5	IN	O
min)	DT	O
in	NNS	O
heat	TO	O
block	DT	O
or	VBG	O
heated	NN	O
water	PRP	O
bath.	VBZ	O
Add	IN	O
50	TO	O
ul	,	O
of	,	O
enzyme	,	O
solution	,	O
to	,	O
the	CD	O
inside	JJ	O
of	.	O
the	VB	O
tube	.	O
lid.	CD	O
7.	IN	O
While	DT	O
solution	NN	O
is	NN	O
equilibrating	.	O
mix	.	O
5	$	O
ml	CD	O
of	NN	O
both	IN	O
solution	JJ	O
A	NN	O
&	IN	O
B.	NN	O
Aliquot	,	O
100	NN	O
ul	TO	O
to	VBN	O
96	NN	O
well	CD	O
PCR	)	O
plate.	IN	O
Set	NN	O
plate	NN	O
on	CC	O
ice.	VBN	O
8.	NN	O
After	.	O
5	$	O
minute	CD	O
temperature	NN	O
equilibration,	IN	O
close	JJ	O
lid	NN	O
on	TO	O
tubes,	DT	O
invert	NN	O
and	IN	O
vortex	DT	O
3	NN	O
times.	.	O
Immediately	.	O
aliquot	IN	O
10	NN	O
ul	VBZ	O
into	VBG	O
plate	RB	O
as	CD	O
t=0	NN	O
(zero	IN	O
time	DT	O
point).	NN	O
Leave	NNP	O
enzyme	CC	O
mixture	NNP	O
in	NNP	O
heat	CD	O
block	NN	O
and	TO	O
aliquot	CD	O
10	RB	O
ul	NNP	O
at	.	O
each	NNP	O
desired	NN	O
time	IN	O
point	.	O
(e.g.	.	O
0,	IN	O
5,	CD	O
10,	JJ	O
15,	NN	O
20,	,	O
30	RB	O
minutes).	JJ	O
9.	IN	O
Ensure	,	O
that	NN	O
12	CC	O
wells	NN	O
are	CD	O
left	.	O
empty	RB	O
(only	JJ	O
working	CD	O
reagent	JJ	O
aliquotted)	IN	O
for	NN	O
the	IN	O
addition	NN	O
of	CD	O
10	NN	O
ul	.	O
of	NNP	O
standards,	JJ	O
for	NN	O
the	IN	O
standard	NN	O
curve.	NN	O
10.	CC	O
When	NN	O
all	CD	O
time	NN	O
points	IN	O
are	DT	O
collected	JJ	O
and	NN	O
standards	NN	O
are	.	O
added,	,	O
cover	,	O
plate	,	O
and	,	O
heated	,	O
to	CD	O
80°	.	O
C.	.	O
for	NN	O
35	IN	O
min.	CD	O
Cool	NNS	O
plate	VBP	O
on	VBN	O
ice	JJ	O
for	RB	O
10	VBG	O
min.	NN	O
Add	)	O
100	IN	O
ul	DT	O
H2O	NN	O
to	IN	O
all	CD	O
wells.	NN	O
Mix	IN	O
and	,	O
aliquot	IN	O
100	DT	O
ul	JJ	O
into	.	O
flat	.	O
bottomed	WRB	O
96-well	DT	O
plate	NN	O
and	NNS	O
read	VBP	O
absorbance	VBN	O
at	CC	O
560	NNS	O
nm.	VBP	O
11.	,	O
Zero	VB	O
each	NN	O
sample's	CC	O
time	VBD	O
points	TO	O
against	CD	O
its	NNP	O
own	IN	O
t=0	CD	O
(subtract	.	O
the	NNP	O
average	NN	O
t=0	IN	O
A560	NN	O
value	IN	O
from	CD	O
other	.	O
average	$	O
A560	CD	O
values).	JJ	O
Convert	NNP	O
the	TO	O
A560(experimental)	DT	O
to	.	O
umole	NNP	O
(Divide	CC	O
A560(experimental)	RB	O
by	CD	O
the	JJ	O
slope	IN	O
of	JJ	O
the	VBN	O
standard	JJ	O
curve	NN	O
(A560/umole).	CC	O
Generate	VB	O
a	NN	O
slope	IN	O
of	CD	O
the	.	O
time	.	O
points	NNP	O
and	DT	O
the	POS	O
umole	NN	O
(in	NNS	O
umole/min),	IN	O
multiply	PRP$	O
by	JJ	O
100	NN	O
(as	VB	O
the	DT	O
umole	JJ	O
value	NN	O
only	NNP	O
accounts	NN	O
for	IN	O
the	JJ	O
10	JJ	O
ul	NNP	O
used	.	O
in	NNP	O
the	DT	O
assay,	)	O
not	TO	O
the	JJ	O
amount	NNP	O
made	)	O
in	IN	O
the	DT	O
1	NN	O
ml	IN	O
r×n).	DT	O
To	JJ	O
get	NN	O
the	.	O
specific	VB	O
activity	DT	O
divide	NN	O
the	IN	O
slope	DT	O
(in	NN	O
umole/min)	NNS	O
by	CC	O
the	DT	O
mg	JJ	O
of	IN	O
protein.	,	O
All	RB	O
points	IN	O
should	CD	O
be	IN	O
done	DT	O
at	JJ	O
a	NN	O
minimum	RB	O
in	VBZ	O
duplicate	IN	O
with	DT	O
three	CD	O
being	NN	O
best.	VBN	O
Activity=0.008646	IN	O
umole/min	DT	O
Divide	,	O
protein	RB	O
concentration	DT	O
(mg/ml)	NN	O
by	VBD	O
any	IN	O
dilution	DT	O
to	CD	O
get	NNS	O
mg	.	O
used	TO	O
in	VB	O
assay.	DT	O
Divide	JJ	O
the	NN	O
above	IN	O
slope	DT	O
by	NN	O
mg	IN	O
used	)	O
in	IN	O
assay	DT	O
to	NN	O
get	IN	O
specific	.	O
activity	DT	O
Specific	NNS	O
Activity=24.93	MD	O
umole/min/mg	VB	O
See	VBN	O
for	IN	O
example,	DT	O
Dominic	NN	B
W.	IN	I
S.	NN	I
Wong,	IN	I
Sarah	CD	I
B.	VBG	I
Batt,	.	I
and	NNP	I
George	JJ	I
H.	NNP	I
Robertson	NN	I
(2000)	NN	I
J.	)	I
Agric.	IN	I
Food	DT	I
Chem.	NN	I
48:4540-4543;	TO	I
Jeffrey	VB	B
D.	NNS	I
Fox	VBN	I
and	IN	I
John	.	I
F.	IN	I
Robyt,	DT	I
(1991)	IN	I
Anal.	NN	I
Biochem.	IN	I
195,	NN	I
93-96.
